PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Nissen, SE				Nissen, SE			ADHD drugs and cardiovascular risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; US FDA, Drug Safety & Risk Management Advisory Comm, Rockville, MD 20857 USA	Cleveland Clinic Foundation; US Food & Drug Administration (FDA)	Nissen, SE (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA.							Food and Drug Administration, 2006, DRUG SAF RISK MAN AD; Kernan WN, 2000, NEW ENGL J MED, V343, P1826, DOI 10.1056/NEJM200012213432501; Kingston RL, 2003, ANN INTERN MED, V139, P385, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00017; Nissen SE, 2005, CIRCULATION, V112, P2043, DOI 10.1161/CIRCULATIONAHA.105.573105; Wilens TE, 2005, J CLIN PSYCHIAT, V66, P253, DOI 10.4088/JCP.v66n0215	5	227	231	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1445	1448		10.1056/NEJMp068049	http://dx.doi.org/10.1056/NEJMp068049			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16549404				2022-12-28	WOS:000236539000001
J	Scantlebury, M; Speakman, JR; Oosthuizen, MK; Roper, TJ; Bennett, NC				Scantlebury, M; Speakman, JR; Oosthuizen, MK; Roper, TJ; Bennett, NC			Energetics reveals physiologically distinct castes in a eusocial mammal	NATURE			English	Article							DAMARALAND MOLE-RAT; CRYPTOMYS-DAMARENSIS RODENTIA; BATHYERGIDAE; DISPERSAL; NAMIBIA	Eusociality, which occurs among mammals only in two species of African mole-rat, is characterized by division of labour between morphologically distinct 'castes' (1). In Damaraland molerats (Cryptomys damarensis), colony labour is divided between 'infrequent worker' and 'frequent worker' castes(2). Frequent workers are active year-round and together perform more than 95% of the total work of the colony, whereas infrequent workers typically perform less than 5% of the total work(3). Anecdotal evidence suggests that infrequent workers may act as dispersers, with dispersal being limited to comparatively rare periods when the soil is softened by moisture(4,5). Here we show that infrequent workers and queens increase their daily energy expenditure after rainfall whereas frequent workers do not. Infrequent workers are also fatter than frequent workers. We suggest that infrequent workers constitute a physiologically distinct dispersing caste, the members of which, instead of contributing to the work of the colony and helping the queen to reproduce, build up their own body reserves in preparation for dispersal and reproduction when environmental conditions are suitable.	Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; Univ Aberdeen, Sch Biol Sci, ACERO, Aberdeen AB24 2TZ, Scotland; Univ Sussex, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England	University of Pretoria; University of Aberdeen; University of Sussex	Scantlebury, M (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	m.scantlebury@zoology.up.ac.za	Bennett, Nigel Charles/E-4238-2010; Speakman, John R./A-9494-2008; Oosthuizen, Maria/U-7276-2019; Oosthuizen, Maria Kathleen/K-7923-2012	Bennett, Nigel Charles/0000-0001-9748-2947; Speakman, John R./0000-0002-2457-1823; Oosthuizen, Maria Kathleen/0000-0001-6305-8283				Bennett N., 2000, AFRICAN MOLE RATS EC, P273; BENNETT NC, 1988, J MAMMAL, V69, P293, DOI 10.2307/1381379; BENNETT NC, 1988, S AFR J ZOOL, V23, P189; Burland TM, 2002, P ROY SOC B-BIOL SCI, V269, P1025, DOI 10.1098/rspb.2002.1978; Emlen S.T., 1991, P301; Emlen Stephen T., 1997, P228; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; HARDY RN, 1972, STUDIES BIOL; Hazell RWA, 2000, J ZOOL, V252, P19; JACOBS DS, 1991, J ZOOL, V224, P553, DOI 10.1111/j.1469-7998.1991.tb03785.x; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P46; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Molteno AJ, 2002, J ZOOL, V256, P445, DOI 10.1017/S0952836902000481; ORiain MJ, 1996, NATURE, V380, P619, DOI 10.1038/380619a0; Scantlebury M, 2005, PHYSIOL BEHAV, V84, P739, DOI 10.1016/j.physbeh.2005.02.022; Solomon N. G., 1997, COOPERATIVE BREEDING; Speakman J.R., 1997, DOUBLY LABELLED WATE; Stacey P.B., 1990, COOPERATIVE BREEDING; Waterman JM, 1998, ANIM BEHAV, V56, P459, DOI 10.1006/anbe.1998.0780; [No title captured]	20	59	60	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2006	440	7085					795	797		10.1038/nature04578	http://dx.doi.org/10.1038/nature04578			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598257				2022-12-28	WOS:000236548400041
J	Roberts, M				Roberts, M			Duffle bag medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												maya.roberts@yale.edu							0	38	38	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1491	1492		10.1001/jama.295.13.1491	http://dx.doi.org/10.1001/jama.295.13.1491			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16595744				2022-12-28	WOS:000236505400001
J	Duncan, JS; Sander, JW; Sisodiya, SM; Walker, MC				Duncan, JS; Sander, JW; Sisodiya, SM; Walker, MC			Adult epilepsy	LANCET			English	Review							TEMPORAL-LOBE EPILEPSY; IDIOPATHIC GENERALIZED EPILEPSY; COMPLEX PARTIAL SEIZURES; SUDDEN UNEXPECTED DEATH; ANTIEPILEPTIC DRUG-USE; QUALITY-OF-LIFE; MAJOR MALFORMATIONS; REFRACTORY EPILEPSY; MAGNETIC-RESONANCE; PREGNANCY REGISTRY	The epilepsies are one of the most common serious brain disorders, can occur at all ages, and have many possible presentations and causes. Although incidence in childhood has fallen over the past three decades in developed countries, this reduction is matched by an increase in elderly people. Monogenic Mendelian epilepsies are rare. A clinical syndrome often has multiple possible genetic causes, and conversely, different mutations in one gene can lead to various epileptic syndromes. Most common epilepsies, however, are probably complex traits with environmental effects acting on inherited susceptibility, mediated by common variation in particular genes. Diagnosis of epilepsy remains clinical, and neurophysiological investigations assist with diagnosis of the syndrome. Brain imaging is making great progress in identifying the structural and functional causes and consequences of the epilepsies. Current antiepileptic drugs suppress seizures without influencing the underlying tendency to generate seizures, and are effective in 60-70% of individuals. Pharmacogenetic studies hold the promise of being able to better individualise treatment for each patient, with maximum possibility of benefit and minimum risk of adverse effects. For people with refractory focal epilepsy, neurosurgical resection offers the possibility of a life-changing cure. Potential new treatments include precise prediction of seizures and focal therapy with drug delivery, neural stimulation, and biological grafts.	UCL, Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; Natl Soc Epilepsy, Gerrards Cross, England	University of London; University College London	Duncan, JS (corresponding author), UCL, Inst Neurol, Dept Clin & Expt Epilepsy, Queen Sq, London WC1N 3BG, England.	j.duncan@ion.ucl.ac.uk	Walker, Matthew C/C-1577-2008; Sander, Josemir W/C-1576-2008	Walker, Matthew C/0000-0002-0812-0352; Sander, Josemir W/0000-0001-6041-9661; Duncan, John S/0000-0002-1373-0681				Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; Adcock JE, 2003, NEUROIMAGE, V18, P423, DOI 10.1016/S1053-8119(02)00013-7; Anderson E, 2002, EPILEPSIA, V43, P1600; Antel SB, 2003, NEUROIMAGE, V19, P1748, DOI 10.1016/S1053-8119(03)00226-X; Artama M, 2005, NEUROLOGY, V64, P1874, DOI 10.1212/01.WNL.0000163771.96962.1F; Aschenbrenner-Scheibe R, 2003, BRAIN, V126, P2616, DOI 10.1093/brain/awg265; Barkovich AJ, 1997, EPILEPSIA, V38, P1255; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Beghi E, 2004, LANCET NEUROL, V3, P618, DOI 10.1016/S1474-4422(04)00882-8; Benbadis SR, 2003, NEUROLOGY, V61, P1793, DOI 10.1212/01.WNL.0000098891.76373.15; Berkovich AJ, 1998, EPILEPSIA, V39, P1375; Bialer M, 2004, EPILEPSY RES, V61, P1, DOI 10.1016/j.eplepsyres.2004.07.010; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Bonanni P, 2004, EPILEPSIA, V45, P149, DOI 10.1111/j.0013-9580.2004.04303.x; Boussinesq M, 2002, T ROY SOC TROP MED H, V96, P537, DOI 10.1016/S0035-9203(02)90433-5; Briellmann RS, 2004, NEUROLOGY, V63, P2303, DOI 10.1212/01.WNL.0000148646.31755.59; Briellmann RS, 2002, ANN NEUROL, V51, P641, DOI 10.1002/ana.10171; Brodie M.J., 2002, NEUROLOGY S5, V58, P2; Brodie MJ, 2005, J NEUROL, V252, P125, DOI 10.1007/s00415-005-0735-x; Carpio A, 2002, LANCET INFECT DIS, V2, P751, DOI 10.1016/S1473-3099(02)00454-1; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; Cascino GD, 2004, EPILEPSIA, V45, P32, DOI 10.1111/j.0013-9580.2004.04007.x; Cascino GD, 2002, EPILEPSIA, V43, P80, DOI 10.1046/j.1528-1157.43.s.3.14.x; Cavalleri GL, 2005, BRAIN, V128, P1832, DOI 10.1093/brain/awh524; Chassoux F, 2004, BRAIN, V127, P164, DOI 10.1093/brain/awh014; Chaves J, 2005, EPILEPSIA, V46, P133, DOI 10.1111/j.1528-1167.2005.00325.x; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Cunnington M, 2005, NEUROLOGY, V64, P955, DOI 10.1212/01.WNL.0000154515.94346.89; de Boer HM, 2002, EPILEPSIA, V43, P7, DOI 10.1046/j.1528-1157.43.s.6.4.x; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; Diop AG, 2003, ACTA TROP, V87, P149, DOI 10.1016/S0001-706X(03)00038-X; Dlugos DJ, 2001, NEUROLOGY, V57, P2259, DOI 10.1212/WNL.57.12.2259; Duncan JS, 2002, J NEUROL NEUROSUR PS, V73, P612, DOI 10.1136/jnnp.73.6.612-a; Ecevit CG, 2004, PEDIATR NEUROL, V31, P279, DOI 10.1016/j.pediatrneurol.2004.03.021; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Ensrud KE, 2004, NEUROLOGY, V62, P2051, DOI 10.1212/01.WNL.0000125185.74276.D2; Everitt AD, 1998, BRIT MED J, V316, P780, DOI 10.1136/bmj.316.7133.780; Federico P, 2005, NEUROLOGY, V64, P1125, DOI 10.1212/01.WNL.0000156358.72670.AD; FineSmith R B, 1999, N J Med, V96, P37; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x; Fuerst D, 2003, ANN NEUROL, V53, P413, DOI 10.1002/ana.10509; Gaitatzis A, 2004, BRAIN, V127, P2427, DOI 10.1093/brain/awh267; Gaitatzis A, 2004, EPILEPTIC DISORD, V6, P3; Gaitatzis A, 2004, EPILEPSIA, V45, P1613, DOI 10.1111/j.0013-9580.2004.17504.x; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Golby AJ, 2002, EPILEPSIA, V43, P855, DOI 10.1046/j.1528-1157.2002.20501.x; Granger N, 2002, REV NEUROL-FRANCE, V158, P1088; Greenberg DA, 2005, AM J HUM GENET, V76, P139, DOI 10.1086/426735; Guerrini R, 2005, EPILEPSIA, V46, P32, DOI 10.1111/j.0013-9580.2005.461010.x; Gutierrez-Delicado E, 2004, CURR OPIN NEUROL, V17, P147, DOI 10.1097/00019052-200404000-00011; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Hammers A, 2003, BRAIN, V126, P1300, DOI 10.1093/brain/awg138; HANNA J, 2002, DEATH SHADOWS NATL S; Hauser WA, 2002, PROG BRAIN RES, V135, P215; Heaney DC, 2002, BMJ-BRIT MED J, V325, P1013, DOI 10.1136/bmj.325.7371.1013; Hirsch E, 2003, CNS DRUGS, V17, P633, DOI 10.2165/00023210-200317090-00003; Holmes LB, 2004, ARCH NEUROL-CHICAGO, V61, P673, DOI 10.1001/archneur.61.5.673; Holmes LB, 2004, EPILEPSIA, V45, P1465, DOI 10.1111/j.0013-9580.2004.451102.x; Jefferys JGR, 2003, EPILEPSIA, V44, P44, DOI 10.1111/j.0013-9580.2003.12004.x; Jouny CC, 2005, CLIN NEUROPHYSIOL, V116, P552, DOI 10.1016/j.clinph.2004.08.024; Juhasz C, 2003, NEUROLOGY, V60, P960, DOI 10.1212/01.WNL.0000049468.05050.F2; Kanai K, 2004, NEUROLOGY, V63, P329, DOI 10.1212/01.WNL.0000129829.31179.5B; Keller SS, 2004, NEUROIMAGE, V23, P860, DOI 10.1016/j.neuroimage.2004.07.030; Kobayashi E, 2005, NEUROLOGY, V64, P1263, DOI 10.1212/01.WNL.0000154640.23656.A3; Kossoff EH, 2004, LANCET NEUROL, V3, P415, DOI 10.1016/S1474-4422(04)00807-5; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Langan Y, 2005, NEUROLOGY, V64, P1131, DOI 10.1212/01.WNL.0000156352.61328.CB; LaRoche SM, 2004, JAMA-J AM MED ASSOC, V291, P615, DOI 10.1001/jama.291.5.615; Lhatoo SD, 2003, EPILEPSIA, V44, P673, DOI 10.1046/j.1528-1157.2003.46002.x; Lhatoo SD, 2001, ANN NEUROL, V49, P336; Liegeois F, 2004, BRAIN, V127, P1229, DOI 10.1093/brain/awh159; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; Liu RSN, 2003, ANN NEUROL, V53, P312, DOI 10.1002/ana.10463; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U; Maguire JH, 2004, NEW ENGL J MED, V350, P215, DOI 10.1056/NEJMp038204; Marini C, 2004, EPILEPSIA, V45, P467, DOI 10.1111/j.0013-9580.2004.46803.x; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; McCorry D, 2004, LANCET NEUROL, V3, P729, DOI 10.1016/S1474-4422(04)00935-4; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Medina MT, 2005, EPILEPSIA, V46, P124, DOI 10.1111/j.0013-9580.2005.11704.x; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Meinardi H, 2001, EPILEPSIA, V42, P136, DOI 10.1046/j.1528-1157.2001.32800.x; Merlet I, 2004, NEUROIMAGE, V22, P886, DOI 10.1016/j.neuroimage.2004.02.014; Morgan CL, 2002, EPILEPSIA, V43, P1251, DOI 10.1046/j.1528-1157.2002.38701.x; Mormann F, 2005, CLIN NEUROPHYSIOL, V116, P569, DOI 10.1016/j.clinph.2004.08.025; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; National Institute for Health and Care Excellence (NICE), EP DIAGN MAN EP AD C; Nicoletti A, 2002, NEUROLOGY, V58, P1256, DOI 10.1212/WNL.58.8.1256; Nicolson A, 2004, J NEUROL NEUROSUR PS, V75, P75; Nilsen KE, 2004, BRAIN RES REV, V44, P141, DOI 10.1016/j.brainresrev.2003.11.003; Nilsson L, 1999, LANCET, V353, P888, DOI 10.1016/S0140-6736(98)05114-9; Noppeney U, 2005, BRAIN, V128, P1377, DOI 10.1093/brain/awh414; Opeskin K, 2003, SEIZURE-EUR J EPILEP, V12, P456, DOI 10.1016/S1059-1311(02)00352-7; Ottman R, 2005, EPILEPSIA, V46, P7, DOI 10.1111/j.1528-1167.2005.00350.x; Pack AM, 2005, ANN NEUROL, V57, P252, DOI 10.1002/ana.20378; Panayiotopoulos CP, 2005, NEUROLOGY, V64, P173; Patsalos PN, 2003, LANCET NEUROL, V2, P347, DOI 10.1016/S1474-4422(03)00409-5; Perucca E, 2004, BMJ-BRIT MED J, V328, P1273, DOI 10.1136/bmj.328.7451.1273; Perucca E, 1998, EPILEPSIA, V39, P5, DOI 10.1111/j.1528-1157.1998.tb01268.x; PICOT MC, 2004, REV NEUROL PARIS, V160; Pisani F, 1999, EPILEPSIA, V40, P1141, DOI 10.1111/j.1528-1157.1999.tb00832.x; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Powell HWR, 2005, NEUROLOGY, V65, P596, DOI 10.1212/01.wnl.0000172858.20354.73; Rabin ML, 2004, BRAIN, V127, P2286, DOI 10.1093/brain/awh281; Remy S, 2003, ANN NEUROL, V53, P469, DOI 10.1002/ana.10473; Richardson MP, 2003, NEUROIMAGE, V20, pS112, DOI 10.1016/j.neuroimage.2003.09.008; Richardson MP, 2004, BRAIN, V127, P2419, DOI 10.1093/brain/awh293; Rowan AJ, 2005, NEUROLOGY, V64, P1868, DOI 10.1212/01.WNL.0000167384.68207.3E; Rugg-Gunn FJ, 2005, NEUROLOGY, V64, P318, DOI 10.1212/01.WNL.0000149642.93493.F4; Rugg-Gunn FJ, 2004, LANCET, V364, P2212, DOI 10.1016/S0140-6736(04)17594-6; Rugg-Gunn FJ, 2003, NEUROLOGY, V60, P1638, DOI 10.1212/01.WNL.0000065891.93179.CC; Rugg-Gunn FJ, 2001, BRAIN, V124, P627, DOI 10.1093/brain/124.3.627; Russell AJC, 2004, EPILEPSIA, V45, P1467, DOI 10.1111/j.0013-9580.2004.451104.x; Sabers A, 2003, NEUROLOGY, V61, P570, DOI 10.1212/01.WNL.0000076485.09353.7A; Sabsevitz DS, 2003, NEUROLOGY, V60, P1788, DOI 10.1212/01.WNL.0000068022.05644.01; Sander JW, 2004, EPILEPSIA, V45, P28, DOI 10.1111/j.0013-9580.2004.455005.x; Sander JW, 2004, J NEUROL NEUROSUR PS, V75, P349, DOI 10.1136/jnnp.2003.029223; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Sander JW, 2004, INFECT ETIOLOGY CHRO, P93; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Scott RA, 2001, B WORLD HEALTH ORGAN, V79, P344; Sheth Raj D, 2005, Semin Pediatr Neurol, V12, P106, DOI 10.1016/j.spen.2005.03.005; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Smith D, 1999, QJM-INT J MED, V92, P15, DOI 10.1093/qjmed/92.1.15; Sperling MR, 1999, ANN NEUROL, V46, P45, DOI 10.1002/1531-8249(199907)46:1<45::AID-ANA8>3.0.CO;2-I; Stein AG, 2000, EPILEPSY RES, V39, P103, DOI 10.1016/S0920-1211(99)00107-2; Surges R, 2003, EPILEPSIA, V44, P150, DOI 10.1046/j.1528-1157.2003.36802.x; Suzuki T, 2004, NAT GENET, V36, P842, DOI 10.1038/ng1393; Tan NCK, 2004, EPILEPSIA, V45, P1429, DOI 10.1111/j.0013-9580.2004.22904.x; Tan NCK, 2004, NEUROLOGY, V63, P1090, DOI 10.1212/01.WNL.0000137051.33486.C7; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; Thadani VM, 2004, NEUROSURG REV, V27, P27, DOI 10.1007/s10143-003-0289-2; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Tomson T, 2004, EPILEPSIA, V45, P1171, DOI 10.1111/j.0013-9580.2004.15104.x; *U LIV, SANAD; Vajda F, 2004, EPILEPSIA, V45, P1466, DOI 10.1111/j.0013-9580.2004.451103.x; Van Paesschen W, 2003, BRAIN, V126, P1103, DOI 10.1093/brain/awg108; Vazquez B, 2004, ARCH NEUROL-CHICAGO, V61, P1361, DOI 10.1001/archneur.61.9.1361; Vestergaard P, 2004, EPILEPSIA, V45, P1330, DOI 10.1111/j.0013-9580.2004.18804.x; Vinten J, 2005, NEUROLOGY, V64, P949, DOI 10.1212/01.WNL.0000154514.82948.69; von Oertzen J, 2002, J NEUROL NEUROSUR PS, V73, P643, DOI 10.1136/jnnp.73.6.643; Walker M. C., 2004, TREATM EP 2 ED, P96; Walker MC, 2002, BRAIN, V125, P1937, DOI 10.1093/brain/awf203; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wide K, 2004, ACTA PAEDIATR, V93, P174, DOI 10.1080/08035250310021118; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wiebe S, 2002, J NEUROL NEUROSUR PS, V73, P116, DOI 10.1136/jnnp.73.2.116; Woermann FG, 1999, BRAIN, V122, P2101, DOI 10.1093/brain/122.11.2101; Woermann FG, 2003, NEUROLOGY, V61, P699, DOI 10.1212/01.WNL.0000078815.03224.57; Wyszynski DF, 2005, NEUROLOGY, V64, P961, DOI 10.1212/01.WNL.0000154516.43630.C5; Zaidi A, 2000, J AM COLL CARDIOL, V36, P181, DOI 10.1016/S0735-1097(00)00700-2	156	566	598	5	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1087	1100		10.1016/S0140-6736(06)68477-8	http://dx.doi.org/10.1016/S0140-6736(06)68477-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581409				2022-12-28	WOS:000236673200034
J	Schaer, BA; Luthy, C				Schaer, BA; Luthy, C			Exploring the heart of the human heart	LANCET			English	Editorial Material									Univ Hosp, Dept Cardiol, CH-4031 Basel, Switzerland; Radboud Univ Nijmegen, Fac Philosophy, NL-6500 HD Nijmegen, Netherlands	Radboud University Nijmegen	Schaer, BA (corresponding author), Univ Hosp, Dept Cardiol, CH-4031 Basel, Switzerland.	bschaer@uhbs.ch							0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					1007	1007		10.1016/S0140-6736(06)68428-6	http://dx.doi.org/10.1016/S0140-6736(06)68428-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564363	Bronze			2022-12-28	WOS:000236474200029
J	Miller, C				Miller, C			CIC chloride channels viewed through a transporter lens	NATURE			English	Review							CYSTEINE ACCESSIBILITY; ION PERMEATION; PORES; CLC-1; CONSERVATION; CONDUCTION; SELECTIVITY; EXPRESSION; DEPENDENCE; MUTATIONS	Since its discovery, the ClC family of chloride channels has presented biophysicists with unexpected behaviours and unusual surprises. The latest of these is the realization that not only does the family feature genuine chloride channels, it also includes proton-coupled chloride transporters, which move chloride ions and protons across the membrane in opposite directions. The crystal structure of such a transporter serves as a useful platform for understanding ClC channels, and features of chloride/proton exchange-transport may provide a key for comprehending voltage-dependent gating of the channels.	Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute	Miller, C (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Dept Biochem, Waltham, MA 02454 USA.	cmiller@brandeis.edu						Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2003, J GEN PHYSIOL, V122, P277, DOI 10.1085/jgp.200308834; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Adelroth P, 2004, BBA-BIOENERGETICS, V1655, P102, DOI 10.1016/j.bbabio.2003.10.018; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Chen MF, 2003, J GEN PHYSIOL, V122, P133, DOI 10.1085/jgp.200308844; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Chen TY, 2005, ANNU REV PHYSIOL, V67, P809, DOI 10.1146/annurev.physiol.67.032003.153012; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Cohen J, 2004, BIOPHYS J, V86, P836, DOI 10.1016/S0006-3495(04)74159-4; Corry B, 2004, BIOPHYS J, V86, P846, DOI 10.1016/S0006-3495(04)74160-0; de Santiago JA, 2005, J GEN PHYSIOL, V126, P591, DOI 10.1085/jgp.200509310; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Engh AM, 2005, J GEN PHYSIOL, V125, P601, DOI 10.1085/jgp.200509258; Estevez R, 2004, J PHYSIOL-LONDON, V557, P363, DOI 10.1113/jphysiol.2003.058453; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; Fahlke C, 1997, J GEN PHYSIOL, V110, P551, DOI 10.1085/jgp.110.5.551; Fahlke C, 2001, AM J PHYSIOL-RENAL, V280, pF748, DOI 10.1152/ajprenal.2001.280.5.F748; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; HANKE W, 1983, J GEN PHYSIOL, V82, P25, DOI 10.1085/jgp.82.1.25; Haug K, 2003, NAT GENET, V33, P527, DOI 10.1038/ng1121; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jordt SE, 1997, EMBO J, V16, P1582, DOI 10.1093/emboj/16.7.1582; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lin CW, 2003, J GEN PHYSIOL, V122, P147, DOI 10.1085/jgp.200308845; LOBET S, IN PRESS EMBO J; Ludewig U, 1997, J PHYSIOL-LONDON, V498, P691, DOI 10.1113/jphysiol.1997.sp021893; Ludewig U, 1997, BIOPHYS J, V73, P789, DOI 10.1016/S0006-3495(97)78111-6; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Miller C, 1999, J GEN PHYSIOL, V113, P783, DOI 10.1085/jgp.113.6.783; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Miloshevsky GV, 2004, BIOPHYS J, V86, P825, DOI 10.1016/S0006-3495(04)74158-2; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Pusch M, 2004, BIOCHEMISTRY-US, V43, P1135, DOI 10.1021/bi0359776; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RAVERSO S, 2006, J GEN PHYSIOL, V127, P51; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Rychkov GY, 1996, J PHYSIOL-LONDON, V497, P423, DOI 10.1113/jphysiol.1996.sp021778; Rychkov GY, 2001, J PHYSIOL-LONDON, V530, P379, DOI 10.1111/j.1469-7793.2001.0379k.x; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; WHITE MM, 1981, J GEN PHYSIOL, V78, P1, DOI 10.1085/jgp.78.1.1; Yin J, 2004, PROTEINS, V57, P414, DOI 10.1002/prot.20208; Zuniga L, 2004, J PHYSIOL-LONDON, V555, P671, DOI 10.1113/jphysiol.2003.060046	61	249	251	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					484	489		10.1038/nature04713	http://dx.doi.org/10.1038/nature04713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554809				2022-12-28	WOS:000236176100046
J	Soares, BS; Nepstad, DC; Curran, LM; Cerqueira, GC; Garcia, RA; Ramos, CA; Voll, E; McDonald, A; Lefebvre, P; Schlesinger, P				Soares, BS; Nepstad, DC; Curran, LM; Cerqueira, GC; Garcia, RA; Ramos, CA; Voll, E; McDonald, A; Lefebvre, P; Schlesinger, P			Modelling conservation in the Amazon basin	NATURE			English	Article							LAND-COVER; DEFORESTATION; GOVERNANCE; FORESTS	Expansion of the cattle and soy industries in the Amazon basin has increased deforestation rates and will soon push all-weather highways into the region's core(1-4). In the face of this growing pressure, a comprehensive conservation strategy for the Amazon basin should protect its watersheds, the full range of species and ecosystem diversity, and the stability of regional climates. Here we report that protected areas in the Amazon basin-the central feature of prevailing conservation approaches(5-8)-are an important but insufficient component of this strategy, based on policy-sensitive simulations of future deforestation. By 2050, current trends in agricultural expansion will eliminate a total of 40% of Amazon forests, including at least two-thirds of the forest cover of six major watersheds and 12 ecoregions, releasing 32 +/- 8 Pg of carbon to the atmosphere. One-quarter of the 382 mammalian species examined will lose more than 40% of the forest within their Amazon ranges. Although an expanded and enforced network of protected areas could avoid as much as one-third of this projected forest loss, conservation on private lands is also essential. Expanding market pressures for sound land management and prevention of forest clearing on lands unsuitable for agriculture are critical ingredients of a strategy for comprehensive conservation(3,4).	Univ Fed Minas Gerais, Ctr Sensoriamento Remoto, BR-31270901 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Ctr Desenvolvimento & Planejamento Reg, BR-31270901 Belo Horizonte, MG, Brazil; Woods Hole Res Ctr, Woods Hole, MA 02543 USA; Yale Univ, Sch Forestry & Environm Studies, Trop Resources Inst, New Haven, CT 06511 USA; Inst Pesquisa Ambiental Amazonia, BR-66035170 Belem, Para, Brazil; Fed Univ Para, Nucleo Altos Estudos Amazon, BR-66075110 Belem, Para, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Woods Hole Research Center; Yale University; Universidade Federal do Para	Soares, BS (corresponding author), Univ Fed Minas Gerais, Ctr Sensoriamento Remoto, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	britaldo@csr.ufmg.br; dnepstad@whrc.org	Cerqueira, Gustavo/AAV-7398-2020; Lynch, Christopher J./E-6875-2010	Cerqueira, Gustavo/0000-0002-7692-3886; Lynch, Christopher J./0000-0003-2453-5838; Curran, Lisa M./0000-0002-2813-5578				Alencar A., 2004, DESMATAMENTO AMAZONI; ALENCAR A, 2004, DESENVOLVIMENTO QUER; [Anonymous], 2004, HAMBURGER CONNECTION; CAPOBIANCO JPR, 2001, BIODIVERSIDADE AMAZO; Costa MH, 2003, J HYDROL, V283, P206, DOI 10.1016/S0022-1694(03)00267-1; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Dias MAFS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000335; Fearnside PM, 2003, AMBIO, V32, P343, DOI 10.1639/0044-7447(2003)032[0343:DCIMGA]2.0.CO;2; FEARNSIDE PM, 1995, CONSERV BIOL, V9, P1134, DOI 10.1046/j.1523-1739.1995.9051127.x-i1; Houghton RA, 2001, GLOBAL CHANGE BIOL, V7, P731, DOI 10.1046/j.1365-2486.2001.00426.x; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; *IMAC, 2000, ZON EC EC ACR; *MAP, 2005, MADR DIOS ACR PAND I; MONTIEL F, 2004, PROGRAMA AREAS PROTE; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; NEPSTAD D, IN PRESS CONSERV BIO; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; NOBRE CA, 1996, AMAZONIAN DEFORESTAT, P577; Oyama MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018600; PERES CA, 1995, CONSERV BIOL, V9, P34, DOI 10.1046/j.1523-1739.1995.09010034.x; Santilli M, 2005, CLIMATIC CHANGE, V71, P267, DOI 10.1007/s10584-005-8074-6; Schwartzman S, 2000, CONSERV BIOL, V14, P1351, DOI 10.1046/j.1523-1739.2000.99329.x; Soares B, 2004, GLOBAL CHANGE BIOL, V10, P745, DOI 10.1111/j.1529-8817.2003.00769.x; SOUZA C, 2004, AVANCO ESTRADAS ENDO; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Verissimo A, 2002, SCIENCE, V297, P1478, DOI 10.1126/science.1072807; Werth D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000717	28	829	866	7	341	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					520	523		10.1038/nature04389	http://dx.doi.org/10.1038/nature04389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554817				2022-12-28	WOS:000236176100054
J	Hayden, JA; Cote, P; Bombardier, C				Hayden, JA; Cote, P; Bombardier, C			Evaluation of the quality of prognosis studies in systematic reviews	ANNALS OF INTERNAL MEDICINE			English	Review							OF-THE-LITERATURE; CORONARY-HEART-DISEASE; HORMONE REPLACEMENT THERAPY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CELL LUNG-CARCINOMA; FACTOR-V-LEIDEN; RISK-FACTORS; BREAST-CANCER; PROSPECTIVE COHORT; VENOUS THROMBOEMBOLISM	Background: To provide valid assessments of answers to prognostic questions, systematic reviews must appraise the quality of the available evidence. However, no standard quality assessment method is currently available. Purpose: To appraise how authors assess the quality of individual studies in systematic reviews about prognosis and to propose recommendations for these quality assessments. Data Sources: English-language publications listed in MEDLINE from 1966 to October 2005 and review of cited references. Study Selection: 163 systematic reviews about prognosis that included assessments of the quality of studies. Data Extraction: A total of 882 distinct quality items were extracted from the assessments that were reported in the various reviews. Using an iterative process, 2 independent reviewers grouped the items into 25 domains. The authors then specifically identified domains necessary to assess potential biases of studies and evaluated how often those domains had been addressed in each review. Data Synthesis: Fourteen of the domains addressed 6 sources of bias related to study participation, study attrition, measurement of prognostic factors, measurement of and controlling for confounding variables, measurement of outcomes, and analysis approaches. Reviews assessed a median of 2 of the 6 potential biases; only 2 (1%) included criteria aimed at appraising all potential sources of bias. Few reviews adequately assessed the impact of confounding (12%), although more than half (59%) appraised the methods used to measure the prognostic factors of interest. Limitations: Reviews may have been missed by the search or misclassified because of incomplete reporting. Validity and reliability testing of the authors' recommendations are required. Conclusions: Quality appraisal, a necessary step in systematic reviews, is incomplete in most reviews of prognosis studies. Adequate quality assessment should include judgments about 6 areas of potential study biases. Authors should incorporate these quality assessments into their synthesis of evidence about prognosis.	Univ Toronto, Inst Work & Hlth, Toronto, ON M5G 2E9, Canada; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	Institute for Work & Health; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Hayden, JA (corresponding author), Univ Toronto, Inst Work & Hlth, 481 Univ Ave,Suite 800,8th Floor, Toronto, ON M5G 2E9, Canada.	jhayden@iwh.on.ca	Côté, Pierre/AAG-5358-2021	Côté, Pierre/0000-0002-6986-6676; Hayden, Jill Alison/0000-0001-7026-144X; Bombardier, Claire/0000-0001-5083-2137				Almeida OP, 2002, ADDICTION, V97, P15, DOI 10.1046/j.1360-0443.2002.00016.x; Altman DG, 1998, BREAST CANCER RES TR, V52, P289, DOI 10.1023/A:1006193704132; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758; Ariens GA, 2000, SCAND J WORK ENV HEA, V26, P7, DOI 10.5271/sjweh.504; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Aveyard P, 2002, BJU INT, V90, P228, DOI 10.1046/j.1464-410X.2002.02880.x; Bernal-Delgado E, 1998, FERTIL STERIL, V70, P191, DOI 10.1016/S0015-0282(98)00142-3; Bonell C, 2000, INT J STD AIDS, V11, P697, DOI 10.1258/0956462001915066; Bongers PM, 2002, AM J IND MED, V41, P315, DOI 10.1002/ajim.10050; Borghouts JAJ, 1998, PAIN, V77, P1, DOI 10.1016/S0304-3959(98)00058-X; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Brooks RG, 2002, ACAD MED, V77, P790, DOI 10.1097/00001888-200208000-00008; Burt B A, 2001, J Dent Educ, V65, P1024; Campbell SE, 2004, AGE AGEING, V33, P110, DOI 10.1093/ageing/afh036; Cantor-Graae E, 2005, AM J PSYCHIAT, V162, P12, DOI 10.1176/appi.ajp.162.1.12; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Carter JA, 2003, BRAIN RES REV, V43, P57, DOI 10.1016/S0165-0173(03)00192-9; Chow E, 2001, CLIN ONCOL-UK, V13, P209, DOI 10.1007/s001740170078; Christenfeld NJS, 2004, PSYCHOSOM MED, V66, P868, DOI 10.1097/01.psy.0000140008.70959.41; Cole DC, 1996, AM J IND MED, V29, P657, DOI 10.1002/(SICI)1097-0274(199606)29:6<657::AID-AJIM10>3.0.CO;2-Z; Cole MG, 2003, AM J PSYCHIAT, V160, P1147, DOI 10.1176/appi.ajp.160.6.1147; Cole MG, 1997, AM J GERIAT PSYCHIAT, V5, P4; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Coo H, 2004, NEUROEPIDEMIOLOGY, V23, P1, DOI 10.1159/000073969; Cote P, 2001, Spine (Phila Pa 1976), V26, pE445, DOI 10.1097/00007632-200110010-00020; Counsell C, 2001, CEREBROVASC DIS, V12, P159, DOI 10.1159/000047699; Counsell CE, 1998, J NEURO-ONCOL, V37, P241, DOI 10.1023/A:1005861024679; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Critchley JA, 2004, EUR J CARDIOV PREV R, V11, P101, DOI 10.1097/01.hjr.0000114971.39211.d7; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Critchley JA, 2003, THORAX, V58, P435, DOI 10.1136/thorax.58.5.435; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Damany DS, 2005, INJURY, V36, P131, DOI 10.1016/j.injury.2004.05.023; Danesh J, 1999, ALIMENT PHARM THERAP, V13, P851; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; de Bock GH, 2004, J CLIN ONCOL, V22, P4010, DOI 10.1200/JCO.2004.06.080; Deeks J J, 2003, Health Technol Assess, V7, piii; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; Ding X, 2005, WORLD J GASTROENTERO, V11, P2656, DOI 10.3748/wjg.v11.i17.2656; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Doust JA, 2005, BRIT MED J, V330, P625, DOI 10.1136/bmj.330.7492.625; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Dwyer T, 2001, J CLIN EPIDEMIOL, V54, P440, DOI 10.1016/S0895-4356(00)00313-9; El-Wakeel H, 2003, BREAST, V12, P302, DOI 10.1016/S0960-9776(03)00123-1; Emery CA, 2003, CLIN J SPORT MED, V13, P256, DOI 10.1097/00042752-200307000-00011; Espallargues M, 2001, OSTEOPOROSIS INT, V12, P811, DOI 10.1007/s001980170031; Etminan M, 2005, BMJ-BRIT MED J, V330, P63, DOI 10.1136/bmj.38302.504063.8F; Evans DJ, 2001, ARCH DIS CHILD-FETAL, V84, pF79, DOI 10.1136/fn.84.2.F79; Farrell T, 1999, BRIT J OBSTET GYNAEC, V106, P783, DOI 10.1111/j.1471-0528.1999.tb08398.x; FLEGAL KM, 1991, AM J EPIDEMIOL, V134, P1233, DOI 10.1093/oxfordjournals.aje.a116026; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Flynn CA, 1999, J FAM PRACTICE, V48, P885; Ford ES, 2002, INT J EPIDEMIOL, V31, P59, DOI 10.1093/ije/31.1.59; Fowkes FJI, 2003, EUR J VASC ENDOVASC, V25, P1, DOI 10.1053/ejvs.2002.1778; Fowler-Brown Angela, 2004, Ann Intern Med, V140, pW9; Fraser AB, 2003, OBSTET GYNECOL SURV, V58, P265, DOI 10.1097/00006254-200304000-00022; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; Gdalevich M, 2001, J AM ACAD DERMATOL, V45, P520, DOI 10.1067/mjd.2001.114741; Ghali WA, 2005, AM J MED, V118, P101, DOI 10.1016/j.amjmed.2004.06.048; Gonzalez MA, 1998, INT J EPIDEMIOL, V27, P350, DOI 10.1093/ije/27.3.350; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; Guise JM, 2004, BMJ-BRIT MED J, V329, P19, DOI 10.1136/bmj.329.7456.19; Harris Rebecca, 2004, Community Dent Health, V21, P71; Harvie M, 2003, Obes Rev, V4, P157, DOI 10.1046/j.1467-789X.2003.00108.x; Haw C, 2005, SUICIDE LIFE-THREAT, V35, P50, DOI 10.1521/suli.35.1.50.59260; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1629, DOI 10.1053/apmr.2002.35473; Hendricks HT, 2002, ARCH PHYS MED REHAB, V83, P1303, DOI 10.1053/apmr.2002.34284; Hermens MLM, 2004, GEN HOSP PSYCHIAT, V26, P453, DOI 10.1016/j.genhosppsych.2004.08.006; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Herpertz S, 2004, OBES RES, V12, P1554, DOI 10.1038/oby.2004.195; Hodgkinson Brent, 2003, Int J Nurs Pract, V9, pS19, DOI 10.1046/j.1440-172X.2003.00425.x; Honest H, 2005, EUR J OBSTET GYN R B, V119, P11, DOI 10.1016/j.ejogrb.2004.07.041; Honest H, 2004, ULTRASOUND OBST GYN, V24, P94, DOI 10.1002/uog.1062; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Hooi JD, 1999, BRIT J GEN PRACT, V49, P49; Howard AA, 2004, ANN INTERN MED, V140, P211, DOI 10.7326/0003-4819-140-6-200403160-00011; Howley HEA, 2005, AM J OBSTET GYNECOL, V192, P694, DOI 10.1016/j.ajog.2004.09.011; Hughes EG, 1996, FERTIL STERIL, V66, P679; Humphrey LL, 2002, ANN INTERN MED, V137, P273, DOI 10.7326/0003-4819-137-4-200208200-00012; Jefferson T, 2003, VACCINE, V21, P2003, DOI 10.1016/S0264-410X(02)00770-3; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; KERNAN WN, 1991, STROKE, V22, P1108, DOI 10.1161/01.STR.22.9.1108; Khader YS, 2005, J PERIODONTOL, V76, P161, DOI 10.1902/jop.2005.76.2.161; Khanna MP, 2003, TRANSFUS MED REV, V17, P110, DOI 10.1053/tmrv.2003.50008; Kim RJ, 2003, AM HEART J, V146, P948, DOI 10.1016/S0002-8703(03)00519-2; Kremer LCM, 2002, ANN ONCOL, V13, P503, DOI 10.1093/annonc/mdf118; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kuijpers T, 2004, PAIN, V109, P420, DOI 10.1016/j.pain.2004.02.017; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Kurihara N, 2004, IND HEALTH, V42, P303, DOI 10.2486/indhealth.42.303; Kwon HL, 2004, AM J OBSTET GYNECOL, V190, P1201, DOI 10.1016/j.ajog.2003.09.057; Langlois NJ, 2003, THROMB HAEMOSTASIS, V90, P17, DOI 10.1055/s-0037-1613594; Lanigan JA, 2001, EUR J CLIN NUTR, V55, P309, DOI 10.1038/sj.ejcn.1601168; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; Lievense A, 2001, J RHEUMATOL, V28, P2520; Lievense AM, 2004, ANN RHEUM DIS, V63, P621, DOI 10.1136/ard.2003.009860; Lievense AM, 2002, ARTHRIT RHEUM-ARTHR, V47, P556, DOI 10.1002/art.10660; Lin SJ, 2001, CLIN INFECT DIS, V32, P358, DOI 10.1086/318483; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Marckmann P, 1999, EUR J CLIN NUTR, V53, P585, DOI 10.1038/sj.ejcn.1600832; Marras C, 2002, ARCH NEUROL-CHICAGO, V59, P1724, DOI 10.1001/archneur.59.11.1724; Martin B, 2003, BRIT J CANCER, V89, P55, DOI 10.1038/sj.bjc.6601095; Marx BE, 1997, KIDNEY INT, V51, P873, DOI 10.1038/ki.1997.123; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; McDonald S, 2005, AM J OBSTET GYNECOL, V193, P141, DOI 10.1016/j.ajog.2004.11.064; McDonald SD, 2005, J OBSTET GYNAECOL CA, V27, P449, DOI 10.1016/S1701-2163(16)30527-8; MCKIBBON K, 1999, PDQ SERIES; Meert AP, 2003, BRIT J CANCER, V89, P959, DOI 10.1038/sj.bjc.6601252; Meijer R, 2004, DISABIL REHABIL, V26, P191, DOI 10.1080/09638280310001636437; Meijer R, 2003, CLIN REHABIL, V17, P512, DOI 10.1191/0269215503cr644oa; Meijer R, 2003, CLIN REHABIL, V17, P119, DOI 10.1191/0269215503cr585oa; Mondloch MV, 2001, CAN MED ASSOC J, V165, P174; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Montori VM, 2002, DIABETES CARE, V25, P583, DOI 10.2337/diacare.25.3.583; Moreland JD, 2004, J AM GERIATR SOC, V52, P1121, DOI 10.1111/j.1532-5415.2004.52310.x; NEEDLEMAN HL, 1990, JAMA-J AM MED ASSOC, V263, P673, DOI 10.1001/jama.263.5.673; Newsome CA, 2003, DIABETIC MED, V20, P339, DOI 10.1046/j.1464-5491.2003.00871.x; O'Leary D, 2001, J CLIN PSYCHIAT, V62, P804, DOI 10.4088/JCP.v62n1009; Oliver D, 2004, AGE AGEING, V33, P122, DOI 10.1093/ageing/afh017; Peloso PM, 2004, J REHABIL MED, V36, P106, DOI 10.1080/16501960410023868; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Petticrew M, 2002, BRIT MED J, V325, P1066, DOI 10.1136/bmj.325.7372.1066; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; POCOCK SJ, 1994, BRIT MED J, V309, P1189, DOI 10.1136/bmj.309.6963.1189; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; Ramirez AJ, 1999, LANCET, V353, P1127, DOI 10.1016/S0140-6736(99)02142-X; Reas DL, 2001, INT J EAT DISORDER, V30, P1, DOI 10.1002/eat.1049; Reid M Carrington, 2002, Subst Abus, V23, P149; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Ross SD, 2004, ARCH INTERN MED, V164, P1098, DOI 10.1001/archinte.164.10.1098; Rubenstein JH, 2004, ALIMENT PHARM THER, V20, P373, DOI 10.1111/j.1365-2036.2004.02092.x; Rubin GJ, 2004, J PSYCHOSOM RES, V57, P317, DOI 10.1016/S0022-3999(03)00615-9; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Scannapieco Frank A, 2003, Ann Periodontol, V8, P54, DOI 10.1902/annals.2003.8.1.54; Scannapieco Frank A, 2003, Ann Periodontol, V8, P70, DOI 10.1902/annals.2003.8.1.70; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Schoemaker C, 1997, INT J EAT DISORDER, V21, P1; Schoetzau A, 2001, EUR J PEDIATR, V160, P323, DOI 10.1007/PL00008442; Scholten-Peeters GGM, 2003, PAIN, V104, P303, DOI 10.1016/S0304-3959(03)00050-2; Shekelle P G, 1999, J Spinal Cord Med, V22, P258; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Spencer N, 2004, J EPIDEMIOL COMMUN H, V58, P366, DOI 10.1136/jech.2003.011551; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; STOCK SR, 1991, AM J IND MED, V19, P87, DOI 10.1002/ajim.4700190111; Stolwijk-Swuste JM, 2005, ARCH PHYS MED REHAB, V86, P1693, DOI 10.1016/j.apmr.2004.12.022; Thacker SB, 2003, J SPORT MED PHYS FIT, V43, P165; Thomas SL, 1998, INT J EPIDEMIOL, V27, P108, DOI 10.1093/ije/27.1.108; Turner C, 2004, ACCIDENT ANAL PREV, V36, P93, DOI 10.1016/S0001-4575(02)00131-8; Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957; van Dalen EC, 2004, EUR J CANCER, V40, P643, DOI 10.1016/j.ejca.2003.12.006; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; van den Born BJH, 2005, BMJ-BRIT MED J, V331, P73, DOI 10.1136/bmj.331.7508.73; van der Windt DAWM, 2000, OCCUP ENVIRON MED, V57, P433, DOI 10.1136/oem.57.7.433; van Dijk D, 2000, J THORAC CARDIOV SUR, V120, P632, DOI 10.1067/mtc.2000.108901; van Dijk MAJ, 2003, CLIN CHEM, V49, P1437, DOI 10.1373/49.9.1437; Vigano A, 2000, PALLIATIVE MED, V14, P363, DOI 10.1191/026921600701536192; Wang WH, 2003, JNCI-J NATL CANCER I, V95, P1784, DOI 10.1093/jnci/djg106; Wasswa-Kintu S, 2005, THORAX, V60, P570, DOI 10.1136/thx.2004.037135; Watine J, 1999, CLIN CHEM LAB MED, V37, P931, DOI 10.1515/CCLM.1999.138; Watine J, 2000, SCAND J CLIN LAB INV, V60, P259, DOI 10.1080/003655100750046422; Watine J, 2001, DIS COLON RECTUM, V44, P1791, DOI 10.1007/BF02234457; Welch T P, 2000, Int J Infect Dis, V4, P100, DOI 10.1016/S1201-9712(00)90102-4; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534; Wortman P.M., 1994, HDB RES SYNTHESIS, VVolume 97; Wu O, 2005, THROMB HAEMOSTASIS, V94, P17, DOI 10.1160/TH04-11-0759; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3; Xu LZ, 2004, BRIT J NUTR, V91, P625, DOI 10.1079/BJN20031085; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q	176	1620	1635	1	42	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					427	437		10.7326/0003-4819-144-6-200603210-00010	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	025FX	16549855				2022-12-28	WOS:000236251800007
J	Cross, M				Cross, M			Information technology - Keeping the NHS electronic spine on track	BRITISH MEDICAL JOURNAL			English	Editorial Material											Cross, M (corresponding author), POB 40073, London N6 5ZJ, England.	michaelcross@fastmail.fm						*CONN HLTH, SPEND PROGR UPD 2006; *CONN HLTH, 2006, UPD REC SERV ISS 16; *CONN HLTH, RESP CHILD HLTH INT; Drife JO, 2006, BRIT MED J, V332, P127, DOI 10.1136/bmj.332.7533.127-a; *I MED, 1997, COMP BAS PAT REC, P55; *MED, 2006, DOCT VIEWS NAT PROGR; *NHS, 2005, CAR REC GUAR; NHS Information Authority The Consumers' Association, 2002, SHAR CAR PEOPL VIEWS; St John of God Health Care, 2019, OUR VIS	9	13	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					656	658		10.1136/bmj.332.7542.656	http://dx.doi.org/10.1136/bmj.332.7542.656			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543338	Green Published			2022-12-28	WOS:000236314700026
J	Davies, DE				Davies, DE			Lesson of the week - Parental suicide after the expected death of a child at home	BRITISH MEDICAL JOURNAL			English	Article							DIVERSION; MORTALITY; DENMARK; TRENDS; ABUSE; PAIN		Univ Alberta, Dept Paediat, Edmonton, AB T6G 2J3, Canada	University of Alberta	Davies, DE (corresponding author), Univ Alberta, Dept Paediat, 11402 Univ Ave, Edmonton, AB T6G 2J3, Canada.	dawn.davies@ualberta.ca						Bercovitch M, 2004, CANCER-AM CANCER SOC, V101, P1473, DOI 10.1002/cncr.20485; Fishman SM, 2004, PAIN MED, V5, P309, DOI 10.1111/j.1526-4637.2004.04049.x; Gilson AM, 2004, J PAIN SYMPTOM MANAG, V28, P176, DOI 10.1016/j.jpainsymman.2004.01.003; Hulse Kathy, 2004, J Healthc Qual, V26, P6; Levav I, 2000, AM J PUBLIC HEALTH, V90, P1601, DOI 10.2105/AJPH.90.10.1601; LEVAV I, 1988, NEW ENGL J MED, V319, P457, DOI 10.1056/NEJM198808253190801; Li J, 2003, LANCET, V361, P363, DOI 10.1016/S0140-6736(03)12387-2; Li J, 2002, CIRCULATION, V106, P1634, DOI 10.1161/01.CIR.0000031569.45667.58; Murphy Shirley A, 2003, Issues Ment Health Nurs, V24, P5, DOI 10.1080/01612840305307; Primm BJ, 2004, J NATL MED ASSOC, V96, P1152; Qin P, 2003, ARCH GEN PSYCHIAT, V60, P797, DOI 10.1001/archpsyc.60.8.797; Weschules DJ, 2003, PAIN MED, V4, P269, DOI 10.1046/j.1526-4637.2003.03031.x	12	13	13	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					647	648		10.1136/bmj.332.7542.647	http://dx.doi.org/10.1136/bmj.332.7542.647			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543334	Green Published			2022-12-28	WOS:000236314700024
J	Manuel, DG; Lim, J; Tanuseputro, P; Anderson, GM; Alter, DA; Laupacis, A; Mustard, CA				Manuel, DG; Lim, J; Tanuseputro, P; Anderson, GM; Alter, DA; Laupacis, A; Mustard, CA			Preventive medicine - Revisiting Rose: strategies for reducing coronary heart disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MONICA PROJECT POPULATIONS; CARDIOVASCULAR-DISEASE; EVENT RATES; RISK; ADHERENCE; PROFILE; TRENDS		Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Inst Work & Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; Institute for Work & Health	Manuel, DG (corresponding author), Inst Clin Evaluat Sci, G106-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	doug.manuel@ices.on.ca	; Manuel, Doug/D-7100-2014	Tanuseputro, Peter/0000-0002-4409-0795; Manuel, Doug/0000-0003-0912-0845				ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; *BHF, 2005, UPD GUID CARD DIS RI; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Genest J, 2003, CAN MED ASSOC J, V169, P921; Heidenreich PA, 2004, AM J MED, V117, P130, DOI 10.1016/j.amjmed.2004.03.007; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackevicius CA, 2003, CAN J CARDIOL, V19, P1359; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Liao YL, 1999, AM HEART J, V137, P837, DOI 10.1016/S0002-8703(99)70407-2; MACLEAN DR, 1992, CAN MED ASSOC J, V146, P1969; Mantel-Teeuwisse AK, 2004, HEART, V90, P1065, DOI 10.1136/hrt.2003.026187; *NAT ADV COMM SARS, 2004, LEARN SARS REN PUBL; National Cholesterol Education Program, 2002, DET EV TREATM HIGH B; National Heart Foundation of Australia, 2001, MED J AUST S, V175, pS57; NZGG, 2003, ASS MAN CARD RISK; Rose G, 2001, B WORLD HEALTH ORGAN, V79, P990; Rose G., 1992, STRATEGY PREVENTIVE; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Vartiainen E, 1991, Int J Technol Assess Health Care, V7, P315; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	22	137	145	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2006	332	7542					659	662		10.1136/bmj.332.7542.659	http://dx.doi.org/10.1136/bmj.332.7542.659			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543339	Green Published			2022-12-28	WOS:000236314700027
J	Krug, RM				Krug, RM			Virology - Clues to the virulence of H5N1 viruses in humans	SCIENCE			English	Editorial Material							INFLUENZA-A VIRUSES; ANTIVIRAL RESPONSES; NS1 PROTEIN; BINDING; RNA		Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Krug, RM (corresponding author), Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA.	rkrug@mail.utexas.edu						Chien CY, 2004, BIOCHEMISTRY-US, V43, P1950, DOI 10.1021/bi030176o; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Noah DL, 2005, ADV VIRUS RES, V65, P121, DOI 10.1016/S0065-3527(05)65004-X; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030	11	29	31	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2006	311	5767					1562	1563		10.1126/science.1125998	http://dx.doi.org/10.1126/science.1125998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543447				2022-12-28	WOS:000236029500030
J	Cai, L; Friedman, N; Xie, XS				Cai, L; Friedman, N; Xie, XS			Stochastic protein expression in individual cells at the single molecule level	NATURE			English	Article							EUKARYOTIC GENE-EXPRESSION; BETA-D-GALACTOSIDASE; ESCHERICHIA-COLI; TRANSCRIPTION; TRANSLATION; POPULATION; BACTERIA; NOISE; LACZ	In a living cell, gene expression - the transcription of DNA to messenger RNA followed by translation to protein - occurs stochastically, as a consequence of the low copy number of DNA and mRNA molecules involved(1-6). These stochastic events of protein production are difficult to observe directly with measurements on large ensembles of cells owing to lack of synchronization among cells. Measurements so far on single cells lack the sensitivity to resolve individual events of protein production. Here we demonstrate a microfluidic- based assay that allows real- time observation of the expression of beta-galactosidase in living Escherichia coli cells with single molecule sensitivity. We observe that protein production occurs in bursts, with the number of molecules per burst following an exponential distribution. We show that the two key parameters of protein expression - the burst size and frequency - can be either determined directly from real- time monitoring of protein production or extracted from a measurement of the steady- state copy number distribution in a population of cells. Application of this assay to probe gene expression in individual budding yeast and mouse embryonic stem cells demonstrates its generality. Many important proteins are expressed at low levels(7,8), and are thus inaccessible by current genomic and proteomic techniques. This microfluidic single cell assay opens up possibilities for system- wide characterization of the expression of these low copy number proteins.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER; NIH HHS [DP1 OD000277] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Efron B., 1994, MONOGRAPHS STAT APPL; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; KENNELL D, 1977, J MOL BIOL, V114, P1, DOI 10.1016/0022-2836(77)90279-0; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; MONOD J, 1952, BIOCHIM BIOPHYS ACTA, V9, P648, DOI 10.1016/0006-3002(52)90227-8; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; ROTMAN B, 1961, P NATL ACAD SCI USA, V47, P1981, DOI 10.1073/pnas.47.12.1981; RUSSOMARIE F, 1993, P NATL ACAD SCI USA, V90, P8194, DOI 10.1073/pnas.90.17.8194; SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wu HK, 2004, P NATL ACAD SCI USA, V101, P12809, DOI 10.1073/pnas.0405299101; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	30	842	870	4	265	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					358	362		10.1038/nature04599	http://dx.doi.org/10.1038/nature04599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541077				2022-12-28	WOS:000235997600057
J	Daneman, D				Daneman, D			Type 1 diabetes	LANCET			English	Review							SUBCUTANEOUS INSULIN INFUSION; IMPROVED GLYCEMIC CONTROL; ACCELERATOR HYPOTHESIS; BLOOD-GLUCOSE; FOLLOW-UP; MICROVASCULAR COMPLICATIONS; HYPOGLYCEMIC EPISODES; SECULAR TRENDS; CELIAC-DISEASE; NATURAL COURSE	Type 1 diabetes accounts for only about 5-10% of all cases of diabetes; however, its incidence continues to increase worldwide and it has serious short-term and long-term implications. The disorder has a strong genetic component, inherited mainly through the HLA complex, but the factors that trigger onset of clinical disease remain largely unknown. Management of type 1 diabetes is best undertaken in the context of a multidisciplinary health team and requires continuing attention to many aspects, including insulin administration, blood glucose monitoring, meal planning, and screening for comorbid conditions and diabetes-related complications. These complications consist of microvascular and macrovascular disease, which account for the major morbidity and mortality associated with type 1 diabetes. Newer treatment approaches have facilitated improved outcomes in terms of both glycaemic control and reduced risks for development of complications. Nonetheless, major challenges remain in the development of approaches to the prevention and management of type 1 diabetes and its complications.	Hosp Sick Children, Dept Paediat, Div Endocrinol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Daneman, D (corresponding author), Hosp Sick Children, Dept Paediat, Div Endocrinol, Toronto, ON M5G 1X8, Canada.	denis.daneman@sickkids.ca						Abiru N, 2002, DIABETES-METAB RES, V18, P357, DOI 10.1002/dmrr.323; Akerblom HK, 2002, AM J MED GENET, V115, P18, DOI 10.1002/ajmg.10340; *AM DIAB ASS, 2005, DIABETES CARE S1, V28, pS1; American Diabetes Association, 2004, DIABETES CARE, V27, pS15; Anjos S, 2004, MOL GENET METAB, V81, P187, DOI 10.1016/j.ymgme.2003.11.010; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; Bailey Clifford J, 2005, Curr Diab Rep, V5, P353, DOI 10.1007/s11892-005-0093-1; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barker JM, 2005, DIABETES CARE, V28, P850, DOI 10.2337/diacare.28.4.850; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; Betts P, 2005, DIABETIC MED, V22, P144, DOI 10.1111/j.1464-5491.2004.01368.x; BOOTH GL, 2001, EVIDENCE BASED DIABE, P68; Brand-Miller J, 2003, DIABETES CARE, V26, P2261, DOI 10.2337/diacare.26.8.2261; Brands AMA, 2005, DIABETES CARE, V28, P726, DOI 10.2337/diacare.28.3.726; Bui H, 2005, PEDIATR DIABETES, V6, P50, DOI 10.1111/j.1399-543X.2005.00095.x; *CAN DIAB ASS CLIN, 2003, CAN J DIABETES S2, V27, pS21; Casu A, 2004, DIABETES CARE, V27, P1623, DOI 10.2337/diacare.27.7.1623; Chase HP, 2003, J PEDIATR-US, V143, P737, DOI 10.1067/S0022-3476(03)00415-3; CHINN S, 1998, ARCH DIS CHILD, V19, P162; Colquitt J, 2003, DIABETIC MED, V20, P863, DOI 10.1046/j.1464-5491.2003.01018.x; COLQUITT JL, 2004, HEALTH TECHNOL ASSES, V43, P1; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; CURTIS J, 2001, EVIDENCE BASED DIABE, P107; Dahlquist G, 2000, ACTA PAEDIATR, V89, P1231, DOI 10.1080/080352500750027628; Daneman D, 2005, HORM RES, V63, P75, DOI 10.1159/000083692; Daneman D, 2005, DIABETIC MED, V22, P115, DOI 10.1111/j.1464-5491.2005.01532.x; Danne T, 2001, DIABETES CARE, V24, P1342, DOI 10.2337/diacare.24.8.1342; Davis TME, 2005, DIABETIC MED, V22, P551, DOI 10.1111/j.1464-5491.2005.01462.x; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; DRAELOS MT, 1995, AM J MED, V98, P135, DOI 10.1016/S0002-9343(99)80397-0; Dunger DB, 2004, ARCH DIS CHILD, V89, P188, DOI 10.1136/adc.2003.044875; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; Engel S, 2003, NEW ENGL J MED, V348, P2294; Evans JMM, 1999, BMJ-BRIT MED J, V319, P83, DOI 10.1136/bmj.319.7202.83; Feudtner C, 1996, PERSPECT BIOL MED, V39, P158; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Fioretto P, 2005, J AM SOC NEPHROL, V16, pS18, DOI 10.1681/ASN.2004110962; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Ford-Adams ME, 2003, DIABETIC MED, V20, P656, DOI 10.1046/j.1464-5491.2003.01013.x; Franz MJ, 2002, DIABETES CARE, V25, P148, DOI 10.2337/diacare.25.1.148; Fukami K, 2005, EXPERT OPIN INV DRUG, V14, P279, DOI 10.1517/13543784.14.3.279; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; Gale EAM, 2005, DIABETOLOGIA, V48, P1435, DOI 10.1007/s00125-005-1833-0; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Garg SK, 2004, DIABETES RES CLIN PR, V66, P49, DOI 10.1016/j.diabres.2004.02.008; Genuth S, 2001, J PEDIATR-US, V139, P804, DOI 10.1067/mpd.2001.118887; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; Green A, 2000, LANCET, V355, P873; Griffin S, 2000, COCHRANE DB SYST REV, V2; Guerci B, 2003, DIABETES CARE, V26, P582, DOI 10.2337/diacare.26.3.582; Haller MJ, 2004, J PEDIATR-US, V144, P660, DOI 10.1016/j.jpeds.2003.12.042; Hamilton J, 2003, DIABETES CARE, V26, P138, DOI 10.2337/diacare.26.1.138; Hampson S E, 2001, Health Technol Assess, V5, P1; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; HELGASON T, 1981, LANCET, V2, P716; Heptulla RA, 2005, DIABETES, V54, P1100, DOI 10.2337/diabetes.54.4.1100; Herman WH, 1998, DIABETES CARE, V21, pC19, DOI 10.2337/diacare.21.3.C19; Hviid A, 2004, NEW ENGL J MED, V350, P1398, DOI 10.1056/NEJMoa032665; Jacobson AM, 1997, J PEDIATR-US, V131, P727, DOI 10.1016/S0022-3476(97)70101-X; Jacobson AM, 2002, INT REV NEUROBIOL, V51, P455, DOI 10.1016/S0074-7742(02)51013-8; Jones JM, 2000, BMJ-BRIT MED J, V320, P1563, DOI 10.1136/bmj.320.7249.1563; Kaila B, 2001, DIABETES CARE, V24, P1353, DOI 10.2337/diacare.24.8.1353; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; Kautiainen S, 2002, INT J OBESITY, V26, P544, DOI 10.1038/sj.ijo.0801928; Keers JC, 2005, J EVAL CLIN PRACT, V11, P293, DOI 10.1111/j.1365-2753.2005.00536.x; Klein R, 2005, DIABETES, V54, P527, DOI 10.2337/diabetes.54.2.527; Kordonouri O, 2005, ARCH DIS CHILD, V90, P411, DOI 10.1136/adc.2004.056424; KOVACS M, 1992, J AM ACAD CHILD PSY, V31, P1112, DOI 10.1097/00004583-199211000-00020; Krischer JP, 2003, J CLIN ENDOCR METAB, V88, P103, DOI 10.1210/jc.2002-020760; Laing SP, 2005, DIABETES CARE, V28, P1618, DOI 10.2337/diacare.28.7.1618; Lambert AP, 2004, J CLIN ENDOCR METAB, V89, P4037, DOI 10.1210/jc.2003-032084; Lammi N, 2005, MED SCI MONITOR, V11, pRA63; LAWSONML, 1999, DIABETES CARE S2, V22, pB35; Leiter LA, 2005, DIABETES RES CLIN PR, V68, pS3, DOI 10.1016/j.diabres.2005.03.015; Levitsky LL, 2004, NEW ENGL J MED, V350, P1380, DOI 10.1056/NEJMp048034; Levy S, 2001, SOLID STATE TECHNOL, V44, P75; Li XH, 2000, BIOMED ENVIRON SCI, V13, P263; Lovell HG, 2001, COCHRANE DB SYST REV, V1; Loveman E, 2003, COCHRANE DB SYST REV, V2; Maclaren N, 1999, J AUTOIMMUN, V12, P279, DOI 10.1006/jaut.1999.0281; McQueen MJ, 2005, SCAND J CLIN LAB INV, V65, P143, DOI 10.1080/00365510500236366; Meyer L, 2003, DIABETES CARE, V26, P1655, DOI 10.2337/diacare.26.5.1655-a; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Mortensen HB, 1997, DIABETES CARE, V20, P714, DOI 10.2337/diacare.20.5.714; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; Nauck MA, 2005, REGUL PEPTIDES, V128, P135, DOI 10.1016/j.regpep.2004.07.014; Newhook LA, 2004, DIABETES CARE, V27, P885, DOI 10.2337/diacare.27.4.885; Nordfeldt S, 2005, J PEDIATR ENDOCR MET, V18, P83; Norris JM, 2005, JAMA-J AM MED ASSOC, V293, P2343, DOI 10.1001/jama.293.19.2343; Norris JM, 2003, JAMA-J AM MED ASSOC, V290, P1713, DOI 10.1001/jama.290.13.1713; Northam EA, 2001, DIABETES CARE, V24, P1541, DOI 10.2337/diacare.24.9.1541; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; Opperman AM, 2004, BRIT J NUTR, V92, P367, DOI 10.1079/BJN20041203; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; Owens DR, 2001, LANCET, V358, P739, DOI 10.1016/S0140-6736(01)05842-1; Palmer AJ, 2004, CURR MED RES OPIN, V20, P1729, DOI 10.1185/030079904X5661; Perkins BA, 2005, NEW ENGL J MED, V352, P408, DOI 10.1056/NEJMe048340; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Perkins Bruce A, 2002, Curr Diab Rep, V2, P495, DOI 10.1007/s11892-002-0119-x; Plank J, 2005, ARCH INTERN MED, V165, P1337, DOI 10.1001/archinte.165.12.1337; Radermecker RP, 2004, DIABETES-METAB RES, V20, P178, DOI 10.1002/dmrr.447; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Raymond NT, 2001, DIABETOLOGIA, V44, pB32, DOI 10.1007/PL00002951; Redondo MJ, 2001, RECENT PROG HORM RES, V56, P69, DOI 10.1210/rp.56.1.69; Renders CM, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD001481]; Retnakaran R, 2004, DIABETES CARE, V27, P2590, DOI 10.2337/diacare.27.11.2590; Robles DT, 2001, J AUTOIMMUN, V16, P355, DOI 10.1006/jaut.2000.0483; RYAN C, 1985, PEDIATRICS, V75, P921; Ryan CM, 2003, DIABETOLOGIA, V46, P940, DOI 10.1007/s00125-003-1128-2; Ryan CM, 2002, DIABETES CARE, V25, P852, DOI 10.2337/diacare.25.5.852; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Ryan Edmond A, 2004, Curr Diab Rep, V4, P304, DOI 10.1007/s11892-004-0083-8; Rydall AC, 1997, NEW ENGL J MED, V336, P1849, DOI 10.1056/NEJM199706263362601; Sacks DB, 2005, CLIN CHEM, V51, P681, DOI 10.1373/clinchem.2004.047431; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; Siebenhofer A, 2004, DIABETOLOGIA, V47, P1895, DOI 10.1007/s00125-004-1545-x; Siebenhofer A, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003287.PUB4; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Skovbjerg H, 2005, DIABETOLOGIA, V48, P1416, DOI 10.1007/s00125-005-1776-5; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Smith D, 2002, DIABETOLOGIA, V45, P949, DOI 10.1007/s00125-002-0877-7; SOCHETT EB, 1987, DIABETOLOGIA, V30, P453, DOI 10.1007/BF00279611; Steffes M, 2005, CLIN CHEM, V51, P753, DOI 10.1373/clinchem.2004.042143; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tamborlane WV, 2005, PEDIATR DIABETES, V6, P13; Thorsdottir I, 2003, ANN NUTR METAB, V47, P267, DOI 10.1159/000072399; Tremblay MS, 2000, CAN MED ASSOC J, V163, P1429; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; USA American Diabetes Association, 2004, Diabetes Care, V27, pS36; Vaarala O, 1999, DIABETES, V48, P1389, DOI 10.2337/diabetes.48.7.1389; Vague P, 2003, DIABETES CARE, V26, P590, DOI 10.2337/diacare.26.3.590; VIBERTI GC, 1982, LANCET, V1, P1430; Virtanen SM, 2000, DIABETES, V49, P912, DOI 10.2337/diabetes.49.6.912; VONMUTIUS E, 1994, BRIT MED J, V308, P692, DOI 10.1136/bmj.308.6930.692; Weets I, 2002, DIABETES CARE, V25, P840, DOI 10.2337/diacare.25.5.840; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; YKIJARVINEN H, 1986, NEW ENGL J MED, V315, P224, DOI 10.1056/NEJM198607243150404	146	603	626	2	80	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					847	858		10.1016/S0140-6736(06)68341-4	http://dx.doi.org/10.1016/S0140-6736(06)68341-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530579				2022-12-28	WOS:000236016500030
J	Bonetta, L				Bonetta, L			The aftermath of scientific fraud	CELL			English	Editorial Material								Scientists who have come face to face with scientific misconduct consider its consequences years later.											0	13	14	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 10	2006	124	5					873	875		10.1016/j.cell.2006.02.032	http://dx.doi.org/10.1016/j.cell.2006.02.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530031	Bronze			2022-12-28	WOS:000237241200006
J	Basson, R				Basson, R			Sexual desire and arousal disorders in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGICALLY MENOPAUSAL WOMEN; QUALITY-OF-LIFE; TESTOSTERONE PATCH; ANDROGEN LEVELS; MIDLIFE WOMEN; ORAL-CONTRACEPTIVES; SILDENAFIL CITRATE; DYSFUNCTION; HEALTH; PREVALENCE		Vancouver Gen Hosp, British Columbia Ctr Sexual Med, Vancouver, BC V5Z 1M9, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Basson, R (corresponding author), Vancouver Gen Hosp, British Columbia Ctr Sexual Med, 855 W 12th Ave, Vancouver, BC V5Z 1M9, Canada.	sexmed@interchange.ubc.ca						American Psychiatric Association, 2003, DIAGN STAT MAN MENT; [Anonymous], 2005, MENOPAUSE, V12, P497, DOI 10.1097/01.gme.0000177709.65944.b0; Arlt W, 1999, NEW ENGL J MED, V341, P1013, DOI 10.1056/NEJM199909303411401; Avis NE, 2005, MENOPAUSE, V12, P385, DOI 10.1097/01.GME.0000151656.92317.A9; Bancroft J, 2003, ARCH SEX BEHAV, V32, P193, DOI 10.1023/A:1023420431760; Barnhart KT, 1999, J CLIN ENDOCR METAB, V84, P3896, DOI 10.1210/jc.84.11.3896; Basson R, 2003, J PSYCHOSOM OBST GYN, V24, P221, DOI 10.3109/01674820309074686; Basson R, 2003, BJOG-INT J OBSTET GY, V110, P1014, DOI 10.1016/S1470-0328(03)02938-0; Basson R, 2002, J WOMEN HEALTH GEN-B, V11, P367, DOI 10.1089/152460902317586001; BASSON R, 2003, CLIN UPDATES WOMENS, V2, P1; Basson R, 2004, J SEX MED, V1, P24, DOI 10.1111/j.1743-6109.2004.10105.x; Blake J, 2006, J OBSTET GYNAECOL CA, V28, P185, DOI 10.1016/S1701-2163(16)32096-5; Braunstein GD, 2005, ARCH INTERN MED, V165, P1582, DOI 10.1001/archinte.165.14.1582; Buster JE, 2005, OBSTET GYNECOL, V105, P944, DOI 10.1097/01.AOG.0000158103.27672.0d; Cain VS, 2003, J SEX RES, V40, P266, DOI 10.1080/00224490309552191; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; DasGupta R, 2004, J UROLOGY, V171, P1189, DOI 10.1097/01.ju.0000113145.43174.24; Davis SR, 2005, JAMA-J AM MED ASSOC, V294, P91, DOI 10.1001/jama.294.1.91; DAVIS SR, IN PRESS MENOPAUSE; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; Dennerstein L, 2004, J SEX MARITAL THER, V30, P173, DOI 10.1080/00926230490262375; Dunn KM, 1998, FAM PRACT, V15, P519, DOI 10.1093/fampra/15.6.519; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; Hartmann U, 2004, MENOPAUSE, V11, P726, DOI 10.1097/01.GME.0000143705.42486.33; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Heiman JR, 2002, ARCH SEX BEHAV, V31, P445, DOI 10.1023/A:1019848310142; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Lobo RA, 2003, FERTIL STERIL, V79, P1341, DOI 10.1016/S0015-0282(03)00358-3; Lovas K, 2003, J CLIN ENDOCR METAB, V88, P1112, DOI 10.1210/jc.2002-020769; Maravilla KR, 2003, J SEX MARITAL THER, V29, P71, DOI 10.1080/713847132; MATTHIESEN S, 2004, FAMILIENDYNAMIK, V29, P136; Mercer CH, 2003, BRIT MED J, V327, P426, DOI 10.1136/bmj.327.7412.426; Meston CM, 1998, ARCH GEN PSYCHIAT, V55, P652, DOI 10.1001/archpsyc.55.7.652; Meston CM, 2002, ARCH SEX BEHAV, V31, P323, DOI 10.1023/A:1016220225392; NathorstBoos J, 1997, MATURITAS, V26, P15, DOI 10.1016/S0378-5122(96)01069-9; Palmer BF, 2003, ADV RENAL REPLACE TH, V10, P48, DOI 10.1053/jarr.2003.50003; Panzer C, 2006, J SEX MED, V3, P104, DOI 10.1111/j.1743-6109.2005.00198.x; Sanders SA, 2001, CONTRACEPTION, V64, P51, DOI 10.1016/S0010-7824(01)00218-9; Santoro N, 2005, J CLIN ENDOCR METAB, V90, P4836, DOI 10.1210/jc.2004-2063; Segraves RT, 2004, J CLIN PSYCHOPHARM, V24, P339, DOI 10.1097/01.jcp.0000125686.20338.c1; Simon J, 2005, J CLIN ENDOCR METAB, V90, P5226, DOI 10.1210/jc.2004-1747; Stenberg A, 1996, MATURITAS, V24, P31, DOI 10.1016/0378-5122(95)00996-5; Taylor MJ, 2005, J AFFECT DISORDERS, V88, P241, DOI 10.1016/j.jad.2005.07.006; Trudel G., 2001, SEX RELATSH THER, V16, P145, DOI DOI 10.1080/14681990120040078; van Lunsen RHW, 2004, MENOPAUSE, V11, P741, DOI 10.1097/01.GME.0000143704.48324.46; van Thiel SW, 2005, J CLIN ENDOCR METAB, V90, P3295, DOI 10.1210/jc.2004-1802; Verhaak CM, 2005, HUM REPROD, V20, P2253, DOI 10.1093/humrep/dei015; Zorzon M, 1999, MULT SCLER J, V5, P418, DOI 10.1191/135245899678846456	50	98	103	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1497	1506		10.1056/NEJMcp050154	http://dx.doi.org/10.1056/NEJMcp050154			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	029DP	16598046				2022-12-28	WOS:000236539000008
J	Telford, K; Waters, L; Vyas, H; Manktelow, BN; Draper, ES; Marlow, N				Telford, K; Waters, L; Vyas, H; Manktelow, BN; Draper, ES; Marlow, N			Outcome after neonatal continuous negative-pressure ventilation: follow-up assessment	LANCET			English	Article							PRETERM INFANTS; AGE	Background A previous randomised trial of continuous negative extrathoracic pressure (CNEP) versus standard treatment for newborn infants with respiratory distress syndrome raised public concerns about mortality and neonatal morbidity. We studied the outcome in late childhood of children entered into the trial to establish whether there were long-term sequelae attributable to either mode of ventilation. Methods Outpatient assessment of neurological outcome, cognitive function, and disability was done by a paediatrician and a psychologist using standardised tests. 133 of 205 survivors from the original trial were assessed at 9-15 years of age. Of the original pairs randomly assigned to each ventilation mode, the results from 65 complete pairs were available. The primary outcome was death or severe disability. Findings Primary outcome was equally distributed between groups (odds ratio for the CNEP group 1.0; 95% CI 0.41-2.41). In impaired analysis there was no significant difference between treatment modalities (1.05; 0.54-2.06). Full IQ did not differ significantly between the groups, but mean performance IQ was 6.8 points higher in the CNEP group than in the conventional-treatment group (95% CI 1.5-12.1). Results of neuropsychological testing were consistent with this finding, with scores on language production and visuospatial skills being significantly higher in the CNEP group. Interpretation We saw no evidence of poorer long-term outcome after neonatal CNEP whether analysis was by original pairing or by impaired comparisons, despite small differences in adverse neonatal outcomes. The experience of our study indicates that future studies of neonatal interventions with the potential to influence later morbidity should be designed with longer-term outcomes in mind.	Univ Nottingham, Queens Med Ctr, Sch Human Dev, Acad Div Child Hlth, Nottingham NG7 2UH, England; Queens Med Ctr, Childrens Serv, Nottingham NG7 2UH, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of Nottingham; University of Nottingham; University of Leicester	Marlow, N (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Human Dev, Acad Div Child Hlth, Nottingham NG7 2UH, England.	neil.marlow@nottingham.ac.uk	Draper, Elizabeth S/I-6304-2018; Marlow, Neil/D-2918-2009; Draper, Elizabeth/S-6874-2019; Manktelow, Bradley N/G-2794-2011	Draper, Elizabeth S/0000-0001-9340-8176; Marlow, Neil/0000-0001-5890-2953; Draper, Elizabeth/0000-0001-9340-8176; Manktelow, Bradley N/0000-0002-3264-0323				Bennett CC, 2001, LANCET, V357, P1094, DOI 10.1016/S0140-6736(00)04310-5; Feeny D. H., 1996, QUALITY LIFE PHARMAC, V2, P239; FLEISS JL, 2003, STAT METHODS RATES P, P425; Furlong WJ, 2002, HLTH UTILITIES INDEX; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; GRIFFITHS, REPORT REV RES FRAME; HIFI Study Group, 1989, N Engl J Med, V320, P88; Jobe AH, 2004, NEW ENGL J MED, V350, P1349, DOI 10.1056/NEJMe048031; Korkman M., 2007, NEPSY 2, V2nd; LYNN HS, 1992, BIOMETRICS, V48, P397, DOI 10.2307/2532299; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marlow N, 2004, ARCH DIS CHILD-FETAL, V89, pF224, DOI 10.1136/adc.2002.019752; Moriette G, 2001, PEDIATRICS, V107, P363, DOI 10.1542/peds.107.2.363; *OFF POP CENS SURV, 1990, SOC OCC CLASS; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Samuels MP, 1996, PEDIATRICS, V98, P1154; Schmidt B, 2001, NEW ENGL J MED, V344, P1966, DOI 10.1056/NEJM200106283442602; SHAH PS, 2003, COCHRANE DB SYST REV, V3; Wechsler D., 2007, WASI 2 WECHSLER ABBR	19	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1080	1085		10.1016/S0140-6736(06)68475-4	http://dx.doi.org/10.1016/S0140-6736(06)68475-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581407				2022-12-28	WOS:000236673200032
J	Keegstra, K; Walton, J				Keegstra, K; Walton, J			Plant science - beta-glucans - Brewer's bane, dietician's delight	SCIENCE			English	Editorial Material							SYNTHASE; FAMILY; GENES	Identification of the enzyme that synthesizes a polysaccharide in plant cell walls will allow manipulation of grasses to enhance their utility as food, feed, and fuel.	Michigan State Univ, US DOE, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; United States Department of Energy (DOE)	Keegstra, K (corresponding author), Michigan State Univ, US DOE, Plant Res Lab, Plant Biol Bldg, E Lansing, MI 48824 USA.	keegstra@msu.edu; walton@msu.edu						Bamforth C. W., 1994, Brewers' Digest, V69, P12; Brennan CS, 2005, J CEREAL SCI, V42, P1, DOI 10.1016/j.jcs.2005.01.002; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Dhugga KS, 2004, SCIENCE, V303, P363, DOI 10.1126/science.1090908; HAN F, 1995, THEOR APPL GENET, V91, P921, DOI 10.1007/BF00223901; Hazen SP, 2002, PLANT PHYSIOL, V128, P336, DOI 10.1104/pp.010875; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765	11	26	29	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2006	311	5769					1872	1873		10.1126/science.1125938	http://dx.doi.org/10.1126/science.1125938			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574854				2022-12-28	WOS:000236387800029
J	Kalab, P; Pralle, A; Isacoff, EY; Heald, R; Weis, K				Kalab, P; Pralle, A; Isacoff, EY; Heald, R; Weis, K			Analysis of a RanGTP-regulated gradient in mitotic somatic cells	NATURE			English	Article							IMPORTIN-BETA; NUCLEAR IMPORT; GTP; TRANSPORT	The RanGTPase cycle provides directionality to nucleocytoplasmic transport, regulating interactions between cargoes and nuclear transport receptors of the importin-beta family(1,2). The Ran importin-beta system also functions in mitotic spindle assembly and nuclear pore and nuclear envelope formation(1,3,4). The common principle underlying these diverse functions throughout the cell cycle is thought to be anisotropy of the distribution of RanGTP ( the RanGTP gradient), driven by the chromatin-associated guanine nucleotide exchange factor RCC1 ( refs 1, 4, 5). However, the existence and function of a RanGTP gradient during mitosis in cells is unclear. Here we examine the Ran - importin-beta system in cells by conventional and fluorescence lifetime microscopy using a biosensor, termed Rango, that increases its fluorescence resonance energy transfer signal when released from importin-beta by RanGTP. Rango is predominantly free in mitotic cells, but is further liberated around mitotic chromatin. In vitro experiments and modelling show that this localized increase of free cargoes corresponds to changes in RanGTP concentration sufficient to stabilize microtubules in extracts. In cells, the Ran - importin- beta - cargo gradient kinetically promotes spindle formation but is largely dispensable once the spindle has been established. Consistent with previous reports(6-8), we observe that the Ran system also affects spindle pole formation and chromosome congression in vivo. Our results demonstrate that conserved Ran-regulated pathways are involved in multiple, parallel processes required for spindle function, but that their relative contribution differs in chromatin-versus centrosome/ kinetochore-driven spindle assembly systems.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	heald@socrates.berkeley.edu; kweis@berkeley.edu	Kalab, Petr/B-2478-2009; Pralle, Arnd/M-9832-2013; isacoff, ehud/AAP-1459-2020; Weis, Karsten/F-5719-2011	Pralle, Arnd/0000-0002-6079-109X; Weis, Karsten/0000-0001-7224-925X; Isacoff, Ehud Y./0000-0003-4775-9359; Heald, Rebecca/0000-0001-6671-6528				Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Arnaoutov A, 2003, DEV CELL, V5, P99, DOI 10.1016/S1534-5807(03)00194-1; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2002, NAT CELL BIOL, V4, pE177, DOI 10.1038/ncb0702-e177; Huber J, 2002, J CELL BIOL, V156, P467, DOI 10.1083/jcb.200108114; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Wollman R, 2005, CURR BIOL, V15, P828, DOI 10.1016/j.cub.2005.03.019	18	279	284	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					697	701		10.1038/nature04589	http://dx.doi.org/10.1038/nature04589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572176				2022-12-28	WOS:000236350400050
J	Clarke, MF; Fuller, M				Clarke, MF; Fuller, M			Stem cells and cancer: Two faces of eve	CELL			English	Editorial Material							SOMATIC SUPPORT CELLS; SELF-RENEWAL; BMI-1; IDENTIFICATION; GERMLINE; NICHE; PROLIFERATION	Recent evidence suggests that a subset of cancer cells within some tumors, the so-called cancer stem cells, may drive the growth and metastasis of these tumors. Understanding the pathways that regulate proliferation, self-renewal, survival, and differentiation of malignant and normal stem cells may shed light on mechanisms that lead to cancer and suggest better, modes of treatment.	Stanford Inst Stem Biol & Regenerat Med, Stanford, CA USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Clarke, MF (corresponding author), Stanford Inst Stem Biol & Regenerat Med, Stanford, CA USA.	mfclarke@stanford.edu		Fuller, Margaret T/0000-0002-3804-4987				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Schulz C, 2002, DEVELOPMENT, V129, P4523; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	23	683	732	0	58	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1111	1115		10.1016/j.cell.2006.03.011	http://dx.doi.org/10.1016/j.cell.2006.03.011			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564000	Bronze			2022-12-28	WOS:000237241400007
J	Ekstrom, G; Nettles, M; Tsai, VC				Ekstrom, G; Nettles, M; Tsai, VC			Seasonality and increasing frequency of Greenland glacial earthquakes	SCIENCE			English	Article								Some glaciers and ice streams periodically lurch forward with sufficient force to generate emissions of elastic waves that are recorded on seismometers worldwide. Such glacial earthquakes on Greenland show a strong seasonality as well as a doubling of their rate of occurrence over the past 5 years. These temporal patterns suggest a link to the hydrological cycle and are indicative of a dynamic glacial response to changing climate conditions.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Harvard University; Columbia University	Ekstrom, G (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	ekstrom@seismology.harvard.edu	Ekstrom, Goran/C-9771-2012; Tsai, Victor C/J-8405-2012; Nettles, Meredith/A-8638-2012	Ekstrom, Goran/0000-0001-6410-275X; Tsai, Victor C/0000-0003-1809-6672; Nettles, Meredith/0000-0003-4613-4162				Butler R., 2004, EOS T AM GEOPHYS UN, V85, P225; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; Ekstrom G, 2003, SCIENCE, V302, P622, DOI 10.1126/science.1088057; EKSTROM G, IN PRESS B SEISMOL S; HAMILTON GS, 2005, EOS, V86; Howat IM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024737; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; KAWAKATSU H, 1989, J GEOPHYS RES-SOLID, V94, P12363, DOI 10.1029/JB094iB09p12363; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Luckman A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022519; MEIER M, 1994, J GEOPHYS RES-SOL EA, V99, P15219, DOI 10.1029/94JB00237; QAMAR A, 1988, J GEOPHYS RES-SOLID, V93, P6615, DOI 10.1029/JB093iB06p06615; RIGNOT E, 2005, EOS, V86; Steffen K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020444; TSAI VC, 2005, EOS, V86; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	16	106	110	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1756	1758		10.1126/science.1122112	http://dx.doi.org/10.1126/science.1122112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556839				2022-12-28	WOS:000236204300039
J	Brent, R; Bruck, J				Brent, R; Bruck, J			Can computers help to explain biology?	NATURE			English	Editorial Material									Inst Mol Sci, Berkeley, CA 94704 USA; CALTECH, Pasadena, CA 91125 USA	The Molecular Sciences Institute; California Institute of Technology	Brent, R (corresponding author), Inst Mol Sci, Berkeley, CA 94704 USA.			Bruck, Jehoshua/0000-0001-8474-0812				Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Fields S, 1997, NAT GENET, V15, P325, DOI 10.1038/ng0497-325; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kirschner MW, 2005, CELL, V121, P503, DOI 10.1016/j.cell.2005.05.005; Shannon CE, 1948, MATH THEORY COMMUNIC, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simon H. A., 1969, SCI ARTIFICIAL; SUSSMAN GJ, 2001, NCR CSTB S FUND COMP; Weinstein JN, 1998, SCIENCE, V282, P628	11	34	36	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					416	417		10.1038/440416a	http://dx.doi.org/10.1038/440416a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554784				2022-12-28	WOS:000236176100022
J	Hurtado, RM; Sahani, DV; Kradin, RL; Schapiro, RH; Harris, NL; Tseng, JF; Peppercorn, AF				Hurtado, RM; Sahani, DV; Kradin, RL; Schapiro, RH; Harris, NL; Tseng, JF; Peppercorn, AF			35-year-old woman with recurrent right-upper-quadrant pain - Hepatolithiasis and cholangitis (recurrent pyogenic cholangiohepatitis) with infection by Ascaris lumbricoides and gram-negative bacteria consistent with klebsiella species. Mildly active chronic hepatitis due to hepatitis C infection. Chronic cholecystitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTRAHEPATIC STONES; BILIARY ASCARIASIS; PANCREATITIS; MANAGEMENT		Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Hurtado, RM (corresponding author), Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA.							BALDWIN M, 1993, AM J GASTROENTEROL, V88, P2119; CARMONA RH, 1984, AM J SURG, V148, P117, DOI 10.1016/0002-9610(84)90298-8; CHANG TM, 1983, AM J SURG, V146, P241, DOI 10.1016/0002-9610(83)90382-3; Cheung K L, 1996, Adv Surg, V29, P111; CHOI TK, 1989, BRIT J SURG, V76, P213, DOI 10.1002/bjs.1800760303; CHOI TK, 1982, BRIT J SURG, V69, P86, DOI 10.1002/bjs.1800690210; CHOI TK, 1986, CLIN GASTROENTEROL, V15, P393; CHOU ST, 1980, PATHOLOGY, V12, P415, DOI 10.3109/00313028009077105; DANZI JT, 1976, AM J GASTROENTEROL, V65, P109; Digby KH, 1930, BRIT J SURG, V17, P578, DOI 10.1002/bjs.1800176804; Dinc H, 1998, EUR RADIOL, V8, P788, DOI 10.1007/s003300050473; KHUROO MS, 1993, GASTROINTEST ENDOSC, V39, P674; KHUROO MS, 1990, LANCET, V335, P1503, DOI 10.1016/0140-6736(90)93037-P; KHUROO MS, 1985, GASTROENTEROLOGY, V88, P418, DOI 10.1016/0016-5085(85)90501-3; Leung JW, 1997, BAILLIERE CLIN GASTR, V11, P681, DOI 10.1016/S0950-3528(97)90016-6; Lim K. G., 1994, Singapore Medical Journal, V35, P400; MAIRIANG E, 1993, T ROY SOC TROP MED H, V87, P194, DOI 10.1016/0035-9203(93)90489-D; Meyers WM, 2000, PATHOLOGY INFECT DIS, V1; OHTA T, 1984, INTRAHEPATIC CALCULI, P91; ONG GB, 1962, ARCH SURG-CHICAGO, V84, P199; PITT HA, 1994, ANN SURG, V219, P527, DOI 10.1097/00000658-199405000-00011; PLANE P, 1980, J CHIR-PARIS, V117, P193; Shukla VK, 2000, DIGEST DIS SCI, V45, P900, DOI 10.1023/A:1005564822630	23	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1295	1303		10.1056/NEJMcpc059044	http://dx.doi.org/10.1056/NEJMcpc059044			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554532				2022-12-28	WOS:000236164200010
J	Campbell, NC				Campbell, NC			A 28 year old postpartum woman with right sided chest discomfort: case outcome - Commentary: Diagnosing chest pain in general practice	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland	University of Aberdeen	Campbell, NC (corresponding author), Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland.	n.campbell@abdn.ac.uk						Brindle PM, 2005, BRIT J GEN PRACT, V55, P838; Dwivedi G, 2006, BRIT MED J, V332, P643, DOI 10.1136/bmj.332.7542.643; Electronic responses, 2006, BMJ; *NHS SCOTL, COR HEART DIS STAT 2; *SIGN, 2001, MAN STABL ANG	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					646	647		10.1136/bmj.332.7542.646-a	http://dx.doi.org/10.1136/bmj.332.7542.646-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543332	Green Published			2022-12-28	WOS:000236314700023
J	Sibley, DA; Bevier, LR; Patten, MA; Elphick, CS				Sibley, DA; Bevier, LR; Patten, MA; Elphick, CS			Comment on "ivory-billed woodpecker (Campephilus principalis) persists in continental North America"	SCIENCE			English	Editorial Material								We reanalyzed video presented as confirmation that an ivory-billed woodpecker (Campephilus principalis) persists in Arkansas (Fitzpatrick et al., Reports, 3 June 2005, p. 1460). None of the features described as diagnostic of the ivory-billed woodpecker eliminate a normal pileated woodpecker (Dryocopus pileatus). Although we support efforts to find and protect ivory-billed woodpeckers, the video evidence does not demonstrate that the species persists in the United States.	Colby Coll, Dept Biol, Waterville, ME 04901 USA; Univ Oklahoma, Oklahoma Biol Survey, Sutton Avian Res Ctr, Norman, OK 73019 USA; Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; Univ Connecticut, Storrs, CT 06269 USA	Colby College; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Connecticut	Sibley, DA (corresponding author), POB 1031, Concord, MA 01742 USA.	sibleyart@yahoo.com						Charif RA, 2005, SCIENCE, V309, P1489; Fitzpatrick JW, 2005, SCIENCE, V308, P1460, DOI 10.1126/science.1114103; Gallagher T., 2005, GRAIL BIRD HOT TRAIL; Hoose Phillip M., 2004, RACE SAVE LORD GOD B; Jackson J.A., 2002, BIRDS N AM, V711; Jackson JA, 2006, AUK, V123, P1, DOI 10.1642/0004-8038(2006)123[0001:IWCPHA]2.0.CO;2; Jackson JJ, 2004, SEARCH IVORY BILLED; QUEENY EM, 1947, PRAIRIE WINGS; Rosenberg NK, 2005, NORD J PSYCHIAT, V59, P198, DOI 10.1080/08039480510027670; Walters JR, 2005, AVIAN CONSERV ECOL, V1	10	39	45	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1555	+		10.1126/science.1122778	http://dx.doi.org/10.1126/science.1122778			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543443	Green Submitted			2022-12-28	WOS:000236029500024
J	Jeffcoate, W				Jeffcoate, W			Drive to eliminate the burden of type 1 diabetes	LANCET			English	Editorial Material							ISLET; CELL		Lancet, London NW1 7BY, England		Jeffcoate, W (corresponding author), Lancet, London NW1 7BY, England.	william.jeffcoate@lancet.com						*ET1DGN, EUR TYP 1 DIAB GEN N; Gale EAM, 2005, DIABETOLOGIA, V48, P2445, DOI 10.1007/s00125-005-0028-z; *IDF, 2005, DIAB ATL; *INT DIAB FED, NAT DIAB RES NETW LA; *ISCF, 2006, INT STEM CELL FOR HO; *JDRF, 2006, JUV DIAB RES FDN HOM; *JDRF, 2006, BET CELL THER; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Shapiro AMJ, 2005, TRANSPLANTATION, V79, P1304, DOI 10.1097/01.TP.0000157300.53976.2A; Stainier D, 2006, NEW ENGL J MED, V354, P521, DOI 10.1056/NEJMcibr055048; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0	11	5	5	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					795	797		10.1016/S0140-6736(06)68314-1	http://dx.doi.org/10.1016/S0140-6736(06)68314-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530560				2022-12-28	WOS:000236016500007
J	Wolff, S; Ma, H; Burch, D; Maciel, GA; Hunter, T; Dillin, A				Wolff, S; Ma, H; Burch, D; Maciel, GA; Hunter, T; Dillin, A			SMK-1, an essential regulator of DAF-16-mediated longevity	CELL			English	Article							C-ELEGANS DAF-16; AGE-1 PI3 KINASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; CONSERVED PROTEIN; GENE-EXPRESSION; CLK-1 MUTANTS; LONG	Insulin/IGF-1 signaling (IIS) regulates aging in worms, flies, and mice through a well-characterized, highly conserved core set of components. IIS also regulates early developmental decisions, the reproductive status of the animal, innate immunity, and stress-resistance functions. In C. elegans, the sole insulin/IGF-1 receptor, DAF-2, negatively regulates the FOXO transcription factor, DAF-16. We report here on a new component of the IIS longevity pathway, SMK-11, which specifically influences DAF-16-dependent regulation of the aging process in C. elegans by regulating the transcriptional specificity of DAF-16 activity. Localization analysis of DAF-16 places SMK-1 downstream of DAF-16's phosphorylation-dependent relocation to the nucleus. Physiological and transcription analyses indicate that smk-1 is required for the innate immune, UV, and oxidative stress but not the thermal stress functions of DAF-16. SMK-11 therefore plays a role in longevity by modulating DAF-16 transcriptional specificity without affecting other processes regulated by IIS.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Dillin, A (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Maciel, Gustavo A/D-2291-2009	Maciel, Gustavo A/0000-0001-9097-8528	NCI NIH HHS [CA82863] Funding Source: Medline; NIDDK NIH HHS [DK60367-02, DK070696] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070696, F32DK060367] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DORMAN JB, 1995, GENETICS, V141, P1399; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Friedman D.B., 1988, Journals of Gerontology, V43, P102; FRIEDMAN DB, 1988, GENETICS, V118, P75; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gems D, 1998, GENETICS, V150, P129; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; GOTTLIEB S, 1994, GENETICS, V137, P107; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mendoza MC, 2005, MOL CELL BIOL, V25, P7839, DOI 10.1128/MCB.25.17.7839-7853.2005; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Riddle DL, 1997, C ELEGANS; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Spradling AC, 1999, GENETICS, V153, P135; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tissenbaum HA, 1998, GENETICS, V148, P703; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wu HI, 2004, CANCER RES, V64, P3940, DOI 10.1158/0008-5472.CAN-03-3113	52	164	182	3	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 10	2006	124	5					1039	1053		10.1016/j.cell.2005.12.042	http://dx.doi.org/10.1016/j.cell.2005.12.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530049	Bronze			2022-12-28	WOS:000237241200024
J	Peers, G; Price, NM				Peers, G; Price, NM			Copper-containing plastocyanin used for electron transport by an oceanic diatom	NATURE			English	Article							TRACE-METALS; IRON REQUIREMENT; CENTRIC DIATOMS; COASTAL; PHYTOPLANKTON; CADMIUM; GROWTH; GENE; ZINC; LIMITATION	The supply of some essential metals to pelagic ecosystems is less than the demand, so many phytoplankton have slow rates of photosynthetic production and restricted growth(1). The types and amounts of metals required by phytoplankton depends on their evolutionary history(2) and on their adaptations to metal availability(3,4), which varies widely among ocean habitats. Diatoms, for example, need considerably less iron ( Fe) to grow than chlorophyll-b-containing taxa(2), and the oceanic species demand roughly one-tenth the amount of coastal strains(5-7). Like Fe, copper (Cu) is scarce in the open sea, but notably higher concentrations of it are required for the growth of oceanic than of coastal isolates(8). Here we report that the greater Cu requirement in an oceanic diatom, Thalassiosira oceanica, is entirely due to a single Cu-containing protein, plastocyanin, which - until now - was only known to exist in organisms with chlorophyll b and cyanobacteria. Algae containing chlorophyll c, including the closely related coastal species T. weissflogii, are thought to lack plastocyanin and contain a functionally equivalent Fe-containing homologue, cytochrome c(6) (ref. 9). Copper deficiency in T. oceanica inhibits electron transport regardless of Fe status, implying a constitutive role for plastocyanin in the light reactions of photosynthesis in this species. The results suggest that selection pressure imposed by Fe limitation has resulted in the use of a Cu protein for photosynthesis in an oceanic diatom. This biochemical switch reduces the need for Fe and increases the requirement for Cu, which is relatively more abundant in the open sea.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Peers, G (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	graham.peers@mail.mcgill.ca	Price, Neil M./A-8963-2008	Price, Neil M./0000-0001-9986-9213; Peers, Graham/0000-0002-3590-7820				Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Armbrust EV, 2001, APPL ENVIRON MICROB, V67, P3501, DOI 10.1128/AEM.67.8.3501-3513.2001; BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182, DOI 10.4319/lo.1983.28.6.1182; BRULAND KW, 1991, LIMNOL OCEANOGR, V36, P1555, DOI 10.4319/lo.1991.36.8.1555; BRULAND KW, 1980, EARTH PLANET SC LETT, V47, P176, DOI 10.1016/0012-821X(80)90035-7; Chang SI, 2000, ENVIRON SCI TECHNOL, V34, P4931, DOI 10.1021/es001213r; COALE KH, 1988, LIMNOL OCEANOGR, V33, P1084, DOI 10.4319/lo.1988.33.5.1084; Cullen JT, 1999, NATURE, V402, P165, DOI 10.1038/46007; da Silva J. J. R. Frausto, 2001, BIOL CHEM ELEMENTS; Inda LA, 1999, PHYTOCHEMISTRY, V51, P1, DOI 10.1016/S0031-9422(98)00493-2; La Fontaine S, 2002, EUKARYOT CELL, V1, P736, DOI 10.1128/EC.1.5.736-757.2002; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; MOFFETT JW, 1990, DEEP-SEA RES, V37, P27, DOI 10.1016/0198-0149(90)90027-S; Moffett JW, 1997, LIMNOL OCEANOGR, V42, P789, DOI 10.4319/lo.1997.42.5.0789; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Navarro JA, 2004, METH MOL B, V274, P79; Papageorgiou G.C., 2004, CHLOROPHYLL FLUORESC; Peers G, 2005, LIMNOL OCEANOGR, V50, P1149, DOI 10.4319/lo.2005.50.4.1149; Peers G, 2004, LIMNOL OCEANOGR, V49, P1774, DOI 10.4319/lo.2004.49.5.1774; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; RYTHER JH, 1961, ECOLOGY, V42, P444, DOI 10.2307/1932105; Schottler MA, 2004, PLANT PHYSIOL, V136, P4265, DOI 10.1104/pp.104.052324; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; STRZEPEK RF, 2003, THESIS U BRIT COLUMB; SUNDA WG, 1995, LIMNOL OCEANOGR, V40, P132, DOI 10.4319/lo.1995.40.1.0132; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Tortell PD, 1996, MAR ECOL PROG SER, V138, P245, DOI 10.3354/meps138245; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200	30	258	269	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					341	344		10.1038/nature04630	http://dx.doi.org/10.1038/nature04630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16572122				2022-12-28	WOS:000237593200046
J	Stellwagen, D; Malenka, RC				Stellwagen, D; Malenka, RC			Synaptic scaling mediated by glial TNF-alpha	NATURE			English	Article							QUANTAL AMPLITUDE; AMPA RECEPTORS; HOMEOSTATIC PLASTICITY; NEOCORTICAL SYNAPSES; DEFICIENT MICE; REQUIREMENT; REDISTRIBUTION; TRAFFICKING; ASTROCYTES; RESPONSES	Two general forms of synaptic plasticity that operate on different timescales are thought to contribute to the activity-dependent refinement of neural circuitry during development: (1) long-term potentiation (LTP) and long-term depression (LTD), which involve rapid adjustments in the strengths of individual synapses in response to specific patterns of correlated synaptic activity, and (2) homeostatic synaptic scaling, which entails uniform adjustments in the strength of all synapses on a cell in response to prolonged changes in the cell's electrical activity(1,2). Without homeostatic synaptic scaling, neural networks can become unstable and perform suboptimally(1-3). Although much is known about the mechanisms underlying LTP and LTD4, little is known about the mechanisms responsible for synaptic scaling except that such scaling is due, at least in part, to alterations in receptor content at synapses(5-7). Here we show that synaptic scaling in response to prolonged blockade of activity is mediated by the pro-inflammatory cytokine tumour-necrosis factor-alpha (TNF-alpha). Using mixtures of wild-type and TNF-alpha-deficient neurons and glia, we also show that glia are the source of the TNF-alpha that is required for this form of synaptic scaling. We suggest that by modulating TNF-alpha levels, glia actively participate in the homeostatic activity-dependent regulation of synaptic connectivity.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu						Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aguado F, 2002, J NEUROSCI, V22, P9430; Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Diamond JS, 2005, J NEUROSCI, V25, P2906, DOI 10.1523/JNEUROSCI.5125-04.2005; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Leslie KR, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-19-j0005.2001; Lin SC, 2004, GLIA, V47, P290, DOI 10.1002/glia.20060; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, J IMMUNOL, V160, P943; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; TROST LC, 1994, ANAL BIOCHEM, V220, P149, DOI 10.1006/abio.1994.1311; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005	30	1202	1225	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1054	1059		10.1038/nature04671	http://dx.doi.org/10.1038/nature04671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16547515				2022-12-28	WOS:000236906000037
J	Cook, G; Depares, J; Singh, M; McElduff, P				Cook, G; Depares, J; Singh, M; McElduff, P			Readmission after hysterectomy and prophylactic low molecular weight heparin: retrospective case-control study	BRITISH MEDICAL JOURNAL			English	Article								Objective To determine whether use of tinzaparin, a low molecular weight heparin introduced for prophylactic management of deep vein thrombosis increases the risk of serious postoperative bleeding leading to a higher than expected 28 day readmission rate after discharge for hysterectomy. Design Retrospective case-control study using computerised hospital inpatient data and review of case notes. Setting District general hospital. Subjects 2108 patients undergoing hysterectomy between August 1997 and March 2003. Main outcome measures Readmission and reoperation associated with bleeding. Results 54 cases of serious postoperative bleeding were identified, 46 of which were readmissions. These 54 cases were compared with 179 controls. Regression analysis indicated a positive relation between prophylaxis with tinzaparin and serious postoperative bleeding. There was a significant twofold increase in odds (odds ratio 2.02, 95% confidence interval 1.02 to 4.05) after adjustment for type of operation, age, and type of pain relief. Conclusions In the prophylactic treatment of thromboembolic disease after hysterectomy, compared with calci-heparin, tinzaperin is associated with a twofold increase in risk of serious postoperative bleeding.	Stepping Hill Hosp, Stockport NHS Trust, Dept Obstet & Gynaecol, Stockport SK2 7JE, Lancs, England; Hunter New England Populat Hlth, Hunter New England Area Hlth Serv, Wallsend, Australia		Cook, G (corresponding author), Stepping Hill Hosp, Stockport NHS Trust, Dept Obstet & Gynaecol, Stockport SK2 7JE, Lancs, England.	Gary.cook@stockport.nhs.uk		Singh, Maneesh/0000-0003-0852-7475				[Anonymous], EM READM HOSP FOLL D; Levine M N, 1988, Acta Chir Scand Suppl, V543, P73; *NHS EX, 2001, QUAL PERF NHS PERF I; STEINER RA, 1989, ARCH GYNECOL OBSTET, V244, P141, DOI 10.1007/BF00931291; VALLANO FA, 2002, REV CLIN ESP, V202, P583	5	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 8	2006	332	7545					819	820		10.1136/bmj.38783.624444.55	http://dx.doi.org/10.1136/bmj.38783.624444.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16540480	Bronze, Green Published			2022-12-28	WOS:000236815900017
J	Ponton, F; Lebarbenchon, C; Lefevre, T; Biron, DG; Duneau, D; Hughes, DP; Thomas, F				Ponton, F; Lebarbenchon, C; Lefevre, T; Biron, DG; Duneau, D; Hughes, DP; Thomas, F			Parasitology - Parasite survives predation on its host	NATURE			English	Editorial Material							TROPHIC TRANSMISSION; EVOLUTION; VIRULENCE		IRD, UMR CNRS IRD 2724, GEMI, F-34394 Montpellier 5, France; Stn Biol Tour Valat, F-13200 Arles, France; Inst Biol, Ctr Social Evolut, DK-21000 Copenhagen, Denmark	Institut de Recherche pour le Developpement (IRD)	Ponton, F (corresponding author), IRD, UMR CNRS IRD 2724, GEMI, BP 64501, F-34394 Montpellier 5, France.		PONTON, FLEUR/A-5516-2011; Lefèvre, Thierry/E-2157-2011; Lebarbenchon, Camille/H-7245-2013; duneau, david/E-2114-2011; Lebarbenchon, Camille/GLQ-7287-2022	Lefèvre, Thierry/0000-0002-9736-6142; Lebarbenchon, Camille/0000-0002-0922-7573; duneau, david/0000-0002-8323-1511; Lebarbenchon, Camille/0000-0002-0922-7573; Ponton, Fleur/0000-0001-7156-3896; THOMAS, Frederic/0000-0003-2238-1978				Brodeur Jacques, 1994, Norwegian Journal of Agricultural Sciences Supplement, V16, P147; Choisy M, 2003, AM NAT, V162, P172, DOI 10.1086/375681; Day T, 2002, P ROY SOC B-BIOL SCI, V269, P1317, DOI 10.1098/rspb.2002.2021; Ebert D, 1996, PARASITOL TODAY, V12, P96, DOI 10.1016/0169-4758(96)80668-5; Harvey JA, 2002, ECOLOGY, V83, P2439, DOI 10.1890/0012-9658(2002)083[2439:TDSOEW]2.0.CO;2; Lafferty KD, 1999, PARASITOL TODAY, V15, P111, DOI 10.1016/S0169-4758(99)01397-6; Moore J., 2002, PARASITES BEHAV ANIM; Parker GA, 2003, NATURE, V425, P480, DOI 10.1038/nature02012; Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x	10	35	37	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2006	440	7085					756	756		10.1038/440756a	http://dx.doi.org/10.1038/440756a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598248	Green Published			2022-12-28	WOS:000236548400032
J	Elmer, PJ; Obarzanek, E; Vollmer, WM; Simons-Morton, D; Stevens, VJ; Young, DR; Lin, PH; Champagne, C; Harsha, DW; Svetkey, LP; Ard, J; Brantley, PJ; Proschan, MA; Erlinger, TP; Appel, LJ				Elmer, PJ; Obarzanek, E; Vollmer, WM; Simons-Morton, D; Stevens, VJ; Young, DR; Lin, PH; Champagne, C; Harsha, DW; Svetkey, LP; Ard, J; Brantley, PJ; Proschan, MA; Erlinger, TP; Appel, LJ		PREMIER Collaborative Res Grp	Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-Month results of a randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							JOINT-NATIONAL-COMMITTEE; UNITED-STATES; VEGETABLE INTAKE; CLINICAL-TRIAL; 7TH REPORT; HYPERTENSION; RISK; PREVENTION; FRUIT; PATTERNS	Background: The main 6-month results from the PREMIER trial showed that comprehensive behavioral intervention programs improve lifestyle behaviors and lower blood pressure. Objective: To compare the 18-month effects of 2 multicomponent behavioral interventions versus advice only on hypertension status, lifestyle changes, and blood pressure. Design: Multicenter, 3-arm, randomized trial conducted from January 2000 through November 2002. Setting: 4 clinical centers and a coordinating center. Patients: 810 adult volunteers with prehypertension or stage 1 hypertension (systolic blood pressure, 120 to 159 mm Hg; diastolic blood pressure, 80 to 95 mm Hg). Interventions: A multicomponent behavioral intervention that implemented long-established recommendations ("established"); a multicomponent behavioral intervention that implemented the established recommendations plus the Dietary Approaches to Stop Hypertension (DASH) diet ("established plus DASH"); and advice only. Measurements: Lifestyle variables and blood pressure status. Follow-up for blood pressure measurement at 18 months was 94%. Results: Compared with advice only, both behavioral interventions statistically significantly reduced weight, fat intake, and sodium intake. The established plus DASH intervention also statistically significantly increased fruit, vegetable, dairy, fiber, and mineral intakes. Relative to the advice only group, the odds ratios for hypertension at 18 months were 0.83 (95% Cl, 0.67 to 1.04) for the established group and 0.77 (Cl, 0.62 to 0.97) for the established plus DASH group. Although reductions in absolute blood pressure at 18 months were greater for participants in the established and the established plus DASH groups than for the advice only group, the differences were not statistically significant. Limitations: The exclusion criteria and the volunteer nature of this cohort may limit generalizability. Although blood pressure is a well-accepted risk factor for cardiovascular disease, the authors were not able to assess intervention effects on clinical cardiovascular events in this limited time and with this sample size. Conclusions: Over 18 months, persons with prehypertension and stage 1 hypertension can sustain multiple lifestyle modifications that improve control of blood pressure and could reduce the risk for chronic disease.	Kaiser Permanente, Ctr Hlth Res, Portland, OR 97227 USA; NHLBI, Bethesda, MD 20892 USA; Univ Maryland, College Pk, MD 20742 USA; Duke Univ, Med Ctr, Durham, NC 27706 USA; Pennington Biomed Res Ctr, Baton Rouge, LA USA; Univ Alabama Birmingham, Birmingham, AL 35233 USA; Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Kaiser Permanente; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Maryland; University of Maryland College Park; Duke University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University; Johns Hopkins Medicine	Vollmer, WM (corresponding author), Kaiser Permanente, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	William.Vollmer@kpchr.org	Brantley, Phillip/N-1952-2017; Champagne, Catherine/N-1956-2017; Appel, Larry/GLT-2608-2022	Brantley, Phillip/0000-0003-4721-7445; Champagne, Catherine/0000-0001-6127-1072; Ard, Jamy/0000-0002-1643-6795	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL060573, U01HL060570, U01HL060571, U01HL060574, U01HL062828] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AM CANC SOC, 2003, CANC FACTS FIG; [Anonymous], 2001, JAMA-J AM MED ASSOC, V285, P785, DOI [DOI 10.1001/JAMA.285.6.785, 10.1001/jama.285.6.785]; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BLAIR SN, 1985, AM J EPIDEMIOL, V122, P794, DOI 10.1093/oxfordjournals.aje.a114163; Blaufox M D, 1984, J Hypertens Suppl, V2, pS179; Byers T, 2002, CA-CANCER J CLIN, V52, P92, DOI 10.3322/canjclin.52.2.92; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; DRINKWATER BL, 1995, MED SCI SPORT EXER, V27, pR1; Fields LE, 2004, HYPERTENSION, V44, P398, DOI 10.1161/01.HYP.0000142248.54761.56; Ford ES, 2001, PREV MED, V32, P33, DOI 10.1006/pmed.2000.0772; FOX TA, 1992, J AM DIET ASSOC, V92, P729; Fung TT, 2001, ARCH INTERN MED, V161, P1857, DOI 10.1001/archinte.161.15.1857; FUNK KL, 2006, IN PRESS HLTH PROMOT; Glade M.J., 1997, AM I CANC RES CANC R, V15, P523, DOI [10.1016/s0899-9007(99)00021-0, DOI 10.1016/S0899-9007(99)00021-0]; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Heimendinger J, 1996, ADV EXP MED BIOL, V401, P199; Hill JO, 2002, OBES RES, V10, p124S, DOI 10.1038/oby.2002.205; HOLM S, 1979, SCAND J STAT, V6, P65; *I MED, 2002, DIET INT EN CARB FIB; *I MED, 1999, DRI DIET TREF INT CA, P190; Institute of Medicine, 1998, DIET REF INT THIAM R; Institute of Medicine, 2001, DIET REF INT VIT A V; IOM, 2000, DIET REF INT VIT C V; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Karanja NM, 1999, J AM DIET ASSOC, V99, pS19, DOI 10.1016/S0002-8223(99)00412-5; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Lewis CE, 2000, AM J EPIDEMIOL, V151, P1172, DOI 10.1093/oxfordjournals.aje.a010167; McCullough ML, 2000, AM J CLIN NUTR, V72, P1223; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Reeves MJ, 2005, ARCH INTERN MED, V165, P854, DOI 10.1001/archinte.165.8.854; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Stamler J, 2002, HYPERTENSION, V39, P1000, DOI 10.1161/01.HYP.0000016178.80811.D9; Stevens VJ, 2001, ANN INTERN MED, V134, P1, DOI 10.7326/0003-4819-134-1-200101020-00007; SUBAR AF, 1995, AM J HEALTH PROMOT, V9, P352, DOI 10.4278/0890-1171-9.5.352; Svetkey LP, 2003, ANN EPIDEMIOL, V13, P462, DOI 10.1016/S1047-2797(03)00006-1; Tucker KL, 1999, AM J CLIN NUTR, V69, P727; *US DHHS, 1998, CLIN GUID ID EV TREA; *US DHHS, 2001, SURG GEN CALL ACT PR; *USDA, 2005, HOM GARD B, V232; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Whelton PK, 1998, JAMA-J AM MED ASSOC, V279, P839, DOI 10.1001/jama.279.11.839; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657	50	416	441	0	58	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					485	495		10.7326/0003-4819-144-7-200604040-00007	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585662				2022-12-28	WOS:000236685100003
J	Ramzy, RMR; El Setouhy, M; Helmy, H; Ahmed, ES; Abd Elaziz, KM; Farid, HA; Shannon, WD; Weil, GJ				Ramzy, RMR; El Setouhy, M; Helmy, H; Ahmed, ES; Abd Elaziz, KM; Farid, HA; Shannon, WD; Weil, GJ			Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; WUCHERERIA-BANCROFTI; LYMPHATIC FILARIASIS; CULEX-PIPIENS; HUMAN BLOOD; DIAGNOSIS; INFECTION; PROGRAM; MICROFILAREMIA; TRANSMISSION	Background Egypt was one of the first countries to implement a national programme to eliminate lymphatic filariasis based on WHO's strategy of repeated rounds of mass drug administration (MDA) with diethylcarbamazine and albendazole (target population, 2.5 million in 181 localities). We assessed the effect of five yearly rounds of MDA on filariasis in four sentinel villages in Egypt. Methods We studied two areas with different infection rates before MDA: the Qalubyia study area had a low infection rate because of previous treatment with diethylcarbamazine; this was typical of most filariasis-endemic villages in Egypt before MDA. The Giza study area had a high baseline infection rate. We undertook repeated surveys in villages for treatment compliance and tests for microfilaraemia. and circulating filarial antigenaemia, antibodies to filarial antigen Bm14 in schoolchildren, and infections in indoor-resting mosquitoes (assessed by PCR). Findings MDA compliance rates were excellent (>80%). In Giza after MDA, prevalence rates of microfilaraemia and circulating filarial antigenaemia fell from 11.5% to 1.2%, and from 19.0% to 4.8%, respectively (p<0.0001). Corresponding rates in Qalubyia fell from 3.1% to 0% and 13.6% to 3.1%, respectively (p<0.0001). Rates of antifilarial antibody and circulating filarial antigenaemia in schoolchildren (aged about 7-8 years), fell from 18.3% to 0.2% (p<0.0001) and from 10.0% to 0.4% (p<0.0001) in Giza, respectively, and from 1.7% to 0% and 1.7% to 0% (both p=0.13) in Qalubyia, respectively. Mosquito infection rates fell from 3.07% (95% CI 2.38-3.88) to 0.19% (0.08-0.38) in Giza and from 4.37% (3.07-5.99) to 0% (0-0.05) in Qalubyia. Interpretation MDA greatly affects variables related to infection (microfilaraemia and circulating filarial antigenaemia prevalence rates) and transmission (antifilarial antibodies in young children and mosquito infection rates). Our results suggest that after five rounds of MDA filariasis is likely to have been eliminated in most endemic localities in Egypt.	Washington Univ, Sch Med, Div Infect Dis, St Louis, MO 63110 USA; Ain Shams Univ, Res & Traiing Ctr Vectors Dis, Cairo, Egypt	Washington University (WUSTL); Egyptian Knowledge Bank (EKB); Ain Shams University	Weil, GJ (corresponding author), Washington Univ, Sch Med, Div Infect Dis, Campus Box 8051, St Louis, MO 63110 USA.	gweil@im.wustl.edu	Elaziz, Khaled Abd/R-1620-2019; El-Setouhy, Maged/B-6021-2019; Ramzy, Reda/AAE-4906-2020	Elaziz, Khaled Abd/0000-0002-4437-128X; Ramzy, Reda/0000-0003-0225-2669; Farid, Hoda/0000-0001-6384-7151	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035855] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-35855] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; CHANDRASHEKAR R, 1994, MOL BIOCHEM PARASIT, V64, P261, DOI 10.1016/0166-6851(94)00035-2; De Rochars MB, 2005, AM J TROP MED HYG, V73, P888, DOI 10.4269/ajtmh.2005.73.888; Dean A.G., 1994, EPI INFO VERSION 6 W; El Setouhy M, 2004, AM J TROP MED HYG, V70, P191, DOI 10.4269/ajtmh.2004.70.191; Farid HA, 2003, AM J TROP MED HYG, V68, P286, DOI 10.4269/ajtmh.2003.68.286; Farid HA, 2001, T ROY SOC TROP MED H, V95, P29, DOI 10.1016/S0035-9203(01)90322-0; FARIS R, 1993, T ROY SOC TROP MED H, V87, P659, DOI 10.1016/0035-9203(93)90277-W; Fraser M, 2005, AM J TROP MED HYG, V73, P753, DOI 10.4269/ajtmh.2005.73.753; HARB M, 1993, B WORLD HEALTH ORGAN, V71, P49; Ismail MM, 2001, T ROY SOC TROP MED H, V95, P332, DOI 10.1016/S0035-9203(01)90257-3; Lammie Patrick J, 2004, Filaria J, V3, P9, DOI 10.1186/1475-2883-3-9; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; MICHAEL E, IN PRESS TRENDS PARA; MOLYNEUX D, 2001, T R SOC TROP MED HYG, V94, P589; Ottesen EA, 1997, B WORLD HEALTH ORGAN, V75, P491; Rajendran R, 2004, T ROY SOC TROP MED H, V98, P174, DOI 10.1016/S0035-9203(03)00042-7; Ramzy R M, 1999, East Mediterr Health J, V5, P880; Ramzy RMR, 1997, T ROY SOC TROP MED H, V91, P156, DOI 10.1016/S0035-9203(97)90205-4; RAMZY RMR, 1995, ANN TROP MED PARASIT, V89, P443, DOI 10.1080/00034983.1995.11812974; Ramzy RMR, 2002, AM J TROP MED HYG, V67, P196, DOI 10.4269/ajtmh.2002.67.196; REMME J, 1986, B WORLD HEALTH ORGAN, V64, P667; Simonsen PE, 2004, AM J TROP MED HYG, V70, P63, DOI 10.4269/ajtmh.2004.70.63; Southgate B A, 1979, Trop Dis Bull, V76, P1045; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; Weil GJ, 1997, PARASITOL TODAY, V13, P401, DOI 10.1016/S0169-4758(97)01130-7; WHO, 2005, WHOCDSCPECEE200550; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P202; Xu BL, 1997, CHINESE MED J-PEKING, V110, P807; 2003, GLOBAL ELIMINATION L	32	140	143	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					992	999		10.1016/S0140-6736(06)68426-2	http://dx.doi.org/10.1016/S0140-6736(06)68426-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564361				2022-12-28	WOS:000236474200027
J	Qian, SB; McDonough, H; Boellmann, F; Cyr, DM; Patterson, C				Qian, SB; McDonough, H; Boellmann, F; Cyr, DM; Patterson, C			CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70	NATURE			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTIONAL ACTIVITY; CHAPERONE; PROTEIN; LIGASE; DEGRADATION; ACTIVATION; PROTECTION; THERMOTOLERANCE; IDENTIFICATION	Exposure of cells to various stresses often leads to the induction of a group of proteins called heat shock proteins (HSPs, molecular chaperones)(1,2). Hsp70 is one of the most highly inducible molecular chaperones, but its expression must be maintained at low levels under physiological conditions to permit constitutive cellular activities to proceed(3,4). Heat shock transcription factor 1 (HSF1) is the transcriptional regulator of HSP gene expression(5), but it remains poorly understood how newly synthesized HSPs return to basal levels when HSF1 activity is attenuated. CHIP (carboxy terminus of Hsp70-binding protein), a dual-function co-chaperone/ubiquitin ligase, targets a broad range of chaperone substrates for proteasomal degradation(6-11). Here we show that CHIP not only enhances Hsp70 induction during acute stress but also mediates its turnover during the stress recovery process. Central to this dual-phase regulation is its substrate dependence: CHIP preferentially ubiquitinates chaperone-bound substrates, whereas degradation of Hsp70 by CHIP-dependent targeting to the ubiquitin-proteasome system occurs when misfolded substrates have been depleted. The sequential catalysis of the CHIP-associated chaperone adaptor and its bound substrate provides an elegant mechanism for maintaining homeostasis by tuning chaperone levels appropriately to reflect the status of protein folding within the cytoplasm.	Univ N Carolina, Sch Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Patterson, C (corresponding author), Univ N Carolina, Sch Med, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA.	cpatters@med.unc.edu		Cyr, Douglas/0000-0002-4928-3414	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061728] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061728] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Guo YL, 2001, J BIOL CHEM, V276, P45791, DOI 10.1074/jbc.M105931200; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	26	274	289	3	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					551	555		10.1038/nature04600	http://dx.doi.org/10.1038/nature04600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554822	Green Accepted, Green Published			2022-12-28	WOS:000236176100060
J	Pompilio, L; Kacelnik, A; Behmer, ST				Pompilio, L; Kacelnik, A; Behmer, ST			State-dependent learned valuation drives choice in an invertebrate	SCIENCE			English	Article							PHYTOPHAGOUS INSECTS; DIETARY SELECTION; HUNGRY LOCUST; STARLINGS; SENSITIVITY	Humans and other vertebrates occasionally show a preference for items remembered to be costly or experienced when the subject was in a poor condition (this is known as a sunk-costs fallacy or state-dependent valuation). Whether these mechanisms shared across vertebrates are the result of convergence toward an adaptive solution or evolutionary relicts reflecting common ancestral traits is unknown. Here we show that state-dependent valuation also occurs in an invertebrate, the desert locust Schistocerca gregaria (Orthoptera: Acrididae). Given the latter's phylogenetic and neurobiological distance from those groups in which the phenomenon was already known, we suggest that state-dependent valuation mechanisms are probably ecologically rational solutions to widespread problems of choice.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Kacelnik, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	alex.kacelnik@zoo.ox.ac.uk		Behmer, Spencer/0000-0002-5038-1046				ABISGOLD JD, 1988, J EXP BIOL, V135, P215; BALLEINE BW, 2006, BEHAV LAB RATS HDB T, P436; Behmer ST, 2005, J EXP BIOL, V208, P3463, DOI 10.1242/jeb.01767; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Burrows M., 1996, NEUROBIOLOGY INSECT; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Clement TS, 2000, PSYCHON B REV, V7, P100, DOI 10.3758/BF03210727; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Gigerenzer G, 2004, BEHAV BRAIN SCI, V27, P336, DOI 10.1017/S0140525X04310083; Kacelnik A, 2002, ANIM BEHAV, V63, P245, DOI 10.1006/anbe.2001.1900; Marsh B, 2004, BEHAV ECOL, V15, P396, DOI 10.1093/beheco/arh034; Pompilio L, 2005, ANIM BEHAV, V70, P571, DOI 10.1016/j.anbehav.2004.12.009; REAL LA, 1992, AM NAT, V140, P108; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Sibly R.M., 1981, P109; SIMPSON CL, 1990, ENTOMOL EXP APPL, V56, P259, DOI 10.1007/BF00163697; Simpson SJ, 2000, ADV STUD BEHAV, V29, P1, DOI 10.1016/S0065-3454(08)60102-3; SIMPSON SJ, 1992, J EXP BIOL, V168, P269; SIMPSON SJ, 1991, APPETITE, V17, P141, DOI 10.1016/0195-6663(91)90069-5	20	107	109	1	192	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1613	1615		10.1126/science.1123924	http://dx.doi.org/10.1126/science.1123924			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543461				2022-12-28	WOS:000236029500047
J	Papanikolaou, EG; Camus, M; Kolibianakis, EM; Van Landuyt, L; Van Steirteghem, A; Devroey, P				Papanikolaou, EG; Camus, M; Kolibianakis, EM; Van Landuyt, L; Van Steirteghem, A; Devroey, P			In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; ANEUPLOID EMBRYOS; BIRTH; IVF; CULTURE; COUPLES; IMPLANTATION; PREGNANCY; CYCLES; TRIAL	Background: Single-embryo transfer has been recommended to reduce the incidence of multiple gestations when in vitro fertilization is performed in women under 36 years of age. We designed a prospective, randomized, controlled trial to determine whether there were any differences in the rates of pregnancy and delivery between women undergoing transfer of a single cleavage-stage (day 3) embryo and those undergoing transfer of a single blastocyst-stage (day 5) embryo. Methods: We studied 351 infertile women under 36 years of age who were randomly assigned to undergo transfer of either a single cleavage-stage embryo (176 patients) or a single blastocyst-stage embryo (175 patients). Multifollicular ovarian stimulation was performed with a gonadotropin-releasing hormone antagonist and recombinant follicle-stimulating hormone. Results: The study was terminated early after a prespecified interim analysis (which included 50 percent of the planned number of patients) found a higher rate of pregnancy among women undergoing transfer of a single blastocyst-stage embryo (P=0.02). The rate of delivery was also significantly higher in this group than in the group undergoing transfer of a single cleavage-stage embryo (32.0 percent vs. 21.6 percent; relative risk, 1.48; 95 percent confidence interval, 1.04 to 2.11). Two multiple births occurred, both of monozygotic twins, both of which were in the group undergoing transfer of a single cleavage-stage embryo. Conclusions: These findings support the transfer of a single blastocyst-stage (day 5) embryo in infertile women under 36 years of age.	Free Univ Brussels, Akad Ziekenhuis, Ctr Reprod Med, B-1090 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Papanikolaou, EG (corresponding author), Free Univ Brussels, Akad Ziekenhuis, Ctr Reprod Med, Laarbeeklaan 101, B-1090 Brussels, Belgium.	evangelos.papanikolaou@vub.ac.be	Kolibianakis, Efstratios/P-3441-2014	Kolibianakis, Efstratios/0000-0003-0031-9460; Van Landuyt, Lisbet/0000-0003-0043-3677				Andersen AN, 2004, HUM REPROD, V19, P490, DOI 10.1093/humrep/deh129; Barlow DH, 2005, HUM REPROD, V20, P1, DOI 10.1093/humrep/deh649; Behr B, 2000, J ASSIST REPROD GEN, V17, P349, DOI 10.1023/A:1009461213139; Bergh C, 2005, HUM REPROD, V20, P323, DOI 10.1093/humrep/deh744; Blake DA, 2004, HUM REPROD, V19, P2174, DOI 10.1093/humrep/deh480; Blennborn M, 2005, HUM REPROD, V20, P1292, DOI 10.1093/humrep/deh785; Coetsier T, 1998, HUM REPROD, V13, P2663, DOI 10.1093/humrep/13.10.2663; Crowther CA, 2002, HIGH RISK PREGNANCY, P129; Davis OK, 2004, NEW ENGL J MED, V351, P2440, DOI 10.1056/NEJMe048268; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Gardner David K, 2003, Reprod Biomed Online, V6, P470; Gardner DK, 2004, FERTIL STERIL, V81, P551, DOI 10.1016/j.fertnstert.2003.07.023; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Gerris JMR, 2005, HUM REPROD UPDATE, V11, P105, DOI 10.1093/humupd/dmh049; Kissin DM, 2005, HUM REPROD, V20, P2215, DOI 10.1093/humrep/dei025; Magli MC, 2000, HUM REPROD, V15, P1781, DOI 10.1093/humrep/15.8.1781; Marek D, 1999, FERTIL STERIL, V72, P1035, DOI 10.1016/S0015-0282(99)00409-4; Milki AA, 2004, FERTIL STERIL, V81, P1697, DOI 10.1016/j.fertnstert.2003.10.050; Milki AA, 2003, FERTIL STERIL, V79, P503, DOI 10.1016/S0015-0282(02)04754-4; Munne S, 2004, PRENATAL DIAG, V24, P638, DOI 10.1002/pd.957; Olivius C, 2004, FERTIL STERIL, V81, P258, DOI 10.1016/j.fertnstert.2003.06.029; Ombelet W, 2005, HUM REPROD UPDATE, V11, P3, DOI 10.1093/humupd/dmh048; Papanikolaou EG, 2005, HUM REPROD, V20, P3198, DOI 10.1093/humrep/dei217; Papanikolaou EG, 2005, HUM REPROD, V20, P1541, DOI 10.1093/humrep/deh793; Rijnders PM, 1998, HUM REPROD, V13, P2869, DOI 10.1093/humrep/13.10.2869; Soc As Reprod Tech Amer Reprod Med, 2004, FERTIL STERIL, V81, P1207, DOI 10.1016/j.fertnstert.2004.01.017; Staessen C, 2004, HUM REPROD, V19, P2849, DOI 10.1093/humrep/deh536; STEPTOE PC, 1978, LANCET, V2, P366; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; Tsirigotis M, 1998, HUM REPROD, V13, P3285, DOI 10.1093/humrep/13.12.3285; Van den Abbeel E, 2005, HUM REPROD, V20, P2939, DOI 10.1093/humrep/dei134; Van Landuyt L, 2005, FERTIL STERIL, V83, P1397, DOI 10.1016/j.fertnstert.2004.10.054	33	265	283	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1139	1146		10.1056/NEJMoa053524	http://dx.doi.org/10.1056/NEJMoa053524			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540614	Bronze			2022-12-28	WOS:000235981700007
J	Rytter, MJH; Kjaeldgaard, AL; Bronnum-Hansen, H; Helweg-Larsen, K				Rytter, Maren Johanne Heilskov; Kjaeldgaard, Anne-Lene; Bronnum-Hansen, Henrik; Helweg-Larsen, Karin			Effects of armed conflict on access to emergency health care in Palestinian West Bank: systematic collection of data in emergency departments	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To assess the impact of restrictions in access to hospital services imposed on the civilian population during the armed conflict in the Palestinian territories occupied by Israel. Design Consecutive registration of demographic and medical data, with information about transportation time, delay in access to hospital, and course of hospital contact. Setting Three hospital emergency departments in Bethlehem and Nablus, in the occupied Palestinian West Bank, during one week in each hospital. Participants All patients seeking health care in the three hospitals during the study period. Results A total of 394 of the 2228 emergency department contacts reported being delayed at checkpoints or by detours on their way to the emergency department. Hospital admission was significantly more common for these patients: 32% (n = 125) compared with 13% (n = 205) among those who were not delayed. Conclusion 18% of the emergency department contacts were delayed because of the occupation. The higher hospital admission rate in this group suggests that restrictions in access to hospital services influence the severity of the medical conditions presented.	Natl Inst Publ Hlth, DK-1399 Copenhagen, Denmark		Helweg-Larsen, K (corresponding author), Natl Inst Publ Hlth, Oster Farimagsgade 5A, DK-1399 Copenhagen, Denmark.	khl@niph.dk	Rytter, Maren JH/G-3279-2016	Rytter, Maren JH/0000-0002-9490-9586; Bronnum-Hansen, Henrik/0000-0003-3513-7245				Bertini Catherine, 2002, MISSION REPORT; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; LENIN Y, 2004, FORBIDDEN ROAD ISRAE	3	20	21	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2006	332	7550					1122	1124		10.1136/bmj.38793.695081.AE	http://dx.doi.org/10.1136/bmj.38793.695081.AE			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16585049	Green Published, Bronze			2022-12-28	WOS:000237682700016
J	Gewin, V				Gewin, V			Biologist aims to ease the pain for entrepreneurs	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2006	440	7085					738	739		10.1038/440738a	http://dx.doi.org/10.1038/440738a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598227				2022-12-28	WOS:000236548400014
J	Lunin, VV; Dobrovetsky, E; Khutoreskaya, G; Zhang, RG; Joachimiak, A; Doyle, DA; Bochkarev, A; Maguire, ME; Edwards, AM; Koth, CM				Lunin, VV; Dobrovetsky, E; Khutoreskaya, G; Zhang, RG; Joachimiak, A; Doyle, DA; Bochkarev, A; Maguire, ME; Edwards, AM; Koth, CM			Crystal structure of the CorA Mg2+ transporter	NATURE			English	Article							GATED ION CHANNELS; MAGNESIUM TRANSPORT; SALMONELLA-TYPHIMURIUM; TRANSMEMBRANE HELICES; POTASSIUM CHANNEL; CONDUCTION; MEMBRANE; PROTEINS; RECEPTOR; HOMOLOG	The magnesium ion, Mg2+, is essential for myriad biochemical processes and remains the only major biological ion whose transport mechanisms remain unknown. The CorA family of magnesium transporters is the primary Mg2+ uptake system of most prokaryotes(1-3) and a functional homologue of the eukaryotic mitochondrial magnesium transporter(4). Here we determine crystal structures of the full-length Thermotoga maritima CorA in an apparent closed state and its isolated cytoplasmic domain at 3.9 angstrom and 1.85 angstrom resolution, respectively. The transporter is a funnel-shaped homopentamer with two transmembrane helices per monomer. The channel is formed by an inner group of five helices and putatively gated by bulky hydrophobic residues. The large cytoplasmic domain forms a funnel whose wide mouth points into the cell and whose walls are formed by five long helices that are extensions of the transmembrane helices. The cytoplasmic neck of the pore is surrounded, on the outside of the funnel, by a ring of highly conserved positively charged residues. Two negatively charged helices in the cytoplasmic domain extend back towards the membrane on the outside of the funnel and abut the ring of positive charge. An apparent Mg2+ ion was bound between monomers at a conserved site in the cytoplasmic domain, suggesting a mechanism to link gating of the pore to the intracellular concentration of Mg2+.	Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L6, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5G 1L6, Canada; Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; Argonne Natl Lab, Midwest Ctr Struct Genom, Biosci Div, Argonne, IL 60439 USA; Botnar Res Ctr, Struct Genom Consortium, Oxford OX3 7LD, England; Banting & Best Inst, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	University of Toronto; University of Toronto; University of Toronto; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Oxford; University of Toronto; Structural Genomics Consortium; Case Western Reserve University	Maguire, ME (corresponding author), Univ Toronto, Dept Med Biophys, 112 Coll St, Toronto, ON M5G 1L6, Canada.	mem6@cwru.edu; aled.edwards@utoronto.ca		Koth, Christopher/0000-0003-3939-8856; Edwards, Aled/0000-0002-4782-6016	NIGMS NIH HHS [U54 GM074942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; DeLano W., PYMOL; Doyle DA, 2004, MOL MEMBR BIOL, V21, P221, DOI 10.1080/09687680410001716844; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gardner RC, 2003, CURR OPIN PLANT BIOL, V6, P263, DOI 10.1016/S1369-5266(03)00032-3; HMIEL SP, 1986, J BACTERIOL, V168, P1444, DOI 10.1128/jb.168.3.1444-1450.1986; Kehres D G, 1998, Microb Comp Genomics, V3, P151, DOI 10.1089/omi.1.1998.3.151; Kehres DG, 2002, BIOMETALS, V15, P261, DOI 10.1023/A:1016078832697; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LESTER HA, 1992, ANNU REV BIOPH BIOM, V21, P267, DOI 10.1146/annurev.bb.21.060192.001411; MacKinnon R, 2004, BIOSCIENCE REP, V24, P75, DOI 10.1007/s10540-004-7190-2; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; NELSON DL, 1971, J BIOL CHEM, V246, P3042; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Szegedy MA, 1999, J BIOL CHEM, V274, P36973, DOI 10.1074/jbc.274.52.36973; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Worlock AJ, 2002, J BACTERIOL, V184, P4369, DOI 10.1128/JB.184.16.4369-4373.2002	25	185	196	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					833	837		10.1038/nature04642	http://dx.doi.org/10.1038/nature04642			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598263	Green Accepted			2022-12-28	WOS:000236548400049
J	Pal, C; Papp, B; Lercher, MJ; Csermely, P; Oliver, SG; Hurst, LD				Pal, C; Papp, B; Lercher, MJ; Csermely, P; Oliver, SG; Hurst, LD			Chance and necessity in the evolution of minimal metabolic networks	NATURE			English	Article							GENOME SEQUENCE; GENE-SETS; BUCHNERA; SYMBIONTS; BACTERIA; SIZE	It is possible to infer aspects of an organism's lifestyle from its gene content(1). Can the reverse also be done? Here we consider this issue by modelling evolution of the reduced genomes of endosymbiotic bacteria. The diversity of gene content in these bacteria may reflect both variation in selective forces and contingency-dependent loss of alternative pathways. Using an in silico representation of the metabolic network of Escherichia coli, we examine the role of contingency by repeatedly simulating the successive loss of genes while controlling for the environment. The minimal networks that result are variable in both gene content and number. Partially different metabolisms can thus evolve owing to contingency alone. The simulation outcomes do preserve a core metabolism, however, which is over-represented in strict intracellular bacteria. Moreover, differences between minimal networks based on lifestyle are predictable: by simulating their respective environmental conditions, we can model evolution of the gene content in Buchnera aphidicola and Wigglesworthia glossinidia with over 80% accuracy. We conclude that, at least for the particular cases considered here, gene content of an organism can be predicted with knowledge of its distant ancestors and its current lifestyle.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; European Mol Biol Lab, D-69012 Heidelberg, Germany; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Semmelweis Univ, Dept Med Chem, H-1444 Budapest, Hungary	University of Bath; European Molecular Biology Laboratory (EMBL); University of Oxford; University of Manchester; Semmelweis University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Csermely, Peter/J-2067-2017; Lercher, Martin/K-7939-2013; Hurst, Laurence/F-9215-2010	Csermely, Peter/0000-0001-9234-0659; Lercher, Martin/0000-0003-3940-1621; Papp, Balazs/0000-0003-3093-8852; Hurst, Laurence/0000-0002-1002-1054	Biotechnology and Biological Sciences Research Council [E19354] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Burgard AP, 2001, BIOTECHNOL PROGR, V17, P791, DOI 10.1021/bp0100880; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Cormen T.H., 2001, INTRO ALGORITHMS, V2nd ed.; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Moran NA, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-12-research0054; Mushegian AR, 1996, P NATL ACAD SCI USA, V93, P10268, DOI 10.1073/pnas.93.19.10268; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oliver SG, 1996, NATURE, V379, P597, DOI 10.1038/379597a0; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	30	172	182	0	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					667	670		10.1038/nature04568	http://dx.doi.org/10.1038/nature04568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572170				2022-12-28	WOS:000236350400043
J	Beckstead, RB; Thummell, CS				Beckstead, RB; Thummell, CS			Indicted: Worms caught using steroids	CELL			English	Review							C-ELEGANS; LIFE-SPAN; REPRODUCTIVE DEVELOPMENT; DAUER DIAPAUSE; SIGNALS; CYTOCHROME-P450; RECEPTOR; DAF-16	Three recent papers provide new insights into endocrinology in the worm Caenorhabditis elegans. These studies identify natural steroid ligands for the DAF-12 nuclear receptor, define a new enzyme in the hormone biosynthetic pathway, and clarify the role of endocrine signaling in adult longevity.	Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Thummell, CS (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA.	carl.thummel@genetics.utah.edu						Antebi A, 2000, GENE DEV, V14, P1512; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Gerisch B, 2004, DEVELOPMENT, V131, P1765, DOI 10.1242/dev.01068; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gill MS, 2004, AGING CELL, V3, P413, DOI 10.1111/j.1474-9728.2004.00126.x; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Jia KL, 2002, DEVELOPMENT, V129, P221; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; King-Jones K, 2005, SCIENCE, V310, P630, DOI 10.1126/science.1120410; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Mak HY, 2004, DEVELOPMENT, V131, P1777, DOI 10.1242/dev.01069; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; PARDEE K, 2004, SCI AGING KNOWLEDGE, pRE8, DOI DOI 10.1126/SAGEKE.2004.47.RE8; Riddle DL, 1997, C ELEGANS, P739; ROTTIERS V, 2006, DEV CELL; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2	17	23	25	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1137	1140		10.1016/j.cell.2006.03.001	http://dx.doi.org/10.1016/j.cell.2006.03.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564008	Bronze			2022-12-28	WOS:000237241400015
J	Chen, ZH; Appenzeller, J; Lin, YM; Sippel-Oakley, J; Rinzler, AG; Tang, JY; Wind, SJ; Solomon, PM; Avouris, P				Chen, ZH; Appenzeller, J; Lin, YM; Sippel-Oakley, J; Rinzler, AG; Tang, JY; Wind, SJ; Solomon, PM; Avouris, P			An integrated logic circuit assembled on a single carbon nanotube	SCIENCE			English	Article							TRANSISTORS		IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Univ Florida, Dept Phys, Gainesville, FL 32611 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA; Columbia Univ, Dept Appl Phys & Appl Math, New York, NY 10027 USA	International Business Machines (IBM); State University System of Florida; University of Florida; Columbia University; Columbia University	Appenzeller, J (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	joerga@us.ibm.com; avouris@us.ibm.com	Chen, Zhihong/D-2019-2012; Tang, Jinyao/I-3851-2012	Avouris, Phaedon/0000-0001-9902-8000; Tang, Jinyao/0000-0002-0051-148X				Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Javey A, 2002, NANO LETT, V2, P929, DOI [10.1021/nl025647r, 10.1021/n1025647r]; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; Tans SJ, 1998, NATURE, V393, P49, DOI 10.1038/29954	4	476	538	2	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1735	1735		10.1126/science.1122797	http://dx.doi.org/10.1126/science.1122797			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556834				2022-12-28	WOS:000236204300032
J	Joughin, I				Joughin, I			Climate change - Greenland rumbles louder as glaciers accelerate	SCIENCE			English	Editorial Material							ICE-SHEET		Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Joughin, I (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, 1013 NE 40th St, Seattle, WA 98105 USA.	ian@apl.washington.edu	Joughin, Ian R/A-2998-2008; Joughin, Ian/AAR-7778-2021	Joughin, Ian R/0000-0001-6229-679X; Joughin, Ian/0000-0001-6229-679X				Bindschadler RA, 2003, SCIENCE, V301, P1087, DOI 10.1126/science.1087231; Chylek P, 2004, CLIMATIC CHANGE, V63, P201, DOI 10.1023/B:CLIM.0000018509.74228.03; Ekstrom G, 2006, SCIENCE, V311, P1756, DOI 10.1126/science.1122112; Ekstrom G, 2003, SCIENCE, V302, P622, DOI 10.1126/science.1088057; Howat IM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024737; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Sohn HG, 1998, GEOPHYS RES LETT, V25, P2699, DOI 10.1029/98GL01973; WEIDICK A, 1995, 1386C US GEOL SOC	9	27	27	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1719	1720		10.1126/science.1124496	http://dx.doi.org/10.1126/science.1124496			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556827				2022-12-28	WOS:000236204300025
J	Weissman, MM; Pilowsky, DJ; Wickramaratne, PJ; Talati, A; Wisniewski, SR; Fava, M; Hughes, CW; Garber, J; Malloy, E; King, CA; Cerda, G; Sood, AB; Alpert, JE; Trivedi, MH; Rush, AJ				Weissman, MM; Pilowsky, DJ; Wickramaratne, PJ; Talati, A; Wisniewski, SR; Fava, M; Hughes, CW; Garber, J; Malloy, E; King, CA; Cerda, G; Sood, AB; Alpert, JE; Trivedi, MH; Rush, AJ		STAR D-Child Team	Remissions in maternal depression and child psychopathology - A STAR* D-Child report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEQUENCED TREATMENT ALTERNATIVES; REPORT QIDS-SR; QUICK INVENTORY; DISORDERS; SYMPTOMATOLOGY; SYMPTOMS; BEHAVIOR; RISK; RATIONALE; AGREEMENT	Context Children of depressed parents have high rates of anxiety, disruptive, and depressive disorders that begin early, often continue into adulthood, and are impairing. Objective To determine whether effective treatment with medication of women with major depression is associated with reduction of symptoms and diagnoses in their children. Design Assessments of children whose depressed mothers were being treated with medication as part of the multicenter Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial conducted ( between December 16, 2001 and April 24, 2004) in broadly representative primary and psychiatric outpatient practices. Children were assessed by a team of evaluators not involved in maternal treatment and unaware of maternal outcomes. Study is ongoing with cases followed at 3-month intervals. Setting and Patients One hundred fifty-one mother-child pairs in 8 primary care and 11 psychiatric outpatient clinics across 7 regional centers in the United States. Children were aged 7 to 17 years. Main Outcome Measures Child diagnoses based on the Kiddie Schedule for Affective Disorders and Schizophrenia; child symptoms based on the Child Behavior Checklist; child functioning based on the Child Global Assessment Scale in mothers whose depression with treatment remitted with a score of 7 or lower or whose depression did not remit with a score higher than 7 on the Hamilton Rating Scale for Depression. Results Remission of maternal depression after 3 months of medication treatment was significantly associated with reductions in the children's diagnoses and symptoms. There was an overall 11% decrease in rates of diagnoses in children of mothers whose depression remitted compared with an approximate 8% increase in rates of diagnoses in children of mothers whose depression did not. This rate difference remained statistically significant after controlling for the child's age and sex, and possible confounding factors (P =. 01). Of the children with a diagnosis at baseline, remission was reported in 33% of those whose mothers' depression remitted compared with only a 12% remission rate among children of mothers whose depression did not remit. All children of mothers whose depression remitted after treatment and who themselves had no baseline diagnosis for depression remained free of psychiatric diagnoses at 3 months, whereas 17% of the children whose mothers remained depressed acquired a diagnosis. Findings were similar using child symptoms as an outcome. Greater level of maternal response was associated with fewer current diagnoses and symptoms in the children, and a maternal response of at least 50% was required to detect an improvement in the child. Conclusions Remission of maternal depression has a positive effect on both mothers and their children, whereas mothers who remain depressed may increase the rates of their children's disorders. These findings support the importance of vigorous treatment for depressed mothers in primary care or psychiatric clinics and suggest the utility of evaluating the children, especially children whose mothers continue to be depressed.	Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, Unit 24, New York, NY 10032 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX USA; Vanderbilt Univ, Dept Psychol & Human Dev, Nashville, TN USA; Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; Harvard Univ, Dept Psychiat, Boston, MA 02115 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA	Columbia University; New York State Psychiatry Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Virginia Commonwealth University; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Weissman, MM (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, Unit 24, 1051 Riverside Dr, New York, NY 10032 USA.	mmw3@columbia.edu	Trivedi, Madhukar/A-9029-2013; Fava, Maurizio/AAH-3548-2020; Talati, Ardesheer/GOP-3671-2022; Talati, Ardesheer/N-3979-2017	Trivedi, Madhukar/0000-0002-2983-1110; Weissman, Myrna/0000-0003-3490-3075; Rush, Augustus/0000-0003-2004-2382; Alpert, Jonathan/0000-0002-4332-908X; Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH066249, N01MH090003, R01MH063852] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Achenbach T.M., 1991, MANUAL CHILD BEHAV C, DOI DOI 10.1023/A; AGRESTI A, 2002, CATEGORICAL DATA ANA, P120; Beardslee WR, 2003, PEDIATRICS, V112, pE119, DOI 10.1542/peds.112.2.e119; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cicchetti D, 1998, DEV PSYCHOPATHOL, V10, P283, DOI 10.1017/S0954579498001618; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Diggle PJ, 1994, ANAL LONGITUDINAL DA; DOWNEY G, 1990, PSYCHOL BULL, V108, P50, DOI 10.1037/0033-2909.108.1.50; EDELBROCK C, 1986, J CHILD PSYCHOL PSYC, V27, P181, DOI 10.1111/j.1469-7610.1986.tb02329.x; Fava M, 2003, PSYCHIAT CLIN N AM, V26, P457, DOI 10.1016/S0193-953X(02)00107-7; Fleiss JL., 1986, DESIGN ANAL CLIN EXP, DOI [10.1002/9781118032923.ch1, DOI 10.1002/9781118032923.CH1, DOI 10.1002/9781118032923]; Gotlib IH, 1999, DEVELOPMENTAL ISSUES IN THE CLINICAL TREATMENT OF CHILDREN, P415; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; HAMMEN C, 1990, ARCH GEN PSYCHIAT, V47, P1112; HODGES K, 1990, J CHILD PSYCHOL PSYC, V31, P427, DOI 10.1111/j.1469-7610.1990.tb01579.x; Holmans P, 2004, AM J HUM GENET, V74, P1154, DOI 10.1086/421333; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Kim-Cohen J, 2005, ARCH GEN PSYCHIAT, V62, P173, DOI 10.1001/archpsyc.62.2.173; Klein DN, 2001, ARCH GEN PSYCHIAT, V58, P13, DOI 10.1001/archpsyc.58.1.13; Koran LM, 2001, J AFFECT DISORDERS, V65, P27, DOI 10.1016/S0165-0327(00)00272-X; Lavori PW, 2001, BIOL PSYCHIAT, V50, P792, DOI 10.1016/S0006-3223(01)01223-9; Levinson DF, 2003, AM J MED GENET B, V119B, P118, DOI 10.1002/ajmg.b.20009; Lyons-Ruth K, 1999, MONOGR SOC RES CHILD, V64, P67, DOI 10.1111/1540-5834.00034; MINTZ J, 1993, ARCH GEN PSYCHIAT, V50, P241; MINTZ J, 1992, ARCH GEN PSYCHIAT, V49, P761; Miranda J, 2005, SOC PSYCH PSYCH EPID, V40, P253, DOI 10.1007/s00127-005-0879-0; Pilowsky DJ, 2006, J CLIN PSYCHIAT, V67, P126, DOI 10.4088/JCP.v67n0119; PUIGANTICH J, 1985, ARCH GEN PSYCHIAT, V42, P511; Rush AJ, 2005, J AFFECT DISORDERS, V87, P43, DOI 10.1016/j.jad.2005.03.005; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Rush AJ, 2003, BIOL PSYCHIAT, V54, P585, DOI 10.1016/S0006-3223(03)00786-8; Rush AJ, 2003, AM J PSYCHIAT, V160, P237, DOI 10.1176/appi.ajp.160.2.237; RUSH AJ, IN PRESS BIOL PSYCHI; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Verdeli H, 2004, DEPRESS ANXIETY, V19, P51, DOI 10.1002/da.10139; Weissman MM, 2005, ARCH GEN PSYCHIAT, V62, P29, DOI 10.1001/archpsyc.62.1.29; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P932; WEISSMAN MM, IN PRESS AM J PSYCHI; Weller Elizabeth B, 2005, Curr Psychiatry Rep, V7, P87, DOI 10.1007/s11920-005-0003-x	45	500	507	0	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1389	1398		10.1001/jama.295.12.1389	http://dx.doi.org/10.1001/jama.295.12.1389			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	023WU	16551710	Bronze			2022-12-28	WOS:000236157700016
J	Dorling, D; Shaw, M; Smith, GD				Dorling, D; Shaw, M; Smith, GD			HIV and global health - Global inequality of life expectancy due to AIDS	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; Univ Bristol, S W Publ Hlth Observ, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Sheffield; University of Bristol	Dorling, D (corresponding author), Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England.	Daniel.Dorling@sheffield.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				Benach J., 2002, REDUCING INEQUALITIE, P262; Low A, 2004, J PUBLIC HEALTH-UK, V26, P388, DOI 10.1093/pubmed/fdh175; Moser K, 2005, B WORLD HEALTH ORGAN, V83, P202; Shaw M, 2005, BMJ-BRIT MED J, V330, P1016, DOI 10.1136/bmj.330.7498.1016; *UN, WORLD POP PROSP 2004; *UN, UN POP HIV AIDS WALL; *UN, WORLD URB PROSP 2003; United Nations Development Program, HUM DEV IND	8	28	29	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					662	664		10.1136/bmj.332.7542.662	http://dx.doi.org/10.1136/bmj.332.7542.662			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	026CQ	16543340	Green Published			2022-12-28	WOS:000236314700028
J	Feng, AS; Narins, PM; Xu, CH; Lin, WY; Yu, ZL; Qiu, Q; Xu, ZM; Shen, JX				Feng, AS; Narins, PM; Xu, CH; Lin, WY; Yu, ZL; Qiu, Q; Xu, ZM; Shen, JX			Ultrasonic communication in frogs	NATURE			English	Article							BULLFROG RANA-CATESBEIANA; MIDDLE-EAR; AUDITORY-CORTEX; FREQUENCY; NOISE	Among vertebrates, only microchiropteran bats, cetaceans and some rodents are known to produce and detect ultrasounds ( frequencies greater than 20 kHz) for the purpose of communication and/ or echolocation, suggesting that this capacity might be restricted to mammals(1,2). Amphibians, reptiles and most birds generally have limited hearing capacity, with the ability to detect and produce sounds below similar to 12 kHz. Here we report evidence of ultrasonic communication in an amphibian, the concave- eared torrent frog ( Amolops tormotus) from Huangshan Hot Springs, China. Males of A. tormotus produce diverse bird- like melodic calls with pronounced frequency modulations that often contain spectral energy in the ultrasonic range(3,4). To determine whether A. tormotus communicates using ultrasound to avoid masking by the wideband background noise of local fast- flowing streams, or whether the ultrasound is simply a by- product of the sound-production mechanism, we conducted acoustic playback experiments in the frogs' natural habitat. We found that the audible as well as the ultrasonic components of an A. tormotus call can evoke male vocal responses. Electrophysiological recordings from the auditory midbrain confirmed the ultrasonic hearing capacity of these frogs and that of a sympatric species facing similar environmental constraints. This extraordinary upward extension into the ultrasonic range of both the harmonic content of the advertisement calls and the frog's hearing sensitivity is likely to have co-evolved in response to the intense, predominantly low- frequency ambient noise from local streams. Because amphibians are a distinct evolutionary lineage from microchiropterans and cetaceans ( which have evolved ultrasonic hearing to minimize congestion in the frequency bands used for sound communication(5) and to increase hunting efficacy in darkness(2)), ultrasonic perception in these animals represents a new example of independent evolution.	Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; Univ Calif Los Angeles, Dept Physiol Sci & Ecol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Evolutionary Biol, Los Angeles, CA 90095 USA; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Feng, AS (corresponding author), Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA.	afeng1@uiuc.edu	YU, ZULIN/D-7979-2012					ANSON M, 1985, J ACOUST SOC AM, V78, P916, DOI 10.1121/1.392922; Bradbury Jack W., 1998, pi; CHEN BH, 1991, AMPHIBIAN REPTILIAN; CORSO JF, 1963, J ACOUST SOC AM, V35, P1738, DOI 10.1121/1.1918804; DIEROFF HG, 1975, ARCH OTO-RHINO-LARYN, V209, P277, DOI 10.1007/BF00456548; FEI L, 1999, ATLAS AMPHIBIANS CHI, P162; FENG AS, 1975, J COMP PHYSIOL, V100, P221, DOI 10.1007/BF00614532; Feng AS, 2002, NATURWISSENSCHAFTEN, V89, P352, DOI 10.1007/s00114-002-0335-x; HAUSER MD, 1996, EVOLUTION COMMUNICAT, P124; Hosoi H, 1998, LANCET, V351, P496, DOI 10.1016/S0140-6736(05)78683-9; Imaizumi S, 2001, NEUROREPORT, V12, P583, DOI 10.1097/00001756-200103050-00030; Jorgensen MB, 1998, J COMP PHYSIOL A, V182, P59; KINSLER LE, 1962, FUNDAMENTALS ACOUSTI, P186; LEWIS ER, 1999, COMP HEARING FISH AM, P218; LOFTUSHILLS JJ, 1970, J ACOUST SOC AM, V47, P1131, DOI 10.1121/1.1912015; MANLEY GA, 1972, J COMP PHYSIOL, V81, P239, DOI 10.1007/BF00693629; Mason MJ, 2002, J EXP BIOL, V205, P3167; Mason MJ, 2002, J EXP BIOL, V205, P3153; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; OHR EA, 1976, COMP BIOCHEM PHYS C, V54, P13, DOI 10.1016/0306-4492(76)90018-6; PUMPHREY RJ, 1950, NATURE, V166, P571, DOI 10.1038/166571b0; Purgue AP, 1997, J COMP PHYSIOL A, V181, P438, DOI 10.1007/s003590050127; Rand A.S., 1988, P415; SALES G, 1974, ULTRASONIC COMMUNICA, P23; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a	26	217	240	7	122	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					333	336		10.1038/nature04416	http://dx.doi.org/10.1038/nature04416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541072				2022-12-28	WOS:000235997600052
J	Feske, S; Gwack, Y; Prakriya, M; Srikanth, S; Puppel, SH; Tanasa, B; Hogan, PG; Lewis, RS; Daly, M; Rao, A				Feske, S; Gwack, Y; Prakriya, M; Srikanth, S; Puppel, SH; Tanasa, B; Hogan, PG; Lewis, RS; Daly, M; Rao, A			A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function	NATURE			English	Article							T-CELL-RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; ANHIDROTIC ECTODERMAL DYSPLASIA; ACTIVATED CALCIUM-CHANNEL; KAPPA-B; LINKAGE ANALYSIS; PORE PROPERTIES; NUCLEAR-FACTOR; CA2+ CHANNELS; I-CRAC	Antigen stimulation of immune cells triggers Ca(2+) entry through Ca(2+) release-activated Ca(2+) ( CRAC) channels, promoting the immune response to pathogens by activating the transcription factor NFAT. We have previously shown that cells from patients with one form of hereditary severe combined immune deficiency ( SCID) syndrome are defective in store-operated Ca(2+) entry and CRAC channel function. Here we identify the genetic defect in these patients, using a combination of two unbiased genome-wide approaches: a modified linkage analysis with single-nucleotide polymorphism arrays, and a Drosophila RNA interference screen designed to identify regulators of store-operated Ca(2+) entry and NFAT nuclear import. Both approaches converged on a novel protein that we call Orai1, which contains four putative transmembrane segments. The SCID patients are homozygous for a single missense mutation in ORAI1, and expression of wild-type Orai1 in SCID T cells restores store-operated Ca(2+) influx and the CRAC current ( I CRAC). We propose that Orai1 is an essential component or regulator of the CRAC channel complex.	Harvard Univ, Sch Med, Ctr Blood Res, Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Broad Inst, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Rao, A (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu	Feske, stefan/ABB-3554-2021	Feske, stefan/0000-0001-5431-8178; Lewis, Richard/0000-0002-6010-7403; Puppel, Sven-Holger/0000-0003-2745-5120; Prakriya, Murali/0000-0003-0781-4480	NIGMS NIH HHS [R01 GM045374] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045374] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Courtois G, 2003, J CLIN INVEST, V112, P1108, DOI 10.1172/JCI200318714; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Feske S, 2003, BIOCHEM BIOPH RES CO, V311, P1117, DOI 10.1016/j.bbrc.2003.09.174; Feske S, 2000, IMMUNOBIOLOGY, V202, P134, DOI 10.1016/S0171-2985(00)80060-1; Feske S, 2000, J IMMUNOL, V165, P297, DOI 10.4049/jimmunol.165.1.297; Feske S, 1996, EUR J IMMUNOL, V26, P2119, DOI 10.1002/eji.1830260924; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; GWACK Y, 2006, NATURE          0301, DOI DOI 10.1038/NATURE04631; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Homer, 1990, ILIAD; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Kanno T, 1996, J IMMUNOL, V157, P5277; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEDEIST F, 1995, BLOOD, V85, P1053, DOI 10.1182/blood.V85.4.1053.bloodjournal8541053; LeppleWienhues A, 1996, BIOPHYS J, V71, P787, DOI 10.1016/S0006-3495(96)79278-0; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Leykin I, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-7; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Philipp S, 2003, J BIOL CHEM, V278, P26629, DOI 10.1074/jbc.M304044200; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Putney JW, 2005, J CELL BIOL, V169, P381, DOI 10.1083/jcb.200503161; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schlesier M, 1993, Immunodeficiency, V4, P133; Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; STEWART M, 2005, GREEK MYTHOLOGY ILIA; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	47	1711	1777	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2006	441	7090					179	185		10.1038/nature04702	http://dx.doi.org/10.1038/nature04702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16582901				2022-12-28	WOS:000237418800037
J	Heilbronn, LK; de Jonge, L; Frisard, MI; DeLany, JP; Larson-Meyer, DE; Rood, J; Nguyen, T; Martin, CK; Volaufova, J; Most, MM; Greenway, FL; Smith, SR; Deutsch, WA; Williamson, DA; Ravussin, E				Heilbronn, LK; de Jonge, L; Frisard, MI; DeLany, JP; Larson-Meyer, DE; Rood, J; Nguyen, T; Martin, CK; Volaufova, J; Most, MM; Greenway, FL; Smith, SR; Deutsch, WA; Williamson, DA; Ravussin, E		Pennington CALERIE Team	Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENERGY-EXPENDITURE; RHESUS-MONKEYS; DIETARY RESTRICTION; BODY-COMPOSITION; LIPID-PEROXIDATION; SKELETAL-MUSCLE; WEIGHT-LOSS; DAMAGE; AGE; RAT	Context Prolonged calorie restriction increases life span in rodents. Whether prolonged calorie restriction affects biomarkers of longevity or markers of oxidative stress, or reduces metabolic rate beyond that expected from reduced metabolic mass, has not been investigated in humans. Objective To examine the effects of 6 months of calorie restriction, with or without exercise, in overweight, nonobese ( body mass index, 25 to < 30) men and women. Design, Setting, and Participants Randomized controlled trial of healthy, sedentary men and women (N=48) conducted between March 2002 and August 2004 at a research center in Baton Rouge, La. Intervention Participants were randomized to 1 of 4 groups for 6 months: control ( weight maintenance diet); calorie restriction (25% calorie restriction of baseline energy requirements); calorie restriction with exercise (12.5% calorie restriction plus 12.5% increase in energy expenditure by structured exercise); very low-calorie diet ( 890 kcal/d until 15% weight reduction, followed by a weight maintenance diet). Main Outcome Measures Body composition; dehydroepiandrosterone sulfate (DHEAS), glucose, and insulin levels; protein carbonyls; DNA damage; 24-hour energy expenditure; and core body temperature. Results Mean (SEM) weight change at 6 months in the 4 groups was as follows: controls, - 1.0% (1.1%); calorie restriction, - 10.4% (0.9%); calorie restriction with exercise, - 10.0% (0.8%); and very low-calorie diet, - 13.9% (0.7%). At 6 months, fasting insulin levels were significantly reduced from baseline in the intervention groups(all P <. 01), whereas DHEAS and glucose levels were unchanged. Core body temperature was reduced in the calorie restriction and calorie restriction with exercise groups ( both P <. 05). After adjustment for changes in body composition, sedentary 24-hour energy expenditure was unchanged in controls, but decreased in the calorie restriction (- 135 kcal/d [ 42 kcal/d]), calorie restriction with exercise (- 117 kcal/d [ 52 kcal/d]), and very low-calorie diet (- 125 kcal/d [ 35 kcal/d]) groups ( all P <. 008). These "metabolic adaptations" (similar to 6% more than expected based on loss of metabolic mass) were statistically different from controls ( P <. 05). Protein carbonyl concentrations were not changed from baseline to month 6 in any group, whereas DNA damage was also reduced from baseline in all intervention groups ( P <. 005). Conclusions Our findings suggest that 2 biomarkers of longevity ( fasting insulin level and body temperature) are decreased by prolonged calorie restriction in humans and support the theory that metabolic rate is reduced beyond the level expected from reduced metabolic body mass. Studies of longer duration are required to determine if calorie restriction attenuates the aging process in humans. Trial Registration ClinicalTrials. gov Identifier: NCT00099151.	Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Ravussin, E (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	ravusse@pbrc.edu	Martin, Corby K./N-1976-2017; Ravussin, Eric/N-1985-2017; Smith, Steven/HDM-9496-2022; Biguzzi, Felipe A/E-4724-2015; Nguyen, Thao/HCH-9537-2022; Greenway, Frank/N-1966-2017; Nguyen, Thao/GWN-0419-2022; Nguyen, Tuan V/B-6147-2008; Heilbronn, Leonie K/H-1874-2013	Martin, Corby K./0000-0002-8125-4015; Ravussin, Eric/0000-0003-2129-547X; Greenway, Frank/0000-0002-1766-6111; Nguyen, Tuan V/0000-0002-3246-6281; Heilbronn, Leonie K/0000-0003-2106-7303; DeLany, James/0000-0003-0366-3849; de Jonge, Lilian/0000-0001-5900-0695; Smith, Steven/0000-0002-5098-8147	NIA NIH HHS [U01 AG020478-01, U01 AG020478, U01 AG020478-05, U01 AG20478] Funding Source: Medline; NIDDK NIH HHS [P30 DK072476] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG020478] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACHESON KJ, 1987, AM J CLIN NUTR, V45, P78, DOI 10.1093/ajcn/45.1.78; BALLOR DL, 1991, J APPL PHYSIOL, V71, P801, DOI 10.1152/jappl.1991.71.3.801; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Blanc S, 2003, J CLIN ENDOCR METAB, V88, P16, DOI 10.1210/jc.2002-020405; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P355, DOI 10.1210/jc.86.1.355; de Oliveira SL, 2003, BRIT J NUTR, V89, P89, DOI 10.1079/BJN2002749; DeLany JP, 1999, J GERONTOL A-BIOL, V54, pB5, DOI 10.1093/gerona/54.1.B5; DELANY JP, 1989, J APPL PHYSIOL, V67, P1922, DOI 10.1152/jappl.1989.67.5.1922; Deutsch WA, 2001, MUTAGENESIS, V16, P439, DOI 10.1093/mutage/16.5.439; Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002; Dubey A, 1996, ARCH BIOCHEM BIOPHYS, V333, P189, DOI 10.1006/abbi.1996.0380; DULLOO AG, 1993, INT J OBESITY, V17, P115; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; Keys A, 1950, BIOL HUMAN STARVATIO; LANE MA, 1995, J GERONTOL A-BIOL, V50, pB295, DOI 10.1093/gerona/50A.5.B295; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Mates JM, 2000, CELL BIOCHEM FUNCT, V18, P77, DOI 10.1002/(SICI)1099-0844(200006)18:2<77::AID-CBF851>3.0.CO;2-Z; MCCARTER R, 1985, AM J PHYSIOL, V248, pE488; MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Nguyen T, 2003, MED BIOL ENG COMPUT, V41, P572, DOI 10.1007/BF02345320; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Ramsey JJ, 2000, FREE RADICAL BIO MED, V29, P946, DOI 10.1016/S0891-5849(00)00417-2; RAVUSSIN E, 1989, AM J CLIN NUTR, V49, P968, DOI 10.1093/ajcn/49.5.968; RISING R, 1992, AM J PHYSIOL, V263, pE730, DOI 10.1152/ajpendo.1992.263.4.E730; RISING R, 1995, INT J OBESITY, V19, P1; Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541; Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851; Roth GS, 2000, EUR J CLIN NUTR, V54, pS15, DOI 10.1038/sj.ejcn.1601020; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; Selman C, 2005, MECH AGEING DEV, V126, P783, DOI 10.1016/j.mad.2005.02.004; SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; TATARANNI PA, 1995, AM J CLIN NUTR, V61, P1013; Toubro S, 1996, J CLIN ENDOCR METAB, V81, P2670, DOI 10.1210/jc.81.7.2670; WEINDRUCH R, 1986, J NUTR, V116, P641, DOI 10.1093/jn/116.4.641; Weinsier RL, 2000, AM J CLIN NUTR, V71, P1138; Weyer C, 2000, AM J CLIN NUTR, V72, P946; Weyer C, 1999, INT J OBESITY, V23, P715, DOI 10.1038/sj.ijo.0800910; Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com	48	655	680	1	112	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1539	1548		10.1001/jama.295.13.1539	http://dx.doi.org/10.1001/jama.295.13.1539			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16595757	Bronze, Green Accepted			2022-12-28	WOS:000236505400021
J	Hey, E; Chalmers, L				Hey, E; Chalmers, L			Are any of the criticisms of the CNEP trial true?	LANCET			English	Editorial Material							MISCONDUCT; FAILURE		James Lind Initiat, Oxford, England		Hey, E (corresponding author), James Lind Initiat, Oxford, England.	shey@easynet.co.uk						Alexander J, 2005, BRIT MED J, V330, P472, DOI 10.1136/bmj.330.7489.472; Farthing M, 2000, BRIT MED J, V321, P1485, DOI 10.1136/bmj.321.7275.1485; Hey E, 2000, BRIT MED J, V321, P752, DOI 10.1136/bmj.321.7263.752; HEY E, 1996, IN PRESS PEDIATRICS; *HOUS COMM, 2003, 5 HOUS COMM CULT MED, V2; LAURANCE J, 2000, INDEPENDENT     0511, P1; *NHS EX W MIDL REG, 2000, REP REV RES FRAM N S; NICHOLSON R, 2003, B MED ETHICS     MAY, P1; Samanta A, 2005, CLIN MED, V5, P235, DOI 10.7861/clinmedicine.5-3-235; Samuels MP, 1996, PEDIATRICS, V98, P1154; Smith R, 2000, BRIT MED J, V321, P715, DOI 10.1136/bmj.321.7263.715; Smith R, 2000, BMJ-BRIT MED J, V320, P1285, DOI 10.1136/bmj.320.7245.1285; Telford K, 2006, LANCET, V367, P1080, DOI 10.1016/S0140-6736(06)68475-4	13	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 1	2006	367	9516					1032	1033		10.1016/S0140-6736(06)68445-6	http://dx.doi.org/10.1016/S0140-6736(06)68445-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581384				2022-12-28	WOS:000236673200005
J	Brown, MD				Brown, MD			Enterobius vermicularis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Rush Univ, Med Ctr, Chicago, IL 60612 USA	Rush University	Brown, MD (corresponding author), Rush Univ, Med Ctr, Chicago, IL 60612 USA.								0	3	3	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					E12	E12		10.1056/NEJMicm040931	http://dx.doi.org/10.1056/NEJMicm040931			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571876				2022-12-28	WOS:000236338000010
J	Ma, JF; Tamai, K; Yamaji, N; Mitani, N; Konishi, S; Katsuhara, M; Ishiguro, M; Murata, Y; Yano, M				Ma, JF; Tamai, K; Yamaji, N; Mitani, N; Konishi, S; Katsuhara, M; Ishiguro, M; Murata, Y; Yano, M			A silicon transporter in rice	NATURE			English	Article							GENE; AQUAPORINS; RESISTANCE; FAMILY	Silicon is beneficial to plant growth and helps plants to overcome abiotic and biotic stresses by preventing lodging ( falling over) and increasing resistance to pests and diseases, as well as other stresses(1-3). Silicon is essential for high and sustainable production of rice(4), but the molecular mechanism responsible for the uptake of silicon is unknown. Here we describe the Low silicon rice 1 (Lsi1) gene, which controls silicon accumulation in rice, a typical silicon-accumulating plant. This gene belongs to the aquaporin family(5) and is constitutively expressed in the roots. Lsi1 is localized on the plasma membrane of the distal side of both exodermis and endodermis cells, where casparian strips are located. Suppression of Lsi1 expression resulted in reduced silicon uptake. Furthermore, expression of Lsi1 in Xenopus oocytes showed transport activity for silicon only. The identification of a silicon transporter provides both an insight into the silicon uptake system in plants, and a new strategy for producing crops with high resistance to multiple stresses by genetic modification of the root's silicon uptake capacity.	Okayama Univ, Bioresources Res Inst, Kurashiki, Okayama 7100046, Japan; Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; Suntory Inst Bioorgan Res, Shimamoto, Osaka 6188503, Japan; Natl Inst Agrobiol Sci, Dept Mol Genet, Tsukuba, Ibaraki 3058602, Japan	Okayama University; Suntory Holdings Ltd; National Institute of Agrobiological Sciences - Japan	Ma, JF (corresponding author), Okayama Univ, Bioresources Res Inst, Chuo 2-20-1, Kurashiki, Okayama 7100046, Japan.	maj@rib.okayama-u.ac.jp	Yano, Masahiro/AAC-5441-2019; Ma, Jianfeng/GZB-0110-2022; YAMAJI, Naoki/B-2524-2011; Feng, Jian/C-7213-2009	YAMAJI, Naoki/0000-0002-7499-3004; Feng, Jian/0000-0003-3411-827X; Katsuhara, Maki/0000-0002-8264-3063; Yano, Masahiro/0000-0003-1510-4622				Casey WH, 2004, PLANT CELL ENVIRON, V27, P51, DOI 10.1046/j.0016-8025.2003.01124.x; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Fauteux F, 2005, FEMS MICROBIOL LETT, V249, P1, DOI 10.1016/j.femsle.2005.06.034; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; HILDEBRAND M, 1993, GENE, V132, P213, DOI 10.1016/0378-1119(93)90198-C; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Luu DT, 2005, PLANT CELL ENVIRON, V28, P85, DOI 10.1111/j.1365-3040.2004.01295.x; Ma J.F., 2002, SOIL FERTILIZER PLAN; Ma J. F., 2003, FERTILIZER, V94, P26; Ma JF, 2004, PLANT PHYSIOL, V136, P3284, DOI 10.1104/pp.104.047365; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2003, PLANT SOIL, V249, P383, DOI 10.1023/A:1022842421926; Ma JF, 2002, PLANT PHYSIOL, V130, P2111, DOI 10.1104/pp.010348; Ma JF, 2001, PLANT PHYSIOL, V127, P1773, DOI 10.1104/pp.010271; Mitani N, 2005, PLANT CELL PHYSIOL, V46, P279, DOI 10.1093/pcp/pci018; Raven J.A., 2001, SILICON AGR, P41, DOI DOI 10.1016/S0928-3420(01)80007-0; Richmond KE, 2003, CURR OPIN PLANT BIOL, V6, P268, DOI 10.1016/S1369-5266(03)00041-4; Savant NK, 1997, ADV AGRON, V58, P151; Sripanyakorn S, 2005, NUTR BULL, V30, P222, DOI 10.1111/j.1467-3010.2005.00507.x; Taiz L, 1998, PLANT PHYSIOL, P103; Takahashi E., 1990, Comments on Agricultural and Food Chemistry, V2, P99; Takahashi E., 1978, J SCI SOIL MANURE, V49, P357; Tallberg P, 2002, WATER RES, V36, P956, DOI 10.1016/S0043-1354(01)00312-8; Tamai K, 2003, NEW PHYTOL, V158, P431, DOI 10.1046/j.1469-8137.2003.00773.x; YOSHIDA SHOICHI, 1965, BULL NAT INST AGR SCI SER B [JAP], V15, P1	27	1056	1170	18	417	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					688	691		10.1038/nature04590	http://dx.doi.org/10.1038/nature04590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572174				2022-12-28	WOS:000236350400048
J	Downs, M; Turner, S; Bryans, M; Wilcock, J; Keady, J; Levin, E; O'Carroll, R; Howie, K; Iliffe, S				Downs, M; Turner, S; Bryans, M; Wilcock, J; Keady, J; Levin, E; O'Carroll, R; Howie, K; Iliffe, S			Effectiveness of educational interventions in improving detection and management of dementia in primary care: cluster randomised controlled study	BRITISH MEDICAL JOURNAL			English	Article							EVIDENCE BASED GUIDELINES; GENERAL-PRACTICE; CONTROLLED-TRIAL; DIAGNOSIS; IMPLEMENTATION; DISEASE	Objective To test the effectiveness of educational interventions in improving detection rates and management of dementia in primary care. Design Unblinded, cluster randomised before and after controlled study. Setting General practices in the United Kingdom (central Scotland and London) between 1999 and 2002. Interventions Three educational interventions: an electronic tutorial carried on a CD Rom; decision support software built into the electronic medical record; and practice based workshops. Participants 36 practices participated in the study. Eight practices were randomly assigned to the electronic tutorial; eight to decision support software; 10 to practice based workshops; and 10 to control. Electronic and manual searches yielded 450 valid and usable medical records. Main outcome measures Rates of detection of dementia and the extent to which medical records showed evidence of improved concordance with guidelines regarding diagnosis and management of dementia. Results Decision support software (P = 0.01) and practice based workshops (P = 0.01) both significantly improved rates of detection compared with control. There were no significant differences by intervention in the measures of concordance with guidelines. Conclusions Decision support systems and practice based workshops are effective educational approaches in improving detection rates in dementia.	Univ Bradford, Bradford Dementia Grp, Div Dementia Studies, Sch Hlth Studies, Bradford BD5 OBB, W Yorkshire, England; Univ Dundee, Dent Hlth Serv Res Unit, Dundee, Scotland; Royal Edinburgh & Associated Hosp, Dept Psychiat, Edinburgh, Midlothian, Scotland; UCL Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London, England; Northumbria Univ, Sch Hlth Educ & Community Studies, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; Social Care Inst Excellence, London, England; Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Univ Stirling, Dept Comp Sci & Math, Stirling FK9 4LA, Scotland	University of Bradford; University of Dundee; Royal Infirmary of Edinburgh; University of London; University College London; UCL Medical School; Northumbria University; University of Stirling; University of Stirling	Downs, M (corresponding author), Univ Bradford, Bradford Dementia Grp, Div Dementia Studies, Sch Hlth Studies, Bradford BD5 OBB, W Yorkshire, England.	m.downs@bradford.ac.uk	Keady, John/P-4992-2014; Wilcock, Jane/AAD-9385-2020; O'Carroll, Ronan E/A-5040-2009; Iliffe, Steve/L-8379-2019	Keady, John/0000-0001-8243-6913; Wilcock, Jane/0000-0002-9779-7073; O'Carroll, Ronan E/0000-0002-5130-291X; Iliffe, Stephen/0000-0003-2806-3997				Ahmad W, 1993, RACE HLTH CONT BRITA; *AUD COMM, 2000, FORG ME NOT DEV MENT; Audit Commission, 2002, FORG ME NOT 2002 DEV; BRODATY H, 1994, MED J AUSTRALIA, V160, P10, DOI 10.5694/j.1326-5377.1994.tb138193.x; Bullock R, 2002, BRIT J PSYCHIAT, V180, P135, DOI 10.1192/bjp.180.2.135; de Lusignan S, 2004, J PUBLIC HEALTH-UK, V26, P34, DOI 10.1093/pubmed/fdh104; Department of Health, 2001, NAT SERV FRAM OLD PE; Downs M, 2002, GERONTOLOGIST, V42, P66; Downs MG, 1996, INT J GERIATR PSYCH, V11, P937, DOI 10.1002/(SICI)1099-1166(199611)11:11<937::AID-GPS540>3.0.CO;2-0; Eccles M, 1998, BMJ-BRIT MED J, V317, P802, DOI 10.1136/bmj.317.7161.802; Eccles M, 2002, BMJ-BRIT MED J, V325, P941, DOI 10.1136/bmj.325.7370.941; EMERY JD, 2002, BRIT MED J, V325, P941; FAHEY T, 2002, BRIT MED J, V325, P941; FEDER G, 1995, BRIT MED J, V311, P1473, DOI 10.1136/bmj.311.7018.1473; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FORTINSKY RH, 1995, RES AGING, V17, P124, DOI 10.1177/0164027595172002; Fugelli P, 2001, BRIT J GEN PRACT, V51, P575; HOFFMAN A, 1991, INT J EPIDEMIOL, V20, P736; Iliffe S, 1999, AGING MENT HEALTH, V3, P129, DOI 10.1080/13607869956280; Iliffe S, 2003, FAM PRACT, V20, P376, DOI 10.1093/fampra/cmg407; Iliffe S, 2002, METHOD INFORM MED, V41, P98; Iliffe S, 1997, AGING MENT HEALTH, V1, P7, DOI 10.1080/13607869757326; Iliffe S., 2002, DEMENTIA, V1, P11, DOI DOI 10.1177/147130120200100111; Jordan K, 2004, FAM PRACT, V21, P396, DOI 10.1093/fampra/cmh409; Kirkpatrick DL, 2006, EVALUATING TRAINING, V3rd; Mann A, 1998, INT REV PSYCHIATR, V10, P148, DOI 10.1080/09540269874970; Manthorpe J, 2003, DEMENTIA, V2, P163, DOI DOI 10.1177/1471301203002002003; Moniz-Cook E, 1997, INT J GERIATR PSYCH, V12, P1143, DOI 10.1002/(SICI)1099-1166(199712)12:12<1143::AID-GPS707>3.0.CO;2-F; *NIH CLIN EXC, 2001, GUID US DAN RIV GAL; *NIH CLIN EXC, 2001, GUID US DON RIV GAL; Suchman L., 1987, PLANS SITUATED ACTIO; Turner S, 2003, AGING MENT HEALTH, V7, P28, DOI 10.1080/1360789021000058148; Twigg J., 1994, CARERS PERCEIVED POL; van Hout H, 2000, PATIENT EDUC COUNS, V39, P219, DOI 10.1016/S0738-3991(99)00034-8; VICKERS AJ, 2001, BIOMED CENTRAL MED R, V6; WILCOCK J, 2003, ED AGEING, V17, P217	36	138	140	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 25	2006	332	7543					692	695		10.1136/bmj.332.7543.692	http://dx.doi.org/10.1136/bmj.332.7543.692			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	027VH	16565124	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000236443300017
J	Chan, JCL				Chan, JCL			Comment on "Changes in tropical cyclone number, duration, and intensity in a warming environment"	SCIENCE			English	Editorial Material								Analyses of tropical cyclone records from the western North Pacific reveal that the recent increase in occurrence of intense typhoons reported by Webster et al. (Reports, 16 Sep. 2005, p. 1844) is not a trend. Rather, it is likely a part of the large interdecadal variations in the number of intense typhoons related to similar temporal fluctuations in the atmospheric environment.	City Univ Hong Kong, Dept Phys & Mat Sci, Lab Atmospher Res, Kowloon, Hong Kong, Peoples R China	City University of Hong Kong	Chan, JCL (corresponding author), City Univ Hong Kong, Dept Phys & Mat Sci, Lab Atmospher Res, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.	johnny.chan@cityu.edu.hk						Camargo SJ, 2005, J CLIMATE, V18, P2996, DOI 10.1175/JCLI3457.1; Chan JCL, 2004, J CLIMATE, V17, P4590, DOI 10.1175/3240.1; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551	5	160	182	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768								10.1126/science.1121522	http://dx.doi.org/10.1126/science.1121522			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556825				2022-12-28	WOS:000236204300018
J	Mayer, ML				Mayer, ML			Glutamate receptors at atomic resolution	NATURE			English	Review							PARTIAL AGONIST ACTION; LIGAND-BINDING; CRYSTAL-STRUCTURES; KAINATE RECEPTORS; STRUCTURAL BASIS; NMDA RECEPTORS; K+ CHANNELS; AMPA; MECHANISM; DESENSITIZATION	At synapses throughout the brain and spinal cord, the amino-acid glutamate is the major excitatory neurotransmitter. During evolution, a family of glutamate-receptor ion channels seems to have been assembled from a kit consisting of discrete ligand-binding, ion-channel, modulatory and cytoplasmic domains. Crystallographic studies that exploit this unique architecture have greatly aided structural analysis of the ligand-binding core, but the results also pose a formidable challenge, namely that of resolving the allosteric mechanisms by which individual domains communicate and function in an intact receptor.	Porter Neurosci Res Ctr, Bethesda, MD 20892 USA		Mayer, ML (corresponding author), Porter Neurosci Res Ctr, Bldg 35,Room 3B1002,35 Lincoln Dr, Bethesda, MD 20892 USA.	mayerm@mail.nih.gov	Mayer, Mark L/H-5500-2013; Mayer, Mark/AAE-7356-2019	Mayer, Mark/0000-0003-4378-8451	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arinaminpathy Y, 2006, MOL PHARMACOL, V69, P5, DOI 10.1124/mol.105.016691; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Banke TG, 2003, NAT NEUROSCI, V6, P144, DOI 10.1038/nn1000; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen PE, 2005, MOL PHARMACOL, V67, P1470, DOI 10.1124/mol.104.008185; COLLINGRIDGE GL, 1989, PHARMACOL REV, V41, P143; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P31; Erreger K, 2005, J NEUROSCI, V25, P7858, DOI 10.1523/JNEUROSCI.1613-05.2005; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; Hollmann M, 1999, HANDB EXP PHARM, V141, P3; Holm MM, 2005, J BIOL CHEM, V280, P35469, DOI 10.1074/jbc.M507800200; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Mamonova T, 2005, PHYS BIOL, V2, pS137, DOI 10.1088/1478-3975/2/4/S08; Mano I, 1996, J BIOL CHEM, V271, P15299, DOI 10.1074/jbc.271.26.15299; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; PERL TM, 1990, NEW ENGL J MED, V322, P1775, DOI 10.1056/NEJM199006213222504; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schorge S, 2005, J PHYSIOL-LONDON, V569, P395, DOI 10.1113/jphysiol.2005.095349; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Sobolevsky AI, 2005, BIOPHYS J, V88, P235, DOI 10.1529/biophysj.104.049411; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vissel B, 2002, MOL PHARMACOL, V61, P595, DOI 10.1124/mol.61.3.595; Watanabe J, 2002, J NEUROSCI, V22, P10209; Watkins JC, 2006, BRIT J PHARMACOL, V147, pS100, DOI 10.1038/sj.bjp.0706444; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	75	232	239	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					456	462		10.1038/nature04709	http://dx.doi.org/10.1038/nature04709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554805				2022-12-28	WOS:000236176100042
J	Migeon, BR				Migeon, BR			The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LESCH-NYHAN-DISEASE; CHROMOSOME INACTIVATION; MONOZYGOTIC TWIN; CELLS; FEMALES; GENE; ADRENOLEUKODYSTROPHY; FIBROBLASTS; INFECTIONS; MUTATIONS	Sex-specific manifestations of disease are most often attributed to differences in the reproductive apparatus or in life experiences. However, a good deal of sex differences in health issues have their origins in the genes on the sex chromosomes themselves and in X inactivation - the developmental program that equalizes their expression in males and females. Most females are mosaics, having a mixture of cells expressing either their mother's or father's X-linked genes. Often, cell mosaicism is advantageous, ameliorating the deleterious effects of X-linked mutations and contributing to physiological diversity. As a consequence, most X-linked mutations produce male-only diseases. Yet, in some cases the dynamic interactions between cells in mosaic females lead to female-specific disease manifestations.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Migeon, BR (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 459 Broadway Res Bldg,733 N Broadway, Baltimore, MD 21205 USA.	bmigeon@jhmi.edu						Azim E, 2005, P NATL ACAD SCI USA, V102, P16496, DOI 10.1073/pnas.0408456102; Bicocchi MP, 2005, EUR J HUM GENET, V13, P635, DOI 10.1038/sj.ejhg.5201386; Brix TH, 2005, J CLIN ENDOCR METAB, V90, P5949, DOI 10.1210/jc.2005-1366; BROOKS D, 2005, NY TIMES        1016, P12; COX RP, 1970, P NATL ACAD SCI USA, V67, P1573, DOI 10.1073/pnas.67.3.1573; De Gregorio L, 2005, MOL GENET METAB, V85, P70, DOI 10.1016/j.ymgme.2004.11.009; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; LYON MF, 1962, AM J HUM GENET, V14, P135; Masuzaki H, 2004, EUR J OBSTET GYN R B, V117, P102, DOI 10.1016/j.ejogrb.2003.12.028; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; Migeon BR, 1998, CYTOGENET CELL GENET, V80, P142, DOI 10.1159/000014971; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; MIGEON BR, 1978, GENETIC MOSAICS CHIM, P417; MIGEON BR, FEMALES ARE MOSAICS, V10; Moser H, 2004, CURR OPIN NEUROL, V17, P263, DOI 10.1097/00019052-200406000-00005; National Center for Biotechnology Information, OMIM ONL MEND INH MA OMIM ONL MEND INH MA; Ozbalkan Z, 2005, ARTHRITIS RHEUM-US, V52, P1564, DOI 10.1002/art.21026; OZCELIK T, IN PRESS EUR J HUM G; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380611; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; Smallwood PM, 2003, P NATL ACAD SCI USA, V100, P11706, DOI 10.1073/pnas.1934712100; Stewart JJ, 1998, IMMUNOL TODAY, V19, P352, DOI 10.1016/S0167-5699(98)01298-5; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; WASHBURN TC, 1965, PEDIATRICS, V35, P57; Winkelstein JA, 2001, JAMA-J AM MED ASSOC, V285, P1348, DOI 10.1001/jama.285.10.1348	29	135	137	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1428	1433		10.1001/jama.295.12.1428	http://dx.doi.org/10.1001/jama.295.12.1428			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551715				2022-12-28	WOS:000236157700021
J	Doherty, TM; Rook, G				Doherty, TM; Rook, G			Progress and hindrances in tuberculosis vaccine development	LANCET			English	Editorial Material							REGULATORY T-CELLS; PULMONARY TUBERCULOSIS; TGF-BETA; INFECTION		UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London W1T 4JF, England; Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	University of London; University College London; UCL Medical School; Statens Serum Institut	Rook, G (corresponding author), UCL Royal Free & Univ Coll Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London W1T 4JF, England.	G.Rook@ucl.ac.uk		Rook, Graham/0000-0002-8041-8110				Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Dheda K, 2005, AM J RESP CRIT CARE, V172, P501, DOI 10.1164/rccm.200502-278OC; Doherty TM, 2005, CLIN MICROBIOL REV, V18, P687, DOI 10.1128/CMR.18.4.687-702.2005; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; GUYOTREVOL V, 2005, AM J RESP CRIT CARE; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Olobo JO, 2001, SCAND J IMMUNOL, V53, P85, DOI 10.1046/j.1365-3083.2001.00844.x; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006	11	15	19	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					947	949		10.1016/S0140-6736(06)68389-X	http://dx.doi.org/10.1016/S0140-6736(06)68389-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546547				2022-12-28	WOS:000236242100035
J	Morris, M; Uchida, K; Do, T				Morris, M; Uchida, K; Do, T			A magnetic torsional wave near the Galactic Centre traced by a 'double helix' nebula	NATURE			English	Article							MOLECULAR-HYDROGEN; EMISSION; FIELD; DISK; CHANDRA; PLASMA; EAST; RING	The magnetic field in the central few hundred parsecs of the Milky Way has a dipolar geometry and is substantially stronger than elsewhere in the Galaxy, with estimates ranging up to a milligauss ( refs 1 - 6). Characterization of the magnetic field at the Galactic Centre is important because it can affect the orbits of molecular clouds by exerting a drag on them, inhibit star formation, and could guide a wind of hot gas or cosmic rays away from the central region. Here we report observations of an infrared nebula having the morphology of an intertwined double helix about 100 parsecs from the Galaxy's dynamical centre, with its axis oriented perpendicular to the Galactic plane. The observed segment is about 25 parsecs in length, and contains about 1.25 full turns of each of the two continuous, helically wound strands. We interpret this feature as a torsional Alfven wave propagating vertically away from the Galactic disk, driven by rotation of the magnetized circumnuclear gas disk. The direct connection between the circumnuclear disk and the double helix is ambiguous, but the images show a possible meandering channel that warrants further investigation.	Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA	University of California System; University of California Los Angeles; Cornell University	Morris, M (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	morris@astro.ucla.edu		Do, Tuan/0000-0001-9554-6062; Morris, Mark/0000-0002-6753-2066				Belmont R, 2005, ASTROPHYS J, V631, pL53, DOI 10.1086/497139; Bland-Hawthorn J, 2003, ASTROPHYS J, V582, P246, DOI 10.1086/344573; Christopher MH, 2005, ASTROPHYS J, V622, P346, DOI 10.1086/427911; GATLEY I, 1986, MON NOT R ASTRON SOC, V222, P299, DOI 10.1093/mnras/222.2.299; GENZEL R, 1985, ASTROPHYS J, V297, P766, DOI 10.1086/163574; GUSTEN R, 1987, ASTROPHYS J, V318, P124, DOI 10.1086/165355; HILDEBRAND RH, 1993, ASTROPHYS J, V417, P565, DOI 10.1086/173336; Lang CC, 1999, ASTROPHYS J, V526, P727, DOI 10.1086/308012; LaRosa TN, 2005, ASTROPHYS J, V626, pL23, DOI 10.1086/431647; Latvakoski HM, 1999, ASTROPHYS J, V511, P761, DOI 10.1086/306689; Maeda Y, 2002, ASTROPHYS J, V570, P671, DOI 10.1086/339773; Morris M, 1996, ANNU REV ASTRON ASTR, V34, P645, DOI 10.1146/annurev.astro.34.1.645; Muno MP, 2004, ASTROPHYS J, V613, P326, DOI 10.1086/422865; Novak G, 2000, ASTROPHYS J, V529, P241, DOI 10.1086/308231; Price SD, 2001, ASTRON J, V121, P2819, DOI 10.1086/320404; PUGET JL, 1989, ANNU REV ASTRON ASTR, V27, P161; Rieke GH, 2004, ASTROPHYS J SUPPL S, V154, P25, DOI 10.1086/422717; Rockefeller G, 2005, ASTROPHYS J, V635, pL141, DOI 10.1086/499360; UCHIDA KI, 1994, ASTROPHYS J, V421, P505, DOI 10.1086/173667; WARDLE M, 1990, ASTROPHYS J, V362, P120, DOI 10.1086/169249; YAMAUCHI S, 1990, ASTROPHYS J, V365, P532, DOI 10.1086/169507; Yusef-Zadeh F, 2004, ASTROPHYS J SUPPL S, V155, P421, DOI 10.1086/425257; Yusef-Zadeh F, 2003, ASTROPHYS J, V598, P325, DOI 10.1086/378715; Yusef-Zadeh F, 2001, ASTROPHYS J, V560, P749, DOI 10.1086/322496; Yusef-Zadeh F, 1999, ASTR SOC P, V186, P197; YUSEFZADEH F, 1984, NATURE, V310, P557, DOI 10.1038/310557a0	26	56	56	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					308	310		10.1038/nature04554	http://dx.doi.org/10.1038/nature04554			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541066				2022-12-28	WOS:000235997600046
J	Wadman, M				Wadman, M			Make or break time in Vioxx drama	NATURE			English	Article																		Khamsi R, 2005, NATURE, V436, P1070, DOI 10.1038/4361070a	1	13	13	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					277	277		10.1038/440277a	http://dx.doi.org/10.1038/440277a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541045	Bronze			2022-12-28	WOS:000235997600023
J	Lam, H; Schofield, WB; Jacobs-Wagner, C				Lam, H; Schofield, WB; Jacobs-Wagner, C			A landmark protein essential for establishing and perpetuating the polarity of a bacterial cell	CELL			English	Article							CAULOBACTER-CRESCENTUS; TOPOLOGY PREDICTION; RESPONSE REGULATOR; HISTIDINE KINASE; DNA-REPLICATION; CYCLE; MREB; DIVISION; DIFFERENTIATION; PROTEOLYSIS	Polarity is often an intrinsic property of the cell, yet little is known about its origin or its maintenance over generations. Here we identify a landmark protein, TipN, which acts as a spatial and temporal cue for setting up the correct polarity in the bacterium Caulobacter crescentus. TipN marks the new pole throughout most of the cell cycle, and its relocation to the nascent poles at the end of division provides a preexisting reference point for orienting the polarity axis in the progeny. Deletion of tipN causes pleiotropic polarity defects, including frequently reversed asymmetry in progeny size and mislocalization of proteins and organelles. Ectopic localization of TipN along the lateral side of the cell creates new axes of polarity leading to cell branching and formation of competent cell poles. Localization defects of the actin-like protein MreB in the Delta tipN mutant suggest that TipN is upstream of MreB in regulating cell polarity.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu		Jacobs-Wagner, Christine/0000-0003-0980-5334	NIGMS NIH HHS [GM065835] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Awram P, 2001, MICROBIOL-SGM, V147, P1451, DOI 10.1099/00221287-147-6-1451; Burton GJ, 1997, J BACTERIOL, V179, P5849, DOI 10.1128/jb.179.18.5849-5853.1997; CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Figge RM, 2004, MOL MICROBIOL, V51, P1321, DOI 10.1111/j.1365-2958.2003.03936.x; Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Gorbatyuk B, 2001, MOL MICROBIOL, V40, P485, DOI 10.1046/j.1365-2958.2001.02404.x; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; NIEMAN WC, 2001, P NATL ACAD SCI USA, V98, P4136; Nilsen T, 2005, J BACTERIOL, V187, P6187, DOI 10.1128/JB.187.17.6187-6196.2005; Ohta N, 1996, TRENDS MICROBIOL, V4, P326, DOI 10.1016/0966-842X(96)10050-0; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; Ryan KR, 2004, P NATL ACAD SCI USA, V101, P7415, DOI 10.1073/pnas.0402153101; Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2; Shih YL, 2005, MOL MICROBIOL, V58, P917, DOI 10.1111/j.1365-2958.2005.04841.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TERRANA B, 1975, DEV BIOL, V44, P380, DOI 10.1016/0012-1606(75)90409-1; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Wagner JK, 2005, J BACTERIOL, V187, P544, DOI 10.1128/JB.187.2.544-553.2005; Wang Y, 2001, MOL MICROBIOL, V40, P347, DOI 10.1046/j.1365-2958.2001.02395.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2	31	144	145	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					1011	1023		10.1016/j.cell.2005.12.040	http://dx.doi.org/10.1016/j.cell.2005.12.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530047	Bronze			2022-12-28	WOS:000237241200022
J	Ngo, VN; Davis, RE; Lamy, L; Yu, X; Zhao, H; Lenz, G; Lam, LT; Dave, S; Yang, LM; Powell, J; Staudt, LM				Ngo, VN; Davis, RE; Lamy, L; Yu, X; Zhao, H; Lenz, G; Lam, LT; Dave, S; Yang, LM; Powell, J; Staudt, LM			A loss-of-function RNA interference screen for molecular targets in cancer	NATURE			English	Article							NF-KAPPA-B; CELL LYMPHOMA; HODGKIN LYMPHOMA; GENETIC SCREEN; MALT LYMPHOMA; ACTIVATION; BCL10; CARMA1; KINASE; TUMORIGENICITY	The pursuit of novel therapeutic agents in cancer relies on the identification and validation of molecular targets. Hallmarks of cancer include self-sufficiency in growth signals and evasion from apoptosis(1); genes that regulate these processes may be optimal for therapeutic attack. Here we describe a loss-of-function screen for genes required for the proliferation and survival of cancer cells using an RNA interference library. We used a doxycycline-inducible retroviral vector for the expression of small hairpin RNAs (shRNAs) to construct a library targeting 2,500 human genes. We used retroviral pools from this library to infect cell lines representing two distinct molecular subgroups of diffuse large B-cell lymphoma (DLBCL), termed activated B-cell-like DLBCL and germinal centre B-cell-like DLBCL. Each vector was engineered to contain a unique 60-base-pair 'bar code', allowing the abundance of an individual shRNA vector within a population of transduced cells to be measured using microarrays of the bar-code sequences. We observed that a subset of shRNA vectors was depleted from the transduced cells after three weeks in culture only if shRNA expression was induced. In activated B-cell-like DLBCL cells, but not germinal centre B-cell-like DLBCL cells, shRNAs targeting the NF-kappa B pathway were depleted, in keeping with the essential role of this pathway in the survival of activated B-cell-like DLBCL. This screen uncovered CARD11 as a key upstream signalling component responsible for the constitutive I kappa B kinase activity in activated B-cell-like DLBCL. The methodology that we describe can be used to establish a functional taxonomy of cancer and help reveal new classes of therapeutic targets distinct from known oncogenes.	NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; CIT, Bioinformat & Mol Anal Sect, Computat Biosci & Engn Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Staudt, LM (corresponding author), NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Staudt, Louis/AAC-5324-2019; Lenz, Georg/I-6844-2012	Ngo, Vu/0000-0002-9501-6990	Intramural NIH HHS Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260, Z01CT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01SC004024] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Lam LT, 2005, CLIN CANCER RES, V11, P28; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Xue LQ, 2003, NAT IMMUNOL, V4, P857, DOI 10.1038/ni963; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	30	486	529	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					106	110		10.1038/nature04687	http://dx.doi.org/10.1038/nature04687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16572121				2022-12-28	WOS:000237248600042
J	Riedel, CG; Katis, VL; Katou, Y; Mori, S; Itoh, T; Helmhart, W; Galova, M; Petronczki, M; Gregan, J; Cetin, B; Mudrak, I; Ogris, E; Mechtler, K; Pelletier, L; Buchholz, F; Shirahige, K; Nasmyth, K				Riedel, CG; Katis, VL; Katou, Y; Mori, S; Itoh, T; Helmhart, W; Galova, M; Petronczki, M; Gregan, J; Cetin, B; Mudrak, I; Ogris, E; Mechtler, K; Pelletier, L; Buchholz, F; Shirahige, K; Nasmyth, K			Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I	NATURE			English	Article							FISSION YEAST; CHROMOSOME SEGREGATION; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; REGULATORY SUBUNITS; HUMAN OOCYTES; KINASE CDC5; MORPHOGENESIS; HOMOLOGS; MEI-S332	Segregation of homologous maternal and paternal centromeres to opposite poles during meiosis I depends on post-replicative crossing over between homologous non-sister chromatids, which creates chiasmata and therefore bivalent chromosomes. Destruction of sister chromatid cohesion along chromosome arms due to proteolytic cleavage of cohesin's Rec8 subunit by separase resolves chiasmata and thereby triggers the first meiotic division. This produces univalent chromosomes, the chromatids of which are held together by centromeric cohesin that has been protected from separase by shugoshin (Sgo1/MEI-S332) proteins. Here we show in both fission and budding yeast that Sgo1 recruits to centromeres a specific form of protein phosphatase 2A (PP2A). Its inactivation causes loss of centromeric cohesin at anaphase I and random segregation of sister centromeres at the second meiotic division. Artificial recruitment of PP2A to chromosome arms prevents Rec8 phosphorylation and hinders resolution of chiasmata. Our data are consistent with the notion that efficient cleavage of Rec8 requires phosphorylation of cohesin and that this is blocked by PP2A at meiosis I centromeres.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Tokyo Inst Technol, Lab Genome Struct & Funct, Div Gene Res, Ctr Biol Resources & Informat,Midori Ku, Yokohama, Kanagawa 2268501, Japan; Mitsubishi Res Inst Inc, Adv Sci & Technol Res Ctr, Chiyoda Ku, Tokyo 1008141, Japan; Med Univ Vienna, Dept Biochem Med, Max F Perutz Labs, Vienna Bioctr, A-1030 Vienna, Austria; MPI CBG, D-01307 Dresden, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Tokyo Institute of Technology; Mitsubishi Research Institute; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Max Planck Society	Nasmyth, K (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Mechtler, Karl/AAF-2717-2019; Gregan, Juraj/I-4161-2014; Itoh, Takehiko/E-8873-2014; Pelletier, Laurence/F-8858-2013; Buchholz, Frank/B-4700-2017	Mechtler, Karl/0000-0002-3392-9946; Gregan, Juraj/0000-0002-2989-8374; Itoh, Takehiko/0000-0002-6113-557X; Buchholz, Frank/0000-0002-4577-3344; Ogris, Egon/0000-0001-5950-9264; Shirahige, Katsuhiko/0000-0002-7862-1144; Riedel, Christian/0000-0002-3689-8022; Nasmyth, Kim/0000-0001-7030-4403; Petronczki, Mark/0000-0003-0139-5692				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Angell R, 1997, AM J HUM GENET, V61, P23, DOI 10.1086/513890; Bernard P, 2001, NAT CELL BIOL, V3, P522, DOI 10.1038/35074598; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Jiang W, 2000, GENETICS, V154, P1025; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kinoshita K, 1996, GENES CELLS, V1, P29, DOI 10.1046/j.1365-2443.1996.02002.x; KINOSHITA N, 1993, GENE DEV, V7, P1059, DOI 10.1101/gad.7.6.1059; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; Kitajima TS, 2003, EMBO J, V22, P5643, DOI 10.1093/emboj/cdg527; Kitajima TS, 2003, SCIENCE, V300, P1152, DOI 10.1126/science.1083634; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kuliev Anver, 2003, Reprod Biomed Online, V6, P54; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Mailhes JB, 2003, CHROMOSOME RES, V11, P619, DOI 10.1023/A:1024909119593; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Nasmyth K, 2005, PHILOS T R SOC B, V360, P483, DOI 10.1098/rstb.2004.1604; Pellestor F, 2003, HUM GENET, V112, P195, DOI 10.1007/s00439-002-0852-x; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; RONNE H, 1991, MOL CELL BIOL, V11, P4876, DOI 10.1128/MCB.11.10.4876; SHIMODA C, 1985, MOL GEN GENET, V200, P252, DOI 10.1007/BF00425432; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Watanabe Y, 1999, NATURE, V400, P461, DOI 10.1038/22774; Yamamoto M, 1996, TRENDS BIOCHEM SCI, V21, P18, DOI 10.1016/0968-0004(96)80880-2; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014; Zhao Y, 1997, J BIOL CHEM, V272, P8256, DOI 10.1074/jbc.272.13.8256	46	350	357	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					53	61		10.1038/nature04664	http://dx.doi.org/10.1038/nature04664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16541024				2022-12-28	WOS:000237248600030
J	Bhatt, DL; Fox, KAA; Hacke, W; Berger, PB; Black, HR; Boden, WE; Cacoub, P; Cohen, EA; Creager, MA; Easton, JD; Flather, MD; Haffner, SM; Hamm, CW; Hankey, GJ; Johnston, SC; Mak, KH; Mas, JL; Montalescot, G; Pearson, TA; Steg, PG; Steinhubl, SR; Weber, MA; Brennan, DM; Fabry-Ribaudo, L; Booth, J; Topol, EJ; Frye, RL; Amarenco, P; Brass, LM; Buyse, M; Cohen, LS; DeMets, DL; Fuster, V; Hart, RG; Marler, JR; McCarthy, C; Schoemig, A; Lincoff, AM; Brener, SJ; Sila, CA; Albuquerque, A; Aroutiounov, G; Artemiev, D; Atkeson, BG; Bartel, T; Basart, DCG; Lima, AB; Belli, G; Bordalo e Sa, AL; Bosch, X; Boysen, G; Busch, EWA; Cavallini, A; Sanchez, AC; Chiu, JH; Dahl, T; Danielsson, E; Fathi, RB; Grande, P; Groundstroem, K; Hamon, M; Haude, M; Held, C; Hesse, B; Hook, MA; Hostetter, JC; Huang, JC; Jones, RC; Kaminska, A; Karlocai, K; Marcheselli, S; Marti-Fabregas, J; Mikulik, R; Neau, JP; Nisanci, Y; Nordal, HJ; Okay, T; Opala, G; Orlova, IA; Parfenov, V; Pasierski, TJ; Permanyer-Miralda, G; Plomaritoglou, A; Pruszczyk, P; Rasmanis, G; Roine, RO; Ronaszeki, A; Rossi, ML; Sas, K; Shields, RW; Sitar, J; Srichai, B; Stam, J; Sweeney, PJ; Syvaenne, P; Tschopp, D; Urbanek, K; Vavuranakis, M; Vecsei, L; Baptista, MV; Vojtisek, P; Woimant, F; Zidar, FJ; Ameriso, SF; Cura, FA; Aylward, P; Hankey, GJ; Boland, BJ; Amato, A; De Paola, V; Cohen, EA; Roussin, A; Teal, P; Ehler, E; Sillesen, H; Nieminen, MS; Steg, PG; Hoffmann, U; Neumann, FJ; Dimas, AP; Forster, T; Ardissino, D; Alvarado, R; Bueller, HR; Indredavik, B; Gaciong, ZA; Morais, J; Mareev, V; Betriu, A; Ruilope, LM; Dalby, AJ; Oestergren, JB; Luscher, TF; Kultursay, H; Flather, MD; Fox, KAA; Boden, WE; Easton, JD; Haffner, SM; Pearson, TA; Steinhubl, SR; Alvarisqueta, A; Ameriso, S; Amuchastegui, LM; Caccavo, A; Parera, IC; Chekherdemian, S; Cura, F; Esnaola y Rojas, MM; Pardal, MF; Ferrari, J; Fideleff, H; Hasbani, E; La Mura, R; Presta, JL; Rey, R; Rey, R; Rivas, R; Starosiliz, DG; Villamil, A; Waitman, J; Zaefferer, P; Amerena, J; Bladin, C; Chew, D; Crimmins, D; Cross, D; Davis, S; Davis, T; Donnan, G; Fitridge, R; Freilich, D; Gibbs, H; Graham, J; Hill, A; Horowitz, J; Hunt, D; Ingham, N; Karrasch, J; Meredith, I; Moses, R; Phillips, P; Rankin, J; Read, S; Rees, D; Roger, S; Sampson, J; Schwartz, R; Walker, P; Watts, G; Whelan, A; Whitbourn, R; Eber, B; Niessner, H; Pilger, E; Schmidt, R; Wascher, T; Willeit, J; Blecic, S; Boland, BJ; Boland, J; Boxho, G; De Deyn, PP; Duchateau, J; Ducobu, J; Heyndrickx, GR; Sanchez-Ruiz, F; Scheen, A; Thijs, V; Van Mieghem, W; Verjans, E; de Paola, AAV; Francischetti, A; Francischetti, E; Bezerra, FAF; Gagliardi, R; Massaro, A; Nagato, Y; Nakiri, K; Rassi, S; Scherr, C; Sgarbi, JA; Felicio, JS; Suplicy, H; Arts, R; Auger, P; Baer, CEH; Bailey, G; Bailey, P; Beaudry, M; Bedard, J; Berger, L; Berlingieri, JD; Bhargava, RK; Bogaty, P; Bruckschwaiger, D; Cameron, MH; Chilvers, M; Connolly, S; Constance, C; Conter, HS; Cote, R; Cusson, J; Desai, H; Desjardins, L; Dlin, RA; Durocher, A; Fortin, C; Gagnon, YD; Glanz, A; Goodman, SG; Gossard, D; Gupta, MK; Hachinski, V; Hambly, D; Hamilton, RD; Hejdankova, B; Hii, J; Hughes, W; Hui, WKK; Janzen, J; Johnston, D; Joyner, C; Klinke, WP; Kouz, S; Allier, PL; Labbe, R; Lam, SSY; Landry, DA; Laroche, C; Lawlor, BJ; Lenis, JHF; Ma, P; Mackey, A; Marr, DR; Milton, J; Minuk, J; Miron, MJ; Misik, KKA; Moddel, G; Monchesky, T; Nault, P; O'Mahony, WF; Panju, A; Penn, A; Perron, P; Phillips, S; Pistawka, K; Ramjattan, BR; Ricci, JA; Rodes, J; Sahlas, D; Selchen, D; Sharma, M; Shuaib, A; Spence, D; Steeves, DC; Studney, D; Sullivan, J; Sussex, BA; Teal, P; Teitelbaum, J; Tildesley, HD; Tishler, SJ; Turpie, AGG; Voll, C; Warnica, JW; Weigel, MA; Winder, T; Winger, M; Woo, VC; Wozniak, P; Yale, JF; Yao, LCH; Zimakas, G; Zimmermann, R; Corbalan, R; Lavados, P; Yovanovich, J; Bar, M; Branny, M; Charvat, J; Ehler, E; Filipensky, B; Filipova, M; Smid, J; Spac, J; Spinar, J; Stanek, F; Zidkova, E; Carstensen, M; Husted, SE; Kraemmer-Nielsen, H; Lindvig, K; Airaksinen, J; Nieminen, MS; Sivenius, J; Abenhaim, N; Agraou, B; Bismuth, M; Boccalon, H; Bourgoin, M; Bousser, MG; Carpentier, P; Cibois-Honnorat, I; Conri, C; Hautefeuille, BD; Dambrine, P; David, M; Decousus, H; Devulder, B; Dubois-Rande, JL; Ferrari, E; Fonteny, R; Fuchs, L; Giroud, M; Guilmot, JL; Krempf, M; Mahagne, MH; Mas, JL; Medvedowsky, A; Montalescot, G; Moulin, T; Pinel, JF; Puel, J; Quere, I; Rodier, G; Rosolacci, T; Rouanet, F; Saillard, D; Steg, G; Stephan, D; Tribouilloy, C; Vogel, JY; Samson, Y; Baran, C; Berrouschot, J; Busse, O; Dichgans, M; Diener, HC; Fritz, HG; Goertler, M; Griewing, B; Haak, T; Haberl, R; Hamm, C; Hein, J; Heitzer, T; Hennerici, M; Hoffmann, U; Horacek, T; Klausmann, G; Lawall, H; Mahla, G; Mauersberger, H; Meinhardt, G; Mueller-Jensen, A; Muenzel, T; Nawroth, P; Neumann, FJ; Ochs, H; Ringleb, P; Samer, H; Sander, D; Scheffler, P; Schulte, KL; Silber, S; Speier, U; Stangl, K; Stark, E; Tiefenbacher, C; von Bilderling, P; Weisbach, M; Wunderlich, J; Dimas, A; Elisaf, M; Karamitsos, D; Melidonis, A; Pagkalos, E; Polydorou, A; Saopoulos, C; Vemmos, K; Ziakas, G; Chan, J; Chan, WK; Chen, WH; Cheung, R; Li, SK; Tan, K; Sing, K; Wong, L; Woo, KS; Acsady, G; Cseh, K; Csiba, L; Csornai, M; Forster, T; Kerekes, C; Kollar, L; Kristof, V; Laszlo, Z; Muranyi, A; Sebestyen, J; Sereg, M; Rosei, EA; Bassi, P; Cucinotta, D; Degli Esposti, E; Federico, F; Forconi, S; Glorioso, N; Gresele, P; Guidetti, D; Mannarino, E; Masini, F; Micieli, G; Morganti, A; Pasquali, R; Rossi, PC; Sacca, L; Sacchetti, ML; Spissu, A; Terrosu, P; Violi, F; bin Kamaruddin, NA; Chan, SP; Tan, KS; Aguilar, C; Alvarado, R; Arauz, A; Ascanio, CG; Barroso, NS; Flota, LF; Hernandez, S; Herrera, R; Leyva, JL; Meaney, E; Miranda, A; Morales, E; Ramirez, B; Ranero, A; Rivera, MA; Ruiz, JL; Sanchez, CJ; Tamez, JA; Atar, D; Indredavik, B; Sirnes, PA; Andziak, P; Brakowiecki, F; Cencora, A; Cholewa, M; Gaciong, Z; Gutowski, P; Huczynski, J; Janik, K; Jawien, A; Kania, G; Kleczkowski, D; Kotowicz, J; Krasowski, W; Kruk, M; Kuczynska-Zardzewialy, A; Kwiecinski, H; Lopatynski, J; Muszynska-Polaszewska, M; Piepiorka, M; Pilarska, K; Podemski, R; Rudzinski, J; Rynkiewicz, A; Strzelecka-Gorzynska, M; Szczudlik, A; Szpajer, M; Wierusz-Wysocka, B; Wojciechowski, D; Wyrzykowski, B; Zaleski, P; Zalska, B; Ziaja, K; Cunha, L; Ferreira, D; Ferro, J; Correia, LG; da Silva, PM; Morais, J; Capitao, LM; Puig, J; Salgado, V; Belousov, J; Gratsiansky, N; Mareev, V; Sinopalnikov, A; Skoromets, A; Skvortsova, V; Stratchounsky, L; Suslina, Z; Auchus, A; Chang, HM; Mak, KH; Ramani, NV; Tay, JC; Blomerus, P; Bryer, A; Burgess, L; Dalby, AJ; Distiller, L; Ebrahim, IO; Ellis, GC; Essop, MR; King, J; Lloyd, E; Moore, R; Sommers, R; Steingo, L; Van Niekerk, M; Aguilera, JM; Alvarez-Sabin, J; Cairols, M; Calvo, C; Castillo, J; Coca, A; Davalos, A; De Alvaro, F; Flores, A; Puig, JG; Gil-Peralta, A; Gomez, P; Heras, M; Macaya, C; Hidalgo, AM; Matias-Guiu, J; Mostacero, E; Romero, R; Die, ER; Ruilope, LM; Serena, J; Vila, N; Vivancos, J; Bokemark, L; Cederin, B; Karacagil, S; Oestergren, J; Strand, T; Unden-Goeransson, R; Baumgartner, I; Beer, JH; Bogousslavsky, J; Bounameaux, H; Caduff, B; Cerny, A; Gallino, A; Luescher, T; Lyrer, P; Pagnamenta, A; Cheng, JJ; Chou, HT; Huang, HW; Ryu, SJ; Biesma, DH; Brandjes, DPM; Bueller, HR; den Hartog, FR; Dippel, DWJ; Kramer, MHH; Lenders, JWM; Michels, HR; Niemeijer, MG; Nierop, PR; Niewold, JUR; Pieterse, MGC; Sanders, EACM; Smak Gregoor, PJH; Teijink, J; Troquay, RPT; van Vlies, B; Balkan, S; Bayazit, M; Gol, K; Ince, B; Kultursay, H; Kumral, E; Kutluk, K; Tuzun, H; Adgey, J; Bath, P; Belch, J; Brack, MJ; Corr, LA; Curless, R; Donnelly, R; Dormandy, JA; Durrington, P; Ellis, SJ; Flather, MD; Fox, KAA; Jenkinson, D; Lees, KR; MacWalter, RS; McEneaney, D; Mehrzad, A; Muir, K; Murphy, C; Purvis, JA; Robinson, T; Shetty, HGM; Sprigings, D; Stansby, G; Venables, GS; Abou-Zamzam, A; Adams, H; Aguirre, FV; Ahmad, B; Allison, JR; Almahameed, A; Altafullah, I; Anderson, J; Arakaki, R; Arnold, G; Avva, R; Axelrod, A; Bacharach, JM; Banish, D; Bank, A; Banks, GG; Bansal, S; Bayron, C; Becker, KJ; Becnel, L; Belber, A; Belden, JR; Bernstein, D; Bhatia, HS; Bittrick, J; Boden, WE; Bordenave, KK; Bowers, T; Bradley, AJ; Brady, JR; Brady, S; Brandes, J; Brateanu, A; Brautigam, D; Brill, D; Brillman, J; Broker, RE; Brotman, D; Brown, C; Bruya, TE; Buckner, JK; Buth, D; Byer, T; Cannon, L; Capodilupo, R; Cappleman, JM; Chaikof, EL; Chambers, J; Chandna, H; Chandrashekhar, YP; Chen, C; Chippendale, T; Chokshi, S; Clagett, P; Cohen, K; Collins, M; Comerota, A; Cook, JR; Corbelli, J; Creager, MA; Cucher, FH; Cummins, FE; Dandapani, B; Dave, K; DeGent, GE; DeGregorio, M; DeHart, DP; DeLeon, J; Devlin, T; DeVries, B; Drehobl, M; Drossner, MN; Dryjski, M; Dulli, D; Eisenberg, D; Ellison, WT; Erlemeier, S; Felten, W; Felton, W; Fenster, PE; Fields, H; Fischel, T; Furlan, A; Gandhi, M; Gaona, R; Gazda, S; Gelormini, J; George, A; George, J; George, W; Gill, S; Glass, JM; Goldberg, MC; Goldman, S; Goldstein, J; Goodman, MA; Grayum, BP; Greenberg, J; Grewal, G; Griffin, J; Griffin, R; Gross-Sawicka, E; Gupta, D; Gupta, S; Gutnik, L; Haake, B; Haist, JL; Hanna, J; Harris, J; Harrison, B; Hart, MV; Hendley, R; Henry, T; Hermany, P; Herrera, C; Hoch, J; Hollander, J; Howard, VN; Huber, T; Hull, R; Hye, RJ; Iteld, B; Jackson, SA; Jacobs, B; Jacobs, L; Jenkins, C; Johnson, C; Jong, LT; Kaplan, K; Kaplan, RA; Katz, S; Kavinsky, CJ; Kelley, R; Kerzner, B; Klein, EJ; Koshkarian, G; Kozak, M; Krisciunas, V; Kutoloski, K; Lakkis, N; Lasala, M; LaSalle, JR; Latthe, B; Lee-Kwen, P; Lehmann, KG; Leifer, D; LeLevier, J; Lender, D; Levin, K; Levine, M; Lewis, P; Libman, R; Little, T; Locke, G; Loeffler, R; Lorch, D; Lowenkopf, TJ; Lurie, M; Maggiacomo, F; Martin, JD; Massie, B; Massin, EK; Mattio, TG; McGuinn, W; Meckler, RJ; Meredith, M; Mersey, JH; Miller, A; Miller, J; Miller, L; Misch, P; Modrall, J; Mooradian, AD; Morelli, JT; Nafziger, A; Nash, SD; Ng, K; Niederman, A; O'Bryan, JP; Ogden, P; Miller-Oppy, J; Orr, JD; Ovalle, F; Overlie, P; Ozaki, CK; Pacheco, T; Peart, B; Perkins, C; Pettyjohn, F; Pines, I; Pita, J; Poling, T; Pollack, AR; Pollock, S; Post, GL; Powers, JB; Prashad, R; Raad, G; Raikhel, M; Rajachandran, M; Reichwein, R; Rendell, M; Reynolds, PS; Rich, M; Richardson, T; Rictor, K; Ring, ME; Rocco, M; Rogers, B; Roth, EM; Ryan, WM; Salmon, J; Sanchez, R; Schecter, JA; Scherbarth, KCJ; Schrenker, J; Schubart, U; Schussheim, A; Seaworth, J; Seigel, P; Shah, S; Shammas, N; Sheldon, WS; Shelhamer, L; Sherman, D; Shey, R; Shook, TL; Shor, R; Sievert, R; Silliman, S; Silver, B; Simon, H; Slater, W; Sloan, G; Smith, J; Smith, WB; Snyder, B; Som, D; Sotolongo, C; Spaedy, A; Spriggs, D; Steen, S; Stenstrom, S; Stonesifer, LD; Subich, D; Suresh, DP; Tamayo, R; Tan, WA; Tefera, G; Thadani, U; Tidman, R; Tilkian, A; Tonkon, MJ; Turel, A; VanSickle, D; Vernon, C; Voyles, W; Walder, J; Warren, M; Weber, K; Weeks, K; Weiss, RJ; Weiss, N; Whitaker, JH; Wolinsky, D; Wu, W; Yadav, J; Yeoman, GD				Bhatt, DL; Fox, KAA; Hacke, W; Berger, PB; Black, HR; Boden, WE; Cacoub, P; Cohen, EA; Creager, MA; Easton, JD; Flather, MD; Haffner, SM; Hamm, CW; Hankey, GJ; Johnston, SC; Mak, KH; Mas, JL; Montalescot, G; Pearson, TA; Steg, PG; Steinhubl, SR; Weber, MA; Brennan, DM; Fabry-Ribaudo, L; Booth, J; Topol, EJ; Frye, RL; Amarenco, P; Brass, LM; Buyse, M; Cohen, LS; DeMets, DL; Fuster, V; Hart, RG; Marler, JR; McCarthy, C; Schoemig, A; Lincoff, AM; Brener, SJ; Sila, CA; Albuquerque, A; Aroutiounov, G; Artemiev, D; Atkeson, BG; Bartel, T; Basart, DCG; Lima, AB; Belli, G; Bordalo e Sa, AL; Bosch, X; Boysen, G; Busch, EWA; Cavallini, A; Sanchez, AC; Chiu, JH; Dahl, T; Danielsson, E; Fathi, RB; Grande, P; Groundstroem, K; Hamon, M; Haude, M; Held, C; Hesse, B; Hook, MA; Hostetter, JC; Huang, JC; Jones, RC; Kaminska, A; Karlocai, K; Marcheselli, S; Marti-Fabregas, J; Mikulik, R; Neau, JP; Nisanci, Y; Nordal, HJ; Okay, T; Opala, G; Orlova, IA; Parfenov, V; Pasierski, TJ; Permanyer-Miralda, G; Plomaritoglou, A; Pruszczyk, P; Rasmanis, G; Roine, RO; Ronaszeki, A; Rossi, ML; Sas, K; Shields, RW; Sitar, J; Srichai, B; Stam, J; Sweeney, PJ; Syvaenne, P; Tschopp, D; Urbanek, K; Vavuranakis, M; Vecsei, L; Baptista, MV; Vojtisek, P; Woimant, F; Zidar, FJ; Ameriso, SF; Cura, FA; Aylward, P; Hankey, GJ; Boland, BJ; Amato, A; De Paola, V; Cohen, EA; Roussin, A; Teal, P; Ehler, E; Sillesen, H; Nieminen, MS; Steg, PG; Hoffmann, U; Neumann, FJ; Dimas, AP; Forster, T; Ardissino, D; Alvarado, R; Bueller, HR; Indredavik, B; Gaciong, ZA; Morais, J; Mareev, V; Betriu, A; Ruilope, LM; Dalby, AJ; Oestergren, JB; Luscher, TF; Kultursay, H; Flather, MD; Fox, KAA; Boden, WE; Easton, JD; Haffner, SM; Pearson, TA; Steinhubl, SR; Alvarisqueta, A; Ameriso, S; Amuchastegui, LM; Caccavo, A; Parera, IC; Chekherdemian, S; Cura, F; Esnaola y Rojas, MM; Pardal, MF; Ferrari, J; Fideleff, H; Hasbani, E; La Mura, R; Presta, JL; Rey, R; Rey, R; Rivas, R; Starosiliz, DG; Villamil, A; Waitman, J; Zaefferer, P; Amerena, J; Bladin, C; Chew, D; Crimmins, D; Cross, D; Davis, S; Davis, T; Donnan, G; Fitridge, R; Freilich, D; Gibbs, H; Graham, J; Hill, A; Horowitz, J; Hunt, D; Ingham, N; Karrasch, J; Meredith, I; Moses, R; Phillips, P; Rankin, J; Read, S; Rees, D; Roger, S; Sampson, J; Schwartz, R; Walker, P; Watts, G; Whelan, A; Whitbourn, R; Eber, B; Niessner, H; Pilger, E; Schmidt, R; Wascher, T; Willeit, J; Blecic, S; Boland, BJ; Boland, J; Boxho, G; De Deyn, PP; Duchateau, J; Ducobu, J; Heyndrickx, GR; Sanchez-Ruiz, F; Scheen, A; Thijs, V; Van Mieghem, W; Verjans, E; de Paola, AAV; Francischetti, A; Francischetti, E; Bezerra, FAF; Gagliardi, R; Massaro, A; Nagato, Y; Nakiri, K; Rassi, S; Scherr, C; Sgarbi, JA; Felicio, JS; Suplicy, H; Arts, R; Auger, P; Baer, CEH; Bailey, G; Bailey, P; Beaudry, M; Bedard, J; Berger, L; Berlingieri, JD; Bhargava, RK; Bogaty, P; Bruckschwaiger, D; Cameron, MH; Chilvers, M; Connolly, S; Constance, C; Conter, HS; Cote, R; Cusson, J; Desai, H; Desjardins, L; Dlin, RA; Durocher, A; Fortin, C; Gagnon, YD; Glanz, A; Goodman, SG; Gossard, D; Gupta, MK; Hachinski, V; Hambly, D; Hamilton, RD; Hejdankova, B; Hii, J; Hughes, W; Hui, WKK; Janzen, J; Johnston, D; Joyner, C; Klinke, WP; Kouz, S; Allier, PL; Labbe, R; Lam, SSY; Landry, DA; Laroche, C; Lawlor, BJ; Lenis, JHF; Ma, P; Mackey, A; Marr, DR; Milton, J; Minuk, J; Miron, MJ; Misik, KKA; Moddel, G; Monchesky, T; Nault, P; O'Mahony, WF; Panju, A; Penn, A; Perron, P; Phillips, S; Pistawka, K; Ramjattan, BR; Ricci, JA; Rodes, J; Sahlas, D; Selchen, D; Sharma, M; Shuaib, A; Spence, D; Steeves, DC; Studney, D; Sullivan, J; Sussex, BA; Teal, P; Teitelbaum, J; Tildesley, HD; Tishler, SJ; Turpie, AGG; Voll, C; Warnica, JW; Weigel, MA; Winder, T; Winger, M; Woo, VC; Wozniak, P; Yale, JF; Yao, LCH; Zimakas, G; Zimmermann, R; Corbalan, R; Lavados, P; Yovanovich, J; Bar, M; Branny, M; Charvat, J; Ehler, E; Filipensky, B; Filipova, M; Smid, J; Spac, J; Spinar, J; Stanek, F; Zidkova, E; Carstensen, M; Husted, SE; Kraemmer-Nielsen, H; Lindvig, K; Airaksinen, J; Nieminen, MS; Sivenius, J; Abenhaim, N; Agraou, B; Bismuth, M; Boccalon, H; Bourgoin, M; Bousser, MG; Carpentier, P; Cibois-Honnorat, I; Conri, C; Hautefeuille, BD; Dambrine, P; David, M; Decousus, H; Devulder, B; Dubois-Rande, JL; Ferrari, E; Fonteny, R; Fuchs, L; Giroud, M; Guilmot, JL; Krempf, M; Mahagne, MH; Mas, JL; Medvedowsky, A; Montalescot, G; Moulin, T; Pinel, JF; Puel, J; Quere, I; Rodier, G; Rosolacci, T; Rouanet, F; Saillard, D; Steg, G; Stephan, D; Tribouilloy, C; Vogel, JY; Samson, Y; Baran, C; Berrouschot, J; Busse, O; Dichgans, M; Diener, HC; Fritz, HG; Goertler, M; Griewing, B; Haak, T; Haberl, R; Hamm, C; Hein, J; Heitzer, T; Hennerici, M; Hoffmann, U; Horacek, T; Klausmann, G; Lawall, H; Mahla, G; Mauersberger, H; Meinhardt, G; Mueller-Jensen, A; Muenzel, T; Nawroth, P; Neumann, FJ; Ochs, H; Ringleb, P; Samer, H; Sander, D; Scheffler, P; Schulte, KL; Silber, S; Speier, U; Stangl, K; Stark, E; Tiefenbacher, C; von Bilderling, P; Weisbach, M; Wunderlich, J; Dimas, A; Elisaf, M; Karamitsos, D; Melidonis, A; Pagkalos, E; Polydorou, A; Saopoulos, C; Vemmos, K; Ziakas, G; Chan, J; Chan, WK; Chen, WH; Cheung, R; Li, SK; Tan, K; Sing, K; Wong, L; Woo, KS; Acsady, G; Cseh, K; Csiba, L; Csornai, M; Forster, T; Kerekes, C; Kollar, L; Kristof, V; Laszlo, Z; Muranyi, A; Sebestyen, J; Sereg, M; Rosei, EA; Bassi, P; Cucinotta, D; Degli Esposti, E; Federico, F; Forconi, S; Glorioso, N; Gresele, P; Guidetti, D; Mannarino, E; Masini, F; Micieli, G; Morganti, A; Pasquali, R; Rossi, PC; Sacca, L; Sacchetti, ML; Spissu, A; Terrosu, P; Violi, F; bin Kamaruddin, NA; Chan, SP; Tan, KS; Aguilar, C; Alvarado, R; Arauz, A; Ascanio, CG; Barroso, NS; Flota, LF; Hernandez, S; Herrera, R; Leyva, JL; Meaney, E; Miranda, A; Morales, E; Ramirez, B; Ranero, A; Rivera, MA; Ruiz, JL; Sanchez, CJ; Tamez, JA; Atar, D; Indredavik, B; Sirnes, PA; Andziak, P; Brakowiecki, F; Cencora, A; Cholewa, M; Gaciong, Z; Gutowski, P; Huczynski, J; Janik, K; Jawien, A; Kania, G; Kleczkowski, D; Kotowicz, J; Krasowski, W; Kruk, M; Kuczynska-Zardzewialy, A; Kwiecinski, H; Lopatynski, J; Muszynska-Polaszewska, M; Piepiorka, M; Pilarska, K; Podemski, R; Rudzinski, J; Rynkiewicz, A; Strzelecka-Gorzynska, M; Szczudlik, A; Szpajer, M; Wierusz-Wysocka, B; Wojciechowski, D; Wyrzykowski, B; Zaleski, P; Zalska, B; Ziaja, K; Cunha, L; Ferreira, D; Ferro, J; Correia, LG; da Silva, PM; Morais, J; Capitao, LM; Puig, J; Salgado, V; Belousov, J; Gratsiansky, N; Mareev, V; Sinopalnikov, A; Skoromets, A; Skvortsova, V; Stratchounsky, L; Suslina, Z; Auchus, A; Chang, HM; Mak, KH; Ramani, NV; Tay, JC; Blomerus, P; Bryer, A; Burgess, L; Dalby, AJ; Distiller, L; Ebrahim, IO; Ellis, GC; Essop, MR; King, J; Lloyd, E; Moore, R; Sommers, R; Steingo, L; Van Niekerk, M; Aguilera, JM; Alvarez-Sabin, J; Cairols, M; Calvo, C; Castillo, J; Coca, A; Davalos, A; De Alvaro, F; Flores, A; Puig, JG; Gil-Peralta, A; Gomez, P; Heras, M; Macaya, C; Hidalgo, AM; Matias-Guiu, J; Mostacero, E; Romero, R; Die, ER; Ruilope, LM; Serena, J; Vila, N; Vivancos, J; Bokemark, L; Cederin, B; Karacagil, S; Oestergren, J; Strand, T; Unden-Goeransson, R; Baumgartner, I; Beer, JH; Bogousslavsky, J; Bounameaux, H; Caduff, B; Cerny, A; Gallino, A; Luescher, T; Lyrer, P; Pagnamenta, A; Cheng, JJ; Chou, HT; Huang, HW; Ryu, SJ; Biesma, DH; Brandjes, DPM; Bueller, HR; den Hartog, FR; Dippel, DWJ; Kramer, MHH; Lenders, JWM; Michels, HR; Niemeijer, MG; Nierop, PR; Niewold, JUR; Pieterse, MGC; Sanders, EACM; Smak Gregoor, PJH; Teijink, J; Troquay, RPT; van Vlies, B; Balkan, S; Bayazit, M; Gol, K; Ince, B; Kultursay, H; Kumral, E; Kutluk, K; Tuzun, H; Adgey, J; Bath, P; Belch, J; Brack, MJ; Corr, LA; Curless, R; Donnelly, R; Dormandy, JA; Durrington, P; Ellis, SJ; Flather, MD; Fox, KAA; Jenkinson, D; Lees, KR; MacWalter, RS; McEneaney, D; Mehrzad, A; Muir, K; Murphy, C; Purvis, JA; Robinson, T; Shetty, HGM; Sprigings, D; Stansby, G; Venables, GS; Abou-Zamzam, A; Adams, H; Aguirre, FV; Ahmad, B; Allison, JR; Almahameed, A; Altafullah, I; Anderson, J; Arakaki, R; Arnold, G; Avva, R; Axelrod, A; Bacharach, JM; Banish, D; Bank, A; Banks, GG; Bansal, S; Bayron, C; Becker, KJ; Becnel, L; Belber, A; Belden, JR; Bernstein, D; Bhatia, HS; Bittrick, J; Boden, WE; Bordenave, KK; Bowers, T; Bradley, AJ; Brady, JR; Brady, S; Brandes, J; Brateanu, A; Brautigam, D; Brill, D; Brillman, J; Broker, RE; Brotman, D; Brown, C; Bruya, TE; Buckner, JK; Buth, D; Byer, T; Cannon, L; Capodilupo, R; Cappleman, JM; Chaikof, EL; Chambers, J; Chandna, H; Chandrashekhar, YP; Chen, C; Chippendale, T; Chokshi, S; Clagett, P; Cohen, K; Collins, M; Comerota, A; Cook, JR; Corbelli, J; Creager, MA; Cucher, FH; Cummins, FE; Dandapani, B; Dave, K; DeGent, GE; DeGregorio, M; DeHart, DP; DeLeon, J; Devlin, T; DeVries, B; Drehobl, M; Drossner, MN; Dryjski, M; Dulli, D; Eisenberg, D; Ellison, WT; Erlemeier, S; Felten, W; Felton, W; Fenster, PE; Fields, H; Fischel, T; Furlan, A; Gandhi, M; Gaona, R; Gazda, S; Gelormini, J; George, A; George, J; George, W; Gill, S; Glass, JM; Goldberg, MC; Goldman, S; Goldstein, J; Goodman, MA; Grayum, BP; Greenberg, J; Grewal, G; Griffin, J; Griffin, R; Gross-Sawicka, E; Gupta, D; Gupta, S; Gutnik, L; Haake, B; Haist, JL; Hanna, J; Harris, J; Harrison, B; Hart, MV; Hendley, R; Henry, T; Hermany, P; Herrera, C; Hoch, J; Hollander, J; Howard, VN; Huber, T; Hull, R; Hye, RJ; Iteld, B; Jackson, SA; Jacobs, B; Jacobs, L; Jenkins, C; Johnson, C; Jong, LT; Kaplan, K; Kaplan, RA; Katz, S; Kavinsky, CJ; Kelley, R; Kerzner, B; Klein, EJ; Koshkarian, G; Kozak, M; Krisciunas, V; Kutoloski, K; Lakkis, N; Lasala, M; LaSalle, JR; Latthe, B; Lee-Kwen, P; Lehmann, KG; Leifer, D; LeLevier, J; Lender, D; Levin, K; Levine, M; Lewis, P; Libman, R; Little, T; Locke, G; Loeffler, R; Lorch, D; Lowenkopf, TJ; Lurie, M; Maggiacomo, F; Martin, JD; Massie, B; Massin, EK; Mattio, TG; McGuinn, W; Meckler, RJ; Meredith, M; Mersey, JH; Miller, A; Miller, J; Miller, L; Misch, P; Modrall, J; Mooradian, AD; Morelli, JT; Nafziger, A; Nash, SD; Ng, K; Niederman, A; O'Bryan, JP; Ogden, P; Miller-Oppy, J; Orr, JD; Ovalle, F; Overlie, P; Ozaki, CK; Pacheco, T; Peart, B; Perkins, C; Pettyjohn, F; Pines, I; Pita, J; Poling, T; Pollack, AR; Pollock, S; Post, GL; Powers, JB; Prashad, R; Raad, G; Raikhel, M; Rajachandran, M; Reichwein, R; Rendell, M; Reynolds, PS; Rich, M; Richardson, T; Rictor, K; Ring, ME; Rocco, M; Rogers, B; Roth, EM; Ryan, WM; Salmon, J; Sanchez, R; Schecter, JA; Scherbarth, KCJ; Schrenker, J; Schubart, U; Schussheim, A; Seaworth, J; Seigel, P; Shah, S; Shammas, N; Sheldon, WS; Shelhamer, L; Sherman, D; Shey, R; Shook, TL; Shor, R; Sievert, R; Silliman, S; Silver, B; Simon, H; Slater, W; Sloan, G; Smith, J; Smith, WB; Snyder, B; Som, D; Sotolongo, C; Spaedy, A; Spriggs, D; Steen, S; Stenstrom, S; Stonesifer, LD; Subich, D; Suresh, DP; Tamayo, R; Tan, WA; Tefera, G; Thadani, U; Tidman, R; Tilkian, A; Tonkon, MJ; Turel, A; VanSickle, D; Vernon, C; Voyles, W; Walder, J; Warren, M; Weber, K; Weeks, K; Weiss, RJ; Weiss, N; Whitaker, JH; Wolinsky, D; Wu, W; Yadav, J; Yeoman, GD		CHARISMA Investigators	Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYOCARDIAL-INFARCTION; RISK; THERAPY	BACKGROUND: Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for atherothrombotic events. METHODS: We randomly assigned 15,603 patients with either clinically evident cardiovascular disease or multiple risk factors to receive clopidogrel (75 mg per day) plus low-dose aspirin (75 to 162 mg per day) or placebo plus low-dose aspirin and followed them for a median of 28 months. The primary efficacy end point was a composite of myocardial infarction, stroke, or death from cardiovascular causes. RESULTS: The rate of the primary efficacy end point was 6.8 percent with clopidogrel plus aspirin and 7.3 percent with placebo plus aspirin (relative risk, 0.93; 95 percent confidence interval, 0.83 to 1.05; P=0.22). The respective rate of the principal secondary efficacy end point, which included hospitalizations for ischemic events, was 16.7 percent and 17.9 percent (relative risk, 0.92; 95 percent confidence interval, 0.86 to 0.995; P=0.04), and the rate of severe bleeding was 1.7 percent and 1.3 percent (relative risk, 1.25; 95 percent confidence interval, 0.97 to 1.61 percent; P=0.09). The rate of the primary end point among patients with multiple risk factors was 6.6 percent with clopidogrel and 5.5 percent with placebo (relative risk, 1.2; 95 percent confidence interval, 0.91 to 1.59; P=0.20) and the rate of death from cardiovascular causes also was higher with clopidogrel (3.9 percent vs. 2.2 percent, P=0.01). In the subgroup with clinically evident atherothrombosis, the rate was 6.9 percent with clopidogrel and 7.9 percent with placebo (relative risk, 0.88; 95 percent confidence interval, 0.77 to 0.998; P=0.046). CONCLUSIONS: In this trial, there was a suggestion of benefit with clopidogrel treatment in patients with symptomatic atherothrombosis and a suggestion of harm in patients with multiple risk factors. Overall, clopidogrel plus aspirin was not significantly more effective than aspirin alone in reducing the rate of myocardial infarction, stroke, or death from cardiovascular causes.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Cleveland Clin, Cleveland, OH 44106 USA; Univ & Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland; Heidelberg Univ, Heidelberg, Germany; Duke Univ, Durham, NC USA; Rush Med Coll, Chicago, IL 60612 USA; Hartford Hosp, Hartford, CT 06115 USA; Hop La Pitie Salpetriere, Paris, France; Hop St Anne, F-75674 Paris, France; CHU Pitie Salpetriere, Inst Cardiol, Paris, France; Hop Bichat Claude Bernard, F-75877 Paris, France; Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Rhode Isl Hosp, Providence, RI USA; Brown Univ, Providence, RI 02912 USA; Royal Brompton Hosp, London SW3 6LY, England; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Kerckhoff Klin Ctr, Bad Nauheim, Germany; Univ Western Australia, Royal Perth Hosp, Perth, WA 6009, Australia; Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; Univ Calif San Francisco, San Francisco, CA 94143 USA; Gleneagles Med Ctr, Singapore, Singapore; Univ Rochester, Sch Med, Rochester, NY USA; Univ Kentucky, Lexington, KY USA; Suny Downstate Med Ctr, Brooklyn, NY 11203 USA	Case Western Reserve University; Cleveland Clinic Foundation; University of Edinburgh; Ruprecht Karls University Heidelberg; Duke University; Rush University; Hartford Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Royal Brompton Hospital; University of Texas System; University of Texas Health San Antonio; Kerckhoff Clinic; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of California System; University of California San Francisco; University of Rochester; University of Kentucky; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Topol, EJ (corresponding author), Case Western Reserve Univ, Dept Genet, BRB 724,10900 Euclid Ave, Cleveland, OH 44106 USA.	eric.topol@case.edu	Biesma, Douwe H./AAV-6343-2020; ameriso, sebastian/AAV-2296-2020; Kovrazhkina, Elena/AAR-2425-2021; Airaksinen, Juhani/AAC-7857-2021; Vécsei, László/B-2066-2010; Hankey, Graeme J/H-4968-2014; Vecsei, Laszlo/ABA-6137-2021; Hacke, Werner/ABE-8661-2020; Diener, Hans-Christoph/AAF-7275-2019; Becker, Kyra/L-1420-2019; Kramer, Mark/GWQ-3502-2022; Thijs, Vincent/C-3647-2009; Hamm, Christian W./I-3155-2017; Quere, Isabelle/AAB-8519-2020; Mareev, Viacheslav Yurivich/Q-1375-2017; Francischetti, Emilio/AAX-8544-2020; Belch, Jill/AAE-9189-2019; Hoffmann, Ulrich/AAF-9798-2020; Munzel, Thomas/A-2912-2014; Dippel, Diederik/AAJ-2192-2020; Sirnes, Per Anton/AAS-2343-2020; Sillesen, Henrik/ABB-5668-2020; Chen, Christopher/E-7023-2013; TAN, KAY SIN/B-9911-2010; ince, birsen/AAI-1704-2019; Ovalle, Fernando/Q-6647-2019; Dichgans, Martin/HCH-3247-2022; Bosch, Xavier/E-7890-2014; Rabuñal, Ramón/K-2795-2013; Fox, keith A A/I-3742-2013; Martí-Fàbregas, Joan/I-5933-2019; Rivera, Maria/GYU-2150-2022; STEG, Philippe Gabriel/Z-1567-2019; Gresele, Paolo/F-6775-2013; marcheselli, simona/L-2972-2013; Pruszczyk, Piotr/AAA-3523-2019; Bar, Michal/I-4516-2017; gresele, paolo/AAG-8019-2019; Cheung, Rebecca/A-9479-2019	Biesma, Douwe H./0000-0001-8334-3057; Airaksinen, Juhani/0000-0002-0193-568X; Vécsei, László/0000-0001-8037-3672; Hankey, Graeme J/0000-0002-6044-7328; Becker, Kyra/0000-0002-8310-4846; Thijs, Vincent/0000-0002-6614-8417; Hamm, Christian W./0000-0001-6763-4161; Quere, Isabelle/0000-0002-1492-9764; Mareev, Viacheslav Yurivich/0000-0002-7285-2048; Belch, Jill/0000-0001-8280-6689; Munzel, Thomas/0000-0001-5503-4150; Dippel, Diederik/0000-0002-9234-3515; Chen, Christopher/0000-0002-1047-9225; Ovalle, Fernando/0000-0002-6711-071X; Dichgans, Martin/0000-0002-0654-387X; Bosch, Xavier/0000-0002-0133-1587; Rabuñal, Ramón/0000-0001-5106-5005; Martí-Fàbregas, Joan/0000-0001-9229-8649; Gresele, Paolo/0000-0001-5365-8445; marcheselli, simona/0000-0002-7238-4088; Bar, Michal/0000-0002-5049-5844; STEG, Philippe Gabriel/0000-0001-6896-2941; Topol, Eric/0000-0002-1478-4729; Cheung, Rebecca/0000-0002-2656-5646; Fox, Keith/0000-0002-0140-2752; Cacoub, Patrice/0000-0002-6727-4992	NHLBI NIH HHS [HL081011, P50 HL077101] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081011, P50HL077101] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bhatt DL, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.03.017; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bhatt DL, 2004, AM HEART J, V148, P263, DOI 10.1016/j.ahj.2004.03.028; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2003, JAMA-J AM MED ASSOC, V289, P987; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol EJ, 2005, J AM COLL CARDIOL, V46, P1456, DOI 10.1016/j.jacc.2005.06.064; Yusuf S, 2001, NEW ENGL J MED, V345, P494	17	1960	2079	2	233	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1706	1717		10.1056/NEJMoa060989	http://dx.doi.org/10.1056/NEJMoa060989			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16531616				2022-12-28	WOS:000236893900007
J	Killaspy, H; Bebbington, P; Blizard, R; Johnson, S; Nolan, F; Pilling, S; King, M				Killaspy, H; Bebbington, P; Blizard, R; Johnson, S; Nolan, F; Pilling, S; King, M			The REACT study: randomised evaluation of assertive community treatment in north London	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRISM PSYCHOSIS; MENTALLY-ILL; PROGRAM; SCALE; FIDELITY; ILLNESS; MODELS; CARE	Objective To compare outcomes of care from assertive community treatment teams with care by community menial health teams for people with serious mental illnesses. Design Non-blind randomised controlled trial. Setting Two inner London boroughs. Participants 251 men and women under the care of adult secondary mental health services with recent high use of inpatient care and difficulties engaging with community services. Interventions Treatment from assertive community treatment team (127 participants) or Continuation of care from community mental health team (124 participants). Main outcome measures Primary outcome was inpatient bed use 18 months after randomisation. Secondary outcomes included symptoms, social function, client satisfaction, and engagement with services. Results No significant differences were found in inpatient bed use (median difference 1, 95% confidence interval -16 to 38) or in clinical or social outcomes For the two treatment groups. Clients who received care from the assertive community team seemed better engaged (adapted homeless engagement acceptance schedule: difference in means 1.1, 1.0 to 1.9), and those who agreed to be interviewed were more satisfied with services (adapted client satisfaction questionnaire: difference in means 7.14, 0.9 to 13.4). Conclusions Community mental health teams are able to support people with serious mental illnesses as effectively as assertive community treatment teams, but assertive community treatment may be better at engaging clients and may lead to greater satisfaction with services.	UCL, Dept Mental Hlth Sci, London NW3 2PF, England; Camden & Islington Mental Hlth & Social Care Trus, London, England; UCL, Ctr Outcomes Res & Effectiveness, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Killaspy, H (corresponding author), UCL, Dept Mental Hlth Sci, London NW3 2PF, England.	h.killaspy@medsch.ucl.ac.uk	Johnson, Sonia/ABF-1457-2020; Bebbington, Paul Ernest/C-1939-2008; King, Michael B/D-7477-2011; Nolan, Fiona/U-3558-2018; Johnson, Sonia/A-5220-2008	Johnson, Sonia/0000-0002-2219-1384; Bebbington, Paul Ernest/0000-0002-6030-7456; King, Michael B/0000-0003-4715-7171; Nolan, Fiona/0000-0002-6633-341X; Johnson, Sonia/0000-0002-2219-1384; Killaspy, Helen/0000-0003-2481-4802				[Anonymous], 1999, BRIT J PSYCHIAT, V174, P74; Burns T, 1999, LANCET, V353, P2185, DOI 10.1016/S0140-6736(98)12191-8; Burns T, 2002, BRIT J PSYCHIAT, V181, P375, DOI 10.1192/bjp.181.5.375; *CAMD ISL MENT HLT, 2004, AN AC INP SERV CAR; *CAMD ISL MENT HLT, 2004, AN AC INP SERV CAR T; *DEP HLTH ASS COMM, 2001, MENT HLTH POL IMPL G; *DEP HLTH COMM MEN, 2002, MENT HLTH POL IMPL G; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2004, NAT SERV FRAM MENT H; Department of Health, 2001, MENT HLTH POL IMPL G; Drake R., 1996, OUTCOMES ASSESSMENT, P113; Gerber GJ, 1999, PSYCHIATR SERV, V50, P546, DOI 10.1176/ps.50.4.546; Glover GR, 1998, SOC PSYCH PSYCH EPID, V33, P89, DOI 10.1007/s001270050027; Holloway F, 1998, BRIT J PSYCHIAT, V172, P19, DOI 10.1192/bjp.172.1.19; HOULT JC, 1986, BRIT J PSYCHIAT, V149, P337; Larsen D L, 1979, Eval Program Plann, V2, P197, DOI 10.1016/0149-7189(79)90094-6; Marshall M, 1999, BRIT J PSYCHIAT, V175, P501, DOI 10.1192/bjp.175.6.501; Marshall M, 2000, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001089, DOI 10.1002/14651858.CD001089]; MCGREW JB, 1991, J CONSULT CLIN PSYCH, V62, P670; MCGREW JH, 1994, J CONSULT CLIN PSYCH, V62, P670, DOI 10.1037/0022-006X.62.4.670; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; MELZER D, 1991, BRIT MED J, V303, P1023, DOI 10.1136/bmj.303.6809.1023; METZER D, 1991, BRIT MED J, V303, P1023; Mueser KT, 1998, SCHIZOPHRENIA BULL, V24, P37, DOI 10.1093/oxfordjournals.schbul.a033314; National Association of Psychiatric Intensive Care & Low Secure Units, 2018, CAPACITY DEV RESOURC; OVERALL JE, 1962, PSYCHOPHARMACOLOGICA, V11, P22; Park MJ, 2002, PSYCHOL MED, V32, P855, DOI 10.1017/S0033291702005913; PARKER G, 1991, ACTA PSYCHIAT SCAND, V83, P145, DOI 10.1111/j.1600-0447.1991.tb07381.x; Priebe S, 1999, INT J SOC PSYCHIATR, V45, P7, DOI 10.1177/002076409904500102; SLADE M, 1999, CAMBERWELL ASSESSMEN; Stein GS, 1999, BRIT J PSYCHIAT, V174, P375, DOI 10.1192/bjp.174.5.375; STEIN LI, 1980, ARCH GEN PSYCHIAT, V37, P392; Teague GB, 1998, AM J ORTHOPSYCHIAT, V68, P216, DOI 10.1037/h0080331; Thornicroft G, 1998, BRIT J PSYCHIAT, V173, P423, DOI 10.1192/bjp.173.5.423; *UK 700 GROUP, 1999, BRIT J PSYCHIAT, V171, P74; VENTURA J, 1993, INT J METH PSYCH RES, V3, P221; WEIDEN P, 1994, SCHIZOPHRENIA BULL, V20, P297, DOI 10.1093/schbul/20.2.297; Wright C, 2003, BRIT J PSYCHIAT, V183, P132, DOI 10.1192/bjp.183.2.132; 1999, LANCET, V353, P2185	39	185	190	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2006	332	7545					815	818A		10.1136/bmj.38773.518322.7C	http://dx.doi.org/10.1136/bmj.38773.518322.7C			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032ZQ	16543298	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000236815900016
J	Kuiken, T; Osterhaus, A; Roeder, P				Kuiken, T; Osterhaus, A; Roeder, P			Feline friend or potential foe?	NATURE			English	Editorial Material							AVIAN INFLUENZA H5N1; CATS; SPREAD		Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands; UN, Food & Agr Org, Anim Prod & Hlth Div, Rome, Italy	Erasmus University Rotterdam; Erasmus MC; Food & Agriculture Organization of the United Nations (FAO)	Kuiken, T (corresponding author), Erasmus Med Ctr, Dept Virol, Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; Kuiken, Thijs/0000-0001-5501-9049; Osterhaus, Albert/0000-0002-6074-1172				Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Butler D, 2006, NATURE, V440, P135, DOI 10.1038/440135a; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Munster VJ, 2006, SCIENCE; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Thanawongnuwech R, 2005, EMERG INFECT DIS, V11, P699, DOI 10.3201/eid1105.050007	8	34	38	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2006	440	7085					741	742		10.1038/440741a	http://dx.doi.org/10.1038/440741a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598234				2022-12-28	WOS:000236548400019
J	Kastrati, A; Mehilli, J; Neumann, FJ; Dotzer, F; ten Berg, JN; Bollwein, H; Graf, I; Ibrahim, M; Pache, J; Seyfarth, M; Schuhlen, H; Dirschinger, J; Berger, PB; Schomig, A				Kastrati, A; Mehilli, J; Neumann, FJ; Dotzer, F; ten Berg, JN; Bollwein, H; Graf, I; Ibrahim, M; Pache, J; Seyfarth, M; Schuhlen, H; Dirschinger, J; Berger, PB; Schomig, A		ISAR-REACT 2 Trial Investigators	Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment - The ISAR-REACT 2 randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLYCOPROTEIN IIB/IIIA INHIBITORS; ELEVATION MYOCARDIAL-INFARCTION; REFRACTORY UNSTABLE ANGINA; EARLY INVASIVE STRATEGY; SERUM TROPONIN-T; ANTIPLATELET THERAPY; BALLOON-ANGIOPLASTY; PLATELET-FUNCTION; CLINICAL-TRIAL; TASK-FORCE	Context No specifically designed studies have addressed the role of the glycoprotein IIb/IIIa inhibitor abciximab in patients with non-ST-segment elevation acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) after pretreatment with 600 mg of clopidogrel. Objective To assess whether abciximab is associated with clinical benefit in high-risk patients with ACS undergoing PCI after pretreatment with 600 mg of clopidogrel. Design, Setting, and Patients International, multicenter, randomized, double-blind, placebo-controlled study conducted from March 2003 through December 2005, enrolling 2022 patients ( mean age, 66 years) with non-ST-segment elevation ACS undergoing PCI. Interventions Patients were assigned to receive either abciximab (0.25 mg/kg of body weight bolus, followed by a 0.125-mu g/kg per minute [ maximum, 10 mu g/min] infusion for 12 hours, plus heparin, 70 U/kg of body weight) or placebo ( placebo bolus and infusion of 12 hours, plus heparin bolus, 140 U/kg). All patients received clopidogrel, 600 mg, at least 2 hours prior to the procedure, as well as 500 mg of oral or intravenous aspirin. Main Outcome Measures The primary end point was a composite of death, myocardial infarction, or urgent target vessel revascularization occurring within 30 days after randomization; secondary end points were rates of in-hospital major and minor bleeding. Results Of 2022 patients enrolled, 1012 were assigned to abciximab and 1010 to placebo. The primary end point was reached in 90 patients (8.9%) assigned to abciximab vs 120 patients (11.9%) assigned to placebo, a 25% reduction in risk with abciximab ( relative risk [RR], 0.75; 95% CI, 0.58-0.97; P=.03). Among patients without an elevated troponin level, there was no difference in the incidence of primary end point events between the abciximab group (23/499 patients [4.6%]) and the placebo group (22/474 patients [ 4.6%]) ( RR, 0.99; 95% CI, 0.56-1.76; P=.98), whereas among patients with an elevated troponin level, the incidence of events was significantly lower in the abciximab group (67/513 patients [13.1%]) compared with the placebo group (98/536 patients [18.3%]), which corresponds to an RR of 0.71 ( 95% CI, 0.54-0.95; P=.02) (P=.07 for interaction). There were no significant differences between the 2 groups regarding the risk of major and minor bleeding as well as need for transfusion. Conclusions Abciximab reduces the risk of adverse events in patients with non-ST-segment elevation ACS undergoing PCI after pretreatment with 600 mg of clopidogrel. The benefits provided by abciximab appear to be confined to patients presenting with an elevated troponin level. Trial Registration ClinicalTrials. gov Identifier: NCT00133003.	Deutsch Herzzentrum, D-80636 Munich, Germany; Tech Univ, Med Klin Rechts Isar 1, Munich, Germany; Herz Zentrum, Bad Krozingen, Germany; Klinikum Garmisch Partenkirchen, Garmisch Partenkirchen, Germany; St Antonius Hosp, Nieuwegein, Netherlands; Duke Clin Res Inst, Durham, NC USA	German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; St. Antonius Hospital Utrecht; Duke University	Kastrati, A (corresponding author), Deutsch Herzzentrum, Lazarettstr 36, D-80636 Munich, Germany.	kastrati@dhm.mhn.de	Mehilli, Julinda/F-2629-2016; , Kastrati/Y-2389-2019	Schuhlen, Helmut/0000-0001-8630-4264				Ault KA, 1999, J AM COLL CARDIOL, V33, P634, DOI 10.1016/S0735-1097(98)00635-4; Bhatt DL, 2000, JAMA-J AM MED ASSOC, V284, P1549, DOI 10.1001/jama.284.12.1549; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; CANNON C, 2005, AM HEART ASS SCI SES; *CAPTURE INV, 1997, LANCET, V350, P744; ELLIS SG, 1990, CIRCULATION, V82, P1193, DOI 10.1161/01.CIR.82.4.1193; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Frossard M, 2004, CIRCULATION, V110, P1392, DOI 10.1161/01.CIR.0000141575.92958.9C; Furman MI, 2005, J THROMB HAEMOST, V3, P312, DOI 10.1111/j.1538-7836.2005.01124.x; Gluckman TJ, 2005, JAMA-J AM MED ASSOC, V293, P349, DOI 10.1001/jama.293.3.349; Gurbel PA, 2005, CIRCULATION, V111, P1153, DOI 10.1161/01.CIR.0000157138.02645.11; Gurbel Paul A, 2004, Expert Rev Cardiovasc Ther, V2, P535, DOI 10.1586/14779072.2.4.535; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Hausleiter J, 2004, J INTERN MED, V256, P388, DOI 10.1111/j.1365-2796.2004.01398.x; Hochholzer W, 2005, CIRCULATION, V111, P2560, DOI 10.1161/01.CIR.0000160869.75810.98; Judge HM, 2005, PLATELETS, V16, P398, DOI 10.1080/09537100500163226; Kandzari DE, 2004, J AM COLL CARDIOL, V44, P2133, DOI 10.1016/j.jacc.2004.08.060; Kastrati A, 2004, NEW ENGL J MED, V350, P232, DOI 10.1056/NEJMoa031859; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Mazzone A, 2001, HEART, V85, P571, DOI 10.1136/heart.85.5.571; Mehilli J, 2004, CIRCULATION, V110, P3627, DOI 10.1161/01.CIR.0000148956.93631.4D; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Montalescot G, 2004, JAMA-J AM MED ASSOC, V292, P362, DOI 10.1001/jama.292.3.362; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Muller I, 2001, HEART, V85, P92, DOI 10.1136/heart.85.1.92; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Roffi M, 2002, EUR HEART J, V23, P1441, DOI 10.1053/euhj.2002.3160; Schomig A, 2005, EUR HEART J, V26, P1379, DOI 10.1093/eurheartj/ehi174; Schulman SP, 2004, JAMA-J AM MED ASSOC, V292, P1875, DOI 10.1001/jama.292.15.1875; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Simoons ML, 1997, LANCET, V349, P1429; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2004, AM HEART J, V148, P764, DOI 10.1016/j.ahj.2004.04.036; Storey RF, 2001, THROMB HAEMOSTASIS, V85, P401; *TIMI STUD GROUP, DEF US TIMI TRIALS; Topol EJ, 1998, LANCET, V352, P87, DOI 10.1016/S0140-6736(98)85010-1; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088; Wiviott SD, 2005, CIRCULATION, V111, P3366, DOI 10.1161/CIRCULATIONAHA.104.502815	42	559	593	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1531	1538		10.1001/jama.295.13.joc60034	http://dx.doi.org/10.1001/jama.295.13.joc60034			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16533938	Bronze			2022-12-28	WOS:000236505400020
J	McGavock, JM; Victor, RG; Unger, RH; Szczepaniak, LS				McGavock, JM; Victor, RG; Unger, RH; Szczepaniak, LS			Adiposity of the heart*, revisited	ANNALS OF INTERNAL MEDICINE			English	Review							MAGNETIC-RESONANCE-SPECTROSCOPY; LIPOTOXIC CARDIOMYOPATHY; OBESE RATS; HEPATIC STEATOSIS; APOLIPOPROTEIN-B; MOUSE MODEL; BETA-CELLS; IN-VIVO; TRIGLYCERIDE; RISK	Obesity is a major risk factor for heart disease. In the face of obesity's growing prevalence, it is important for physicians to be aware of emerging research of novel mechanisms through which adiposity adversely affects the heart. Conventional wisdom suggests that either hemodynamic (that is, increased cardiac output and hypertension) or metabolic (that is, dyslipidemic) derangements associated with obesity may predispose individuals to coronary artery disease and heart failure. The purpose of this review is to highlight a novel mechanism for heart disease in obesity whereby excessive lipid accumulation within the myocardium is directly cardiotoxic and causes left ventricular remodeling and dilated cardiomyopathy. Studies in animal models of obesity reveal that intracellular accumulation of triglyceride renders organs dysfunctional, which leads to several well-recognized clinical syndromes related to obesity (including type 2 diabetes). In these rodent models, excessive lipid accumulation in the myocardium causes left ventricular hypertrophy and nonischemic, dilated cardiomyopathy. Novel magnetic resonance spectroscopy techniques are now available to quantify intracellular lipid content in the myocardium and various other human tissues, which has made it possible to translate these studies into a clinical setting. By using this technology, we have recently begun to study the role of myocardial steatosis in the development of obesity-specific cardiomyopathy in humans. Recent studies in healthy individuals and patients with heart failure reveal that myocardial lipid content increases with the degree of adiposity and may contribute to the adverse structural and functional cardiac adaptations seen in obese persons. These studies parallel the observations in obese animals and provide evidence that myocardial lipid content may be a biomarker and putative therapeutic target for cardiac disease in obese patients.	Univ Texas, SW Med Ctr, Dept Internal Med, Div Hypertens, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Szczepaniak, LS (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med, Div Hypertens, Dallas, TX 75390 USA.	Lidia.szczepaniak@utsouthwestern.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL068736] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00633] Funding Source: Medline; NHLBI NIH HHS [K-25 HL-68736] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39; AMAD KH, 1965, CIRCULATION, V32, P740, DOI 10.1161/01.CIR.32.5.740; BEDFORD E, 1972, BRIT HEART J, V34, P23; Bjorkegren J, 2001, J BIOL CHEM, V276, P38511, DOI 10.1074/jbc.M106839200; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Crisostomo LL, 2001, INT J OBESITY, V25, P233, DOI 10.1038/sj.ijo.0801460; Dewald O, 2005, CIRCULATION, V112, P407, DOI 10.1161/CIRCULATIONAHA.105.536318; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Hirose H, 1996, J BIOL CHEM, V271, P5633, DOI 10.1074/jbc.271.10.5633; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lee Y, 2004, P NATL ACAD SCI USA, V101, P13624, DOI 10.1073/pnas.0405499101; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; PARADISE NF, 1985, AM J PHYSIOL, V248, pH438, DOI 10.1152/ajpheart.1985.248.4.H438; Peterson LR, 2004, J AM COLL CARDIOL, V43, P1399, DOI 10.1016/j.jacc.2003.10.062; Reingold JS, 2005, AM J PHYSIOL-ENDOC M, V289, pE935, DOI 10.1152/ajpendo.00095.2005; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; SCHICK F, 1993, MAGN RESON MED, V29, P158, DOI 10.1007/BF01769418; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Shimabukuro M, 1997, J CLIN INVEST, V100, P1750, DOI 10.1172/JCI119700; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P9558, DOI 10.1073/pnas.95.16.9558; Shulman GI, 2004, PHYSIOLOGY, V19, P183, DOI 10.1152/physiol.00007.2004; Smith HL, 1933, ARCH INTERN MED, V52, P911, DOI 10.1001/archinte.1933.00160060085007; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Szczepaniak LS, 1999, AM J PHYSIOL-ENDOC M, V276, pE977, DOI 10.1152/ajpendo.1999.276.5.E977; Szczepaniak LS, 2003, MAGN RESON MED, V49, P417, DOI 10.1002/mrm.10372; Szczepaniak LS, 2002, MAGN RESON MED, V47, P607, DOI 10.1002/mrm.10086; Unger RH, 2003, ENDOCRINOLOGY, V144, P5159, DOI 10.1210/en.2003-0870; Vasan RS, 1997, NEW ENGL J MED, V336, P1350, DOI 10.1056/NEJM199705083361903; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Yokoyama M, 2004, J BIOL CHEM, V279, P4204, DOI 10.1074/jbc.M311995200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	43	284	296	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					517	524		10.7326/0003-4819-144-7-200604040-00011	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00011			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585666				2022-12-28	WOS:000236685100007
J	Grindlay, JE				Grindlay, JE			Astronomy - A neutron star in F-sharp	SCIENCE			English	Editorial Material							MILLISECOND PULSAR; BINARIES	Discovery of the fastest spinning pulsar gives new constraints on the size of a neutron star and matter under extreme conditions and decreases the need for gravitational waves to impose a limiting maximum spin.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Grindlay, JE (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	josh@cfa.harvard.edu						*AUSTR TEL NAT FAC, AUSTR TEL NAT FAC PU, P10406; BACKER DC, 1982, NATURE, V300, P615, DOI 10.1038/300615a0; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; Bogdanov S, 2005, ASTROPHYS J, V630, P1029, DOI 10.1086/432249; Chakrabarty D, 2003, NATURE, V424, P42, DOI 10.1038/nature01732; Grindlay JE, 2001, SCIENCE, V292, P2290, DOI 10.1126/science.1061135; HEINKE CO, IN PRESS ASTROPHYS J; Hessels JWT, 2006, SCIENCE, V311, P1901, DOI 10.1126/science.1123430; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; Nice DJ, 2005, ASTROPHYS J, V634, P1242, DOI 10.1086/497109; Pavlov GG, 1997, ASTROPHYS J, V490, pL91, DOI 10.1086/311007; WAGONER RV, 1984, ASTROPHYS J, V278, P345, DOI 10.1086/161798; 2004, SCIENCE, V304	13	5	5	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1876	1877		10.1126/science.1125125	http://dx.doi.org/10.1126/science.1125125			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574857				2022-12-28	WOS:000236387800032
J	Avorn, J				Avorn, J			Part "D" for "defective" - The Medicare drug benefit chaos.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02215 USA.							AVORN J, 2004, POWERFUL MED BENFITS; CAPOZZA K, 2006, WILL PBMS DRIVE CURB; KRASNER J, 2006, BOSTON GLOBE    0223; PEAR R, 2006, NY TIMES        0121; Smith V, 2006, TRANSITION DUAL EL D	5	19	19	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1339	1341		10.1056/NEJMp068034	http://dx.doi.org/10.1056/NEJMp068034			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	026KO	16571877				2022-12-28	WOS:000236338000002
J	Shuchman, M; Redelmeier, DA				Shuchman, M; Redelmeier, DA			Politics and independence - The collapse of the Canadian Medical Association Journal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA; Univ Toronto, Toronto, ON, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Toronto	Shuchman, M (corresponding author), SUNY Buffalo, Dept Psychiat, Buffalo, NY 14260 USA.							CHOI S, 2006, IN PRESS CMAJ; ERLICK LS, 2006, IN PRESS CMAJ; KASSIRER JP, IN PRESS CMAJ	3	18	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1337	1339		10.1056/NEJMp068056	http://dx.doi.org/10.1056/NEJMp068056			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16540606				2022-12-28	WOS:000236338000001
J	Akala, FA; El-Saharty, S				Akala, FA; El-Saharty, S			Public-health challenges in the Middle East and North Africa	LANCET			English	Editorial Material									World Bank, Middle E & N Africa Reg, Human Dev Sector, Washington, DC 20433 USA	The World Bank	Akala, FA (corresponding author), World Bank, Middle E & N Africa Reg, Human Dev Sector, 1818 H St NW, Washington, DC 20433 USA.	fakala@worldbank.org						*HARV SCH PUBL HLT, GLOB BURD DIS PUBL S; Jenkins C, 2003, HIV AIDS MIDDLE E N; KHALEGIAN P, 2004, PUBLIC MANAGEMENT ES; *MIDD E FOR, 2002, AR COMP AR HUM DEV R; Peden M., 2004, WORLD REPORT ROAD TR; Pierre-Lewis A, 2004, PUBLIC HLTH MIDDLE E; [Population Reference Bureau Population Reference Bureau.], 2001, POP TRENDS CHALL MID; PRABHAT P, 2002, AM J PUBLIC HEALTH, V92, P1002; (The) World Bank, 2004, BETT GOV DEV MIDDL E; UNDP, 2005, AR HUM DEV REP 2004; *WORLD BANK, PUBL HLTH MIDDL E N; *WORLD BANK, IN PRESS SUST GAINS	12	47	49	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					961	964		10.1016/S0140-6736(06)68402-X	http://dx.doi.org/10.1016/S0140-6736(06)68402-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564342				2022-12-28	WOS:000236474200005
J	Betschinger, J; Mechtler, K; Knoblich, JA				Betschinger, J; Mechtler, K; Knoblich, JA			Asymmetric segregation of the tumor suppressor brat regulates self-renewal in Drosophila neural stem cells	CELL			English	Article							DAUGHTER-CELL; NEUROBLAST LINEAGES; AXONAL OUTGROWTH; PROTEIN; PROSPERO; DIVISION; LOCALIZATION; MIRANDA; IDENTIFICATION; PROLIFERATION	How stem cells generate both differentiating and self-renewing daughter cells is unclear. Here, we show that Drosophila larval neuroblasts-stem cell-like precursors of the adult brain-regulate proliferation by segregating the growth inhibitor Brat and the transcription factor Prospero into only one daughter cell. Like Prospero, Brat binds and cosegregates with the adaptor protein Miranda. In larval neuroblasts, both Brat and Prospero are required to inhibit self-renewal in one of the two daughter cells. While Prospero regulates cell-cycle gene transcription, Brat acts as a posttranscriptional inhibitor of dMyc. In brat or prospero mutants, both daughter cells grow and behave like neuroblasts leading to the formation of larval brain tumors. Similar defects are seen in lethal giant larvae, (Igl) mutants where Brat and Prospero are not asymmetric. We have identified a molecular mechanism that may control self-renewal and prevent tumor formation in other stem cells as well.	Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; Res Inst Mol Pathol, A-1030 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Knoblich, JA (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, Dr Bohr Gasse 3-5, A-1030 Vienna, Austria.	knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Mechtler, Karl/AAF-2717-2019	Knoblich, Juergen A/0000-0002-6751-3404; Mechtler, Karl/0000-0002-3392-9946; Betschinger, Joerg/0000-0002-2627-8479				Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Betschinger J, 2005, CURR BIOL, V15, P276, DOI 10.1016/j.cub.2005.01.012; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Frank DJ, 1998, J CELL BIOL, V140, P1321, DOI 10.1083/jcb.140.6.1321; Frank DJ, 2002, DEVELOPMENT, V129, P399; Fuerstenberg S, 1998, MOL CELL NEUROSCI, V12, P325, DOI 10.1006/mcne.1998.0724; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; HADORN E, 1938, REV SUISSE ZOOL, V46, P425; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Li L, 2000, GENE DEV, V14, P147; Liu TH, 2002, MECH DEVELOP, V112, P25, DOI 10.1016/S0925-4773(01)00626-8; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; Matsuzaki F, 1998, DEVELOPMENT, V125, P4089; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Page SL, 2000, GENETICS, V155, P1757; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez A, 1996, GENETICS, V143, P929; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	59	382	394	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1241	1253		10.1016/j.cell.2006.01.038	http://dx.doi.org/10.1016/j.cell.2006.01.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564014	Bronze			2022-12-28	WOS:000237241400023
J	Mackay, ME; Tuteja, A; Duxbury, PM; Hawker, CJ; Van Horn, B; Guan, ZB; Chen, GH; Krishnan, RS				Mackay, ME; Tuteja, A; Duxbury, PM; Hawker, CJ; Van Horn, B; Guan, ZB; Chen, GH; Krishnan, RS			General strategies for nanoparticle dispersion	SCIENCE			English	Article							CHAIN DIMENSIONS; POLYMER; COMPOSITES; BLENDS	Traditionally the dispersion of particles in polymeric materials has proven difficult and frequently results in phase Separation and agglomeration. We show that thermodynamically stable dispersion of nanoparticles into a polymeric liquid is enhanced for systems where the radius of gyration of the linear polymer is greater than the radius of the nanoparticle. Dispersed nanoparticles swell the linear polymer chains, resulting in a polymer radius of gyration that grows with the nanoparticle volume fraction. It is proposed that this entropically unfavorable process is offset by an enthalpy gain due to an increase in molecular contacts at dispersed nanoparticle surfaces as compared with the surfaces of phase-separated nanoparticles. Even when the dispersed state is thermodynamically stable, it may be inaccessible unless the correct processing strategy is adopted, which is particularly important for the case of fullerene dispersion into linear polymers.	Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA; Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; IBM Corp, Almaden Res Ctr, San Jose, CA 95120 USA; Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA	Michigan State University; Michigan State University; University of California System; University of California Santa Barbara; International Business Machines (IBM); University of California System; University of California Irvine	Mackay, ME (corresponding author), Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA.	mackay@msu.edu	Hawker, Craig J/G-4971-2011; Van Horn, Brooke A/B-4198-2011	Hawker, Craig J/0000-0001-9951-851X; Van Horn, Brooke A/0000-0002-8506-3005; duxbury, Phillip/0000-0003-4549-4764				BATES FS, 1986, PHYS REV LETT, V57, P1429, DOI 10.1103/PhysRevLett.57.1429; Bezmel'nitsyn V. N., 1998, Physics-Uspekhi, V41, P1091, DOI 10.1070/PU1998v041n11ABEH000502; CRAGG LH, 1946, CHEM REV, V39, P79, DOI 10.1021/cr60122a002; DEE GT, 1992, J COLLOID INTERF SCI, V152, P85, DOI 10.1016/0021-9797(92)90010-J; Du FM, 2003, J POLYM SCI POL PHYS, V41, P3333, DOI 10.1002/polb.10701; Flory P. J., 1953, PRINCIPLES POLYM CHE, P672; Gallas JM, 1999, BIOPHYS J, V77, P1135, DOI 10.1016/S0006-3495(99)76964-X; Ginzburg VV, 2005, MACROMOLECULES, V38, P2362, DOI 10.1021/ma0482821; Guan ZB, 1999, SCIENCE, V283, P2059, DOI 10.1126/science.283.5410.2059; Guan ZB, 2003, J POLYM SCI POL CHEM, V41, P3680, DOI 10.1002/pola.10969; Harth E, 2002, J AM CHEM SOC, V124, P8653, DOI 10.1021/ja026208x; Higgins J. S., 2002, POLYM NEUTRON SCATTE, P436; Hooper JB, 2005, MACROMOLECULES, V38, P8858, DOI 10.1021/ma051318k; Hooper JB, 2004, J CHEM PHYS, V121, P6986, DOI 10.1063/1.1790831; Huh J, 2000, MACROMOLECULES, V33, P8085, DOI 10.1021/ma000708y; King S. M., 1999, MODERN TECHNIQUES PO; KRUSE WA, 1976, MAKROMOL CHEM, V177, P1145; Lauter-Pasyuk V, 1998, PHYSICA B, V248, P243, DOI 10.1016/S0921-4526(98)00241-5; Lin Y, 2005, NATURE, V434, P55, DOI 10.1038/nature03310; Mackay ME, 2003, NAT MATER, V2, P762, DOI 10.1038/nmat999; Mackay ME, 2001, LANGMUIR, V17, P1708, DOI 10.1021/la0011230; MARRUCCI G, 1972, T SOC RHEOL, V16, P321, DOI 10.1122/1.549245; Nakatani AI, 2001, POLYMER, V42, P3713, DOI 10.1016/S0032-3861(00)00771-0; O'Hern CS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011306; Park SY, 2001, MACROMOLECULES, V34, P3384, DOI 10.1021/ma001601d; Poon WCK, 2002, J PHYS-CONDENS MAT, V14, pR859, DOI 10.1088/0953-8984/14/33/201; RUSSELL TP, 1982, J POLYM SCI POL PHYS, V20, P1593, DOI 10.1002/pol.1982.180200908; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; SARICIFTCI NS, 1995, SYNTHETIC MET, V70, P1349, DOI 10.1016/0379-6779(94)02874-X; Sharaf MA, 2004, POLYMER, V45, P3943, DOI 10.1016/j.polymer.2004.02.073; Thompson RB, 2001, SCIENCE, V292, P2469, DOI 10.1126/science.1060585; Utracki L. A, 1990, POLYM ALLOYS BLENDS, P356; UTRACKI LA, 1987, POLYM ENG SCI, V27, P1512, DOI 10.1002/pen.760272006; Vacatello M, 2002, MACROMOLECULES, V35, P8191, DOI 10.1021/ma020416s; van Krevelen D.W., 1976, PROPERTIES POLYM THE, P620; Weng D, 1999, EUR POLYM J, V35, P867, DOI 10.1016/S0014-3057(98)00055-X; Zoller P., 1995, STANDARD PRESSURE VO, P412	37	784	808	14	618	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1740	1743		10.1126/science.1122225	http://dx.doi.org/10.1126/science.1122225			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556836				2022-12-28	WOS:000236204300034
J	Salzmann, CG; Radaelli, PG; Hallbrucker, A; Mayer, E; Finney, JL				Salzmann, CG; Radaelli, PG; Hallbrucker, A; Mayer, E; Finney, JL			The preparation and structures of hydrogen ordered phases of ice	SCIENCE			English	Article							RAMAN-SPECTRA; XII; VI; RELAXATION; PRESSURE; WATER	Two hydrogen ordered phases of ice were prepared by cooling the hydrogen disordered ices V and XII under pressure. Previous attempts to unlock the geometrical frustration in hydrogen-bonded structures have focused on doping with potassium hydroxide and have had success in partially increasing the hydrogen ordering in hexagonal ice I (ice Ih). By doping ices V and XII with hydrochloric acid, we have prepared ice XIII and ice XIV, and we analyzed their structures by powder neutron diffraction. The use of hydrogen chloride to release geometrical frustration opens up the possibility of completing the phase diagram of ice.	Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria; Univ Oxford, Inorgan Chem Lab, Oxford OX1 3QR, England; CCLRC, Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; UCL, Dept Phys & Astron, London WC1E 6BT, England	University of Innsbruck; University of Oxford; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of London; University College London	Salzmann, CG (corresponding author), Univ Innsbruck, Inst Gen Inorgan & Theoret Chem, Innrain 52A, A-6020 Innsbruck, Austria.	christoph.salzmann@chemistry.oxford.ac.uk	Radaelli, Paolo G/C-2952-2011	Radaelli, Paolo G/0000-0002-6717-035X	Engineering and Physical Sciences Research Council [GR/R88601/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; BERTIE JE, 1964, J CHEM PHYS, V40, P1637, DOI 10.1063/1.1725373; HAAS C, 1960, J CHEM PHYS, V32, P1763, DOI 10.1063/1.1731017; HANDA YP, 1987, J PHYS-PARIS, V48, P435, DOI 10.1051/jphyscol:1987160; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Johari GP, 2001, J CHEM PHYS, V115, P3274, DOI 10.1063/1.1386903; Johari GP, 2000, J CHEM PHYS, V112, P10957, DOI 10.1063/1.481735; KAMB B, 1967, ACTA CRYSTALLOGR, V22, P706, DOI 10.1107/S0365110X67001409; Kamb B., 1969, J CHEM PHYS, P44, DOI DOI 10.1063/1.1676331; KAMB B, 1974, T AM GEOPHYS UNION, V56, P1202; Koza MM, 2000, PHYS REV LETT, V84, P4112, DOI 10.1103/PhysRevLett.84.4112; Larsen A., 2000, 86748 LAUR LOS AL NA 86748 LAUR LOS AL NA; Line CMB, 1996, J CHEM PHYS, V104, P10008, DOI 10.1063/1.471745; Lobban C, 1998, NATURE, V391, P268, DOI 10.1038/34622; Lobban C, 2000, J CHEM PHYS, V112, P7169, DOI 10.1063/1.481282; MINCEVASUKAROVA B, 1986, J MOL STRUCT, V143, P87, DOI 10.1016/0022-2860(86)85211-5; MINCEVASUKAROVA B, 1988, J MOL STRUCT, V175, P289, DOI 10.1016/S0022-2860(98)80090-2; MISHIMA O, 1984, NATURE, V310, P393, DOI 10.1038/310393a0; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; Petrenko VF, 1999, PHYS ICE; Salzmann C, 2002, J PHYS CHEM B, V106, P1, DOI 10.1021/jp012755d; Salzmann CG, 2004, PHYS CHEM CHEM PHYS, V6, P5156, DOI 10.1039/b412927j; Salzmann CG, 2004, PHYS CHEM CHEM PHYS, V6, P1269, DOI 10.1039/b315180h; Salzmann CG, 2003, PHYS CHEM CHEM PHYS, V5, P3507, DOI 10.1039/b305624d; Snyder J, 2001, NATURE, V413, P48, DOI 10.1038/35092516; TAJIMA Y, 1982, NATURE, V299, P810, DOI 10.1038/299810a0	27	204	208	10	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1758	1761		10.1126/science.1123896	http://dx.doi.org/10.1126/science.1123896			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556840				2022-12-28	WOS:000236204300040
J	Wodarz, A; Gonzalez, C				Wodarz, A; Gonzalez, C			Connecting cancer to the asymmetric division of stem cells	CELL			English	Editorial Material							RIBOSOMAL-RNA SYNTHESIS; DROSOPHILA-MELANOGASTER; BRAIN-TUMOR; PROLIFERATION; NEUROGENESIS; GROWTH	Two studies, one in this issue of Cell (Betschinger et al., 2006) and the other in Developmental Cell (Lee et al., 2006a) show that the cell-fate determinant Brain Tumor (Brat) suppresses self-renewal in one of the daughter cells that arise from the asymmetric division of a neural stem cell. This work suggests a mechanism by which loss of polarity in stem cells may lead to tumorigenesis.	Univ Gottingen, DFG Res Ctr Mol Physiol Brain, Dept Stem Cell Biol, D-37077 Gottingen, Germany; PCB, ICREA, Inst Recerca Biomed, Cell Div Grp, Barcelona 08028, Spain	German Research Foundation (DFG); University of Gottingen; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA; University of Barcelona	Wodarz, A (corresponding author), Univ Gottingen, DFG Res Ctr Mol Physiol Brain, Dept Stem Cell Biol, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	awodarz@gwdg.de	Gonzalez, Cayetano/K-3055-2019; Gonzalez, Cayetano/K-3933-2019; Wodarz, Andreas/D-4642-2013	Gonzalez, Cayetano/0000-0002-5259-3608; Wodarz, Andreas/0000-0002-0007-6289	ICREA Funding Source: Custom	ICREA(ICREA)		Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Frank DJ, 2002, DEVELOPMENT, V129, P399; GATEFF E, 1994, INT J DEV BIOL, V38, P565; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; LEE CY, 2006, DEV CELL; Li L, 2000, GENE DEV, V14, P147; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Wodarz A, 2003, MECH DEVELOP, V120, P1297, DOI 10.1016/j.mod.2003.06.003	11	34	40	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1121	1123		10.1016/j.cell.2006.03.004	http://dx.doi.org/10.1016/j.cell.2006.03.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564003	Bronze			2022-12-28	WOS:000237241400010
J	McDevitt, J				McDevitt, J			The candidate - Washington 2.0	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2006	440	7083					580	580		10.1038/440580a	http://dx.doi.org/10.1038/440580a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554825	Bronze			2022-12-28	WOS:000236176100065
J	Mollicone, D; Eva, HD; Achard, F				Mollicone, D; Eva, HD; Achard, F			Ecology - Human role in Russian wild fires	NATURE			English	Editorial Material							PRODUCTS		Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy	European Commission Joint Research Centre; EC JRC ISPRA Site	Mollicone, D (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, TP 440, I-21020 Ispra, Italy.	frederic.achard@jrc.it	EVA, Hugh D/F-8412-2011					ACHARD F, 2005, IDENTIFICATION HOT S; AKSENOV D, 2002, ATLAS RUSSIAS INTACT; Bartalev SA, 2003, INT J REMOTE SENS, V24, P1977, DOI 10.1080/0143116031000066297; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Dienes L, 2004, EURASIAN GEOGR ECON, V45, P319, DOI 10.2747/1538-7216.45.5.319; GOLDAMMER JG, 2003, INT FOREST FIRE NEWS, V29; Justice CO, 2002, REMOTE SENS ENVIRON, V83, P244, DOI 10.1016/S0034-4257(02)00076-7; Karpachevskiy M., 2004, FOREST FIRES RUSSIAN; Mouillot F, 2005, GLOBAL CHANGE BIOL, V11, P398, DOI 10.1111/j.1365-2486.2005.00920.x; Schiermeier Q, 2005, NATURE, V435, P732, DOI 10.1038/435732a; Sukhinin AI, 2004, REMOTE SENS ENVIRON, V93, P546, DOI 10.1016/j.rse.2004.08.011; Thompson DWJ, 2001, SCIENCE, V293, P85, DOI 10.1126/science.1058958	12	119	131	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					436	437		10.1038/440436a	http://dx.doi.org/10.1038/440436a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554800				2022-12-28	WOS:000236176100037
J	Nissen, SE; Tuzcu, EM; Brewer, HB; Sipahi, I; Nicholls, SJ; Ganz, P; Schoenhagen, P; Waters, DD; Pepine, CJ; Crowe, TD; Davidson, MH; Deanfield, JE; Wisniewski, LM; Hanyok, JJ; Kassalow, LM				Nissen, SE; Tuzcu, EM; Brewer, HB; Sipahi, I; Nicholls, SJ; Ganz, P; Schoenhagen, P; Waters, DD; Pepine, CJ; Crowe, TD; Davidson, MH; Deanfield, JE; Wisniewski, LM; Hanyok, JJ; Kassalow, LM		ACTIVATE Investigators	Effect of ACAT inhibition on the progression of coronary atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COA-CHOLESTEROL ACYLTRANSFERASE; RANDOMIZED CONTROLLED-TRIAL; ACYL-COA; ARTERY-DISEASE; INTRAVASCULAR ULTRASOUND; REDUCES ATHEROSCLEROSIS; FED RATS; EXPRESSION; LESIONS; MACROPHAGES	BACKGROUND The enzyme acyl-coenzyme A:cholesterol acyltransferase (ACAT) esterifies cholesterol in a variety of tissues. In some animal models, ACAT inhibitors have antiatherosclerotic effects. METHODS We performed intravascular ultrasonography in 408 patients with angiographically documented coronary disease. All patients received usual care for secondary prevention, including statins, if indicated. Patients were randomly assigned to receive the ACAT inhibitor pactimibe (100 mg per day) or matching placebo. Ultrasonography was repeated after 18 months to measure the progression of atherosclerosis. RESULTS The primary efficacy variable analyzing the progression of atherosclerosis - the change in percent atheroma volume - was similar in the pactimibe and placebo groups (0.69 percent and 0.59 percent, respectively; P=0.77). However, both secondary efficacy variables assessed by means of intravascular ultrasonography showed unfavorable effects of pactimibe treatment. As compared with baseline values, the normalized total atheroma volume showed significant regression in the placebo group (-5.6 mm(3), P=0.001) but not in the pactimibe group (-1.3 mm(3), P=0.39; P=0.03 for the comparison between groups). The atheroma volume in the most diseased 10-mm subsegment regressed by 3.2 mm(3) in the placebo group, as compared with a decrease of 1.3 mm(3) in the pactimibe group (P=0.01). The combined incidence of adverse cardiovascular outcomes was similar in the two groups (P=0.53). CONCLUSIONS For patients with coronary disease, treatment with an ACAT inhibitor did not improve the primary efficacy variable (percent atheroma volume) and adversely affected two major secondary efficacy measures assessed by intravascular ultrasonography. ACAT inhibition is not an effective strategy for limiting atherosclerosis and may promote atherogenesis.	Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Washington Hosp Ctr, Medstar Res Inst, Washington, DC 20010 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Florida, Gainesville, FL USA; Radiant Res, Chicago, IL USA; Univ London, London, England; Sankyo Pharma, Edison, NJ USA	Cleveland Clinic Foundation; MedStar Washington Hospital Center; Harvard University; Brigham & Women's Hospital; San Francisco General Hospital Medical Center; State University System of Florida; University of Florida; University of London	Nissen, SE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org	Schoenhagen, Paul/A-2808-2012; SIPAHI, ILKE/K-9745-2013; Deanfield, John E/C-5178-2008	Schoenhagen, Paul/0000-0002-7751-5243; SIPAHI, ILKE/0000-0001-8581-9557; Ganz, Peter/0000-0002-0437-8882; Nicholls, Stephen/0000-0002-9668-4368; Deanfield, John/0000-0001-8806-6052				Accad M, 2000, J CLIN INVEST, V105, P711, DOI 10.1172/JCI9021; Azen SP, 1996, CIRCULATION, V93, P34, DOI 10.1161/01.CIR.93.1.34; Azuma Y, 1998, JPN J PHARMACOL, V78, P355, DOI 10.1254/jjp.78.355; BOCAN TMA, 1993, ATHEROSCLEROSIS, V99, P175, DOI 10.1016/0021-9150(93)90020-U; Bocan TMA, 2000, ARTERIOSCL THROM VAS, V20, P70, DOI 10.1161/01.ATV.20.1.70; Bocan TMA, 2001, ATHEROSCLEROSIS, V157, P97, DOI 10.1016/S0021-9150(00)00713-9; Cases S, 1998, J BIOL CHEM, V273, P26755, DOI 10.1074/jbc.273.41.26755; Delsing DJM, 2001, CIRCULATION, V103, P1778, DOI 10.1161/01.CIR.103.13.1778; Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171; Fazio S, 2001, J CLIN INVEST, V107, P163, DOI 10.1172/JCI10310; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Heinonen Therese M, 2002, Curr Atheroscler Rep, V4, P65, DOI 10.1007/s11883-002-0064-9; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; Kusunoki J, 2001, CIRCULATION, V103, P2604; Lee RG, 2000, J LIPID RES, V41, P1991; Libby P, 2005, J AM COLL CARDIOL, V46, P1225, DOI 10.1016/j.jacc.2005.07.006; MARZETTA CA, 1994, J LIPID RES, V35, P1829; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Miyazaki A, 1998, ARTERIOSCL THROM VAS, V18, P1568, DOI 10.1161/01.ATV.18.10.1568; Miyazaki Akira, 2003, Curr Opin Investig Drugs, V4, P1095; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Perrey S, 2001, ATHEROSCLEROSIS, V155, P359, DOI 10.1016/S0021-9150(00)00599-2; Sahi J, 2003, J PHARMACOL EXP THER, V306, P1027, DOI 10.1124/jpet.103.050526; Schoenhagen P, 2005, J AM SOC ECHOCARDIOG, V18, P193, DOI 10.1016/j.echo.2004.11.013; Schoenhagen P, 2003, J AM SOC ECHOCARDIOG, V16, P277, DOI 10.1067/mje.2003.45; Schoenhagen P, 2001, J AM COLL CARDIOL, V38, P297, DOI 10.1016/S0735-1097(01)01374-2; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; WATERS D, 1993, CIRCULATION, V87, P1067, DOI 10.1161/01.CIR.87.4.1067	33	320	328	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1253	1263		10.1056/NEJMoa054699	http://dx.doi.org/10.1056/NEJMoa054699			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554527				2022-12-28	WOS:000236164200004
J	Wilson, MR				Wilson, MR			Hauntings	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												michael.wilson@ucsf.edu		Wilson, Michael/0000-0002-8705-5084					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1347	1348		10.1001/jama.295.12.1347	http://dx.doi.org/10.1001/jama.295.12.1347			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551702				2022-12-28	WOS:000236157700001
J	Benson, A; Dickson, WA; Boyce, DE				Benson, A; Dickson, WA; Boyce, DE			ABC of wound healing - Burns	BRITISH MEDICAL JOURNAL			English	Editorial Material									Whiston Hosp, Mersey Reg Plast Surg Unit, Liverpool, Merseyside, England; Morriston Hosp, Welsh Ctr Burns & Plast Surg, Swansea, W Glam, Wales	Whiston Hospital; Morriston Hospital	Benson, A (corresponding author), Whiston Hosp, Mersey Reg Plast Surg Unit, Liverpool, Merseyside, England.							Herndon DN, 2018, TOTAL BURN CARE; *NAT BURN CAR REV, 2001, STAND STRAT BURN CAR, P68	2	35	42	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					649	652		10.1136/bmj.332.7542.649	http://dx.doi.org/10.1136/bmj.332.7542.649			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543335	Green Published			2022-12-28	WOS:000236314700025
J	Garner, P; Volmink, J				Garner, P; Volmink, J			Families help cure tuberculosis	LANCET			English	Editorial Material									Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Res Grp, Liverpool L3 5QA, Merseyside, England; Univ Stellenbosch, Fac Hlth Sci, ZA-7505 Tygerberg, South Africa	Liverpool School of Tropical Medicine; University of Liverpool; Stellenbosch University	Garner, P (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Int Hlth Res Grp, Liverpool L3 5QA, Merseyside, England.	pgarner@liverpool.ac.uk	Garner, Paul/HII-5856-2022; Garner, Paul/Y-8385-2019	Garner, Paul/0000-0002-0607-6941				BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5; *CHIN CTR DIS CONT, 2002, OP GUID TUB CONTR, P35; GARNER P, 1985, PAPUA NEW GUINEA MED, V28, P291; Garner P, 2003, BRIT MED J, V327, P823, DOI 10.1136/bmj.327.7419.823; Katz D., 1966, ADMIN SCI QUART, V46, P118; Kochi A, 1997, WORLD HEALTH FORUM, V18, P225; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; VOLMINK J, 2006, IN PRESS COCHRANE DA, V2, DOI UNSP CD003343; *WHO, 1997, WHO23; Wright J, 2004, TROP MED INT HEALTH, V9, P559, DOI 10.1111/j.1365-3156.2004.01230.x; GLOBAL PLAN STOP TB	11	12	12	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					878	879		10.1016/S0140-6736(06)68356-6	http://dx.doi.org/10.1016/S0140-6736(06)68356-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546521				2022-12-28	WOS:000236242100005
J	Wightman, RM				Wightman, RM			Probing cellular chemistry in biological systems with microelectrodes	SCIENCE			English	Review							SCANNING ELECTROCHEMICAL MICROSCOPY; HAIRLESS MOUSE SKIN; REAL-TIME; CHROMAFFIN CELLS; INDIVIDUAL CELLS; CAUDATE-PUTAMEN; VESICLE RELEASE; FUSION PORE; DOPAMINE; COCAINE	Over the past 20 years, the technological impediments to fabricating electrodes of micrometer dimensions have been largely overcome. These small electrodes can be readily applied to probe chemical events at the surface of tissues or individual biological cells; they can even be used to monitor concentration changes within intact animals. These measurements can be made on rapid time scales and with minimal perturbation of the system under study. Several recent applications have provided important insights into chemical processes at cells and in tissues. Examples include molecular flux measurements at the surface of single cells and through skin - which can offer insights into oxidative stress, exocytosis, and drug delivery - and real-time brain neurotransmitter monitoring in living rats, which reveals correlations between behavior and molecular events in the brain. Such findings can promote interdisciplinary collaborations and may lead to a broader understanding of the chemical aspects of biology.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Wightman, RM (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	rmw@unc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038879, R01NS015841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010900] Funding Source: NIH RePORTER; NIDA NIH HHS [DA 10900] Funding Source: Medline; NINDS NIH HHS [NS 15841, NS 38879] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS RN, 1990, PROG NEUROBIOL, V35, P297, DOI 10.1016/0301-0082(90)90014-8; Amatore C, 2000, ANGEW CHEM INT EDIT, V39, P1952, DOI 10.1002/1521-3773(20000602)39:11<1952::AID-ANIE1952>3.0.CO;2-3; Amatore C, 2005, ANAL CHEM, V77, p303A, DOI 10.1021/ac053430m; Arbault S, 2004, CARCINOGENESIS, V25, P509, DOI 10.1093/carcin/bgh046; Baltes N, 2004, ANGEW CHEM INT EDIT, V43, P1431, DOI 10.1002/anie.200352662; Bard A. J., 2001, ELECTROCHEMICAL METH; Bath BD, 2000, PHARMACEUT RES, V17, P471, DOI 10.1023/A:1007589306661; Bath BD, 2000, J PHARM SCI-US, V89, P1537, DOI 10.1002/1520-6017(200012)89:12<1537::AID-JPS4>3.0.CO;2-J; Cans AS, 2003, P NATL ACAD SCI USA, V100, P400, DOI 10.1073/pnas.232702599; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Colliver TL, 2000, J NEUROCHEM, V74, P1086; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Dobson PS, 2005, ANAL CHEM, V77, P424, DOI 10.1021/ac048930e; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gonsalves M, 2000, BIOPHYS J, V78, P1578, DOI 10.1016/S0006-3495(00)76710-5; Hafez I, 2005, P NATL ACAD SCI USA, V102, P13879, DOI 10.1073/pnas.0504098102; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Hengstenberg A, 2001, ANGEW CHEM INT EDIT, V40, P905, DOI 10.1002/1521-3773(20010302)40:5<905::AID-ANIE905>3.3.CO;2-R; Hochstetler SE, 2000, ANAL CHEM, V72, P489, DOI 10.1021/ac991119x; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Kennedy RT, 1996, J AM CHEM SOC, V118, P1795, DOI 10.1021/ja953271w; Liebetrau JM, 2003, ANAL CHEM, V75, P563, DOI 10.1021/ac026166v; Liu B, 2005, ANAL CHEM, V77, P3013, DOI 10.1021/ac0482918; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mauzeroll J, 2004, P NATL ACAD SCI USA, V101, P17582, DOI 10.1073/pnas.0407613101; Mirkin M. V., 2001, SCANNING ELECTROCHEM; Mosharov EV, 2003, J NEUROSCI, V23, P5835; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Samaha AN, 2004, J NEUROSCI, V24, P6362, DOI 10.1523/JNEUROSCI.1205-04.2004; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; Travis ER, 1998, ANNU REV BIOPH BIOM, V27, P77, DOI 10.1146/annurev.biophys.27.1.77; Troyer KP, 2002, J BIOL CHEM, V277, P29101, DOI 10.1074/jbc.M202856200; Venton BJ, 2003, J NEUROCHEM, V87, P1284, DOI 10.1046/j.1471-4159.2003.02109.x; Venton BJ, 2003, J NEUROCHEM, V84, P373, DOI 10.1046/j.1471-4159.2003.01527.x; WIGHTMAN RM, 1988, SCIENCE, V240, P415, DOI 10.1126/science.240.4851.415; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; [No title captured]	40	335	346	5	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1570	1574		10.1126/science.1120027	http://dx.doi.org/10.1126/science.1120027			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543451				2022-12-28	WOS:000236029500034
J	Chiang, KH; Chou, AS				Chiang, KH; Chou, AS			Pneumomediastinum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Buddhist Tzu Chi Med Ctr, Hualien, Taiwan	Buddhist Tzu Chi General Hospital	Chiang, KH (corresponding author), Buddhist Tzu Chi Med Ctr, Hualien, Taiwan.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1177	1177		10.1056/NEJMicm050132	http://dx.doi.org/10.1056/NEJMicm050132			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540618				2022-12-28	WOS:000235981700011
J	Barrick, D; Kopan, R				Barrick, D; Kopan, R			The Notch transcription activation complex makes its move	CELL			English	Editorial Material							ANKYRIN DOMAIN; REGION; CSL	Two papers in this issue of Cell (Nam et al., 2006; Wilson and Kovall, 2006) report the crystal structure of the Notch transcriptional activation complex. These structures show that the ANK domain of Notch is an integral part of the transcription complex and supports MAM binding, whereas the RAM domain may trigger allosteric changes in the structure needed for the derepression of transcription.	Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Johns Hopkins University; Washington University (WUSTL); Washington University (WUSTL)	Kopan, R (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	kopan@wustl.edu	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022	Kopan, Raphael/0000-0002-0350-2730				Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Mello CC, 2004, P NATL ACAD SCI USA, V101, P14102, DOI 10.1073/pnas.0403386101; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	11	34	36	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					883	885		10.1016/j.cell.2006.02.028	http://dx.doi.org/10.1016/j.cell.2006.02.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530033	Bronze			2022-12-28	WOS:000237241200008
J	Grimaud, C; Bantignies, F; Pal-Bhadra, M; Ghana, P; Bhadra, U; Cavalli, G				Grimaud, C; Bantignies, F; Pal-Bhadra, M; Ghana, P; Bhadra, U; Cavalli, G			RNAi components are required for nuclear clustering of polycomb group response elements	CELL			English	Article							BITHORAX COMPLEX; GROUP PROTEINS; EPIGENETIC INHERITANCE; DISTINCT ROLES; DROSOPHILA; HETEROCHROMATIN; CHROMATIN; GENE; INTERFERENCE; TRITHORAX	Drosophila Polycomb group (PcG) proteins silence homeotic genes through binding to Polycomb group response elements (PREs). Fab-7 is a PRE-containing regulatory element from the homeotic gene Abdominai-B. When present in multiple copies in the genome, Fab-7 can induce long-distance gene contacts that enhance PcG-dependent silencing. We show here that components of the RNA interference (RNAi) machinery are involved in PcG-mediated silencing at Fab-7 and in the production of small RNAs at transgenic Fab-7 copies. In general, these mutations do not affect the recruitment of PcG components, but they are specifically required for the maintenance of long-range contacts between Fab-7 copies. Dicer-2, PIWI, and Argonaute1, three RNAi components, frequently colocalize with PcG bodies, and their mutation significantly reduces the frequency of PcG-dependent chromosomal associations of endogenous homeotic genes. This suggests a novel role for the RNAi machinery in regulating the nuclear organization of PcG chromatin targets.	Inst Human Genet, CNRS, F-34396 Montpellier 5, France; Indian Inst Chem Technol, Dept Biol Chem, Hyderabad 500007, Andhra Pradesh, India; Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Cavalli, G (corresponding author), Inst Human Genet, CNRS, 141 Rue Cardonille, F-34396 Montpellier 5, France.	giacomo.cavalli@igh.cnrs.fr	cavalli, giacomo/Z-2754-2019; grimaud, charlotte/Y-6689-2019; Cavalli, Giacomo/A-7958-2008	cavalli, giacomo/0000-0003-3709-3469; grimaud, charlotte/0000-0001-7944-5931; Cavalli, Giacomo/0000-0003-3709-3469				Abranches R, 2000, PLANT J, V24, P713, DOI 10.1046/j.1365-313x.2000.00908.x; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Cox DN, 2000, DEVELOPMENT, V127, P503; Dejardin J, 2005, PROG MOLEC, V38, P31; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; FAUVARQUE MO, 1993, GENE DEV, V7, P1508, DOI 10.1101/gad.7.8.1508; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Harris AN, 2001, DEVELOPMENT, V128, P2823; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kassis JA, 2002, ADV GENET, V46, P421; Lavrov S, 2004, METH MOL B, V247, P289; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Mohd-Sarip A, 2005, GENE DEV, V19, P1755, DOI 10.1101/gad.347005; Muller M, 1999, GENETICS, V153, P1333; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; PARO R, 1993, MECH DEVELOP, V40, P37, DOI 10.1016/0925-4773(93)90086-D; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Srinivasan L, 2004, GENE DEV, V18, P2596, DOI 10.1101/gad.1228204; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tillib S, 1999, MOL CELL BIOL, V19, P5189; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Williams RW, 2002, P NATL ACAD SCI USA, V99, P6889, DOI 10.1073/pnas.072190799; ZINK D, 1995, EMBO J, V14, P5660, DOI 10.1002/j.1460-2075.1995.tb00253.x	55	239	256	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					957	971		10.1016/j.cell.2006.01.036	http://dx.doi.org/10.1016/j.cell.2006.01.036			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530043	Bronze			2022-12-28	WOS:000237241200018
J	Hsieh, HH; Jewitt, D				Hsieh, HH; Jewitt, D			A population of comets in the main asteroid belt	SCIENCE			English	Article							JUPITER-FAMILY COMETS; KUIPER-BELT; WATER; EVOLUTION	Comets are icy bodies that sublimate and become active when close to the Sun. They are believed to-originate in two cold reservoirs beyond the orbit of Neptune: the Kuiper Belt (equilibrium temperatures of similar to 40 kelvin) and the Oort Cloud (similar to 10 kelvin). We present optical data showing the existence of a population of comets originating in a third reservoir: the main asteroid belt. The main-belt comets are unlike the Kuiper Belt and Oort Cloud comets in that they likely formed where they currently reside and may be collisionally activated. The existence of the mainbelt comets lends new support to the idea that main-belt objects could be a major source of terrestrial water.	Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA	University of Hawaii System	Hsieh, HH (corresponding author), Univ Hawaii, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	hsieh@ifa.hawaii.edu						AGHI S, 1973, ASTRON ASTROPHYS, V24, P107; AHEARN MF, 1992, ICARUS, V98, P54, DOI 10.1016/0019-1035(92)90206-M; Carvano JM, 2003, ICARUS, V161, P356, DOI 10.1016/S0019-1035(02)00035-0; Cheng AF, 2004, ICARUS, V169, P357, DOI 10.1016/j.icarus.2004.02.002; Cohen BA, 2000, ICARUS, V145, P369, DOI 10.1006/icar.2000.6329; Cyr KE, 1998, ICARUS, V135, P537, DOI 10.1006/icar.1998.5959; DE BR, 1977, J GEOPHYS RES-SPACE, V82, P999, DOI 10.1029/JA082i007p00999; Di Sisto RP, 2005, ICARUS, V174, P81, DOI 10.1016/j.icarus.2004.10.024; EIST EW, 1996, 6456 IAU, P1; FANALE FP, 1989, ICARUS, V82, P97, DOI 10.1016/0019-1035(89)90026-2; Fernandez JA, 2002, ICARUS, V159, P358, DOI 10.1006/icar.2002.6903; Hodapp KW, 2004, ASTRON NACHR, V325, P636, DOI 10.1002/asna.200410300; Hsieh HH, 2004, ASTRON J, V127, P2997, DOI 10.1086/383208; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; JEWITT DC, 1990, ASTRON J, V100, P933, DOI 10.1086/115572; Jewitt DC, 2004, SPACE SCI S, P659; JONES TD, 1990, ICARUS, V88, P172, DOI 10.1016/0019-1035(90)90184-B; Keil K, 2000, PLANET SPACE SCI, V48, P887, DOI 10.1016/S0032-0633(00)00054-4; KRESAK L, 1980, MOON PLANETS, V22, P83, DOI 10.1007/BF00896869; LEBOFSKY LA, 1981, ICARUS, V48, P453, DOI 10.1016/0019-1035(81)90055-5; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Levison HF, 1996, ASTR SOC P, V107, P173; Oort J. H., 1950, B ASTRON I NETH, V11, P91; OWEN T, 1991, ASTROPHYS SPACE SC L, V167, P429; Pittich EA, 2004, ASTRON ASTROPHYS, V422, P369, DOI 10.1051/0004-6361:20034085; READ MT, 2005, 8624 IAU, P1; Sasselov DD, 2000, ASTROPHYS J, V528, P995, DOI 10.1086/308209; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272	29	308	309	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					561	563		10.1126/science.1125150	http://dx.doi.org/10.1126/science.1125150			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16556801				2022-12-28	WOS:000237296700040
J	Davies, M; Elwyn, G				Davies, M; Elwyn, G			Health policy - Referral management centres: promising innovations or Trojan horses?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGING DEMAND; GENERAL-PRACTITIONERS; PRIMARY-CARE		Cardiff Univ, Dept Gen Practice, Ctr Hlth Sci Res, Cardiff CF14 4YS, Wales	Cardiff University	Elwyn, G (corresponding author), Cardiff Univ, Dept Gen Practice, Ctr Hlth Sci Res, Heath Pk, Cardiff CF14 4YS, Wales.	elwyng@Cardiff.ac.uk	Davies, Myfanwy/B-5321-2009; Elwyn, Glyn/B-4798-2009; Elwyn, G./L-4292-2015	Elwyn, Glyn/0000-0002-0917-6286; 				Aish Harley, 2003, N Z Med J, V116, pU326; *BMA, 2006, REF MAN FREQ ASK QUE; Bunn F, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004180.PUB2, 10.1002/14651858.CD004180.pub2]; *CHESH MERS STRAT, LOC DEL PLAN 2003 20; Department of Health, 2004, CHOOS BOOK PAT CHOIC; Faulkner A, 2003, BRIT J GEN PRACT, V53, P878; Gillam S, 1998, BMJ-BRIT MED J, V316, P1895; *GREAT MANCH STRAT, ANN REP 2002 3; Grimshaw JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471; Hollingum J, 1996, ASSEMBLY AUTOM, V16, P32, DOI 10.1108/01445159610126401; *HOUNSL PRIM CAR T, 2004, ANN REP 2003 4; OSWALD N, 1992, HOSP REFERRALS, P15; Pencheon D, 1998, BRIT MED J, V316, P1665, DOI 10.1136/bmj.316.7145.1665; REYNOLDS GA, 1991, BMJ-BRIT MED J, V302, P1250, DOI 10.1136/bmj.302.6787.1250; Rogers A, 1998, BRIT MED J, V316, P1816, DOI 10.1136/bmj.316.7147.1816; ROLAND MO, 1990, BRIT MED J, V301, P98, DOI 10.1136/bmj.301.6743.98; Ruston A, 2004, HEALTH RISK SOC, V6, P25, DOI 10.1080/1369857042000193066; Shaw I, 2005, QUAL HEALTH RES, V15, P116, DOI 10.1177/1049732304270725; *SOM COAST PRIM CA, 2004, ANN REP 2003 4; *VAL GLAM LOC HLTH, 2005, REF MAN CTR STRAT OV; 1997, CAPITATION MANAG REP, V4, P140	21	25	25	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2006	332	7545					844	846		10.1136/bmj.332.7545.844	http://dx.doi.org/10.1136/bmj.332.7545.844			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16601048	Green Submitted, Green Published			2022-12-28	WOS:000236815900026
J	Federman, DD				Federman, DD			Current concepts: The biology of human sex differences	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ESTROGEN-RECEPTORS; X-INACTIVATION; Y-CHROMOSOME; GENE; COREGULATORS; DEFICIENCY; SEQUENCE; REGION; DNA		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Federman, DD (corresponding author), Harvard Univ, Sch Med, 25 Shattuck St, Boston, MA 02115 USA.	daniel_federman@hms.harvard.edu						Bianchi DW, 2000, AM J MED GENET, V91, P22, DOI 10.1002/(SICI)1096-8628(20000306)91:1<22::AID-AJMG4>3.0.CO;2-3; Brown CJ, 2001, SEMIN REPROD MED, V19, P125, DOI 10.1055/s-2001-15392; Bulun S. E., 2003, WILLIAMS TXB ENDOCRI, P587; Bulun SE, 1996, J CLIN ENDOCR METAB, V81, P867, DOI 10.1210/jc.81.3.867; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; Fortunati N, 1999, J ENDOCRINOL INVEST, V22, P223, DOI 10.1007/BF03343547; Griffin JE, 2003, WILLIAMS TXB ENDOCRI, P709; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Kantor B, 2004, HUM MOL GENET, V13, P751, DOI 10.1093/hmg/ddh085; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Koopman P, 2001, CELL, V105, P843, DOI 10.1016/S0092-8674(01)00408-1; Labrie F, 2000, TRENDS ENDOCRIN MET, V11, P421, DOI 10.1016/S1043-2760(00)00342-8; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Morita Y, 1999, DEV BIOL, V213, P1, DOI 10.1006/dbio.1999.9344; Page DC, 2004, AM J HUM GENET, V74, P399, DOI 10.1086/382659; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Sebastian S, 2001, J CLIN ENDOCR METAB, V86, P4600, DOI 10.1210/jc.86.10.4600; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; SMITH EP, 1995, NEW ENGL J MED, V332, P131; Takimoto GS, 1999, J STEROID BIOCHEM, V69, P45, DOI 10.1016/S0960-0760(98)00148-4; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Vermeulen A, 2000, MATURITAS, V34, P5, DOI 10.1016/S0378-5122(99)00075-4; WILLARD HF, 2001, METABOLIC MOL BASES, P1191; WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577; Wizemann T. M., 2001, EXPLORING BIOL CONTR; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	32	94	99	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1507	1514		10.1056/NEJMra052529	http://dx.doi.org/10.1056/NEJMra052529			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16598047				2022-12-28	WOS:000236539000009
J	Saaddine, JB; Cadwell, B; Gregg, EW; Engelgau, MM; Vinicor, F; Imperatore, G; Narayan, KMV				Saaddine, JB; Cadwell, B; Gregg, EW; Engelgau, MM; Vinicor, F; Imperatore, G; Narayan, KMV			Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002	ANNALS OF INTERNAL MEDICINE			English	Article						n	GLYCEMIC CONTROL; MANAGED CARE; RISK-FACTORS; EYE CARE; QUALITY; HEALTH; MELLITUS; ADULTS; REDUCTION; DISEASE	Background: Progress of diabetes care is a subject of public health concern. Objective: To assess changes in quality of diabetes care in the United States by using standardized measures. Design: National population-based, serial cross-sectional surveys. Setting: National Health and Nutrition Examination Survey (19881994 and 1999-2002) and the Behavioral Risk Factor Surveillance System (1995 and 2002). Participants: Survey participants 18 to 75 years of age who reported a diagnosis of diabetes. Measurements: Glycemic control, blood pressure, low-density lipoprotein (LDL) cholesterol level, annual cholesterol level monitoring, and annual foot and dilated eye examination, as defined by the National Diabetes Quality Improvement Alliance measures. Results: In the past decade, the proportion of persons with diabetes with poor glycemic control (hemoglobin A(1c) > 9%) showed a non statistically significant decrease of 3.9% (95% Cl, -10.4% to 2.5%), while the proportion of persons with fair or good lipid control (LDL cholesterol level < 3.4 mmol/L [< 130 mg/dL]) had a statistically significant increase of 21.9% (Cl, 12.4% to 31.3%). Mean LDL cholesterol level decreased by 0.5 mmol/L (18.8 mg/dL). Although mean hemoglobin A, did not change, the proportion of persons with hemoglobin A, of 6% to 8% increased from 34.2% to 47.0%. The blood pressure distribution did not change. Annual lipid testing, dilated eye examination, and foot examination increased by 8.3% (Cl, 4.0% to 12.7%), 4.5% (Cl, 0.5% to 8.5%), and 3.8% (Cl, -0.1% to 7.7%), respectively. The proportion of persons reporting annual influenza vaccination and aspirin use improved by 6.8 percentage points (Cl, 2.9 percentage points to 10.7 percentage points) and 13.1 percentage points (Cl, 5.4 percentage points to 20.7 percentage points), respectively. Limitations: Data are self-reported, and the surveys do not have all National Diabetes Quality Improvement Alliance indicators. Conclusion: Diabetes processes of care and intermediate outcomes have improved nationally in the past decade. But 2 in 5 persons with diabetes still have poor LDL cholesterol control, 1 in 3 persons still has poor blood pressure control, and 1 in 5 persons still has poor glycemic control.	Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Saaddine, JB (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Highway,NE MS-K10, Atlanta, GA 30341 USA.	jsaddine@cdc.gov	Narayan, K.M. Venkat/J-9819-2012	Narayan, K.M. Venkat/0000-0001-8621-5405; Gregg, Edward/0000-0003-2381-6822				*AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P40; [Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 1994, VITAL HLTH STAT, P1; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Berwick DM, 2003, JAMA-J AM MED ASSOC, V289, P1969, DOI 10.1001/jama.289.15.1969; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; Bridges RB, 1996, J PERIODONTOL, V67, P1185, DOI 10.1902/jop.1996.67.11.1185; Brown AF, 2005, ARCH OPHTHALMOL-CHIC, V123, P669, DOI 10.1001/archopht.123.5.669; *CDCP, 2005, NAT DIAB FACT SHEET; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Engelgau MM, 1998, DIABETES CARE, V21, P2062, DOI 10.2337/diacare.21.12.2062; Fleming BB, 2001, DIABETES CARE, V24, P1815, DOI 10.2337/diacare.24.10.1815; Fowles JB, 1999, INT J QUAL HEALTH C, V11, P407, DOI 10.1093/intqhc/11.5.407; Frazier EL, 1992, USING CHRONIC DIS DA, P1; Gerstein HC, 2000, LANCET, V355, P253; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; Honeycutt Amanda A, 2003, Health Care Manag Sci, V6, P155, DOI 10.1023/A:1024467522972; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; JAVITT JC, 1994, DIABETES CARE, V17, P909, DOI 10.2337/diacare.17.8.909; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; KENNY SJ, 1993, DIABETES CARE, V16, P1507, DOI 10.2337/diacare.16.11.1507; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; KORN EL, 1999, WILEY S PRO STAT SUR, P1; LITZELMAN DK, 1993, ANN INTERN MED, V119, P36, DOI 10.7326/0003-4819-119-1-199307010-00006; McClain MR, 2003, DIABETES CARE, V26, P597, DOI 10.2337/diacare.26.3.597; Mealey B, 1999, J PERIODONTOL, V70, P935; Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; National Center for Health Statistics, NHANES 1999 2000 DAT; Petersen M, 2003, DIABETES CARE, V26, P917; Roubideaux Y, 2004, AM J PUBLIC HEALTH, V94, P60, DOI 10.2105/AJPH.94.1.60; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Sawin CT, 2004, DIABETES CARE, V27, pB90, DOI 10.2337/diacare.27.suppl_2.B90; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; SCHWARTZ JS, 1997, CIRCULATION S1, V96, P1504; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SIEGEL JE, 1992, J AM SOC NEPHROL, V3, pS111; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; STEIN AD, 1995, AM J EPIDEMIOL, V141, P1097, DOI 10.1093/oxfordjournals.aje.a117375; STEIN AD, 1993, AM J PUBLIC HEALTH, V83, P1768, DOI 10.2105/AJPH.83.12.1768; Taylor GW, 1996, J PERIODONTOL, V67, P1085, DOI 10.1902/jop.1996.67.10s.1085; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; U.S. Department of Health and Human Services (DHHS) National Center for Health Statistics, 1996, 3 NAT HLTH NUTR EX S; WEINBERER M, 1995, J GEN INTERN MED, V10, P59, DOI 10.1007/BF02600227; 2002, DIABETES CARE S1, V25, pS33; 2002, DIABETES CARE S1, V25, pS80	52	437	453	1	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					465	474		10.7326/0003-4819-144-7-200604040-00005	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585660				2022-12-28	WOS:000236685100001
J	Bilham, R				Bilham, R			Geophysics - Dangerous tectonics, fragile buildings, and tough decisions	SCIENCE			English	Editorial Material							STRESS TRANSFER; EARTHQUAKES; RUPTURE	The occurrence of four fatal earthquakes within and around the Indian plate in the last 5 years, including two great ones, highlights the need for earthquake-resistant construction and replacement throughout the region.	Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Bilham, R (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	roger.bilham@colorado.edu		Bilham, Roger/0000-0002-5547-4102				Ambraseys N, 2003, CURR SCI INDIA, V84, P570; ANDO M, 1975, TECTONOPHYSICS, V27, P119, DOI 10.1016/0040-1951(75)90102-X; Bendick R., 2001, SEISMOL RES LETT, V72, P328, DOI [DOI 10.1785/gssrl.72.3.328, 10.1785/gssrl.72.3.328, DOI 10.1785/GSSRL.72.3.328]; Bilham R., 2005, GEOL SURV INDIA SPEC, V85, P1; Briggs RW, 2006, SCIENCE, V311, P1897, DOI 10.1126/science.1122602; Chery J, 2001, EARTH PLANET SC LETT, V194, P277, DOI 10.1016/S0012-821X(01)00552-0; HARRIS RA, 1991, GEOPHYS RES LETT, V18, P893, DOI 10.1029/91GL01061; Hough SE, 2001, B SEISMOL SOC AM, V91, P1574, DOI 10.1785/0120000259; HOUGH SE, 2005, EARTH QUAKES; IYENGAR RN, 1998, EARTHQUAKE HIST INDI; KANAMORI H, 1978, NATURE, V271, P411, DOI 10.1038/271411a0; KING G, 1985, SCIENCE, V228, P984, DOI 10.1126/science.228.4702.984; McCloskey J, 2005, NATURE, V434, P291, DOI 10.1038/434291a; Sieh K, 2005, NATURE, V434, P573, DOI 10.1038/434573a; Sleep NH, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000991; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Zachariasen J, 2000, B SEISMOL SOC AM, V90, P897, DOI 10.1785/0119980016	17	13	14	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1873	1875		10.1126/science.1125176	http://dx.doi.org/10.1126/science.1125176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574855				2022-12-28	WOS:000236387800030
J	Hill, MS; Hitchcock, PB; Pongtavornpinyo, R				Hill, MS; Hitchcock, PB; Pongtavornpinyo, R			A linear homocatenated compound containing six indium Centers	SCIENCE			English	Article							IN-IN; BONDS; GA; AL; POLYSTANNANES; GROUP-13; ANALOG; TL	In contrast to carbon and its heavier congeners, group 13 elements are rarely observed to catenate into linear chains. Here, we find that treatment of indium(I) iodide with a protonated N-xylyl beta-diketiminate and a strong potassium base in tetrahydrofuran yields a hexa-indium chain. X-ray crystallography revealed one beta-diketiminate ligand bound to each indium center with no bridging ligands supporting the five indium-indium single bonds. The terminal indium centers were capped with iodine. Electronic spectroscopy and computations on a model compound offer preliminary support for sigma delocalization along the chain.	Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; Univ Sussex, Chem Lab, Brighton BN1 9QJ, E Sussex, England	Imperial College London; University of Sussex	Hill, MS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, Exhibit Rd, London SW7 2AZ, England.	mike.hill@imperial.ac.uk	Hill, Michael/I-5324-2014	Hill, Michael/0000-0001-9784-9649				ADAMS S, 1987, ANGEW CHEM INT EDIT, V26, P1255, DOI 10.1002/anie.198712551; Brothers PJ, 1996, ANGEW CHEM INT EDIT, V35, P2355, DOI 10.1002/anie.199623551; Davidson P. J., 1973, J CHEM SOC CHEM COMM, p317a; Devylder N, 1996, CHEM COMMUN, P711, DOI 10.1039/cc9960000711; Downs A. J., 1993, CHEM ALUMINIUM GALLI; Fogarty HA, 2003, PURE APPL CHEM, V75, P999, DOI 10.1351/pac200375080999; Frisch M.J., 2016, GAUSSIAN16 REV B01; Hill MS, 2005, ANGEW CHEM INT EDIT, V44, P4231, DOI 10.1002/anie.200500764; Hill MS, 2004, CHEM COMMUN, P1818, DOI 10.1039/b406017b; Huheey J. E., 1995, INORGANIC CHEM; IMORI T, 1995, J AM CHEM SOC, V117, P9931, DOI 10.1021/ja00145a001; Manners I, 2004, SYNTHETIC METAL CONT; NEUMANN WP, 1978, ORGANOMETALLIC COORD, P71; Schnepf A, 1997, CHEM COMMUN, P2111, DOI 10.1039/a703776g; Schnockel H, 2005, DALTON T, P3131, DOI 10.1039/b507002n; Shibata K, 1998, ORGANOMETALLICS, V17, P2241, DOI 10.1021/om980013+; SITA LR, 1992, ORGANOMETALLICS, V11, P1442, DOI 10.1021/om00040a007; Stender M, 2002, POLYHEDRON, V21, P525, DOI 10.1016/S0277-5387(01)01033-6; Stender M, 2001, INORG CHEM, V40, P2794, DOI 10.1021/ic001311d; TUCK DG, 1990, POLYHEDRON, V9, P377, DOI 10.1016/S0277-5387(00)80594-X; TUCK DG, 1993, CHEM SOC REV, V22, P270; Uhl W, 2004, ADV ORGANOMET CHEM, V51, P53, DOI 10.1016/S0065-3055(03)51002-4; UHL W, 1989, J ORGANOMET CHEM, V368, P139, DOI 10.1016/0022-328X(89)85308-2; Wiberg N, 1996, ANGEW CHEM INT EDIT, V35, P65, DOI 10.1002/anie.199600651	24	92	93	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2006	311	5769					1904	1907		10.1126/science.1123945	http://dx.doi.org/10.1126/science.1123945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574862				2022-12-28	WOS:000236387800039
J	Embley, TM; Martin, W				Embley, TM; Martin, W			Eukaryotic evolution, changes and challenges	NATURE			English	Review							MITOCHONDRIAL REMNANT; GENOME SEQUENCE; UNIVERSAL TREE; PROTEIN IMPORT; RIBOSOMAL-RNA; GENE-TRANSFER; ORIGIN; HYDROGENOSOMES; ROOT; PHYLOGENY	The idea that some eukaryotes primitively lacked mitochondria and were true intermediates in the prokaryote-to-eukaryote transition was an exciting prospect. It spawned major advances in understanding anaerobic and parasitic eukaryotes and those with previously overlooked mitochondria. But the evolutionary gap between prokaryotes and eukaryotes is now deeper, and the nature of the host that acquired the mitochondrion more obscure, than ever before.	Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Dusseldorf, Inst Bot 3, D-40225 Dusseldorf, Germany	Newcastle University - UK; Heinrich Heine University Dusseldorf	Embley, TM (corresponding author), Newcastle Univ, Sch Biol, Devonshire Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	martin.embley@ncl.ac.uk; w.martin@uni-duesseldorf.de	Martin, William F./O-5446-2015; Puigbò, Pere/A-2214-2008; Martin, William/C-5680-2008	Martin, William F./0000-0003-1478-6449; Embley, Thomas Martin/0000-0002-1484-340X				Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Ali V, 2004, J BIOL CHEM, V279, P16863, DOI 10.1074/jbc.M313314200; Arisue N, 2005, MOL BIOL EVOL, V22, P409, DOI 10.1093/molbev/msi023; Baldauf SL, 1996, P NATL ACAD SCI USA, V93, P7749, DOI 10.1073/pnas.93.15.7749; Benton MJ, 2003, SCIENCE, V300, P1698, DOI 10.1126/science.1077795; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Butterfield NJ, 2000, PALEOBIOLOGY, V26, P386, DOI 10.1666/0094-8373(2000)026<0386:BPNGNS>2.0.CO;2; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Cavalier-Smith T, 1983, ENDOCYTOBIOLOGY, pl027; CAVALIERSMITH T, 1983, ENDOCYTOBIOLOGY, V2, P265; Chan KW, 2005, CURR BIOL, V15, P737, DOI 10.1016/j.cub.2005.02.068; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Darwin C., 1877, ORIGIN SPECIES; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Doolittle WE, 1998, TRENDS GENET, V14, P307; Doolittle WF, 1999, TRENDS CELL BIOL, V15, P5, DOI DOI 10.1016/S0168-9525(99)01877-6; Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Fenchel T., 1995, ECOLOGY EVOLUTION AN; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Hashimoto T, 1997, ARCH PROTISTENKD, V148, P287; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Ho SYW, 2004, SYST BIOL, V53, P623, DOI 10.1080/10635150490503035; Horiike T, 2004, J MOL EVOL, V59, P606, DOI 10.1007/s00239-004-2652-5; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Javaux EJ, 2001, NATURE, V412, P66, DOI 10.1038/35083562; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Keithly JS, 2005, J EUKARYOT MICROBIOL, V52, P132, DOI 10.1111/j.1550-7408.2005.04-3317.x; Knoll AH, 2003, LIFE YOUNG PLANET 1; Komuniecki R., 2003, MOL MEDICAL PARASITO, P339; Kunin V, 2005, GENOME RES, V15, P954, DOI 10.1101/gr.3666505; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; LAKE J, 2005, MICROBIAL PHYLOGENY, P184; LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0; LEIPE DD, 1993, MOL BIOCHEM PARASIT, V59, P41, DOI 10.1016/0166-6851(93)90005-I; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Margulis L, 2000, P NATL ACAD SCI USA, V97, P6954, DOI 10.1073/pnas.97.13.6954; Margulis L, 2005, PALEOBIOLOGY, V31, P175, DOI 10.1666/0094-8373(2005)031[0175:IAOITO]2.0.CO;2; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; Muller M., 2003, MOL MED PARASITOLOGY, P125, DOI DOI 10.1016/B978-012473346-6/50008-9; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Penny D, 2001, J MOL EVOL, V53, P711, DOI 10.1007/s002390010258; PENNY D, 1976, J MOL EVOL, V8, P95, DOI 10.1007/BF01739097; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Philippe H, 1998, SYST ASSOC SPEC VOL, V56, P25; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Ribeiro S, 1998, MOL BIOL EVOL, V15, P779, DOI 10.1093/oxfordjournals.molbev.a025983; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; Rodriguez-Ezpeleta N, 2005, CURR BIOL, V15, P1325, DOI 10.1016/j.cub.2005.06.040; Roger AJ, 2002, NATURE, V418, P827, DOI 10.1038/418827a; Roger AJ, 1999, AM NAT, V154, pS146, DOI 10.1086/303290; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; Searcy Dennis G., 1992, P47; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Stechmann A, 2003, CURR BIOL, V13, pR665, DOI 10.1016/S0960-9822(03)00602-X; Steenkamp ET, 2006, MOL BIOL EVOL, V23, P93, DOI 10.1093/molbev/msj011; Stiller JW, 1999, MOL BIOL EVOL, V16, P1270, DOI 10.1093/oxfordjournals.molbev.a026217; Sutak R, 2004, P NATL ACAD SCI USA, V101, P10368, DOI 10.1073/pnas.0401319101; Tielens AGM, 2002, TRENDS BIOCHEM SCI, V27, P564, DOI 10.1016/S0968-0004(02)02193-X; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tjaden J, 2004, MOL MICROBIOL, V51, P1439, DOI 10.1111/j.1365-2958.2004.03918.x; Tourasse NJ, 1999, MOL PHYLOGENET EVOL, V13, P159, DOI 10.1006/mpev.1999.0675; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Vellai T, 1998, J MOL EVOL, V46, P499, DOI 10.1007/PL00006331; von Dohlen CD, 2001, NATURE, V412, P433, DOI 10.1038/35086563; WHATLEY JM, 1979, PROC R SOC SER B-BIO, V204, P165, DOI 10.1098/rspb.1979.0020; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; ZILLIG W, 1985, CURR TOP MICROBIOL, V114, P1	93	641	666	6	214	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					623	630		10.1038/nature04546	http://dx.doi.org/10.1038/nature04546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572163	Green Submitted			2022-12-28	WOS:000236350400034
J	Treanor, JJ; Campbell, JD; Zangwill, KM; Rowe, T; Wolff, M				Treanor, JJ; Campbell, JD; Zangwill, KM; Rowe, T; Wolff, M			Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							A/DUCK/SINGAPORE/97 VACCINE; MF59-ADJUVANTED INFLUENZA; VIRUS-VACCINE; ANTIBODY; PROTECTION; INFECTION; RESPONSES; SERUM	BACKGROUND: Influenza A (H5N1) viruses could cause a severe worldwide epidemic, with high attack rates, large numbers of deaths and hospitalizations, and wide disruption. Effective vaccines against these viruses in humans are urgently needed. METHODS: We conducted a multicenter, double-blind two-stage study involving 451 healthy adults 18 to 64 years of age who were randomly assigned in a 2:2:2:2:1 ratio to receive two intramuscular doses of a subvirion influenza A (H5N1) vaccine of 90, 45, 15, or 7.5 microg of hemagglutinin antigen or placebo. The subjects were followed for the safety analysis for 56 days. Serum samples obtained before each vaccination and again 28 days after the second vaccination were tested for H5 antibody by microneutralization and hemagglutination inhibition. RESULTS: Mild pain at the injection site was the most common adverse event for all doses of vaccine. The frequency of a serum antibody response was highest among subjects receiving doses of 45 microg or 90 microg. Among those who received two doses of 90 microg, neutralization antibody titers reached 1:40 or greater in 54 percent, and hemagglutination-inhibition titers reached 1:40 or greater in 58 percent. Neutralization titers of 1:40 or greater were seen in 43 percent, 22 percent, and 9 percent of the subjects receiving two doses of 45, 15, and 7.5 microg, respectively. No responses were seen in placebo recipients. CONCLUSIONS: A two-dose regimen of 90 microg of subvirion influenza A (H5N1) vaccine does not cause severe side effects and, in the majority of recipients, generates neutralizing antibody responses typically associated with protection against influenza. A conventional subvirion H5 influenza vaccine may be effective in preventing influenza A (H5N1) disease in humans.	Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA USA; Harbor UCLA Med Ctr, UCLA Ctr Vaccine Res, Los Angeles, CA USA; So Res Inst, Birmingham, AL 35255 USA; EMMES, Rockville, MD USA	University of Rochester; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Treanor, JJ (corresponding author), Univ Rochester, Med Ctr, Dept Med, 601 Elmwood Ave,Rm 3-6309, Rochester, NY 14642 USA.	john_treanor@urmc.rochester.edu	Campbell, James D/AFN-5982-2022; Rowe, Thomas/AAW-4899-2020		NCRR NIH HHS [M01 RR165001, M01 RR00044, M01-RR00425] Funding Source: Medline; NIAID NIH HHS [AI 25463, N01 AI 25460, AI 30068, AI 25461] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, M01RR000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025460, N01AI025461, N01AI025463, R01AI030068] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*ACIP, 2005, MMWR RECOMM REP, V54, P750; *ACIP, 2005, MMWR-MORBID MORTAL W, V54, P1; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; CATE TR, 1982, INFECT IMMUN, V38, P141, DOI 10.1128/IAI.38.1.141-146.1982; COUCH RB, 1979, J INFECT DIS, V140, P553, DOI 10.1093/infdis/140.4.553; COUCH RB, 1971, J INFECT DIS, V124, P473, DOI 10.1093/infdis/124.5.473; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Hehme N, 2004, VIRUS RES, V103, P163, DOI 10.1016/j.virusres.2004.02.029; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; KENDAL AP, 1982, CONCEPTS PRCEDURES L; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; MEIKLEJOHN G, 1983, J INFECT DIS, V148, P775, DOI 10.1093/infdis/148.5.775; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Treanor JJ, 2001, VACCINE, V19, P1732, DOI 10.1016/S0264-410X(00)00395-9; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; WALLS HH, 1986, J CLIN MICROBIOL, V23, P240, DOI 10.1128/JCM.23.2.240-245.1986; 2006, H5N1 AVIAN INFLUENZA; 2006, CUMULATIVE NUMBER CO	25	574	652	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1343	1351		10.1056/NEJMoa055778	http://dx.doi.org/10.1056/NEJMoa055778			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571878	Bronze			2022-12-28	WOS:000236338000003
J	Karam, EG; Mneimneh, ZN; Karam, AN; Fayyad, JA; Nasser, SC; Chatterji, S; Kessler, RC				Karam, EG; Mneimneh, ZN; Karam, AN; Fayyad, JA; Nasser, SC; Chatterji, S; Kessler, RC			Prevalence and treatment of mental disorders in Lebanon: a national epidemiological survey	LANCET			English	Article							MAJOR DEPRESSION; UNITED-STATES; HEALTH	Background Mental disorders are believed to account for a large portion of disease burden worldwide. However, no national studies have been undertaken to assess this assumption in the Arab world. Methods As part of the WHO World Mental Health (WMH) Survey Initiative, a nationally representative psychiatric epidemiological survey of 2857 adults (aged >= 18 years) was done in Lebanon between September, 2002, and September, 2003, through a study called LEBANON (Lebanese Evaluation of the Burden of Ailments and Needs Of the Nation). 12-month prevalence and severity of DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, fourth edition) disorders, and treatment were assessed with the WHO Composite International Diagnostic Interview (CIDI, version 3.0). Information was also obtained for sociodemographics and exposure to traumatic events in the Lebanon wars. Findings 308 (17.0%) of respondents met criteria for at least one 12-month DSM-IV/CIDI disorder, 108 (27.0%) of whom were classified serious and an additional 112 (36.0%) moderate. Nearly half of respondents had a history of exposure to war-related traumatic events. Significantly elevated odds ratios (OR) of mood, anxiety, and impulse-control disorders were associated with two (OR 2.0-3.6) or more (2.2-9.1) war-related traumatic events, resulting in substantially higher proportions of moderate and severe 12-month mental disorders in respondents exposed to multiple war-related traumata (16.8-20.4%) compared with other respondents (3.3-3.5%). Only 47 (10.9%) respondents with 12-month disorders obtained treatment. 85% of people were treated in the general medical sector and the mental-health-care system, and the rest by religious or spiritual advisers, counsellors, herbalists, or fortune-tellers. Interpretation Mental disorders are common in Lebanon, with a prevalence equivalent to that in Western Europe. However, the number of individuals with mental disorders who are not receiving treatment is considerably higher in Lebanon than in Western countries.	IDRAC, Beirut 1100 2110, Lebanon; Univ Med Ctr, St George Hosp, Dept Psychiat & Clin Psychol, Beirut, Lebanon; Balamand Univ, Fac Med, Dept Psychiat & Clin Psychol, Beirut, Lebanon; Lebanese Amer Univ, Sch Pharm, Byblos, Lebanon; WHO, CH-1211 Geneva, Switzerland; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	University Balamand; Lebanese American University; World Health Organization; Harvard University; Harvard Medical School	Karam, EG (corresponding author), IDRAC, POB 166227, Beirut 1100 2110, Lebanon.	idrac@idrac.org.lb	Mneimneh, Zeina/ABG-3516-2020; CHATTERJI, Somnath/ABE-6832-2020	Nasser, Soumana/0000-0003-4202-7116	FIC NIH HHS [R03 TW006481-02, R03 TW006481, R01-TW006481] Funding Source: Medline; NIDA NIH HHS [K05 DA015799, R01 DA016558-03, R01 DA011121-05, R01 DA016558] Funding Source: Medline; NIMH NIH HHS [R01MH070884, R01 MH069864, R13 MH066849-03, R01-MH069864, R13-MH066849, R01 MH069864-02, R01 MH070884, R01 MH070884-01A2, U13 MH066849, R13 MH066849] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R03TW006481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070884, U13MH066849, R01MH069864, R13MH066849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011121, K05DA015799, R01DA016558] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abou-Saleh MT, 2001, SOC PSYCH PSYCH EPID, V36, P20, DOI 10.1007/s001270050286; *ADM CENTR STAT, 1998, COND VIE MEN; ALHAMMADI A, 1994, TRAUMATIC EVENTS MEN; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P47; [Anonymous], 2000, Bull World Health Organ, V78, P413; [Anonymous], 2001, WORLD HLTH REP MENT; Bijl RV, 2003, HEALTH AFFAIR, V22, P122, DOI 10.1377/hlthaff.22.3.122; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; Henderson S, 2000, AUST NZ J PSYCHIAT, V34, P197, DOI 10.1080/j.1440-1614.2000.00686.x; Jenkins R, 2003, INT REV PSYCHIATR, V15, P29, DOI 10.1080/0954026021000045921; Karam E, 1995, ARAB J PSYCHIAT, V6, P19; Karam EG, 2004, DRUG ALCOHOL DEPEN, V76, P273, DOI 10.1016/j.drugalcdep.2004.06.003; Karam EG, 1998, EUR ARCH PSY CLIN N, V248, P225, DOI 10.1007/s004060050042; KARAM EG, 2003, SUBSTANCE ABUSE MISU; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P768; KESSLER RC, 1995, EPIDEMIOL REV, V17, P192, DOI 10.1093/oxfordjournals.epirev.a036176; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kish L., 1967, SURVEY SAMPLING; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; Muntaner C, 2004, EPIDEMIOL REV, V26, P53, DOI 10.1093/epirev/mxh001; Murray C. J. L., 1996, GLOBAL BURDEN DIS; OKASHA A, 1998, EGYPT J PSYCHIAT, V11, P167; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; Robins L.N., 1991, PSYCHIAT DISORDERS A; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293	29	182	185	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					1000	1006		10.1016/S0140-6736(06)68427-4	http://dx.doi.org/10.1016/S0140-6736(06)68427-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	028GE	16564362	Green Accepted			2022-12-28	WOS:000236474200028
J	Raymond, J; Segre, D				Raymond, J; Segre, D			The effect of oxygen on biochemical networks and the evolution of complex life	SCIENCE			English	Article							ATMOSPHERIC OXYGEN; EARTH	The evolution of oxygenic photosynthesis and ensuing oxygenation of Earth's atmosphere represent a major transition in the history of life. Although many organisms retreated to anoxic environments, others evolved to use oxygen as a. high-potential redox couple white concomitantly mitigating its toxicity. To understand the changes in biochemistry and enzymology that accompanied adaptation to O-2, we integrated network analysis with information on enzyme evolution to infer how oxygen availability changed the architecture of metabolic networks. Our analysis revealed the existence of four discrete groups of networks of increasing complexity, with transitions between groups being contingent on the presence of key metabolites, including molecular oxygen, which was required for transition into the largest networks.	Lawrence Livermore Natl Lab, Microbial Syst Div, Biosci Directorate, Livermore, CA 94550 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; Boston Univ, Dept Biol, Bioinformat Program, Boston, MA 02215 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Boston University; Boston University	Raymond, J (corresponding author), Lawrence Livermore Natl Lab, Microbial Syst Div, Biosci Directorate, POB 5508, Livermore, CA 94550 USA.		Segrè, Daniel/A-1993-2009	Segrè, Daniel/0000-0003-4859-1914				Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Des Marais DJ, 2000, SCIENCE, V289, P1703; Dismukes GC, 2001, P NATL ACAD SCI USA, V98, P2170, DOI 10.1073/pnas.061514798; Ebenhoh Oliver, 2005, Genome Inform, V16, P203; Ebenhoh Oliver, 2004, Genome Inform, V15, P35; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Handorf T, 2005, J MOL EVOL, V61, P498, DOI 10.1007/s00239-005-0027-1; HAYES JM, 1994, NOBEL S, V84; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kirschvink JL, 2000, P NATL ACAD SCI USA, V97, P1400, DOI 10.1073/pnas.97.4.1400; Knoll AH, 2003, GEOBIOLOGY, V1, P3, DOI 10.1046/j.1472-4669.2003.00002.x; Morowitz Harold J., 1999, Complexity, V4, P39, DOI 10.1002/(SICI)1099-0526(199907/08)4:6<39::AID-CPLX8>3.0.CO;2-2; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Raymond J, 2004, GEOBIOLOGY, V2, P199, DOI 10.1111/j.1472-4677.2004.00037.x; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724	20	314	326	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1764	1767		10.1126/science.1118439	http://dx.doi.org/10.1126/science.1118439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556842				2022-12-28	WOS:000236204300042
J	Dwivedi, G; Hayat, SA; Violaris, AG; Senior, R				Dwivedi, G; Hayat, SA; Violaris, AG; Senior, R			Interactive case report - A 28 year old postpartum woman with right sided chest discomfort: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material							ECHOCARDIOGRAPHY		Northwick Pk Hosp & Clin Res Ctr, Dept Cardiovasc Med, Harrow HA1 3UJ, Middx, England	Imperial College London	Senior, R (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Dept Cardiovasc Med, Harrow HA1 3UJ, Middx, England.	roxy.senior@virgin.net		Hayat, Sajad Ahmed/0000-0002-9281-7733; Hayat, Sajad/0000-0002-7802-987X				DETRANO R, 1989, PROG CARDIOVASC DIS, V32, P173, DOI 10.1016/0033-0620(89)90025-X; Marwick TH, 2001, CIRCULATION, V103, P2566; Senior R, 2005, HEART, V91, P427, DOI 10.1136/hrt.2004.044396	3	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					643	643		10.1136/bmj.332.7542.643	http://dx.doi.org/10.1136/bmj.332.7542.643			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543328	Green Published			2022-12-28	WOS:000236314700018
J	Scannell, DR; Byrne, KP; Gordon, JL; Wong, S; Wolfe, KH				Scannell, DR; Byrne, KP; Gordon, JL; Wong, S; Wolfe, KH			Multiple rounds of speciation associated with reciprocal gene loss in polyploid yeasts	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME DUPLICATION; EVOLUTION; HYBRID; DIVERGENT; STERILITY; ORDER	A whole- genome duplication occurred in a shared ancestor of the yeast species Saccharomyces cerevisiae, Saccharomyces castellii and Candida glabrata. Here we trace the subsequent losses of duplicated genes, and show that the pattern of loss differs among the three species at 20% of all loci. For example, several transcription factor genes, including STE12, TEC1, TUP1 and MCM1, are single-copy in S. cerevisiae but are retained in duplicate in S. castellii and C. glabrata. At many loci, different species have lost different members of a duplicated gene pair, so that 4 - 7% of single- copy genes compared between any two species are not orthologues. This pattern of gene loss provides strong evidence for speciation through a version of the Bateson - Dobzhansky - Muller mechanism, in which the loss of alternative copies of duplicated genes leads to reproductive isolation(1,2). We show that the lineages leading to the three species diverged shortly after the whole-genome duplication, during a period of precipitous gene loss. The set of loci at which single- copy paralogues are retained is biased towards genes involved in ribosome biogenesis and genes that evolve slowly, consistent with the hypothesis that reciprocal gene loss is more likely to occur between duplicated genes that are functionally indistinguishable. We propose a simple, unified model in which a single mechanism - passive gene loss - enabled whole- genome duplication and led to the rapid emergence of new yeast species.	Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland	Trinity College Dublin	Wolfe, KH (corresponding author), Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland.	khwolfe@tcd.ie	Wolfe, Kenneth H/B-4653-2009	Gordon, Jonathan/0000-0002-1033-4368; Scannell, Devin/0000-0002-8188-5992; Wolfe, Kenneth/0000-0003-4992-4979; Byrne, Kevin/0000-0002-6368-154X				Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Coyne J.A., 2004, SPECIATION; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fischer G, 2001, GENOME RES, V11, P2009, DOI 10.1101/gr.212701; Goffeau A, 1997, NATURE, V387, P5, DOI DOI 10.1038/387005B0.PUBMED:9169864; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Greig D, 2002, P ROY SOC B-BIOL SCI, V269, P1167, DOI 10.1098/rspb.2002.1989; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Lynch M, 2000, AM NAT, V156, P590, DOI 10.1086/316992; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Taylor JS, 2001, TRENDS GENET, V17, P299, DOI 10.1016/S0168-9525(01)02318-6; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648	25	302	318	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					341	345		10.1038/nature04562	http://dx.doi.org/10.1038/nature04562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541074	Green Published			2022-12-28	WOS:000235997600054
J	Wilson, KA; McBride, MF; Bode, M; Possingham, HP				Wilson, KA; McBride, MF; Bode, M; Possingham, HP			Prioritizing global conservation efforts	NATURE			English	Article							BIODIVERSITY; HOTSPOTS; COSTS	One of the most pressing issues facing the global conservation community is how to distribute limited resources between regions identified as priorities for biodiversity conservation(1-3). Approaches such as biodiversity hotspots(4), endemic bird areas(5) and ecoregions(6) are used by international organizations to prioritize conservation efforts globally(7). Although identifying priority regions is an important first step in solving this problem, it does not indicate how limited resources should be allocated between regions. Here we formulate how to allocate optimally conservation resources between regions identified as priorities for conservation - the 'conservation resource allocation problem'. Stochastic dynamic programming is used to find the optimal schedule of resource allocation for small problems but is intractable for large problems owing to the " curse of dimensionality"(8). We identify two easy- to- use and easy- to- interpret heuristics that closely approximate the optimal solution. We also show the importance of both correctly formulating the problem and using information on how investment returns change through time. Our conservation resource allocation approach can be applied at any spatial scale. We demonstrate the approach with an example of optimal resource allocation among five priority regions in Wallacea and Sundaland, the transition zone between Asia and Australasia.	Univ Queensland, Ctr Ecol, Sch Integrat Biol, Brisbane, Qld 4072, Australia; Univ Queensland, Ctr Ecol, Sch Phys Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Wilson, KA (corresponding author), Univ Queensland, Ctr Ecol, Sch Integrat Biol, Brisbane, Qld 4072, Australia.	k.wilson2@uq.edu.au	Wilson, Kerrie/W-4181-2019; Possingham, Hugh/B-1337-2008; Bode, Michael/A-7116-2009; POSSINGHAM, HUGH/R-8310-2019; Bode, Michael/P-1333-2019; Wilson, Kerrie A/C-8058-2009; McBride, Marissa FC/D-5573-2009	Wilson, Kerrie/0000-0002-0092-935X; Possingham, Hugh/0000-0001-7755-996X; Bode, Michael/0000-0002-5886-4421; POSSINGHAM, HUGH/0000-0001-7755-996X; Bode, Michael/0000-0002-5886-4421; Wilson, Kerrie A/0000-0002-0092-935X; McBride, Marissa/0000-0002-7498-292X				Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; BALMFORD A, 2000, CONSERV BIOL, V14, P1; Bellman R., 1957, DYNAMIC PROGRAMMING; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Clark CW, 2000, OX ECOL EV; Costello C, 2004, RESOUR ENERGY ECON, V26, P157, DOI 10.1016/j.reseneeco.2003.11.005; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Dalton R, 2000, NATURE, V406, P818, DOI 10.1038/35022727; Drechsler M, 2005, BIOL CONSERV, V122, P253, DOI 10.1016/j.biocon.2004.07.015; Frazee SR, 2003, BIOL CONSERV, V112, P275, DOI 10.1016/S0006-3207(02)00400-7; Groves C., 2000, DESIGNING GEOGRAPHY; HALPERN BS, IN PRESS CONSERV BIO; Linkie M, 2004, BIODIVERS CONSERV, V13, P1809, DOI 10.1023/B:BIOC.0000035867.90891.ea; MacArthur R, 1967, THEORY ISLAND BIOGEO; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Moore J, 2004, BIOL CONSERV, V117, P343, DOI 10.1016/j.biocon.2003.12.013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Odling-Smee L, 2005, NATURE, V437, P614, DOI 10.1038/437614a; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; POSSINGHAM H, 1993, DECISION SCI TOOLS T, P536; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Possingham HP, 2001, CONSERVATION BIOLOGY: RESEARCH PRIORITIES FOR THE NEXT DECADE, P225; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9	28	428	449	2	241	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					337	340		10.1038/nature04366	http://dx.doi.org/10.1038/nature04366			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541073				2022-12-28	WOS:000235997600053
J	Hallal, PC; Wells, JCK; Reichert, FF; Anselmi, L; Victora, CG				Hallal, PC; Wells, JCK; Reichert, FF; Anselmi, L; Victora, CG			Early determinants of physical activity in adolescence: prospective birth cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; FAMILIAL AGGREGATION; CHILDHOOD; OBESITY; PARTICIPATION; OVERWEIGHT; TRACKING; FITNESS; ADULTS; LIFE	Objective To examine the effects of early social, anthropometric, and behavioural variables on physical activity in adolescence. Design Prospective birth cohort study. Setting Pelotas, southern Brazil. Participants 4453 adolescents aged 10-12 years participating in the Pelotas 1993 birth cohort study (follow-up rate 87.5%). Main outcome measures Sedentary lifestyle (< 300 Minutes of physical activity per week) and median physical activity score (minutes per week). Results The prevalence Of a sedentary lifestyle at age 10-12 years was 58.2% (95% confidence interval 56.7% to 59.7%). Risk factors for a sedentary lifestyle in adolescence were female sex, high family income at birth, high maternal education at birth, and low birth order. Weight gain variables at ages 0-1, 1-4, and 4-11 years and overweight at age 1 or 4 years were not significant predictors of physical activity Levels of physical activity at age 4 years, based on maternal report, were inversely related to a sedentary lifestyle at age 10-12 years. Conclusions Physical activity in adolescence does not seem to be programmed by physiological factors in infancy A positive association between birth order and activity may be due to greater intensity of play in childhood and adolescence. Tracking of physical activity from age 4 to 10-12),cars, however, Suggests that. genetic factors or early habit formation may be important.	Univ Fed Pelotas, Postgrad Program Epidemiol, BR-96030002 Pelotas, RS, Brazil; Inst Child Hlth, MRC, Childhood Nutr Ctr, London, England; Univ Fed Rio Grande do Sul, Inst Psychol, BR-90046900 Porto Alegre, RS, Brazil	Universidade Federal de Pelotas; University of London; University College London; Universidade Federal do Rio Grande do Sul	Hallal, PC (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Duque Caxias 250 3 Piso, BR-96030002 Pelotas, RS, Brazil.	prchallal@terra.com.br	Hallal, Pedro C/A-3249-2011; Reichert, Felipe F/E-4899-2012; Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019; Wells, Jonathan/A-4604-2009	Hallal, Pedro C/0000-0003-1470-6461; Reichert, Felipe F/0000-0002-0951-9875; Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180; Wells, Jonathan/0000-0003-0411-8025	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alfano CM, 2002, PREV MED, V34, P82, DOI 10.1006/pmed.2001.0963; [Anonymous], 1991, MANUAL CHILD BEHAV C; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4; Beunen GP, 2004, MED SCI SPORT EXER, V36, P1930, DOI 10.1249/01.MSS.0000145536.87255.3A; Biddle S, 1998, YOUNG ACTIVE YOUNG P; DASILVA RC, 2000, CAD SAUDE PUBLICA, V16, P1991; Dias-da-Costa Juvenal Soares, 2005, Cad. Saúde Pública, V21, P275, DOI 10.1590/S0102-311X2005000100030; EATON WO, 1989, DEV PSYCHOL, V25, P668, DOI 10.1037/0012-1649.25.4.668; Forrester T, 2004, J NUTR, V134, P211, DOI 10.1093/jn/134.1.211; FREUD S, 1962, SEXUALITY PSYCHOL LO; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Hallal PC, 2003, MED SCI SPORT EXER, V35, P1894, DOI 10.1249/01.MSS.0000093615.33774.0E; Harpham T., 2003, J INT DEV, V15, P353, DOI DOI 10.1002/(ISSN)1099-1328; Horta BL, 2003, J EPIDEMIOL COMMUN H, V57, P226, DOI 10.1136/jech.57.3.226; Janz KF, 2000, MED SCI SPORT EXER, V32, P1250, DOI 10.1097/00005768-200007000-00011; Kemper HCG, 2001, EUR J APPL PHYSIOL, V84, P395, DOI 10.1007/s004210100392; KORNER AF, 1985, CHILD DEV, V56, P38, DOI 10.2307/1130171; Kraut A, 2003, MED SCI SPORT EXER, V35, P2038, DOI 10.1249/01.MSS.0000099087.96549.96; LUCAS A, 1991, CIBA F SYMP, V156, P38; MACCOBY EE, 1979, CHILD DEV, V50, P632, DOI 10.2307/1128928; Malina RM, 1996, RES Q EXERCISE SPORT, V67, pS48, DOI 10.1080/02701367.1996.10608853; MARCUS J, 1985, DEV PSYCHOBIOL, V18, P327, DOI 10.1002/dev.420180405; McMurray RG, 2003, MED SCI SPORT EXER, V35, P1914, DOI 10.1249/01.MSS.0000093612.59984.0E; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Merom D, 2004, J SCI MED SPORT, V7, P32, DOI 10.1016/S1440-2440(04)80041-0; Mitchell BD, 2003, ANN EPIDEMIOL, V13, P128, DOI 10.1016/S1047-2797(02)00255-7; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Morabia A, 2005, AM J PUBLIC HEALTH, V95, P632, DOI 10.2105/2004.047877; OEHLSCHLAEGER MH, 2000, REV SAUDE PUBL, V38, P157; Ong KK, 2004, EUR J ENDOCRINOL, V151, pU131, DOI 10.1530/eje.0.151U131; Parks SE, 2003, J EPIDEMIOL COMMUN H, V57, P29, DOI 10.1136/jech.57.1.29; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Pomerleau J, 2000, PREV MED, V31, P665, DOI 10.1006/pmed.2000.0761; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; SAUDINO KJ, 1995, BRIT J DEV PSYCHOL, V13, P81, DOI 10.1111/j.2044-835X.1995.tb00666.x; Simonen RL, 2002, MED SCI SPORT EXER, V34, P1137, DOI 10.1097/00005768-200207000-00014; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Strauss RS, 2001, JAMA-J AM MED ASSOC, V286, P2845, DOI 10.1001/jama.286.22.2845; Tammelin T, 2003, AM J PREV MED, V24, P22, DOI 10.1016/S0749-3797(02)00575-5; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wells JCK, 1996, AM J HUM BIOL, V8, P465, DOI 10.1002/(SICI)1520-6300(1996)8:4<465::AID-AJHB6>3.0.CO;2-X; WHO Expert Committee, 1995, PHYS STAT US INT ANT; World Health Organization, 2004, GLOB STRAT DIET PHYS	48	103	115	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1002	1005		10.1136/bmj.38776.434560.7C	http://dx.doi.org/10.1136/bmj.38776.434560.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040TK	16601016	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000237403100015
J	Stevens, J; Blixt, O; Tumpey, TM; Taubenberger, JK; Paulson, JC; Wilson, IA				Stevens, J; Blixt, O; Tumpey, TM; Taubenberger, JK; Paulson, JC; Wilson, IA			Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus	SCIENCE			English	Article							BINDING PROPERTIES; SIALIC-ACID; GLYCOSYLATION; DETERMINANTS; OLIGOSACCHARIDES; GLYCOPEPTIDES; EVOLUTION; SUBTYPES; HUMANS; FUSION	The hemagglutinin (HA) structure at 2.9 angstrom resolution, from a highly pathogenic Vietnamese H5N1 influenza virus, is more related to the 1918 and other human H1 HAS than to a 1997 duck H5 HA. Glycan microarray analysis of this Viet04 HA reveals an avian alpha 2-3 sialic acid receptor binding preference. Introduction of mutations that can convert H1 serotype HAS to human alpha 2-6 receptor specificity only enhanced or reduced affinity for avian-type receptors. However, mutations that can convert avian H2 and H3 HAS to human receptor specificity, when inserted onto the Viet04 H5 HA framework, permitted binding to a natural human alpha 2-6 glycan, which suggests a path for this H5N1 virus to gain a foothold in the human population.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Consortium Funct Glycom, Glycan Array Synth Core D, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA; Armed Forces Inst Pathol, Dept Mol Pathol, Washington, DC 20306 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Centers for Disease Control & Prevention - USA; United States Department of Defense	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Paulson, James/AAG-3565-2019; Taubenberger, Jeffery/AAQ-1407-2021	Blixt, Ola/0000-0003-4143-6276	NCI NIH HHS [CA55896] Funding Source: Medline; NIAID NIH HHS [AI42266, AI058113] Funding Source: Medline; NIGMS NIH HHS [GM060938, GM062116] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA055896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, P01AI058113, R37AI042266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, R01GM060938] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; BAUM LG, 1990, ACTA HISTOCHEM, P35; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Harvey R, 2004, J VIROL, V78, P502, DOI 10.1128/JVI.78.1.502-507.2004; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; JOZIASSE DH, 1987, J BIOL CHEM, V262, P2025; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; KAWAOKA Y, 1989, VIROLOGY, V169, P283, DOI 10.1016/0042-6822(89)90153-0; KIDO H, 1992, J BIOL CHEM, V267, P13573; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Klenk HD, 2002, VIRUS RES, V82, P73; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Lamblin G, 2001, GLYCOCONJUGATE J, V18, P661, DOI 10.1023/A:1020867221861; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Nobusawa E, 2000, VIROLOGY, V278, P587, DOI 10.1006/viro.2000.0679; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Perdue ML, 2000, VET MICROBIOL, V74, P77, DOI 10.1016/S0378-1135(00)00168-1; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROGERS GN, 1989, VIROLOGY, V173, P317, DOI 10.1016/0042-6822(89)90249-3; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0	47	764	915	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					404	410		10.1126/science.1124513	http://dx.doi.org/10.1126/science.1124513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16543414				2022-12-28	WOS:000236941800041
J	Champion, L; Stern, M; Israel-Biet, D; Mamzer-Bruneel, MF; Peraldi, MN; Kreis, H; Porcher, R; Morelon, E				Champion, L; Stern, M; Israel-Biet, D; Mamzer-Bruneel, MF; Peraldi, MN; Kreis, H; Porcher, R; Morelon, E			Brief communication: Sirolimus-associated pneumonitis: 24 cases in renal transplant recipients	ANNALS OF INTERNAL MEDICINE			English	Article							INTERSTITIAL PNEUMONITIS; LIVER-TRANSPLANTATION; THERAPY; REJECTION; EFFICACY	Background: Interstitial pneumonitis is an ill-defined side effect of sirolimus, a new immunosuppressant drug recently introduced for patients having organ transplantation. Objective: To evaluate clinical and laboratory features of sirolimus-associated pneumonitis. Design: Case series. Setting: 1 transplantation center in Paris, France. Patients: 24 patients who had renal transplantation and developed sirolimus-associated pneumonitis, including 8 patients previously reported. Measurements: Symptoms; laboratory tests, including broncho alveolar fluid analysis; and computed tomography (CT) of the chest. Intervention: Withdrawal or dose reduction of sirolimus. Results: Clinical symptoms included cough (23 patients), fatigue (20 patients), fever (16 patients), and dyspnea (8 patients). Computed tomography of the chest showed reticular and ground-glass opacities (4 patients), bronchiolitis obliterans- organizing pneumonia (19 patients), and lobar consolidation (1 patient). Bronchoalveolar lavage showed lymphocytic (19 patients) or eosinophilic (3 patients) alveolitis or pulmonary hemorrhage (2 patients). A reduction in the sirolimus dose resulted in transient clinical improvement in 2 patients, but discontinuation of drug therapy was eventually necessary in all patients. All patients recovered completely within 6 months. Limitations: The sirolimus trough level in patients from this single center was higher than that usually used in patients having renal transplantation, Conclusion: Lymphocytic alveolitis and radiologic bronchiolitis obliterans- organizing pneumonia are the key findings in sirolimus-associated pneumonitis. Sirolimus withdrawal was associated with recovery within 6 months.	Hop St Louis, Paris, France; Hop Necker Enfants Malad, Paris, France; Hop Foch, Paris, France; Hop Georges Pompidou, Paris, France; Hop Edouard Herriot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon	Morelon, E (corresponding author), Univ Lyon 1, Hop Edouard Herriot, Serv Nephrol Med, 3 Pl Arsonval, F-69437 Lyon 3, France.	emmanuel.morelon@chu-lyon.fr	Mamzer, Marie-France/V-1713-2017	Mamzer, Marie-France/0000-0001-7570-1803; Porcher, Raphael/0000-0002-5277-4679; STERN, Marc/0000-0001-5275-6959; ISRAEL-BIET, Dominique/0000-0003-4308-4411				Avitzur Y, 2003, J PEDIATR GASTR NUTR, V37, P91, DOI 10.1097/00005176-200307000-00017; Dupont P, 2003, QJM-INT J MED, V96, P401, DOI 10.1093/qjmed/hcg072; FOURNIER E, 1985, CHEST, V88, P563, DOI 10.1378/chest.88.4.563; Haydar AA, 2004, AM J TRANSPLANT, V4, P137, DOI 10.1046/j.1600-6135.2003.00292.x; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kreis H, 2004, J AM SOC NEPHROL, V15, P809, DOI 10.1097/01.ASN.0000113248.59077.76; Lennon A, 2001, TRANSPLANTATION, V72, P1166, DOI 10.1097/00007890-200109270-00034; Lindenfeld JA, 2005, AM J TRANSPLANT, V5, P1392, DOI 10.1111/j.1600-6143.2005.00849.x; MacDonald AS, 2001, TRANSPLANTATION, V71, P271, DOI 10.1097/00007890-200101270-00019; Mahalati K, 2000, TRANSPLANTATION, V69, P1531; Mahe E, 2005, TRANSPLANTATION, V79, P476, DOI 10.1097/01.TP.0000151630.25127.3A; Manito N, 2004, J HEART LUNG TRANSPL, V23, P780, DOI 10.1016/j.healun.2003.07.008; McWilliams TJ, 2003, J HEART LUNG TRANSPL, V22, P210, DOI 10.1016/S1053-2498(02)00564-8; Morelon E, 2003, TRANSPLANT P, V35, p52S, DOI 10.1016/S0041-1345(03)00244-6; Morelon E, 2001, TRANSPLANTATION, V72, P787, DOI 10.1097/00007890-200109150-00008; Pham PTT, 2004, TRANSPLANTATION, V77, P1215, DOI 10.1097/01.TP.0000118413.92211.B6	16	142	173	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					505	509		10.7326/0003-4819-144-7-200604040-00009	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585664				2022-12-28	WOS:000236685100005
J	Tiscareno, MS; Burns, JA; Hedman, MM; Porco, CC; Weiss, JW; Dones, L; Richardson, DC; Murray, CD				Tiscareno, MS; Burns, JA; Hedman, MM; Porco, CC; Weiss, JW; Dones, L; Richardson, DC; Murray, CD			100-metre-diameter moonlets in Saturn's A ring from observations of 'propeller' structures	NATURE			English	Article							CASSINI IMAGING SCIENCE; STELLAR OCCULTATION; PLANETARY RINGS; PARTICLES; SATELLITES; DISKS	Saturn's main rings are composed predominantly of water-ice particles ranging between about 1 centimetre and 10 metres in radius. Above this size range, the number of particles drops sharply, according to the interpretation of spacecraft(1) and stellar(2) occultations. Other than the gap moons Pan and Daphnis ( the provisional name of S/2005 S1), which have sizes of several kilometres, no individual bodies in the rings have been directly observed, and the population of ring particles larger than ten metres has been essentially unknown. Here we report the observation of four longitudinal double-streaks in an otherwise bland part of the mid-A ring. We infer that these 'propeller'-shaped perturbations(3-5) arise from the effects of embedded moonlets approximately 40 to 120 m in diameter. Direct observation of this phenomenon validates models of proto-planetary disks in which similar processes are posited(4,6). A population of moonlets, as implied by the size distribution that we find, could help explain gaps in the more tenuous regions of the Cassini division and the C ring(7). The existence of such large embedded moonlets is most naturally compatible with a ring originating in the break-up of a larger body(8-11), but accretion from a circumplanetary disk(12) is also plausible if subsequent growth onto large particles occurs after the primary accretion phase has concluded(13,14).	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Cornell Univ, Dept Theoret & Appl Mech, Ithaca, NY 14853 USA; CICLOPS, Space Sci Inst, Boulder, CO 80301 USA; SW Res Inst, Boulder, CO 80302 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Queen Mary Univ London, Astron Unit, London E1 4NS, England	Cornell University; Cornell University; University System of Maryland; University of Maryland College Park; University of London; Queen Mary University London	Tiscareno, MS (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	matthewt@astro.cornell.edu	Richardson, Derek C/J-4257-2018; Tiscareno, Matthew/D-6963-2011	Richardson, Derek C/0000-0002-0054-6850; 				Brahic A., 1984, IAU C, V75, P513; COLWELL JE, 1994, PLANET SPACE SCI, V42, P1139, DOI 10.1016/0032-0633(94)90013-2; Cuzzi J.N., 1984, PLANETARY RINGS, V75, P73; Daisaka H, 2001, ICARUS, V154, P296, DOI 10.1006/icar.2001.6716; DONES L, 1993, ICARUS, V105, P184, DOI 10.1006/icar.1993.1118; DONES L, 1991, ICARUS, V92, P194, DOI 10.1016/0019-1035(91)90045-U; Dones L., 1989, B AM ASTRON SOC, V21, P929; ESPOSITO LW, 1983, ICARUS, V56, P439, DOI 10.1016/0019-1035(83)90165-3; French RG, 2000, ICARUS, V145, P502, DOI 10.1006/icar.2000.6357; HARIS AW, 1984, PLANETARY RINGS, P641; HENON M, 1981, NATURE, V293, P33, DOI 10.1038/293033a0; JULIAN WH, 1966, ASTROPHYS J, V146, P810, DOI 10.1086/148957; Karjalainen R, 2004, ICARUS, V172, P328, DOI 10.1016/j.icarus.2004.05.022; Lewis MC, 2005, ICARUS, V178, P124, DOI 10.1016/j.icarus.2005.04.009; LISSAUER JJ, 1981, NATURE, V292, P707, DOI 10.1038/292707a0; MURRAY CD, 1999, SOLAR SYSTEM DYNAMCI; Nicholson PD, 2000, ICARUS, V145, P474, DOI 10.1006/icar.2000.6356; POLLACK JB, 1975, SPACE SCI REV, V18, P3, DOI 10.1007/BF00350197; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2005, SCIENCE, V307, P1226, DOI 10.1126/science.1108056; SALO H, 1995, ICARUS, V117, P287, DOI 10.1006/icar.1995.1157; Seiss M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022506; SHOWALTER MR, 1990, ICARUS, V87, P285, DOI 10.1016/0019-1035(90)90135-V; SHOWALTER MR, 1986, ICARUS, V66, P297, DOI 10.1016/0019-1035(86)90160-0; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Spahn F, 2000, ASTRON ASTROPHYS, V358, P368; Sremcevic M, 2002, MON NOT R ASTRON SOC, V337, P1139, DOI 10.1046/j.1365-8711.2002.06011.x; Weidenschilling S.J., 1984, PLANETARY RINGS, P367; ZEBKER HA, 1985, ICARUS, V64, P531, DOI 10.1016/0019-1035(85)90074-0	30	80	80	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					648	650		10.1038/nature04581	http://dx.doi.org/10.1038/nature04581			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572165				2022-12-28	WOS:000236350400038
J	Bautista, DM; Jordt, SE; Nikai, T; Tsuruda, PR; Read, AJ; Poblete, J; Yamoah, EN; Basbaum, AI; Julius, D				Bautista, DM; Jordt, SE; Nikai, T; Tsuruda, PR; Read, AJ; Poblete, J; Yamoah, EN; Basbaum, AI; Julius, D			TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents	CELL			English	Article							ION-CHANNEL TRPA1; CAPSAICIN-RECEPTOR; VANILLOID RECEPTOR; CYCLOPHOSPHAMIDE CYSTITIS; NOCICEPTIVE NEURONS; GANGLION NEURONS; PULMONARY-EDEMA; AIR-POLLUTANTS; GUINEA-PIGS; ACROLEIN	TRPA1 is an excitatory ion channel targeted by pungent irritants from mustard and garlic. TRPA1 has been proposed to function in diverse sensory processes, including thermal (cold) nociception, hearing, and inflammatory pain. Using TRPA1-deficient mice, we now show that this channel is the sole target through which mustard oil and garlic activate primary afferent nociceptors to produce inflammatory pain. TRPA1 is also targeted by environmental irritants, such as acrolein, that account for toxic and inflammatory actions of tear gas, vehicle exhaust, and metabolic byproducts of chemotherapeutic agents. TRPA1-deficient mice display normal cold sensitivity and unimpaired auditory function, suggesting that this channel is not required for the initial detection of noxious cold or sound. However, TRPA1-deficient mice exhibit pronounced deficits in bradykinin-evoked nociceptor excitation and pain hypersensitivity. Thus, TRPA1 is an important component of the transduction machinery through which environmental irritants and endogenous proalgesic agents depolarize nociceptors, to elicit inflammatory pain.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Univ Calif San Francisco, Dept Anat & Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Otolaryngol, Davis, CA 95616 USA	University of California System; University of California San Francisco; Yale University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis	Julius, D (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	julius@cmp.ucsf.edu	Jordt, Sven-Eric/ABE-6517-2020	Jordt, Sven-Eric/0000-0001-6171-5622; Read, Andrew/0000-0001-7336-8496				AHLUWALIA A, 1994, BRIT J PHARMACOL, V111, P1017, DOI 10.1111/j.1476-5381.1994.tb14845.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1999, P NATL ACAD SCI USA, V96, P7658, DOI 10.1073/pnas.96.14.7658; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; COX PJ, 1979, BIOCHEM PHARMACOL, V28, P2045, DOI 10.1016/0006-2952(79)90222-3; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dinis P, 2004, J NEUROSCI, V24, P11253, DOI 10.1523/JNEUROSCI.2657-04.2004; Dou HV, 2004, JARO-J ASSOC RES OTO, V5, P215, DOI 10.1007/s10162-003-4020-3; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; DUNN PM, 1990, BRIT J PHARMACOL, V100, P656, DOI 10.1111/j.1476-5381.1990.tb15863.x; FLEMING RA, 1997, PHARMACOTHERAPY, V17, P146; Ghilarducci DP, 1995, REV ENVIRON CONTAM T, V144, P95; HALES CA, 1992, J APPL PHYSIOL, V72, P555, DOI 10.1152/jappl.1992.72.2.555; HALES CA, 1988, J APPL PHYSIOL, V64, P1121, DOI 10.1152/jappl.1988.64.3.1121; Handzel Z T, 2000, Rev Environ Health, V15, P325; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Inoue T, 2005, PAIN, V117, P193, DOI 10.1016/j.pain.2005.06.012; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Kollarik M, 2004, J PHYSIOL-LONDON, V555, P115, DOI 10.1113/jphysiol.2003.054890; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; LEIKAUF GD, 1989, J APPL PHYSIOL, V66, P171, DOI 10.1152/jappl.1989.66.1.171; Leikauf GD, 2002, ENVIRON HEALTH PERSP, V110, P505, DOI 10.1289/ehp.02110s4505; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; MAGGI CA, 1992, J AUTONOM NERV SYST, V38, P201, DOI 10.1016/0165-1838(92)90031-B; Martinez-Caro L, 2000, NEUROREPORT, V11, P1213, DOI 10.1097/00001756-200004270-00014; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morris JB, 1999, J APPL PHYSIOL, V87, P1877, DOI 10.1152/jappl.1999.87.5.1877; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Nicol D, 2002, INTERN MED J, V32, P199, DOI 10.1046/j.1445-5994.2002.00222.x; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Reid G, 2002, NEUROSCI LETT, V324, P164, DOI 10.1016/S0304-3940(02)00181-7; SPRINGALL DR, 1990, ENVIRON HEALTH PERSP, V85, P151, DOI 10.2307/3430678; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Symanowicz PT, 2004, NEUROSCI LETT, V362, P150, DOI 10.1016/j.neulet.2004.03.016; Takamoto S, 2004, J CHROMATOGR B, V806, P59, DOI 10.1016/j.jchromb.2004.02.008; TURNER CR, 1993, J APPL PHYSIOL, V75, P2456, DOI 10.1152/jappl.1993.75.6.2456; Undem BJ, 2001, RESP RES, V2, P234, DOI 10.1186/rr62; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011	51	1367	1436	3	132	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1269	1282		10.1016/j.cell.2006.02.023	http://dx.doi.org/10.1016/j.cell.2006.02.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564016	Bronze			2022-12-28	WOS:000237241400025
J	Voorhoeve, PM; le Sage, C; Schrier, M; Gillis, AJM; Stoop, H; Nagel, R; Liu, YP; van Duijse, J; Drost, J; Griekspoor, A; Zlotorynski, E; Yabuta, N; De Vita, G; Nojima, H; Looijenga, LHJ; Agami, R				Voorhoeve, PM; le Sage, C; Schrier, M; Gillis, AJM; Stoop, H; Nagel, R; Liu, YP; van Duijse, J; Drost, J; Griekspoor, A; Zlotorynski, E; Yabuta, N; De Vita, G; Nojima, H; Looijenga, LHJ; Agami, R			A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors	CELL			English	Article							MICRORNA TARGETS; DNA-DAMAGE; TREATMENT RESPONSE; LET-7 MICRORNA; CYCLE ARREST; P53; EXPRESSION; SENESCENCE; PROTEIN; RAS	Endogenous small RNAs (miRNAs) regulate gene expression by mechanisms conserved across metazoans. While the number of verified human miRNAs is still expanding, only few have been functionally annotated. To perform genetic screens for novel functions of miRNAs, we developed a library of vectors expressing the majority of cloned human miRNAs and created corresponding DNA barcode arrays. In a screen for miRNAs that cooperate with oncogenes in cellular transformation, we identified miR-372 and miR-373, each permitting proliferation and tumorigenesis of primary human cells that harbor both oncogenic RAS and active wild-type p53. These miRNAs neutralize p53-mediated CDK inhibition, possibly through direct inhibition of the expression of the tumor-suppressor LATS2. We provide evidence that these miRNAs are potential novel oncogenes participating in the development of human testicular germ cell tumors by numbing the p53 pathway, thus allowing tumorigenic growth in the presence of wild-type p53.	Netherlands Canc Inst, Div Tumour Biol, Amsterdam, Netherlands; Erasmus Univ, Med Ctr Rotterdam, Dr Daniel Denhoed Canc Ctr, Dept Pathol,Josephine Nefkens Inst, Rotterdam, Netherlands; Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, CEINGE Biotecnol Avanzate, Naples, Italy; Osaka Univ, Dept Mol Genet, Osaka, Japan	Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; CEINGE Biotecnologie Avanzate; University of Naples Federico II; Osaka University	Agami, R (corresponding author), Netherlands Canc Inst, Div Tumour Biol, Plesmanlaan 121, Amsterdam, Netherlands.	r.agami@nki.nl	Looijenga, Leendert/B-8145-2019; agami, reuven/GOG-8289-2022; De Vita, Glauco/AAH-3128-2020; Drost, Jarno/M-6964-2017; Drost, Jarno/J-9758-2012; De Vita, Gabriella/H-4422-2011	Looijenga, Leendert/0000-0002-8146-1911; De Vita, Glauco/0000-0001-6679-9474; Drost, Jarno/0000-0002-2941-6179; Drost, Jarno/0000-0002-2941-6179; De Vita, Gabriella/0000-0002-7302-1174; Agami, Reuven/0000-0002-2848-2473; Griekspoor, Alexander/0000-0003-0144-4335; Liu, Ying Poi/0000-0002-9932-718X; , Ying Poi/0000-0002-4152-9168				Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burger H, 1998, BRIT J CANCER, V77, P1562, DOI 10.1038/bjc.1998.257; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Duursma A, 2005, MOL CELL BIOL, V25, P6937, DOI 10.1128/MCB.25.16.6937-6947.2005; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kersemaekers AMF, 2002, J CLIN ONCOL, V20, P1551, DOI 10.1200/JCO.20.6.1551; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YY, 2003, COMMUN PUR APPL ANAL, V2, P1; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lutzker SG, 1996, NAT MED, V2, P804, DOI 10.1038/nm0796-804; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Mayer F, 2003, CLIN CANCER RES, V9, P767; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mostert M, 2000, LAB INVEST, V80, P1055, DOI 10.1038/labinvest.3780110; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; XU TA, 1995, DEVELOPMENT, V121, P1053; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	50	994	1086	0	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1169	1181		10.1016/j.cell.2006.02.037	http://dx.doi.org/10.1016/j.cell.2006.02.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564011	Bronze			2022-12-28	WOS:000237241400018
J	Walsh, T; Casadei, S; Coats, KH; Swisher, E; Stray, SM; Higgins, J; Roach, KC; Mandell, J; Lee, MK; Ciernikova, S; Foretova, L; Soucek, P; King, MC				Walsh, T; Casadei, S; Coats, KH; Swisher, E; Stray, SM; Higgins, J; Roach, KC; Mandell, J; Lee, MK; Ciernikova, S; Foretova, L; Soucek, P; King, MC			Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXONIC SPLICING ENHANCERS; POPULATION-BASED SAMPLE; LARGE GENOMIC DELETIONS; OVARIAN-CANCER; INHERITED MUTATIONS; PROSTATE-CANCER; COWDEN-SYNDROME; PROPHYLACTIC OOPHORECTOMY; FOLLOW-UP; GENE	Context Genetic testing for inherited mutations in BRCA1 and BRCA2 has become integral to the care of women with a severe family history of breast or ovarian cancer, but an unknown number of patients receive negative (ie, wild-type) results when they actually carry a pathogenic BRCA1 or BRCA2 mutation. Furthermore, other breast cancer genes generally are not evaluated. Objective To determine the frequency and types of undetected cancer-predisposing mutations in BRCA1, BRCA2, CHEK2, TP53, and PTEN among patients with breast cancer from high-risk families with negative (wild-type) genetic test results for BRCA1 and BRCA2. Design, Setting, and Participants Between 2002-2005, probands from 300 US families with 4 or more cases of breast or ovarian cancer but with negative (wild-type) commercial genetic test results for BRCA1 and BRCA2 were screened by multiple DNA-based and RNA-based methods to detect genomic rearrangements in BRCA1 and BRCA2 and germline mutations of all classes in CHEK2, TP53, and PTEN. Main Outcome Measures Previously undetected germline mutations in BRCA1, BRCA2, CHEK2, TP53, and PTEN that predispose to breast cancer; frequencies of these mutations among families with negative genetic test results. Results Of the 300 probands, 52 (17%) carried previously undetected mutations, including 35 (12%) with genomic rearrangements of BRCA1 or BRCA2, 14 (5%) with CHEK2 mutations, and 3 (1%) with TP53 mutations. At BRCA1 and BRCA2, 22 different genomic rearrangements were found, of sizes less than 1 kb to greater than 170 kb; of these, 14 were not previously described and all were individually rare. At CHEK2, a novel 5.6-kb genomic deletion was discovered in 2 families of Czechoslovakian ancestry. This deletion was found in 8 of 631 (1.3%) patients with breast cancer and in none of 367 healthy controls in the Czech and Slovak Republics. For all rearrangements, exact genomic breakpoints were determined and diagnostic primers validated. The 3 families with TP53 mutations included cases of childhood sarcoma or brain tumors in addition to multiple cases of breast cancer. Conclusions The mutational spectra of BRCA1 and BRCA2 include many high-penetrance, individually rare genomic rearrangements. Among patients with breast cancer and severe family histories of cancer who test negative ( wild type) for BRCA1 and BRCA2, approximately 12% can be expected to carry a large genomic deletion or duplication in one of these genes, and approximately 5% can be expected to carry a mutation in CHEK2 or TP53. Effective methods for identifying these mutations should be made available to women at high risk.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; Morgagni Pierantoni Hosp, Dept Med Oncol, Forli, Italy; Slovak Acad Sci, Canc Res Inst, Dept Canc Genet, Bratislava, Slovakia; Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; Natl Inst Publ Hlth, Ctr Occupat Dis, Prague, Czech Republic	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Slovak Academy of Sciences; Masaryk Memorial Cancer Institute; National Institute of Public Health (SZU) - Czech Republic	King, MC (corresponding author), Univ Washington, Dept Med, Box 357720, Seattle, WA 98195 USA.	mcking@u.washington.edu	Ciernikova, Sona/ABB-3569-2021; Soucek, Pavel/H-8018-2019	Soucek, Pavel/0000-0002-4294-6799; Foretova, Lenka/0000-0003-0494-2620; King, Mary-Claire/0000-0001-9426-1743; Walsh, Tom/0000-0002-8875-0310	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013160] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES13160] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Agata S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032789; Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Bogdanova N, 2005, INT J CANCER, V116, P263, DOI 10.1002/ijc.21022; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Campos Berta, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9176; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Claverie-Martin F, 2005, J HUM GENET, V50, P370, DOI 10.1007/s10038-005-0265-5; Cybulski C, 2004, AM J HUM GENET, V75, P1131, DOI 10.1086/426403; Cybulski C, 2004, CANCER RES, V64, P2677, DOI 10.1158/0008-5472.CAN-04-0341; Dong XY, 2003, AM J HUM GENET, V72, P270, DOI 10.1086/346094; Dufault MR, 2004, INT J CANCER, V110, P320, DOI 10.1002/ijc.20073; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Eisen A, 2005, J CLIN ONCOL, V23, P7491, DOI 10.1200/JCO.2004.00.7138; Eng C, 2000, J MED GENET, V37, P828, DOI 10.1136/jmg.37.11.828; Fackenthal JD, 2002, AM J HUM GENET, V71, P625, DOI 10.1086/342192; FitzGerald MG, 1998, ONCOGENE, V17, P727, DOI 10.1038/sj.onc.1201984; Foretova L, 2004, HUM MUTAT, V23, DOI 10.1002/humu.9226; Fortin J, 2005, BBA-GENE STRUCT EXPR, V1731, P57, DOI 10.1016/j.bbaexp.2005.08.011; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; Gad S, 2002, ONCOGENE, V21, P6841, DOI 10.1038/sj.onc.1205685; Gorski B, 2005, BREAST CANCER RES TR, V92, P19, DOI 10.1007/s10549-005-1409-1; Hartmann Carolin, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9291; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hendrickson BC, 2005, GENE CHROMOSOME CANC, V43, P309, DOI 10.1002/gcc.20189; Hirsh-Yechezkel G, 2003, GYNECOL ONCOL, V89, P494, DOI 10.1016/S0090-8258(03)00152-5; Hogervorst FBL, 2003, CANCER RES, V63, P1449; Huzarski T, 2005, BREAST CANCER RES TR, V90, P187, DOI 10.1007/s10549-004-3778-2; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Kilpivaara O, 2004, INT J CANCER, V111, P543, DOI 10.1002/ijc.20299; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Kramer JL, 2005, J CLIN ONCOL, V23, P8629, DOI 10.1200/JCO.2005.02.9199; Langston AA, 1996, NEW ENGL J MED, V334, P137, DOI 10.1056/NEJM199601183340301; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Malone KE, 2000, CANCER, V88, P1393, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1393::AID-CNCR17>3.0.CO;2-P; Mazoyer S, 2005, HUM MUTAT, V25, P415, DOI 10.1002/humu.20169; McNeil Nicole, 2004, Journal of the Association of Genetic Technologists, V30, P41; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MELJERSHELJBOER H, 2001, NEW ENGL J MED, V345, P159; Montagna M, 2003, HUM MOL GENET, V12, P1055, DOI 10.1093/hmg/ddg120; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; Nelson HD, 2005, ANN INTERN MED, V143, P362, DOI 10.7326/0003-4819-143-5-200509060-00012; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; Nichols KE, 2001, CANCER EPIDEM BIOMAR, V10, P83; Oldenburg RA, 2003, CANCER RES, V63, P8153; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Pettigrew C, 2005, BREAST CANCER RES, V7, pR929, DOI 10.1186/bcr1324; Rapakko K, 2001, BRIT J CANCER, V84, P116, DOI 10.1054/bjoc.2000.1530; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Sarmanova J, 2004, EUR J HUM GENET, V12, P848, DOI 10.1038/sj.ejhg.5201249; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Schutte M, 2003, AM J HUM GENET, V72, P1023, DOI 10.1086/373965; Seppala EH, 2003, BRIT J CANCER, V89, P1966, DOI 10.1038/sj.bjc.6601425; Shaag A, 2005, HUM MOL GENET, V14, P555, DOI 10.1093/hmg/ddi052; Sorek R, 2004, MOL CELL, V14, P221, DOI 10.1016/S1097-2765(04)00181-9; STARINK TM, 1986, CLIN GENET, V29, P222; Susani L, 2004, HUM MUTAT, V24, P225, DOI 10.1002/humu.20076; Tournier I, 2004, CANCER RES, V64, P8143, DOI 10.1158/0008-5472.CAN-04-2467; Tsou HC, 1997, AM J HUM GENET, V61, P1036, DOI 10.1086/301607; Unger MA, 2000, AM J HUM GENET, V67, P841, DOI 10.1086/303076; Warner E, 2005, LANCET, V365, P1747, DOI 10.1016/S0140-6736(05)66520-8; Woodward AM, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.027961; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109	68	469	508	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1379	1388		10.1001/jama.295.12.1379	http://dx.doi.org/10.1001/jama.295.12.1379			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551709	Bronze			2022-12-28	WOS:000236157700015
J	Raviglione, MC; Uplekar, MW				Raviglione, MC; Uplekar, MW			WHO's new Stop TB Strategy	LANCET			English	Editorial Material									WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland	World Health Organization	Raviglione, MC (corresponding author), WHO, Stop TB Dept, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	raviglionem@who.int		RAVIGLIONE, Mario/0000-0002-9331-2067				Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Hopewell PC, 2005, JAMA-J AM MED ASSOC, V293, P2790, DOI 10.1001/jama.293.22.2790; Kumaresan J, 2004, INT J TUBERC LUNG D, V8, P130; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; *STOP TB PARTN WHO, 2006, WHOHTMSTB200635; *WHO, 2004, WKLY EPIDEMIOL REC, V1, P6; *WHO, 2003, WHOCDSTB2003312; *WHO, 2004, WHOHTMSTB200428; World Health Organization, 2005, WHA582005REC1 WHO; World Health Organization, 2005, WHOHTMTB2006361; World Health Organization, 2005, WHOHTMTB2005351; 2005, LANCET, V5, P366	12	290	300	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					952	955		10.1016/S0140-6736(06)68392-X	http://dx.doi.org/10.1016/S0140-6736(06)68392-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546550				2022-12-28	WOS:000236242100038
J	Akbari, O; Faul, JL; Hoyte, EG; Berry, GJ; Wahlstrom, J; Kronenberg, M; DeKruyff, RH; Umetsu, DT				Akbari, O; Faul, JL; Hoyte, EG; Berry, GJ; Wahlstrom, J; Kronenberg, M; DeKruyff, RH; Umetsu, DT			CD4+ invariant T-cell-receptor plus natural killer T cells in bronchial asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							V-ALPHA-14 NKT CELLS; ANTIGEN PRESENTATION; AIRWAY INFLAMMATION; ATOPIC ASTHMA; RECOGNITION; SARCOIDOSIS; IL-13; HYPERREACTIVITY; REQUIREMENT; CYTOKINES	Background: Bronchial asthma is associated with an inflammatory process that is characterized by the presence in the airways of large numbers of CD4+ T cells producing interleukin-4 and interleukin-13. However, the CD4 antigen is expressed not only by class II major histocompatibility complex (MHC)-restricted CD4+ T cells, but also by a newly identified subgroup of T cells, CD1d-restricted natural killer T cells. These cells express a conserved (invariant) T-cell receptor and have a potent immunoregulatory function. Because mouse models of allergic asthma indicate that natural killer T cells are required for the development of allergen-induced airway hyperreactivity, we hypothesized that natural killer T cells play an important role in human asthma. Methods: We used CD1d-tetramers, antibodies specific for natural killer T cells, as well as reverse-transcriptase-polymerase-chain-reaction analysis of the invariant T-cell receptor of natural killer T cells to assess the frequency and distribution of natural killer T cells in the lungs and in the circulating blood of 14 patients with asthma. Results: About 60 percent of the pulmonary CD4+CD3+ cells in patients with moderate-to-severe persistent asthma were not class II MHC-restricted CD4+ T cells but, rather, natural killer T cells. The natural killer T cells expressed an invariant T-cell receptor and produced type 2 helper cytokines. In contrast, the CD4+ T cells found in the lungs of patients with sarcoidosis were conventional CD4+CD3+ T cells, not natural killer T cells. Conclusions: Together with studies in mice indicating a requirement for natural killer T cells in the development of allergen-induced airway hyperreactivity, our results strongly suggest that CD4+ natural killer T cells play a prominent pathogenic role in human asthma.	Harvard Univ, Sch Med, Childrens Hosp Boston, Karp Res Labs,Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Stanford Univ, Dept Med, Div Pulm & Crit Care, Stanford, CA 94305 USA; Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; Karolinska Inst, Div Resp Med, Stockholm, Sweden; Karolinska Inst, Dept Med, Stockholm, Sweden; La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Stanford University; Stanford University; Stanford University; Karolinska Institutet; Karolinska Institutet; La Jolla Institute for Immunology	Umetsu, DT (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Karp Res Labs,Div Immunol, 1 Blackfan Cir,Rm 10127, Boston, MA 02115 USA.	dale.umetsu@childrens.harvard.edu		Berry, Gerald/0000-0002-6176-2629	NATIONAL CANCER INSTITUTE [R01CA052511] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026322, P01AI054456] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA52511] Funding Source: Medline; NCRR NIH HHS [M01-RR00070] Funding Source: Medline; NHLBI NIH HHS [R01 HL69507] Funding Source: Medline; NIAID NIH HHS [R01 AI26322, P01AI054456] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agea E, 2005, J EXP MED, V202, P295, DOI 10.1084/jem.20050773; Agostini C, 2002, CURR OPIN PULM MED, V8, P435, DOI 10.1097/00063198-200209000-00016; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DJUKANOVIC R, 1991, AM REV RESPIR DIS, V143, P772, DOI 10.1164/ajrccm/143.4_Pt_1.772; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Faul JL, 1999, AM J RESP CRIT CARE, V160, P1457, DOI 10.1164/ajrccm.160.5.9812027; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Holt PG, 1999, NATURE, V402, pB12; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Naidenko OV, 1999, J EXP MED, V190, P1069, DOI 10.1084/jem.190.8.1069; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Shigehara K, 2001, J IMMUNOL, V166, P642, DOI 10.4049/jimmunol.166.1.642; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Wahlstrom J, 2001, AM J RESP CRIT CARE, V163, P115, DOI 10.1164/ajrccm.163.1.9906071; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Yang S, 2005, J IMMUNOL, V175, P4914, DOI 10.4049/jimmunol.175.8.4914; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; Ziegenhagen MW, 2003, J INTERN MED, V253, P18, DOI 10.1046/j.1365-2796.2003.01074.x	35	317	342	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1117	1129		10.1056/NEJMoa053614	http://dx.doi.org/10.1056/NEJMoa053614			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540612				2022-12-28	WOS:000235981700005
J	Asch, SM; Kerr, EA; Keesey, J; Adams, JL; Setodji, CM; Malik, S; McGlynn, EA				Asch, SM; Kerr, EA; Keesey, J; Adams, JL; Setodji, CM; Malik, S; McGlynn, EA			Who is at greatest risk for receiving poor-quality health care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-CARE; RACIAL-DIFFERENCES; PHYSICIAN COMMUNICATION; HEART-FAILURE; UNITED-STATES; BENEFICIARIES; INSURANCE; ADULTS; BLACK	Background: American adults frequently do not receive recommended health care. The extent to which the quality of health care varies among sociodemographic groups is unknown. Methods: We used data from medical records and telephone interviews of a random sample of people living in 12 communities to assess the quality of care received by those who had made at least one visit to a health care provider during the previous two years. We constructed aggregate scores from 439 indicators of the quality of care for 30 chronic and acute conditions and for disease prevention. We estimated the rates at which members of different sociodemographic subgroups received recommended care, with adjustment for the number of chronic and acute conditions, use of health care services, and other sociodemographic characteristics. Results: Overall, participants received 54.9 percent of recommended care. Even after adjustment, there was only moderate variation in quality-of-care scores among sociodemographic subgroups. Women had higher overall scores than men (56.6 percent vs. 52.3 percent, P<0.001), and participants below the age of 31 years had higher scores than those over the age of 64 years (57.5 percent vs. 52.1 percent, P<0.001). Blacks (57.6 percent) and Hispanics (57.5 percent) had slightly higher scores than whites (54.1 percent, P<0.001 for both comparisons). Those with annual household incomes over $50,000 had higher scores than those with incomes of less than $15,000 (56.6 percent vs. 53.1 percent, P<0.001). Conclusions: The differences among sociodemographic subgroups in the observed quality of health care are small in comparison with the gap for each subgroup between observed and desirable quality of health care. Quality-improvement programs that focus solely on reducing disparities among sociodemographic subgroups may miss larger opportunities to improve care.	RAND Hlth, Santa Monica, CA 90407 USA; Vet Affairs Greater Los Angeles Hlth Care Syst, Los Angeles, CA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA; Vet Affairs Ann Arbor Hlth Care Syst, Vet Affairs Ctr Practice Management & Outcomes Re, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; Univ Calif Irvine, Dept Med, Div Cardiol, Irvine, CA 92717 USA	RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of California System; University of California Irvine	Asch, SM (corresponding author), RAND Hlth, Santa Monica, CA 90407 USA.		Adams, John/ABE-6170-2021; Young, Alexander/A-1523-2009; Wilkins, Thad/G-2541-2010; Greiver, Michelle/N-8764-2015	Young, Alexander/0000-0002-9367-9213; Greiver, Michelle/0000-0001-8957-0285				Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Asch SM, 2000, JAMA-J AM MED ASSOC, V284, P2325, DOI 10.1001/jama.284.18.2325; Asch SM, 2001, ARCH INTERN MED, V161, P1329, DOI 10.1001/archinte.161.10.1329; ASCH SM, 2003, JAMA-J AM MED ASSOC, V289, P1782; Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; Brook R. H., 1994, AHCPR PUB, P59; Collins TC, 2002, MED CARE, V40, P27; Escarce JJ, 2004, AM J PUBLIC HEALTH, V94, P1795, DOI 10.2105/AJPH.94.10.1795; Ferris TG, 2002, J GEN INTERN MED, V17, P905, DOI 10.1046/j.1525-1497.2002.20230.x; Gordon HS, 2002, MED CARE, V40, P824, DOI 10.1097/00005650-200209000-00011; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Higashi T, 2005, ANN INTERN MED, V143, P274, DOI 10.7326/0003-4819-143-4-200508160-00008; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; Kemper P, 1996, INQUIRY-J HEALTH CAR, V33, P195; Kerr EA, 2004, HEALTH AFFAIR, V23, P247, DOI 10.1377/hlthaff.23.3.247; KERR EA, 2000, RAND PUBLICATION; Kossovsky MP, 2004, EUR J PUBLIC HEALTH, V14, P123, DOI 10.1093/eurpub/14.2.123; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Luck J, 2002, BMJ-BRIT MED J, V325, P679, DOI 10.1136/bmj.325.7366.679; Malin JL, 2000, CANCER-AM CANCER SOC, V88, P701, DOI 10.1002/(SICI)1097-0142(20000201)88:3<701::AID-CNCR29>3.0.CO;2-V; Marshall M, 2003, MEASURING GEN PRACTI; McBean AM, 2003, DIABETES CARE, V26, P3250, DOI 10.2337/diacare.26.12.3250; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; SAS Institute, 1999, SAS US GUID VERS 8 2; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Smith JL, 2001, MED CARE, V39, P910, DOI 10.1097/00005650-200109000-00002; Thompson HS, 2004, PREV MED, V38, P209, DOI 10.1016/j.ypmed.2003.09.041; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; WEISSMAN JS, 1992, JAMA-J AM MED ASSOC, V268, P2388, DOI 10.1001/jama.268.17.2388	32	351	355	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1147	1156		10.1056/NEJMsa044464	http://dx.doi.org/10.1056/NEJMsa044464			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021KI	16540615	Bronze			2022-12-28	WOS:000235981700008
J	Nakatsu, T; Ichiyama, S; Hiratake, J; Saldanha, A; Kobashi, N; Sakata, K; Kato, H				Nakatsu, T; Ichiyama, S; Hiratake, J; Saldanha, A; Kobashi, N; Sakata, K; Kato, H			Structural basis for the spectral difference in luciferase bioluminescence	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; FIREFLY LUCIFERASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; LIGHT; COLOR; BIOSYNTHESIS; SUPERFAMILY; SYNTHETASES; REFINEMENT	Fireflies communicate with each other by emitting yellow- green to yellow- orange brilliant light. The bioluminescence reaction, which uses luciferin, Mg- ATP and molecular oxygen to yield an electronically excited oxyluciferin species, is carried out by the enzyme luciferase. Visible light is emitted during relaxation of excited oxyluciferin to its ground state. The high quantum yield(1) of the luciferin/ luciferase reaction and the change in bioluminescence colour caused by subtle structural differences in luciferase have attracted much research interest. In fact, a single amino acid substitution in luciferase changes the emission colour from yellow- green to red(2-5). Although the crystal structure of luciferase from the North American firefly ( Photinus pyralis) has been described(6,7), the detailed mechanism for the bioluminescence colour change is still unclear(8-11). Here we report the crystal structures of wild- type and red mutant ( S286N) luciferases from the Japanese Genji- botaru ( Luciola cruciata) in complex with a high- energy intermediate analogue, 5' - O-[ N-( dehydroluciferyl)-sulfamoyl] adenosine ( DLSA). Comparing these structures to those of the wild- type luciferase complexed with AMP plus oxyluciferin ( products) reveals a significant conformational change in the wild- type enzyme but not in the red mutant. This conformational change involves movement of the hydrophobic side chain of Ile 288 towards the benzothiazole ring of DLSA. Our results indicate that the degree of molecular rigidity of the excited state of oxyluciferin, which is controlled by a transient movement of Ile 288, determines the colour of bioluminescence during the emission reaction.	RIKEN Harima Inst SPring8, Kinet Crystallog Res Team, Membrane Dynam Res Grp, Mikazuki, Hyogo 6795148, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Chem Res Inst, Kyoto 6110011, Japan	RIKEN; Kyoto University; Kyoto University	Kato, H (corresponding author), RIKEN Harima Inst SPring8, Kinet Crystallog Res Team, Membrane Dynam Res Grp, 1-1-1 Kouto, Mikazuki, Hyogo 6795148, Japan.	katohiro@pharm.kyoto-u.ac.jp		Kato, Hiroaki/0000-0002-5993-4532; Nakatsu, Toru/0000-0002-9582-4023				Adachi S, 2001, NUCL INSTRUM METH A, V467, P711, DOI 10.1016/S0168-9002(01)00472-7; BABBITT PC, 1992, BIOCHEMISTRY-US, V31, P5594, DOI 10.1021/bi00139a024; Branchini BR, 2005, BIOORG MED CHEM LETT, V15, P3860, DOI 10.1016/j.bmcl.2005.05.115; Branchini BR, 2004, BIOCHEMISTRY-US, V43, P7255, DOI 10.1021/bi036175d; Branchini BR, 2003, BIOCHEMISTRY-US, V42, P10429, DOI 10.1021/bi030099x; Branchini BR, 1999, BIOCHEMISTRY-US, V38, P13223, DOI 10.1021/bi991181o; Chang KH, 1997, BIOCHEMISTRY-US, V36, P15650, DOI 10.1021/bi971262p; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; DeLano W.L, PYMOL MOL GRAPHICS S; DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O; DELUCA M, 1976, ADV ENZYMOL RAMB, V44, P37; DELUCA M, 1969, BIOCHEMISTRY-US, V8, P160, DOI 10.1021/bi00829a023; Franks NP, 1998, BIOPHYS J, V75, P2205, DOI 10.1016/S0006-3495(98)77664-7; KAJIYAMA N, 1991, PROTEIN ENG, V4, P691, DOI 10.1093/protein/4.6.691; Kleinkauf H, 1996, EUR J BIOCHEM, V236, P335, DOI 10.1111/j.1432-1033.1996.00335.x; Kumasaka T, 2002, STRUCTURE, V10, P1205, DOI 10.1016/S0969-2126(02)00830-4; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Mamaev SV, 1996, J AM CHEM SOC, V118, P7243, DOI 10.1021/ja961053c; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McCapra F., 1994, BIOLUMINESCENCE CHEM, P387; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; ROUSSEL A, 1996, TURBO FRODO MANUAL; SELIGER HH, 1960, ARCH BIOCHEM BIOPHYS, V88, P136, DOI 10.1016/0003-9861(60)90208-3; UEDA H, 1991, BIOCHIM BIOPHYS ACTA, V1080, P126, DOI 10.1016/0167-4838(91)90138-P; WHITE EH, 1969, J AM CHEM SOC, V91, P2178, DOI 10.1021/ja01036a093	29	429	443	6	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					372	376		10.1038/nature04542	http://dx.doi.org/10.1038/nature04542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541080				2022-12-28	WOS:000235997600060
J	Ding, EL; Song, YQ; Malik, VS; Liu, SM				Ding, EL; Song, YQ; Malik, VS; Liu, SM			Sex differences of endogenous sex hormones and risk of type 2 diabetes - A systematic review and meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POLYCYSTIC-OVARY-SYNDROME; BODY-FAT DISTRIBUTION; ESTROGEN REPLACEMENT THERAPY; IMPAIRED GLUCOSE-TOLERANCE; NECROSIS-FACTOR-ALPHA; HEALTHY ADULT MEN; MIDDLE-AGED MEN; BINDING GLOBULIN; POSTMENOPAUSAL WOMEN; INSULIN-RESISTANCE	Context Inconsistent data suggest that endogenous sex hormones may have a role in sex-dependent etiologies of type 2 diabetes, such that hyperandrogenism may increase risk in women while decreasing risk in men. Objective To systematically assess studies evaluating the association of plasma levels of testosterone, sex hormone-binding globulin (SHBG), and estradiol with risk of type 2 diabetes. Data Sources Systematic search of EMBASE and MEDLINE (1966-June 2005) for English-language articles using the keywords diabetes, testosterone, sex-hormone-binding-globulin, and estradiol; references of retrieved articles; and direct author contact. Study Selection From 80 retrieved articles, 43 prospective and cross-sectional studies were identified, comprising 6974 women and 6427 men and presenting relative risks (RRs) or hormone levels for cases and controls. Data Extraction Information on study design, participant characteristics, hormone levels, and risk estimates were independently extracted by 2 investigators using a standardized protocol. Data Synthesis Results were pooled using random effects and meta-regressions. Cross-sectional studies indicated that testosterone level was significantly lower in men with type 2 diabetes (mean difference, -76.6 ng/dL; 95% confidence interval [CI], -99.4 to -53.6) and higher in women with type 2 diabetes compared with controls (mean difference, 6.1 ng/dL; 95% CI, 2.3 to 10.1) (P<.001 for sex difference). Similarly, prospective studies showed that men with higher testosterone levels (range, 449.6-605.2 ng/dL) had a 42% lower risk of type 2 diabetes (RR, 0.58; 95% CI, 0.39 to 0.87), while there was suggestion that testosterone increased risk in women (P=.06 for sex difference). Cross-sectional and prospective studies both found that SHBG was more protective in women than in men (P<.01 for sex difference for both), with prospective studies indicating that women with higher SHBG levels (>60 vs <= 60 nmol/L) had an 80% lower risk of type 2 diabetes (RR, 0.20; 95% CI, 0.12 to 0.30), while men with higher SHBG levels (>28.3 vs <= 28.3 nmol/L) had a 52% lower risk ( RR, 0.48; 95% CI, 0.33 to 0.69). Estradiol levels were elevated among men and postmenopausal women with diabetes compared with controls (P=.007). Conclusions This systematic review indicates that endogenous sex hormones may differentially modulate glycemic status and risk of type 2 diabetes in men and women. High testosterone levels are associated with higher risk of type 2 diabetes in women but with lower risk in men; the inverse association of SHBG with risk was stronger in women than in men.	Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Program Genom & Nutr, Los Angeles, CA 90095 USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Liu, SM (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Program Genom & Nutr, CHS 73-265,Box 951772,650 Charles E Young Dr S, Los Angeles, CA 90095 USA.	siminliu@ucla.edu	Liu, Simin/GSN-4159-2022; Ding, Eric L./K-1118-2019; Liu, Simin/I-3689-2014	Ding, Eric L./0000-0002-5881-8097; Liu, Simin/0000-0003-2098-3844	NCI NIH HHS [CA009001-29] Funding Source: Medline; NIDDK NIH HHS [DK066401-02] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066401] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abate N, 2002, J CLIN ENDOCR METAB, V87, P4522, DOI 10.1210/jc.2002-020567; ANDERSSON B, 1994, DIABETES CARE, V17, P405, DOI 10.2337/diacare.17.5.405; ANDO S, 1984, J ENDOCRINOL INVEST, V7, P21, DOI 10.1007/BF03348370; BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539; Bener A, 2001, MATURITAS, V40, P53, DOI 10.1016/S0378-5122(01)00227-4; Bhasin S, 2000, JAMA-J AM MED ASSOC, V283, P763, DOI 10.1001/jama.283.6.763; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; BIRKELAND KI, 1993, J CLIN ENDOCR METAB, V76, P275, DOI 10.1210/jc.76.2.275; Bjorntorp P, 1996, INT J OBESITY, V20, P291; Bouman A, 2004, AM J REPROD IMMUNOL, V52, P19, DOI 10.1111/j.1600-0897.2004.00177.x; Boyanov M A, 2003, Aging Male, V6, P1; CHANG TC, 1994, GERONTOLOGY, V40, P260; Chearskul Supornpim, 2000, Journal of the Medical Association of Thailand, V83, P266; Christodoulakos G, 2005, MATURITAS, V50, P321, DOI 10.1016/j.maturitas.2004.08.002; Ciampelli M, 1999, METABOLISM, V48, P167, DOI 10.1016/S0026-0495(99)90028-8; Corrales JJ, 2004, METABOLISM, V53, P666, DOI 10.1016/j.metabol.2003.12.016; DAUBRESSE JC, 1978, DIABETES METAB, V4, P233; Defay R, 1998, INT J OBESITY, V22, P927, DOI 10.1038/sj.ijo.0800697; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUNN JF, 1981, J CLIN ENDOCR METAB, V53, P58, DOI 10.1210/jcem-53-1-58; Egger M, 2001, SYSTEMATIC REV HLTH; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Endre T, 1996, J HUM HYPERTENS, V10, P755; Ford ES, 2005, AM J EPIDEMIOL, V161, P1102, DOI 10.1093/aje/kwi148; Gambineri A, 2004, DIABETES, V53, P2353, DOI 10.2337/diabetes.53.9.2353; Gambineri A, 2003, J ENDOCRINOL INVEST, V26, P629, DOI 10.1007/BF03347020; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Golden SH, 2004, AM J EPIDEMIOL, V160, P540, DOI 10.1093/aje/kwh250; Goodman-Gruen D, 2000, DIABETES CARE, V23, P912, DOI 10.2337/diacare.23.7.912; GoodmanGruen D, 1997, DIABETES CARE, V20, P645, DOI 10.2337/diacare.20.4.645; Gyllenborg J, 2001, METABOLISM, V50, P882, DOI 10.1053/meta.2001.24916; Haffner SM, 1996, AM J EPIDEMIOL, V143, P889; HAFFNER SM, 1992, METABOLISM, V41, P278, DOI 10.1016/0026-0495(92)90271-B; HAFFNER SM, 1994, METABOLISM, V43, P599, DOI 10.1016/0026-0495(94)90202-X; HAFFNER SM, 1993, J CLIN ENDOCR METAB, V77, P56, DOI 10.1210/jc.77.1.56; HAFFNER SM, 1994, DIABETES, V43, P212, DOI 10.2337/diabetes.43.2.212; Haffner SM, 1996, HORM RES, V45, P233, DOI 10.1159/000184794; Hammes A, 2005, CELL, V122, P751, DOI 10.1016/j.cell.2005.06.032; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Ibanez L, 2002, J CLIN ENDOCR METAB, V87, P2870, DOI 10.1210/jc.87.6.2870; Jang YS, 2001, AM J CLIN NUTR, V73, P68; Jayagopal V, 2004, DIABETES CARE, V27, P278, DOI 10.2337/diacare.27.1.278; Kalish GM, 2003, J CLIN ENDOCR METAB, V88, P1646, DOI 10.1210/jc.2002-021375; Kalme T, 2005, J CLIN ENDOCR METAB, V90, P1550, DOI 10.1210/jc.2004-0762; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; Key TJ, 2003, CANCER EPIDEM BIOMAR, V12, P1457; Khaw K T, 1992, Ann Epidemiol, V2, P675, DOI 10.1016/1047-2797(92)90012-F; KHAW KT, 1991, CLIN SCI, V80, P199, DOI 10.1042/cs0800199; Korhonen S, 2001, AM J OBSTET GYNECOL, V184, P289, DOI 10.1067/mob.2001.109596; Laaksonen DE, 2004, DIABETES CARE, V27, P1036, DOI 10.2337/diacare.27.5.1036; Lee CC, 2004, METABOLISM, V53, P507, DOI 10.1016/j.metabol.2003.10.018; Lin HY, 2005, DIABETES, V54, P1717, DOI 10.2337/diabetes.54.6.1717; LINDSTEDT G, 1991, DIABETES, V40, P123, DOI 10.2337/diabetes.40.1.123; Liu PY, 2003, J CLIN ENDOCR METAB, V88, P3605, DOI 10.1210/jc.2003-030236; Lovejoy JC, 1996, J CLIN ENDOCR METAB, V81, P2198, DOI 10.1210/jc.81.6.2198; Malkin CJ, 2004, J CLIN ENDOCR METAB, V89, P3313, DOI 10.1210/jc.2003-031069; Malkin CJ, 2004, HEART, V90, P871, DOI 10.1136/hrt.2003.021121; MARIN P, 1995, J CLIN ENDOCR METAB, V80, P239, DOI 10.1210/jc.80.1.239; MARIN P, 1992, INT J OBESITY, V16, P991; Marin P, 1995, OBES RES, V3, pS609, DOI 10.1002/j.1550-8528.1995.tb00233.x; Matsumoto AM, 2004, J CLIN ENDOCR METAB, V89, P520, DOI 10.1210/jc.2003-032175; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P525, DOI 10.1210/jc.2003-030680; Muller M, 2005, J CLIN ENDOCR METAB, V90, P2618, DOI 10.1210/jc.2004-1158; O'Sullivan AJ, 1998, J CLIN INVEST, V102, P1035, DOI 10.1172/JCI2773; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; Okubo M, 2000, DIABETES RES CLIN PR, V47, P71, DOI 10.1016/S0168-8227(99)00106-0; Ozata M, 2001, OBES RES, V9, P662, DOI 10.1038/oby.2001.90; Pagotto U, 2003, J CLIN ENDOCR METAB, V88, P4139, DOI 10.1210/jc.2003-030554; Park KH, 2001, INT J GYNECOL OBSTET, V74, P261, DOI 10.1016/S0020-7292(01)00442-8; PASQUALI R, 1991, METABOLISM, V40, P101, DOI 10.1016/0026-0495(91)90199-7; Pasquali R, 1997, METABOLISM, V46, P526, DOI 10.1016/S0026-0495(97)90189-X; PHILLIPS GB, 1993, METABOLISM, V42, P116, DOI 10.1016/0026-0495(93)90181-M; PHILLIPS GB, 1977, P NATL ACAD SCI USA, V74, P1729, DOI 10.1073/pnas.74.4.1729; Phillips GB, 2000, DIABETES CARE, V23, P74, DOI 10.2337/diacare.23.1.74; PHILLIPS GB, 1984, AM J MED, V76, P1041, DOI 10.1016/0002-9343(84)90855-6; Pietschmann P, 2003, EXP GERONTOL, V38, P1119, DOI 10.1016/S0531-5565(03)00189-X; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Pitteloud N, 2005, J CLIN ENDOCR METAB, V90, P2636, DOI 10.1210/jc.2004-2190; REBUFFESCRIVE M, 1991, INT J OBESITY, V15, P791; Rinaldi S, 2002, CANCER EPIDEM BIOMAR, V11, P1065; Rincon J, 1996, DIABETES, V45, P615, DOI 10.2337/diabetes.45.5.615; Rodin DA, 1998, CLIN ENDOCRINOL, V49, P91, DOI 10.1046/j.1365-2265.1998.00492.x; Rosmond R, 2003, J INTERN MED, V254, P386, DOI 10.1046/j.1365-2796.2003.01205.x; Rosner W, 1999, J STEROID BIOCHEM, V69, P481, DOI 10.1016/S0960-0760(99)00070-9; Rosner W, 1997, J CLIN ENDOCR METAB, V82, P2014, DOI 10.1210/jcem.82.6.9999; Rosner W, 2001, J CLIN ENDOCR METAB, V86, P2903, DOI 10.1210/jc.86.6.2903; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; SEIDELL JC, 1990, METABOLISM, V39, P897, DOI 10.1016/0026-0495(90)90297-P; SEMPLE CG, 1988, DIABETIC MED, V5, P122, DOI 10.1111/j.1464-5491.1988.tb00957.x; SHAHWAN MM, 1978, DIABETOLOGIA, V15, P13, DOI 10.1007/BF01219321; SIMON D, 1992, DIABETOLOGIA, V35, P173, DOI 10.1007/BF00402551; Simon D, 2001, DIABETES CARE, V24, P2149, DOI 10.2337/diacare.24.12.2149; SMALL M, 1987, Q J MED, V64, P617; Smith JC, 2001, J CLIN ENDOCR METAB, V86, P4261, DOI 10.1210/jc.86.9.4261; SMITH MR, 2006, J CLIN ENDOCRIN 0124; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; Sowers M, 2003, J CLIN ENDOCR METAB, V88, P4904, DOI 10.1210/jc.2003-030350; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stamataki KE, 1996, CLIN ENDOCRINOL, V45, P615, DOI 10.1046/j.1365-2265.1996.00795.x; Stellato RK, 2000, DIABETES CARE, V23, P490, DOI 10.2337/diacare.23.4.490; Stoney RM, 1998, DIABETES CARE, V21, P828, DOI 10.2337/diacare.21.5.828; Strandberg TE, 2003, AM J CARDIOL, V92, P212, DOI 10.1016/S0002-9149(03)00542-3; Svartberg J, 2004, DIABETES METAB, V30, P29, DOI 10.1016/S1262-3636(07)70086-1; TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210/jc.75.4.1092; Tibblin G, 1996, DIABETES, V45, P1605, DOI 10.2337/diabetes.45.11.1605; Tok EC, 2004, J REPROD MED, V49, P746; Toprak S, 2001, HORM RES, V55, P65, DOI 10.1159/000049972; Tsai EC, 2004, DIABETES CARE, V27, P861, DOI 10.2337/diacare.27.4.861; Tsai EC, 2000, INT J OBESITY, V24, P485, DOI 10.1038/sj.ijo.0801183; *US CDCP, 2005, NAT DIAB FACT SHEET; Valverde AM, 1998, ENDOCRINOLOGY, V139, P1229, DOI 10.1210/en.139.3.1229; van der Merwe MT, 2001, J CLIN ENDOCR METAB, V86, P3296, DOI 10.1210/jc.86.7.3296; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Vehkavaara S, 2001, THROMB HAEMOSTASIS, V85, P619, DOI 10.1055/s-0037-1615643; Vermeulen A, 1996, J CLIN ENDOCR METAB, V81, P1821, DOI 10.1210/jc.81.5.1821; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Walker KZ, 1999, DIABETES CARE, V22, P555, DOI 10.2337/diacare.22.4.555; Wang C, 2000, J CLIN ENDOCR METAB, V85, P2839, DOI 10.1210/jc.85.8.2839; Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287; Weerakiet S, 2001, INT J GYNECOL OBSTET, V75, P177, DOI 10.1016/S0020-7292(01)00477-5; WILKE TJ, 1987, CLIN CHEM, V33, P1372; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; Zietz, 2000, Eur J Intern Med, V11, P322, DOI 10.1016/S0953-6205(00)00122-9	129	957	1012	1	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2006	295	11					1288	1299		10.1001/jama.295.11.1288	http://dx.doi.org/10.1001/jama.295.11.1288			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021GV	16537739				2022-12-28	WOS:000235972600027
J	Parry, J; Mathers, J; Stevens, A; Parsons, A; Lilford, R; Spurgeon, P; Thomas, H				Parry, J; Mathers, J; Stevens, A; Parsons, A; Lilford, R; Spurgeon, P; Thomas, H			Admissions processes for five year medical courses at English schools: review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RELIABILITY; PERFORMANCE	Objective To describe the current. methods Used by English medical schools to identify prospective medical students for admission to the five degree course. Design Review study including documentary analysis mid interviews with admissions tutors. Setting All schools (n = 22) participating in the national expansion of medical schools programme in England. Results Though there is some commonality across schools with regard to the criteria used to select future students (academic ability coupled with a "well rounded" personality demonstrated by motivation for Medicine, extracurricular interests, and experience of team working and leadership skills) the processes used vary substantially. Some schools do not interview; some shortlist for interview only on predicted academic performance while those that shortlist oil a wider range use various techniques and tools to do so. Some schools use information presented in the candidate's personal statement and referee's report while others Ignore this because of concerns over bias. A few schools seek additional information from supplementary questionnaires filled in by the candidates. Once students are shortlisted, interviews vary in terms of length, panel composition, structure, content, and scoring methods. Conclusion The stated criteria for admission to medical school show commonality. Universities differ greatly, however, in how they apply these criteria and in the methods used to select students. Different approaches to admissions should be developed and tested.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Hlth Impact Assessment Res Unit, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Hlth Serv Management Ctr, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Sch Educ, Birmingham B15 2TT, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Parry, J (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.	J.M.Parry.1@bham.ac.uk	Mathers, Jonathan/ABE-1164-2021	Mathers, Jonathan/0000-0001-6651-6286; Stevens, Andrew/0000-0003-2079-3397				Admissions to Higher Education Steering Group, 2004, FAIR ADM HIGH ED REC; Albanese MA, 2003, ACAD MED, V78, P313, DOI 10.1097/00001888-200303000-00016; COEBERGH J, 2003, STUDENT BMJ, V11, P138; ESMAIL A, 1995, BRIT MED J, V310, P501, DOI 10.1136/bmj.310.6978.501; Ferguson E, 2003, BRIT MED J, V326, P429, DOI 10.1136/bmj.326.7386.429; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; FERGUSON F, 2003, BRIT MED J, V326, P429; Kreiter CD, 2004, ADV HEALTH SCI EDUC, V9, P147, DOI 10.1023/B:AHSE.0000027464.22411.0f; Lumb AB, 2004, MED EDUC, V38, P1002, DOI 10.1111/j.1365-2929.2004.01912.x; Lumsden MA, 2005, MED EDUC, V39, P258, DOI 10.1111/j.1365-2929.2005.02087.x; McManus IC, 2005, BRIT MED J, V331, P555, DOI 10.1136/bmj.331.7516.555; McManus IC, 2003, BRIT MED J, V327, P139, DOI 10.1136/bmj.327.7407.139; McManus IC, 1998, BRIT MED J, V317, P1111; Nicholson S, 2005, BRIT MED J, V331, P559, DOI 10.1136/bmj.331.7516.559; Salvatori P, 2001, ADV HEALTH SCI EDUC, V6, P159, DOI 10.1023/A:1011489618208	15	76	76	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1005	1008		10.1136/bmj.38768.590174.55	http://dx.doi.org/10.1136/bmj.38768.590174.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16543300	Green Published, Bronze			2022-12-28	WOS:000237403100016
J	Bottle, A; Aylin, P				Bottle, A; Aylin, P			Mortality associated with delay in operation after hip fracture: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NECK	Objective To estimate the number of deaths and readmissions associated with delay in Operation after femoral fracture. Design Analysis of inpatient hospital episode statistics. Setting NHS hospital trusts in England with at least 100 admissions for fractured neck Of femur during the study period. Patients People aged >= 65 admitted from home with fractured neck of femur and discharged between April 2001 and March 2004. Main outcome measures In hospital mortality and emergency readmission within 28 days. Results There were 129 522 admissions for fractured neck Of femur in 151 trusts With 18 508 deaths in hospital (14.3%). Delay in operation was associated with all increased risk of death in hospital, which was reduced but persisted after adjustment for comorbidity. For all deaths in hospital, the odds ratio for more than one clay's delay relative to one day or less was 1.27 (95% confidence interval 1.23 to 1.32) after adjustment for comorbidity. The proportion with more than two days' delay ranged from 1.1% to 62.4% between trusts. If death rates in patients with at most one day's delay had been repeated throughout all 151 trusts in this study, there would have been all average of 581 (478 to 683) fewer total deaths per year (9.4% of the total). There was little evidence of all association between delay and emergency readmission. Conclusions Delay in operation is associated With all increased risk of death but nit readmission after a fractured neck of femur, even with adjustment for comorbidity, and there is wide variation between trusts.	Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, Dept Primary Care & Social Med, London W6 8RP, England	Imperial College London	Bottle, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, Dept Primary Care & Social Med, London W6 8RP, England.	robert.bottle@imperial.ac.uk	Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743				Cooper C, 1996, OSTEOPOROSIS NEW PER, P1; COOPER G, 1996, OSTEOPOROSIS NEW PER, P1; Cree M, 2000, J AM GERIATR SOC, V48, P283, DOI 10.1111/j.1532-5415.2000.tb02647.x; *DEP ENV TRANSP RE, 2000, 31 DETR; FOX HJ, 1994, INJURY, V25, P297, DOI 10.1016/0020-1383(94)90239-9; Hansell A, 2001, J PUBLIC HEALTH MED, V23, P51, DOI 10.1093/pubmed/23.1.51; *HEALTHC COMM, PERF IND 2005; *HLTHC COMM, 2005, PERF IND; HOLMBERG S, 1987, CLIN ORTHOP RELAT R, P42; HOLT EM, 1994, INJURY, V25, P91, DOI 10.1016/0020-1383(94)90109-0; Lyons Anthony R., 1997, American Journal of Medicine, V103, p51S, DOI 10.1016/S0002-9343(97)90027-9; Lyons AR, 1997, AM J MED, V103, P51; McKee M, 1993, Qual Health Care, V2, P104, DOI 10.1136/qshc.2.2.104; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; ROGERS FB, 1995, J TRAUMA, V39, P261, DOI 10.1097/00005373-199508000-00012; *ROYAL COLL PHYS, 1989, FRACT NECK FEM PREV; Turner P, 1997, AUST NZ J SURG, V67, P126, DOI 10.1111/j.1445-2197.1997.tb01917.x; WOLFINGER RD, 1999, 287 SAS I	18	301	322	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					947	950		10.1136/bmj.38790.468519.55	http://dx.doi.org/10.1136/bmj.38790.468519.55			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16554334	Green Published, Bronze			2022-12-28	WOS:000237143900017
J	Hoyos, CD; Agudelo, PA; Webster, PJ; Curry, JA				Hoyos, CD; Agudelo, PA; Webster, PJ; Curry, JA			Deconvolution of the factors contributing to the increase in global hurricane intensity	SCIENCE			English	Article							METEOROLOGY	To better understand the change in global hurricane intensity since 1970, we examined the joint distribution of hurricane intensity with variables identified in the literature as contributing to the intensification of hurricanes. We used a methodology based on information theory, isolating the trend from the shorter-term natural modes of variability. The results show that the trend of increasing numbers of category 4 and 5 hurricanes for the period 1970-2004 is directly linked to the trend in sea-surface temperature; other aspects of the tropical environment, although they influence shorter-term variations in hurricane intensity, do not contribute substantially to the observed global trend.	Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Hoyos, CD (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	choyos@eas.gatech.edu	Hoyos, Carlos/C-2915-2008; Agudelo, Paula/C-4432-2008	Hoyos, Carlos/0000-0002-9010-9784; 				CURRY JA, UNPUB; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2005, NATURE, V438, pE13, DOI 10.1038/nature04427; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; HIRSCH RM, 1982, WATER RESOUR RES, V18, P107, DOI 10.1029/WR018i001p00107; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Landsea CW, 2005, NATURE, V438, pE11, DOI 10.1038/nature04477; LIGHTHILL J, 1994, B AM METEOROL SOC, V75, P2147; Pielke RA, 2005, B AM METEOROL SOC, V86, P1571, DOI 10.1175/BAMS-86-11-1571; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shapiro LJ, 1998, J CLIMATE, V11, P578, DOI 10.1175/1520-0442(1998)011<0578:ASSTAT>2.0.CO;2; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Trenberth K, 2005, SCIENCE, V308, P1753, DOI 10.1126/science.1112551; WEBSTER PJ, 2005, 85 AM MET SOC ANN M	15	224	236	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2006	312	5770					94	97		10.1126/science.1123560	http://dx.doi.org/10.1126/science.1123560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029SJ	16543416				2022-12-28	WOS:000236584400038
J	Schanz, S; Ulmer, A				Schanz, S; Ulmer, A			A medical mystery - Gangrene and cutaneous nodules	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Tubingen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Schanz, S (corresponding author), Univ Tubingen, D-72076 Tubingen, Germany.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1515	1515		10.1056/NEJMicm040933	http://dx.doi.org/10.1056/NEJMicm040933			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16598048				2022-12-28	WOS:000236539000010
J	Griffiths, R				Griffiths, R			CNEP and research governance	LANCET			English	Editorial Material									Fac Publ Hlth, London NW1 4LB, England		Griffiths, R (corresponding author), Fac Publ Hlth, London NW1 4LB, England.	President@fph.org.uk						Hey E, 2006, LANCET, V367, P1032, DOI 10.1016/S0140-6736(06)68445-6; *NHS EX W MIDL REG, 2000, REP REV RES FRAM N S; Telford K, 2006, LANCET, V367, P1080, DOI 10.1016/S0140-6736(06)68475-4; UK Department of Health, 2000, ORG MEM REP EXP GROU	4	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1037	1038		10.1016/S0140-6736(06)68448-1	http://dx.doi.org/10.1016/S0140-6736(06)68448-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581387				2022-12-28	WOS:000236673200008
J	Harnden, A				Harnden, A			Avian influenza - Preparing for the pandemic - Dealing with uncertainty: perspective from primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk						*DEP HLTH, 2005, UK HLTH DEP INFL PAN; World Health Organization, CUM NUMB CONF HUM CA	2	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 1	2006	332	7544					791	792		10.1136/bmj.332.7544.791	http://dx.doi.org/10.1136/bmj.332.7544.791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032JA	16575089	Green Published			2022-12-28	WOS:000236769500033
J	Smeeth, L; Cook, C; Thomas, S; Hall, AJ; Hubbard, R; Vallance, P				Smeeth, L; Cook, C; Thomas, S; Hall, AJ; Hubbard, R; Vallance, P			Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting	LANCET			English	Article							VENOUS THROMBOEMBOLISM; MYOCARDIAL-INFARCTION; DISEASE; VACCINATION; POPULATION; PREVENTION; MEDENOX; TRIAL	Background Acute infection increases the risk of arterial cardiovascular events, but effects on venous thromboembolic disease are less well established. Our aim was to investigate whether acute infections transiently increase the risk of venous thromboembolism. Methods We used the self-controlled case-series method to study the risk of first deep vein thrombosis (DVT) (n=7278) and first pulmonary embolism (PE) (n=3755) after acute respiratory and urinary tract infections. Data were obtained from records from general practices who had registered patients with the UK's Health Improvement Network database between 1987 and 2004. Findings The risks of DVT and PE were significantly raised, and were highest in the first two weeks, after urinary tract infection. The incidence ratio for DVT was 2.10 (95% CI 1.56-2.82), and that for PE 2.11 (1.38-3.23). The risk gradually fell over the subsequent months, returning to the baseline value after 1 year. The risk of DVT was also higher after respiratory tract infection, but possible diagnostic misclassification precluded a reliable estimate of the risk of PE after respiratory infection. Interpretation Acute infections are associated with a transient increased risk of venous thromboembolic events in a community setting. Our results confirm that infection should be added to the list of precipitants for venous thromboembolism, and suggest a causal relation.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Univ Nottingham, Div Resp Med, Nottingham NG7 2RD, England; UCL, British Heart Fdn Labs, Ctr Clin Pharmacol, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; University of London; University College London	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	liam.smeeth@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022	MRC [G108/492] Funding Source: UKRI; Medical Research Council [G108/492] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alikhan R, 2004, ARCH INTERN MED, V164, P963, DOI 10.1001/archinte.164.9.963; Alikhan R, 2003, BLOOD COAGUL FIBRIN, V14, P341, DOI 10.1097/00001721-200306000-00004; Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430; Bhagat K, 1996, CARDIOVASC RES, V32, P822; Bhagat K, 1997, CIRCULATION, V96, P3042, DOI 10.1161/01.CIR.96.9.3042; Bourke Alison, 2004, Inform Prim Care, V12, P171; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Fowkes FJI, 2003, EUR J VASC ENDOVASC, V25, P1, DOI 10.1053/ejvs.2002.1778; Gardlund B, 1996, LANCET, V347, P1357; Koster T, 2000, LANCET, V355, P1694, DOI 10.1016/S0140-6736(00)02244-3; Kyrle PA, 2005, LANCET, V365, P1163, DOI 10.1016/S0140-6736(05)71880-8; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Lozinguez O, 2000, THROMB HAEMOSTASIS, V83, P887, DOI 10.1055/s-0037-1613938; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Melbye H, 2004, BRIT J GEN PRACT, V54, P653; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Tata LJ, 2003, THORAX, V58, P835, DOI 10.1136/thorax.58.10.835; VIRCHOW RLK, 1998, THROMBOSE EMBOLIE TH	22	321	340	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 1	2006	367	9516					1075	1079		10.1016/S0140-6736(06)68474-2	http://dx.doi.org/10.1016/S0140-6736(06)68474-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581406				2022-12-28	WOS:000236673200031
J	Juhas, P; Cherba, DM; Duxbury, PM; Punch, WF; Billinge, SJL				Juhas, P; Cherba, DM; Duxbury, PM; Punch, WF; Billinge, SJL			Ab initio determination of solid-state nanostructure	NATURE			English	Article							3-DIMENSIONAL FOURIER SYNTHESIS; MONTE-CARLO-SIMULATION; GEOMETRY OPTIMIZATION; NANOPARTICLES; DIFFRACTION; RESOLUTION; ALGORITHM; CLUSTERS	Advances in materials science and molecular biology followed rapidly from the ability to characterize atomic structure using single crystals(1-4). Structure determination is more difficult if single crystals are not available(5). Many complex inorganic materials that are of interest in nanotechnology have no periodic long-range order and so their structures cannot be solved using crystallographic methods(6). Here we demonstrate that ab initio structure solution of these nanostructured materials is feasible using diffraction data in combination with distance geometry methods. Precise, sub-angstrom resolution distance data are experimentally available from the atomic pair distribution function (PDF)(6,7). Current PDF analysis consists of structure refinement from reasonable initial structure guesses(6,7) and it is not clear, a priori, that sufficient information exists in the PDF to obtain a unique structural solution. Here we present and validate two algorithms for structure reconstruction from precise unassigned interatomic distances for a range of clusters. We then apply the algorithms to find a unique, ab initio, structural solution for C-60 from PDF data alone. This opens the door to sub-angstrom resolution structure solution of nanomaterials, even when crystallographic methods fail.	Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; Michigan State Univ, Dept Comp Sci & Engn, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Billinge, SJL (corresponding author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.	billinge@pa.msu.edu	Juhas, Pavol/A-6544-2008; Juhas, Pavol/Q-7225-2019	Juhas, Pavol/0000-0001-8751-4458; Juhas, Pavol/0000-0001-8751-4458; Billinge, Simon/0000-0002-9734-4998; duxbury, Phillip/0000-0003-4549-4764				Billinge SJL, 2004, CHEM COMMUN, P749, DOI 10.1039/b309577k; Biswas P, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.054204; Bragg WH, 1913, P R SOC LOND A-CONTA, V88, P428, DOI 10.1098/rspa.1913.0040; Cai WS, 2002, J COMPUT CHEM, V23, P427, DOI 10.1002/jcc.10029; Chupas PJ, 2003, J APPL CRYSTALLOGR, V36, P1342, DOI 10.1107/S0021889803017564; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Crippen GM, 1988, DISTANCE GEOMETRY MO; David W. I. F., 2002, STRUCTURE DETERMINAT; DEAVEN DM, 1995, PHYS REV LETT, V75, P288, DOI 10.1103/PhysRevLett.75.288; Deaven DM, 1996, CHEM PHYS LETT, V256, P195, DOI 10.1016/0009-2614(96)00406-X; Egami T, 2003, PERGAMON MATER SER, V7, pVII; Friedrich W, 1913, ANN PHYS-BERLIN, V41, P971; Gilbert B, 2004, SCIENCE, V305, P651, DOI 10.1126/science.1098454; Hartke B, 1999, J COMPUT CHEM, V20, P1752, DOI 10.1002/(SICI)1096-987X(199912)20:16<1752::AID-JCC7>3.0.CO;2-0; HENDRICKSON B, 1995, SIAM J OPTIMIZ, V5, P835, DOI 10.1137/0805040; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; McGreevy RL, 1988, MOL SIMULAT, V1, P359, DOI 10.1080/08927028808080958; Millis AJ, 1998, NATURE, V392, P147, DOI 10.1038/32348; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Page K, 2004, CHEM PHYS LETT, V393, P385, DOI 10.1016/j.cplett.2004.05.107; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Petkov V, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.092105; Soper AK, 1996, CHEM PHYS, V202, P295, DOI 10.1016/0301-0104(95)00357-6; Thorpe MF, 2002, FUNDMAT RES, P105; Wales DJ, 1999, SCIENCE, V285, P1368, DOI 10.1126/science.285.5432.1368; Wright AC, 1998, GLASS PHYS CHEM+, V24, P148; Zhang HZ, 2003, NATURE, V424, P1025, DOI 10.1038/nature01845; Zuo JM, 2003, SCIENCE, V300, P1419, DOI 10.1126/science.1083887	29	157	160	2	85	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					655	658		10.1038/nature04556	http://dx.doi.org/10.1038/nature04556			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572167				2022-12-28	WOS:000236350400040
J	Strauss, KA; Puffenberger, EG; Huentelman, MJ; Gottlieb, S; Dobrin, SE; Parod, JM; Stephan, DA; Morton, DH				Strauss, KA; Puffenberger, EG; Huentelman, MJ; Gottlieb, S; Dobrin, SE; Parod, JM; Stephan, DA; Morton, DH			Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TEMPORAL-LOBE EPILEPSY; GATED POTASSIUM CHANNEL; MYELINATED AXONS; BRAIN; PLASTICITY; CHILDHOOD; MUTATION; CASPR2; TAG-1; KV1.1	Contactin-associated protein-like 2 (CASPR2) is encoded by CNTNAP2 and clusters voltage-gated potassium channels (K(v)1.1) at the nodes of Ranvier. We report a homozygous mutation of CNTNAP2 in Old Order Amish children with cortical dysplasia, focal epilepsy, relative macrocephaly, and diminished deep-tendon reflexes. Intractable focal seizures began in early childhood, after which language regression, hyperactivity, impulsive and aggressive behavior, and mental retardation developed in all children. Resective surgery did not prevent the recurrence of seizures. Temporal-lobe specimens showed evidence of abnormalities of neuronal migration and structure, widespread astrogliosis, and reduced expression of CASPR2.	Clin Special Children, Strasburg, PA 17579 USA; Lancaster Gen Hosp, Lancaster, PA USA; Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; Translat Genom Res Inst, Phoenix, AZ 85004 USA	Translational Genomics Research Institute	Strauss, KA (corresponding author), Clin Special Children, 535 Bunker Hill Rd, Strasburg, PA 17579 USA.	kstrauss@clinicforspecialchildren.org; dstephan@tgen.org		Puffenberger, Erik/0000-0002-6388-9148				Ashcroft FM, 2000, ION CHANNELS DIS; Avery RA, 1999, EUR J NUCL MED, V26, P830, DOI 10.1007/s002590050456; Bocti C, 2003, NEUROLOGY, V60, P191, DOI 10.1212/01.WNL.0000044055.73747.9F; Crino PB, 2004, ADV EXP MED BIOL, V548, P175; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Fogarasi A, 2002, EPILEPSIA, V43, P638, DOI 10.1046/j.1528-1157.2002.46801.x; Holmes GL, 2001, PEDIATR RES, V49, P320, DOI 10.1203/00006450-200103000-00004; HONOVAR M, 2002, GREENFIELDS NEUROPAT, P899; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Luiz DM, 2001, CHILD CARE HLTH DEV, V27, P73, DOI 10.1046/j.1365-2214.2001.00158.x; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Petersson S, 2003, EUR J NEUROSCI, V18, P3231, DOI 10.1111/j.1460-9568.2003.03044.x; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Robinson R, 2004, ANN MED, V36, P89, DOI 10.1080/07853890310019952; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Wass CT, 2001, EPILEPSIA, V42, P1340, DOI 10.1046/j.1528-1157.2001.05901.x; Yamakawa K, 2005, NEUROREPORT, V16, P1, DOI 10.1097/00001756-200501190-00001; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	24	466	482	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1370	1377		10.1056/NEJMoa052773	http://dx.doi.org/10.1056/NEJMoa052773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571880				2022-12-28	WOS:000236338000006
J	Castel, H; Montianno, D; Bodenheimer, G; Levi, I; Sztarkier, I; Harman-Boehm, I				Castel, H; Montianno, D; Bodenheimer, G; Levi, I; Sztarkier, I; Harman-Boehm, I			Hodgkin's lymphoma: an obscure cause of cholestasis	LANCET			English	Editorial Material							INTRAHEPATIC CHOLESTASIS; DISEASE		Soroka Univ Med Ctr, Dept Internal Med C, IL-84101 Beer Sheva, Israel; Soroka Univ Med Ctr, Dept Haematol, IL-84101 Beer Sheva, Israel; Soroka Univ Med Ctr, Inst Pathol, IL-84101 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84101 Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Castel, H (corresponding author), Soroka Univ Med Ctr, Dept Internal Med C, POB 151, IL-84101 Beer Sheva, Israel.	castel@bgu.ac.il						Cervantes F, 1996, ANN HEMATOL, V72, P357, DOI 10.1007/s002770050186; Desilets DJ, 2001, AM J GASTROENTEROL, V96, P2257, DOI 10.1016/S0002-9270(01)02535-7; HUBSCHER SG, 1993, HEPATOLOGY, V17, P70, DOI 10.1016/0270-9139(93)90194-R; Katsanos Konstantinos H., 2002, Eur J Intern Med, V13, P132, DOI 10.1016/S0953-6205(02)00002-X; LIEBERMAN DA, 1986, J CLIN GASTROENTEROL, V8, P304, DOI 10.1097/00004836-198606000-00022	5	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					1028	1028		10.1016/S0140-6736(06)68432-8	http://dx.doi.org/10.1016/S0140-6736(06)68432-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564367				2022-12-28	WOS:000236474200033
J	Gadsby, DC; Vergani, P; Csanady, L				Gadsby, DC; Vergani, P; Csanady, L			The ABC protein turned chloride channel whose failure causes cystic fibrosis	NATURE			English	Review							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAINS; CFTR CL-CHANNEL; R-DOMAIN; ATP-BINDING; PHOSPHORYLATION SITES; P-GLYCOPROTEIN; CASSETTE TRANSPORTERS; KINASE-A; HYDROLYSIS	CFTR chloride channels are encoded by the gene mutated in patients with cystic fibrosis. These channels belong to the superfamily of ABC transporter ATPases. ATP-driven conformational changes, which in other ABC proteins fuel uphill substrate transport across cellular membranes, in CFTR open and close a gate to allow transmembrane flow of anions down their electrochemical gradient. New structural and biochemical information from prokaryotic ABC proteins and functional information from CFTR channels has led to a unifying mechanism explaining those ATP-driven conformational changes.	Rockefeller Univ, Lab Cardiac Membrane Physiol, New York, NY 10021 USA; UCL, Dept Pharmacol, London WC1E 6BT, England; Semmelweis Univ, Dept Med Biochem, H-1444 Budapest, Hungary	Rockefeller University; University of London; University College London; Semmelweis University	Gadsby, DC (corresponding author), Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10021 USA.	gadsby@rockefeller.edu	Vergani, Paola/C-2019-2008; Csanády, László/O-5784-2017	Vergani, Paola/0000-0002-5422-4662; Csanády, László/0000-0002-6547-5889	MRC [G0501200] Funding Source: UKRI; Medical Research Council [G0501200] Funding Source: Medline; NIDDK NIH HHS [R01 DK051767, R01 DK051767-10] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051767] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aleksandrov AA, 2000, J PHYSIOL-LONDON, V528, P259, DOI 10.1111/j.1469-7793.2000.00259.x; Aleksandrov AA, 1998, FEBS LETT, V431, P97, DOI 10.1016/S0014-5793(98)00713-3; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Altschuler Y, 2003, CURR OPIN CELL BIOL, V15, P423, DOI 10.1016/S0955-0674(03)00084-X; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; BERGER HA, 1993, J BIOL CHEM, V268, P2037; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen JH, 2002, J MEMBRANE BIOL, V188, P55, DOI 10.1007/s00232-001-0174-2; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Csanady L, 2005, J GEN PHYSIOL, V125, P43, DOI 10.1085/jgp.200409174; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626; Davies JC, 2005, ADV GENET, V54, P291, DOI 10.1016/S0065-2660(05)54012-4; DAWSON DC, 2003, CFTR CHLORIDE CHANNE, P1; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dousmanis AG, 2002, J GEN PHYSIOL, V119, P545, DOI 10.1085/jgp.20028594; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; DULHANTY AM, 1994, BIOCHEMISTRY-US, V33, P4072, DOI 10.1021/bi00179a036; DULHANTY AM, 1995, BIOCHEM BIOPH RES CO, V206, P207, DOI 10.1006/bbrc.1995.1029; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; GROSS CH, IN PRESS J BIOL CHEM; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; GUNDERSON KL, 1994, J BIOL CHEM, V269, P19349; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HWANG TC, 1994, P NATL ACAD SCI USA, V91, P4698, DOI 10.1073/pnas.91.11.4698; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; Kogan I, 2003, EMBO J, V22, P1981, DOI 10.1093/emboj/cdg194; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li CY, 2005, PHARMACOL THERAPEUT, V108, P208, DOI 10.1016/j.pharmthera.2005.04.004; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Mathews CJ, 1998, J MEMBRANE BIOL, V163, P55, DOI 10.1007/s002329900370; MENSE M, 2006, BIOPHYS J, V90, pA310; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Naren AP, 1999, SCIENCE, V286, P544, DOI 10.1126/science.286.5439.544; Neville DCA, 1997, PROTEIN SCI, V6, P2436; Ostedgaard LS, 1997, BIOCHEMISTRY-US, V36, P1287, DOI 10.1021/bi962174s; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; Raghuram V, 2001, P NATL ACAD SCI USA, V98, P1300, DOI 10.1073/pnas.031538898; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Randak CO, 2005, J BIOL CHEM, V280, P34385, DOI 10.1074/jbc.R500009200; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RICH DP, 1993, J BIOL CHEM, V268, P20259; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Szabo K, 1999, J BIOL CHEM, V274, P12209, DOI 10.1074/jbc.274.18.12209; TABCHARANI JA, 1993, NATURE, V366, P79, DOI 10.1038/366079a0; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; TRAVIS SM, 1993, J BIOL CHEM, V268, P15336; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Wine JJ, 2006, AM J PHYSIOL-CELL PH, V290, pC669, DOI 10.1152/ajpcell.00525.2005; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Xie JX, 2000, BIOPHYS J, V78, P1293, DOI 10.1016/S0006-3495(00)76685-9; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhang ZR, 2005, J BIOL CHEM, V280, P458, DOI 10.1074/jbc.M409626200	87	501	517	2	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2006	440	7083					477	483		10.1038/nature04712	http://dx.doi.org/10.1038/nature04712			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554808	Green Accepted			2022-12-28	WOS:000236176100045
J	Muraoka, T; Kinbara, K; Aida, T				Muraoka, T; Kinbara, K; Aida, T			Mechanical twisting of a guest by a photoresponsive host	NATURE			English	Article							CONFORMATIONAL DYNAMICS; MOLECULAR MACHINES; ROTATION; CHIRALITY; SYSTEMS; MOTION; ROTOR	Molecular analogues of a variety of mechanical devices such as shuttles, brakes, unidirectional rotors and tweezers have been created(1-11). But these 'molecular machines' have not yet been used to mechanically manipulate a second molecule in a controlled and reversible manner. Here we show that light-induced scissor-like conformational changes of one molecule(5) can give rise to mechanical twisting of a non-covalently bound guest molecule. To realize this coupling of molecular motions, we use a previously designed system(5): a ferrocene moiety with an azobenzene strap, each end of which is attached to one of the two cyclopentadienyl rings of the ferrocene unit, acts as a pivot so that photoisomerization of the strap rotates the ferrocene rings relative to each other and thereby also changes the relative position of two 'pedal' moieties attached to the ferrocene rings. We translate this effect into intermolecular coupling of motion by endowing the pedals with binding sites, which allow the host system to form a stable complex with a bidentate rotor molecule. Using circular dichroism spectroscopy, we show that the photoinduced conformational changes of the host are indeed transmitted and induce mechanical twisting of the rotor molecule. This design concept, which significantly extends the successful coupling of motion beyond the intramolecular level seen in synthetic allosteric receptors(12), might allow for the remote control of molecular events in larger interlocked molecular systems.	Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Ctr NanoBio Integrat, Bunkyo Ku, Tokyo 1138656, Japan; Japan Sci Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Kinbara, K (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	kinbara@macro.t.u-tokyo.ac.jp	Aida, Takuzo/I-9117-2012; Kinbara, Kazushi/E-6347-2017; Muraoka, Takahiro/C-6262-2017	Kinbara, Kazushi/0000-0002-5945-9612; Muraoka, Takahiro/0000-0001-6744-048X				Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; Borovkov VV, 2004, ACCOUNTS CHEM RES, V37, P449, DOI 10.1021/ar0302437; Collin JP, 2001, ACCOUNTS CHEM RES, V34, P477, DOI 10.1021/ar0001766; GARDNER AB, 1981, CHEM PHYS, V57, P453, DOI 10.1016/0301-0104(81)80224-8; Guo YM, 2004, J AM CHEM SOC, V126, P716, DOI 10.1021/ja039369p; HANAZAKI I, 1972, J AM CHEM SOC, V94, P4102, DOI 10.1021/ja00767a007; HARADA N, 1975, J AM CHEM SOC, V97, P5345, DOI 10.1021/ja00852a005; Huang XF, 2002, J AM CHEM SOC, V124, P10320, DOI 10.1021/ja020520p; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Kelly TR, 1999, NATURE, V401, P150, DOI 10.1038/43639; Kinbara K, 2005, CHEM REV, V105, P1377, DOI 10.1021/cr030071r; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Leigh DA, 2003, NATURE, V424, P174, DOI 10.1038/nature01758; Muraoka T, 2003, J AM CHEM SOC, V125, P5612, DOI 10.1021/ja034994f; REBEK J, 1980, J AM CHEM SOC, V102, P4853, DOI 10.1021/ja00534a058; SHINKAI S, 1979, TETRAHEDRON LETT, V20, P4569; Sporlein S, 2002, P NATL ACAD SCI USA, V99, P7998, DOI 10.1073/pnas.122238799; STEPHENSON DS, 1978, J MAGN RESON, V30, P625, DOI 10.1016/0022-2364(78)90291-3; Tamai N, 2000, CHEM REV, V100, P1875, DOI 10.1021/cr9800816; Tashiro K, 2000, J AM CHEM SOC, V122, P7921, DOI 10.1021/ja000356a; Wachtveitl J, 2004, BIOPHYS J, V86, P2350, DOI 10.1016/S0006-3495(04)74292-7	22	561	563	4	281	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					512	515		10.1038/nature04635	http://dx.doi.org/10.1038/nature04635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554815				2022-12-28	WOS:000236176100052
J	Rieseberg, LH; Wood, TE; Baack, EJ				Rieseberg, LH; Wood, TE; Baack, EJ			The nature of plant species	NATURE			English	Article							POSTZYGOTIC ISOLATION; PATTERNS; EVOLUTION; DIVERSITY	Many botanists doubt the existence of plant species(1-5), viewing them as arbitrary constructs of the human mind, as opposed to discrete, objective entities that represent reproductively independent lineages or 'units of evolution'. However, the discreteness of plant species and their correspondence with reproductive communities have not been tested quantitatively, allowing zoologists to argue that botanists have been overly influenced by a few 'botanical horror stories', such as dandelions, blackberries and oaks(6,7). Here we analyse phenetic and/or crossing relationships in over 400 genera of plants and animals. We show that although discrete phenotypic clusters exist in most genera (>80%), the correspondence of taxonomic species to these clusters is poor (<60%) and no different between plants and animals. Lack of congruence is caused by polyploidy, asexual reproduction and over-differentiation by taxonomists, but not by contemporary hybridization. Nonetheless, crossability data indicate that 70% of taxonomic species and 75% of phenotypic clusters in plants correspond to reproductively independent lineages (as measured by postmating isolation), and thus represent biologically real entities. Contrary to conventional wisdom(8), plant species are more likely than animal species to represent reproductively independent lineages.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Rieseberg, LH (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lriesebe@indiana.edu	Rieseberg, Loren H/B-3591-2013; Wood, Troy/F-7302-2010	Rieseberg, Loren H/0000-0002-2712-2417; 	NIGMS NIH HHS [R01 GM059065-06] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059065] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Bachmann K, 1998, THEOR BIOSCI, V117, P213; BAKER HG, 1953, SYM SOC EXP BIOL, V7, P114; Berlin B., 1974, PRINCIPLES TZELTAL P, DOI [10.1016/C2013-0-07678-5, DOI 10.1016/C2013-0-07678-5]; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; DIAMOND JM, 1992, NATURE, V360, P627, DOI 10.1038/360627a0; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; Fisher R. A., 1954, P84; GRANT V, 1957, SPECIES PROBLEM, P38; Gray A.P., 1972, MAMMALIAN HYBRIDS CH; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Levin D. A., 2000, OX ECOL EV; LEVIN DA, 1979, SCIENCE, V204, P381, DOI 10.1126/science.204.4391.381; MAYR E, 1992, AM J BOT, V79, P222, DOI 10.2307/2445111; MAYR E, 1982, GROWTH BIOL THROUGHT; MCDADE LA, 1982, SYST BOT, V7, P13, DOI 10.2307/2418649; MCDADE LA, 1995, SYST BOT, V20, P606, DOI 10.2307/2419813; Mishler BD, 1999, SPECIES, P307; MISHLER BD, 1982, SYST ZOOL, V31, P491, DOI 10.2307/2413371; Morjan CL, 2004, MOL ECOL, V13, P1341, DOI 10.1111/j.1365-294X.2004.02164.x; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; Raven P. H., 1986, MODERN ASPECTS SPECI, P11; Ridley M., 1996, EVOLUTION; Russell ST, 2003, ANN ZOOL FENN, V40, P321; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Sokal RR, 1963, PRINCIPLES NUMERICAL; Wang JX, 2004, CONSERV BIOL, V18, P1139, DOI 10.1111/j.1523-1739.2004.00075.x; Whitlock MC, 2003, GENETICS, V164, P767	30	187	203	8	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					524	527		10.1038/nature04402	http://dx.doi.org/10.1038/nature04402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554818	Green Accepted			2022-12-28	WOS:000236176100055
J	Ross, LF				Ross, LF			Ethical considerations related to pregnancy in transplant recipients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RENAL-TRANSPLANTATION; LIVER-TRANSPLANTATION; OUTCOMES; CHILDREN; RETRANSPLANTATION; IMMUNOSUPPRESSION; EXPERIENCE; MOTHERS		Univ Chicago, Dept Pediat, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA	University of Chicago	Ross, LF (corresponding author), Univ Chicago, Dept Pediat, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA.							Armenti V T, 2000, Clin Transpl, P123; Armenti Vincent T, 2002, Clin Transpl, P121; Armenti VT, 1998, DRUG SAFETY, V19, P219, DOI 10.2165/00002018-199819030-00005; Arsan A, 1997, TRANSPLANT P, V29, P2479, DOI 10.1016/S0041-1345(97)00457-0; Bar J, 1996, ISRAEL J MED SCI, V32, P1183; BARTHOLER E, 1993, FAMILY BONDS ADOPTIO; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Dickenson D., 1995, Acta Geneticae Medicae et Gemellologiae, V44, P75; *FRENCH TRANSPL SO, 1997, TRANSPLANT P, V29, P2455; GHAHRAMANI N, 1993, TRANSPLANT P, V25, P2190; Glannon W, 1998, J MED PHILOS, V23, P31, DOI 10.1076/jmep.23.1.31.2595; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; HOPE T, 1995, BRIT MED J, V310, P1455, DOI 10.1136/bmj.310.6992.1455; Huddy CLJ, 2001, ARCH DIS CHILD-FETAL, V85, pF23, DOI 10.1136/fn.85.1.F23; Jain AB, 2003, TRANSPLANTATION, V76, P827, DOI 10.1097/01.TP.0000084823.89528.89; JONES HW, 1993, NEW ENGL J MED, V329, P1710, DOI 10.1056/NEJM199312023292307; KASS NE, 1994, ACTA PAEDIATR, V83, P95, DOI 10.1111/j.1651-2227.1994.tb13344.x; Le Ray C, 2004, OBSTET GYNECOL, V103, P1091, DOI 10.1097/01.AOG.0000124986.32858.ba; Lessan-Pezeshki M, 2002, NEPHROL DIAL TRANSPL, V17, P703, DOI 10.1093/ndt/17.5.703; Mahowald Mary Briody, 1993, WOMEN CHILDREN HLTH; Miranda CTBC, 2002, TRANSPLANT P, V34, P506, DOI 10.1016/S0041-1345(02)02612-X; MOSS AH, 1991, JAMA-J AM MED ASSOC, V265, P1295, DOI 10.1001/jama.265.10.1295; MURRAY JE, 1963, NEW ENGL J MED, V269, P341, DOI 10.1056/NEJM196308152690704; Nagy S, 2003, OBSTET GYNECOL, V102, P121, DOI 10.1016/S0029-7844(03)00369-7; Ourahma S, 1998, TRANSPLANT P, V30, P2808, DOI 10.1016/S0041-1345(98)00818-5; PAHL MV, 1993, TRANSPL P, V25, P2727; Rawls J., 1971, THEORY JUSTICE; Robertson JA., 1994, CHILDREN CHOICE FREE; Salooja N, 2001, LANCET, V358, P271, DOI 10.1016/S0140-6736(01)05482-4; Sano T, 2002, NEPHROL DIAL TRANSPL, V17, P50, DOI 10.1093/ndt/17.1.50; Sgro MD, 2002, TERATOLOGY, V65, P5, DOI 10.1002/tera.1092; Tendron A, 2002, PEDIATR NEPHROL, V17, P121, DOI 10.1007/s00467-001-0776-z; Thompson BC, 2003, QJM-INT J MED, V96, P837, DOI 10.1093/qjmed/hcg142; UBEL PA, 1995, HEALTH POLICY, V34, P145, DOI 10.1016/0168-8510(95)00714-4; UBEL PA, 1993, JAMA-J AM MED ASSOC, V270, P2469, DOI 10.1001/jama.270.20.2469; Veatch R. M., 2000, TRANSPLANTATION ETHI; Willis FR, 2000, J PAEDIATR CHILD H, V36, P230, DOI 10.1046/j.1440-1754.2000.00500.x	37	39	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1313	1316		10.1056/NEJMsb041648	http://dx.doi.org/10.1056/NEJMsb041648			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554536				2022-12-28	WOS:000236164200014
J	Ueno, Y; Yamada, K; Yoshida, N; Maruyama, S; Isozaki, Y				Ueno, Y; Yamada, K; Yoshida, N; Maruyama, S; Isozaki, Y			Evidence from fluid inclusions for microbial methanogenesis in the early Archaean era	NATURE			English	Article							WESTERN-AUSTRALIA; ISOTOPE FRACTIONATION; WARRAWOONA GROUP; NORTH-POLE; CARBON; GEOCHEMISTRY; SIGNATURES; REDUCTION; EVOLUTION; HYDROGEN	Methanogenic microbes may be one of the most primitive organisms(1), although it is uncertain when methanogens first appeared on Earth. During the Archaean era (before 2.5 Gyr ago), methanogens may have been important in regulating climate, because they could have provided sufficient amounts of the greenhouse gas methane to mitigate a severely frozen condition that could have resulted from lower solar luminosity(2) during these times. Nevertheless, no direct geological evidence has hitherto been available in support of the existence of methanogens in the Archaean period, although circumstantial evidence is available in the form of similar to 2.8-Gyr-old carbon-isotope-depleted kerogen(3). Here we report crushing extraction and carbon isotope analysis of methane-bearing fluid inclusions in similar to 3.5-Gyr-old hydrothermal precipitates from Pilbara craton, Australia. Our results indicate that the extracted fluids contain microbial methane with carbon isotopic compositions of less than -56 parts per thousand included within original precipitates. This provides the oldest evidence of methanogen (>3.46 Gyr ago), pre-dating previous geochemical evidence by about 700 million years.	Tokyo Inst Technol, Res Ctr Evolving Earth & Planet, Meguro Ku, Tokyo 1528551, Japan; Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Tokyo Inst Technol, Dept Environm Sci & Technol, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Tokyo Inst Technol, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Japan Sci & Technol Corp, SORST Project, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Tokyo Institute of Technology; Tokyo Institute of Technology; Japan Science & Technology Agency (JST); University of Tokyo	Ueno, Y (corresponding author), Tokyo Inst Technol, Res Ctr Evolving Earth & Planet, Meguro Ku, Tokyo 1528551, Japan.	yueno@depe.titech.ac.jp	Yamaichi, Takeshi/A-5595-2010; Yoshida, Naohiro/A-8335-2010; Isozaki, Yukio/A-1806-2009; Maruyama, Shigenori/C-8288-2009; Ueno, Yuichiro/A-9959-2014	Yoshida, Naohiro/0000-0003-0454-3849; Isozaki, Yukio/0000-0002-3596-581X; Ueno, Yuichiro/0000-0002-9095-4742				AWRAMIK SM, 1983, PRECAMBRIAN RES, V20, P357, DOI 10.1016/0301-9268(83)90081-5; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; BUICK R, 1990, SEDIMENTOLOGY, V37, P247, DOI 10.1111/j.1365-3091.1990.tb00958.x; BUICK R, 1990, Palaios, V5, P441, DOI 10.2307/3514837; Charlou JL, 2002, CHEM GEOL, V191, P345, DOI 10.1016/S0009-2541(02)00134-1; CLAYTON C, 1991, MAR PETROL GEOL, V8, P232, DOI 10.1016/0264-8172(91)90010-X; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Hayes J. M., 1994, EARLY LIFE EARTH, P220; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Kasting JF, 2003, ANNU REV ASTRON ASTR, V41, P429, DOI 10.1146/annurev.astro.41.071601.170049; Kitajima K, 2001, J METAMORPH GEOL, V19, P581; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; McCollom TM, 2001, GEOCHIM COSMOCHIM AC, V65, P3769, DOI 10.1016/S0016-7037(01)00655-X; Nijman W, 1999, PRECAMBRIAN RES, V95, P245; Pinti DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2301, DOI 10.1016/S0016-7037(01)00590-7; RICHET P, 1977, ANNU REV EARTH PL SC, V5, P65, DOI 10.1146/annurev.ea.05.050177.000433; Roedder E., 1984, REV MINERALOGY, V12; SCHOELL M, 1983, AAPG BULL, V67, P2225; Shen YA, 2001, NATURE, V410, P77, DOI 10.1038/35065071; THORPE RI, 1992, U W AUSTR PUBLICATIO, V9, P395; Ueno Y, 2004, GEOCHIM COSMOCHIM AC, V68, P573, DOI 10.1016/S0016-7037(03)00462-9; Ueno Y, 2001, INT GEOL REV, V43, P196, DOI 10.1080/00206810109465008; Valentine DL, 2004, GEOCHIM COSMOCHIM AC, V68, P1571, DOI 10.1016/j.gca.2003.10.012; Van Kranendonk MJ, 2004, GEOCHEM-EXPLOR ENV A, V4, P253, DOI 10.1144/1467-7873/04-205; WELHAN JA, 1988, CHEM GEOL, V71, P183, DOI 10.1016/0009-2541(88)90114-3; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	27	322	346	3	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					516	519		10.1038/nature04584	http://dx.doi.org/10.1038/nature04584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554816				2022-12-28	WOS:000236176100053
J	Anderson, K; Jacobson, JS; Heitjan, DF; Zivin, JG; Hershman, D; Neugut, AI; Grann, VR				Anderson, K; Jacobson, JS; Heitjan, DF; Zivin, JG; Hershman, D; Neugut, AI; Grann, VR			Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation	ANNALS OF INTERNAL MEDICINE			English	Article							SURGICAL ADJUVANT BREAST; BILATERAL PROPHYLACTIC MASTECTOMY; ORAL-CONTRACEPTIVE USE; OVARIAN-CANCER RISKS; DECISION-ANALYSIS; INHERITED MUTATIONS; MEDICARE PAYMENTS; LIFE EXPECTANCY; TAMOXIFEN; OOPHORECTOMY	Background: For BRCA1 or BRCA2 mutation carriers, decision analysis indicates that prophylactic surgery or chemoprevention leads to better survival than surveillance alone. Objective: To evaluate the cost-effectiveness of the preventive strategies that are available to unaffected women carrying a single BRCA1 or BRCA2 mutation with high cancer penetrance. Design: Markov modeling with Monte Carlo simulations and probabilistic sensitivity analyses. Data Sources: Breast and ovarian cancer incidence and mortality rates, preference ratings, and costs derived from the literature; the Surveillance, Epidemiology, and End Results (SEER) Program; and the Health Care Financing Administration (now the Centers for Medicare & Medicaid Services). Target Population: Unaffected carriers of a single BRCA1 or BRCA2 mutation 35 to 50 years of age. Time Horizon: Lifetime. Perspective: Health policy, societal. Interventions: Tamoxifen, oral contraceptives, bilateral salpingo-oophorectomy, mastectomy, both surgeries, or surveillance. Outcome Measures: Cost-effectiveness. Results of Base-Case Analysis: For mutation carriers 35 years of age, both surgeries (prophylactic bilateral mastectomy and oophorectomy) had an incremental cost-effectiveness ratio over oophorectomy alone of $2352 per life-year for BRCA1 and $100 per life-year for BRCA2. With quality adjustment, oophorectomy dominated all other strategies for BRCA1 and had an incremental cost-effectiveness ratio of $2281 per life-year for BRCA2. Results of Sensitivity Analysis: Older age at intervention increased the cost-effectiveness of prophylactic mastectomy for BRCA1 mutation carriers to $73 755 per life-year. Varying the penetrance, mortality rates, costs, discount rates, and preferences had minimal effects on outcomes. Limitations: Results are dependent on the accuracy of model assumptions. Conclusion: On the basis of this model, the most cost-effective strategies for BRCA mutation carriers, with and without quality adjustment, were oophorectomy alone and oophorectomy and mastectomy, respectively.	Columbia Univ, Joseph L Mailman Sch Publ Hlth, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; New York Presbyterian Hosp, New York, NY USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	Columbia University; NewYork-Presbyterian Hospital; University of Pennsylvania	Grann, VR (corresponding author), Columbia Univ, Joseph L Mailman Sch Publ Hlth, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, Room 734,722 W 168th St, New York, NY 10032 USA.	VRG2@columbia.edu	Hershman, Dawn/AAG-2114-2020; Zivin, Joshua Graff/ABF-1697-2020		NATIONAL CANCER INSTITUTE [K05CA089155, K07CA095597] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA-95597, K05 CA89155] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133; Armstrong K, 2004, J CLIN ONCOL, V22, P1045, DOI 10.1200/JCO.2004.06.090; Bass EB, 1997, MED DECIS MAKING, V17, P324, DOI 10.1177/0272989X9701700309; BECK JR, 1983, MED DECIS MAKING, V3, P419, DOI 10.1177/0272989X8300300403; Brown ML, 2002, MED CARE, V40, P104; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; CARSON JL, 1992, NEW ENGL J MED, V326, P1240, DOI 10.1056/NEJM199205073261902; Chappuis PO, 1999, ANN ONCOL, V10, P1163, DOI 10.1023/A:1008301314812; Chappuis PO, 2001, J NATL CANCER I, V93, P152, DOI 10.1093/jnci/93.2.152-a; Clement PB, 2002, ADV ANAT PATHOL, V9, P145, DOI 10.1097/00125480-200205000-00001; COUCH FJ, 1998, GENETIC BASIS HUMAN, P549; Cuzick J, 2002, LANCET, V360, P817; DeVita VT, 1997, CANC PRINCIPLES PRAC; Easton DF, 2004, SCIENCE, V306, P2187; EDDY DM, 1990, ANN INTERN MED, V113, P214, DOI 10.7326/0003-4819-113-3-214; Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980; Farmer RDT, 1998, AM J OBSTET GYNECOL, V179, pS78, DOI 10.1053/ob.1998.v179.a92634; Fireman BH, 1997, HEALTH CARE FINANC R, V18, P51; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fisher B, 1999, J CLIN ONCOL, V17, P1632, DOI 10.1200/JCO.1999.17.5.1632; Gold MR, 1996, COST EFFECTIVENESS H; Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101; Grann VR, 1998, J CLIN ONCOL, V16, P979, DOI 10.1200/JCO.1998.16.3.979; Grann VR, 1999, CANCER J, V5, P283; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; *HARV SCH PUBL HLT, 2005, CAT PREF SCOR COST E; Hershman D, 2002, J CLIN ONCOL, V20, P9, DOI 10.1200/JCO.20.1.9; Kaleli S, 2002, EUR J OBSTET GYN R B, V101, P204, DOI 10.1016/S0301-2115(01)00529-2; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lawrence WF, 2001, CANCER EPIDEM BIOMAR, V10, P475; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Matloff ET, 2000, J CLIN ONCOL, V18, P2484, DOI 10.1200/JCO.2000.18.12.2484; Meijers-Heijboer EJ, 2000, LANCET, V355, P2015, DOI 10.1016/S0140-6736(00)02347-3; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Meijers-Heijboer H, 2003, J CLIN ONCOL, V21, P1675, DOI 10.1200/JCO.2003.09.052; Milne RL, 2005, CANCER EPIDEM BIOMAR, V14, P350, DOI 10.1158/1055-9965.EPI-04-0376; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; *NAT CANC I DIV CA, 2001, SEER CANC STAT REV P; *NAT COMPR CANC NE, 2006, GEN FAM HIGH RISK AS, V1; Oestreicher N, 2005, CANCER, V104, P2054, DOI 10.1002/cncr.21464; Osin P P, 1999, Breast Cancer Res, V1, P36, DOI 10.1186/bcr11; POTOSKY AL, 1993, MED CARE, V31, P732; Powles T, 1998, LANCET, V352, P98; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; RILEY GF, 1995, MED CARE, V33, P828, DOI 10.1097/00005650-199508000-00007; Robson ME, 2004, BREAST CANCER RES, V6, pR8, DOI 10.1186/bcr658; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Schrag D, 1997, NEW ENGL J MED, V336, P1465, DOI 10.1056/NEJM199705153362022; Schwartz PE, 2001, OBSTET GYN CLIN N AM, V28, P637, DOI 10.1016/S0889-8545(05)70226-6; Secker-Walker RH, 1999, J NATL CANCER I, V91, P702, DOI 10.1093/jnci/91.8.702; Swisher Elizabeth, 2003, Curr Treat Options Oncol, V4, P105, DOI 10.1007/s11864-003-0011-1; Tengs TO, 1998, MED DECIS MAKING, V18, P365, DOI 10.1177/0272989X9801800402; *THOMS PDR, 2004, 2004 DRUG TOP RED BO; *US BUR LAB STAT, 2004, CONS PRIC IND ALL UR; van Oostrom I, 2003, J CLIN ONCOL, V21, P3867, DOI 10.1200/JCO.2003.10.100; van Roosmalen MS, 2002, J CLIN ONCOL, V20, P2092, DOI 10.1200/jco.2002.08.035; Verhoog LC, 1998, LANCET, V351, P316, DOI 10.1016/S0140-6736(97)07065-7; Verhoog LC, 2000, J CLIN ONCOL, V18, p119S; Veronesi U, 1998, LANCET, V352, P93; Weinstein M C, 1983, Obstet Gynecol Surv, V38, P445, DOI 10.1097/00006254-198308000-00001; Whittemore AS, 2004, BRIT J CANCER, V91, P1911, DOI 10.1038/sj.bjc.6602239; Wickerham DL, 2002, J CLIN ONCOL, V20, P2758, DOI 10.1200/JCO.2002.20.11.2758; 2001, DRG GUIDEBOOK COMPRE	70	132	134	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					397	406		10.7326/0003-4819-144-6-200603210-00006	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549852				2022-12-28	WOS:000236251800003
J	Sharp, D				Sharp, D			Meloxicam to prevent rabies?	LANCET			English	Editorial Material							DICLOFENAC; VULTURES		The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							Agarwal N, 2004, TROP DOCT, V34, P76, DOI 10.1177/004947550403400205; Meteyer CU, 2005, J WILDLIFE DIS, V41, P707, DOI 10.7589/0090-3558-41.4.707; Pain DJ, 2003, CONSERV BIOL, V17, P661, DOI 10.1046/j.1523-1739.2003.01740.x; Shultz S, 2004, P ROY SOC B-BIOL SCI, V271, pS458, DOI 10.1098/rsbl.2004.0223; Sudarshan M. K., 2001, Journal of Communicable Diseases, V33, P245; Swan G, 2006, PLOS BIOL, V4, P395, DOI 10.1371/journal.pbio.0040066	6	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					887	888		10.1016/S0140-6736(06)68361-X	http://dx.doi.org/10.1016/S0140-6736(06)68361-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546526				2022-12-28	WOS:000236242100010
J	Steffen, LM; Nettleton, JA				Steffen, LM; Nettleton, JA			Carbohydrates: how low can you go?	LANCET			English	Editorial Material							VEGETABLES; DISEASE; ATKINS; FRUIT; DIET; RISK		Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA	University of Minnesota System; University of Minnesota Twin Cities	Steffen, LM (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55454 USA.	steffen@epi.umn.edu		Steffen, Lyn M/0000-0002-4053-6729				[Anonymous], 2005, US DIET GUID AM; Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Chen TY, 2006, LANCET, V367, P958, DOI 10.1016/S0140-6736(06)68394-3; Cummings S, 2002, J AM DIET ASSOC, V102, P1145, DOI 10.1016/S0002-8223(02)90255-5; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; FREEDMAN M, 2001, OBESITY REV S1, V9, P1, DOI DOI 10.1038/0BY.2001.113; Malin AS, 2003, INT J CANCER, V105, P413, DOI 10.1002/ijc.11088; Metges CC, 2000, J NUTR, V130, P886, DOI 10.1093/jn/130.4.886; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; Nutrition and Food Security Programme WHO Regional Office for Europe, 2003, FOOD BAS DIET GUID W; Samaha FF, 2003, NEW ENGL J MED, V348, P2074, DOI 10.1056/NEJMoa022637; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383; *USDA, MY PYR GOV STEPS HLT	13	9	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					880	881		10.1016/S0140-6736(06)68357-8	http://dx.doi.org/10.1016/S0140-6736(06)68357-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546522				2022-12-28	WOS:000236242100006
J	Gohlich, UB; Chiappe, LM				Gohlich, UB; Chiappe, LM			A new carnivorous dinosaur from the Late Jurassic Solnhofen archipelago	NATURE			English	Article							FEATHERED DINOSAURS; NORTHEASTERN CHINA; THEROPOD DINOSAUR; YIXIAN FORMATION; PROTOFEATHERS; EVOLUTION; BIRDS	Small Late Jurassic theropod dinosaurs are rare worldwide. In Europe these carnivorous dinosaurs are represented primarily by only two skeletons of Compsognathus(1,2), neither of which is well preserved. Here we describe a small new theropod dinosaur from the Late Jurassic period of Schamhaupten in southern Germany(3,4). Being exquisitely preserved and complete from the snout to the distal third of the tail, the new fossil is the best- preserved predatory, non- avian dinosaur in Europe. It possesses a suite of characters that support its identification as a basal coelurosaur. A cladistic analysis indicates that the new taxon is closer to maniraptorans than to tyrannosauroids, grouping it with taxa often considered to be compsognathids. Large portions of integument are preserved along its tail. The absence of feathers or feather- like structures in a fossil phylogenetically nested within feathered theropods(5,6) indicates that the evolution of these integumentary structures might be more complex than previously thought.	Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA; Univ Munich, Dept Geo & Environm Sci, Sect Paleontol, D-80333 Munich, Germany	University of Munich	Chiappe, LM (corresponding author), Nat Hist Museum Los Angeles Cty, Dinosaur Inst, 900 Exposit Blvd, Los Angeles, CA 90007 USA.	chiappe@nhm.org		Chiappe, Luis/0000-0001-9661-0601; Gohlich, Ursula/0000-0002-9553-3488				Barthel K.W., 1990, SOLNHOFEN STUDY MESO; BIDAR A, 1972, EXTR ANN MUS HIST NA, V1, P3; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Chiappe LM, 2002, ANNU REV ECOL SYST, V33, P91, DOI 10.1146/annurev.ecolsys.33.010802.150517; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Czerkas S. A., 1997, ENCY DINOSAURS, P669; Dal Sasso C, 1998, NATURE, V392, P383; Frey E., 1988, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), P1; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P428, DOI 10.1007/s00114-003-0448-x; Naish Darren, 2004, Historical Biology, V16, P57, DOI 10.1080/08912960410001674200; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; OSTROM J H, 1978, Zitteliana, V4, P73; PEYER K, 2004, THESIS MUSEUM NATL H; Renesto Silvio, 1997, Archaeopteryx, V15, P27; Sanz JL, 1997, SCIENCE, V276, P1543, DOI 10.1126/science.276.5318.1543; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; VIOHL G, 2005, ZITTELIANA B, V26, P27; Viohl Guenter, 1999, Archaeopteryx, V17, P15; Weishampel DB., 2004, DINOSAURIA; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855	28	67	72	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					329	332		10.1038/nature04579	http://dx.doi.org/10.1038/nature04579			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541071	Green Published			2022-12-28	WOS:000235997600051
J	Stricker, H				Stricker, H			Clotting in the air	LANCET			English	Editorial Material							DEEP-VEIN THROMBOSIS; ACTIVATED PROTEIN-C; LONG-HAUL FLIGHTS; VENOUS THROMBOSIS; REPLACEMENT THERAPY; RANDOMIZED TRIAL; TRAVEL; RISK; COAGULATION; PREVENTION		Osped Carita, Dept Internal Med Angiol, CH-6600 Locarno, Switzerland		Stricker, H (corresponding author), Osped Carita, Dept Internal Med Angiol, CH-6600 Locarno, Switzerland.	hans.stricker@eoc.ch						Boccalon H, 2005, J THROMB HAEMOST, V3, P1539, DOI 10.1111/j.1538-7836.2005.01469.x; Cesarone MR, 2002, ANGIOLOGY, V53, P1, DOI 10.1177/000331970205300101; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; Dalen JE, 2003, ARCH INTERN MED, V163, P2674, DOI 10.1001/archinte.163.22.2674; Ferrari E, 1999, CHEST, V115, P440, DOI 10.1378/chest.115.2.440; Hoibraaten E, 2001, BRIT J HAEMATOL, V115, P415, DOI 10.1046/j.1365-2141.2001.03111.x; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; Kelman CW, 2003, BRIT MED J, V327, P1072, DOI 10.1136/bmj.327.7423.1072; KOSTER T, 1993, LANCET, V342, P1503, DOI 10.1016/S0140-6736(05)80081-9; Kraaijenhagen RA, 2000, LANCET, V356, P1492, DOI 10.1016/S0140-6736(00)02878-6; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Rosendaal FR, 2002, BRIT J HAEMATOL, V116, P851, DOI 10.1046/j.0007-1048.2002.03356.x; Schreijer AJM, 2006, LANCET, V367, P832, DOI 10.1016/S0140-6736(06)68339-6; Scurr JH, 2001, LANCET, V357, P1485, DOI 10.1016/S0140-6736(00)04645-6; Stricker H, 2003, J THROMB HAEMOST, V1, P380, DOI 10.1046/j.1538-7836.2003.00047.x	16	3	3	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					792	794		10.1016/S0140-6736(06)68312-8	http://dx.doi.org/10.1016/S0140-6736(06)68312-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530558				2022-12-28	WOS:000236016500005
J	Zacchigna, L; Vecchione, C; Notte, A; Cordenonsi, M; Dupont, S; Maretto, S; Cifelli, G; Ferrari, A; Maffei, A; Fabbro, C; Braghetta, P; Marino, G; Selvetella, G; Aretini, A; Colonnese, C; Bettarini, U; Russo, G; Soligo, S; Adorno, M; Bonaldo, P; Volpin, D; Piccolo, S; Lembo, G; Bressan, GM				Zacchigna, L; Vecchione, C; Notte, A; Cordenonsi, M; Dupont, S; Maretto, S; Cifelli, G; Ferrari, A; Maffei, A; Fabbro, C; Braghetta, P; Marino, G; Selvetella, G; Aretini, A; Colonnese, C; Bettarini, U; Russo, G; Soligo, S; Adorno, M; Bonaldo, P; Volpin, D; Piccolo, S; Lembo, G; Bressan, GM			Emilin1 links TGF-beta maturation to blood pressure homeostasis	CELL			English	Article							GROWTH-FACTOR-BETA; ACTIVATION; EXPRESSION; INHIBITOR	TGF-beta proteins are main regulators of blood vessel development and maintenance. Here, we report an unprecedented link between TGF-beta signaling and arterial hypertension based on the analysis of mice mutant for Emilin1, a cysteine-rich secreted glycoprotein expressed in the vascular tree. Emilin1 knockout animals display increased blood pressure, increased peripheral vascular resistance, and reduced vessel size. Mechanistically, we found that Emilin1 inhibits TGF-beta signaling by binding specifically to the proTGF-beta precursor and preventing its maturation by furin convertases; in the extracellular space. In support of these findings, genetic inactivation of Emifin1 causes increased TGF-beta signaling in the vascular wall. Strikingly, high blood pressure observed in Emilin1 mutants is rescued to normal levels upon inactivation of a single TGF-beta 1 allele. This study highlights the importance of modulation of TGF-beta availability in the pathogenesis of hypertension.	Univ Padua, Dev Signaling Lab, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy; IRCCS, Neuromed Inst, Dept Angiocardioneurol, I-86077 Pozzilli, IS, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00161 Rome, Italy; Univ Padua, Mouse Genet Lab, Dept Histol Microbiol & Med Biotechnol, I-35121 Padua, Italy	University of Padua; IRCCS Neuromed; Sapienza University Rome; University of Padua	Piccolo, S (corresponding author), Univ Padua, Dev Signaling Lab, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35121 Padua, Italy.	piccolo@civ.bio.unipd.it; lembo@neuromed.it; bressan@civ.bio.unipd.it	Vecchione, Carmine/K-2175-2018; colonnese, claudio/AAB-9727-2020; Selvetella, Giulio/J-4342-2012; Lembo, Giuseppe/AAE-8096-2020; Cordenonsi, Michelangelo/K-7692-2016; maffei, angelo/AAC-2219-2020; Dupont, Sirio/AAP-8133-2021; Cifelli, Giuseppe/AAB-6938-2019; Braghetta, Paola/K-5478-2016	colonnese, claudio/0000-0003-4249-4689; Lembo, Giuseppe/0000-0002-3510-223X; Cordenonsi, Michelangelo/0000-0002-8253-5724; Cifelli, Giuseppe/0000-0002-6417-7185; Braghetta, Paola/0000-0003-2547-8679; Vecchione, Carmine/0000-0002-2473-4565; maffei, angelo/0000-0002-7491-0344; Dupont, Sirio/0000-0002-6869-1966; PICCOLO, STEFANO/0000-0002-2037-0004; Bonaldo, Paolo/0000-0002-9571-8140	Telethon [GGP04030] Funding Source: Medline	Telethon(Fondazione Telethon)		Agrotis Alex, 2005, Current Vascular Pharmacology, V3, P55, DOI 10.2174/1570161052773951; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; BRESSAN GM, 1993, J CELL BIOL, V121, P201, DOI 10.1083/jcb.121.1.201; De Acetis M, 2005, CIRC RES, V96, P1087, DOI 10.1161/01.RES.0000168028.36081.e0; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Eimon PM, 2002, DEVELOPMENT, V129, P3089; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; Hamilton PK, 2007, CLIN SCI, V113, P157, DOI 10.1042/CS20070080; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Khanna A, 2004, AM J PHYSIOL-HEART C, V286, pH1133, DOI 10.1152/ajpheart.00462.2003; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; Mongiat M, 2000, J BIOL CHEM, V275, P25471, DOI 10.1074/jbc.M001426200; Mulvany MJ, 2002, NEWS PHYSIOL SCI, V17, P105, DOI 10.1152/nips.01366.2001; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Staessen JA, 2003, LANCET, V361, P1629, DOI 10.1016/S0140-6736(03)13302-8; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Ventura JJ, 2004, MOL CELL, V15, P269, DOI 10.1016/j.molcel.2004.06.007; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	22	230	247	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					929	942		10.1016/j.cell.2005.12.035	http://dx.doi.org/10.1016/j.cell.2005.12.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530041	Bronze			2022-12-28	WOS:000237241200016
J	Arron, JR; Winslow, MM; Polleri, A; Chang, CP; Wu, H; Gao, X; Neilson, JR; Chen, L; Heit, JJ; Kim, SK; Yamasaki, N; Miyakawa, T; Francke, U; Graef, IA; Crabtree, GR				Arron, Joseph R.; Winslow, Monte M.; Polleri, Alberto; Chang, Ching-Pin; Wu, Hai; Gao, Xin; Neilson, Joel R.; Chen, Lei; Heit, Jeremy J.; Kim, Seung K.; Yamasaki, Nobuyuki; Miyakawa, Tsuyoshi; Francke, Uta; Graef, Isabella A.; Crabtree, Gerald R.			NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21	NATURE			English	Article							DOWN-SYNDROME PHENOTYPES; TRANSCRIPTION FACTOR; REGULATORY NETWORK; CRITICAL REGION; MOUSE MODEL; CALCINEURIN; MICE; CALCIUM; SIGNALS; ATC	Trisomy 21 results in Down's syndrome, but little is known about how a 1.5-fold increase in gene dosage produces the pleiotropic phenotypes of Down's syndrome. Here we report that two genes, DSCR1 and DYRK1A, lie within the critical region of human chromosome 21 and act synergistically to prevent nuclear occupancy of NFATc transcription factors, which are regulators of vertebrate development. We use mathematical modelling to predict that autoregulation within the pathway accentuates the effects of trisomy of DSCR1 and DYRK1A, leading to failure to activate NFATc target genes under specific conditions. Our observations of calcineurin- and Nfatc-deficient mice, Dscr1- and Dyrk1a-overexpressing mice, mouse models of Down's syndrome and human trisomy 21 are consistent with these predictions. We suggest that the 1.5-fold increase in dosage of DSCR1 and DYRK1A cooperatively destabilizes a regulatory circuit, leading to reduced NFATc activity and many of the features of Down's syndrome. More generally, these observations suggest that the destabilization of regulatory circuits can underlie human disease.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Program Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Kyoto Univ, Grad Sch Med, HMRO, Genet Engn & Funct Genom Unit, Kyoto 6068501, Japan	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Kyoto University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	igraef@stanford.edu; crabtree@stanford.edu	Miyakawa, Tsuyoshi/A-7741-2008	Miyakawa, Tsuyoshi/0000-0003-0137-8200; Kim, Seung/0000-0001-6135-7810; Arron, Joseph/0000-0001-7677-9979; Neilson, Joel R./0000-0002-3408-608X; Heit, Jeremy/0000-0003-1055-8000	Medical Research Council [MC_U120097116] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Baxter LL, 2000, HUM MOL GENET, V9, P195, DOI 10.1093/hmg/9.2.195; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Epstein C.J, 1986, CONSEQUENCES CHROMOS; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holtzman D M, 1992, Mol Genet Med, V2, P105; Kegley KM, 2001, DEV BIOL, V232, P115, DOI 10.1006/dbio.2001.0179; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; KORENBERG JR, 1990, AM J MED GENET, P91; McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Olson LE, 2004, SCIENCE, V306, P687, DOI 10.1126/science.1098992; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	42	515	531	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					595	600		10.1038/nature04678	http://dx.doi.org/10.1038/nature04678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16554754				2022-12-28	WOS:000237920800038
J	Julius, S; Nesbitt, SD; Egan, BM; Weber, MA; Michelson, EL; Kaciroti, N; Black, HR; Grimm, RH; Messerli, FH; Oparil, S; Schork, MA				Julius, S; Nesbitt, SD; Egan, BM; Weber, MA; Michelson, EL; Kaciroti, N; Black, HR; Grimm, RH; Messerli, FH; Oparil, S; Schork, MA		TROPHY Study Investigators	Feasibility of treating prehypertension with an angiotensin-receptor blocker	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING-ENZYME-INHIBITOR; SPONTANEOUSLY HYPERTENSIVE-RATS; NORMAL BLOOD-PRESSURE; BORDERLINE HYPERTENSION; UNITED-STATES; RISK-FACTORS; PREVENTION; PROGRESSION; PREVALENCE; TECUMSEH	BACKGROUND: Prehypertension is considered a precursor of stage 1 hypertension and a predictor of excessive cardiovascular risk. We investigated whether pharmacologic treatment of prehypertension prevents or postpones stage 1 hypertension. METHODS: Participants with repeated measurements of systolic pressure of 130 to 139 mm Hg and diastolic pressure of 89 mm Hg or lower, or systolic pressure of 139 mm Hg or lower and diastolic pressure of 85 to 89 mm Hg, were randomly assigned to receive two years of candesartan (Atacand, AstraZeneca) or placebo, followed by two years of placebo for all. When a participant reached the study end point of stage 1 hypertension, treatment with antihypertensive agents was initiated. Both the candesartan group and the placebo group were instructed to make changes in lifestyle to reduce blood pressure throughout the trial. RESULTS: A total of 409 participants were randomly assigned to candesartan, and 400 to placebo. Data on 772 participants (391 in the candesartan group and 381 in the placebo group; mean age, 48.5 years; 59.6 percent men) were available for analysis. During the first two years, hypertension developed in 154 participants in the placebo group and 53 of those in the candesartan group (relative risk reduction, 66.3 percent; P<0.001). After four years, hypertension had developed in 240 participants in the placebo group and 208 of those in the candesartan group (relative risk reduction, 15.6 percent; P<0.007). Serious adverse events occurred in 3.5 percent of the participants assigned to candesartan and 5.9 percent of those receiving placebo. CONCLUSIONS: Over a period of four years, stage 1 hypertension developed in nearly two thirds of patients with untreated prehypertension (the placebo group). Treatment of prehypertension with candesartan appeared to be well tolerated and reduced the risk of incident hypertension during the study period. Thus, treatment of prehypertension appears to be feasible.	Univ Michigan, Dept Internal Med, Dept Cardiovasc Med, Ann Arbor, MI 48106 USA; Univ Texas, SW Med Ctr, Dallas, TX USA; Med Univ S Carolina, Charleston, SC 29425 USA; SUNY Downstate Coll Med, Brooklyn, NY USA; AstraZeneca, Wilmington, DE USA; Rush Univ, Med Ctr, Chicago, IL 60612 USA; Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; St Lukes Roosevelt Hosp, New York, NY USA; Univ Alabama Birmingham, Birmingham, AL USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Medical University of South Carolina; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; AstraZeneca; Rush University; Hennepin County Medical Center; Mount Sinai St. Luke's; Mount Sinai West; University of Alabama System; University of Alabama Birmingham	Julius, S (corresponding author), Univ Michigan, Dept Internal Med, Dept Cardiovasc Med, 24 Frank Lloyd Wright Dr,Lobby M,3rd Fl, Ann Arbor, MI 48106 USA.	sjulius@umich.edu	Messerli, Franz/AAR-4783-2021; Kaciroti, Niko/AAG-3988-2021; Kaciroti, Niko/AAI-2613-2021	Kaciroti, Niko/0000-0001-8843-8231; 				[Anonymous], 1990, Arch Intern Med, V150, P153, DOI 10.1001/archinte.150.1.153; Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd; EGAN B, 1987, J CLIN INVEST, V80, P812, DOI 10.1172/JCI113138; ESLER M, 1977, NEW ENGL J MED, V296, P405, DOI 10.1056/NEJM197702242960801; FOLKOW B, 1982, PHYSIOL REV, V62, P347, DOI 10.1152/physrev.1982.62.2.347; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; HARRAP SB, 1990, HYPERTENSION, V16, P603, DOI 10.1161/01.HYP.16.6.603; HART MN, 1980, HYPERTENSION, V2, P419, DOI 10.1161/01.HYP.2.4.419; JENNINGS G, 1986, CIRCULATION, V73, P30, DOI 10.1161/01.CIR.73.1.30; *JOINT NAT COMM PR, 1997, NIH PUBL; JULIUS S, 1990, JAMA-J AM MED ASSOC, V264, P354; Julius S, 2004, HYPERTENSION, V44, P146, DOI 10.1161/01.HYP.0000130174.70055.ca; JULIUS S, 1971, J CHRON DIS, V23, P723, DOI 10.1016/0021-9681(71)90005-1; JULIUS S, 1991, J HYPERTENS, V9, P77, DOI 10.1097/00004872-199101000-00012; LEITSCHUH M, 1991, HYPERTENSION, V17, P22, DOI 10.1161/01.HYP.17.1.22; LEVY RL, 1945, JAMA-J AM MED ASSOC, V128, P1059, DOI 10.1001/jama.1945.02860320001001; Levy RL, 1944, J AMER MED ASSOC, V126, P829, DOI 10.1001/jama.1944.02850480029008; Liszka HA, 2005, ANN FAM MED, V3, P294, DOI 10.1370/afm.312; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; NEATON JD, 1995, HYPERTENSION PATHOPH, V1, P127; Nesbitt SD, 2005, AM J HYPERTENS, V18, P980, DOI 10.1016/j.amjhyper.2005.01.021; NEUTEL JM, 1992, AM HEART J, V124, P435, DOI 10.1016/0002-8703(92)90610-8; PANZA JA, 1993, CIRCULATION, V87, P1468, DOI 10.1161/01.CIR.87.5.1468; Qureshi AI, 2005, MED SCI MONITOR, V11, pCR403; Qureshi AI, 2005, STROKE, V36, P1859, DOI 10.1161/01.STR.0000177495.45580.f1; SCHIFFRIN EL, 1995, AM J HYPERTENS, V8, P229, DOI 10.1016/0895-7061(95)96211-2; SCHIFFRIN EL, 1995, HYPERTENSION, V25, P699, DOI 10.1161/01.HYP.25.4.699; THOMSON KJ, 1950, P ANN M MED SECT AM, V38, P85; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; WEBER MA, 1991, AM J MED, V91, pS4, DOI 10.1016/0002-9343(91)90057-5; Whelton PK, 1997, ARCH INTERN MED, V157, P657, DOI 10.1001/archinte.157.6.657; WU JN, 1993, HYPERTENSION, V22, P139, DOI 10.1161/01.HYP.22.2.139	37	674	727	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2006	354	16					1685	1697		10.1056/NEJMoa060838	http://dx.doi.org/10.1056/NEJMoa060838			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033ZP	16537662	Bronze			2022-12-28	WOS:000236893900005
J	Darios, F; Davletov, B				Darios, F; Davletov, B			Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3	NATURE			English	Article							NERVE GROWTH-FACTOR; PHOSPHOLIPASE A(2) ACTIVITY; ARACHIDONIC-ACID; DOCOSAHEXAENOIC ACID; NEURITE OUTGROWTH; SNARE COMPLEXES; PLASMA-MEMBRANE; AXONAL GROWTH; IN-VITRO; PROTEIN	Growth of neurite processes from the cell body is the critical step in neuronal development and involves a large increase in cell membrane surface area(1). Arachidonic-acid-releasing phospholipases are highly enriched in nerve growth cones and have previously been implicated in neurite outgrowth(2,3). Cell membrane expansion is achieved through the fusion of transport organelles with the plasma membrane(4); however, the identity of the molecular target of arachidonic acid has remained elusive. Here we show that syntaxin 3 (STX3), a plasma membrane protein, has an important role in the growth of neurites, and also serves as a direct target for omega-6 arachidonic acid. By using syntaxin 3 in a screening assay, we determined that the dietary omega-3 linolenic and docosahexaenoic acids can efficiently substitute for arachidonic acid in activating syntaxin 3. Our findings provide a molecular basis for the previously established action of omega-3 and omega-6 polyunsaturated fatty acids in membrane expansion at the growth cones, and represent the first identification of a single effector molecule for these essential nutrients.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Davletov, B (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	email@bazbek.com	Davletov, Bazbek/ABA-8569-2021	Darios, Frederic/0000-0001-9800-5990; Davletov, Bazbek/0000-0003-4658-3275	MRC [MC_U105178791] Funding Source: UKRI; Medical Research Council [MC_U105178791] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bajohrs M, 2005, BIOCHEM J, V392, P283, DOI 10.1042/BJ20050583; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Farkas T, 2000, P NATL ACAD SCI USA, V97, P6362, DOI 10.1073/pnas.120157297; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; Hornfelt M, 1999, NEUROSCIENCE, V91, P1539, DOI 10.1016/S0306-4522(98)00684-8; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; Kane CD, 1996, ANAL BIOCHEM, V233, P197, DOI 10.1006/abio.1996.0028; Kelly RB, 1999, TRENDS CELL BIOL, V9, pM29, DOI 10.1016/S0962-8924(99)01687-6; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; NAKAMURA S, 1993, NEUROREPORT, V4, P371, DOI 10.1097/00001756-199304000-00007; NEGREAMINOU P, 1993, J NEUROCHEM, V60, P1126, DOI 10.1111/j.1471-4159.1993.tb03263.x; NegreAminou P, 1996, J NEUROCHEM, V67, P2599; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; Rickman C, 2005, CHEM BIOL, V12, P545, DOI 10.1016/j.chembiol.2005.03.004; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Rohrbough J, 2005, NAT REV NEUROSCI, V6, P139, DOI 10.1038/nrn1608; SCHIAVO G, 1995, J BIOL CHEM, V270, P10566, DOI 10.1074/jbc.270.18.10566; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Tang BL, 2001, J NEUROCHEM, V79, P923, DOI 10.1046/j.1471-4159.2001.00674.x; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Wainwright PE, 2002, P NUTR SOC, V61, P61, DOI 10.1079/PNS2001130; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101; Zheng WH, 1996, J NEUROCHEM, V66, P1868	30	266	283	4	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					813	817		10.1038/nature04598	http://dx.doi.org/10.1038/nature04598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598260				2022-12-28	WOS:000236548400045
J	Yusuf, S; Mehta, SR; Chrolavicius, S; Afzal, R; Pogue, J; Granger, CB; Budaj, A; Peters, RJG; Bassand, JP; Wallentin, L; Joyner, C; Fox, KAA				Yusuf, S; Mehta, SR; Chrolavicius, S; Afzal, R; Pogue, J; Granger, CB; Budaj, A; Peters, RJG; Bassand, JP; Wallentin, L; Joyner, C; Fox, KAA		OASIS-6 Trial Grp	Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction - The OASIS-6 randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							THERAPY	Context Despite many therapeutic advances, mortality in patients with acute ST-segment elevation myocardial infarction ( STEMI) remains high. The role of additional antithrombotic agents is unclear, especially among patients not receiving reperfusion therapy. Objective To evaluate the effect of fondaparinux, a factor Xa inhibitor, when initiated early and given for up to 8 days vs usual care ( placebo in those in whom unfractionated heparin [ UFH] is not indicated [ stratum 1] or unfractionated heparin for up to 48 hours followed by placebo for up to 8 days [ stratum 2]) in patients with STEMI. Design, Setting, and Participants Randomized double-blind comparison of fondaparinux 2.5 mg once daily or control for up to 8 days in 12 092 patients with STEMI from 447 hospitals in 41 countries ( September 2003-January 2006). From day 3 through day 9, all patients received either fondaparinux or placebo according to the original randomized assignment. Main Outcome Measures Composite of death or reinfarction at 30 days ( primary) with secondary assessments at 9 days and at final follow-up ( 3 or 6 months). Results Death or reinfarction at 30 days was significantly reduced from 677 (11.2%) of 6056 patients in the control group to 585 (9.7%) of 6036 patients in the fondaparinux group ( hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.77-0.96; P=.008); absolute risk reduction, 1.5%; 95% CI, 0.4%-2.6%). These benefits were observed at 9 days ( 537 [8.9%] placebo vs 444 [7.4%] fondaparinux; HR, 0.83; 95% CI, 0.73-0.94; P=.003, and at study end (857 [14.8%] placebo vs 756 [13.4%] fondaparinux; HR, 0.88; 95% CI, 0.79-0.97; P=.008). Mortality was significantly reduced throughout the study. There was no heterogeneity of the effects of fondaparinux in the 2 strata by planned heparin use. However, there was no benefit in those undergoing primary percutaneous coronary intervention. In other patients in stratum 2, fondaparinux was superior to unfractionated heparin in preventing death or reinfarction at 30 days ( HR, 0.82; 95% CI, 0.66-1.02; P=.08) and at study end ( HR, 0.77; 95% CI, 0.64-0.93; P=.008). Significant benefits were observed in those receiving thrombolytic therapy ( HR, 0.79; P=.003) and those not receiving any reperfusion therapy ( HR, 0.80; P=.03). There was a tendency to fewer severe bleeds ( 79 for placebo vs 61 for fondaparinux; P=.13), with significantly fewer cardiac tamponade ( 48 vs 28; P=.02) with fondaparinux at 9 days. Conclusion In patients with STEMI, particularly those not undergoing primary percutaneous coronary intervention, fondaparinux significantly reduces mortality and reinfarction without increasing bleeding and strokes. Trial Registration Clinical Trials. gov Identifier NCT00064428.	McMaster Univ, Dept Med, Hamilton, ON, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada; Duke Univ, Div Cardiol, Durham, NC USA; Grochowski Hosp, Div Cardiol, Warsaw, Poland; Univ Amsterdam, Div Cardiol, Amsterdam, Netherlands; Univ Besancon, Div Cardiol, F-25030 Besancon, France; Uppsala Univ, Div Cardiol, Uppsala, Sweden; Univ Toronto, Div Cardiol, Toronto, ON, Canada; Sunnybrook Med Ctr, Toronto, ON, Canada; Univ Edinburgh, Cardiovasc Res Div, Edinburgh, Midlothian, Scotland	McMaster University; McMaster University; Duke University; Centre of Postgraduate Medical Education - Poland; University of Amsterdam; Universite de Franche-Comte; Uppsala University; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Edinburgh	Yusuf, S (corresponding author), McMaster Univ, Hamilton Gen Hosp, McMaster Clin, Room 252,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca	Granger, Christopher B/D-3458-2014; Manolis, Antonis/F-5003-2014; Fox, keith A A/I-3742-2013; Malynovsky, Yaroslav/T-1898-2017; Grinshtein, Yury/M-4091-2014	Granger, Christopher B/0000-0002-0045-3291; Manolis, Antonis/0000-0002-0336-4745; Malynovsky, Yaroslav/0000-0002-9118-1104; Yusuf, Salim/0000-0003-4776-5601; Grinshtein, Yury/0000-0001-8847-235X; Fox, Keith/0000-0002-0140-2752				[Anonymous], 1988, LANCET, Vii, P349; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collins R, 1997, NEW ENGL J MED, V336, P847, DOI 10.1056/NEJM199703203361207; COLLINS R, 1995, LANCET, V345, P669; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; *OASIS 5 INV, IN PRESS N ENGL J ME; Topol EJ, 2001, LANCET, V357, P1905; Turpie Alexander G G, 2002, J South Orthop Assoc, V11, P182; Van de Werf F, 2001, LANCET, V358, P605; Weitz JI, 2001, CHEST, V119, p95S, DOI 10.1378/chest.119.1_suppl.95S; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2005, JAMA-J AM MED ASSOC, V293, P427; Yusuf S, 2002, LANCET, V359, P294	17	595	652	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1519	1530						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16537725				2022-12-28	WOS:000236505400019
J	Temte, JL				Temte, JL			Child health - Should all children be immunised against hepatitis A?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNITED-STATES; COST-EFFECTIVENESS; VACCINATION; ERA		Univ Wisconsin, Dept Family Med, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison	Temte, JL (corresponding author), Univ Wisconsin, Dept Family Med, Madison, WI 53715 USA.	Jon.Temte@fammed.wisc.edu						[Anonymous], 1999, MMWR Recomm Rep, V48, P1; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P717; [Anonymous], 2005, MMWR-MORBID MORTAL W, V54, P893; Armstrong GL, 2002, PEDIATRICS, V109, P839, DOI 10.1542/peds.109.5.839; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P1156; CDC, EP PREV VACC PREV DI; *CDC, DIS BURD HEP A B C U; *CDC, 2006, REC CHILDH AD IMM SC; *CDC, 2000, MMWR-MORBID MORTAL W, V49, P35; Centers for Disease C., 2005, MMWR MORB MORTAL WKL, V54, P279; Charatan Fred, 2005, BMJ, V331, P1102, DOI 10.1136/bmj.331.7525.1102-c; Di Giammarino L, 2005, NEW ENGL J MED, V353, P944, DOI 10.1056/NEJMe058152; Fiore A., 2005, Morbidity and Mortality Weekly Report, V54, P141; Jacobs RJ, 2003, PEDIATR INFECT DIS J, V22, P904, DOI 10.1097/01.inf.0000091295.53969.6a; Josefson Deborah, 2003, BMJ, V327, P1188, DOI 10.1136/bmj.327.7425.1188-c; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Leach CT, 2004, PEDIATR INFECT DIS J, V23, P551, DOI 10.1097/01.inf.0000130071.03003.c2; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Posfay-Barbe KM, 2005, PEDIATRICS, V116, pE623, DOI 10.1542/peds.2005-0885; Taylor JA, 2002, PEDIATRICS, V110, P1110, DOI 10.1542/peds.110.6.1110; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Valenzuela MT, 2005, VACCINE, V23, P4110, DOI 10.1016/j.vaccine.2005.03.021; Wasley A, 2005, JAMA-J AM MED ASSOC, V294, P194, DOI 10.1001/jama.294.2.194; Zhou FJ, 2005, ARCH PEDIAT ADOL MED, V159, P1136, DOI 10.1001/archpedi.159.12.1136	24	12	12	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2006	332	7543					715	718		10.1136/bmj.332.7543.715	http://dx.doi.org/10.1136/bmj.332.7543.715			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	027VH	16565129	Green Published			2022-12-28	WOS:000236443300027
J	Bianchi, A; Shore, D				Bianchi, A; Shore, D			The KEOPS complex: A Rosetta stone for telomere regulation?	CELL			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; PROTEIN; ACCESS; CDC13; DNA	The detailed mechanisms underlying telomere capping and its relationship to telomerase activity are still unclear, although many proteins have been implicated in either or both processes. In this issue of Cell, Downey et al. (2006) present the surprising identification of a new complex, called KEOPS, which promotes both telomere uncapping and elongation.	Univ Geneva, Dept Biol Mol, CH-1211 Geneva 4, Switzerland; Univ Geneva, NCCR Program Frontiers Genet, CH-1211 Geneva 4, Switzerland	University of Geneva; University of Geneva	Bianchi, A (corresponding author), Univ Geneva, Dept Biol Mol, Sci 3,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	david.shore@molbio.unige.ch	Shore, David/F-6240-2015	Shore, David/0000-0002-9859-143X; Bianchi, Alessandro/0000-0001-6583-1671				de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Schramke V, 2004, NAT GENET, V36, P46, DOI 10.1038/ng1284; Takata H, 2005, MOL CELL, V17, P573, DOI 10.1016/j.molcel.2005.01.014; Tsukamoto Y, 2001, CURR BIOL, V11, P1328, DOI 10.1016/S0960-9822(01)00372-4	9	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1125	1128		10.1016/j.cell.2006.03.008	http://dx.doi.org/10.1016/j.cell.2006.03.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564005	Bronze			2022-12-28	WOS:000237241400012
J	Moffat, J; Grueneberg, DA; Yang, XP; Kim, SY; Kloepfer, AM; Hinkle, G; Piqani, B; Eisenhaure, TM; Luo, B; Grenier, JK; Carpenter, AE; Foo, SY; Stewart, SA; Stockwell, BR; Hacohen, N; Hahn, WC; Lander, ES; Sabatini, DM; Root, DE				Moffat, J; Grueneberg, DA; Yang, XP; Kim, SY; Kloepfer, AM; Hinkle, G; Piqani, B; Eisenhaure, TM; Luo, B; Grenier, JK; Carpenter, AE; Foo, SY; Stewart, SA; Stockwell, BR; Hacohen, N; Hahn, WC; Lander, ES; Sabatini, DM; Root, DE			A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen	CELL			English	Article							CULTURED-MAMMALIAN-CELLS; CAENORHABDITIS-ELEGANS; INTERFERING RNAS; HUMAN KINASES; IN-VIVO; GENOME; IDENTIFICATION; APOPTOSIS; PATHWAY; COMPONENTS	To enable arrayed or pooled loss-of-function screens in a wide range of mammalian cell types, including primary and nondividing cells, we are developing lentiviral short hairpin RNA (shRNA) libraries targeting the human and murine genomes. The libraries currently contain 104,000 vectors, targeting each of 22,000 human and mouse genes with multiple sequence-verified constructs. To test the utility of the library for arrayed screens, we developed a screen based on high-content imaging to identify genes required for mitotic progression in human cancer cells and applied it to an arrayed set of 5,000 unique shRNA-expressing lentiviruses that target 1,028 human genes. The screen identified several known and similar to 100 candidate regulators of mitotic progression and proliferation; the availability of multiple shRNAs targeting the same gene facilitated functional validation of putative hits. This work provides a widely applicable resource for loss-of-function screens, as well as a roadmap for its application to biological discovery.	MIT, Broad Inst, Cambridge, MA 02139 USA; Harvard Univ, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Columbia Univ, Dept Chem, Dept Sci Biol, New York, NY 10027 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington University (WUSTL); Columbia University	Root, DE (corresponding author), MIT, Broad Inst, Cambridge, MA 02139 USA.	droot@broad.mit.edu	Stockwell, Brent R/AAE-7200-2019; Stewart, Sheila A/C-5213-2012; Moffat, Jason/AAC-1110-2020; Carpenter, Anne/C-4982-2008	Stockwell, Brent R/0000-0002-3532-3868; Moffat, Jason/0000-0002-5663-8586; Carpenter, Anne/0000-0003-1555-8261; /0000-0002-1446-7256	NATIONAL CANCER INSTITUTE [R01CA097061, R01CA103866] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA112962, R01CA97061, CA103866] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; FEDERICO ME, 2003, LENTIVIRUS GENE ENG, V229; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gasparri F, 2004, J BIOMOL SCREEN, V9, P232, DOI 10.1177/1087057103262836; Golsteyn RM, 2005, CANCER LETT, V217, P129, DOI 10.1016/j.canlet.2004.08.005; Gumireddy K, 2005, CANCER CELL, V7, P275, DOI 10.1016/j.ccr.2005.02.009; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harborth J, 2001, J CELL SCI, V114, P4557; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kolfschoten IGM, 2005, CELL, V121, P849, DOI 10.1016/j.cell.2005.04.017; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marron MB, 2000, J BIOL CHEM, V275, P39741, DOI 10.1074/jbc.M007189200; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Sandy P, 2005, BIOTECHNIQUES, V39, P215, DOI 10.2144/05392RV01; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tsiamis AC, 2002, MICROVASC RES, V63, P149, DOI 10.1006/mvre.2001.2377; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	42	1273	1344	1	94	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1283	1298		10.1016/j.cell.2006.01.040	http://dx.doi.org/10.1016/j.cell.2006.01.040			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564017	Bronze			2022-12-28	WOS:000237241400026
J	Patel, SD; Ciatto, C; Chen, CP; Bahna, F; Rajebhosale, M; Arkus, N; Schieren, I; Jessell, TM; Honig, B; Price, SR; Shapiro, L				Patel, SD; Ciatto, C; Chen, CP; Bahna, F; Rajebhosale, M; Arkus, N; Schieren, I; Jessell, TM; Honig, B; Price, SR; Shapiro, L			Type II cadherin ectodomain structures: Implications for classical cadherin specificity	CELL			English	Article							CELL-CELL ADHESION; N-CADHERIN; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; IDENTIFICATION; EXPRESSION; BINDING; LOCALIZATION; DIMERIZATION; MOLECULES	Type I and II classical cadherins help to determine the adhesive specificities of animal cells. Crystal-structure determination of ectodomain regions from three type II cadherins reveals adhesive dimers formed by exchange of N-terminal beta strands between partner extracellular cadherin-1 (EC1) domains. These interfaces have two conserved tryptophan side chains that anchor each swapped strand, compared with one in type I cadherins, and include large hydrophobic regions unique to type II interfaces. The EC1 domains of type I and type II cadherins appear to encode cell adhesive specificity in vitro. Moreover, perturbation of motor neuron segregation with chimeric cadherins depends on EC1 domain identity, suggesting that this region, which includes the structurally defined adhesive interface, encodes type II cadherin functional specificity in vivo.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Columbia Univ, Edward S Harkness Eye Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; University of London; University College London; Columbia University	Price, SR (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ucgaspr@ucl.ac.uk; lss8@columbia.edu	Shapiro, Lawrence/AAE-7172-2019	Price, Stephen/0000-0001-7804-9849; Patel, Saurabh/0000-0002-5738-3175	NIGMS NIH HHS [GM-30518, GM-062270] Funding Source: Medline; Wellcome Trust [072914] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030518, R01GM030518, R01GM062270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bekirov IH, 2002, NEUROSCIENCE, V115, P213, DOI 10.1016/S0306-4522(02)00375-5; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Espeseth A, 1998, DEVELOPMENT, V125, P301; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harrison OJ, 2005, J CELL SCI, V118, P711, DOI 10.1242/jcs.01665; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; May C, 2005, BLOOD, V105, P4337, DOI 10.1182/blood-2005-01-0010; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NAKAGAWA S, 1995, DEVELOPMENT, V121, P1321; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Redies C, 2003, J PHYSIOL-PARIS, V97, P5, DOI 10.1016/j.jphysparis.2003.10.002; Redies C, 1996, DEV BIOL, V180, P413, DOI 10.1006/dbio.1996.0315; Shan WS, 2004, J BIOL CHEM, V279, P55914, DOI 10.1074/jbc.M407827200; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Shan WS, 1999, BIOPHYS CHEM, V82, P157, DOI 10.1016/S0301-4622(99)00115-5; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Shimoyama Y, 1999, J BIOL CHEM, V274, P11987, DOI 10.1074/jbc.274.17.11987; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; TAKEICHI M, 1981, DEV BIOL, V87, P340, DOI 10.1016/0012-1606(81)90157-3; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Tanaka Y, 2003, MOL BIOL CELL, V14, P1597, DOI 10.1091/mbc.E02-10-0632; Troyanovsky RB, 2003, MOL CELL BIOL, V23, P7965, DOI 10.1128/MCB.23.22.7965-7972.2003; Troyanovsky S, 2005, EUR J CELL BIOL, V84, P225, DOI 10.1016/j.ejcb.2004.12.009; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	42	213	227	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1255	1268		10.1016/j.cell.2005.12.046	http://dx.doi.org/10.1016/j.cell.2005.12.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564015	Bronze			2022-12-28	WOS:000237241400024
J	Bozhevolnyi, SI; Volkov, VS; Devaux, E; Laluet, JY; Ebbesen, TW				Bozhevolnyi, SI; Volkov, VS; Devaux, E; Laluet, JY; Ebbesen, TW			Channel plasmon subwavelength waveguide components including interferometers and ring resonators	NATURE			English	Article							ELECTROMAGNETIC ENERGY-TRANSPORT; METAL-SURFACE; POLARITON; BENDS	Photonic components are superior to electronic ones in terms of operational bandwidth, but the diffraction limit of light poses a significant challenge to the miniaturization and high-density integration of optical circuits. The main approach to circumvent this problem is to exploit the hybrid nature of surface plasmon polaritons (SPPs), which are light waves coupled to free electron oscillations in a metal(1,2) that can be laterally confined below the diffraction limit using subwavelength metal structures(3-8). However, the simultaneous realization of strong confinement and a propagation loss sufficiently low for practical applications has long been out of reach. Channel SPP modes-channel plasmon polaritons (CPPs)(8)-are electromagnetic waves that are bound to and propagate along the bottom of V-shaped grooves milled in a metal film. They are expected to exhibit useful subwavelength confinement, relatively low propagation loss(9), single-mode operation(10) and efficient transmission around sharp bends(11). Our previous experiments showed that CPPs do exist and that they propagate over tens of micrometres along straight subwavelength grooves(12). Here we report the design, fabrication and characterization of CPP-based subwavelength waveguide components operating at telecom wavelengths: Y-splitters, Mach-Zehnder interferometers and waveguide-ring resonators. We demonstrate that CPP guides can indeed be used for large-angle bending and splitting of radiation, thereby enabling the realization of ultracompact plasmonic components and paving the way for a new class of integrated optical circuits.	Univ Aalborg, Dept Phys & Nanotechnol, DK-9220 Aalborg, Denmark; Univ Strasbourg 1, ISIS, CNRS, UMR 7006, F-67083 Strasbourg, France	Aalborg University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bozhevolnyi, SI (corresponding author), Univ Aalborg, Dept Phys & Nanotechnol, Skjernvej 4A, DK-9220 Aalborg, Denmark.	sergey@physics.aau.dk	Volkov, Valentyn S/M-5489-2013; Bozhevolnyi, Sergey I/E-9423-2011	Volkov, Valentyn S/0000-0003-2637-1371; Bozhevolnyi, Sergey I/0000-0002-0393-4859				Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bozhevolnyi SI, 2004, PHILOS T R SOC A, V362, P757, DOI 10.1098/rsta.2003.1345; Bozhevolnyi SI, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.046802; Gramotnev DK, 2004, APPL PHYS LETT, V85, P6323, DOI 10.1063/1.1839283; Kumar A, 1998, MICROW OPT TECHN LET, V19, P289, DOI 10.1002/(SICI)1098-2760(199811)19:4<289::AID-MOP13>3.0.CO;2-Y; Maier SA, 2003, NAT MATER, V2, P229, DOI 10.1038/nmat852; Nikolajsen T, 2004, APPL PHYS LETT, V85, P5833, DOI 10.1063/1.1835997; Novikov IV, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.035403; Pile DEP, 2005, OPT LETT, V30, P1186, DOI 10.1364/OL.30.001186; Pile DFP, 2004, OPT LETT, V29, P1069, DOI 10.1364/OL.29.001069; Quinten M, 1998, OPT LETT, V23, P1331, DOI 10.1364/OL.23.001331; Raether H., 1988, SURFACE PLASMONS; Takahara J, 1997, OPT LETT, V22, P475, DOI 10.1364/OL.22.000475; Tanaka K, 2003, APPL PHYS LETT, V82, P1158, DOI 10.1063/1.1557323; Weeber JC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.045411; Yariv A, 2000, ELECTRON LETT, V36, P321, DOI 10.1049/el:20000340	16	1879	1942	14	1008	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					508	511		10.1038/nature04594	http://dx.doi.org/10.1038/nature04594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554814				2022-12-28	WOS:000236176100051
J	Suel, GM; Garcia-Ojalvo, J; Liberman, LM; Elowitz, MB				Suel, GM; Garcia-Ojalvo, J; Liberman, LM; Elowitz, MB			An excitable gene regulatory circuit induces transient cellular differentiation	NATURE			English	Article							COMPETENCE TRANSCRIPTION FACTOR; BACILLUS-SUBTILIS; FEEDBACK LOOP; EXPRESSION; NOISE; CELLS; SYSTEMS; MODULE; GROWTH; STATE	Certain types of cellular differentiation are probabilistic and transient(1-3). In such systems individual cells can switch to an alternative state and, after some time, switch back again. In Bacillus subtilis, competence is an example of such a transiently differentiated state associated with the capability for DNA uptake from the environment. Individual genes and proteins underlying differentiation into the competent state have been identified(4,5), but it has been unclear how these genes interact dynamically in individual cells to control both spontaneous entry into competence and return to vegetative growth. Here we show that this behaviour can be understood in terms of excitability in the underlying genetic circuit. Using quantitative fluorescence time-lapse microscopy, we directly observed the activities of multiple circuit components simultaneously in individual cells, and analysed the resulting data in terms of a mathematical model. We find that an excitable core module containing positive and negative feedback loops can explain both entry into, and exit from, the competent state. We further tested this model by analysing initiation in sister cells, and by re-engineering the gene circuit to specifically block exit. Excitable dynamics driven by noise naturally generate stochastic and transient responses(6), thereby providing an ideal mechanism for competence regulation.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; Univ Politecn Catalunya, Dept Fis & Engn Nucl, E-08222 Terrassa, Spain	California Institute of Technology; California Institute of Technology; Universitat Politecnica de Catalunya	Elowitz, MB (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	melowitz@caltech.edu	Garcia-Ojalvo, Jordi/A-4574-2009	Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Liberman, Louisa/0000-0002-1315-0097				Dupin E, 2003, P NATL ACAD SCI USA, V100, P5229, DOI 10.1073/pnas.0831229100; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; HAHN J, 1991, J BACTERIOL, V173, P7275, DOI 10.1128/jb.173.22.7275-7282.1991; Hahn J, 1996, MOL MICROBIOL, V21, P763, DOI 10.1046/j.1365-2958.1996.371407.x; HAHN J, 1994, J BACTERIOL, V176, P5753, DOI 10.1128/JB.176.18.5753-5761.1994; Haijema BJ, 2001, MOL MICROBIOL, V40, P52, DOI 10.1046/j.1365-2958.2001.02363.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Keener J., 1998, MATH PHYSL; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee EJ, 2005, MOL ENDOCRINOL, V19, P964, DOI 10.1210/me.2004-0034; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; Meeks JC, 2002, ARCH MICROBIOL, V178, P395, DOI 10.1007/s00203-002-0476-5; NAKANO MM, 1991, J BACTERIOL, V173, P7269, DOI 10.1128/jb.173.22.7269-7274.1991; Ogura M, 1999, MOL MICROBIOL, V32, P799, DOI 10.1046/j.1365-2958.1999.01399.x; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Serror P, 1996, J BACTERIOL, V178, P5910, DOI 10.1128/jb.178.20.5910-5915.1996; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Turgay K, 1998, EMBO J, V17, P6730; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	24	546	557	3	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					545	550		10.1038/nature04588	http://dx.doi.org/10.1038/nature04588			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554821				2022-12-28	WOS:000236176100059
J	Robinson, JK				Robinson, JK			Anatomical and hormonal influences on women's dermatologic health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMMUNITY; HIV-1; SEX				Robinson, JK (corresponding author), 132 E Delaware Pl,5806, Chicago, IL 60611 USA.	archdermatol@jama-archives.org						Ackerman LS, 2006, ARCH DERMATOL, V142, P371, DOI 10.1001/archderm.142.3.371; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Cutolo M, 2004, J RHEUMATOL, V31, P419; DeAngelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2662, DOI 10.1001/jama.293.21.2662; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Madkan VK, 2006, ARCH DERMATOL, V142, P365, DOI 10.1001/archderm.142.3.365; Mor G, 2003, J IMMUNOL, V170, P114, DOI 10.4049/jimmunol.170.1.114; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Ray SC, 2000, NAT MED, V6, P23, DOI 10.1038/71487; Robinson JK, 2006, ARCH DERMATOL, V142, P362, DOI 10.1001/archderm.142.3.362; van Ginkel FW, 2000, EMERG INFECT DIS, V6, P123, DOI 10.3201/eid0602.000204; van Vollenhoven Ronald F, 2002, Expert Opin Pharmacother, V3, P23, DOI 10.1517/14656566.3.1.23; World Health Organisation, 2004, UNAIDS WHO AIDS EP U; HIST INT WOMENS DAY	14	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1443	1445		10.1001/jama.295.12.1443	http://dx.doi.org/10.1001/jama.295.12.1443			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16555383				2022-12-28	WOS:000236157700023
J	Whang, W; Manson, JE; Hu, FB; Chae, CU; Rexrode, KM; Willett, WC; Stampfer, MJ; Albert, CM				Whang, W; Manson, JE; Hu, FB; Chae, CU; Rexrode, KM; Willett, WC; Stampfer, MJ; Albert, CM			Physical exertion, exercise, and sudden cardiac death in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; RISK-FACTORS; MORTALITY; PREVENTION; FITNESS; MEN	Context Exercise is associated with a lower risk of cardiovascular events but may transiently increase the risk of ventricular arrhythmias. Its short-term and long-term associations with risk of sudden cardiac death among women are unclear. Objectives To compare the risk of sudden cardiac death in women during moderate to vigorous exertion with the risk of sudden cardiac death during lighter or no exertion; and to assess the long-term association between moderate to vigorous exercise and sudden cardiac death. Design, Setting, and Participants Prospective, nested case-crossover study of 288 cases of sudden cardiac death within the Nurses' Health Study (1980-2004); and a prospective cohort analysis of 69 693 participants without prior cardiovascular disease followed up from 1986-2004. Main Outcome Measure Risk of sudden cardiac death associated with moderate to vigorous exertion. Results The absolute risk of sudden cardiac death associated with moderate to vigorous exertion was exceedingly low at 1 per 36.5 million hours of exertion. In case-crossover analyses, the risk of sudden cardiac death was transiently elevated during moderate to vigorous exertion ( relative risk [RR], 2.38; 95% confidence interval [CI], 1.23-4.60; P=.01) compared with the risk during lesser or no exertion. Habitual moderate to vigorous exertion modified this transient risk (P=.005 for interaction) and the risk was no longer significantly elevated among those who exercised 2 or more hours per week. In the cohort analyses, an increasing amount of moderate to vigorous exercise was associated with a lower long-term risk of sudden cardiac death in age-adjusted and multivariable models that excluded biological intermediates (P=.006 for trend). This relationship was attenuated when biological intermediates were included (P=.06 for trend); however, the reduction in risk remained significant among women who exercised 4 or more hours per week ( adjusted RR, 0.41; 95% CI, 0.20-0.83; P=.01) compared with women who did not exercise. Conclusions These prospective data suggest that sudden cardiac death during exertion is an extremely rare event in women. Regular exercise may significantly minimize this small transient risk and may lower the overall long-term risk of sudden cardiac death.	Brigham & Womens Hosp, Div Prevent Med, Ctr Arrhythmia Prevent, Boston, MA 02215 USA; Massachusetts Gen Hosp, Div Cardiovasc, Boston, MA 02114 USA; Harvard Univ, Sch Med, Channing Lab, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Albert, CM (corresponding author), Brigham & Womens Hosp, Div Prevent Med, Ctr Arrhythmia Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	calbert@partners.org	Rexrode, Kathryn M/I-1177-2018	Rexrode, Kathryn/0000-0003-3387-8429; Albert, Christine/0000-0002-2081-1121	NCI NIH HHS [CA-87969] Funding Source: Medline; NHLBI NIH HHS [HL-03783, HL-34594] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-11] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; Albert CM, 2003, CIRCULATION, V107, P2096, DOI 10.1161/01.CIR.0000065223.21530.11; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110; COBB LA, 1986, J AM COLL CARDIOL, V7, P215, DOI 10.1016/S0735-1097(86)80284-4; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; KANNEL WB, 1982, ANN NY ACAD SCI, V382, P3, DOI 10.1111/j.1749-6632.1982.tb55203.x; Kannel WB, 1998, AM HEART J, V136, P205, DOI 10.1053/hj.1998.v136.90226; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; KOHL HW, 1992, EPIDEMIOL REV, V14, P37, DOI 10.1093/oxfordjournals.epirev.a036091; Kushi LH, 1997, JAMA-J AM MED ASSOC, V277, P1287, DOI 10.1001/jama.277.16.1287; Lemaitre RN, 1999, ARCH INTERN MED, V159, P686, DOI 10.1001/archinte.159.7.686; LEON AS, 1987, JAMA-J AM MED ASSOC, V258, P2388, DOI 10.1001/jama.258.17.2388; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Rockhill B, 2001, AM J PUBLIC HEALTH, V91, P578, DOI 10.2105/AJPH.91.4.578; SCRAGG R, 1987, AM J EPIDEMIOL, V126, P77, DOI 10.1093/oxfordjournals.aje.a114664; Siscovick David S., 1997, Cardiology Clinics, V15, P467, DOI 10.1016/S0733-8651(05)70352-0; SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; Thompson PD, 2005, CIRCULATION, V112, P2354, DOI 10.1161/CIRCULATIONAHA.104.502591; VUORI I, 1986, ACTA MED SCAND, P205; WANNAMETHEE G, 1995, CIRCULATION, V91, P1749, DOI 10.1161/01.CIR.91.6.1749; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	28	107	109	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1399	1403		10.1001/jama.295.12.1399	http://dx.doi.org/10.1001/jama.295.12.1399			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551711	Bronze			2022-12-28	WOS:000236157700017
J	Harries, AD; Chimzizi, R; Zachariah, R				Harries, AD; Chimzizi, R; Zachariah, R			Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings	LANCET			English	Editorial Material									Minist Hlth, HIV Unit, Lilongwe, Malawi; London Sch Hyg & Trop Med, London WC1, England; Natl TB Control Programme, Community Hlth Sci Unit, Lilongwe, Malawi; Med Sans Frontieres, HIV TB Operat Res Unit, Brussels, Belgium	University of London; London School of Hygiene & Tropical Medicine; Doctors Without Borders	Harries, AD (corresponding author), Family Hlth Int, Malawi Country Off, Arwa House,3rd Floor,POB 30455, Lilongwe 3, Malawi.	adharries@malawi.net						Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Breen RAM, 2005, AIDS, V19, P1201, DOI 10.1097/01.aids.0000176221.33237.67; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Manosuthi W, 2005, AIDS, V19, P1481, DOI 10.1097/01.aids.0000183630.27665.30; Pedral-Sampaio Diana B., 2004, Braz J Infect Dis, V8, P211, DOI 10.1590/S1413-86702004000300004; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC	9	24	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					944	945		10.1016/S0140-6736(06)68387-6	http://dx.doi.org/10.1016/S0140-6736(06)68387-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546545				2022-12-28	WOS:000236242100033
J	Henriksen, PA; Boon, NA				Henriksen, PA; Boon, NA			A 28 year old postpartum woman with right sided chest discomfort: case outcome - Commentary: Cardiological management	BRITISH MEDICAL JOURNAL			English	Editorial Material									New Royal Infirm Edinburgh, Dept Cardiol, Edinburgh EH16 4SA, Midlothian, Scotland		Henriksen, PA (corresponding author), New Royal Infirm Edinburgh, Dept Cardiol, Edinburgh EH16 4SA, Midlothian, Scotland.	p.henriksen@blueyonder.co.uk						Dwivedi G, 2006, BRIT MED J, V332, P643, DOI 10.1136/bmj.332.7542.643; Electronic responses, 2006, BMJ; Eslick GD, 2005, AM J CARDIOL, V95, P1228, DOI 10.1016/j.amjcard.2005.01.052; Lewis JF, 2005, AM HEART J, V149, P527, DOI 10.1016/j.ahj.2004.03.068; Okamatsu K, 2004, CIRCULATION, V109, P465, DOI 10.1161/01.CIR.0000109696.92474.92	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					644	645		10.1136/bmj.332.7542.644-a	http://dx.doi.org/10.1136/bmj.332.7542.644-a			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543329	Green Published			2022-12-28	WOS:000236314700020
J	Kalish, RB; McCullough, LB; Chervenak, FA				Kalish, RB; McCullough, LB; Chervenak, FA			Decision-making about caesarean delivery	LANCET			English	Editorial Material							SECTION; WOMEN; OUTCOMES; TRIAL; LABOR		Cornell Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, New York, NY 10021 USA; Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Obstet & Gynecol, New York, NY USA	Cornell University; Baylor College of Medicine; Cornell University; NewYork-Presbyterian Hospital	Kalish, RB (corresponding author), Cornell Univ, Dept Obstet & Gynecol, Div Maternal Fetal Med, New York, NY 10021 USA.	robinkal@aol.com	Sampiev, Abdulmutalip/N-4757-2019; Chervenak, Frank/P-3555-2017	Sampiev, Abdulmutalip/0000-0002-5100-2239; Chervenak, Frank/0000-0002-4600-0853				Anderson GM, 2004, BMJ-BRIT MED J, V329, P696, DOI 10.1136/bmj.329.7468.696; Creasy RK, 2004, MATERNAL FETAL MED; CUNNINGHAM FG, 2001, WILLIIAMS OBSTET; Hannah ME, 2004, CAN MED ASSOC J, V170, P813, DOI 10.1503/cmaj.1032002; Hannah ME, 2002, JAMA-J AM MED ASSOC, V287, P1822, DOI 10.1001/jama.287.14.1822; James D.K., 2006, HIGH RISK PREGNANCY, V3rd ed.; Kalish RB, 2004, OBSTET GYNECOL, V103, P1137, DOI 10.1097/01.AOG.0000128118.37737.df; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Minkoff H, 2003, NEW ENGL J MED, V348, P946, DOI 10.1056/NEJMsb022734; Nicolaides KH, 2005, AM J OBSTET GYNECOL, V193, P322, DOI 10.1016/j.ajog.2005.02.134; Osis MJD, 2001, INT J GYNECOL OBSTET, V75, pS59, DOI 10.1016/S0020-7292(01)00518-5; Schenker JG, 1999, INT J GYNECOL OBSTET, V64, P317; Whitney SN, 2004, ANN INTERN MED, V140, P54, DOI 10.7326/0003-4819-140-1-200401060-00012; 2006, FED REG, V71, P5346	14	20	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					883	885		10.1016/S0140-6736(06)68359-1	http://dx.doi.org/10.1016/S0140-6736(06)68359-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546524				2022-12-28	WOS:000236242100008
J	Katsuki, H; Chiba, H; Girard, B; Meier, C; Ohmori, K				Katsuki, H; Chiba, H; Girard, B; Meier, C; Ohmori, K			Visualizing picometric quantum ripples of ultrafast wave-packet interference	SCIENCE			English	Article							KINETIC-ENERGY PHOTOELECTRON; FRACTIONAL REVIVALS; PUMP-PROBE; DYNAMICS; SPECTROSCOPY; I-2; PHOTOIONIZATION; INTERFEROMETER; DIFFRACTION; EVOLUTION	Interference fringes in vibrating molecules are a signature of quantum mechanics, but are often so short-lived and closely spaced that they elude visualization. We have experimentally visualized dynamical quantum interferences, which appear and disappear in less than 100 femtoseconds in the iodine molecule synchronously with the periodic crossing of two counterpropagating nuclear wave packets. The obtained images have picometer and femtosecond spatiotemporal resolution, representing a detailed picture of the quantum interference.	Univ Toulouse 3, CNRS, Inst Rech Syst Atom & Mol Complexes, Lab Collis Agregats,UMR 5589, F-31062 Toulouse, France; Inst Mol Sci, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies SOKENDAI, Okazaki, Aichi 4448585, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan	Meier, C (corresponding author), Univ Toulouse 3, CNRS, Inst Rech Syst Atom & Mol Complexes, Lab Collis Agregats,UMR 5589, F-31062 Toulouse, France.	chris@irsamc.ups-tlse.fr; ohmori@ims.ac.jp	Girard, Bertrand/A-8522-2012; Katsuki, Hiroyuki/AAT-3269-2021	Katsuki, Hiroyuki/0000-0002-7879-3042; Ohmori, Kenji/0000-0001-9584-5177				Andrews MR, 1997, SCIENCE, V275, P637, DOI 10.1126/science.275.5300.637; Assion A, 1996, PHYS REV A, V54, pR4605, DOI 10.1103/PhysRevA.54.R4605; Averbukh IS, 1996, PHYS REV LETT, V77, P3518, DOI 10.1103/PhysRevLett.77.3518; AVERBUKH IS, 1989, PHYS LETT A, V139, P449, DOI 10.1016/0375-9601(89)90943-2; BAUMERT T, 1992, CHEM PHYS LETT, V191, P639, DOI 10.1016/0009-2614(92)85602-7; Bihary Z, 2004, J CHEM PHYS, V120, P7576, DOI 10.1063/1.1689958; BOWMAN RM, 1989, CHEM PHYS LETT, V161, P297, DOI 10.1016/0009-2614(89)85088-2; BRAUN M, 1995, J CHEM PHYS, V103, P7907, DOI 10.1063/1.470208; Brezger B, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.100404; Davisson C, 1927, PHYS REV, V30, P705, DOI 10.1103/PhysRev.30.705; Degert J, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.041402; FISCHER I, 1995, J CHEM PHYS, V102, P5566, DOI 10.1063/1.469285; Fischer I, 1996, CHEM PHYS, V207, P331, DOI 10.1016/0301-0104(95)00404-1; Gregoire G, 1998, EUR PHYS J D, V1, P187, DOI 10.1007/s100530050079; GRUEBELE M, 1993, J CHEM PHYS, V98, P883, DOI 10.1063/1.464253; Heufelder J, 1997, CHEM PHYS LETT, V269, P1, DOI 10.1016/S0009-2614(97)00240-6; KASEVICH M, 1991, PHYS REV LETT, V67, P181, DOI 10.1103/PhysRevLett.67.181; Knockel H, 2004, EUR PHYS J D, V28, P199, DOI 10.1140/epjd/e2003-00313-4; Knospe O, 1996, PHYS REV A, V54, P1154, DOI 10.1103/PhysRevA.54.1154; Leichtle C, 1996, PHYS REV LETT, V77, P3999, DOI 10.1103/PhysRevLett.77.3999; Lohmuller T, 2004, J CHEM PHYS, V120, P10442, DOI 10.1063/1.1711809; MARTON L, 1953, PHYS REV, V90, P490, DOI 10.1103/PhysRev.90.490; Nicole C, 1999, J CHEM PHYS, V111, P7857, DOI 10.1063/1.480121; Ohmori K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.093002; Petersen C, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.033404; Schleich W. P., 2001, QUANTUM OPTICS PHASE; Skovsen E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.133004; STAPELFELDT H, 1995, PHYS REV LETT, V74, P3780, DOI 10.1103/PhysRevLett.74.3780; Szriftgiser P, 1996, PHYS REV LETT, V77, P4, DOI 10.1103/PhysRevLett.77.4; Ungar LW, 1997, ADV CHEM PHYS <D>, V100, P171, DOI 10.1002/9780470141595.ch2; VRAKKING MJJ, 1996, PHYS REV A, V54, P37; YEAZELL JA, 1990, PHYS REV LETT, V64, P2007, DOI 10.1103/PhysRevLett.64.2007; YEAZELL JA, 1991, PHYS REV A, V43, P5153, DOI 10.1103/PhysRevA.43.5153	35	104	105	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1589	1592		10.1126/science.1121240	http://dx.doi.org/10.1126/science.1121240			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543456				2022-12-28	WOS:000236029500040
J	Bjornerud, MG; Austrheim, H				Bjornerud, MG; Austrheim, H			Hot fluids or rock in eclogite metamorphism?	NATURE			English	Editorial Material							DEEP CRUST; ECLOGITIZATION; DEFORMATION		Lawrence Univ, Dept Geol, Appleton, WI 54912 USA; Univ Oslo, Dept Earth Sci, Phys Geol Proc Project, N-0316 Oslo, Norway	Lawrence University; University of Oslo	Bjornerud, MG (corresponding author), Lawrence Univ, Dept Geol, Appleton, WI 54912 USA.	bjornerm@lawrence.edu	Austrheim, Håkon/AAT-7057-2021					AUSTRHEIM H, 1985, CHEM GEOL, V50, P267, DOI 10.1016/0009-2541(85)90124-X; AUSTRHEIM H, 1994, SCIENCE, V265, P82, DOI 10.1126/science.265.5168.82; Bjornerud MG, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000527; Camacho A, 2005, NATURE, V435, P1191, DOI 10.1038/nature03643; Jackson JA, 2004, GEOLOGY, V32, P625, DOI 10.1130/G20397.1; Jamtveit B, 2000, NATURE, V408, P75, DOI 10.1038/35040537; Mackwell SJ, 1998, J GEOPHYS RES-SOL EA, V103, P975, DOI 10.1029/97JB02671; RUBEY D, 1990, DEFORMATION PROCESSE, P262	8	7	7	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					E4	E4		10.1038/nature04714	http://dx.doi.org/10.1038/nature04714			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541027	Bronze			2022-12-28	WOS:000235997600042
J	Czech, MP				Czech, MP			MicroRNAs as therapeutic targets	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RNAS		Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.							Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Eckstein F, 2005, TRENDS BIOCHEM SCI, V30, P445, DOI 10.1016/j.tibs.2005.06.008; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	5	101	157	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1194	1195		10.1056/NEJMcibr060065	http://dx.doi.org/10.1056/NEJMcibr060065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540623				2022-12-28	WOS:000235981700018
J	Holmes, DR; Teirstein, P; Satler, L; Sketch, M; O'Malley, J; Popma, JJ; Kuntz, RE; Fitzgerald, PJ; Wang, H; Caramanica, E; Cohen, SA				Holmes, DR; Teirstein, P; Satler, L; Sketch, M; O'Malley, J; Popma, JJ; Kuntz, RE; Fitzgerald, PJ; Wang, H; Caramanica, E; Cohen, SA		SISR Investigators	Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents - The SISR randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GAMMA-RADIATION THERAPY; INTRACORONARY BETA-RADIATION; FOLLOW-UP; BALLOON ANGIOPLASTY; INHIBIT RESTENOSIS; CLINICAL-OUTCOMES; STANDARD STENT; SLOW-RELEASE; CORONARY; PACLITAXEL	Context Although vascular brachytherapy is the only approved therapy for restenosis following bare-metal stent implantation, drug-eluting stents are now being used. Data on the relative merits of each are limited. Objective To determine the safety and efficacy of the sirolimus-eluting stent compared with vascular brachytherapy for the treatment of patients with restenosis within a bare-metal stent. Design, Setting, and Patients Prospective, multicenter, randomized trial of 384 patients with in-stent restenosis who were enrolled between February 2003 and July 2004 at 26 academic and community medical centers. Data presented represent all follow-up as of June 30, 2005. Interventions Vascular brachytherapy (n = 125) or the sirolimus-eluting stent (n = 259). Main Outcome Measure Target vessel failure (cardiac death, myocardial infarction, or target vessel revascularization) at 9 months postprocedure. Results Baseline patient characteristics were well matched. Lesion length was similar between vascular brachytherapy and sirolimus-eluting stent patients (mean [SD], 16.76 [8.55] mm vs 17.22 [7.97] mm, respectively; P = .61). Procedural success was 99.2% (124/125) in the vascular brachytherapy group and 97.3% (250/257) in the sirolimus-eluting stent group (P = .28). The rate of target vessel failure was 21.6% (27/125) with vascular brachytherapy and 12.4% (32/259) with the sirolimus-eluting stent (relative risk [RR], 1.7; 95% confidence interval [CI], 1.1-2.8; P = .02). Target lesion revascularization was required in 19.2% (24/125) of the vascular brachytherapy group and 8.5% (22/259) of the sirolimus-eluting stent group (RR, 2.3 [ 95% CI, 1.3-3.9]; P = .004). At follow-up angiography, the rate of binary angiographic restenosis for the analysis segment was 29.5% (31/105) for the vascular brachytherapy group and 19.8% (45/227) for the sirolimus-eluting stent group (RR, 1.5 [ 95% CI, 1.0-2.2]; P = .07). Compared with the vascular brachytherapy group, minimal lumen diameter was larger in the sirolimus-eluting stent group at 6-month follow-up (mean [ SD], 1.52 [0.63] mm vs 1.80 [ 0.63] mm; P < .001), reflecting greater net lumen gain in the analysis segment (0.68 [0.60] vs 1.0 [0.61] mm; P < .001) due to stenting and no edge restenosis. Conclusion Sirolimus-eluting stents result in superior clinical and angiographic outcomes compared with vascular brachytherapy for the treatment of restenosis within a bare-metal stent.	Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA; Scripts Clin, La Jolla, CA USA; Washington Hosp Ctr, Dept Cardiol, Washington, DC 20010 USA; Duke Univ, Med Ctr, Dept Cardiol, Durham, NC USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Cardiol, Boston, MA 02115 USA; Stanford Univ, Med Ctr, Dept Cardiol, Stanford, CA 94305 USA; Cordis Corp, Warren, NJ USA; Hosp Univ Penn, Dept Cardiol, Philadelphia, PA 19104 USA	Mayo Clinic; MedStar Washington Hospital Center; Duke University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Stanford University; Johnson & Johnson; Johnson & Johnson USA; University of Pennsylvania; Pennsylvania Medicine	Holmes, DR (corresponding author), Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	holmes.david@mayo.edu						Ahmed JM, 2000, CIRCULATION, V102, P7, DOI 10.1161/01.CIR.102.1.7; Commeau P, 2005, CATHETER CARDIO INTE, V66, P158, DOI 10.1002/ccd.20441; Degertekin M, 2003, J AM COLL CARDIOL, V41, P184, DOI 10.1016/S0735-1097(02)02704-3; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Goy JJ, 2005, J AM COLL CARDIOL, V45, P308, DOI 10.1016/j.jacc.2004.10.062; Grise MA, 2002, CIRCULATION, V105, P2737, DOI 10.1161/01.CIR.0000018126.87045.E0; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Kasaoka S, 1998, J AM COLL CARDIOL, V32, P1630, DOI 10.1016/S0735-1097(98)00404-5; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; KASTRATI A, 2005, JAMA-J AM MED ASSOC, V294, P519; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Neumann FJ, 2005, CIRCULATION, V111, P2107, DOI 10.1161/01.CIR.0000162467.53001.6B; POCOCK SJ, 1976, J CHRON DIS, V29, P175, DOI 10.1016/0021-9681(76)90044-8; Popma JJ, 2002, CIRCULATION, V106, P1090, DOI 10.1161/01.CIR.0000027814.96651.72; Radke PW, 2004, EUR HEART J, V25, P920, DOI 10.1016/j.ehj.2004.02.014; Regar E, 2002, CIRCULATION, V106, P1949, DOI 10.1161/01.CIR.0000034045.36219.12; Saia F, 2004, CATHETER CARDIO INTE, V62, P283, DOI 10.1002/ccd.20068; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Smith SC, 2001, CIRCULATION, V103, P3019, DOI 10.1161/01.CIR.103.24.3019; Sousa JE, 2003, CIRCULATION, V107, P24, DOI 10.1161/01.CIR.0000047063.22006.41; Sousa JE, 2003, CIRCULATION, V107, P381, DOI 10.1161/01.CIR.0000051720.59095.6D; Stone GW, 2004, CIRCULATION, V109, P1942, DOI 10.1161/01.CIR.0000127110.49192.72; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; Teirstein PS, 2000, CIRCULATION, V101, P360, DOI 10.1161/01.CIR.101.4.360; Teirstein PS, 1997, NEW ENGL J MED, V336, P1697, DOI 10.1056/NEJM199706123362402; Virmani R, 1999, CURR OPIN LIPIDOL, V10, P499, DOI 10.1097/00041433-199912000-00004; Waksman R, 2000, CIRCULATION, V101, P2165, DOI 10.1161/01.CIR.101.18.2165; Waksman R, 2004, CIRCULATION, V109, P340, DOI 10.1161/01.CIR.0000109488.62415.01; Waksman R, 2002, NEW ENGL J MED, V346, P1194, DOI 10.1056/NEJMoa012579; Waksman R, 2002, LANCET, V359, P551, DOI 10.1016/S0140-6736(02)07741-3	38	197	209	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2006	295	11					1264	1273		10.1001/jama.295.11.1264	http://dx.doi.org/10.1001/jama.295.11.1264			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021GV	16531619				2022-12-28	WOS:000235972600024
J	Delaney, B				Delaney, B			Commentary: Is society losing control of the medical research agenda?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Birmingham, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Delaney, B (corresponding author), Univ Birmingham, Birmingham B15 2TT, W Midlands, England.	b.c.delaney@bham.ac.uk	Delaney, Brendan C/C-5578-2008	Delaney, Brendan/0000-0002-3518-0131				Department of Health, 2006, BEST RES BEST HLTH; DOUGLAS K, 1987, M THATCHER INTE 0923; *NAT I HLTH CLIN E, 2004, MAN DYSP AD PAT PRIM; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; SOO S, 2001, COCHRANE LIB; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101	6	11	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 6	2006	332	7549					1063	1064		10.1136/bmj.38771.471563.80	http://dx.doi.org/10.1136/bmj.38771.471563.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16547013	Green Published, Bronze			2022-12-28	WOS:000237518400016
J	Kitajima, TS; Sakuno, T; Ishiguro, K; Iemura, S; Natsume, T; Kawashima, SA; Watanabe, Y				Kitajima, TS; Sakuno, T; Ishiguro, K; Iemura, S; Natsume, T; Kawashima, SA; Watanabe, Y			Shugoshin collaborates with protein phosphatase 2A to protect cohesin	NATURE			English	Article							MEIOSIS-I; OKADAIC ACID; SISTER CHROMATIDS; KINASE CDC5; PHOSPHORYLATION; CENTROMERES; CHROMOSOME; MITOSIS; MAINTENANCE; SEPARATION	Sister chromatid cohesion, mediated by a complex called cohesin, is crucial-particularly at centromeres-for proper chromosome segregation in mitosis and meiosis. In animal mitotic cells, phosphorylation of cohesin promotes its dissociation from chromosomes, but centromeric cohesin is protected by shugoshin until kinetochores are properly captured by the spindle microtubules. However, the mechanism of shugoshin-dependent protection of cohesin is unknown. Here we find a specific subtype of serine/threonine protein phosphatase 2A (PP2A) associating with human shugoshin. PP2A colocalizes with shugoshin at centromeres and is required for centromeric protection. Purified shugoshin complex has an ability to reverse the phosphorylation of cohesin in vitro, suggesting that dephosphorylation of cohesin is the mechanism of protection at centromeres. Meiotic shugoshin of fission yeast also associates with PP2A, with both proteins collaboratively protecting Rec8-containing cohesin at centromeres. Thus, we have revealed a conserved mechanism of centromeric protection of eukaryotic chromosomes in mitosis and meiosis.	Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; Univ Tokyo, Grad Program Biophys & Biochem, Tokyo 1130032, Japan; Japan Sci & Technol Agcy, SORST, Tokyo 1130032, Japan; Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo 1350064, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Watanabe, Y (corresponding author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Ishiguro, Kei-ichiro/K-3340-2019; Kitajima, Tomoya/A-7049-2016; Sakuno, Takeshi/Y-9478-2019; Natsume, Tohru/M-7627-2018; Kawashima, Shigehiro/Q-6937-2017	Ishiguro, Kei-ichiro/0000-0002-7515-1511; Kitajima, Tomoya/0000-0002-6486-7143; Natsume, Tohru/0000-0002-1510-2582; Watanabe, Yoshinori/0000-0002-5488-4812				Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Clarke AS, 2005, DEV CELL, V8, P53, DOI 10.1016/j.devcel.2004.12.003; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Hamant O, 2005, CURR BIOL, V15, P948, DOI 10.1016/j.cub.2005.04.049; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jiang W, 2000, GENETICS, V154, P1025; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Le Goff X, 2001, FEBS LETT, V508, P136, DOI 10.1016/S0014-5793(01)03047-2; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Mailhes JB, 2003, CHROMOSOME RES, V11, P619, DOI 10.1023/A:1024909119593; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Milutinovich M, 2003, SCIENCE, V300, P1101, DOI 10.1126/science.1084478; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Uhlmann F, 2003, CURR BIOL, V13, pR104, DOI 10.1016/S0960-9822(03)00039-3; VANDOLAH FM, 1992, J CELL PHYSIOL, V152, P190, DOI 10.1002/jcp.1041520124; VANDRE DD, 1992, J CELL SCI, V101, P79; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003	36	437	458	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					46	52		10.1038/nature04663	http://dx.doi.org/10.1038/nature04663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16541025				2022-12-28	WOS:000237248600029
J	Jones, RB; Pearson, J; Cawsey, AJ; Bental, D; Barrett, A; White, J; White, CA; Gilmour, WH				Jones, RB; Pearson, J; Cawsey, AJ; Bental, D; Barrett, A; White, J; White, CA; Gilmour, WH			Effect of different forms of information produced for cancer patients on their use of the information, social support, and anxiety: randomised trial	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; DEPRESSION; INTERVENTIONS; ADJUSTMENT; DISEASE; NEEDS	Objective To explore the hypothesis that different methods of selecting and printing information for cancer patients could improve emotional support by affecting interaction with others, and so lead to improved psychological wellbeing. Design Randomised trial with eight groups (three factors, 2x2x2). Data collected at recruitment and three month follow-up. Participants 400 patients starting radiotherapy, Of whom 325 with breast or prostate cancer and complete anxiety and depression data were included in the analysis. Interventions Printed booklets: half had only general information from CancerBACUP about each patients cancer and half had personalised information from the patient's medical record plus selected general information; half were composed of information chosen interactively by the patient and half were produced automatically with a larger volume of material; mid half had additional advice on anxiety management. Main outcome measures Patients' views of the information, use of their booklets with others; change in reported social support; change in anxiety and depression. Results The larger booklets produced automatically were more likely to be found useful and to tell patients something new and less likely to be seen as too limited than the booklets produced interactively, but they were also more likely to overwhelm some patients. Personalised booklets were more likely than general booklets to tell patients something new. There was no difference in patients' perceived understanding of their cancer by any of the intervention factors. Patients with personalised information were more likely to show their booklets to others and to think it helped in discussing their, cancer or its treatment. There were no major differences in social support, anxiety, or depression by an), intervention factors. Conclusions Patients were more likely to show personalised information to their confidants than general information. Further research is needed into the effects of sharing information on patients' social Support and anxiety.	Univ Plymouth, Fac Hlth & Social Work, Plymouth PL4 8AA, Devon, England; Ayrshire Cent Hosp, NHS Ayrshire & Arran, Irvine KA12 8SS, Scotland; Univ Glasgow, Div Community Based Sci, Publ Hlth & Hlth Policy Sect, Glasgow G12 8QQ, Lanark, Scotland; Heriot Watt Univ, Sch Math & Comp Sci, Edinburgh, Midlothian, Scotland; Univ E Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; Greater Glasgow Primary Care NHS Trust, STEPS, Glasgow G42 8AT, Lanark, Scotland	University of Plymouth; University of Glasgow; Heriot Watt University; University of East Anglia	Jones, RB (corresponding author), Univ Plymouth, Fac Hlth & Social Work, Drake Circus, Plymouth PL4 8AA, Devon, England.	ray.jones@plymouth.ac.uk		White, Craig/0000-0001-8695-8014				AYMANNS P, 1995, BRIT J SOC PSYCHOL, V34, P107, DOI 10.1111/j.2044-8309.1995.tb01051.x; Brown RF, 2001, BRIT J CANCER, V85, P1273, DOI 10.1054/bjoc.2001.2073; De Boer MF, 1999, PATIENT EDUC COUNS, V37, P215, DOI 10.1016/S0738-3991(99)00029-4; Drury M, 2000, BRIT J GEN PRACT, V50, P105; Edwards B, 2004, PSYCHO-ONCOLOGY, V13, P562, DOI 10.1002/pon.773; Fallowfield L, 1997, PATIENT EDUC COUNS, V30, P209, DOI 10.1016/S0738-3991(96)00947-0; Febbraro GAR, 1999, BEHAV THER, V30, P209, DOI 10.1016/S0005-7894(99)80004-5; Gatherer L, 2000, BRIT MED J, V321, P48; Helgeson VS, 1996, HEALTH PSYCHOL, V15, P135, DOI 10.1037/0278-6133.15.2.135; Helgeson VS, 1999, ARCH GEN PSYCHIAT, V56, P340, DOI 10.1001/archpsyc.56.4.340; Jones R, 1999, BRIT MED J, V319, P1241, DOI 10.1136/bmj.319.7219.1241; Jones R, 2002, PATIENT EDUC COUNS, V47, P369, DOI 10.1016/S0738-3991(02)00011-3; Kiss A, 2001, BMJ-BRIT MED J, V323, P1055, DOI 10.1136/bmj.323.7320.1055; Meredith C, 1996, BMJ-BRIT MED J, V313, P724; MILLER SM, 1995, CANCER, V76, P167, DOI 10.1002/1097-0142(19950715)76:2<167::AID-CNCR2820760203>3.0.CO;2-K; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	17	50	52	1	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 22	2006	332	7547					942	946A		10.1136/bmj.38807.571042.68	http://dx.doi.org/10.1136/bmj.38807.571042.68			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037JV	16597660	Green Published, Bronze			2022-12-28	WOS:000237143900016
J	Antman, EM; Morrow, DA; McCabe, CH; Murphy, SA; Ruda, M; Sadowski, Z; Budaj, A; Lopez-Sendon, JL; Guneri, S; Jiang, F; White, HD; Fox, KAA; Braunwald, E				Antman, EM; Morrow, DA; McCabe, CH; Murphy, SA; Ruda, M; Sadowski, Z; Budaj, A; Lopez-Sendon, JL; Guneri, S; Jiang, F; White, HD; Fox, KAA; Braunwald, E		ExTRACT-TIMI 25 Investigators	Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE PLASMINOGEN-ACTIVATOR; EARLY INTRAVENOUS HEPARIN; MOLECULAR-WEIGHT HEPARIN; THROMBOLYSIS; THERAPY; REPERFUSION; ASPIRIN; REINFARCTION; REOCCLUSION; TRIAL	Background: Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients with ST-elevation myocardial infarction. We compared a low-molecular-weight heparin, enoxaparin, with unfractionated heparin for this purpose. Methods: We randomly assigned 20,506 patients with ST-elevation myocardial infarction who were scheduled to undergo fibrinolysis to receive enoxaparin throughout the index hospitalization or weight-based unfractionated heparin for at least 48 hours. The primary efficacy end point was death or nonfatal recurrent myocardial infarction through 30 days. Results: The primary end point occurred in 12.0 percent of patients in the unfractionated heparin group and 9.9 percent of those in the enoxaparin group (17 percent reduction in relative risk, P < 0.001). Nonfatal reinfarction occurred in 4.5 percent of the patients receiving unfractionated heparin and 3.0 percent of those receiving enoxaparin (33 percent reduction in relative risk, P < 0.001); 7.5 percent of patients given unfractionated heparin died, as did 6.9 percent of those given enoxaparin (P=0.11). The composite of death, nonfatal reinfarction, or urgent revascularization occurred in 14.5 percent of patients given unfractionated heparin and 11.7 percent of those given enoxaparin (P < 0.001); major bleeding occurred in 1.4 percent and 2.1 percent, respectively (P < 0.001). The composite of death, nonfatal reinfarction, or nonfatal intracranial hemorrhage (a measure of net clinical benefit) occurred in 12.2 percent of patients given unfractionated heparin and 10.1 percent of those given enoxaparin (P < 0.001). Conclusions: In patients receiving fibrinolysis for ST-elevation myocardial infarction, treatment with enoxaparin throughout the index hospitalization is superior to treatment with unfractionated heparin for 48 hours but is associated with an increase in major bleeding episodes. These findings should be interpreted in the context of net clinical benefit.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Cardiol Res Ctr, Dept Emergency Cardiol, Moscow 121552, Russia; Natl Inst Cardiol, Warsaw, Poland; Grochowski Hosp, Postgrad Med Sch, Dept Cardiol, Warsaw, Poland; Hosp Univ La Paz, Madrid, Spain; Dokuz Eylul Univ, Izmir, Turkey; Sanofi Aventis, Int Clin Dev, Bridgewater, NJ USA; Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; Univ Edinburgh, Edinburgh, Midlothian, Scotland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Medical Research Center of Cardiology; Institute of Cardiology - Poland; Centre of Postgraduate Medical Education - Poland; Hospital Universitario La Paz; Dokuz Eylul University; Sanofi-Aventis; Auckland City Hospital; University of Edinburgh	Antman, EM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA.	eantman@rics.bwh.harvard.edu	Fox, keith A A/I-3742-2013	Budaj, Andrzej/0000-0002-6395-2098; Fox, Keith/0000-0002-0140-2752				[Anonymous], 1990, LANCET, V336, P65; Antman EM, 2005, AM HEART J, V149, P217, DOI 10.1016/j.ahj.2004.08.038; Antman EM, 1996, CIRCULATION, V94, P911, DOI 10.1161/01.CIR.94.5.911; Antman EM, 2001, CIRCULATION, V103, P2310; ANTMAN EM, 2004, ACC AHA GUIDELINES M; DEBONO DP, 1992, BRIT HEART J, V67, P122; Eikelboom JW, 2005, CIRCULATION, V112, P3855, DOI 10.1161/CIRCULATIONAHA.105.573550; GASH AK, 1986, AM J CARDIOL, V57, P175, DOI 10.1016/0002-9149(86)90975-6; Gibson CM, 2003, J AM COLL CARDIOL, V42, P7, DOI 10.1016/S0735-1097(03)00506-0; GULBA DC, 1991, CIRCULATION, V83, P937, DOI 10.1161/01.CIR.83.3.937; HARRISON DG, 1984, CIRCULATION, V69, P991, DOI 10.1161/01.CIR.69.5.991; HSIA J, 1990, NEW ENGL J MED, V323, P1433, DOI 10.1056/NEJM199011223232101; HUNT D, 1992, LANCET, V339, P753; MUELLER HS, 1995, J AM COLL CARDIOL, V26, P900, DOI 10.1016/0735-1097(95)00270-1; OHMAN EM, 1990, CIRCULATION, V82, P781, DOI 10.1161/01.CIR.82.3.781; THOMPSON PL, 1991, CIRCULATION, V83, P1534, DOI 10.1161/01.CIR.83.5.1534; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; TOPOL EJ, 1989, CIRCULATION, V79, P281, DOI 10.1161/01.CIR.79.2.281; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; VandeWerf F, 1997, NEW ENGL J MED, V337, P1124; Wallentin L, 2003, CIRCULATION, V108, P135, DOI 10.1161/01.CIR.0000081659.72985.A8; Weitz JI, 1997, NEW ENGL J MED, V337, P1567	24	404	445	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1477	1488		10.1056/NEJMoa060898	http://dx.doi.org/10.1056/NEJMoa060898			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16537665	Green Submitted, Green Published			2022-12-28	WOS:000236539000006
J	Hozumi, S; Maeda, R; Taniguchi, K; Kanai, M; Shirakabe, S; Sasamura, T; Speder, P; Noselli, S; Aigaki, T; Murakami, R; Matsuno, K				Hozumi, S; Maeda, R; Taniguchi, K; Kanai, M; Shirakabe, S; Sasamura, T; Speder, P; Noselli, S; Aigaki, T; Murakami, R; Matsuno, K			An unconventional myosin in Drosophila reverses the default handedness in visceral organs	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; DYNAMICS; EMBRYO; CYTOSKELETON; EXPRESSION; POLARITY; HINDGUT; GTPASES; TISSUE; MEMORY	The internal organs of animals often have left - right asymmetry(1,2). Although the formation of the anterior - posterior and dorsal ventral axes in Drosophila is well understood, left - right asymmetry has not been extensively studied. Here we find that the handedness of the embryonic gut and the adult gut and testes is reversed ( not randomized) in viable and fertile homozygous Myo31DF mutants. Myo31DF encodes an unconventional myosin, Drosophila MyoIA ( also referred to as MyoID in mammals; refs 3, 4), and is the first actin-based motor protein to be implicated in left - right patterning. We find that Myo31DF is required in the hindgut epithelium for normal embryonic handedness. Disruption of actin filaments in the hindgut epithelium randomizes the handedness of the embryonic gut, suggesting that Myo31DF function requires the actin cytoskeleton. Consistent with this, we find that Myo31DF colocalizes with the cytoskeleton. Overexpression of Myo61F, another myosin I ( ref. 4), reverses the handedness of the embryonic gut, and its knockdown also causes a left - right patterning defect. These two unconventional myosin I proteins may have antagonistic functions in left - right patterning. We suggest that the actin cytoskeleton and myosin I proteins may be crucial for generating left - right asymmetry in invertebrates.	Tokyo Univ Sci, Dept Biol Sci & Technol, Chiba 2788510, Japan; Tokyo Univ Sci, Genome & Drug Res Ctr, Chiba 2788510, Japan; Univ Nice, Inst Signalling Dev Biol & Canc, CNRS, UMR6543, F-06108 Nice 2, France; Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan; Yamaguchi Univ, Dept Phys Biol & Informat, Yamaguchi 7538512, Japan	Tokyo University of Science; Tokyo University of Science; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Tokyo Metropolitan University; Yamaguchi University	Matsuno, K (corresponding author), Tokyo Univ Sci, Dept Biol Sci & Technol, 2641 Yamazaki, Chiba 2788510, Japan.	matsuno@rs.noda.tus.ac.jp	Taniguchi, Kiichiro/ACL-8906-2022; Hozumi, Shunya/Q-8610-2019; Kanai, Motomu/J-6807-2016	Taniguchi, Kiichiro/0000-0003-2321-7280; Kanai, Motomu/0000-0003-1977-7648; Maeda, Reo/0000-0002-2727-3012; Speder, Pauline/0000-0002-2934-5841; Noselli, stephane/0000-0002-7296-324X				Adam G, 2003, DEVELOPMENT, V130, P2397, DOI 10.1242/dev.00460; BRAND AH, 1993, DEVELOPMENT, V118, P401; EATON S, 1995, J CELL BIOL, V131, P151, DOI 10.1083/jcb.131.1.151; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frydman HM, 2001, DEVELOPMENT, V128, P3209; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Hayashi M, 2005, DEV GROWTH DIFFER, V47, P457, DOI 10.1111/j.1440-169X.2005.00817.x; Hayashi T, 2001, DEV GROWTH DIFFER, V43, P239; Huber LA, 2000, TRAFFIC, V1, P494, DOI 10.1034/j.1600-0854.2000.010607.x; Iwaki DD, 2001, DEV BIOL, V240, P611, DOI 10.1006/dbio.2001.0483; Iwaki DD, 2002, MECH DEVELOP, V114, P71, DOI 10.1016/S0925-4773(02)00061-8; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Ligoxygakis P, 2001, DEVELOPMENT, V128, P1171; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MartinBermudo MD, 1997, EMBO J, V16, P4184, DOI 10.1093/emboj/16.14.4184; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mercola M, 2001, ANNU REV CELL DEV BI, V17, P779, DOI 10.1146/annurev.cellbio.17.1.779; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; Pascual A, 2004, NATURE, V427, P605, DOI 10.1038/427605a; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; SULLIVAN W, 2000, PROTOCOLS; Tracey WD, 2000, GENETICS, V154, P273; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; Wood WB, 1997, ANNU REV CELL DEV BI, V13, P53	29	135	140	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					798	802		10.1038/nature04625	http://dx.doi.org/10.1038/nature04625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598258				2022-12-28	WOS:000236548400042
J	Rodondi, N; Peng, T; Karter, AJ; Bauer, DC; Vittinghoff, E; Tang, S; Pettitt, D; Kerr, EA; Selby, JV				Rodondi, N; Peng, T; Karter, AJ; Bauer, DC; Vittinghoff, E; Tang, S; Pettitt, D; Kerr, EA; Selby, JV			Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus	ANNALS OF INTERNAL MEDICINE			English	Article							GLYCEMIC CONTROL; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; UNITED-STATES; PRIMARY-CARE; RISK-FACTORS; QUALITY; CHOLESTEROL; MANAGEMENT; HEALTH	Background: Poorly controlled cardiovascular risk factors are common. Evaluating whether physicians respond appropriately to poor risk factor control in patients may better reflect quality of care than measuring proportions of patients whose conditions are controlled. Objectives: To evaluate therapy modifications in response to poor control of hypertension, dyslipidemia, or diabetes in a large clinical population. Design: Retrospective cohort study within an 18-month period in 2002 to 2003. Setting: Kaiser Permanente of Northern California. Patients: 253 238 adult members with poor control of 1 or more of these conditions. Measurements: The authors assessed the proportion of patients with poor control who experienced a change in pharmacotherapy within 6 months, and they defined "appropriate care" as a therapy modification or return to control without therapy modification within 6 months. Results: A total of 64% of patients experienced modifications in therapy for poorly controlled systolic blood pressure, 71% forpoorly controlled diastolic blood pressure, 56% for poorly controlled low-density lipoprotein cholesterol level, and 66% for poorly controlled hemoglobin A, level. Most frequent modifications were increases in number of drug classes (from 70% to 84%) and increased dosage (from 15% to 40%). An additional 7% to 11% of those with poorly controlled blood pressure, but only 3% to 4% of those with elevated low-density lipoprotein cholesterol level or hemoglobin A(1c) level, returned to control without therapy modification. Patients with more than 1 of the 3 conditions, higher baseline values, and target organ damage were more likely to receive "appropriate care." Limitations: Patient preferences and suboptimal adherence to therapy were not measured and may explain some failures to act. Conclusions: As an additional measure of the quality of care, measuring therapy modifications in response to poor control in a large population is feasible. Many patients with poorly controlled hypertension, dyslipidemia, or diabetes had their therapy modified and, thus, seemed to receive clinically "appropriate care" with this new quality measure.	Univ Lausanne, Univ Outpatient Clin, CH-1011 Lausanne, Switzerland; Univ Calif San Francisco, San Francisco, CA 94143 USA; Kaiser Permanente Med Care Program, Oakland, CA 94611 USA; Pfizer Outcomes Res, New York, NY USA; Vet Affairs Healthcare Syst, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA	University of Lausanne; University of California System; University of California San Francisco; Kaiser Permanente; Pfizer; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Rodondi, N (corresponding author), Univ Lausanne, Univ Outpatient Clin, Bugnon 44, CH-1011 Lausanne, Switzerland.	nicolas.rodondi@hospvd.ch		Rodondi, Nicolas/0000-0001-9083-6896	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, P30DK020572] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asai Y, 2002, J HUM HYPERTENS, V16, P313, DOI 10.1038/sj.jhh.1001385; Asch Steven M, 2005, BMC Cardiovasc Disord, V5, P1, DOI 10.1186/1471-2261-5-1; Bell RA, 2001, AM J PREV MED, V21, P124, DOI 10.1016/S0749-3797(01)00328-2; Benetos A, 2002, ARCH INTERN MED, V162, P577, DOI 10.1001/archinte.162.5.577; Berlowitz DR, 1998, NEW ENGL J MED, V339, P1957, DOI 10.1056/NEJM199812313392701; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Cook CB, 1999, DIABETES CARE, V22, P1494, DOI 10.2337/diacare.22.9.1494; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; Davis S, 2004, J DIABETES COMPLICAT, V18, P60, DOI 10.1016/S1056-8727(03)00058-8; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; Greenland S, 1995, AM J EPIDEMIOL, V142, P1255, DOI 10.1093/oxfordjournals.aje.a117592; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; KANNEL WB, 2000, AM J HYPERTENS 2, V0013; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; Kerr EA, 2003, MED CARE, V41, P1173, DOI 10.1097/01.MLR.0000088453.57269.29; Kerr EA, 2001, AM J MANAG CARE, V7, P1033; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lenfant C, 1999, JAMA-J AM MED ASSOC, V282, P2068, DOI 10.1001/jama.282.21.2068; *MED ED CO, 2001, PHYS DESK REF; *NAT COMM QUAL INS, HLTH PLAN EMPL DAT I; Oliveria SA, 2002, ARCH INTERN MED, V162, P413, DOI 10.1001/archinte.162.4.413; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Selby JV, 2004, AM J MANAG CARE, V10, P163; Stafford RS, 1997, J AM COLL CARDIOL, V29, P139, DOI 10.1016/S0735-1097(96)00441-X; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Whyte J L, 2001, J Clin Hypertens (Greenwich), V3, P211, DOI 10.1111/j.1524-6175.2001.00461.x; Yarnall KSH, 2003, AM J PUBLIC HEALTH, V93, P635, DOI 10.2105/AJPH.93.4.635; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	43	149	150	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					475	484		10.7326/0003-4819-144-7-200604040-00006	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585661	Green Accepted, Green Submitted			2022-12-28	WOS:000236685100002
J	Hogan, DB				Hogan, DB			Donepezil for severe Alzheimers disease	LANCET			English	Editorial Material							CLINICAL-TRIALS		Univ Calgary, Hlth Sci Ctr, Div Geriatr Med, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Hogan, DB (corresponding author), Univ Calgary, Hlth Sci Ctr, Div Geriatr Med, Calgary, AB T2N 4N1, Canada.	dhogan@ucalgary.ca	Hogan, David Bryan/I-4360-2013	Hogan, David Bryan/0000-0002-9462-5460				Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Gasper Mason C, 2005, Am J Geriatr Pharmacother, V3, P1, DOI 10.1016/j.amjopharm.2005.02.001; Last JM, 2001, DICT EPIDEMIOLOGY, P129; Lopez OL, 2002, J NEUROL NEUROSUR PS, V72, P310, DOI 10.1136/jnnp.72.3.310; PANISSET M, 1994, ARCH NEUROL-CHICAGO, V51, P41, DOI 10.1001/archneur.1994.00540130067012; Rockwood K, 2002, J NEUROL NEUROSUR PS, V73, P500, DOI 10.1136/jnnp.73.5.500; Streiner DL, 2002, CAN J PSYCHIAT, V47, P68; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; van Walraven C, 1999, J CLIN EPIDEMIOL, V52, P717, DOI 10.1016/S0895-4356(99)00050-5; Winblad B, 2006, LANCET, V367, P1057, DOI 10.1016/S0140-6736(06)68350-5	10	19	21	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 1	2006	367	9516					1031	1032		10.1016/S0140-6736(06)68395-5	http://dx.doi.org/10.1016/S0140-6736(06)68395-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581383				2022-12-28	WOS:000236673200004
J	Hooper, L; Thompson, RL; Harrison, RA; Summerbell, CD; Ness, AR; Moore, H; Worthington, HV; Durrington, PN; Higgins, JPT; Capps, NE; Riemersma, RA; Ebrahim, SB; Smith, GD				Hooper, L; Thompson, RL; Harrison, RA; Summerbell, CD; Ness, AR; Moore, H; Worthington, HV; Durrington, PN; Higgins, JPT; Capps, NE; Riemersma, RA; Ebrahim, SB; Smith, GD			Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FISH-OIL-SUPPLEMENTATION; CORONARY-HEART-DISEASE; ALPHA-LINOLENIC ACID; LIPOPROTEIN-CHOLESTEROL LEVELS; ACUTE MYOCARDIAL-INFARCTION; DEPENDENT DIABETIC-PATIENTS; PLACEBO-CONTROLLED TRIAL; LONG-TERM INFLUENCE; DOUBLE-BLIND; SERUM-LIPIDS	Objective 16 review systematically the evidence for an effect of long chain and shorter chain omega 3 fatty acids on total mortality, cardiovascular events, and cancer. Data sources Electronic databases searched to February 2002; authors contacted and bibliographies of randomised controlled trials (RCTs) checked to locate Studies. Review methods Review of RCTs of omega 3 intake 0 for >= 6 months in adults (with Or without risk factors for cardiovascular disease) with data on a relevant outcome. Cohort studies that estimated omega 3 intake and related this to clinical outcome during at least 6 Months were also included. Application of inclusion criteria, data extraction, and quality assessments were performed independently in duplicate. Results Of 15 159 titles and abstracts assessed, 48 RCTs (36 9 13 participants) and 41 cohort studies were analysed. The trial results were inconsistent. The pooled estimate showed no strong evidence of reduced risk of total mortality (relative risk 0.87, 95% confidence interval 0.73 to 1.03) or combined cardiovascular events (0.95, 0.82 to 1.12) in participants taking additional omega 3 fats. The few studies at low risk of bias were more consistent, but the), showed no effect of omega 3 on total mortality (0.98, 0.70 to 1.36) or cardiovascular events (1.09, 0.87 to 1.37). When data from the subgroup Of Studies Of long chain omega 3 fats were analysed separately, total Mortality (0.86, 0.70 to 1.04; 138 events) and cardiovascular events (0.93, 0.79 to 1.11) were not clearly reduced. Neither RCTs nor cohort studies Suggested increased risk of cancer with a higher intake of omega 3 (trials: 1.07, 0.88 to 1.30, cohort studies: 1.02, 0.87 to 1.19), but clinically important harm Could not be excluded. Conclusion Long chain and shorter chain omega 3 fats do not have a clear effect on total mortality, combined cardiovascular events, or cancer.	Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; Univ Southampton, Inst Human Nutr, Southampton SO16 6YD, Hants, England; Bolton Primary Care Trust, Bolton BL1 1PP, England; Univ Teesside, Sch Hlth & Social Care, Middlesbrough TS1 3BA, Cleveland, England; Univ Bristol, Dept Community Based Med, Bristol BS8 1TQ, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Manchester, Sch Dent, Manchester M15 6FH, Lancs, England; Univ Manchester, Dept Med, Manchester M13 9PL, Lancs, England; MRC, Biostat Unit, Cambridge CB2 2SR, England; Shrewsbury & Telford Hosp NHS Trust, Princess Royal Hosp, Dept Clin Biochem, Telford TF1 6TF, Shrops, England; Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	University of East Anglia; University of Southampton; University of Teesside; University of Bristol; University of Bristol; University of Manchester; University of Manchester; MRC Biostatistics Unit; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine	Hooper, L (corresponding author), Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England.	l.hooper@oea.ac.uk	Worthington, Helen V/G-7432-2015; Worthington, Helen/U-8971-2019; Summerbell, Carolyn/AAC-3159-2019; Hooper, Lee/D-2795-2009; Summerbell, Carolyn D/O-3001-2015; Higgins, Julian PT/H-4008-2011; Davey Smith, George/A-7407-2013; Ness, Andy R/M-7612-2013; Summerbell, Carolyn D/O-3759-2015	Worthington, Helen V/0000-0002-4851-7469; Worthington, Helen/0000-0002-4851-7469; Summerbell, Carolyn/0000-0003-1910-9383; Hooper, Lee/0000-0002-7904-3331; Summerbell, Carolyn D/0000-0003-1910-9383; Higgins, Julian PT/0000-0002-8323-2514; Davey Smith, George/0000-0002-1407-8314; Ness, Andy R/0000-0003-3548-9523; Summerbell, Carolyn D/0000-0003-1910-9383; Moore, Helen J/0000-0002-0165-7552; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Harrison, Roger/0000-0001-5909-7669				Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Almallah YZ, 1998, BRIT J SURG, V85, P690; Almallah YZ, 1998, AM J GASTROENTEROL, V93, P804, DOI 10.1111/j.1572-0241.1998.229_a.x; Almallah YZ, 2000, J CLIN IMMUNOL, V20, P68, DOI 10.1023/A:1006698728816; ALMALLAH YZ, 1996, BRIT J SURG, V83, P685; ALMALLAH YZ, 1996, BRIT J SURG, V83, P2; [Anonymous], 2005, BMJ, V331, P266; ASCHERIO A, 1995, NEW ENGL J MED, V332, P977, DOI 10.1056/NEJM199504133321501; BAIRATI I, 1993, CAN J CARDIOL, V9, P225; BAIRATI I, 1992, CIRCULATION, V85, P950, DOI 10.1161/01.CIR.85.3.950; BAIRATI I, 1992, CAN J CARDIOL, V8, P41; BANG HO, 1972, ACTA MED SCAND, V192, P85; BELLAMY CM, 1992, EUR HEART J, V13, P1626, DOI 10.1093/oxfordjournals.eurheartj.a060115; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Bemelmans WJE, 2000, PUBLIC HEALTH NUTR, V3, P273, DOI 10.1017/S1368980000000318; Bemelmans WJE, 2002, AM J CLIN NUTR, V75, P221, DOI 10.1093/ajcn/75.2.221; Bhatnagar D, 2003, INT J CLIN PRACT, V57, P305; Blok WL, 1997, EUR J CLIN INVEST, V27, P1003, DOI 10.1046/j.1365-2362.1997.2240775.x; BONNEMA SJ, 1995, DIABETES NUTR METAB, V8, P81; BORCHGREVINK CF, 1966, LANCET, V2, P187; BORCHGREVINK CF, 1965, LANCET, V2, P980; Brox J, 2001, LIPIDS, V36, P7, DOI 10.1007/s11745-001-0661-4; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; BURR ML, 1992, EUR HEART J, V13, P166, DOI 10.1093/oxfordjournals.eurheartj.a060141; BURR ML, 1989, EUR HEART J, V10, P558, DOI 10.1093/oxfordjournals.eurheartj.a059528; BURR ML, 1991, WORLD REV NUTR DIET, V66, P306; BURR ML, 1994, EUR HEART J, V15, P1152, DOI 10.1093/oxfordjournals.eurheartj.a060645; Chajes V, 1999, LIPIDS, V34, pS113, DOI 10.1007/BF02562253; Cho E, 2001, AM J CLIN NUTR, V73, P209; CONNOR WE, 1993, ANN NY ACAD SCI, V683, P337; DEHMER GJ, 1988, NEW ENGL J MED, V319, P733, DOI 10.1056/NEJM198809223191201; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deslypere J P, 1992, Verh K Acad Geneeskd Belg, V54, P189; Din JN, 2004, BMJ-BRIT MED J, V328, P30, DOI 10.1136/bmj.328.7430.30; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; DOLECEK TA, 1992, P SOC EXP BIOL MED, V200, P177, DOI 10.3181/00379727-200-43413; DRY J, 1991, INT ARCH ALLER A IMM, V95, P156, DOI 10.1159/000235421; Egeland G M, 2001, Int J Circumpolar Health, V60, P143; ERITSLAND J, 1993, THROMB HAEMOSTASIS, V69, P1065; ERITSLAND J, 1995, SCAND J CLIN LAB INV, V55, P295, DOI 10.3109/00365519509104966; ERITSLAND J, 1995, AM J CLIN NUTR, V61, P831, DOI 10.1093/ajcn/61.4.831; ERITSLAND J, 1995, THROMB RES, V77, P337, DOI 10.1016/0049-3848(95)93837-P; ERITSLAND J, 1994, SCAND J CLIN LAB INV, V54, P273, DOI 10.3109/00365519409087522; Eritsland J., 1994, European Heart Journal, V15, P29; ERITSLAND J, 1994, FIBRINOLYSIS, V8, P120, DOI 10.1016/S0268-9499(05)80029-3; Eritsland J, 1996, AM J CARDIOL, V77, P31, DOI 10.1016/S0002-9149(97)89130-8; ERITSLAND J, 1995, BLOOD COAGUL FIBRIN, V6, P17, DOI 10.1097/00001721-199502000-00003; Eritsland J, 1992, THROMB RES, V65, P75; Erkkila AT, 2003, AM J CLIN NUTR, V78, P65, DOI 10.1093/ajcn/78.1.65; FEHILY A M, 1991, Journal of Human Nutrition and Dietetics, V4, P33, DOI 10.1111/j.1365-277X.1991.tb00074.x; FEHILY AM, 1989, J HUMAN NUTR DIETETI, V2; *FOOD STAND AG, 2000, DIOX PCHS UK DIET 19; FRANZEN D, 1993, MED KLIN, V88, P134; FRANZEN D, 1993, CATHETER CARDIO DIAG, V28, P301, DOI 10.1002/ccd.1810280407; Franzosi MG, 2001, PHARMACOECONOMICS, V19, P411, DOI 10.2165/00019053-200119040-00008; GANN PH, 1994, J NATL CANCER I, V86, P281, DOI 10.1093/jnci/86.4.281; Geelen A, 2004, CURR OPIN LIPIDOL, V15, P25, DOI 10.1097/00041433-200402000-00006; GEUSENS P, 1994, ARTHRITIS RHEUM, V37, P824, DOI 10.1002/art.1780370608; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; GREENFIELD SM, 1993, ALIMENT PHARM THERAP, V7, P159; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; GUALLAR E, 1995, J AM COLL CARDIOL, V25, P387, DOI 10.1016/0735-1097(94)00370-6; Harvei S, 1997, INT J CANCER, V71, P545, DOI 10.1002/(SICI)1097-0215(19970516)71:4<545::AID-IJC7>3.0.CO;2-U; HAWTHORNE AB, 1992, GUT, V33, P922, DOI 10.1136/gut.33.7.922; He JA, 1998, HYPERTENSION, V31, P1130, DOI 10.1161/01.HYP.31.5.1130; He K, 2004, STROKE, V35, P1538, DOI 10.1161/01.STR.0000130856.31468.47; He K, 2002, JAMA-J AM MED ASSOC, V288, P3130, DOI 10.1001/jama.288.24.3130; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holmes MD, 1999, JAMA-J AM MED ASSOC, V281, P914, DOI 10.1001/jama.281.10.914; Hooper L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003177.PUB2; Hu FB, 1999, AM J CLIN NUTR, V69, P890; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Hu FB, 2003, CIRCULATION, V107, P1852, DOI 10.1161/01.CIR.0000062644.42133.5F; Ilsey CDJ, 1987, AUSTR NZ J MED, V17, P559; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Johansen O, 1999, ARTERIOSCL THROM VAS, V19, P1681, DOI 10.1161/01.ATV.19.7.1681; Johansen O, 1999, J AM COLL CARDIOL, V33, P1619, DOI 10.1016/S0735-1097(99)00054-6; Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029; Katan MB, 1997, J LIPID RES, V38, P2012; Kato I, 1997, NUTR CANCER, V28, P276, DOI 10.1080/01635589709514588; KAUL U, 1992, INT J CARDIOL, V35, P87, DOI 10.1016/0167-5273(92)90059-C; KINGSBURY KJ, 1974, POSTGRAD MED J, V50, P425, DOI 10.1136/pgmj.50.585.425; Kyle DJ, 1999, LIPIDS, V34, pS245, DOI 10.1007/BF02562306; LAU CS, 1993, BRIT J RHEUMATOL, V32, P982; LAU CS, 1995, CLIN EXP RHEUMATOL, V13, P87; Lau CS, 1991, BRIT J RHEUMATOL, V30, P137; LEAF A, 1994, CIRCULATION, V90, P2248, DOI 10.1161/01.CIR.90.5.2248; Loeschke K, 1996, DIGEST DIS SCI, V41, P2087, DOI 10.1007/BF02093614; LorenzMeyer H, 1996, SCAND J GASTROENTERO, V31, P778, DOI 10.3109/00365529609010352; MACLURE M, 1991, AM J CLIN NUTR, V54, P649, DOI 10.1093/ajcn/54.4.649; MAFFETTONE A, 1996, G ITAL DIABETOL, V16, P185; MAKINEN E, 1991, European Heart Journal, V12, P168; Malaguarnera M, 1999, BIODRUGS, V11, P285, DOI 10.2165/00063030-199911040-00007; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Marchioli R, 2001, EUR HEART J SUPPL, V3, pD85, DOI 10.1016/S1520-765X(01)90126-9; Marchioli R, 1993, G Ital Cardiol, V23, P933; Marchioli R, 2000, EUR HEART J, V21, P949, DOI 10.1053/euhj.1999.1971; Maresta Aleardo, 2002, Am Heart J, V143, pE5, DOI 10.1067/mhj.2002.121805; MATE J, 1991, Gastroenterology, V100, pA228; MCLENNAN PL, 1989, LANCET, V2, P1451; MEHTA VY, 1995, J AM COLL CARDIOL, V26, P696, DOI 10.1016/0735-1097(95)00335-2; MEILAHN EN, 1990, ARTERIOSCLEROSIS, V10, pA916; MEYER F, 1993, CARDIOLOGY BOARD REV, V10; Meyer KA, 2001, DIABETES CARE, V24, P1528, DOI 10.2337/diacare.24.9.1528; MIEDEMA I, 1993, AM J EPIDEMIOL, V138, P37, DOI 10.1093/oxfordjournals.aje.a116775; MIETTINEN TA, 1982, BRIT MED J, V285, P993, DOI 10.1136/bmj.285.6347.993; MILNER MR, 1989, AM J CARDIOL, V64, P294, DOI 10.1016/0002-9149(89)90522-5; MILNER MR, 1988, CIRCULATION, V76, P634; *MIN AGR FISH FOOD, 1998, CONC MENT OTH EL MAR; MORRIS MC, 1995, AM J EPIDEMIOL, V142, P166, DOI 10.1093/oxfordjournals.aje.a117615; Myrup B, 2001, SCAND J CLIN LAB INV, V61, P349, DOI 10.1080/003655101316911387; NATVIG H, 1968, SCAND J CLIN LAB INV, VS 22, P1; Ness AR, 2002, EUR J CLIN NUTR, V56, P512, DOI 10.1038/sj.ejcn.1601342; Ness AR, 2003, NUTR NEUROSCI, V6, P63, DOI 10.1080/1028415021000056069; Ness AR, 1999, J HUM HYPERTENS, V13, P729, DOI 10.1038/sj.jhh.1000913; NETTLETON JA, 1991, J AM DIET ASSOC, V91, P331; Nilsen DWT, 2001, AM J CLIN NUTR, V74, P50; NYE ER, 1990, AUST NZ J MED, V20, P549, DOI 10.1111/j.1445-5994.1990.tb01311.x; Oomen CM, 2000, AM J EPIDEMIOL, V151, P999, DOI 10.1093/oxfordjournals.aje.a010144; Oomen CM, 2001, AM J CLIN NUTR, V74, P457; Patti L, 1999, ATHEROSCLEROSIS, V146, P361, DOI 10.1016/S0021-9150(99)00149-5; Pietinen P, 1997, AM J EPIDEMIOL, V145, P876, DOI 10.1093/oxfordjournals.aje.a009047; REIS GJ, 1990, AM J CARDIOL, V66, P1171, DOI 10.1016/0002-9149(90)91093-L; REIS GJ, 1989, LANCET, V2, P177; REIS GJ, 1991, AM J CARDIOL, V68, P1431, DOI 10.1016/0002-9149(91)90275-P; REIS GJ, 1988, CIRCULATION, V78, P291; REIS GJ, 1988, CIRCULATION, V78, P385; Risher JF, 2002, TOXICOL IND HEALTH, V18, P109, DOI 10.1191/0748233702th138oa; Rissanen T, 2000, CIRCULATION, V102, P2677, DOI 10.1161/01.CIR.102.22.2677; Rivellese AA, 1996, DIABETES CARE, V19, P1207, DOI 10.2337/diacare.19.11.1207; Rossing P, 1996, DIABETES CARE, V19, P1214, DOI 10.2337/diacare.19.11.1214; ROY L, 1991, CIRCULATION S2, V84, P365; SACKS FM, 1995, J AM COLL CARDIOL, V25, P1492, DOI 10.1016/0735-1097(95)00095-L; SACKS FM, 1994, J HYPERTENS, V12, P209, DOI 10.1097/00004872-199402000-00014; SACKS FM, 1994, J HYPERTENS, V12, pS23; SACN, 2004, ADV FISH CONS BEN RI; SARKKINEN ES, 1994, AM J CLIN NUTR, V59, P364, DOI 10.1093/ajcn/59.2.364; SARKKINEN ES, 1994, ATHEROSCLEROSIS, V105, P9, DOI 10.1016/0021-9150(94)90003-5; Sarkkinen ES, 1998, METABOLISM, V47, P744, DOI 10.1016/S0026-0495(98)90040-3; SATTERFIELD S, 1993, AM J PREV MED, V9, P237, DOI 10.1016/S0749-3797(18)30721-9; Schuurman AG, 1999, CANCER, V86, P1019, DOI 10.1002/(SICI)1097-0142(19990915)86:6&lt;1019::AID-CNCR18&gt;3.0.CO;2-H; Scottish Intercollegiate Guidelines Network (SIGN), 2002, CARD REH NAT CLIN GU; Seljeflot I, 1999, THROMB HAEMOSTASIS, V81, P566; SELVAIS PL, 1995, DIABETOLOGIA, V38, P253, DOI 10.1007/BF00400104; SHIMIZU H, 1995, DIABETES RES CLIN PR, V28, P35, DOI 10.1016/0168-8227(95)01056-J; Singh RB, 1997, CARDIOVASC DRUG THER, V11, P485, DOI 10.1023/A:1007757724505; SIPPERLY ME, 1988, CIRCULATION, V78, P614; Sirtori CR, 1998, ATHEROSCLEROSIS, V137, P419, DOI 10.1016/S0021-9150(97)00298-0; Sirtori CR, 1997, AM J CLIN NUTR, V65, P1874, DOI 10.1093/ajcn/65.6.1874; SKOLDSTAM L, 1992, SCAND J RHEUMATOL, V21, P178, DOI 10.3109/03009749209099218; Steenland K, 2004, ENVIRON HEALTH PERSP, V112, P1265, DOI 10.1289/ehp.7219; Terano T, 1999, LIPIDS, V34, pS345, DOI 10.1007/BF02562338; Terry P, 2001, CANCER EPIDEM BIOMAR, V10, P913; THIEN FCK, 1993, AM REV RESPIR DIS, V147, P1138, DOI 10.1164/ajrccm/147.5.1138; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Tornwall ME, 2000, AM J EPIDEMIOL, V151, P892, DOI 10.1093/oxfordjournals.aje.a010293; TROISI RJ, 1995, AM J RESP CRIT CARE, V151, P1401, DOI 10.1164/ajrccm.151.5.7735592; ULLMANN D, 1990, ARTERIOSCLEROSIS, V10, pA881; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; VEALE DJ, 1994, BRIT J RHEUMATOL, V33, P954; Veierod MB, 1997, INT J CANCER, V71, P600, DOI 10.1002/(SICI)1097-0215(19970516)71:4&lt;600::AID-IJC15&gt;3.0.CO;2-F; Veierod MB, 1997, EUR J CANCER PREV, V6, P540, DOI 10.1097/00008469-199712000-00009; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; von Schacky C, 1999, ANN INTERN MED, V130, P554, DOI 10.7326/0003-4819-130-7-199904060-00003; WANG C, 2004, EFFECTS OMEGA 3 FATT; Whelton Paul K., 1997, American Journal of Clinical Nutrition, V65, p652S, DOI 10.1093/ajcn/65.2.652S; WHELTON PK, 1992, JAMA-J AM MED ASSOC, V267, P1213, DOI 10.1001/jama.1992.03480090061028; Wood D, 1998, HEART, V80, pS1; Yuan JM, 2001, AM J EPIDEMIOL, V154, P809, DOI 10.1093/aje/154.9.809; Zhang SMM, 2000, AM J EPIDEMIOL, V152, P1056, DOI 10.1093/aje/152.11.1056; Zheng ZJ, 1999, AM J EPIDEMIOL, V150, P492, DOI 10.1093/oxfordjournals.aje.a010038	174	465	489	1	71	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					752	755		10.1136/bmj.38755.366331.2F	http://dx.doi.org/10.1136/bmj.38755.366331.2F			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032JA	16565093	Green Published, Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000236769500016
J	Tryggvason, K; Patrakka, J; Wartiovaara, J				Tryggvason, K; Patrakka, J; Wartiovaara, J			Mechanisms of disease: Hereditary proteinuria syndromes and mechanisms of proteinuria	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GLOMERULAR-BASEMENT-MEMBRANE; CONGENITAL NEPHROTIC SYNDROME; FOCAL-SEGMENTAL GLOMERULOSCLEROSIS; NAIL-PATELLA SYNDROME; DISTINCT EYE ABNORMALITIES; TIGHT JUNCTION PROTEIN; DENYS-DRASH-SYNDROME; SLIT DIAPHRAGM; HEPARAN-SULFATE; MICE LACKING		Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, Helsinki, Finland	Karolinska Institutet; University of Helsinki	Tryggvason, K (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	karl.tryggvason@ki.se	Patrakka, Jaakko/AAG-8796-2019					Ahola H, 2003, J AM SOC NEPHROL, V14, P1731, DOI 10.1097/01.ASN.0000075553.33781.9F; AHVENAINEN E K, 1956, Ann Paediatr Fenn, V2, P227; Avasthi P S, 1988, Contrib Nephrol, V68, P104; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Barletta GM, 2003, J BIOL CHEM, V278, P19266, DOI 10.1074/jbc.M301279200; Beltcheva O, 2001, HUM MUTAT, V17, P368, DOI 10.1002/humu.1111; Bongers EMHF, 2002, PEDIATR NEPHROL, V17, P703, DOI 10.1007/s00467-002-0911-5; Boute N, 2000, NAT GENET, V25, P125; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Caridi G, 2003, KIDNEY INT, V64, P365, DOI 10.1046/j.1523-1755.2003.00084.x; CAULFIELD JP, 1976, P NATL ACAD SCI USA, V73, P1646, DOI 10.1073/pnas.73.5.1646; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; DENYS P, 1967, ARCH FR PEDIATR, V24, P729; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; DRASH A, 1970, J PEDIATR-US, V76, P585, DOI 10.1016/S0022-3476(70)80409-7; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; Eremina V, 2004, CURR OPIN NEPHROL HY, V13, P9, DOI 10.1097/00041552-200401000-00002; FRASIER SD, 1964, J PEDIATR-US, V64, P740, DOI 10.1016/S0022-3476(64)80622-3; Frishberg Y, 2002, J AM SOC NEPHROL, V13, P400, DOI 10.1681/ASN.V132400; Gerke P, 2005, J AM SOC NEPHROL, V16, P1693, DOI 10.1681/ASN.2004060439; Gerke P, 2003, J AM SOC NEPHROL, V14, P918, DOI 10.1097/01.ASN.0000057853.05686.89; Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; Haraldsson B, 2004, NEWS PHYSIOL SCI, V19, P7, DOI 10.1152/nips.01461.2003; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Henry CBS, 1999, AM J PHYSIOL-HEART C, V277, pH508, DOI 10.1152/ajpheart.1999.277.2.H508; Hirabayashi S, 2005, LAB INVEST, V85, P1528, DOI 10.1038/labinvest.3700347; Hirabayashi S, 2003, MOL CELL BIOL, V23, P4267, DOI 10.1128/MCB.23.12.4267-4282.2003; HOLMBERG C, 1995, PEDIATR NEPHROL, V9, P87, DOI 10.1007/BF00858984; Holthofer H, 1999, AM J PATHOL, V155, P1681, DOI 10.1016/S0002-9440(10)65483-1; Holzman LB, 1999, KIDNEY INT, V56, P1481, DOI 10.1046/j.1523-1755.1999.00719.x; HORA K, 1990, EUR J CELL BIOL, V53, P402; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; HUTTUNEN NP, 1976, NEPHRON, V16, P401, DOI 10.1159/000180664; Ihalmo P, 2003, BIOCHEM BIOPH RES CO, V300, P364, DOI 10.1016/S0006-291X(02)02854-1; Inoue T, 2001, KIDNEY INT, V59, P1003, DOI 10.1046/j.1523-1755.2001.00583.x; KANWAR YS, 1980, J CELL BIOL, V86, P688, DOI 10.1083/jcb.86.2.688; KANWAR YS, 1991, SEMIN NEPHROL, V11, P390; KANWAR YS, 1979, J CELL BIOL, V81, P137, DOI 10.1083/jcb.81.1.137; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Karle SM, 2002, J AM SOC NEPHROL, V13, P388, DOI 10.1681/ASN.V132388; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Khoshnoodi J, 2003, AM J PATHOL, V163, P2337, DOI 10.1016/S0002-9440(10)63590-0; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Koziell A, 2002, HUM MOL GENET, V11, P379, DOI 10.1093/hmg/11.4.379; Koziell AB, 1999, AM J HUM GENET, V64, P1778, DOI 10.1086/302409; Lahdenkari AT, 2004, J AM SOC NEPHROL, V15, P2611, DOI 10.1097/01.ASN.0000139478.03463.D9; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Lehtonen S, 2004, AM J PATHOL, V165, P923, DOI 10.1016/S0002-9440(10)63354-8; Lenkkeri U, 1999, AM J HUM GENET, V64, P51, DOI 10.1086/302182; Mathis BJ, 1998, KIDNEY INT, V53, P282, DOI 10.1046/j.1523-1755.1998.00828.x; McIntosh I, 1998, AM J HUM GENET, V63, P1651, DOI 10.1086/302165; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Miner JH, 2002, J CLIN INVEST, V109, P1065, DOI 10.1172/JCi200213954; Morello R, 2001, NAT GENET, V27, P205, DOI 10.1038/84853; Morita H, 2005, J AM SOC NEPHROL, V16, P1703, DOI 10.1681/ASN.2004050387; Nishibori Y, 2004, KIDNEY INT, V66, P1755, DOI 10.1111/j.1523-1755.2004.00898.x; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Patek CE, 2003, HUM MOL GENET, V12, P2379, DOI 10.1093/hmg/ddg240; Patrakka J, 2000, KIDNEY INT, V58, P972, DOI 10.1046/j.1523-1755.2000.00254.x; Patrakka J, 2002, LANCET, V359, P1575, DOI 10.1016/S0140-6736(02)08504-5; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Pereira AC, 2004, KIDNEY INT, V65, P1026, DOI 10.1111/j.1523-1755.2004.00479.x; PIERSON M, 1963, J GENET HUM, V12, P184; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; RENNKE HG, 1975, J CELL BIOL, V67, P638, DOI 10.1083/jcb.67.3.638; RODEWALD R, 1974, J CELL BIOL, V60, P423, DOI 10.1083/jcb.60.2.423; Rohr C, 2002, J CLIN INVEST, V109, P1073, DOI 10.1172/JCI200213961; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Roselli S, 2002, AM J PATHOL, V160, P131, DOI 10.1016/S0002-9440(10)64357-X; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shih NY, 2001, AM J PATHOL, V159, P2303, DOI 10.1016/S0002-9440(10)63080-5; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Smithies O, 2003, P NATL ACAD SCI USA, V100, P4108, DOI 10.1073/pnas.0730776100; SUN YPJ, 2005, J AM SOC NEPHROL, V16, pA108; Tryggvason K, 1999, J AM SOC NEPHROL, V10, P2440; Tsukaguchi H, 2002, J CLIN INVEST, V110, P1659, DOI 10.1172/JCI200216242; Verma R, 2005, J BIOL CHEM, V280, P26640; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; VERNIER RL, 1983, NEW ENGL J MED, V309, P1001, DOI 10.1056/NEJM198310273091701; Vollrath D, 1998, HUM MOL GENET, V7, P1333; Wartiovaara J, 2004, J CLIN INVEST, V114, P1475, DOI 10.1172/JCI200422562; Weber S, 2004, KIDNEY INT, V66, P571, DOI 10.1111/j.1523-1755.2004.00776.x; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Winn MP, 1999, GENOMICS, V58, P113, DOI 10.1006/geno.1999.5828; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284; Zenker M, 2004, AM J MED GENET A, V130A, P138, DOI 10.1002/ajmg.a.30310; [No title captured]	108	401	432	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1387	1401		10.1056/NEJMra052131	http://dx.doi.org/10.1056/NEJMra052131			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571882				2022-12-28	WOS:000236338000008
J	Ahmed, QA; Arabi, YM; Memish, ZA				Ahmed, QA; Arabi, YM; Memish, ZA			Health risks at the Hajj	LANCET			English	Review							RIFT-VALLEY FEVER; INFLUENZA-A H5N1; MYCOBACTERIUM-TUBERCULOSIS INFECTION; SAUDI-ARABIA; MENINGOCOCCAL DISEASE; HEMORRHAGIC-FEVER; POLYSACCHARIDE VACCINE; PATTERN; PILGRIMAGE; TRANSMISSION	Annually, millions of Muslims embark on a religious pilgrimage called the "Hajj" to Mecca in Saudi Arabia. The mass migration during the Haij is unparalleled in scale, and pilgrims face numerous health hazards. The extreme congestion of people and vehicles during this time amplifies health risks, such as those from infectious diseases, that vary each year. Since the Hajj is dictated by the lunar calendar, which is shorter than the Gregorian calendar, it presents public-health policy planners with a moving target, demanding constant preparedness. We review the communicable and non-communicable hazards that pilgrims face. With the rise in global travel, preventing disease transmission has become paramount to avoid the spread of infectious diseases, including SARS (severe acute respiratory syndrome), avian influenza, and haemorrhagic fever. We examine the response of clinicians, the Saudi Ministry of Health, and Hajj authorities to these unique problems, and list health recommendations for prospective pilgrims.	Med Univ S Carolina, Charleston, SC 29425 USA; King Abdul Aziz Med City, Dept Intens Care, Riyadh, Saudi Arabia; King Fahd Natl Guard Hosp, King Abdulaziz Med City, Dept Internal Med, Riyadh 11426, Saudi Arabia; King Fahd Natl Guard Hosp, King Abdulaziz Med City, Dept Infect Prevent & Control, Riyadh 11426, Saudi Arabia	Medical University of South Carolina; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh	Memish, ZA (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.	zmemish@yahoo.com	Arabi, Yaseen/ABF-3316-2020; Memish, Ziad Ahmed/AEJ-9424-2022	Arabi, Yaseen/0000-0001-5735-6241; Memish, Ziad Ahmed/0000-0002-5099-0714				Al-Abri SS, 2005, LANCET INFECT DIS, V5, P349, DOI 10.1016/S1473-3099(05)70139-0; Al-Ghamdi SM, 2003, SAUDI MED J, V24, P1073; Al-Harthi ASM, 2001, SAUDI MED J, V22, P523; Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671; Al-Jahdali H, 2005, AM J INFECT CONTROL, V33, P151, DOI 10.1016/j.ajic.2005.01.005; Al-Jahdali H, 2003, INT J ANTIMICROB AG, V21, P125, DOI 10.1016/S0924-8579(02)00283-2; Al-Mazrou YY, 2004, SAUDI MED J, V25, P1410; Al-Mazrou YY, 2004, SAUDI MED J, V25, P11; Al-Qattan MM, 2000, BURNS, V26, P102, DOI 10.1016/S0305-4179(99)00097-2; Al-Shihry A., 1999, SAUDI EPIDEMIOL B, V6, P29; AlGahtani YM, 1995, EPIDEMIOL INFECT, V115, P399, DOI 10.1017/S0950268800058556; ALKASSIMI FA, 1993, TUBERCLE LUNG DIS, V74, P254, DOI 10.1016/0962-8479(93)90051-X; AlMazrou Y, 2005, INFECT IMMUN, V73, P2932, DOI 10.1128/IAI.73.5.2932-2939.2005; ALSALAMA AA, 1998, SAUDI EPIDEMIOL B, V5, P3; Alzeer A, 1998, J INFECTION, V36, P303, DOI 10.1016/S0163-4453(98)94315-8; [Anonymous], 2005, MED LETT DRUGS THER, V47, P29; [Anonymous], SAUDI EPIDEMIOL B; Ansari S, 2000, PUBLIC HEALTH, V114, P37, DOI 10.1016/S0033-3506(00)00306-1; Australian/New Zealand Standard, 1999, AS3980, P1; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P107, DOI 10.1016/S0924-8579(02)00356-4; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Balkhy HH, 2004, J TRAVEL MED, V11, P82, DOI 10.2310/7060.2004.17027; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; BENER A, 1992, ACCIDENT ANAL PREV, V24, P143, DOI 10.1016/0001-4575(92)90030-M; BIANCHI RR, 2004, GUESTS GOD PILGRIMAG, P7; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Bubshait SA, 2000, Int J Infect Dis, V4, P198, DOI 10.1016/S1201-9712(00)90109-7; CDC, 2000, MMWR-MORBID MORTAL W, p[1065, 1066]; *CDCP, 1999, JAMA-J AM MED ASSOC, V281, P892; *CDCP, 2000, JAMA-J AM MED ASSOC, V284, P2989; Charrel RN, 2001, BIOCHEM BIOPH RES CO, V287, P455, DOI 10.1006/bbrc.2001.5610; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; CLAIRE B, 1987, J CULT GEOG, V7, P67; DRIVER CR, 1994, JAMA-J AM MED ASSOC, V272, P1031, DOI 10.1001/jama.272.13.1031; El-Sheikh SM, 1998, TROP MED INT HEALTH, V3, P205; Eltahawy AT, 2004, SAUDI MED J, V25, P1730; Ericsson CD, 2003, INT J ANTIMICROB AG, V21, P116, DOI 10.1016/S0924-8579(02)00282-0; Fagbo SF, 2002, ANN NY ACAD SCI, V969, P201, DOI 10.1111/j.1749-6632.2002.tb04378.x; Fatani MI, 2000, INT J DERMATOL, V39, P493, DOI 10.1046/j.1365-4362.2000.00009.x; Fatani MI, 2002, SAUDI MED J, V23, P782; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; Freedman DO, 2005, J TRAVEL MED, V12, P36, DOI 10.2310/7060.2005.00007; Fried M, 1996, BURNS, V22, P644, DOI 10.1016/S0305-4179(96)00048-4; Gatrad AR, 2001, ARCH DIS CHILD, V84, P375; Gatrad AR, 2005, BRIT MED J, V330, P133, DOI 10.1136/bmj.330.7483.133; GHAZNAWI HI, 1988, SAUDI MED J, V9, P274; Harrison LH, 2006, CLIN MICROBIOL REV, V19, P142, DOI 10.1128/CMR.19.1.142-164.2006; Hawary MB, 1997, J HAND SURG-BRIT EUR, V22B, P550, DOI 10.1016/S0266-7681(97)80291-4; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Johnston Victoria J, 2003, Travel Med Infect Dis, V1, P205, DOI 10.1016/j.tmaid.2003.11.002; Jokhdar H, 2004, CLIN DIAGN LAB IMMUN, V11, P83, DOI 10.1128/CDLI.11.1.83-88.2004; Jupp PG, 2002, MED VET ENTOMOL, V16, P245, DOI 10.1046/j.1365-2915.2002.00371.x; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Khalil M, 2005, CLIN DIAGN LAB IMMUN, V12, P1251, DOI 10.1128/CDLI.12.10.1251-1253.2005; Khan MY, 2001, INT J ANTIMICROB AG, V17, P415, DOI 10.1016/S0924-8579(01)00298-9; Ku A, 1999, J PAEDIATR CHILD H, V35, P207, DOI 10.1046/j.1440-1754.1999.t01-1-00329.x; MacDonald R, 2000, BRIT MED J, V321, P1037, DOI 10.1136/bmj.321.7268.1037; Madani TA, 2005, J INFECTION, V51, P91, DOI 10.1016/j.jinf.2004.11.012; Madani TAA, 2004, AM J INFECT CONTROL, V32, P120, DOI 10.1016/j.ajic.2003.09.006; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; MCFARLAND JW, 1993, LANCET, V342, P112, DOI 10.1016/0140-6736(93)91311-9; Memish Z, 2003, MIL MED, V168, P565, DOI 10.1093/milmed/168.7.565; Memish ZA, 2005, BRIT J BIOMED SCI, V62, P37, DOI 10.1080/09674845.2005.11978070; Memish ZA, 2003, INT J ANTIMICROB AG, V21, P96, DOI 10.1016/S0924-8579(02)00364-3; Memish ZA, 2004, J TRAVEL MED, V11, P127, DOI 10.2310/7060.2004.16954; Memish ZA, 2002, AM J INFECT CONTROL, V30, P57, DOI 10.1067/mic.2002.120905; Memish ZA, 2002, J TRAVEL MED, V9, P202, DOI 10.2310/7060.2002.24557; Memish ZA, 2001, MIL MED, V166, P11, DOI 10.1093/milmed/166.1.11; Memish ZA, 2002, CLIN INFECT DIS, V34, P84, DOI 10.1086/323403; Merican M I, 1989, Med J Malaysia, V44, P183; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Mustafa Amal Nasir, 2003, International Journal of Infectious Diseases, V7, P210, DOI 10.1016/S1201-9712(03)90054-3; Onishchenko G G, 1995, Zh Mikrobiol Epidemiol Immunobiol, VSuppl 2, P9; Onishchenko G G, 1995, Zh Mikrobiol Epidemiol Immunobiol, VSuppl 2, P3; Ormerod P, 2000, HOSP MED, V61, P171, DOI 10.12968/hosp.2000.61.3.1294; PAHO's Area of Health Analysis and Information Systems (AIS), 2003, Epidemiol Bull, V24, P1; Rahman MM, 1999, ANN PLAS SURG, V43, P154; Saudi Ministry of Health, 2005, HLTH STAT; SHAFI S, 2005, EUROSURVEILLANCE, P10; Tufenkeji H, 2000, VACCINE, V18, pS65, DOI 10.1016/S0264-410X(99)00468-5; VANKATESH S, 2004, E MEDITERR HEALTH J, V10, P655; WEINER JS, 1980, LANCET, V1, P507; Whitney CG, 2003, GERIATRICS-US, V58, P20; Wilder-Smith A, 2005, TROP MED INT HEALTH, V10, P336, DOI 10.1111/j.1365-3156.2005.01395.x; Wilder-Smith A, 2003, CLIN INFECT DIS, V37, P1270, DOI 10.1086/378748; Wilder-Smith A, 2003, INT J ANTIMICROB AG, V21, P102, DOI 10.1016/S0924-8579(02)00284-4; WILDERSMITH A, 2003, J TRAVEL MED, V10, P275; Zaki AM, 1997, T ROY SOC TROP MED H, V91, P179, DOI 10.1016/S0035-9203(97)90215-7; 2005, WKLY EPIDEMIOL REC, V80, P2; 2001, MMWR MORB MORTAL WKL, V50, P97; 2001, CAN COMMUNIC DIS REP, V27, P49; 1999, MMWR MORB MORTAL WKL, V48, P104; 2005, WKLY EPIDEMIOL REC, V80, P431	93	266	272	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					1008	1015		10.1016/S0140-6736(06)68429-8	http://dx.doi.org/10.1016/S0140-6736(06)68429-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564364	Bronze, Green Published			2022-12-28	WOS:000236474200030
J	Palmer, N; Strong, L; Wali, A; Sondorp, L				Palmer, N; Strong, L; Wali, A; Sondorp, L			Health policy - Contracting out health services in fragile states	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AFGHANISTAN; DELIVERY		Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Palmer, N (corresponding author), Univ London London Sch Hyg & Trop Med, Hlth Policy Unit, Keppel St, London WC1E 7HT, England.	Natasha.palmer@lshtm.ac.uk						Bartlett LA, 2005, LANCET, V365, P864, DOI 10.1016/S0140-6736(05)71044-8; Department for International Development, 2005, WHY WE NEED WORK MOR; Fleck F, 2004, BRIT MED J, V329, P420, DOI 10.1136/bmj.329.7463.420; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Palmer N, 2003, HEALTH ECON, V12, P1005, DOI 10.1002/hec.792; Palmer N, 2006, ELGAR ORIG REF, P250; Richardson RC, 2002, CLIO, V32, P1; Ridde V, 2002, LANCET, V360, P1976, DOI 10.1016/S0140-6736(02)11873-3; Schwartz B., 2002, ACHIEVING TWIN OBJEC; STRONG L, HLTH POLICY AFGHANIS; 2005, KABUT WEEKLY    0416, P1	11	85	85	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2006	332	7543					718	721		10.1136/bmj.332.7543.718	http://dx.doi.org/10.1136/bmj.332.7543.718			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	027VH	16565130	Green Published, Green Accepted			2022-12-28	WOS:000236443300028
J	Papania, M; Rodewald, L				Papania, M; Rodewald, L			For better immunisation coverage, measure coverage better	LANCET			English	Editorial Material							VACCINATION COVERAGE		Ctr Dis Control & Prevent, Immunizat Safety Off, Off Chief Sci Officer, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Papania, M (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, Off Chief Sci Officer, Atlanta, GA 30333 USA.	mpapania@cdc.gov		Rodewald, Lance/0000-0003-2593-542X				Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P717; BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547; Belmaker I, 2006, LANCET, V367, P987, DOI 10.1016/S0140-6736(06)68425-0; CDC, 1999, MMWR MORB MORTAL WKL, V48, P243; Hinman AR, 2000, AM J PREV MED, V18, P92; LeBaron CW, 1997, JAMA-J AM MED ASSOC, V277, P631, DOI 10.1001/jama.277.8.631; National Vaccine Advisory Committee, 2003, Pediatrics, V112, P958; SMITH PJ, 2005, VITAL HLTH STAT 2, V138, P1; *WHO, IMM PROF OM; *WHO AFR REG OFF, 2005, VACC PREV DIS B WHO, V56; ZELL ER, 1994, JAMA-J AM MED ASSOC, V271, P833, DOI 10.1001/jama.271.11.833	11	18	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					965	966		10.1016/S0140-6736(06)68403-1	http://dx.doi.org/10.1016/S0140-6736(06)68403-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564344				2022-12-28	WOS:000236474200006
J	McKay, DB; Josephson, MA				McKay, DB; Josephson, MA			Medical progress - Pregnancy in recipients of solid organs - Effects on mother and child	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RENAL-ALLOGRAFT RECIPIENTS; T-CELL DEVELOPMENT; CYCLOSPORINE-A; FEMALE KIDNEY; LIVER-TRANSPLANTATION; REPRODUCTIVE ISSUES; DIALYSIS PATIENTS; AZATHIOPRINE; OUTCOMES; IMMUNOSUPPRESSION		Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Chicago, Dept Med, Nephrol Sect, Chicago, IL 60637 USA	Scripps Research Institute; University of Chicago	McKay, DB (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dmckay@scripps.edu						Aluvihare VR, 2005, J MOL MED-JMM, V83, P88, DOI 10.1007/s00109-004-0608-2; ANDERSON GG, 1981, AM J OBSTET GYNECOL, V140, P699, DOI 10.1016/0002-9378(81)90207-6; [Anonymous], 1975, LANCET, V2, P801; [Anonymous], 1980, BRIT J OBSTET GYNAEC, V87, P839; Armenti V T, 1998, Nephrol News Issues, V12, P19; Armenti V T, 1997, Clin Liver Dis, V1, P471, DOI 10.1016/S1089-3261(05)70281-6; Armenti Vincent T, 2003, Clin Transpl, P131; Armenti Vincent T, 2004, Clin Transpl, P103; Armenti Vincent T, 2002, Clin Transpl, P121; Armenti VT, 1998, DRUG SAFETY, V19, P219, DOI 10.2165/00002018-199819030-00005; ARMENTI VT, 1995, TRANSPLANTATION, V59, P476; ARMENTI VT, 1994, TRANSPLANTATION, V57, P502; Armenti VT, 2003, PEDIATR CLIN N AM, V50, P1543, DOI 10.1016/S0031-3955(03)00130-5; Armenti VT, 2002, DRUGS, V62, P2361, DOI 10.2165/00003495-200262160-00004; ARMENTI VT, 2000, CLIN TRANSPLANTS 200, P97; Armentl V T, 1999, Clin Transpl, P111; Arsan A, 1997, TRANSPLANT P, V29, P2479, DOI 10.1016/S0041-1345(97)00457-0; Bar J, 1996, ISRAEL J MED SCI, V32, P1183; Bar-Oz B, 2001, TRANSPLANTATION, V71, P1051, DOI 10.1097/00007890-200104270-00006; Baron O, 2002, J HEART LUNG TRANSPL, V21, P914, DOI 10.1016/S1053-2498(02)00388-1; BLANFORD AT, 1977, AM J OBSTET GYNECOL, V127, P264, DOI 10.1016/0002-9378(77)90466-5; BOURGET P, 1991, TRANSPLANTATION, V51, P1306, DOI 10.1097/00007890-199106000-00033; Briggs J D, 2001, Nephrol Dial Transplant, V16, P1130, DOI 10.1093/ndt/16.6.1130; BROWN PAJ, 1985, BIOL NEONATE, V48, P172; Canobbio MM, 2005, INT J CARDIOL, V98, P379, DOI 10.1016/j.ijcard.2003.11.021; CEDERQVIST LL, 1977, AM J OBSTET GYNECOL, V129, P687, DOI 10.1016/0002-9378(77)90653-6; Chambers CD, 2001, TERATOLOGY, V64, P252, DOI 10.1002/tera.1071; Cheng SW, 2004, EARLY HUM DEV, V76, P39, DOI 10.1016/j.earlhumdev.2003.10.004; COULAM CB, 1982, TRANSPLANT P, V14, P605; CUNDY TF, 1990, GUT, V31, P337, DOI 10.1136/gut.31.3.337; Davison J. M., 2002, MED DISORDERS OBSTET, P198; DAVISON JM, 1985, BRIT J OBSTET GYNAEC, V92, P233, DOI 10.1111/j.1471-0528.1985.tb01088.x; DAVISON JM, 1976, BRIT J OBSTET GYNAEC, V83, P518, DOI 10.1111/j.1471-0528.1976.tb00879.x; DAVISON JM, 1987, BAILLIERE CLIN OB GY, V1, P1027, DOI 10.1016/S0950-3552(87)80048-2; DAVISON JM, 1991, AM J KIDNEY DIS, V17, P127, DOI 10.1016/S0272-6386(12)81116-4; DAVISON JM, 1985, CLIN PERINATOL, V12, P497, DOI 10.1016/S0095-5108(18)30852-2; Davison JM, 2003, J OBSTET GYNAECOL RE, V29, P227, DOI 10.1046/j.1341-8076.2003.00106.x; Davison JM, 1997, BRIT J UROL, V80, P29; Davison JM, 1997, BRIT J OBSTET GYNAEC, V104, P1106, DOI 10.1111/j.1471-0528.1997.tb10930.x; DAVISON JM, 2005, OXFORD TXB CLIN NEPH, P2243; DAVISON JM, 1985, J INT MED, V10, P38; Davison JM, 2004, MATERNAL FETAL MED P, P901; DAVISON JM, 1996, MED DISORDERS OBSTET, P226; DAVISON JM, 1984, MED DISORDERS OBSTET, P192; DEKONING ND, 1990, DIGESTION, V46, P239, DOI 10.1159/000200352; Di Paolo S, 2000, TRANSPLANTATION, V69, P2049, DOI 10.1097/00007890-200005270-00013; Dieperink H, 1987, Nephrol Dial Transplant, V1, P251; Donaldson S, 1996, CHEST, V110, P293, DOI 10.1378/chest.110.1.293; FARLEY DE, 1991, TRANSPLANTATION, V52, P106, DOI 10.1097/00007890-199107000-00022; FEIN A, 1989, BIOL NEONATE, V56, P165; FIRST MR, 1995, TRANSPLANTATION, V59, P472; FLECHNER SM, 1985, AM J KIDNEY DIS, V5, P60, DOI 10.1016/S0272-6386(85)80138-4; GHAHRAMANI N, 1993, TRANSPLANT P, V25, P2190; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; GITHENS JH, 1965, J PEDIATR-US, V66, P959, DOI 10.1016/S0022-3476(65)80071-3; GREEN TP, 1979, ANNU REV PHARMACOL, V19, P285, DOI 10.1146/annurev.pa.19.040179.001441; GRIMM VE, 1987, DEV PHARMACOL THERAP, V10, P328, DOI 10.1159/000457763; HEEG K, 1989, SCAND J IMMUNOL, V30, P703, DOI 10.1111/j.1365-3083.1989.tb02479.x; Holladay SD, 2000, ENVIRON HEALTH PERSP, V108, P463, DOI 10.2307/3454538; HOLLANDER GA, 1994, TRANSFUS SCI, V15, P207, DOI 10.1016/0955-3886(94)90133-3; Holley JL, 1997, AM J KIDNEY DIS, V29, P685, DOI 10.1016/S0272-6386(97)90120-7; Holley JL, 2003, SEMIN DIALYSIS, V16, P384, DOI 10.1046/j.1525-139X.2003.16085.x; Hou S, 2003, SEMIN DIALYSIS, V16, P376, DOI 10.1046/j.1525-139X.2003.16083.x; Hou S, 2003, ADV RENAL REPLACE TH, V10, P40, DOI 10.1053/jarr.2003.50002; Hou S, 1999, AM J KIDNEY DIS, V33, P235, DOI 10.1016/S0272-6386(99)70296-9; Jain A, 1997, TRANSPLANTATION, V64, P559, DOI 10.1097/00007890-199708270-00002; Jain AB, 2004, TRANSPLANTATION, V77, P897, DOI 10.1097/01.TP.0000117564.50117.FB; Jain AB, 2003, TRANSPLANTATION, V76, P827, DOI 10.1097/01.TP.0000084823.89528.89; JENKINS MK, 1988, SCIENCE, V241, P1655, DOI 10.1126/science.3262237; Kainz A, 2000, Transpl Int, V13 Suppl 1, pS299, DOI 10.1111/j.1432-2277.2000.tb02043.x; KAUFFMAN RE, 1994, PEDIATRICS, V93, P137; KAUFMAN JJ, 1967, J AMER MED ASSOC, V200, P338, DOI 10.1001/jama.200.4.338; Le Ray C, 2004, OBSTET GYNECOL, V103, P1091, DOI 10.1097/01.AOG.0000124986.32858.ba; Leavey SF, 2002, ENDOCRIN METAB CLIN, V31, P107, DOI 10.1016/S0889-8529(01)00006-8; Lessan-Pezeshki M, 2004, TRANSPL P, V36, P1405, DOI 10.1016/j.transproceed.2004.04.090; Levine RJ, 2005, CLIN OBSTET GYNECOL, V48, P372, DOI 10.1097/01.grf.0000160313.82606.d7; MASON RJ, 1985, TRANSPLANTATION, V39, P9; Mastrobattista JM, 2004, OBSTET GYN CLIN N AM, V31, P415, DOI 10.1016/j.ogc.2004.03.005; McKay DB, 2005, AM J TRANSPLANT, V5, P1592, DOI 10.1111/j.1600-6143.2005.00969.x; Miniero R, 2004, J HEART LUNG TRANSPL, V23, P898, DOI 10.1016/j.healun.2003.08.002; Miniero R, 2002, J NEPHROL, V15, P626; Miranda CTBC, 2002, TRANSPLANT P, V34, P506, DOI 10.1016/S0041-1345(02)02612-X; MORALES JM, 1990, NEPHRON, V56, P97, DOI 10.1159/000186109; Moretti ME, 2003, TRANSPLANTATION, V75, P2144, DOI 10.1097/01.TP.0000066352.86763.D0; MUIRHEAD N, 1992, TRANSPLANTATION, V54, P429, DOI 10.1097/00007890-199209000-00008; MURRAY JE, 1963, NEW ENGL J MED, V269, P341, DOI 10.1056/NEJM196308152690704; Ostensen M, 2004, LUPUS, V13, P746, DOI 10.1191/0961203303lu2004oa; PAHL MV, 1993, TRANSPL P, V25, P2727; Parry D, 1996, THORAX, V51, P1162, DOI 10.1136/thx.51.11.1162; Parry D, 1997, TRANSPL P, V29, P629, DOI 10.1016/S0041-1345(96)00365-X; Petri M, 2003, AUTOIMMUNITY, V36, P51, DOI 10.1080/0891693031000067296; PILARSKI LM, 1994, TRANSPLANTATION, V57, P133, DOI 10.1097/00007890-199401000-00021; PINSKY L, 1965, SCIENCE, V147, P402, DOI 10.1126/science.147.3656.402; Podymow T, 2004, SEMIN NEPHROL, V24, P616, DOI 10.1016/j.semnephrol.2004.07.010; RADOMSKI JS, 1995, TRANSPLANT P, V27, P1089; Riely CA, 2001, LIVER TRANSPLANT, V7, pS74, DOI 10.1053/jlts.2001.28644; RIZZONI G, 1992, NEPHROL DIAL TRANSPL, V7, P279, DOI 10.1093/oxfordjournals.ndt.a092129; ROSE ML, 1989, TRANSPLANTATION, V48, P223, DOI 10.1097/00007890-198908000-00008; ROSENKRA.JG, 1967, AM J OBSTET GYNECOL, V97, P387, DOI 10.1016/0002-9378(67)90503-0; Ross LF, 2006, NEW ENGL J MED, V354, P1313, DOI 10.1056/NEJMsb041648; SAARIKOSKI S, 1973, AM J OBSTET GYNECOL, V115, P1100, DOI 10.1016/0002-9378(73)90559-0; SAKAGUCHI S, 1989, J IMMUNOL, V142, P471; SALMELA KT, 1993, TRANSPLANTATION, V56, P1372, DOI 10.1097/00007890-199312000-00018; Sano T, 2002, NEPHROL DIAL TRANSPL, V17, P50, DOI 10.1093/ndt/17.1.50; Scott JR, 2002, TRANSPLANTATION, V73, P815, DOI 10.1097/00007890-200203150-00028; Sgro MD, 2002, TERATOLOGY, V65, P5, DOI 10.1002/tera.1092; SHAHEEN FAM, 1993, TRANSPLANTATION, V56, P224, DOI 10.1097/00007890-199307000-00044; Shlay JC, 2003, AM J OBSTET GYNECOL, V189, P473, DOI 10.1067/S0002-9378(03)00493-9; SIBANDA N, 2004, HYPERTENS PREGNAN S1, V23, P136; SIMS CJ, 1991, CLIN OBSTET GYNECOL, V34, P100, DOI 10.1097/00003081-199103000-00013; Stanley CW, 1999, TRANSPLANT P, V31, P241, DOI 10.1016/S0041-1345(98)01519-X; Stratta P, 2003, J NEPHROL, V16, P792; Streilein JW, 1996, TRANSPLANT P, V28, P2066; STURGISS SN, 1995, AM J KIDNEY DIS, V26, P54, DOI 10.1016/0272-6386(95)90153-1; SZEKERESBARTHO J, 1983, J REPROD IMMUNOL, V5, P81, DOI 10.1016/0165-0378(83)90003-7; TAKAHASHI N, 1994, TRANSPLANTATION, V57, P1617; TALLENT MB, 1970, J AMER MED ASSOC, V211, P1854, DOI 10.1001/jama.211.11.1854; Thomas AG, 1997, OBSTET GYNECOL, V90, P916, DOI 10.1016/S0029-7844(97)00535-8; *THOMS PDR, 2006, PHYS DESK REF, P2751; VENKATARAMANAN R, 1988, TRANSPLANTATION, V46, P468, DOI 10.1097/00007890-198809000-00032; Wallace IF, 1997, CLIN OBSTET GYNECOL, V40, P843, DOI 10.1097/00003081-199712000-00018; Warner TD, 2002, J LEARN DISABIL-US, V35, P500; WILLIAMSON RA, 1981, OBSTET GYNECOL, V58, P247; Willis FR, 2000, J PAEDIATR CHILD H, V36, P230, DOI 10.1046/j.1440-1754.2000.00500.x; ZERNER J, 1981, J REPROD MED, V26, P99	125	248	262	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1281	1293		10.1056/NEJMra050431	http://dx.doi.org/10.1056/NEJMra050431			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554530				2022-12-28	WOS:000236164200007
J	Shamovsky, I; Ivannikov, M; Kandel, ES; Gershon, D; Nudler, E				Shamovsky, I; Ivannikov, M; Kandel, ES; Gershon, D; Nudler, E			RNA-mediated response to heat shock in mammalian cells	NATURE			English	Article							TRANSCRIPTION FACTOR; STRESS-RESPONSE; FACTOR-I; ACTIVATION; FACTOR-1; COMPLEX; HSF; TEMPERATURE; EXPRESSION; REPRESSION	The heat-shock transcription factor 1 (HSF1) has an important role in the heat-shock response in vertebrates by inducing the expression of heat-shock proteins (HSPs) and other cytoprotective proteins(1). HSF1 is present in unstressed cells in an inactive monomeric form and becomes activated by heat and other stress stimuli. HSF1 activation involves trimerization and acquisition of a site-specific DNA-binding activity(2,3), which is negatively regulated by interaction with certain HSPs(4-6). Here we show that HSF1 activation by heat shock is an active process that is mediated by a ribonucleoprotein complex containing translation elongation factor eEF1A and a previously unknown non-coding RNA that we term HSR1 (heat shock RNA-1). HSR1 is constitutively expressed in human and rodent cells and its homologues are functionally interchangeable. Both HSR1 and eEF1A are required for HSF1 activation in vitro; antisense oligonucleotides or short interfering (si)RNA against HSR1 impair the heat-shock response in vivo, rendering cells thermosensitive. The central role of HSR1 during heat shock implies that targeting this RNA could serve as a new therapeutic model for cancer, inflammation and other conditions associated with HSF1 deregulation.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; Redox Pharmaceut Corp, Greenvale, NY 11548 USA	New York University; Technion Israel Institute of Technology; Cleveland Clinic Foundation	Gershon, D (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	dgershon@redoxpharm.com; evgeny.nudler@med.nyu.edu		Nudler, Evgeny/0000-0002-8811-3071	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069800] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM069800] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ali A, 1998, MOL CELL BIOL, V18, P4949, DOI 10.1128/MCB.18.9.4949; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; Batulan Z, 2003, J NEUROSCI, V23, P5789; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; CLOS J, 1993, NATURE, V364, P252, DOI 10.1038/364252a0; Farkas T, 1998, MOL CELL BIOL, V18, P906, DOI 10.1128/MCB.18.2.906; Gothard LQ, 2003, J BIOL CHEM, V278, P9322, DOI 10.1074/jbc.M209412200; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Kristensen P, 1998, BIOCHEM BIOPH RES CO, V245, P810, DOI 10.1006/bbrc.1998.8510; Marchler G, 2001, EMBO J, V20, P499, DOI 10.1093/emboj/20.3.499; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; SARGE KD, 1991, GENE DEV, V5, P1902, DOI 10.1101/gad.5.10.1902; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Shopland LS, 1996, CHROMOSOMA, V105, P158, DOI 10.1007/BF02509497; SHOPLAND LS, 1995, GENE DEV, V9, P2756, DOI 10.1101/gad.9.22.2756; Storz G, 1999, GENE DEV, V13, P633, DOI 10.1101/gad.13.6.633; Szymaski M, 2003, INT REV CYTOL, V231, P197, DOI 10.1016/S0074-7696(03)31005-8; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WESTWOOD JT, 1993, MOL CELL BIOL, V13, P3481, DOI 10.1128/MCB.13.6.3481; Zhong M, 1999, J BIOL CHEM, V274, P3135, DOI 10.1074/jbc.274.5.3135; Zhong M, 1998, MOL CELL, V2, P101, DOI 10.1016/S1097-2765(00)80118-5; ZIMARINO V, 1990, MOL CELL BIOL, V10, P752, DOI 10.1128/MCB.10.2.752; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	30	274	297	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					556	560		10.1038/nature04518	http://dx.doi.org/10.1038/nature04518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554823				2022-12-28	WOS:000236176100061
J	Taylor, TD; Noguchi, H; Totoki, Y; Toyoda, A; Kuroki, Y; Dewar, K; Lloyd, C; Itoh, T; Takeda, T; Kim, DW; She, XW; Barlow, KF; Bloom, T; Bruford, E; Chang, JL; Cuomo, CA; Eichler, E; FitzGerald, MG; Jaffe, DB; LaButti, K; Nicol, R; Park, HS; Seaman, C; Sougnez, C; Yang, XP; Zimmer, AR; Zody, MC; Birren, BW; Nusbaum, C; Fujiyama, A; Hattori, M; Rogers, J; Lander, ES; Sakaki, Y				Taylor, TD; Noguchi, H; Totoki, Y; Toyoda, A; Kuroki, Y; Dewar, K; Lloyd, C; Itoh, T; Takeda, T; Kim, DW; She, XW; Barlow, KF; Bloom, T; Bruford, E; Chang, JL; Cuomo, CA; Eichler, E; FitzGerald, MG; Jaffe, DB; LaButti, K; Nicol, R; Park, HS; Seaman, C; Sougnez, C; Yang, XP; Zimmer, AR; Zody, MC; Birren, BW; Nusbaum, C; Fujiyama, A; Hattori, M; Rogers, J; Lander, ES; Sakaki, Y			Human chromosome 11 DNA sequence and analysis including novel gene identification	NATURE			English	Article							HUMAN GENOME; CHROMOSOME; RECOMBINATION; REGION; MAP	Chromosome 11, although average in size, is one of the most gene- and disease-rich chromosomes in the human genome. Initial gene annotation indicates an average gene density of 11.6 genes per megabase, including 1,524 protein-coding genes, some of which were identified using novel methods, and 765 pseudogenes. One-quarter of the protein-coding genes shows overlap with other genes. Of the 856 olfactory receptor genes in the human genome, more than 40% are located in 28 single- and multi-gene clusters along this chromosome. Out of the 171 disorders currently attributed to the chromosome, 86 remain for which the underlying molecular basis is not yet known, including several mendelian traits, cancer and susceptibility loci. The high-quality data presented here-nearly 134.5 million base pairs representing 99.8% coverage of the euchromatic sequence-provide scientists with a solid foundation for understanding the genetic basis of these disorders and other biological phenomena.	RIKEN Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Mitsubishi Res Inst Inc, Chiyoda Ku, Tokyo 1008141, Japan; Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea; Univ Washington, Seattle, WA 98195 USA; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England; Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; Kitasato Univ, Kitasato Inst Life Sci, Kanagawa 2288555, Japan	RIKEN; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Wellcome Trust Sanger Institute; Mitsubishi Research Institute; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Washington; University of Washington Seattle; University of London; University College London; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Kitasato University	Taylor, TD (corresponding author), RIKEN Genom Sci Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	taylor@gsc.riken.jp	Bruford, Elspeth/AAU-4961-2020; Hattori, Masahira/AAD-3785-2019; Itoh, Takehiko/E-8873-2014; Taylor, Todd/A-7121-2009; Cuomo, Christina/L-2222-2019; Hattori, Masahira/C-6958-2016	Bruford, Elspeth/0000-0002-8380-5247; Itoh, Takehiko/0000-0002-6113-557X; Taylor, Todd/0000-0003-4247-6253; Cuomo, Christina/0000-0002-5778-960X; Hattori, Masahira/0000-0001-9467-0344; Nicol, Robert/0000-0003-1932-1392	Medical Research Council [G0000107] Funding Source: researchfish; MRC [G0000107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BRAGG L, 1952, PROC R SOC LON SER-A, V213, P425, DOI 10.1098/rspa.1952.0136; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Krogh A, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P179; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Olender Tsviya, 2004, Genet Mol Res, V3, P545; Park HS, 2000, FEBS LETT, V475, P167, DOI 10.1016/S0014-5793(00)01632-X; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SANGER F, 1951, BIOCHEM J, V49, P463, DOI 10.1042/bj0490463; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Suto Y, 1996, GENOMICS, V33, P321, DOI 10.1006/geno.1996.0202; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WIEDEMANN H. R., 1964, J GENET HUM, V13, P223; Yada T, 2003, Pac Symp Biocomput, P375	28	55	788	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					497	500		10.1038/nature04632	http://dx.doi.org/10.1038/nature04632			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554811	Bronze			2022-12-28	WOS:000236176100048
J	Catalona, WJ; Loeb, S; Han, M				Catalona, WJ; Loeb, S; Han, M			Viewpoint: Expanding prostate cancer screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; PSA VELOCITY; PREOPERATIVE PSA; ANTIGEN LEVELS; 2.6 NG/ML; MEN; RISK; DISEASE; DEATH	Prostate cancer screening is controversial, and major professional associations offer differing screening guidelines. The authors address 3 key issues about prostate cancer screening: 1) the prostate-specific antigen (PSA) criteria to recommend a prostate biopsy, 2) the appropriate age to start screening, and 3) the appropriate age to stop screening. The authors argue, on the basis of evidence published since 2000, that data supporting the efficacy of PSA screening are convincing. They recommend screening for risk assessment for average-risk men beginning at age 40 years, screening selected healthy men older than age 70 years, and lowering the PSA threshold for considering biopsy to 2.5 ng/mL for all men.	Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Georgetown Univ, Sch Med, Washington, DC USA	Northwestern University; Feinberg School of Medicine; Georgetown University	Catalona, WJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, 303 E Chicago Ave,Tarry 16-703, Chicago, IL 60611 USA.	wcatalona@nmff.org		Loeb, Stacy/0000-0003-3933-9207				Antenor JAV, 2005, UROLOGY, V66, P156, DOI 10.1016/j.urology.2005.01.008; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; CARTER HB, 1992, JAMA-J AM MED ASSOC, V267, P2215, DOI 10.1001/jama.267.16.2215; CATALONA WJ, 1994, J UROLOGY, V152, P2037, DOI 10.1016/S0022-5347(17)32300-5; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; D'Amico AV, 2005, JAMA-J AM MED ASSOC, V294, P440, DOI 10.1001/jama.294.4.440; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; Fang J, 2002, UROLOGY, V59, P889, DOI 10.1016/S0090-4295(02)01646-1; Howard DH, 2005, J HEALTH ECON, V24, P891, DOI 10.1016/j.jhealeco.2005.03.002; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Krumholtz JS, 2002, UROLOGY, V60, P474; Kundu SD, 2004, J UROLOGY, V172, P2227, DOI 10.1097/01.ju.0000145222.94455.73; KUNDU SD, 2005, AGE SPECIFIC RISK PR, P258; LOEB S, 2006, IN PRESS J UROL; LOEB S, 2005, BASELINE PROSTATE SP, P533; Nadler RB, 2005, J UROLOGY, V174, P2154, DOI 10.1097/01.ju.0000181213.07447.8f; *NAT COMPR CANC NE, 2005, PROST CANC EARL DET; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Pelzer AE, 2005, UROLOGY, V66, P1029, DOI 10.1016/j.urology.2005.05.025; Punglia RS, 2003, NEW ENGL J MED, V349, P335, DOI 10.1056/NEJMoa021659; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Whittemore AS, 2005, J UROLOGY, V174, P872, DOI 10.1097/01.ju.0000169262.18000.8a	22	41	45	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					441	443		10.7326/0003-4819-144-6-200603210-00012	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549857				2022-12-28	WOS:000236251800009
J	Vollset, SE; Tverdal, A; Gjessing, HK				Vollset, SE; Tverdal, A; Gjessing, HK			Smoking and deaths between 40 and 70 years of age in women and men	ANNALS OF INTERNAL MEDICINE			English	Article							LIFE EXPECTANCY; FOLLOW-UP; MORTALITY; TOBACCO; CANCER; CESSATION; HAZARDS; RATES	Background: The vast scientific literature on smoking and health contains few large studies with direct estimates of long-term mortality by smoking habits. Data have been lacking, particularly for women. Objective: To study smoking and deaths and causes of death in women and men of middle age (40 to 70 years of age). Design: Population-based cohort study. Setting: Norway (the Norwegian Counties Study). Participants: 24 505 women and 25 034 men who were born between 1925 and 1941. Measurements: Initial information on smoking habits was collected between 1974 and 1978. Smoking status was also assessed about 5 years and 10 years after the first examination. Death during 1974 to 2000 was studied by using death certificate information. Results: During follow-up, 2333 women and 4680 men died in middle age. Among women and men, 9% and 14% of never smokers, respectively, and 26% and 41% of continuing heavy smokers ( >= 20 cigarettes per day), respectively, died in middle age. Years of life lost among heavy smokers between 40 and 70 years of age were 1.4 years in women and 2.7 years in men, compared with never smokers. Rates of smoking-associated lung cancer were similar in women and men, while lower cardiovascular mortality rates in women explained most of the difference in smoking-associated all-cause mortality between men and women. Limitations: Data on changes in smoking habits after the baseline examination were not available for all participants and for the last 15 years of follow-up. Mortality levels in middle age may not apply to non-Norwegian populations. Conclusions: Continuing smoking strongly increased and smoking cessation decreased the risk for death between 40 and 70 years of age for both women and men. Despite similar rates for lung cancer death, women who smoked had lower mortality rates in middle age than men with similar smoking histories due to fewer cardiovascular deaths in women.	Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5018 Bergen, Norway; Norwegian Inst Publ Hlth, Oslo, Norway	University of Bergen; Norwegian Institute of Public Health (NIPH)	Vollset, SE (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, Kalfarveien 31, N-5018 Bergen, Norway.		Gjessing, Hakon K/A-5871-2012	Tverdal, Aage/0000-0002-2909-5678				Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Bain C, 2004, JNCI-J NATL CANCER I, V96, P826, DOI 10.1093/jnci/djh143; Bjartveit K, 1979, Acta Med Scand Suppl, V634, P1; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 1998, Stat Methods Med Res, V7, P87, DOI 10.1191/096228098668199908; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Ghali WA, 2001, JAMA-J AM MED ASSOC, V286, P1494, DOI 10.1001/jama.286.12.1494; HAMMOND EC, 1954, JAMA-J AM MED ASSOC, V155, P1316, DOI 10.1001/jama.1954.03690330020006; KALBFLEICH JD, 2002, STAT ANAL FAILURE TI, P253; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Liu BQ, 1998, BMJ-BRIT MED J, V317, P1411, DOI 10.1136/bmj.317.7170.1411; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; MAKUCH RW, 1982, J CHRON DIS, V35, P437, DOI 10.1016/0021-9681(82)90058-3; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Pearl R, 1938, SCIENCE, V87, P216, DOI 10.1126/science.87.2253.216; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Peto R, 1994, MORTALITY SMOKING DE; Peto R, 2006, MORTALITY SMOKING DE; Phillips AN, 1996, BRIT MED J, V313, P907; Prescott E, 1998, INT J EPIDEMIOL, V27, P27, DOI 10.1093/ije/27.1.27; Prescott E, 1998, J EPIDEMIOL COMMUN H, V52, P131, DOI 10.1136/jech.52.2.131; *STAT NORW, 2004, STAT YB NORW 2004; Tanuseputro P, 2005, AM J EPIDEMIOL, V161, P787, DOI 10.1093/aje/kwi093; Therneau TM, 2000, MODELING SURVIVAL DA; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; Thun MJ, 1997, PREV MED, V26, P422, DOI 10.1006/pmed.1997.0182; Thun MJ, 2000, JAMA-J AM MED ASSOC, V284, P706, DOI 10.1001/jama.284.6.706; Thun MJ, 2002, ONCOGENE, V21, P7307, DOI 10.1038/sj.onc.1205807; TVERDAL A, 1993, J CLIN EPIDEMIOL, V46, P475, DOI 10.1016/0895-4356(93)90025-V; U.S. Department of Health and Human Services, 2001, WOM SMOK REP SURG GE; *US DEP HHS, 1989, RED HLTH CONS SMOK 2; *US DHEW, 1964, PHS PUBL, V1103; *WHO, 2003, WORLD HLTH REP 2003, P91; 2002, HLTH STAT ATLAS MORT	37	75	80	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					381	389		10.7326/0003-4819-144-6-200603210-00004	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549850				2022-12-28	WOS:000236251800001
J	Mullany, LC; Darmstadt, GL; Khatry, SK; Katz, J; LeClerq, SC; Shrestha, S; Adhikari, R; Tielsch, JM				Mullany, LC; Darmstadt, GL; Khatry, SK; Katz, J; LeClerq, SC; Shrestha, S; Adhikari, R; Tielsch, JM			Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trial	LANCET			English	Article; Proceedings Paper	43rd Annual Meeting of the Infectious-Diseases-Society-of-America	OCT 06-09, 2005	San Francisco, CA	Infect Dis Soc Amer			BACTERIAL-COLONIZATION; STREPTOCOCCAL COLONIZATION; NEWBORN BABIES; RISK-FACTORS; TETANUS; CARE; INFECTIONS; ANTIMICROBIALS; INTERVENTION; DISINFECTION	Background Omphalitis contributes to neonatal morbidity and mortality in developing countries. Umbilical cord cleansing with antiseptics might reduce infection and mortality risk, but has not been rigorously investigated. Methods In our community-based, cluster-randomised trial, 413 communities in Sarlahi, Nepal, were randomly assigned to one of three cord-care regimens. 4934 infants were assigned to 4.0% chlorhexidine, 5107 to cleansing with soap and water, and 5082 to dry cord care. In intervention clusters, the newborn cord was cleansed in the home on days 1-4, 6, 8, and 10. in all clusters, the cord was examined for signs of infection (pus, redness, or swelling) on these visits and in follow-up visits on days 12, 14, 21, and 28. Incidence of omphalitis was defined under three sign-based algorithms, with increasing severity. Infant vital status was recorded for 28 completed days. The primary outcomes were incidence of neonatal omphalitis and neonatal mortality. Analysis was by intention-to-treat. This trial is registered with Clinicaltrials.gov, number NCT00109616. Findings Frequency of omphalitis by all three definitions was reduced significantly in the chlorhexidine group. Severe omphalitis in chlorhexidine clusters was reduced by 75% (incidence rate ratio 0.25, 95% CI 0.12-0.53; 13 infections/4839 neonatal periods) compared with dry cord-care clusters (52/4930). Neonatal mortality was 24% lower in the chlorhexidine group (relative risk 0.76 [95% CI 0.55-1.04]) than in the dry cord care group. In infants enrolled within the first 24 h, mortality was significantly reduced by 34% in the chlorhexidine group (0.66 [0.46-0.95]). Soap and water did not reduce infection or mortality risk. Interpretation Recommendations for dry cord care should be reconsidered on the basis of these findings that early antisepsis with chlorhexidine of the umbilical cord reduces local cord infections and overall neonatal mortality.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21211 USA; Nepal Nutr Intervent Project, Sarlahi Kathmandu, Nepal; Tribhuvan Univ, Inst Med, Kathmandu, Nepal	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Mullany, LC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21211 USA.	lmullany@jhsph.edu	Darmstadt, Gary/AAU-7488-2020	Katz, Joanne/0000-0002-5997-7823; Darmstadt, Gary/0000-0002-7522-5824; Tielsch, James/0000-0002-1151-060X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038753, R01HD044004] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD044004-03, R01 HD038753-04, HD38753, R01 HD044004, HD44004, R01 HD038753] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AGGETT PJ, 1981, ARCH DIS CHILD, V56, P878, DOI 10.1136/adc.56.11.878; AIREDE AI, 1992, J TROP PEDIATRICS, V38, P129, DOI 10.1093/tropej/38.3.129; ALDER VG, 1980, ARCH DIS CHILD, V55, P277, DOI 10.1136/adc.55.4.277; AYLIFFE GAJ, 1988, J HOSP INFECT, V11, P226, DOI 10.1016/0195-6701(88)90101-6; BELFRAGE E, 1985, SCAND J INFECT DIS, V17, P413; Bennett J, 1997, INT J EPIDEMIOL, V26, P897, DOI 10.1093/ije/26.4.897; Bennett J, 1999, INT J EPIDEMIOL, V28, P263, DOI 10.1093/ije/28.2.263; Bennett J, 1996, INT J EPIDEMIOL, V25, P879, DOI 10.1093/ije/25.4.879; Bennett J, 1999, INT J EPIDEMIOL, V28, P1172, DOI 10.1093/ije/28.6.1172; Chai F, 2004, INT J EPIDEMIOL, V33, P551, DOI 10.1093/ije/dyh073; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Denton GW, 2001, DISINFECTION STERILI, P321; DOEBBELING BN, 1992, NEW ENGL J MED, V327, P88, DOI 10.1056/NEJM199207093270205; Faoagali J, 1995, AM J INFECT CONTROL, V23, P337, DOI 10.1016/0196-6553(95)90263-5; Faridi M M, 1993, J Indian Med Assoc, V91, P283; Freeman JV, 2005, PAEDIATR PERINAT EP, V19, P323, DOI 10.1111/j.1365-3016.2005.00652.x; Garland JS, 2001, PEDIATRICS, V107, P1431, DOI 10.1542/peds.107.6.1431; GARNER P, 1994, J TROP PEDIATRICS, V40, P24, DOI 10.1093/tropej/40.1.24; Gurkan F, 1999, EUR J EPIDEMIOL, V15, P171, DOI 10.1023/A:1007500109522; Guvenc H, 1997, J TROP PEDIATRICS, V43, P368, DOI 10.1093/tropej/43.6.368; GUVENC HY, 1991, SCAND J INFECT DIS, V23, P613, DOI 10.3109/00365549109105186; *HO, 1998, CAR UMB CORD; ISLAM MS, 1982, J TROP PEDIATRICS, V28, P299, DOI 10.1093/tropej/28.6.299; Janssen PA, 2003, PEDIATRICS, V111, P15, DOI 10.1542/peds.111.1.15; JOHNSSON J, 1987, ACTA PAEDIATR SCAND, V76, P675, DOI 10.1111/j.1651-2227.1987.tb10544.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2004, LANCET, V364, P2020, DOI 10.1016/S0140-6736(04)17511-9; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; MEBERG A, 1985, ACTA PAEDIATR SCAND, V74, P366, DOI 10.1111/j.1651-2227.1985.tb10985.x; Montville R, 2002, INT J FOOD MICROBIOL, V73, P305, DOI 10.1016/S0168-1605(01)00666-3; Mullany LC, 2006, ARCH DIS CHILD-FETAL, V91, pF99, DOI 10.1136/adc.2005.080093; Mullany LC, 2003, PEDIATR INFECT DIS J, V22, P996, DOI 10.1097/01.inf.0000095429.97172.48; Parashar UD, 1998, INT J EPIDEMIOL, V27, P904, DOI 10.1093/ije/27.5.904; Quddus A, 2002, INT J EPIDEMIOL, V31, P648, DOI 10.1093/ije/31.3.648; Raza S A, 2004, J Postgrad Med, V50, P247; Sawardekar KP, 2004, PEDIATR INFECT DIS J, V23, P22, DOI 10.1097/01.inf.0000105200.18110.1e; SEEBERG S, 1984, ACTA PAEDIATR SCAND, V73, P498, DOI 10.1111/j.1651-2227.1984.tb09961.x; SPECK WT, 1980, CHEMOTHERAPY, V26, P372, DOI 10.1159/000237929; SPECK WT, 1977, AM J DIS CHILD, V131, P1005, DOI 10.1001/archpedi.1977.02120220071012; TIELSCH JM, 2005, COUNTD 2015 TRACK PR; TRAVERSO HP, 1989, LANCET, V1, P486; United Nations, 2001, SECR GEN REP GEN ASS; WALD ER, 1977, AM J DIS CHILD, V131, P178, DOI 10.1001/archpedi.1977.02120150060011; WATKINSON M, 1992, J HOSP INFECT, V21, P131, DOI 10.1016/0195-6701(92)90032-H; Zupan J, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/1465-1858.CD001057	46	187	187	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					910	918		10.1016/S0140-6736(06)68381-5	http://dx.doi.org/10.1016/S0140-6736(06)68381-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	025CE	16546539	Green Accepted			2022-12-28	WOS:000236242100027
J	Tunstall-Pedoe, H; Connaghan, J; Woodward, M; Tolonen, H; Kuulasmaa, K				Tunstall-Pedoe, H; Connaghan, J; Woodward, M; Tolonen, H; Kuulasmaa, K			Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication	BRITISH MEDICAL JOURNAL			English	Article							EVENT RATES; HYPERTENSION; TRENDS; COMMUNITY	Objective Declining mean systolic and diastolic blood pressures were observed in most populations of the World Health Organization MONICA (monitoring trends and determinants in cardiovascular disease) project from the mid-1980s to mid-1990s. We tested whether pooled results would show mean change associated with decline in high readings only, resulting from better antihypertensive medication, or with similar falls in low, middle, and high readings, implying other causes. Design Independent, random sample, cross sectional population surveys, each end of the MONICA decade. Setting 38 populations in 21 countries across four continents. Participants Design target in each survey of 200 participants in each 10 year age and sex group from age 35 to 64 Main outcome measures Changes in the population in mean systolic and diastolic blood pressure, and in low, middle, and high readings-the 20th, 50th, and 80th centiles-and the differences between these changes. Results Individual populations differed considerably, but pooling the 38 population results gave mean changes in systolic blood pressure of - 2.2 mm Hg in men, - 3.3 mm Hg in women, and in diastolic blood. pressure of - 1.4 mm Hg in men and - 2.2 mm Hg in women (overall average - 2.26 mm Hg, population median - 1.55 mm Hg). Antihypertensive medication, associated with high readings, rose by 0.5% to 11.4%. However, average falls in low and middle blood pressure readings were so similar to those in high readings and in the mean that no effect from improving treatment of hypertension was detected. Results in contrasted subgroups were consistent. Conclusions Blood pressure fell across 38 MONICA populations at all levels of readings, with no differential fall in high readings attributable to better control of hypertension. Despite the importance of medication to individuals, in that decade other determinants of blood pressure lowering must have been more pervasive and powerful in whole populations.	Univ Dundee, Ninewells Hosp, Inst Cardiovasc Res, Cardiovasc Epidemiol Unit, Dundee DD1 9SY, Scotland; George Inst Int Hlth, Sydney, NSW 2050, Australia; Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Int Cardiovasc Dis Epidemiol Unit, SF-00300 Helsinki, Finland	University of Dundee; University of Sydney; Finland National Institute for Health & Welfare	Tunstall-Pedoe, H (corresponding author), Univ Dundee, Ninewells Hosp, Inst Cardiovasc Res, Cardiovasc Epidemiol Unit, Dundee DD1 9SY, Scotland.	h.tunstallpedoe@dundee.ac.uk	Woodward, Mark/L-6817-2017; Woodward, Mark/D-8492-2015	Tolonen, Hanna/0000-0003-3121-4303; Woodward, Mark/0000-0001-9800-5296; Connaghan, John/0000-0001-5558-7986; Kuulasmaa, Kari/0000-0003-2165-1411				Antikainen RL, 2006, EUR J CARDIOV PREV R, V13, P13, DOI 10.1097/00149831-200602000-00004; Barker D., 1994, Microwaves 94. The Applications of RF. Microwave and Millimetre Ware Technologies. Conference Proceedings, P53; *C BOARD GRON GROW, 2006, TOT EC DAT; Chen R, 2003, J HUM HYPERTENS, V17, P751, DOI 10.1038/sj.jhh.1001612; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; EPSTEIN FH, 1973, CIRCULATION, V48, P185, DOI 10.1161/01.CIR.48.1.185; HILL AB, 1991, B HILLS PRINCIPLES M, P266; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; KUULASMAA K, 1998, AGE DATE EXAMINATION; Kuulasmaa K, 1998, QUALITY ASSESSMENT D; Mancia G, 2003, J HYPERTENS, V21, P1011, DOI 10.1097/01.hjh.0000059051.65882.32; PARATI G, 2003, J HYPERTENS, V21, P545; Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Tolonen H, 2000, MONICA POPULATION SU; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; Tunstall-Pedoe H., 2003, MONICA MONOGRAPH MUL; Waterhouse J., 1976, CANCER INCIDENCE 5 C, V3, P456; *WHO MONICA PROJ, 1998, MONICA MAN 3; WHO MONICA Project, 1998, MONICA MAN; WILBER JA, 1973, B NEW YORK ACAD MED, V49, P510; WOLF HK, 1998, PARTICIPATION RATES	22	64	65	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					629	632		10.1136/bmj.38753.779005.BE	http://dx.doi.org/10.1136/bmj.38753.779005.BE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16531419	Bronze, Green Published			2022-12-28	WOS:000236314700013
J	Rothemund, PWK				Rothemund, PWK			Folding DNA to create nanoscale shapes and patterns	NATURE			English	Article							NANOSTRUCTURES; MICROSCOPE; OCTAHEDRON; NANOWIRES; MOLECULE; LATTICES; SURFACE; ARRAYS; DESIGN	'Bottom- up fabrication', which exploits the intrinsic properties of atoms and molecules to direct their self- organization, is widely used to make relatively simple nanostructures. A key goal for this approach is to create nanostructures of high complexity, matching that routinely achieved by ' top- down' methods. The self- assembly of DNA molecules provides an attractive route towards this goal. Here I describe a simple method for folding long, single- stranded DNA molecules into arbitrary two- dimensional shapes. The design for a desired shape is made by raster- filling the shape with a 7- kilobase single- stranded scaffold and by choosing over 200 short oligonucleotide ' staple strands' to hold the scaffold in place. Once synthesized and mixed, the staple and scaffold strands self- assemble in a single step. The resulting DNA structures are roughly 100 nm in diameter and approximate desired shapes such as squares, disks and five- pointed stars with a spatial resolution of 6 nm. Because each oligonucleotide can serve as a 6- nm pixel, the structures can be programmed to bear complex patterns such as words and images on their surfaces. Finally, individual DNA structures can be programmed to form larger assemblies, including extended periodic lattices and a hexamer of triangles ( which constitutes a 30- megadalton molecular complex).	CALTECH, Dept Comp Sci & Computat Neural Syst, Pasadena, CA 91125 USA	California Institute of Technology	Rothemund, PWK (corresponding author), CALTECH, Dept Comp Sci & Computat Neural Syst, Pasadena, CA 91125 USA.	pwkr@dna.caltech.edu						CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Feynman R.P., 1992, J MICROELECTROMECH S, V1, P60, DOI 10.1109/84.128057; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Heinrich AJ, 2002, SCIENCE, V298, P1381, DOI 10.1126/science.1076768; JUNNO T, 1995, APPL PHYS LETT, V66, P3627, DOI 10.1063/1.113809; LABEAN TH, 1999, DIMACS SERIES DISCRE, V54, P123; Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; Park S.H., 2006, ANGEW CHEM, V118, P749; Reif JH, 2002, LECT NOTES COMPUT SC, V2380, P1; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Seeman NC, 2005, REP PROG PHYS, V68, P237, DOI 10.1088/0034-4885/68/1/R05; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Winfree Erik, 1996, DNA BASED COMPUTERS, V27, P199; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yokoyama T, 2001, NATURE, V413, P619, DOI 10.1038/35098059; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006	24	4747	4946	102	2168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					297	302		10.1038/nature04586	http://dx.doi.org/10.1038/nature04586			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541064	Green Published			2022-12-28	WOS:000235997600044
J	Stassun, KG; Mathieu, RD; Valenti, JA				Stassun, KG; Mathieu, RD; Valenti, JA			Discovery of two young brown dwarfs in an eclipsing binary system	NATURE			English	Article							ORION-NEBULA CLUSTER; LOW-MASS STARS; MEASURING FUNDAMENTAL PARAMETERS; MAIN-SEQUENCE STARS; SUBSTELLAR OBJECTS; EVOLUTIONARY MODELS; STELLAR PROPERTIES; MOLECULAR CLOUD; ROTATION; CONSTRAINTS	Brown dwarfs are considered to be ' failed stars' in the sense that they are born with masses between the least massive stars ( 0.072 solar masses, M.)(1) and the most massive planets ( similar to 0.013M.)(2); they therefore serve as a critical link in our understanding of the formation of both stars and planets(3). Even the most fundamental physical properties of brown dwarfs remain, however, largely unconstrained by direct measurement. Here we report the discovery of a brown- dwarf eclipsing binary system, in the Orion Nebula star- forming region, from which we obtain direct measurements of mass and radius for these newly formed brown dwarfs. Our mass measurements establish both objects as brown dwarfs, with masses of 0.054 +/- 0.005M. and 0.034 +/- 0.003M. At the same time, with radii relative to the Sun's of 0.669 +/- 0.034R. and 0.511 +/- 0.026R., these brown dwarfs are more akin to low- mass stars in size. Such large radii are generally consistent with theoretical predictions for young brown dwarfs in the earliest stages of gravitational contraction(4,5). Surprisingly, however, we find that the less- massive brown dwarf is the hotter of the pair; this result is contrary to the predictions of all current theoretical models of coeval brown dwarfs.	Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; Space Telescope Sci Inst, Baltimore, MD 21218 USA	Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; Space Telescope Science Institute	Stassun, KG (corresponding author), Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA.	keivan.stassun@vanderbilt.edu		Stassun, Keivan/0000-0002-3481-9052; Valenti, Jeff/0000-0003-3305-6281				ANDERSEN J, 1991, ASTRON ASTROPHYS REV, V3, P91, DOI 10.1007/BF00873538; Baraffe I, 1998, ASTRON ASTROPHYS, V337, P403; Basri G, 2000, ANNU REV ASTRON ASTR, V38, P485, DOI 10.1146/annurev.astro.38.1.485; Bate MR, 2005, MON NOT R ASTRON SOC, V356, P1201, DOI 10.1111/j.1365-2966.2004.08593.x; BESSELL MS, 1991, ASTRON J, V101, P662, DOI 10.1086/115714; Burrows A, 2001, REV MOD PHYS, V73, P719, DOI 10.1103/RevModPhys.73.719; Carpenter JM, 2001, ASTRON J, V121, P3160, DOI 10.1086/321086; Chabrier G, 2000, ASTROPHYS J, V542, P464, DOI 10.1086/309513; Chabrier G, 2000, ANNU REV ASTRON ASTR, V38, P337, DOI 10.1146/annurev.astro.38.1.337; D'Antona F., 1997, Memorie della Societa Astronomica Italiana, V68, P807; Doppmann GW, 2003, ASTRON J, V126, P3030, DOI 10.1086/379292; Doppmann GW, 2003, ASTRON J, V126, P3043, DOI 10.1086/378958; GENZEL R, 1989, ANNU REV ASTRON ASTR, V27, P41, DOI 10.1146/annurev.aa.27.090189.000353; Hillenbrand LA, 2004, ASTROPHYS J, V604, P741, DOI 10.1086/382021; Hillenbrand LA, 1997, ASTRON J, V113, P1733, DOI 10.1086/118389; Maxted PFL, 2005, MON NOT R ASTRON SOC, V362, pL45, DOI 10.1111/j.1745-3933.2005.00073.x; Mohanty S, 2003, ASTROPHYS J, V583, P451, DOI 10.1086/345097; Mohanty S, 2004, ASTROPHYS J, V609, P854, DOI 10.1086/420923; Mohanty S, 2004, ASTROPHYS J, V609, P885, DOI 10.1086/420924; Osorio MRZ, 2004, ASTROPHYS J, V615, P958, DOI 10.1086/424507; Palla F, 1999, ASTROPHYS J, V525, P772, DOI 10.1086/307928; Pont F, 2005, ASTRON ASTROPHYS, V433, pL21, DOI 10.1051/0004-6361:200500025; Prsa A, 2005, ASTROPHYS J, V628, P426, DOI 10.1086/430591; Reipurth B, 2001, ASTRON J, V122, P432, DOI 10.1086/321121; Scholz A, 2005, ASTRON ASTROPHYS, V429, P1007, DOI 10.1051/0004-6361:20041932; Sicilia-Aguilar A, 2005, ASTRON J, V129, P363, DOI 10.1086/426327; Slesnick CL, 2004, ASTROPHYS J, V610, P1045, DOI 10.1086/421898; Stassun KG, 2004, ASTROPHYS J SUPPL S, V151, P357, DOI 10.1086/382353; WILSON RE, 1971, ASTROPHYS J, V166, P605, DOI 10.1086/150986; [No title captured]	30	211	212	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					311	314		10.1038/nature04570	http://dx.doi.org/10.1038/nature04570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541067				2022-12-28	WOS:000235997600047
J	Pountney, T; Green, EM				Pountney, T; Green, EM			Practice pointer - Hip dislocation in cerebral palsy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GROSS MOTOR FUNCTION; BOTULINUM-TOXIN-A; CHILDREN; SUBLUXATION; PAIN; PATHOGENESIS; PREVENTION; MANAGEMENT; SYSTEM		Chailey Heritage Clin Serv, Chailey BN8 4JN, England		Pountney, T (corresponding author), Chailey Heritage Clin Serv, Chailey BN8 4JN, England.	Terry.Pountney@southdowns.nhs.uk						Abel MF, 1999, J PEDIATR ORTHOPED, V19, P479, DOI 10.1097/00004694-199907000-00011; BAKER LD, 1962, J BONE JOINT SURG AM, V44, P1331, DOI 10.2106/00004623-196244070-00005; Barwood S, 2000, DEV MED CHILD NEUROL, V42, P116, DOI 10.1017/S0012162200000220; Boyd RN, 2001, EUR J NEUROL, V8, P109, DOI 10.1046/j.1468-1331.2001.00043.x; Brunner R, 1997, J PEDIATR ORTHOPED, V17, P585, DOI 10.1097/00004694-199709000-00004; CARR C, 1987, J PEDIATR ORTHOPED, V7, P262, DOI 10.1097/01241398-198705000-00004; COOPERMAN DR, 1987, J PEDIATR ORTHOPED, V7, P268, DOI 10.1097/01241398-198705000-00005; CORNELL MS, 1995, DEV MED CHILD NEUROL, V37, P3; Cottalorda J, 1998, INT ORTHOP, V22, P374, DOI 10.1007/s002640050281; Deleplanque B, 2002, REV CHIR ORTHOP, V88, P279; *DEP HLTH, 2004, 8 DEP HLTH NAT SERV; Dobson F, 2002, J BONE JOINT SURG BR, V84B, P720, DOI 10.1302/0301-620X.84B5.12398; FAIRHURST CBR, 2004, BRIT PAEDIAT NEUROLO, P22; FUJIWARA M, 1976, ARCH PHYS MED REHAB, V57, P278; Hagglund G, 2005, J BONE JOINT SURG BR, V87B, P95, DOI 10.1302/0301-620X.87B1; Hankinson J, 2002, DEV MED CHILD NEUROL, V44, P177, DOI 10.1017/S001216220100189X; Hodgkinson I, 2001, DEV MED CHILD NEUROL, V43, P806, DOI 10.1017/S0012162201001463; HUMPHREYS G, IN PRESS PHYSIOTHERA; Hunt A, 2004, DEV MED CHILD NEUROL, V46, P9, DOI 10.1017/S0012162204000039; Knapp DR, 2002, J PEDIATR ORTHOPED, V22, P668, DOI 10.1097/00004694-200209000-00018; LONSTEIN JE, 1986, J PEDIATR ORTHOPED, V6, P521, DOI 10.1097/01241398-198609000-00001; Mall V, 2000, J CHILD NEUROL, V15, P214, DOI 10.1177/088307380001500402; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Paterson C, 2005, BMJ-BRIT MED J, V330, P1202, DOI 10.1136/bmj.330.7501.1202; PHELPS WM, 1959, J BONE JOINT SURG AM, V41, P440, DOI 10.2106/00004623-195941030-00008; Pountney T, 2002, CHILD CARE HLTH DEV, V28, P179, DOI 10.1046/j.1365-2214.2002.00254.x; Pountney T. E., 2004, CHAILEY APPROACH POS; POUNTNEY TE, 2002, EFFECT POSTURAL MANA; Reimers J, 1980, Acta Orthop Scand Suppl, V184, P1; Russell Debra, 2002, CLIN DEV MED; Samilson R L, 1967, Clin Orthop Relat Res, V54, P61; SAMILSON RL, 1972, J BONE JOINT SURG AM, VA 54, P863, DOI 10.2106/00004623-197254040-00017; Schwartz L, 1999, ARCH PHYS MED REHAB, V80, P1243, DOI 10.1016/S0003-9993(99)90023-0; Scrutton D, 1997, ARCH DIS CHILD, V76, P381, DOI 10.1136/adc.76.4.381; Scrutton D, 2001, DEV MED CHILD NEUROL, V43, P586, DOI 10.1017/S0012162201001086; SCRUTTON D, 1978, CARE HANDICAPPED CHI; Sharrard W J, 1967, J Bone Joint Surg Br, V49, P731; Stott NS, 2004, DEV MED CHILD NEUROL, V46, P628, DOI 10.1017/S0012162204001069; Turker RJ, 2000, J PEDIATR ORTHOPED, V20, P370, DOI 10.1097/00004694-200005000-00019; VIDAL J, 1985, INT ORTHOP, V9, P105; YOUNG NL, 1998, PEDIAT PHYS THER, V10, P94	41	24	31	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					772	775		10.1136/bmj.332.7544.772	http://dx.doi.org/10.1136/bmj.332.7544.772			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032JA	16575079	Green Submitted, Green Published			2022-12-28	WOS:000236769500024
J	Salisbury, D				Salisbury, D			Avian influenza - Preparing for the pandemic - Using lessons from the past to plan for pandemic flu - UK government response to Hilary Pickles	BRITISH MEDICAL JOURNAL			English	Editorial Material									Dept Hlth, London SW1, England		Salisbury, D (corresponding author), Dept Hlth, London SW1, England.	David.Salisbury@dh.gsi.gov.uk						*DEP HLTH, 2005, UK HLTH DEP INFL PAN	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 1	2006	332	7544					784	784		10.1136/bmj.332.7544.784	http://dx.doi.org/10.1136/bmj.332.7544.784			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032JA	16575085	Green Published			2022-12-28	WOS:000236769500029
J	Burton, RA; Wilson, SM; Hrmova, M; Harvey, AJ; Shirley, NJ; Stone, BA; Newbigin, EJ; Bacic, A; Fincher, GB				Burton, RA; Wilson, SM; Hrmova, M; Harvey, AJ; Shirley, NJ; Stone, BA; Newbigin, EJ; Bacic, A; Fincher, GB			Cellulose synthase-like CslF genes mediate the synthesis of cell wall (1,3;1,4)-beta-D-glucans	SCIENCE			English	Article							MONOCLONAL-ANTIBODY; HIGHER-PLANTS; BARLEY; FAMILY; ARABIDOPSIS; REVEALS	A characteristic feature of grasses and commercially important cereals is the presence of (1,3; 1,4)-beta-D-glucans in their cell walls. We have used comparative genomics to link a major quantitative trait locus for (1,3; 1,4)-beta-D-glucan content in barley grain to a cluster of cellulose synthase-like CslF genes in rice. After insertion of rice CslF genes into Arabidopsis, we detected (1,3; 1,4)-beta-D-glucan in walls of transgenic plants using specific monoclonal antibodies and enzymatic analysis. Because wild-type Arabidopsis does not contain CslF genes or have (1,3; 1,4)-beta-D-glucans in its walls, these experiments provide direct, gain-of-function evidence for the participation of rice CslF genes in (1,3; 1,4)-beta-D-glucan biosynthesis.	Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Glen Osmond, SA 5064, Australia; Univ Melbourne, Sch Bot, Australian Ctr Plant Funct Genom, Parkville, Vic 3010, Australia; La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia	University of Adelaide; University of Melbourne; La Trobe University	Fincher, GB (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Australian Ctr Plant Funct Genom, Waite Campus, Glen Osmond, SA 5064, Australia.	geoff.fincher@adelaide.edu.au	Hrmova, Maria/AAH-3951-2020; Burton, Rachel A/C-4441-2011	Burton, Rachel A/0000-0002-0638-4709; Newbigin, Ed/0000-0002-9644-302X; Shirley, Neil/0000-0001-8114-9891; Bacic, Tony/0000-0001-7483-8605; Harvey, Andrew John/0000-0002-3488-0531; Hrmova, Maria/0000-0002-3545-0605				Bacic A., 1988, BIOCHEM PLANT, V14, P297, DOI [DOI 10.1016/B978-0-08-092615-5.50014-X, 10.1016/B978-0-08-092615-5.50014-X]; BRAATEN JT, 1994, EUR J CLIN NUTR, V48, P465; Brennan CS, 2005, J CEREAL SCI, V42, P1, DOI 10.1016/j.jcs.2005.01.002; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; BURTON RA, UNPUB; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Coutinho PM, 1999, ROY SOC CH, P3; Dhugga KS, 2004, SCIENCE, V303, P363, DOI 10.1126/science.1090908; Gale MD, 1998, P NATL ACAD SCI USA, V95, P1971, DOI 10.1073/pnas.95.5.1971; HAN F, 1995, THEOR APPL GENET, V91, P921, DOI 10.1007/BF00223901; Hazen SP, 2002, PLANT PHYSIOL, V128, P336, DOI 10.1104/pp.010875; Liepman AH, 2005, P NATL ACAD SCI USA, V102, P2221, DOI 10.1073/pnas.0409179102; McLaren JS, 2005, TRENDS BIOTECHNOL, V23, P339, DOI 10.1016/j.tibtech.2005.04.004; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Saxena IM, 1997, CELLULOSE, V4, P33, DOI 10.1023/A:1018411101036; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Stewart RJ, 2001, PROTEIN ENG, V14, P245, DOI 10.1093/protein/14.4.245; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Trethewey JAK, 2005, AM J BOT, V92, P1660, DOI 10.3732/ajb.92.10.1660; Wilson Z. E., UNPUB; ZABLACKIS E, 1995, PLANT PHYSIOL, V107, P1129, DOI 10.1104/pp.107.4.1129; [No title captured]	24	319	345	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2006	311	5769					1940	1942		10.1126/science.1122975	http://dx.doi.org/10.1126/science.1122975			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574868				2022-12-28	WOS:000236387800049
J	Tanno, K; Willcox, G				Tanno, K; Willcox, G			How fast was wild wheat domesticated?	SCIENCE			English	Article							CULTIVATION		CNRS, Unite Mixte Rech 5133, F-07460 Berrias, France; Res Inst Humanity & Nat, Kyoto 6020878, Japan	Centre National de la Recherche Scientifique (CNRS); Research Institute for Humanity & Nature (RIHN)	Willcox, G (corresponding author), CNRS, Unite Mixte Rech 5133, F-07460 Berrias, France.	george.willcox@mom.fr						Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; HILLMAN GC, 1990, J WORLD PREHIST, V4, P157, DOI 10.1007/BF00974763; Kislev ME, 2002, ISRAEL J PLANT SCI, V50, pS85, DOI 10.1560/QV07-WYET-WPQ5-QRDC; Lev-Yadun S, 2000, SCIENCE, V288, P1602, DOI 10.1126/science.288.5471.1602; Van Zeist W, 1984, PALAEOHISTORIA, V24, P165; Willcox G, 2004, J ARCHAEOL SCI, V31, P145, DOI 10.1016/j.jas.2003.07.003	6	261	284	6	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1886	1886		10.1126/science.1124635	http://dx.doi.org/10.1126/science.1124635			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574859				2022-12-28	WOS:000236387800034
J	Dasgupta, R; Hirschmann, MM				Dasgupta, R; Hirschmann, MM			Melting in the Earth's deep upper mantle caused by carbon dioxide	NATURE			English	Article							EAST PACIFIC RISE; SEISMIC ANISOTROPY; PHASE-RELATIONS; MIDOCEAN RIDGE; OCEANIC-CRUST; LOW-VELOCITY; CO2; SOLIDUS; BENEATH; GPA	The onset of partial melting beneath mid-ocean ridges governs the cycling of highly incompatible elements from the mantle to the crust(1), the flux of key volatiles (such as CO2, He and Ar)(1,2) and the rheological properties of the upper mantle(3). Geophysical observations(4-6) indicate that melting beneath ridges begins at depths approaching 300 km, but the cause of this melting has remained unclear. Here we determine the solidus of carbonated peridotite from 3 to 10 GPa and demonstrate that melting beneath ridges may occur at depths up to 330 km, producing 0.03 - 0.3% carbonatite liquid. We argue that these melts promote recrystallization and realignment of the mineral matrix, which may explain the geophysical observations. Extraction of incipient carbonatite melts from deep within the oceanic mantle produces an abundant source of metasomatic fluids and a vast mantle residue depleted in highly incompatible elements and fractionated in key parent-daughter elements. We infer that carbon, helium, argon and highly incompatible heat-producing elements ( such as uranium, thorium and potassium) are efficiently scavenged from depths of similar to 200 - 330 km in the upper mantle.	Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Dasgupta, R (corresponding author), Univ Minnesota, Dept Geol & Geophys, 30 Pillsbury Dr SE, Minneapolis, MN 55455 USA.	dasg0007@umn.edu	Hirschmann, marc m/B-9455-2016; Dasgupta, Rajdeep/C-7252-2009	Hirschmann, marc m/0000-0003-1213-6645; Dasgupta, Rajdeep/0000-0001-5392-415X				[Anonymous], [No title captured], DOI DOI 10.1130/2005.2388(13); Aubaud C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021341; Bezos A, 2005, GEOCHIM COSMOCHIM AC, V69, P711, DOI 10.1016/j.gca.2004.07.026; CANIL D, 1990, J GEOPHYS RES-SOLID, V95, P15805, DOI 10.1029/JB095iB10p15805; Dalton JA, 1998, CONTRIB MINERAL PETR, V131, P123, DOI 10.1007/s004100050383; Dasgupta R, 2005, CONTRIB MINERAL PETR, V149, P288, DOI 10.1007/s00410-004-0649-0; EGGLER DH, 1976, GEOLOGY, V4, P69, DOI 10.1130/0091-7613(1976)4<69:DCCPMI>2.0.CO;2; Evans RL, 1999, SCIENCE, V286, P752, DOI 10.1126/science.286.5440.752; FALLOON TJ, 1989, EARTH PLANET SC LETT, V94, P364, DOI 10.1016/0012-821X(89)90153-2; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; Frost DJ, 1997, GEOCHIM COSMOCHIM AC, V61, P1565, DOI 10.1016/S0016-7037(97)00035-5; GALER SJG, 1986, CHEM GEOL, V56, P45, DOI 10.1016/0009-2541(86)90109-9; Gu YJ, 2005, EARTH PLANET SC LETT, V232, P259, DOI 10.1016/j.epsl.2005.01.019; Hammouda T, 2000, GEOLOGY, V28, P283, DOI 10.1130/0091-7613(2000)28<283:UMIBCM>2.0.CO;2; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Holtzman BK, 2003, SCIENCE, V301, P1227, DOI 10.1126/science.1087132; ITA J, 1992, J GEOPHYS RES-SOL EA, V97, P6849, DOI 10.1029/92JB00068; JAVOY M, 1991, EARTH PLANET SC LETT, V107, P598, DOI 10.1016/0012-821X(91)90104-P; Karato S, 1998, EARTH PLANET SC LETT, V157, P193, DOI 10.1016/S0012-821X(98)00034-X; Keppler H, 2003, NATURE, V424, P414, DOI 10.1038/nature01828; Kogiso T, 2003, EARTH PLANET SC LETT, V216, P603, DOI 10.1016/S0012-821X(03)00538-7; Marty B, 1998, CHEM GEOL, V145, P233, DOI 10.1016/S0009-2541(97)00145-9; MCKENZIE D, 1985, EARTH PLANET SC LETT, V74, P81, DOI 10.1016/0012-821X(85)90168-2; McKenzie D, 2005, EARTH PLANET SC LETT, V233, P337, DOI 10.1016/j.epsl.2005.02.005; MINARIK WG, 1995, EARTH PLANET SC LETT, V133, P423, DOI 10.1016/0012-821X(95)00085-Q; PLANK T, 1992, J GEOPHYS RES-SOL EA, V97, P19749, DOI 10.1029/92JB01769; Rabinowicz M, 2002, EARTH PLANET SC LETT, V203, P205, DOI 10.1016/S0012-821X(02)00836-1; WALLACE ME, 1988, NATURE, V335, P343, DOI 10.1038/335343a0; Wood BJ, 1996, PHILOS T R SOC A, V354, P1495, DOI 10.1098/rsta.1996.0060; WYLLIE PJ, 1975, NATURE, V257, P297, DOI 10.1038/257297a0; YASUDA A, 1994, J GEOPHYS RES-SOL EA, V99, P9401, DOI 10.1029/93JB03205; ZHANG YX, 1993, EARTH PLANET SC LETT, V117, P331, DOI 10.1016/0012-821X(93)90088-Q	33	411	449	2	149	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					659	662		10.1038/nature04612	http://dx.doi.org/10.1038/nature04612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572168				2022-12-28	WOS:000236350400041
J	Nishioka, NS; Lauwers, GY				Nishioka, NS; Lauwers, GY			Case 10-2006: A 66-year-old woman with Barrett's esophagus with high-grade dysplasia - Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma with regression of dysplasia and regression of Barrett's esophagus after endoscopic mucosal resection and photodynamic therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PORFIMER SODIUM; FOLLOW-UP; CANCER; ADENOCARCINOMA; ABLATION; SURVEILLANCE; MULTICENTER; PROGRESSION; MANAGEMENT; EPITHELIUM		Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Nishioka, NS (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.		Jovani, Manol/AAF-5333-2020					Ban S, 2004, AM J SURG PATHOL, V28, P1466, DOI 10.1097/01.pas.0000141392.91677.7f; Buttar NS, 2001, GASTROINTEST ENDOSC, V54, P682, DOI 10.1067/mge.2001.119875; Ell C, 2000, GASTROENTEROLOGY, V118, P670, DOI 10.1016/S0016-5085(00)70136-3; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Goldblum JR, 2002, SEMIN DIAGN PATHOL, V19, P12, DOI 10.1053/sdia.2002.31767; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; Lightdale C J, 2000, Gastrointest Endosc Clin N Am, V10, P397; LIGHTDALE CJ, 1995, GASTROINTEST ENDOSC, V42, P507, DOI 10.1016/S0016-5107(95)70002-1; Mino-Kenudson M, 2005, AM J SURG PATHOL, V29, P680, DOI 10.1097/01.pas.0000154129.87219.fa; Overholt BF, 2005, GASTROINTEST ENDOSC, V62, P488, DOI 10.1016/j.gie.2005.06.047; Overholt BF, 1999, GASTROINTEST ENDOSC, V49, P1, DOI 10.1016/S0016-5107(99)70437-2; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; Sampliner RE, 2001, GASTROINTEST ENDOSC, V53, P554, DOI 10.1067/mge.2001.114418; Schnell TG, 2001, GASTROENTEROLOGY, V120, P1607, DOI 10.1053/gast.2001.25065; Schulz H, 2000, GASTROINTEST ENDOSC, V51, P659, DOI 10.1016/S0016-5107(00)33002-4; Skacel M, 2000, AM J GASTROENTEROL, V95, P3383; Spechler SJ, 2002, NEW ENGL J MED, V346, P836, DOI 10.1056/NEJMcp012118; Weston AP, 2000, AM J GASTROENTEROL, V95, P1888; Wolfsen HC, 2002, MAYO CLIN PROC, V77, P1176, DOI 10.4065/77.11.1176; Wright TA, 1997, BRIT J SURG, V84, P760, DOI 10.1002/bjs.1800840606	22	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1403	1409		10.1056/NEJMcpc059007	http://dx.doi.org/10.1056/NEJMcpc059007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571884				2022-12-28	WOS:000236338000011
J	Phonsombat, S; Stoller, ML				Phonsombat, S; Stoller, ML			Bilateral renal-vein thrombosis associated with the nephrotic syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Phonsombat, S (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.								0	1	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1402	1402		10.1056/NEJMicm050186	http://dx.doi.org/10.1056/NEJMicm050186			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571883				2022-12-28	WOS:000236338000009
J	Silva, CCD; de Vondel, JV; Morelle, M; Moshchalkov, VV				Silva, CCD; de Vondel, JV; Morelle, M; Moshchalkov, VV			Controlled multiple reversals of a ratchet effect	NATURE			English	Article							THERMAL RATCHETS; TRANSPORT	A single particle confined in an asymmetric potential demonstrates an anticipated ratchet effect by drifting along the 'easy' ratchet direction when subjected to non-equilibrium fluctuations(1-3). This well-known effect can, however, be dramatically changed if the potential captures several interacting particles. Here we demonstrate that the inter-particle interactions in a chain of repelling particles captured by a ratchet potential can, in a controllable way, lead to multiple drift reversals, with the drift sign alternating from positive to negative as the number of particles per ratchet period changes from odd to even. To demonstrate experimentally the validity of this very general prediction, we performed transport measurements on a. c.-driven vortices trapped in a superconductor by an array of nanometre-scale asymmetric traps. We found that the direction of the vortex drift does undergo multiple reversals as the vortex density is increased, in excellent agreement with the model predictions. This drastic change in the drift behaviour between single- and multiparticle systems can shed some light on the different behaviour of ratchets and biomembranes(4) in two drift regimes: diluted ( single particles) and concentrated ( interacting particles).	Katholieke Univ Leuven, INPAC, Nanoscale Superconduct & Magnetism Grp, B-3001 Louvain, Belgium	KU Leuven	Moshchalkov, VV (corresponding author), Katholieke Univ Leuven, INPAC, Nanoscale Superconduct & Magnetism Grp, Celestijnenlaan 200 D, B-3001 Louvain, Belgium.	Victor.Moshchalkov@fys.kuleuven.be	de Souza Silva, Clecio C/G-8640-2012; Van de Vondel, joris/P-1719-2018; Moshchalkov, Victor V/I-7232-2013	de Souza Silva, Clecio C/0000-0002-0910-2543; Van de Vondel, joris/0000-0001-6894-7258; 				Bader JS, 1999, P NATL ACAD SCI USA, V96, P13165, DOI 10.1073/pnas.96.23.13165; BAERT M, 1995, PHYS REV LETT, V74, P3269, DOI 10.1103/PhysRevLett.74.3269; BARTUSSEK R, 1994, EUROPHYS LETT, V28, P459, DOI 10.1209/0295-5075/28/7/001; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; de Souza Silva CC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.014507; DERENYI I, 1995, PHYS REV LETT, V75, P374, DOI 10.1103/PhysRevLett.75.374; FEYNMAN RP, 1966, FEYNMAN LECT PHYS, V1, pCH46; FIORY AT, 1978, APPL PHYS LETT, V32, P73, DOI 10.1063/1.89845; MAGNASCO MO, 1993, PHYS REV LETT, V71, P1477, DOI 10.1103/PhysRevLett.71.1477; Mateos JL, 2000, PHYS REV LETT, V84, P258, DOI 10.1103/PhysRevLett.84.258; Matthias S, 2003, NATURE, V424, P53, DOI 10.1038/nature01736; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; RISKEN H, 1984, FOKKER PLANCK EQUATI, pCH11; Savel'ev S, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.010601; Van de Vondel J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.057003; Villegas JE, 2003, SCIENCE, V302, P1188, DOI 10.1126/science.1090390; von Smoluchowski M, 1912, PHYS Z, V13, P1069	17	231	232	5	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					651	654		10.1038/nature04595	http://dx.doi.org/10.1038/nature04595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572166				2022-12-28	WOS:000236350400039
J	Downey, M; Houlsworth, R; Maringele, L; Rollie, A; Brehme, M; Galicia, S; Guillard, S; Partington, M; Zubko, MK; Krogan, NJ; Emili, A; Greenblatt, JF; Harrington, L; Lydall, D; Durocher, D				Downey, M; Houlsworth, R; Maringele, L; Rollie, A; Brehme, M; Galicia, S; Guillard, S; Partington, M; Zubko, MK; Krogan, NJ; Emili, A; Greenblatt, JF; Harrington, L; Lydall, D; Durocher, D			A genome-wide screen identifies the evolutionarily conserved KEOPS complex as a telomere regulator	CELL			English	Article							SINGLE-STRANDED-DNA; DE-NOVO TELOMERE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME ENDS; CHECKPOINT PATHWAYS; YEAST PID261/BUD32; BINDING PROTEIN; CDC13-1 MUTANTS; IN-VIVO; DAMAGE	Telomere capping is the essential function of telomeres. To identify new genes involved in telomere capping, we carried out a genome-wide screen in Saccharomyces cerevisiae for suppressors of cdc13-1, an allele of the telomere-capping protein Cdc13. We report the identification of five novel suppressors, including the previously uncharacterized gene YML036W, which we name CGI121. Cgi121 is part of a conserved protein complex-the KEOPS complex-containing the protein kinase Bud32, the putative peptidase Kae1, and the uncharacterized protein Gon7. Deletion of CGI121 suppresses cdc13-1 via the dramatic reduction in ssDNA levels that accumulate in cdc13-1 cgi121 mutants. Deletion of BUD32 or other KEOPS components leads to short telomeres and at failure to add telomeres de novo to DNA double-strand breaks. Our results therefore indicate that the KEOPS complex promotes both telomere uncapping and telomere elongation.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 1A8, Canada; Univ Toronto, Grad Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Princess Margaret Hosp, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Res Ctr Mol Med, A-1090 Vienna, Austria; Inst Canc Res, Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England; Univ Newcastle, Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Newcastle, Newcastle Gen Hosp, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Newcastle, Newcastle Gen Hosp, Ctr Integrated Syst Biol Ageing & Nutr, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Manchester; University of London; Institute of Cancer Research - UK; Newcastle General Hospital; Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK	Lydall, D (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	d.a.lydall@ncl.ac.uk; durocher@mshri.on.ca	Brehme, Marc/G-8697-2015; Durocher, Daniel/A-7733-2010	Brehme, Marc/0000-0003-0694-331X; Durocher, Daniel/0000-0003-3863-8635	Wellcome Trust [075294, 054371] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Bianchi A, 2004, MOL CELL, V16, P139, DOI 10.1016/j.molcel.2004.09.009; Booth C, 2001, NUCLEIC ACIDS RES, V29, P4414, DOI 10.1093/nar/29.21.4414; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Cervantes RB, 2002, CURR OPIN CELL BIOL, V14, P351, DOI 10.1016/S0955-0674(02)00325-3; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chen QJ, 2001, MOL CELL BIOL, V21, P1819, DOI 10.1128/MCB.21.5.1819-1827.2001; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; COHN M, 1995, SCIENCE, V269, P396, DOI 10.1126/science.7618104; Craven RJ, 1999, GENETICS, V152, P1531; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; di Fagagna FD, 2004, GENE DEV, V18, P1781, DOI 10.1101/gad.1214504; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; DuBois ML, 2002, GENETICS, V161, P995; Enomoto S, 2004, MOL CELL BIOL, V24, P837, DOI 10.1128/MCB.24.2.837-845.2004; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Facchin S, 2003, FEBS LETT, V549, P63, DOI 10.1016/S0014-5793(03)00770-1; Facchin S, 2002, BIOCHEM J, V364, P457, DOI 10.1042/BJ20011376; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GARVIK B, 1995, MOL CELL BIOL, V15, P6128; Grandin N, 2001, EMBO J, V20, P6127, DOI 10.1093/emboj/20.21.6127; Grandin N, 1997, GENE DEV, V11, P512, DOI 10.1101/gad.11.4.512; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hackett JA, 2003, MOL CELL BIOL, V23, P8450, DOI 10.1128/MCB.23.23.8450-8461.2003; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes TR, 2000, P NATL ACAD SCI USA, V97, P6457, DOI 10.1073/pnas.97.12.6457; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Lopreiato R, 2004, BIOCHEM J, V377, P395, DOI 10.1042/BJ20030638; Lottersberger F, 2003, GENETICS, V165, P1717; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Lydall D, 2003, J CELL SCI, V116, P4057, DOI 10.1242/jcs.00765; Mangahas JL, 2001, MOL BIOL CELL, V12, P4078, DOI 10.1091/mbc.12.12.4078; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Miyoshi A, 2003, BIOCHEM BIOPH RES CO, V303, P399, DOI 10.1016/S0006-291X(03)00333-4; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Seki Y, 2002, GENE, V285, P101, DOI 10.1016/S0378-1119(02)00429-8; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Taggart AKP, 2003, CURR OPIN CELL BIOL, V15, P275, DOI 10.1016/S0955-0674(03)00040-1; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teo SH, 2001, EMBO REP, V2, P197, DOI 10.1093/embo-reports/kve038; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Zhou JL, 2000, MOL CELL BIOL, V20, P1947, DOI 10.1128/MCB.20.6.1947-1955.2000; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	60	139	149	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1155	1168		10.1016/j.cell.2005.12.044	http://dx.doi.org/10.1016/j.cell.2005.12.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564010	Bronze			2022-12-28	WOS:000237241400017
J	Leite, M				Leite, M			Stem cell research in Brazil: A difficult launch	CELL			English	Editorial Material								It has been one year since Brazil passed a law enabling scientists to work with human embryonic stem cells and to derive new stem cell lines from human embryos. But several major hurdles have put human embryonic stem cell research on hold.											0	6	6	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1107	1109		10.1016/j.cell.2006.03.003	http://dx.doi.org/10.1016/j.cell.2006.03.003			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16563999	Bronze			2022-12-28	WOS:000237241400006
J	Becker, DM; Segal, J; Vaidya, D; Yanek, LR; Herrera-Galeano, JE; Bray, PF; Moy, TF; Becker, LC; Faraday, N				Becker, DM; Segal, J; Vaidya, D; Yanek, LR; Herrera-Galeano, JE; Bray, PF; Moy, TF; Becker, LC; Faraday, N			Sex differences in platelet reactivity and response to low-dose aspirin therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY PREVENTION; CARDIOVASCULAR EVENTS; METAANALYSIS; DISEASE; PLASMA; TRIAL	Context Recent randomized trials suggest that women may not accrue the same cardioprotective benefits as men do from low-dose aspirin therapy used in primary prevention. Failure of aspirin to suppress platelet aggregation in women is one hypothesized mechanism. Objective To examine differential platelet reactivity to low-dose aspirin therapy by sex. Design, Setting, and Participants A clinical trial of aspirin at 81 mg/d for 14 days was conducted in 571 men and 711 women. Baseline and post - aspirin therapy measures included platelet aggregation to arachidonic acid, adenosine diphosphate, epinephrine, and platelet function analyzer closure time. Main Outcome Measure Sex differences in cyclooxygenase 1 (COX-1) direct and indirect platelet activation pathways before and after administration of aspirin. Results In 10 of the 12 platelet agonist exposures, women's platelets were significantly more reactive at baseline. However, after aspirin therapy, the percent aggregation to arachidonic acid ( the direct COX-1 pathway) decreased more in women than in men ( P <. 001) and demonstrated near total suppression of residual platelet reactivity in both men and women. In COX-1 indirect pathways, women experienced the same or more platelet inhibition than men in 8 of the 9 assays yet retained modestly greater platelet reactivity after aspirin therapy. In multivariable analysis, female sex significantly predicted aggregation to 2 mu M and 10 mu M of adenosine diphosphate (P=. 02 and <. 001, respectively) and collagen at 5 mu g/mL ( P <. 001) independent of risk factors, age, race, menopausal status, and hormone therapy. Conclusions Women experienced the same or greater decreases in platelet reactivity after aspirin therapy, retaining modestly more platelet reactivity compared with men. However, most women achieved total suppression of aggregation in the direct COX-1 pathway, the putative mechanism for aspirin's cardioprotection.	Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Dept Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; Baylor Coll Med, Thrombosis Res Unit, Houston, TX 77030 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Baylor College of Medicine	Becker, DM (corresponding author), Johns Hopkins Med Inst, Div Internal Med, 1830 E Monument St,8028, Baltimore, MD 21287 USA.	dbecker@jhmi.edu	Vaidya, Dhananjay/AAL-5684-2020	Vaidya, Dhananjay/0000-0002-7164-1601	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072518] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR000052] Funding Source: Medline; NHLBI NIH HHS [U01 HL72518] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Andersen K, 2002, THROMB RES, V108, P37, DOI 10.1016/S0049-3848(02)00405-X; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Berger JS, 2006, JAMA-J AM MED ASSOC, V295, P306, DOI 10.1001/jama.295.3.306; Chen ZM, 2000, STROKE, V31, P1240, DOI 10.1161/01.STR.31.6.1240; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Faraday N, 1997, THROMB HAEMOSTASIS, V77, P748; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gum PA, 2003, J AM COLL CARDIOL, V41, P961, DOI 10.1016/S0735-1097(02)03014-0; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; JOHNSON M, 1975, NATURE, V253, P355, DOI 10.1038/253355a0; Kim M T, 2000, Prog Cardiovasc Nurs, V15, P90, DOI 10.1111/j.1751-7117.2000.tb00211.x; Levin RI, 2005, NEW ENGL J MED, V352, P1366, DOI 10.1056/NEJMe058051; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; Maree AO, 2004, THROMB HAEMOSTASIS, V92, P1175, DOI 10.1160/TH04-02-0127; MEADE TW, 1985, BRIT MED J, V290, P428, DOI 10.1136/bmj.290.6466.428; Michelson AD, 2004, CIRCULATION, V110, pE489, DOI 10.1161/01.CIR.0000147228.29325.F9; MOUSA SA, 1993, CARDIOLOGY, V83, P367, DOI 10.1159/000175993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; SAMRA SK, 1991, ANN CLIN LAB SCI, V21, P315; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; TAYLOR ML, 1992, BRIT J CLIN PHARMACO, V33, P25, DOI 10.1111/j.1365-2125.1992.tb03996.x; Weisman SM, 2002, ARCH INTERN MED, V162, P2197, DOI 10.1001/archinte.162.19.2197	26	221	230	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1420	1427		10.1001/jama.295.12.1420	http://dx.doi.org/10.1001/jama.295.12.1420			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551714				2022-12-28	WOS:000236157700020
J	Corbett, EL; Marston, B; Churchyard, GJ; De Cock, KM				Corbett, EL; Marston, B; Churchyard, GJ; De Cock, KM			Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; NEGATIVE PULMONARY TUBERCULOSIS; HIV-INFECTED PATIENTS; MULTIDRUG-RESISTANT TUBERCULOSIS; DIRECTLY OBSERVED THERAPY; COTE-DIVOIRE; MYCOBACTERIUM-TUBERCULOSIS; GOLD MINERS; COTRIMOXAZOLE PROPHYLAXIS; SOUTH-AFRICA	Rapid scale-up of antiretroviral treatment programmes is happening in Africa, driven by international advocacy and policy directives and supported by unprecedented donor funding and technical assistance. This welcome development offers hope to millions of HIV-infected Africans, among whom tuberculosis is the major cause of serious illness and death. Little in the way of HIV diagnosis or care was previously offered to patients with tuberculosis, by either national tuberculosis or AIDS control programmes, with tuberculosis services focused exclusively on diagnosis and treatment of rising numbers of patients. Tuberculosis control in Africa has yet to adapt to the new climate of antiretroviral availability. Many barriers exist, from drug interactions to historic differences in the way that tuberculosis and HIV are perceived, but failure to successfully integrate HIV and tuberculosis control will threaten the viability of both programmes. Here, we review tuberculosis epidemiology in Africa and policy implications of HIV/AIDS treatment scale-up.	Natl Inst Hlth Res, Biomed Res & Training Inst, Harare, Zimbabwe; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Ctr Dis Control & Prevent, Nairobi, Kenya; Aurum Hlth, Johannesburg, South Africa	Biomedical Research Training Institute; University of London; London School of Hygiene & Tropical Medicine	Corbett, EL (corresponding author), Natl Inst Hlth Res, Biomed Res & Training Inst, Josiah Tongogara Ave,POB CY 1753, Harare, Zimbabwe.	elc1@mweb.co.zw		Corbett, Elizabeth/0000-0002-3552-3181	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABOUYA L, 1995, TUBERCLE LUNG DIS, V76, P436, DOI 10.1016/0962-8479(95)90011-X; ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; Angeby KAK, 2004, INT J TUBERC LUNG D, V8, P806; [Anonymous], GUID PREV TUB HLTH C; Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; Apers L, 2004, INT J TUBERC LUNG D, V8, P945; Apers L, 2003, INT J TUBERC LUNG D, V7, P376; Archibald LK, 1998, CLIN INFECT DIS, V26, P290, DOI 10.1086/516297; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Banda HT, 1998, T ROY SOC TROP MED H, V92, P161, DOI 10.1016/S0035-9203(98)90727-1; Borgdorff MW, 2004, AIDS, V18, P1465, DOI 10.1097/01.aids.0000131337.22924.0d; Borgdorff MW, 2004, EMERG INFECT DIS, V10, P1523, DOI 10.3201/eid1009.040349; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P217; Bosman MCJ, 2000, INT J TUBERC LUNG D, V4, P606; BRINDLE RJ, 1993, AM REV RESPIR DIS, V147, P958, DOI 10.1164/ajrccm/147.4.958; Bucher HC, 1999, AIDS, V13, P501, DOI 10.1097/00002030-199903110-00009; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P7, DOI 10.1164/ajrccm.164.1.2101133; *CDC, 1991, MMWR-MORBID MORTAL W, V40, P585; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chimzizi R, 2004, INT J TUBERC LUNG D, V8, P579; Churchyard CJ, 1999, INT J TUBERC LUNG D, V3, P791; Churchyard GJ, 2003, AIDS, V17, P2063, DOI 10.1097/00002030-200309260-00007; CHURCHYARD GJ, 2002, INT J TUBERC LUNG, V6, pS41; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Colebunders R, 2000, INT J TUBERC LUNG D, V4, P97; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2003, J INFECT DIS, V188, P1156, DOI 10.1086/378519; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; CORBETT EL, 2002, 14 INT AIDS C; CORBETT EL, 2005, TURBERCULOSIS SURVEI, P28; Crampin AC, 2001, INT J TUBERC LUNG D, V5, P994; CURRIE CS, 2005, TSRU PROGR REP, P13; Currie CSM, 2003, AIDS, V17, P2501, DOI 10.1097/00002030-200311210-00013; DALEY CL, 1992, NEW ENGL J MED, V326, P231, DOI 10.1056/NEJM199201233260404; De Cock KM, 2005, AM J RESP CRIT CARE, V172, P3, DOI 10.1164/rccm.2504003; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; de Jong BC, 2004, ANNU REV MED, V55, P283, DOI 10.1146/annurev.med.55.091902.103753; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; DECOCK KM, 1992, JAMA-J AM MED ASSOC, V268, P1581, DOI 10.1001/jama.1992.03490120095035; Drobniewski F, 2002, THORAX, V57, P810, DOI 10.1136/thorax.57.9.810; Dye C, 2002, B WORLD HEALTH ORGAN, V80, P437; EGWAGA SM, 2003, TSRU PROGR REP, P107; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; ENARSON DA, 1995, TUBERCLE LUNG DIS, V76, P95, DOI 10.1016/0962-8479(95)90548-0; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Floyd K, 2002, SCIENCE, V295, P2040, DOI 10.1126/science.1069771; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Friedland G, 2004, CLIN INFECT DIS, V38, pS421, DOI 10.1086/421407; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; GITHUI W, 1992, TUBERCLE LUNG DIS, V73, P203, DOI 10.1016/0962-8479(92)90087-Z; Glynn JR, 2004, AIDS, V18, P1459, DOI 10.1097/01.aids.0000131336.15301.06; Godfrey-Faussett P, 2000, LANCET, V356, P1066, DOI 10.1016/S0140-6736(00)02730-6; Grant AD, 1997, AIDS, V11, P1357, DOI 10.1097/00002030-199711000-00010; GREENBERG AE, 1995, AIDS, V9, P1251, DOI 10.1097/00002030-199511000-00006; Grimwade K, 2005, AIDS, V19, P163, DOI 10.1097/00002030-200501280-00008; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P113; Harries AD, 2004, T ROY SOC TROP MED H, V98, P695, DOI 10.1016/j.trstmh.2004.05.002; Harries AD, 2005, INT J TUBERC LUNG D, V9, P128; Harries AD, 1997, T ROY SOC TROP MED H, V91, P416, DOI 10.1016/S0035-9203(97)90262-5; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1109; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; *IUATLD GPA WHO, 1994, TUBERCLE LUNG DIS, V75, P96; Jack C, 2004, JAIDS-J ACQ IMM DEF, V36, P929, DOI 10.1097/00126334-200408010-00006; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397; *JOINT UN PROGR HI, 2004, REP GLOB HIV AIDS EP; Jones BE, 1997, AM J RESP CRIT CARE, V156, P1270, DOI 10.1164/ajrccm.156.4.9609143; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Kang'ombe CT, 2004, INT J TUBERC LUNG D, V8, P829; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Lockman S, 2001, J CLIN MICROBIOL, V39, P1042, DOI 10.1128/JCM.39.3.1042-1047.2001; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Macias J, 2004, AIDS, V18, P767, DOI [10.1097/01.aids.0000111417.91384.fd, 10.1097/00002030-200403260-00007]; Maher D, 2005, INT J TUBERC LUNG D, V9, P123; Maher D, 2005, INT J TUBERC LUNG D, V9, P17; Mallory KF, 2000, INT J TUBERC LUNG D, V4, P455; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mosimaneotsile B, 2003, LANCET, V362, P1551, DOI 10.1016/S0140-6736(03)14745-9; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Munyati SS, 2005, CLIN INFECT DIS, V40, P1818, DOI 10.1086/429912; MUTULUUZA CK, 2005, 12 C RETR OPP INF, P22; Mwachari C, 1998, J INFECTION, V37, P48, DOI 10.1016/S0163-4453(98)90561-8; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; Navas E, 2002, ARCH INTERN MED, V162, P97, DOI 10.1001/archinte.162.1.97; NELSON AM, 1993, AIDS, V7, P1241, DOI 10.1097/00002030-199309000-00014; Nelson LJ, 2005, LANCET, V366, P488, DOI 10.1016/S0140-6736(05)67062-6; Noeske J, 2004, INT J TUBERC LUNG D, V8, P346; Odhiambo JA, 1999, AM J PUBLIC HEALTH, V89, P1078, DOI 10.2105/AJPH.89.7.1078; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Ribera E, 2001, J ACQ IMMUN DEF SYND, V28, P450, DOI 10.1097/00042560-200112150-00007; RICHARDS SB, 1995, TUBERCLE LUNG DIS, V76, P11, DOI 10.1016/0962-8479(95)90572-3; Ritacco V, 1997, J INFECT DIS, V176, P637, DOI 10.1086/514084; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Siddiqi K, 2003, LANCET INFECT DIS, V3, P288, DOI 10.1016/S1473-3099(03)00609-1; Siriarayapon P, 2002, JAIDS-J ACQ IMM DEF, V31, P80, DOI 10.1097/00126334-200209010-00011; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Stern JO, 2003, JAIDS-J ACQ IMM DEF, V34, pS21, DOI 10.1097/00126334-200309011-00005; Styblo K, 2001, INT J TUBERC LUNG D, V5, P103; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; The Joint United Nations Programme on HIV/AIDS /World Health Organization, 2004, UNAIDS WHO POL STAT; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; van Cleeff MRA, 2003, INT J TUBERC LUNG D, V7, P186; Van Deun A, 2005, INT J TUBERC LUNG D, V9, P355; VYNNYCKY E, 2004, TSRU PROGR REP, P50; *WHO, 2004, INT POL COLL TB HIV; *WHO, 2004, 3 WHO INT UN TUB LUN; *WHO, 2005, WHOHTMTB2005349; WHO/UNAIDS, 1999, WEEKLY EPIDEMIOLOGIC, V74, P385; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Wilkinson D, 1998, BRIT MED J, V317, P625, DOI 10.1136/bmj.317.7159.625; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Health Organization, 2004, SCAL ANT THER RES LT; Zachariah R, 2003, AIDS, V17, P1053, DOI 10.1097/00002030-200305020-00015; Zachariah R, 2005, INT J TUBERC LUNG D, V9, P238; Zachariah R, 2004, INT J TUBERC LUNG D, V8, P1058	134	304	313	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					926	937		10.1016/S0140-6736(06)68383-9	http://dx.doi.org/10.1016/S0140-6736(06)68383-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546541				2022-12-28	WOS:000236242100029
J	Squire, SB; Obasi, A; Nhlema-Simwaka, B				Squire, SB; Obasi, A; Nhlema-Simwaka, B			The Global Plan to Stop TB: a unique opportunity to address poverty and the Millennium Development Goals	LANCET			English	Editorial Material									Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Res Equ & Community Hlth Trust, Lilongwe, Malawi	Liverpool School of Tropical Medicine; University of Liverpool	Squire, SB (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	sbsquire@liv.ac.uk	Obasi, Angela/AAK-4395-2021	Obasi, Angela/0000-0001-6801-8889; Squire, Stephen/0000-0001-7173-9038				Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; TUDORHART J, 1971, LANCET, V1, P405; World Health Organization, 2005, WHOHTMTB2005352; 2005, LANCET, V366, P2063	4	18	20	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					955	957		10.1016/S0140-6736(06)68393-1	http://dx.doi.org/10.1016/S0140-6736(06)68393-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546551				2022-12-28	WOS:000236242100039
J	Berkes, F; Hughes, TP; Steneck, RS; Wilson, JA; Bellwood, DR; Crona, B; Folke, C; Gunderson, LH; Leslie, HM; Norberg, J; Nystrom, M; Olsson, P; Osterblom, H; Scheffer, M; Worm, B				Berkes, F; Hughes, TP; Steneck, RS; Wilson, JA; Bellwood, DR; Crona, B; Folke, C; Gunderson, LH; Leslie, HM; Norberg, J; Nystrom, M; Olsson, P; Osterblom, H; Scheffer, M; Worm, B			Ecology - Globalization, roving bandits, and marine resources	SCIENCE			English	Editorial Material							RESILIENCE; GOVERNANCE		Univ Manitoba, Nat Resources Inst, Winnipeg, MB R3T 2N2, Canada; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; Univ Wageningen & Res Ctr, Dept Environm Sci, Aquat Ecol & Water Qual Management Grp, NL-6700 DD Wageningen, Netherlands; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Emory Univ, Dept Environm Studies, Atlanta, GA 30322 USA; Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden; Stockholm Univ, Ctr Transdisciplinary Environm Res, S-10691 Stockholm, Sweden; Univ Maine, Sch Marine Sci, Orono, ME 04469 USA; Univ Maine, Sch Marine Sci, Walpole, ME 04573 USA; James Cook Univ N Queensland, Sch Marine Biol, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	University of Manitoba; Dalhousie University; Wageningen University & Research; Princeton University; Emory University; Stockholm University; Stockholm University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; James Cook University	Berkes, F (corresponding author), Univ Manitoba, Nat Resources Inst, Winnipeg, MB R3T 2N2, Canada.	berkes@cc.umanitoba.ca	Osterblom, Henrik/D-4249-2012; Leslie, Heather/B-4980-2014; Hughes, Terry P/L-4721-2013; Scheffer, Marten/C-1852-2012; Bellwood, David/E-2497-2011; Folke, Carl/Z-1545-2019; Leslie, Heather M./I-7812-2019; Olsson, Per/AAE-9104-2019	Hughes, Terry P/0000-0002-5257-5063; Leslie, Heather M./0000-0003-4512-9417; Olsson, Per/0000-0002-9038-4786; Nystrom, Magnus/0000-0003-3608-2426; Folke, Carl/0000-0002-4050-3281; Norberg, Jon/0000-0003-1861-5030; Worm, Boris/0000-0002-5742-8716; Osterblom, Henrik/0000-0002-1913-5197; Berkes, Fikret/0000-0001-8402-121X				Andrew NL, 2002, OCEANOGR MAR BIOL, V40, P343; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BERKES F, 2005, INDIGENOUS USE MANAG, P13; Castilla JC, 2005, SCIENCE, V309, P1324; Costanza R, 1999, ECOL ECON, V31, P171, DOI 10.1016/S0921-8009(99)00077-4; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Folke C, 2005, ANNU REV ENV RESOUR, V30, P441, DOI 10.1146/annurev.energy.30.050504.144511; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huitric M, 2005, ECOL SOC, V10; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; OECD, 2004, FISH PIR COMB ILL UN; Olson M, 2000, POWER PROSPERITY; Steneck Robert S., 2005, P110; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Wilson D., 2003, FISHERIES COMANAGEME; Wilson JA, 2006, ECOL SOC, V11; Young O.R., 2002, I DIMENSIONS ENV CHA, V1st ed., DOI DOI 10.7551/MITPRESS/3807.001.0001	21	491	500	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1557	1558		10.1126/science.1122804	http://dx.doi.org/10.1126/science.1122804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543444				2022-12-28	WOS:000236029500027
J	Hegreness, M; Shoresh, N; Hartl, D; Kishony, R				Hegreness, M; Shoresh, N; Hartl, D; Kishony, R			An equivalence principle for the incorporation of favorable mutations in asexual populations	SCIENCE			English	Article							ESCHERICHIA-COLI; BENEFICIAL MUTATIONS; ADAPTIVE EVOLUTION; RNA VIRUSES; ADAPTATION; COMPETITION; LANDSCAPE; SELECTION; GENETICS; SEX	Rapid evolution of asexual populations, such as that of cancer cells or of microorganisms developing drug resistance, can include the simultaneous spread of distinct beneficial mutations. We demonstrate that evolution in such cases is driven by the fitness effects and appearance times of only a small minority of favorable mutations. The complexity of the mutation-selection process is thereby greatly reduced, and much of the evolutionary dynamics can be encapsulated in two parameters - an effective selection coefficient and effective rate of beneficial mutations. We confirm this theoretical finding and estimate the effective parameters for evolving populations of fluorescently labeled Escherichia coli. The effective parameters constitute a simple description and provide a natural standard for comparing adaptation between species and across environments.	Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Harvard Medical School	Kishony, R (corresponding author), Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA.	roy_kishony@hms.harvard.edu						ATWOOD KC, 1951, P NATL ACAD SCI USA, V37, P146, DOI 10.1073/pnas.37.3.146; Bull JJ, 2005, NAT GENET, V37, P342, DOI 10.1038/ng0405-342; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; Colegrave N, 2002, NATURE, V420, P664, DOI 10.1038/nature01191; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HARTL DL, 1981, P NATL ACAD SCI-BIOL, V78, P6344, DOI 10.1073/pnas.78.10.6344; HEPPNER GH, 1984, CANCER RES, V44, P2259; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; KIM J, 1991, ASSESSING ECOLOGICAL, P193; Kimura M., 1983, NEUTRAL THEORY MOL E; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; Orr HA, 2003, GENETICS, V163, P1519; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219	27	168	171	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1615	1617		10.1126/science.1122469	http://dx.doi.org/10.1126/science.1122469			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543462				2022-12-28	WOS:000236029500048
J	Madden, JD				Madden, JD			Materials science - Artificial muscle begins to breathe	SCIENCE			English	Editorial Material													Madden, John DW/B-8948-2009	Madden, John DW/0000-0002-0014-4712				Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Ebron VH, 2006, SCIENCE, V311, P1580, DOI 10.1126/science.1120182; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135	3	27	27	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2006	311	5767					1559	1560		10.1126/science.1123995	http://dx.doi.org/10.1126/science.1123995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543445				2022-12-28	WOS:000236029500028
J	Kraemer, T; Mark, M; Waldburger, P; Danzl, JG; Chin, C; Engeser, B; Lange, AD; Pilch, K; Jaakkola, A; Nagerl, HC; Grimm, R				Kraemer, T; Mark, M; Waldburger, P; Danzl, JG; Chin, C; Engeser, B; Lange, AD; Pilch, K; Jaakkola, A; Nagerl, HC; Grimm, R			Evidence for Efimov quantum states in an ultracold gas of caesium atoms	NATURE			English	Article							RESONANTLY-INTERACTING PARTICLES; BOSE-EINSTEIN CONDENSATE; 3-BODY RECOMBINATION; COLLISIONS	Systems of three interacting particles are notorious for their complex physical behaviour. A landmark theoretical result in few- body quantum physics is Efimov's prediction(1,2) of a universal set of bound trimer states appearing for three identical bosons with a resonant two- body interaction. Counterintuitively, these states even exist in the absence of a corresponding two- body bound state. Since the formulation of Efimov's problem in the context of nuclear physics 35 years ago, it has attracted great interest in many areas of physics(3-8). However, the observation of Efimov quantum states has remained an elusive goal(3,5). Here we report the observation of an Efimov resonance in an ultracold gas of caesium atoms. The resonance occurs in the range of large negative two- body scattering lengths, arising from the coupling of three free atoms to an Efimov trimer. Experimentally, we observe its signature as a giant three- body recombination loss(9,10) when the strength of the two- body interaction is varied. We also detect a minimum(9,11,12) in the recombination loss for positive scattering lengths, indicating destructive interference of decay pathways. Our results confirm central theoretical predictions of Efimov physics and represent a starting point with which to explore the universal properties of resonantly interacting few- body systems(7). While Feshbach resonances(13,14) have provided the key to control quantum- mechanical interactions on the two- body level, Efimov resonances connect ultracold matter(15) to the world of few- body quantum phenomena.	Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; Univ Chicago, James Franck Inst, Dept Phys, Chicago, IL 60637 USA; Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; University of Chicago; Austrian Academy of Sciences	Nagerl, HC (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.	christoph.naegerl@ultracold.at	Danzl, Johann Georg/AGX-2475-2022; Naegerl, Hanns-Christoph/E-7329-2010; Kraemer, Thomas/R-8407-2018; Danzl, Johann/N-9987-2015; Grimm, Rudolf/D-2864-2009	Danzl, Johann Georg/0000-0001-8559-3973; Naegerl, Hanns-Christoph/0000-0002-7789-4431; Kraemer, Thomas/0000-0002-3283-606X; Danzl, Johann/0000-0001-8559-3973; Grimm, Rudolf/0000-0003-1085-5558				Bedaque PF, 2000, PHYS REV LETT, V85, P908, DOI 10.1103/PhysRevLett.85.908; Bolda EL, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.013403; Braaten E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.170402; Braaten E, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.160407; BRAATEN E, 2004, U FEW BODY SYSTEMS L; Bringas F, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.040702; Bruhl R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063002; Chin C, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.032701; D'Incao JP, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.123201; Donley EA, 2001, NATURE, V412, P295, DOI 10.1038/35085500; EFIMOV V, 1979, SOV J NUCL PHYS+, V29, P546; EFIMOV V, 1970, PHYS LETT B, VB 33, P563, DOI 10.1016/0370-2693(70)90349-7; EFIMOV VN, 1971, SOV J NUCL PHYS+, V12, P589; Esry BD, 1999, PHYS REV LETT, V83, P1751, DOI 10.1103/PhysRevLett.83.1751; Fedichev PO, 1996, PHYS REV LETT, V77, P2921, DOI 10.1103/PhysRevLett.77.2921; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Jensen AS, 2004, REV MOD PHYS, V76, P215, DOI 10.1103/RevModPhys.76.215; Kartavtsev OI, 2002, FEW-BODY SYST, V31, P249, DOI 10.1007/s006010200029; KOHLER T, 2006, PRODUCTION COLD MOL; Kraemer T, 2004, APPL PHYS B-LASERS O, V79, P1013, DOI 10.1007/s00340-004-1657-5; LIM TK, 1977, PHYS REV LETT, V38, P341, DOI 10.1103/PhysRevLett.38.341; Nielsen E, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.012705; Nielsen E, 1999, PHYS REV LETT, V83, P1566, DOI 10.1103/PhysRevLett.83.1566; Petrov DS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.143201; Rychtarik D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.173003; Southwell K, 2002, NATURE, V416, P205, DOI 10.1038/416205a; Stoll M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.022714; Thomas LH, 1935, PHYS REV, V47, P0903, DOI 10.1103/PhysRev.47.903; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; Weber T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.123201	30	824	834	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					315	318		10.1038/nature04626	http://dx.doi.org/10.1038/nature04626			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541068	Green Submitted			2022-12-28	WOS:000235997600048
J	Scolnik, D; Coates, AL; Stephens, D; Da Silva, Z; Lavine, E; Schuh, S				Scolnik, D; Coates, AL; Stephens, D; Da Silva, Z; Lavine, E; Schuh, S			Controlled delivery of high vs low humidity vs mist therapy for croup in emergency departments - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEBULIZED BUDESONIDE; VIRAL CROUP; ASTHMATIC-CHILDREN; ORAL DEXAMETHASONE; CURRENT DIAGNOSIS; MODERATE CROUP; INHALATION; MILD; LARYNGOTRACHEITIS; PLACEBO	Context Children with croup are often treated with humidity even though this is not scientifically based, consumes time, and can be harmful. Although humidity using the traditional blow-by technique is similar to room air and no water droplets reach the nasopharynx, particles sized for laryngeal deposition (5-10 mu m) could be beneficial. Objective To determine whether a significant difference in the clinical Westley croup score exists in children with moderate to severe croup who were admitted to the emergency department and who received either 100% humidity or 40% humidity via nebulizer or blow-by humidity. Design and Setting A randomized, single-blind, controlled trial conducted between 2001 and 2004 in a tertiary care pediatric emergency department. Participants A convenience sample of 140 previously healthy children 3 months to 10 years of age with Westley croup score of more than 1 or 2 or higher (scoring system range, 0-17); 21 families refused participation. Intervention Thirty-minute administration of humidity using traditional blow-by technique (commonly used placebo, n = 48), controlled delivery of 40% humidity (optimally delivered placebo, n = 46), or 100% humidity (n = 46) with water particles of mass median diameter 6.21 mu m. Main Outcome Measure A priori defined change in the Westley croup score from baseline to 30 and 60 minutes in the 3 groups. Results Groups were comparable before treatment. At 30 minutes the difference in the improvement in the croup score between the blow-by and low-humidity groups was 0.03 (95% confidence interval [CI], -0.72 to 0.66), between low- and high-humidity groups, 0.16 (95% CI, -0.86 to 0.53), and between blow-by and high-humidity groups, 0.19 (95% CI, -0.87 to 0.49). Results were similar at 60 minutes. Differences between groups in pulse and respiratory rates and oxygen saturation changes were insignificant, as were proportions of excellent responders; proportions with croup score of 0 at study conclusion; and proportions receiving dexamethasone, epinephrine, or requiring additional medical care or hospitalization. Conclusions One hundred percent humidity with particles specifically sized to deposit in the larynx failed to result in greater improvement than 40% humidity or humidity by blow-by technique. This study does not support the use of humidity for moderate croup for patients treated in the emergency department.	Hosp Sick Children, Div Pediat Emergency Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Resp Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Resp Therapy, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Scolnik, D (corresponding author), Hosp Sick Children, Div Pediat Emergency Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	dennis.scolnik@sickkids.ca						ASHER MI, 1999, PEDIAT RESP MED, P530; Ausejo M, 1999, BRIT MED J, V319, P595, DOI 10.1136/bmj.319.7210.595; AVERY ME, 1967, PEDIATRICS, V39, P160; Bjornson CL, 2004, NEW ENGL J MED, V351, P1306, DOI 10.1056/NEJMoa033534; BOURCHIER D, 1984, AUST PAEDIATR J, V20, P289; Callaghan CO, 1997, THORAX, V52, P31; COURIEL JM, 1988, ARCH DIS CHILD, V63, P1305, DOI 10.1136/adc.63.11.1305; DENNY FW, 1983, PEDIATRICS, V71, P871; DULFANO MJ, 1973, AM REV RESPIR DIS, V107, P130; Folland DS, 1997, POSTGRAD MED, V101, P271, DOI 10.3810/pgm.1997.03.188; GREALLY P, 1990, BRIT MED J, V301, P113, DOI 10.1136/bmj.301.6743.113; HENRY R, 1983, ARCH DIS CHILD, V58, P577, DOI 10.1136/adc.58.8.577; HINDS WC, 1982, PARTICLE SIZE STAT A, P69; ILIFF ALBERTA, 1952, CHILD DEVELOPMENT, V23, P237, DOI 10.2307/1126031; JAMSHIDI PB, 2001, ACAD EMERG MED, V8, P417; Johnson DW, 1998, NEW ENGL J MED, V339, P498, DOI 10.1056/NEJM199808203390802; Johnson DW, 1996, ARCH PEDIAT ADOL MED, V150, P349, DOI 10.1001/archpedi.1996.02170290015002; Kaditis AG, 1998, PEDIATR INFECT DIS J, V17, P827, DOI 10.1097/00006454-199809000-00018; KAIRYS SW, 1989, PEDIATRICS, V83, P683; Klassen T, 1995, ARCH PEDIAT ADOLESC, V149, P60; KLASSEN TP, 1994, NEW ENGL J MED, V331, P285, DOI 10.1056/NEJM199408043310501; Klassen TP, 1998, JAMA-J AM MED ASSOC, V279, P1629, DOI 10.1001/jama.279.20.1629; KRISTJANSSON S, 1994, ACTA PAEDIATR, V83, P1156; Kwong WTJ, 2000, J AEROSOL MED, V13, P303, DOI 10.1089/jam.2000.13.303; LENNEY W, 1978, ARCH DIS CHILD, V53, P704, DOI 10.1136/adc.53.9.704; MOCHIZUKI H, 1995, J ALLERGY CLIN IMMUN, V96, P193, DOI 10.1016/S0091-6749(95)70008-0; Neto GM, 2002, ACAD EMERG MED, V9, P873, DOI 10.1197/aemj.9.9.873; OPHIR D, 1987, AM J OTOLARYNG, V8, P149, DOI 10.1016/S0196-0709(87)80037-6; RODRIGUEZ GE, 1975, J ALLERGY CLIN IMMUN, V56, P133, DOI 10.1016/0091-6749(75)90118-9; Rosekrans JA, 1998, MAYO CLIN PROC, V73, P1102, DOI 10.4065/73.11.1102; RUDOLPH G, 1990, J AEROSOL SCI     S1, V21, pS306; SASAKI CT, 1977, PEDIATRICS, V59, P689; SKOLNIK NS, 1989, AM J DIS CHILD, V143, P1045, DOI 10.1001/archpedi.1989.02150210079022; SMITH CM, 1989, J ALLERGY CLIN IMMUN, V84, P781, DOI 10.1016/0091-6749(89)90309-6; STICK S, 1996, INFANT RESP FUNCTION, P117; SZILAGYI PG, 1991, PEDIATR INFECT DIS J, V10, P478; TAMER MA, 1970, J PEDIATR-US, V77, P1051, DOI 10.1016/S0022-3476(70)80092-0; TIBBALLS J, 1992, LANCET, V340, P745, DOI 10.1016/0140-6736(92)92293-O; WESTLEY CR, 1978, AM J DIS CHILD, V132, P484, DOI 10.1001/archpedi.1978.02120300044008; YEH HC, 1976, ENVIRON HEALTH PERSP, V15, P147, DOI 10.2307/3428398	40	39	40	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2006	295	11					1274	1280		10.1001/jama.295.11.1274	http://dx.doi.org/10.1001/jama.295.11.1274			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021GV	16537737	Bronze			2022-12-28	WOS:000235972600025
J	Graves, JAM				Graves, JAM			Sex chromosome specialization and degeneration in mammals	CELL			English	Review							HUMAN Y-CHROMOSOME; HUMAN X-CHROMOSOME; MALE-DRIVEN EVOLUTION; LINKED GENES; DETERMINING REGION; DNA-SEQUENCES; DROSOPHILA Y; INACTIVATION; MICE; SRY	Sex chromosomes-particularly the human Y-have been a source of fascination for decades because of their unique transmission patterns and their peculiar cytology. The outpouring of genomic data confirms that their atypical structure and gene composition break the rules of genome organization, function, and evolution. The X has been shaped by dosage differences to have a biased gene content and to be subject to inactivation in females. The Y chromosome seems to be a product of a perverse evolutionary process that does not select the fittest Y, which may cause its degradation and ultimate extinction.	Australian Natl Univ, Res Sch Biol Sci, Canberra, ACT 2601, Australia	Australian National University	Graves, JAM (corresponding author), Australian Natl Univ, Res Sch Biol Sci, GPO Box 4, Canberra, ACT 2601, Australia.	jenny.graves@anu.edu.au	Graves, Jennifer A.M./A-1387-2008	Graves, Jennifer/0000-0001-6480-7856				Aitken RJ, 2002, NATURE, V415, P963, DOI 10.1038/415963a; Arakawa Y, 2002, CYTOGENET GENOME RES, V99, P303, DOI 10.1159/000071608; Baumstark A, 2005, MAMM GENOME, V16, P281, DOI 10.1007/s00335-004-2019-7; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carvalho AB, 2005, SCIENCE, V307, P108, DOI 10.1126/science.1101675; Carvalho AB, 2002, CURR OPIN GENET DEV, V12, P664, DOI 10.1016/S0959-437X(02)00356-8; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cooper D.W., 1993, Seminars in Developmental Biology, V4, P117, DOI 10.1006/sedb.1993.1014; Delbridge ML, 2004, CHROMOSOME RES, V12, P345, DOI 10.1023/B:CHRO.0000034134.91243.1c; Delbridge ML, 1999, NAT GENET, V22, P223, DOI 10.1038/10279; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; FOSTER JW, 1994, P NATL ACAD SCI USA, V91, P1927, DOI 10.1073/pnas.91.5.1927; FREDGA K, 1983, DIFFERENTIATION, V23, pS23; Fridolfsson AK, 1998, P NATL ACAD SCI USA, V95, P8147, DOI 10.1073/pnas.95.14.8147; Gerrard DT, 2005, MOL BIOL EVOL, V22, P1423, DOI 10.1093/molbev/msi128; Glas R, 1999, MAMM GENOME, V10, P1115, DOI 10.1007/s003359901174; Graves JAM, 1998, CYTOGENET CELL GENET, V80, P94, DOI 10.1159/000014963; Graves JAM, 2002, CYTOGENET GENOME RES, V99, P141, DOI 10.1159/000071585; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Graves JAM, 1998, J EXP ZOOL, V281, P472, DOI 10.1002/(SICI)1097-010X(19980801)281:5&lt;472::AID-JEZ12&gt;3.0.CO;2-B; Graves JAM, 2002, TRENDS GENET, V18, P259, DOI 10.1016/S0168-9525(02)02666-5; Graves JAM, 1992, CURR OPIN GENET DEV, V2, P890, DOI 10.1016/S0959-437X(05)80112-1; Grutzner F, 2004, NATURE, V432, P913, DOI 10.1038/nature03021; GRUTZNER F, 2006, IN PRESS CHROMOSOMA; HAYMAN D, 1981, CHROMOSOMA, V83, P263, DOI 10.1007/BF00286794; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Hoekstra HE, 2000, P ROY SOC B-BIOL SCI, V267, P1825, DOI 10.1098/rspb.2000.1217; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; HURST LD, 1994, HEREDITY, V73, P223, DOI 10.1038/hdy.1994.127; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; JUST W, 1995, NAT GENET, V11, P117, DOI 10.1038/ng1095-117; Kohn M, 2004, TRENDS GENET, V20, P598, DOI 10.1016/j.tig.2004.09.008; Kondo M, 2004, CURR BIOL, V14, P1664, DOI 10.1016/j.cub.2004.09.026; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Marais G, 2003, CURR BIOL, V13, pR641, DOI 10.1016/S0960-9822(03)00570-0; MCCARREY JR, 1987, NATURE, V326, P501, DOI 10.1038/326501a0; Muller HJ, 1914, J EXP ZOOL, V17, P325, DOI 10.1002/jez.1400170303; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; Ohno S., 1967, SEX CHROMOSOMES SEX; ORR HA, 1989, GENETICS, V121, P527; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; Park DJ, 2005, GENE, V362, P29, DOI 10.1016/j.gene.2005.08.003; Pask A, 2000, P NATL ACAD SCI USA, V97, P13198, DOI 10.1073/pnas.230424497; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Qin YJ, 2005, HUM MOL GENET, V14, P1221, DOI 10.1093/hmg/ddi133; Reinke V, 2004, NAT GENET, V36, P548, DOI 10.1038/ng0604-548; Repping S, 2004, GENOMICS, V83, P1046, DOI 10.1016/j.ygeno.2003.12.018; RICE WR, 1987, GENETICS, V116, P161; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; Shetty S, 1999, CHROMOSOME RES, V7, P289, DOI 10.1023/A:1009278914829; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SYKES B, 2003, ADAMS CURSE FUTURE M; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; TRAUT W, 1990, CHROMOSOMA, V99, P407, DOI 10.1007/BF01726692; Tsend-Ayush E, 2005, DEV DYNAM, V234, P682, DOI 10.1002/dvdy.20432; Veyrunes F, 2004, CHROMOSOME RES, V12, P369, DOI 10.1023/B:CHRO.0000034098.09885.e6; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Waters PD, 2001, CYTOGENET CELL GENET, V92, P74, DOI 10.1159/000056872; WATSON CM, 1999, CELL GENET, V81, P54; Wu CI, 2003, TRENDS GENET, V19, P243, DOI 10.1016/S0168-9525(03)00058-1; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5	77	416	433	2	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					901	914		10.1016/j.cell.2006.02.024	http://dx.doi.org/10.1016/j.cell.2006.02.024			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530039	Bronze			2022-12-28	WOS:000237241200014
J	Polo, S; Di Fiore, PP				Polo, S; Di Fiore, PP			Endocytosis conducts the cell signaling orchestra	CELL			English	Review							MEDIATED ENDOCYTOSIS; DROSOPHILA; CLATHRIN; RECEPTOR; ROLES; INTERNALIZATION; TRANSDUCTION; ENDOSOMES; COMPONENT; DYNAMIN	Endocytosis is used by eukaryotic cells to regulate nutrient internalization, signal transduction, and the composition of the plasma membrane. However, a more complex picture is emerging, in which endocytic pathways integrate diverse signals, thereby contributing to a higher level of cellular and organismal organization. In this way, endocytosis and cell signaling are intertwined in many biological processes, such as cell motility and cell fate determination.	IFOM, Ist Oncol Mol, FIRC, I-20134 Milan, Italy; Ist Europeo Oncol, I-20141 Milan, Italy; Univ Milan, Sch Med, I-20122 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); University of Milan	Polo, S (corresponding author), IFOM, Ist Oncol Mol, FIRC, Via Adamello 16, I-20134 Milan, Italy.	simona.polo@ifom-ieo-campus.it; pierpaola.difiore@ifom-ieo-campus.it	Polo, Simona/P-3509-2014; Di Fiore, Pier Paolo/K-2130-2012	Di Fiore, Pier Paolo/0000-0002-2252-0950; Polo, Simona/0000-0001-5536-9399				Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Elde NC, 2005, PLOS GENET, V1, P514, DOI 10.1371/journal.pgen.0010052; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Hutterer A, 2005, EMBO REP, V6, P836, DOI 10.1038/sj.embor.7400500; Jafar-Nejad H, 2005, DEV CELL, V9, P351, DOI 10.1016/j.devcel.2005.06.010; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Kholodenko BN, 2003, J EXP BIOL, V206, P2073, DOI 10.1242/jeb.00298; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Liu G, 2005, BIOINFORMATICS, V21, P1194, DOI 10.1093/bioinformatics/bti118; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wu XY, 2005, DEV CELL, V9, P185, DOI 10.1016/j.devcel.2005.06.006	21	219	223	2	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 10	2006	124	5					897	900		10.1016/j.cell.2006.02.025	http://dx.doi.org/10.1016/j.cell.2006.02.025			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530038	Bronze			2022-12-28	WOS:000237241200013
J	Garrett, TJ; Zhao, CF				Garrett, TJ; Zhao, CF			Increased Arctic cloud longwave emissivity associated with pollution from mid-latitudes	NATURE			English	Article							LIQUID WATER; AEROSOL; SURFACE; CLIMATE; TRENDS; IMPACT; PARTICLES; BARROW; ALBEDO; ALASKA	There is consensus among climate models that Arctic climate is particularly sensitive to anthropogenic greenhouse gases and that, over the next century, Arctic surface temperatures are projected to rise at a rate about twice the global mean(1). The response of Arctic surface temperatures to greenhouse gas thermal emission is modified by Northern Hemisphere synoptic meteorology and local radiative processes(2-4). Aerosols may play a contributing factor through changes to cloud radiative properties. Here we evaluate a previously suggested contribution of anthropogenic aerosols to cloud emission and surface temperatures in the Arctic(5-8). Using four years of ground-based aerosol and radiation measurements obtained near Barrow, Alaska, we show that, where thin water clouds and pollution are coincident, there is an increase in cloud longwave emissivity resulting from elevated haze levels. This results in an estimated surface warming under cloudy skies of between 3.3 and 5.2 W m(-2) or 1 and 1.6 degrees C. Arctic climate is closely tied to cloud longwave emission(2,4,9), but feedback mechanisms in the system are complex(10) and the actual climate response to the described sensitivity remains to be evaluated.	Univ Utah, Dept Meteorol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Garrett, TJ (corresponding author), Univ Utah, Dept Meteorol, Salt Lake City, UT 84112 USA.	tgarrett@met.utah.edu	Zhao, Chuanfeng/G-8546-2013; Zhao, Chuanfeng/O-5626-2019	Zhao, Chuanfeng/0000-0002-5196-3996				[Anonymous], ANN GLACIOL; BARRIE LA, 1986, ATMOS ENVIRON, V20, P643, DOI 10.1016/0004-6981(86)90180-0; Baskaran M, 2001, J AEROSOL SCI, V32, P443, DOI 10.1016/S0021-8502(00)00093-8; Bigg EK, 2001, J GEOPHYS RES-ATMOS, V106, P32155, DOI 10.1029/1999JD901152; Burrows JP, 1999, J ATMOS SCI, V56, P151, DOI 10.1175/1520-0469(1999)056<0151:TGOMEG>2.0.CO;2; Curry JA, 1996, J CLIMATE, V9, P1731, DOI 10.1175/1520-0442(1996)009<1731:OOACAR>2.0.CO;2; Garrett TJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019928; Garrett TJ, 2002, J ATMOS SCI, V59, P769, DOI 10.1175/1520-0469(2002)059<0769:AEOCEA>2.0.CO;2; Houghton J. T., 2001, CLIMATE CHANGE 2001; King MD, 2004, J ATMOS OCEAN TECH, V21, P857, DOI 10.1175/1520-0426(2004)021<0857:RSOLWA>2.0.CO;2; Lubin D, 2006, NATURE, V439, P453, DOI 10.1038/nature04449; Mahesh A, 2001, J APPL METEOROL, V40, P1279, DOI 10.1175/1520-0450(2001)040<1279:GBIRSO>2.0.CO;2; Marchand R, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003843; Miller JR, 2002, J CLIMATE, V15, P3028, DOI 10.1175/1520-0442(2002)015<3028:PIOCCO>2.0.CO;2; Morrison H, 2005, J ATMOS SCI, V62, P3683, DOI 10.1175/JAS3564.1; *NOAA CMDL, 2005, NOAA CMDL POINT BARR; Overland JE, 1997, J CLIMATE, V10, P821, DOI 10.1175/1520-0442(1997)010<0821:RVOWTI>2.0.CO;2; Polissar AV, 1999, ATMOS ENVIRON, V33, P2441, DOI 10.1016/S1352-2310(98)00423-3; RADKE LF, 1976, J APPL METEOROL, V15, P982, DOI 10.1175/1520-0450(1976)015<0982:OOCCNS>2.0.CO;2; Sassen K, 2005, NATURE, V434, P456, DOI 10.1038/434456a; Shupe MD, 2004, J CLIMATE, V17, P616, DOI 10.1175/1520-0442(2004)017<0616:CRFOTA>2.0.CO;2; Sirois A, 1999, J GEOPHYS RES-ATMOS, V104, P11599, DOI 10.1029/1999JD900077; Stamnes K, 1999, J CLIMATE, V12, P46, DOI 10.1175/1520-0442-12.1.46; TWOMEY S, 1991, ATMOS ENVIRON A-GEN, V25, P2435, DOI 10.1016/0960-1686(91)90159-5; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; Vavrus S, 2004, J CLIMATE, V17, P603, DOI 10.1175/1520-0442(2004)017<0603:TIOCFO>2.0.CO;2; Walsh JE, 1998, J CLIMATE, V11, P3030, DOI 10.1175/1520-0442(1998)011<3030:ACRTAI>2.0.CO;2; Wang XJ, 2003, SCIENCE, V299, P1725, DOI 10.1126/science.1078065; Wylie DP, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000759; Zhang T, 1996, J CLIMATE, V9, P2110, DOI 10.1175/1520-0442(1996)009<2110:IOCOSR>2.0.CO;2	30	274	278	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					787	789		10.1038/nature04636	http://dx.doi.org/10.1038/nature04636			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598255				2022-12-28	WOS:000236548400039
J	Shimoda, T; Matsuki, Y; Furusawa, M; Aoki, T; Yudasaka, I; Tanaka, H; Iwasawa, H; Wang, DH; Miyasaka, M; Takeuchi, Y				Shimoda, T; Matsuki, Y; Furusawa, M; Aoki, T; Yudasaka, I; Tanaka, H; Iwasawa, H; Wang, DH; Miyasaka, M; Takeuchi, Y			Solution-processed silicon films and transistors	NATURE			English	Article							RING-OPENING POLYMERIZATION; THIN-FILMS; FABRICATION; POLYSILANE	The use of solution processes - as opposed to conventional vacuum processes and vapour-phase deposition - for the fabrication of electronic devices has received considerable attention for a wide range of applications(1-7), with a view to reducing processing costs. In particular, the ability to print semiconductor devices using liquid-phase materials could prove essential for some envisaged applications, such as large-area flexible displays. Recent research in this area has largely been focused on organic semiconductors(8-11), some of which have mobilities comparable to that of amorphous silicon(11) (a-Si); but issues of reliability remain. Solution processing of metal chalcogenide semiconductors to fabricate stable and high-performance transistors has also been reported(12,13). This class of materials is being explored as a possible substitute for silicon, given the complex and expensive manufacturing processes required to fabricate devices from the latter. However, if high-quality silicon films could be prepared by a solution process, this situation might change drastically. Here we demonstrate the solution processing of silicon thin-film transistors (TFTs) using a silane-based liquid precursor. Using this precursor, we have prepared polycrystalline silicon ( poly-Si) films by both spin-coating and ink-jet printing, from which we fabricate TFTs with mobilities of 108 cm(2) V-1 s(-1) and 6.5 cm(2) V-1 s(-1), respectively. Although the processing conditions have yet to be optimized, these mobilities are already greater than those that have been achieved in solution-processed organic TFTs, and they exceed those of a-Si TFTs (<= 1 cm(2) V-1 s(-1)).	Seiko Epson Corp, Technol Platform Res Ctr, Nagano 3990293, Japan; JSR Corp, Fine Elect Res Labs, Yokaichi 5108552, Japan	Seiko Epson Corporation; JSR Corporation	Furusawa, M (corresponding author), Seiko Epson Corp, Technol Platform Res Ctr, 281 Fujimi, Nagano 3990293, Japan.	furusawa.masahiro@exc.epson.co.jp						Afzali A, 2002, J AM CHEM SOC, V124, P8812, DOI 10.1021/ja0266621; AOKI T, 2004, Patent No. 0029364; Chatgilialoglu C, 1998, ORGANOMETALLICS, V17, P2169, DOI 10.1021/om980011p; CYPRYK M, 1991, J AM CHEM SOC, V113, P1046, DOI 10.1021/ja00003a050; FURUSAWA M, 2002, 2002 SID INT S DIG T, P753; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; HENGGE E, 1975, MONATSH CHEM, V106, P503, DOI 10.1007/BF01150532; Hengge E., 1973, ANGEW CHEM, V85, P304; JOHN P, 1983, J CHEM SOC CHEM COMM, P1496, DOI 10.1039/c39830001496; Kawase T, 2000, INTERNATIONAL ELECTRON DEVICES MEETING 2000, TECHNICAL DIGEST, P623, DOI 10.1109/IEDM.2000.904397; Kipping FS, 1924, J CHEM SOC, V125, P2291, DOI 10.1039/ct9242502291; Kitahara K, 2002, JPN J APPL PHYS 1, V41, P5055, DOI 10.1143/JJAP.41.5055; Mitzi DB, 2004, NATURE, V428, P299, DOI 10.1038/nature02389; MIYASHITA S, 2001, P AS DISPL IDW 01, P1399; Mori K., 2000, Proceedings of the 2000 International Symposium on Antennas and Propagation (ISAP2000), P357; MORII K, 2004, P INT C SYNTH MET, P126; Okamura S, 2002, JPN J APPL PHYS 1, V41, P6714, DOI 10.1143/JJAP.41.6714; Peumans P, 2003, NATURE, V425, P158, DOI 10.1038/nature01949; RAABE G, 1985, CHEM REV, V85, P419, DOI 10.1021/cr00069a005; Ridley BA, 1999, SCIENCE, V286, P746, DOI 10.1126/science.286.5440.746; SAMESHIMA T, 1986, IEEE ELECTR DEVICE L, V7, P276, DOI 10.1109/EDL.1986.26372; SHIMODA T, 2003, Patent No. 6541354; SHIMODA T, 1999, 1999 SID INT S DIG T, P376; Sirringhaus H, 2000, SCIENCE, V290, P2123, DOI 10.1126/science.290.5499.2123; SUZUKI M, 1994, MACROMOLECULES, V27, P2360, DOI 10.1021/ma00086a066; Tahar RBH, 1997, J APPL PHYS, V82, P865, DOI 10.1063/1.365786; YUDASAKA I, 2004, 2004 SID INT S DIG T, P964	27	336	369	3	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					783	786		10.1038/nature04613	http://dx.doi.org/10.1038/nature04613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598254				2022-12-28	WOS:000236548400038
J	Kuehn, BM				Kuehn, BM			PhD programs adopt bench-to-bedside model to speed translational research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Pober JS, 2001, FASEB J, V15, P2303, DOI 10.1096/fj.01-0540lsf; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278	2	11	12	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1506	1507		10.1001/jama.295.13.1506	http://dx.doi.org/10.1001/jama.295.13.1506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16595749				2022-12-28	WOS:000236505400006
J	Marsh, R				Marsh, R			Avian influenza - Preparing for the pandemic - Hard decisions will have to be made: view from intensive care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Northampton Gen Hosp NHS Trust, Northampton NN1 5BD, England		Marsh, R (corresponding author), Northampton Gen Hosp NHS Trust, Northampton NN1 5BD, England.	Richard.Marsh@ngh.nhs.uk						Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; *HLTH PROT AG, INFL PAND CONT PLAN; Rubinson L, 2005, CRIT CARE MED, V33, P2393, DOI 10.1097/01.CCM.0000173411.06574.D5; Scales DC, 2003, EMERG INFECT DIS, V9, P1205, DOI 10.3201/eid0910.030525	4	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					790	791		10.1136/bmj.332.7544.790	http://dx.doi.org/10.1136/bmj.332.7544.790			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032JA	16575088	Green Published			2022-12-28	WOS:000236769500032
J	Krogan, NJ; Cagney, G; Yu, HY; Zhong, GQ; Guo, XH; Ignatchenko, A; Li, J; Pu, SY; Datta, N; Tikuisis, AP; Punna, T; Peregrin-Alvarez, JM; Shales, M; Zhang, X; Davey, M; Robinson, MD; Paccanaro, A; Bray, JE; Sheung, A; Beattie, B; Richards, DP; Canadien, V; Lalev, A; Mena, F; Wong, P; Starostine, A; Canete, MM; Vlasblom, J; Wu, S; Orsi, C; Collins, SR; Chandran, S; Haw, R; Rilstone, JJ; Gandi, K; Thompson, NJ; Musso, G; St Onge, P; Ghanny, S; Lam, MHY; Butland, G; Altaf-Ui, AM; Kanaya, S; Shilatifard, A; O'Shea, E; Weissman, JS; Ingles, CJ; Hughes, TR; Parkinson, J; Gerstein, M; Wodak, SJ; Emili, A; Greenblatt, JF				Krogan, NJ; Cagney, G; Yu, HY; Zhong, GQ; Guo, XH; Ignatchenko, A; Li, J; Pu, SY; Datta, N; Tikuisis, AP; Punna, T; Peregrin-Alvarez, JM; Shales, M; Zhang, X; Davey, M; Robinson, MD; Paccanaro, A; Bray, JE; Sheung, A; Beattie, B; Richards, DP; Canadien, V; Lalev, A; Mena, F; Wong, P; Starostine, A; Canete, MM; Vlasblom, J; Wu, S; Orsi, C; Collins, SR; Chandran, S; Haw, R; Rilstone, JJ; Gandi, K; Thompson, NJ; Musso, G; St Onge, P; Ghanny, S; Lam, MHY; Butland, G; Altaf-Ui, AM; Kanaya, S; Shilatifard, A; O'Shea, E; Weissman, JS; Ingles, CJ; Hughes, TR; Parkinson, J; Gerstein, M; Wodak, SJ; Emili, A; Greenblatt, JF			Global landscape of protein complexes in the yeast Saccharomyces cerevisiae	NATURE			English	Article							INTERACTION NETWORK; MASS-SPECTROMETRY; RNA-POLYMERASES; GENOME; SCALE; METHYLATION; EXPRESSION; GENES; IDENTIFICATION; LOCALIZATION	Identification of protein - protein interactions often provides insight into protein function, and many cellular processes are performed by stable protein complexes. We used tandem affinity purification to process 4,562 different tagged proteins of the yeast Saccharomyces cerevisiae. Each preparation was analysed by both matrix-assisted laser desorption/ ionization - time of flight mass spectrometry and liquid chromatography tandem mass spectrometry to increase coverage and accuracy. Machine learning was used to integrate the mass spectrometry scores and assign probabilities to the protein - protein interactions. Among 4,087 different proteins identified with high confidence by mass spectrometry from 2,357 successful purifications, our core data set ( median precision of 0.69) comprises 7,123 protein - protein interactions involving 2,708 proteins. A Markov clustering algorithm organized these interactions into 547 protein complexes averaging 4.9 subunits per complex, about half of them absent from the MIPS database, as well as 429 additional interactions between pairs of complexes. The data ( all of which are available online) will help future studies on individual proteins as well as functional genomics and systems biology.	Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Hosp Sick Children, Toronto, ON M4K 1X8, Canada; Affinium Pharmaceut, Toronto, ON M5J 1V6, Canada; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Nara Inst Sci & Technol, Comparat Genom Lab, Nara 6300101, Japan; St Louis Univ, Sch Med, Dept Biochem, St Louis, MO 63104 USA; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	University of Toronto; University of Toronto; University College Dublin; Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Howard Hughes Medical Institute; University of California System; University of California San Francisco; Nara Institute of Science & Technology; Saint Louis University; Harvard University; Howard Hughes Medical Institute	Greenblatt, JF (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	Andrew.emili@utoronto.ca; jack.Greenblatt@utoronto.ca	Parkinson, John/A-4424-2008; Haw, Robin/D-1393-2009; Robinson, Mark D/A-6432-2015; Robinson, Mark D./O-2254-2019; Cagney, Gerard/A-4648-2009; Paccanaro, Alberto/AAW-5625-2020	Parkinson, John/0000-0001-9815-1189; Haw, Robin/0000-0002-2013-7835; Robinson, Mark D/0000-0002-3048-5518; Robinson, Mark D./0000-0002-3048-5518; Cagney, Gerard/0000-0001-7189-9496; Tikuisis, Aaron/0000-0001-7326-382X; Ignatchenko, Alexandr/0000-0002-6083-941X; Weissman, Jonathan/0000-0003-2445-670X; Musso, Gabriel/0000-0001-8778-8248; Davey, Michael/0000-0002-1172-5934; Collins, Sean/0000-0002-4276-5840; Alvarez, Jose/0000-0002-7184-832X; wodak, shoshana/0000-0002-0701-6545; BRAY, JAMES/0000-0003-3554-4254				ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BRIGATI C, 1993, MOL CELL BIOL, V13, P1306, DOI 10.1128/MCB.13.2.1306; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Eissenberg JC, 2002, P NATL ACAD SCI USA, V99, P9894, DOI 10.1073/pnas.152193699; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fourel G, 1999, EMBO J, V18, P2522, DOI 10.1093/emboj/18.9.2522; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Korber P, 2004, CELL, V117, P5, DOI 10.1016/S0092-8674(04)00296-X; Krogan NJ, 2004, MOL CELL, V16, P1027, DOI 10.1016/j.molcel.2004.11.033; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Mitchell T.M, 2003, MACH LEARN; Regelmann J, 2003, MOL BIOL CELL, V14, P1652, DOI 10.1091/mbc.E02-08-0456; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Sampath V, 2005, IUBMB LIFE, V57, P93, DOI 10.1080/15216540500078905; Scholes DT, 2001, GENETICS, V159, P1449; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1; Xia Y, 2004, ANNU REV BIOCHEM, V73, P1051, DOI 10.1146/annurev.biochem.73.011303.073950; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	48	2176	2249	4	289	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					637	643		10.1038/nature04670	http://dx.doi.org/10.1038/nature04670			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16554755				2022-12-28	WOS:000236350400036
J	Zody, MC; Garber, M; Sharpe, T; Young, SK; Rowen, L; O'Neill, K; Whittaker, CA; Kamal, M; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Kodira, CD; Madan, A; Qin, SZ; Yang, XP; Abbasi, N; Abouelleil, A; Arachchi, HM; Baradarani, L; Birditt, B; Bloom, S; Bloom, T; Borowsky, ML; Burke, J; Butler, J; Cook, A; DeArellano, K; DeCaprio, D; Dorris, L; Dors, M; Eichler, EE; Engels, R; Fahey, J; Fleetwood, P; Friedman, C; Gearin, G; Hall, JL; Hensley, G; Johnson, E; Jones, C; Kamat, A; Kaur, A; Locke, DP; Madan, A; Munson, G; Jaffe, DB; Lui, A; Macdonald, P; Mauceli, E; Naylor, JW; Nesbitt, R; Nicol, R; O'Leary, SB; Ratcliffe, A; Rounsley, S; She, XW; Sneddon, KMB; Stewart, S; Sougnez, C; Stone, SM; Topham, K; Vincent, D; Wang, SG; Zimmer, AR; Birren, BW; Hood, L; Lander, ES; Nusbaum, C				Zody, MC; Garber, M; Sharpe, T; Young, SK; Rowen, L; O'Neill, K; Whittaker, CA; Kamal, M; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Kodira, CD; Madan, A; Qin, SZ; Yang, XP; Abbasi, N; Abouelleil, A; Arachchi, HM; Baradarani, L; Birditt, B; Bloom, S; Bloom, T; Borowsky, ML; Burke, J; Butler, J; Cook, A; DeArellano, K; DeCaprio, D; Dorris, L; Dors, M; Eichler, EE; Engels, R; Fahey, J; Fleetwood, P; Friedman, C; Gearin, G; Hall, JL; Hensley, G; Johnson, E; Jones, C; Kamat, A; Kaur, A; Locke, DP; Madan, A; Munson, G; Jaffe, DB; Lui, A; Macdonald, P; Mauceli, E; Naylor, JW; Nesbitt, R; Nicol, R; O'Leary, SB; Ratcliffe, A; Rounsley, S; She, XW; Sneddon, KMB; Stewart, S; Sougnez, C; Stone, SM; Topham, K; Vincent, D; Wang, SG; Zimmer, AR; Birren, BW; Hood, L; Lander, ES; Nusbaum, C			Analysis of the DNA sequence and duplication history of human chromosome 15	NATURE			English	Article							HUMAN-GENOME; SEGMENTAL DUPLICATIONS; GENERATION; DATABASE; DISEASE; MAP	Here we present a finished sequence of human chromosome 15, together with a high-quality gene catalogue. As chromosome 15 is one of seven human chromosomes with a high rate of segmental duplication(1), we have carried out a detailed analysis of the duplication structure of the chromosome. Segmental duplications in chromosome 15 are largely clustered in two regions, on proximal and distal 15q; the proximal region is notable because recombination among the segmental duplications can result in deletions causing Prader-Willi and Angelman syndromes(2,3). Sequence analysis shows that the proximal and distal regions of 15q share extensive ancient similarity(4). Using a simple approach, we have been able to reconstruct many of the events by which the current duplication structure arose. We find that most of the intrachromosomal duplications seem to share a common ancestry. Finally, we demonstrate that some remaining gaps in the genome sequence are probably due to structural polymorphisms between haplotypes; this may explain a significant fraction of the gaps remaining in the human genome.	MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Cambridge, MA 02141 USA; Inst Syst Biol, Seattle, WA 98103 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; UCL, Galton Lab, Dept Biol, London NW1 2HE, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Institute for Systems Biology (ISB); University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of London; University College London	Nusbaum, C (corresponding author), MIT, Broad Inst, 320 Charles St, Cambridge, MA 02141 USA.	mczody@broad.mit.edu; chad@broad.mit.edu	Cuomo, Christina/L-2222-2019	Cuomo, Christina/0000-0002-5778-960X; DeCaprio, Dave/0000-0001-8931-9461; Engels, Reinhard/0000-0003-0921-0736; Locke, Devin/0000-0002-2527-0475; Nicol, Robert/0000-0003-1932-1392; Whittaker, Charles/0000-0002-2400-0094	MRC [G0000107] Funding Source: UKRI; Medical Research Council [G0000107] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Kehrer-Sawatzki H, 1998, CHROMOSOME RES, V6, P429, DOI 10.1023/A:1009287223826; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Nusbaum C, 2006, NATURE, V439, P331, DOI 10.1038/nature04406; Nusbaum C, 2005, NATURE, V437, P551, DOI 10.1038/nature03983; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pujana MA, 2001, GENOME RES, V11, P98, DOI 10.1101/gr.155601; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Soejima H, 2005, J CELL BIOCHEM, V95, P226, DOI 10.1002/jcb.20443; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	25	57	451	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					671	675		10.1038/nature04601	http://dx.doi.org/10.1038/nature04601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572171	Bronze			2022-12-28	WOS:000236350400044
J	Loewer, A; Lahav, G				Loewer, A; Lahav, G			Cellular conference call: External feedback affects cell-fate decisions	CELL			English	Editorial Material							SIGNAL-TRANSDUCTION; NEGATIVE FEEDBACK; POSITIVE FEEDBACK; PATHWAY; LOOPS	Cells often need to respond to multiple opposing signals simultaneously. In this issue of Cell, Janes et al. (2006) show that challenging cells with multiple extracellular signals induces an external feedback that involves the release of and response to additional secreted factors with antagonistic functions. These results suggest that an individual cell's decision to die or survive is not wholly independent but depends, at least in part, on feedback from its neighbors.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lahav, G (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	galit@hms.harvard.edu	Loewer, Alexander/AAL-6943-2021	Loewer, Alexander/0000-0002-8819-3040				Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Semino CE, 2006, EXP CELL RES, V312, P289, DOI 10.1016/j.yexcr.2005.10.029; Shvartsman SY, 2002, AM J PHYSIOL-CELL PH, V282, pC545, DOI 10.1152/ajpcell.00260.2001; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	10	8	11	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1128	1130		10.1016/j.cell.2006.03.010	http://dx.doi.org/10.1016/j.cell.2006.03.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564006	Bronze			2022-12-28	WOS:000237241400013
J	Doma, MK; Parker, R				Doma, MK; Parker, R			Endonucleolytic cleavage of eukaryotic mRNAs with stalls in translation elongation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; FACTOR ERF3; YEAST; DEGRADATION; TERMINATION; CODON; TURNOVER; DECAY	A fundamental aspect of the biogenesis and function of eukaryotic messenger RNA is the quality control systems that recognize and degrade non-functional mRNAs. Eukaryotic mRNAs where translation termination occurs too soon (nonsense-mediated decay) 1 or fails to occur (non-stop decay) 2 are rapidly degraded. We show that yeast mRNAs with stalls in translation elongation are recognized and targeted for endonucleolytic cleavage, referred to as 'no-go decay'. The cleavage triggered by no-go decay is dependent on translation and involves Dom34p and Hbs1p. Dom34p and Hbs1p are similar to the translation termination factors eRF1 and eRF3 (refs 3, 4), indicating that these proteins might function in recognizing the stalled ribosome and triggering endonucleolytic cleavage. No-go decay provides a mechanism for clearing the cell of stalled translation elongation complexes, which could occur as a result of damaged mRNAs or ribosomes, or as a mechanism of post-transcriptional control.	Univ Arizona, Dept Mol & Cellular Biol, Howard Hughes Med Inst, Tucson, AZ 85721 USA	Howard Hughes Medical Institute; University of Arizona	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Howard Hughes Med Inst, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu			NIGMS NIH HHS [R37 GM045443] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Chiba Y, 1999, SCIENCE, V286, P1371, DOI 10.1126/science.286.5443.1371; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Davis L, 1998, GENETICS, V149, P45; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Harger JW, 2003, RNA, V9, P1019, DOI 10.1261/rna.5930803; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Inagaki Y, 2003, NUCLEIC ACIDS RES, V31, P4227, DOI 10.1093/nar/gkg440; Inge-Vechtomov S, 2003, BIOL CELL, V95, P195, DOI 10.1016/S0248-4900(03)00035-2; Kong CG, 2004, MOL CELL, V14, P233, DOI 10.1016/S1097-2765(04)00206-0; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; van Hoof A, 2005, GENETICS, V171, P1455, DOI 10.1534/genetics.105.044057; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Withey JH, 2003, ANNU REV MICROBIOL, V57, P101, DOI 10.1146/annurev.micro.57.030502.090945	28	481	496	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					561	564		10.1038/nature04530	http://dx.doi.org/10.1038/nature04530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554824	Green Accepted			2022-12-28	WOS:000236176100062
J	Gawande, A				Gawande, A			When law and ethics collide - Why physicians participate in executions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, A (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.			Gawande, Atul/0000-0002-1824-9176				*AM COLL PHYS, 1994, BREACH TRUST PHYS PA; Farber NJ, 2001, ANN INTERN MED, V135, P884, DOI 10.7326/0003-4819-135-10-200111200-00008; NORBUT M, 2005, MED NEWS        0704, P1; SOLOTAROFF I, 2001, LAST FACE YOULL EVER, P7; TROMBLEY S, 1992, EXECUTION PROTOCOL I	5	65	65	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1221	1229		10.1056/NEJMp068042	http://dx.doi.org/10.1056/NEJMp068042			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	023ZH	16554524				2022-12-28	WOS:000236164200001
J	Duke, T; Keshishiyan, E; Kuttumuratova, A; Ostergren, M; Ryumina, I; Stasii, E; Weber, MW; Tamburlini, G				Duke, T; Keshishiyan, E; Kuttumuratova, A; Ostergren, M; Ryumina, I; Stasii, E; Weber, MW; Tamburlini, G			Quality of hospital care for children in Kazakhstan, Republic of Moldova, and Russia: systematic observational assessment	LANCET			English	Article							HEALTH; COUNTRIES	Background Major concerns about the quality of basic hospital care for children have been raised in developing countries, but no formal assessment applying international standards has been done in the Commonwealth of Independent States. Methods We assessed 1.7 hospitals in Kazakhstan, the Republic of Moldova, and the Russian Federation with a generic WHO hospital assessment framework adapted for use in the WHO European region. WHO management guidelines for paediatric care in peripheral hospitals were used as standards. Findings Hospital access for children was generally good. Good health networks existed, and skilled and committed doctors cared for children. Case-fatality rates were low. However, unnecessary and lengthy hospital stays were common, and most children received excessive and ineffective treatment (in one country median number of drugs prescribed concurrently was 5, IQR 2-6). Several conditions were systematically overdiagnosed, especially neurological disease, or overinvestigated, such as acute diarrhoea. Reasons for these practices included absence of clear evidence-based clinical guidelines, regulations tying duration of admission to financial reimbursement, generalisation of disease-control methods from rare problems to common illnesses, and regulations maintaining financial and professional status of some subspecialties. Many disincentives to efficient practice existed. Interpretation To improve quality of hospital care for children in the Commonwealth of independent States, several issues must be addressed, including: adoption of international guidelines for inpatient management; complementary guidelines for outpatient management; reforms to health regulations governing admission and discharge criteria; improvement of quality of training, availability of medical information, and systems to promote and certify quality of care.	Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia; Moscow Sci Res Inst Paediat & Paediat Surg, Moscow, Russia; WHO, Country Sub Off, Alma Ata, Kazakhstan; WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; WHO, Off Russian Federat, Moscow, Russia; State Med & Pharmaceut Univ Republ Moldova, Kishinev, Moldova; WHO, CH-1211 Geneva, Switzerland; IRCCS Burlo Garofolo, Inst Child Hlth, Trieste, Italy	Royal Children's Hospital Melbourne; University of Melbourne; World Health Organization; World Health Organization; World Health Organization; Nicolae Testemitanu State University of Medicine & Pharmacy; World Health Organization; IRCCS Burlo Garofolo	Duke, T (corresponding author), Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Ctr Int Child Hlth, Parkville, Vic 3052, Australia.	trevor.duke@rch.org.au	Weber, Martin/GPW-6095-2022; Stasii, Ecaterina/EAJ-3597-2022					Balabanova D, 2004, HEALTH SERV RES, V39, P1927, DOI 10.1111/j.1475-6773.2004.00326.x; Conaboy KA, 2005, J CONTIN EDUC HEALTH, V25, P52, DOI 10.1002/chp.9; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Ensor T, 1997, INT J HEALTH PLAN M, V12, P219, DOI 10.1002/(SICI)1099-1751(199707/09)12:3<219::AID-HPM482>3.0.CO;2-I; Freedman LP., 2005, DEVELOPMENT, V48, P19, DOI DOI 10.1057/PALGRAVE.DEVELOPMENT.1100107; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Parfitt T, 2005, LANCET, V366, P357, DOI 10.1016/S0140-6736(05)67007-9; UNICEF, STAT WORLDS CHILDR S; *WHO, IMCI GUID CHART BOOK; *WHO EUR OFF, 2002, TECHN CONS IMPR QUAL; World Health Organization, 2000, IMPR QUAL PAED CAR S; World Health Organization, 2000, MAN CHILD SER INF SE	12	39	42	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					919	925		10.1016/S0140-6736(06)68382-7	http://dx.doi.org/10.1016/S0140-6736(06)68382-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546540				2022-12-28	WOS:000236242100028
J	Peile, E				Peile, E			A 28 year old postpartum woman with right sided chest discomfort: case outcome - Commentary: Knowing and knowing about	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England	University of Warwick	Peile, E (corresponding author), Univ Warwick, Warwick Med Sch, Div Med Educ, Coventry CV4 7AL, W Midlands, England.	ed.peile@warwick.ac.uk						Dwivedi G, 2006, BRIT MED J, V332, P643, DOI 10.1136/bmj.332.7542.643; Miller GE, 1990, ACAD MED S, V9, P63; Polanyi M., 2005, PERSONAL KNOWLEDGE P; Svelby K. E., 1997, NEW ORG WEALTH MANAG	4	5	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					645	645		10.1136/bmj.332.7542.645	http://dx.doi.org/10.1136/bmj.332.7542.645			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543331	Green Published			2022-12-28	WOS:000236314700021
J	Henter, JI; Chow, CB; Leung, CW; Lau, YL				Henter, JI; Chow, CB; Leung, CW; Lau, YL			Cytotoxic therapy for severe avian influenza A (H5N1) infection	LANCET			English	Article							FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; VIRUS-INFECTION; IMMUNOCHEMOTHERAPY; ETOPOSIDE; DISEASE; CHILD; MODEL	The mortality rate in documented avian influenza A virus subtype H5N1 infection is still high, which is currently reported by WHO at about 50%. Post-mortem analyses in affected patients have revealed haemophagocytosis similar to that found in patients with haemophagocytic lymphohistiocytosis (HLH); such haemophagocytosis could be a very prominent post-mortem feature in H5N1 infection. There are also clinical similarities between H5N1 infection and HLH, such as massive hypercytokinaemia, cytopenia, and acute encephalitis. Importantly, patients with another severe viral infection that may be complicated by secondary HLH, severe Epstein-Barr-vir-us-associated HLH, have significantly better survival if specific HLH therapy (including the cytotoxic and pro-apoptotic drug etoposide) is initiated early, with survival reported to rise from about 50% to 90%. With this notable improvement in survival, specific HLH treatment, including cytotoxic therapy, could be considered in patients with severe avian influenza A infection complicated by secondary HLH.	Karolinska Univ Hosp Q6 05, Karolinska Inst, Dept Woman & Child Hlth, Childhood Canc Res Unit, SE-17176 Stockholm, Sweden; Princess Margaret Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China	Karolinska Institutet; Karolinska University Hospital; University of Hong Kong	Henter, JI (corresponding author), Karolinska Univ Hosp Q6 05, Karolinska Inst, Dept Woman & Child Hlth, Childhood Canc Res Unit, SE-17176 Stockholm, Sweden.	Jan-Inge.Henter@ki.se	; Lau, Yu Lung/C-4322-2009	Henter, Jan-Inge/0000-0002-0629-2126; Lau, Yu Lung/0000-0002-4780-0289				Aleem A, 2005, CLIN LAB HAEMATOL, V27, P395, DOI 10.1111/j.1365-2257.2005.00728.x; Chokephaibulkit K, 2005, PEDIATR INFECT DIS J, V24, P162, DOI 10.1097/01.inf.0000151037.25237.1e; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Fadeel B, 2001, LEUKEMIA LYMPHOMA, V42, P13, DOI 10.3109/10428190109097672; Fadeel B, 1999, BRIT J HAEMATOL, V106, P406, DOI 10.1046/j.1365-2141.1999.01538.x; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Henter JI, 2002, BLOOD, V100, P2367, DOI 10.1182/blood-2002-01-0172; HENTER JI, 1992, LANCET, V339, P104, DOI 10.1016/0140-6736(92)91008-V; HENTER JI, 1991, BLOOD, V78, P2918, DOI 10.1182/blood.V78.11.2918.2918; Henter JI, 1997, J PEDIATR-US, V130, P358, DOI 10.1016/S0022-3476(97)70196-3; Henter JI, 2004, CRIT REV ONCOL HEMAT, V50, P157, DOI 10.1016/j.critrevonc.2004.01.002; HENTER JI, 1991, SEMIN ONCOL, V18, P29; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Imashuku S, 2001, J CLIN ONCOL, V19, P2665, DOI 10.1200/JCO.2001.19.10.2665; Imashuku S, 2003, MED PEDIATR ONCOL, V41, P103, DOI 10.1002/mpo.10314; Imashuku S, 1999, BLOOD, V93, P1869; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lipatov AS, 2005, J INFECT DIS, V191, P1216, DOI 10.1086/428951; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Normile D, 2005, SCIENCE, V310, P1256; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; TOTINO PRR, 2005, CELL BIOL INT   1102; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076	31	68	84	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					870	873		10.1016/S0140-6736(06)68232-9	http://dx.doi.org/10.1016/S0140-6736(06)68232-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530581				2022-12-28	WOS:000236016500032
J	Dong, M; Yeh, F; Tepp, WH; Dean, C; Johnson, EA; Janz, R; Chapman, ER				Dong, M; Yeh, F; Tepp, WH; Dean, C; Johnson, EA; Janz, R; Chapman, ER			SV2 is the protein receptor for botulinum neurotoxin A	SCIENCE			English	Article							SYNAPTIC VESICLE PROTEIN; SYNAPTOTAGMIN-I; NEUROTRANSMITTER RELEASE; B NEUROTOXIN; GANGLIOSIDES; BINDING; CELLS; TETANUS; TOXINS; IDENTIFICATION	How the widely used botulinum neurotoxin A (BoNT/A) recognizes and enters neurons is poorly understood. We found that BoNT/A enters neurons by binding to the synaptic vesicle protein SV2 (isoforms A, B, and C). Fragments of SV2 that harbor the toxin interaction domain inhibited BoNT/A from binding to neurons. BoNT/A binding to SV2A and SV2B knockout hippocampal neurons was abolished and was restored by expressing SV2A, SV2B, or SV2C. Reduction of SV2 expression in PC12 and Neuro-2a cells also inhibited entry of BoNT/A, which could be restored by expressing SV2 isoforms. Finally, mice that lacked an SV2 isoform (SV2B) displayed reduced sensitivity to BoNT/A. Thus, SV2 acts as the protein receptor for BoNT/A.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; Univ Wisconsin, Dept Food Microbiol & Toxicol, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Pharmacol Program, Madison, WI 53706 USA; Univ Texas, Houston Med Sch, WM Keck Ctr Learning & Memory, Houston, TX 77030 USA; Univ Texas, Houston Med Sch, Dept Neurobiol & Anat, Houston, TX 77030 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	chapman@physiology.wisc.edu	Taylor, Graham/A-4027-2012	Chapman, Edwin/0000-0001-9787-8140; Janz, Roger/0000-0002-9872-0596	NATIONAL EYE INSTITUTE [R01EY016452] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016452, R01 EY016452-03] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Bullens RWM, 2002, J NEUROSCI, V22, P6876; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; HUGHES R, 1962, J PHYSIOL-LONDON, V160, P221, DOI 10.1113/jphysiol.1962.sp006843; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Johnson EA, 1999, ANNU REV MICROBIOL, V53, P551, DOI 10.1146/annurev.micro.53.1.551; Keller JE, 2004, BIOCHEMISTRY-US, V43, P526, DOI 10.1021/bi0356698; KITAMURA M, 1980, BIOCHIM BIOPHYS ACTA, V628, P328, DOI 10.1016/0304-4165(80)90382-7; Kitamura M, 1999, BBA-MOL CELL BIOL L, V1441, P1, DOI 10.1016/S1388-1981(99)00140-7; Malizio CJ, 2000, METH MOL B, V145, P27; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3; Nishiki T, 1996, FEBS LETT, V378, P253, DOI 10.1016/0014-5793(95)01471-3; NISHIKI T, 1994, J BIOL CHEM, V269, P10498; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1993, FEBS LETT, V335, P99, DOI 10.1016/0014-5793(93)80448-4; SIMPSON LL, 1971, J NEUROCHEM, V18, P1341, DOI 10.1111/j.1471-4159.1971.tb00235.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Yowler BC, 2004, BIOCHEMISTRY-US, V43, P9725, DOI 10.1021/bi0494673; Yowler BC, 2002, J BIOL CHEM, V277, P32815, DOI 10.1074/jbc.M205258200	31	551	588	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					592	596		10.1126/science.1123654	http://dx.doi.org/10.1126/science.1123654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16543415				2022-12-28	WOS:000237296700049
J	Drife, JO				Drife, JO			Commentary: Not another innovation	BRITISH MEDICAL JOURNAL			English	Editorial Material									Leeds Teaching Hosp NHS Trust, Acad Unit Paediat Obstet & Gynaecol, Leeds LS2 9NS, W Yorkshire, England	University of Leeds	Drife, JO (corresponding author), Leeds Teaching Hosp NHS Trust, Acad Unit Paediat Obstet & Gynaecol, Leeds LS2 9NS, W Yorkshire, England.	j.o.drife@leeds.ac.uk						Davies M, 2006, BMJ-BRIT MED J, V332, P844, DOI 10.1136/bmj.332.7545.844; Drife JO, 2006, BRIT MED J, V332, P127, DOI 10.1136/bmj.332.7533.127-a	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 8	2006	332	7545					847	848		10.1136/bmj.332.7545.847	http://dx.doi.org/10.1136/bmj.332.7545.847			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16601050	Green Published			2022-12-28	WOS:000236815900028
J	Coppa, A; Bondioli, L; Cucina, A; Frayer, DW; Jarrige, C; Jarrige, JF; Quivron, G; Rossi, M; Vidale, M; Macchiarelli, R				Coppa, A; Bondioli, L; Cucina, A; Frayer, DW; Jarrige, C; Jarrige, JF; Quivron, G; Rossi, M; Vidale, M; Macchiarelli, R			Early Neolithic tradition of dentistry - Flint tips were surprisingly effective for drilling tooth enamel in a prehistoric population.	NATURE			English	Editorial Material									Univ Roma La Sapienza, Dipartimento BAU, I-00185 Rome, Italy; Museo Nazl Preistor Etnog L Pigorini, Sez Antropol, I-00144 Rome, Italy; Univ Autonoma Yucatan, Fac Ciencias Antropol, Merida, Yucatan, Mexico; Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA; Musee Natl Arts Asiat Guimet, F-75116 Paris, France; Univ Bologna, Dipartimento Fis, I-40127 Bologna, Italy; Ist Cent Restauro, I-00184 Rome, Italy; Univ Poitiers, UMR 6046, Lab GBPH, F-86022 Poitiers, France	Sapienza University Rome; Universidad Autonoma de Yucatan; University of Kansas; University of Bologna; Universite de Poitiers	Coppa, A (corresponding author), Univ Roma La Sapienza, Dipartimento BAU, I-00185 Rome, Italy.			coppa, alfredo/0000-0002-7708-2484; Bondlioli, Luca/0000-0002-8511-7667				ALT KW, 1998, DENT ANTHR, P389; Bennike P., 1986, B HIST DENT, V34, P81; Jarrige C., 1995, MEHRGARH FIELD REPOR; KENOYER JM, 1991, WORLD ARCHAEOL, V23, P44, DOI 10.1080/00438243.1991.9980158; KENOYER JM, 1992, MAT ISSUES ART ARCHA, V3, P495; LUKACS JR, 1992, S ASIAN ARCHAEOLOGY, P167; SCHWARTZ JH, 1995, AM J PHYS ANTHROPOL, V97, P77, DOI 10.1002/ajpa.1330970106; White TD, 1997, AM J PHYS ANTHROPOL, V103, P409, DOI 10.1002/(SICI)1096-8644(199707)103:3<409::AID-AJPA10>3.3.CO;2-B	8	50	53	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2006	440	7085					755	756		10.1038/440755a	http://dx.doi.org/10.1038/440755a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598247				2022-12-28	WOS:000236548400031
J	McDonald, CJ				McDonald, CJ			Computerization can create safety hazards: A bar-coding near miss	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN ORDER ENTRY; ADVERSE DRUG EVENTS; MEDICATION ERRORS; INFORMATION-TECHNOLOGY; PATIENT SAFETY; HEALTH-CARE; SYSTEMS; RATES; HOSPITALS; INCREASE	Increasing numbers of hospitals are implementing bar-coding systems to prevent errors in patient identification. In the present case, a diabetic patient admitted to a teaching hospital was mistakenly given the bar-coded identification wristband of another patient who was admitted at the same time. When a laboratory result that documented the diabetic patient's severe hyperglycemia was entered into the other patient's electronic medical record, the latter patient seemed to have a very high glucose level and was almost given what could have been a fatal dose of insulin. This near miss shows that computer systems, although having the potential to improve safety, may create new kinds of errors if not accompanied by well-designed, well-implemented cross-check processes and a culture of safety. Moreover, computer systems may have the pernicious effect of weakening human vigilance, removing an important safety protection. Researchers should continue to study realworld implementation of computerized systems to understand their benefits and potential harms, and administrators and providers should seek ways to anticipate these harms and mitigate them.	Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc	McDonald, CJ (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.	cmcdonald@regenstrief.org			NATIONAL LIBRARY OF MEDICINE [G08LM008232] Funding Source: NIH RePORTER; NLM NIH HHS [G08 LM008232] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Ash JS, 2004, J AM MED INFORM ASSN, V11, P104, DOI 10.1197/jamia.M1471; Bates DW, 2000, BRIT MED J, V320, P788, DOI 10.1136/bmj.320.7237.788; Bierstock S, 2005, JAMA-J AM MED ASSOC, V294, P178, DOI 10.1001/jama.294.2.178-b; BREWIN B, 2004, COMP WORLD      0226; BRODER C, 2005, JCAHO DROPS BAR CODI; Dexter PR, 2001, NEW ENGL J MED, V345, P965, DOI 10.1056/NEJMsa010181; Dexter PR, 2004, JAMA-J AM MED ASSOC, V292, P2366, DOI 10.1001/jama.292.19.2366; Doolan DF, 2002, HEALTH AFFAIR, V21, P180, DOI 10.1377/hlthaff.21.4.180; Gallian JA, 1996, ACM COMPUT SURV, V28, P504, DOI 10.1145/243439.243457; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Grannis SJ, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P305; GRUDIN JT, 2003, COGNITIVE ASPECTS SK, P121; Halamka J, 2005, NEW ENGL J MED, V353, P331, DOI 10.1056/NEJMp058077; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; HICKS RW, 2004, MEDMARX 5 ANNIVERSAR; Horsky J, 2005, J AM MED INFORM ASSN, V12, P377, DOI 10.1197/jamia.M1740; *JOINT COMM ACCR H, 2005, HOSP NAT PAT SAF GOA; Keillor A, 2005, JAMA-J AM MED ASSOC, V294, P178, DOI 10.1001/jama.294.2.178-a; KLEMMER ET, 1962, J APPL PSYCHOL, V46, P401, DOI 10.1037/h0048461; Koppel R, 2005, J BIOMED INFORM, V38, P267, DOI 10.1016/j.jbi.2005.05.006; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Larrabee Susanne, 2003, Jt Comm J Qual Saf, V29, P345; Lee SU, 2005, J BACK MUSCULOSKELET, V18, P15, DOI 10.3233/BMR-2005-181-203; Levick D, 2005, JAMA-J AM MED ASSOC, V294, P179, DOI 10.1001/jama.294.2.179-c; Linden JV, 2000, TRANSFUSION, V40, P1207, DOI 10.1046/j.1537-2995.2000.40101207.x; MacKay DJC, 1999, IEEE T INFORM THEORY, V45, P399, DOI 10.1109/18.748992; McDonald CJ, 2004, J AM MED INFORM ASSN, V11, P121, DOI 10.1197/jamia.M1488; Nebeker JR, 2005, ARCH INTERN MED, V165, P1111, DOI 10.1001/archinte.165.10.1111; Oren E, 2003, AM J HEALTH-SYST PH, V60, P1447, DOI 10.1093/ajhp/60.14.1447; Patterson ES, 2002, J AM MED INFORM ASSN, V9, P540, DOI 10.1197/jamia.M1061; PAVLIDIS T, 1990, COMPUTER, V23, P74, DOI 10.1109/2.55471; Phillips DP, 1998, LANCET, V351, P643, DOI 10.1016/S0140-6736(98)24009-8; Potts AL, 2004, PEDIATRICS, V113, P59, DOI 10.1542/peds.113.1.59; Rooney C, 1998, LANCET, V351, P1656, DOI 10.1016/S0140-6736(05)77710-2; ROSENTHAL M, 2003, CHECK WRISTBAND AHRQ; Shulman R, 2005, CRIT CARE, V9, pR516, DOI 10.1186/cc3793; STEIN R, 2004, WASHINGTON POST 1014; TIERNEY WM, 1993, JAMA-J AM MED ASSOC, V269, P379, DOI 10.1001/jama.269.3.379; WAGNER NR, 1989, COMMUN ACM, V32, P106, DOI 10.1145/63238.63246; WALD H, 2005, AHRQ PUBLICATION; WANT R, 2004, QCM QUEUE, V2; Wright AA, 2005, NEW ENGL J MED, V353, P329, DOI 10.1056/NEJMp058101; CREDIT CARD VALIDATI; 2005, MMWR MORB MORTAL WKL, P33	44	92	92	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					510	516		10.7326/0003-4819-144-7-200604040-00010	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031DU	16585665				2022-12-28	WOS:000236685100006
J	Self, CH; Thompson, S				Self, CH; Thompson, S			How specific are therapeutic rnonoclonal antibodies?	LANCET			English	Editorial Material									Newcastle Univ, Sch Med, Sch Clin & Lab Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Self, CH (corresponding author), Newcastle Univ, Sch Med, Sch Clin & Lab Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	C.H.Self@ncl.ac.uk						Bodey B, 2000, CURR PHARM DESIGN, V6, P261, DOI 10.2174/1381612003401109; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Christiansen J, 2004, MOL CANCER THER, V3, P1493; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Levine MN, 2005, J CLIN ONCOL, V23, P7775, DOI 10.1200/JCO.2005.04.1558; Morrow KJ, 2005, GENET ENG NEWS, V25, P1; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Self CH, 1996, NAT MED, V2, P817, DOI 10.1038/nm0796-817; Smith KA, 2004, J CLIN PATHOL, V57, P912, DOI 10.1136/jcp.2003.014407; Stockwin LH, 2003, EXPERT OPIN BIOL TH, V3, P1133, DOI 10.1517/14712598.3.7.1133; Thompson JF, 2001, ANN SURG ONCOL, V8, P564, DOI 10.1245/aso.2001.8.7.564	11	12	16	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1038	1039		10.1016/S0140-6736(06)68396-7	http://dx.doi.org/10.1016/S0140-6736(06)68396-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581388				2022-12-28	WOS:000236673200009
J	Moore, KA; Lemischka, IR				Moore, KA; Lemischka, IR			Stem cells and their niches	SCIENCE			English	Review							HAIR FOLLICLE MORPHOGENESIS; LABEL-RETAINING CELLS; HEMATOPOIETIC STEM; BETA-CATENIN; SELF-RENEWAL; PROGENITOR CELLS; TRANSIENT ACTIVATION; DIFFERENTIATION; PROLIFERATION; EXPRESSION	A constellation of intrinsic and extrinsic cellular mechanisms regulates the balance of self-renewal and differentiation in all stem cells. Stem cells, their progeny, and elements of their microenvironment make up an anatomical structure that coordinates normal homeostatic production of functional mature cells. Here we discuss the stem cell niche concept, highlight recent progress, and identify important unanswered questions. We focus on three mammalian stem cell systems where large numbers of mature cells must be continuously produced throughout adult life: intestinal epithelium, epidermal structures, and bone marrow.	Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA	Princeton University	Moore, KA (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA.	kamoore@princeton.edu						Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Alonso L, 2003, P NATL ACAD SCI USA, V100, P11830, DOI 10.1073/pnas.1734203100; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Byun T, 2005, J CLIN PATHOL, V58, P515, DOI 10.1136/jcp.2004.018598; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Eckfeldt CE, 2005, NAT REV MOL CELL BIO, V6, P726, DOI 10.1038/nrm1713; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Giudicelli F, 2004, CURR OPIN GENET DEV, V14, P407, DOI 10.1016/j.gde.2004.06.014; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Joseph NM, 2005, DEV CELL, V9, P173, DOI 10.1016/j.devcel.2005.07.001; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	80	1138	1242	4	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1880	1885		10.1126/science.1110542	http://dx.doi.org/10.1126/science.1110542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574858				2022-12-28	WOS:000236387800033
J	Jansen, VAA; van Baalen, M				Jansen, VAA; van Baalen, M			Altruism through beard chromodynamics	NATURE			English	Article							GREEN BEARD; EVOLUTION; COOPERATION; SELECTION	The evolution of altruism, a behaviour that benefits others at one's own fitness expense, poses a darwinian paradox. The paradox is resolved if many interactions are with related individuals so that the benefits of altruism are reaped by copies of the altruistic gene in other individuals(1), a mechanism called kin selection(2). However, recognition of altruists could provide an alternative route towards the evolution of altruism(1,3-5). Arguably the simplest recognition system is a conspicuous, heritable tag, such as a green beard(1,3). Despite the fact that such genes have been reported(6-8), the 'green beard effect'(3) has often been dismissed because it is unlikely that a single gene can code for altruism and a recognizable tag(1,3,9). Here we model the green beard effect and find that if recognition and altruism are always inherited together, the dynamics are highly unstable, leading to the loss of altruism. In contrast, if the effect is caused by loosely coupled separate genes, altruism is facilitated through beard chromodynamics in which many beard colours co-occur. This allows altruism to persist even in weakly structured populations and implies that the green beard effect, in the form of a fluid association of altruistic traits with a recognition tag, can be much more prevalent than hitherto assumed.	Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England; Univ Paris 06, CNRS, UMR 7625, Lab Ecol ENS, F-75252 Paris 05, France	University of London; Royal Holloway University London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Jansen, VAA (corresponding author), Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England.	vincent.jansen@rhul.ac.uk; minus.van.baalen@ens.fr	van Baalen, Minus/J-9285-2012; Jansen, Vincent A A/C-8353-2009	van Baalen, Minus/0000-0002-3713-5967; Jansen, Vincent A.A./0000-0002-6518-2090				Axelrod R, 2004, EVOLUTION, V58, P1833; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BLAUSTEIN AR, 1983, AM NAT, V121, P749, DOI 10.1086/284101; Dawkins R., 1982, pi; Dawkins Richard, 1976, SELFISH GENE; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; Haig David, 1997, P284; Hamilton W.D., 1987, P417; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; Summers K, 2005, P ROY SOC B-BIOL SCI, V272, P643, DOI 10.1098/rspb.2004.2890; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; van Baalen M, 2003, P ROY SOC B-BIOL SCI, V270, P69, DOI 10.1098/rspb.2002.2151; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507	20	206	212	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					663	666		10.1038/nature04387	http://dx.doi.org/10.1038/nature04387			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572169	Green Submitted			2022-12-28	WOS:000236350400042
J	Ahmed, QA; Memish, ZA; Allegranzi, B; Pittet, D				Ahmed, QA; Memish, ZA; Allegranzi, B; Pittet, D		WHO Global Patient Safety Challeng	Muslim health-care workers and alcohol-based handrubs	LANCET			English	Editorial Material							INFECTION-CONTROL; HYGIENE		Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; Med Univ S Carolina, Div Pulm & Crit Care Med, Charleston, SC 29425 USA; King Fahad Natl Guard Hosp, King Abdulaziz Med City, Saudi Arabian Natl Guard Hlth Affairs, Adult Infect Dis Sect,Dept Med, Riyadh, Saudi Arabia; King Fahad Natl Guard Hosp, King Abdulaziz Med City, Saudi Arabian Natl Guard Hlth Affairs, Infect Prevent & Control Programme, Riyadh, Saudi Arabia; Univ Verona, Dept Infect Dis, I-37100 Verona, Italy; WHO, Global Patient Safety Challenge, World Alliance Patient Safety, WHO Headquarters, CH-1211 Geneva, Switzerland	University of Geneva; Medical University of South Carolina; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; National Guard Health Affairs - Saudi Arabia; King Abdulaziz Medical City; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; National Guard Health Affairs - Saudi Arabia; University of Verona; World Health Organization	Pittet, D (corresponding author), Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland.	didier.pittet@hcuge.ch	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				ALBERT RK, 1981, NEW ENGL J MED, V304, P1465, DOI 10.1056/NEJM198106113042404; BINABDULAZIZALM.M, 2001, ISLAMIC VERDICTS, V2, P26; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; *COUNC AM ISL REL, ISL AM MUSL; Douglas Mary, 1966, PURITY DANGER ANAL C, p[8, 41]; DOUTHAT R, 2005, ATLANTIC MONTHLY, V295, P58; HENLEY A, 1999, CULTURE RELIG PATIEN, P92; Hugonnet S, 2002, ARCH INTERN MED, V162, P1037, DOI 10.1001/archinte.162.9.1037; Jumaa PA, 2005, INT J INFECT DIS, V9, P3, DOI 10.1016/j.ijid.2004.05.005; Katme AM, 1999, BRIT MED J, V319, P520; Kretzer EK, 1998, AM J INFECT CONTROL, V26, P245, DOI 10.1016/S0196-6553(98)80008-4; Lankford MG, 2003, EMERG INFECT DIS, V9, P217; MARECHAL B, 2002, GUIDEBOOK ISLAM MUSL; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pittet D, 2000, INFECT CONT HOSP EP, V21, P381, DOI 10.1086/501777; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 1999, ANN INTERN MED, V130, P126, DOI 10.7326/0003-4819-130-2-199901190-00006; Pittet D, 2004, J HOSP INFECT, V58, P1, DOI 10.1016/j.jhin.2004.06.002; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Pittet D, 2003, LANCET INFECT DIS, V3, P269, DOI 10.1016/S1473-3099(03)00601-7; Pittet D, 2001, LANCET, P9; Pittet D, 2005, LANCET, V366, P1246, DOI 10.1016/S0140-6736(05)67506-X; ROBINSON BA, 2002, MANY MUSLIMS ARE US; Stone S, 2001, LANCET, V357, P479, DOI 10.1016/S0140-6736(05)71288-5; Teare L, 2001, BRIT MED J, V323, P411, DOI 10.1136/bmj.323.7310.411; Turner P, 2004, J HOSP INFECT, V56, P287, DOI 10.1016/j.jhin.2004.01.005; World Health Organization (WHO), WHO GUID HAND HYG HL; [No title captured]; 30 DAYS MUSLIM WORLD	29	60	62	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					1025	1027		10.1016/S0140-6736(06)68431-6	http://dx.doi.org/10.1016/S0140-6736(06)68431-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564366				2022-12-28	WOS:000236474200032
J	Falkowski, PG				Falkowski, PG			Evolution - Tracing oxygen's imprint on Earth's metabolic evolution	SCIENCE			English	Editorial Material							GENES		Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Falkowski, PG (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA.	falko@imcs.rutgers.edu						Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Blankenship RE, 2001, TRENDS PLANT SCI, V6, P4, DOI 10.1016/S1360-1385(00)01831-8; Falkowski P.G., 2013, AQUATIC PHOTOSYNTHES; FALKOWSKI PG, 2001, ENCY BIODIVERS, V1, P437, DOI DOI 10.1006/RWBD.1999.0030; FALKOWSKI PG, 2006, EVOLUTION AQUATIC PH; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Knoll AH, 2003, LIFE YOUNG PLANET 1; Lane N., 2004, OXYGEN MOL MADE WORL; MAUZERALL D, 1992, PHOTOSYNTH RES, V33, P163, DOI 10.1007/BF00039178; Nealson KH, 1999, PHILOS T R SOC B, V354, P1923, DOI 10.1098/rstb.1999.0532; Raymond J, 2006, SCIENCE, V311, P1764, DOI 10.1126/science.1118439; Shi T, 2005, MOL BIOL EVOL, V22, P2179, DOI 10.1093/molbev/msi216; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851	15	105	118	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1724	1725		10.1126/science.1125937	http://dx.doi.org/10.1126/science.1125937			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556831				2022-12-28	WOS:000236204300029
J	El-Jabali, F; Cohen, S				El-Jabali, F; Cohen, S			Talc retinopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ S Florida, Sch Med, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	El-Jabali, F (corresponding author), Univ S Florida, Sch Med, Tampa, FL 33612 USA.								0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					E11	E11		10.1056/NEJMicm050711	http://dx.doi.org/10.1056/NEJMicm050711			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554523				2022-12-28	WOS:000236164200009
J	Leonard, DC; Filippenko, AV; Ganeshalingam, M; Serduke, FJD; Li, WD; Swift, BJ; Gal-Yam, A; Foley, RJ; Fox, DB; Park, S; Hoffman, JL; Wong, DS				Leonard, DC; Filippenko, AV; Ganeshalingam, M; Serduke, FJD; Li, WD; Swift, BJ; Gal-Yam, A; Foley, RJ; Fox, DB; Park, S; Hoffman, JL; Wong, DS			A non-spherical core in the explosion of supernova SN 2004dj	NATURE			English	Article							IIP SUPERNOVA; SPECTROPOLARIMETRY; 1999EM; SPECTROSCOPY; POLARIZATION; PROGENITOR; PHOTOMETRY; SPECTRA; LIGHT	An important and perhaps critical clue to the mechanism driving the explosion of massive stars as supernovae is provided by the accumulating evidence for asymmetry in the explosion. Indirect evidence comes from high pulsar velocities(1), associations of supernovae with long-soft gamma-ray bursts(2,3), and asymmetries in late-time emission-line profiles(4). Spectropolarimetry provides a direct probe of young supernova geometry, with higher polarization generally indicating a greater departure from spherical symmetry(5,6). Large polarizations have been measured for 'stripped-envelope' (that is, type Ic; ref. 7) supernovae, which confirms their non-spherical morphology(8,9); but the explosions of massive stars with intact hydrogen envelopes(7,10) (type II-P supernovae) have shown only weak polarizations at the early times observed(11,12). Here we report multi-epoch spectropolarimetry of a classic type II-P supernova that reveals the abrupt appearance of significant polarization when the inner core is first exposed in the thinning ejecta (similar to 90 days after explosion). We infer a departure from spherical symmetry of at least 30 per cent for the inner ejecta. Combined with earlier results, this suggests that a strongly non-spherical explosion may be a generic feature of core-collapse supernovae of all types, where the asphericity in type II-P supernovae is cloaked at early times by the massive, opaque, hydrogen envelope.	CALTECH, Dept Astron, Pasadena, CA 91125 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	California Institute of Technology; University of California System; University of California Berkeley	Leonard, DC (corresponding author), San Diego State Univ, Dept Astron, San Diego, CA 92182 USA.	leonard@sciences.sdsu.edu		Fox, Derek/0000-0002-3714-672X; Hoffman, Jennifer/0000-0003-1495-2275; Foley, Ryan/0000-0002-2445-5275				Chatterjee S, 2005, ASTROPHYS J, V630, pL61, DOI 10.1086/491701; EASTMAN RG, 1994, ASTROPHYS J, V430, P300, DOI 10.1086/174404; Elmhamdi A, 2003, MON NOT R ASTRON SOC, V338, P939, DOI 10.1046/j.1365-8711.2003.06150.x; Filippenko AV, 1997, ANNU REV ASTRON ASTR, V35, P309, DOI 10.1146/annurev.astro.35.1.309; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; HOFLICH P, 1995, ASTROPHYS J, V440, P821, DOI 10.1086/175317; HOFLICH P, 1991, ASTRON ASTROPHYS, V246, P481; HOFLICH P, 1996, J ASTROPHYS J, V459, P307; HOFLICH P, 2001, 20 TEX S REL ASTR, P459; HOFLICH PA, 2003, P IAU S, V212, P387; JEFFERY DJ, 1991, ASTROPHYS J, V375, P264, DOI 10.1086/170187; Leonard DC, 2005, ASTROPHYS J, V632, P450, DOI 10.1086/432866; Leonard DC, 2002, PUBL ASTRON SOC PAC, V114, P35, DOI 10.1086/324785; Leonard DC, 2001, ASTROPHYS J, V553, P861, DOI 10.1086/320959; Leonard DC, 2001, PUBL ASTRON SOC PAC, V113, P920, DOI 10.1086/322151; LEONARD DC, 2005, SUPERNOVAE COSMOLOGI, P330; Li WD, 2005, PUBL ASTRON SOC PAC, V117, P121, DOI 10.1086/428278; Maeda K, 2002, ASTROPHYS J, V565, P405, DOI 10.1086/324487; MAEDER A, 1994, ANNU REV ASTRON ASTR, V32, P227; Matheson T, 2003, ASTROPHYS J, V599, P394, DOI 10.1086/379228; Mazzali PA, 2005, SCIENCE, V308, P1284, DOI 10.1126/science.1111384; NAKANO S, 2004, 8377 IAU; PATAT F, 2004, 8378 IAU; SHAPIRO PR, 1982, ASTROPHYS J, V263, P902, DOI 10.1086/160559; Wang LF, 2003, ASTROPHYS J, V592, P457, DOI 10.1086/375576; Wang XF, 2005, ASTROPHYS J, V626, pL89, DOI 10.1086/431903; Wheeler JC, 2002, ASTROPHYS J, V568, P807, DOI 10.1086/338953	30	147	148	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2006	440	7083					505	507		10.1038/nature04558	http://dx.doi.org/10.1038/nature04558			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554813	Green Accepted			2022-12-28	WOS:000236176100050
J	Craik, DJ				Craik, DJ			Chemistry - Seamless proteins tie up their loose ends	SCIENCE			English	Editorial Material							PEPTIDE; CYCLOTIDES		Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010	Craik, David/0000-0003-0007-6796				Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AM, 2004, CURR PROTEIN PEPT SC, V5, P373, DOI 10.2174/1389203043379657; Craik DJ, 2006, CURR OPIN DRUG DISC, V9, P251; Eisenbrandt R, 1999, J BIOL CHEM, V274, P22548, DOI 10.1074/jbc.274.32.22548; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1	13	243	254	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2006	311	5767					1563	1564		10.1126/science.1125248	http://dx.doi.org/10.1126/science.1125248			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543448				2022-12-28	WOS:000236029500031
J	Sazio, PJA; Amezcua-Correa, A; Finlayson, CE; Hayes, JR; Scheidemantel, TJ; Baril, NF; Jackson, BR; Won, DJ; Zhang, F; Margine, ER; Gopalan, V; Crespi, VH; Badding, JV				Sazio, PJA; Amezcua-Correa, A; Finlayson, CE; Hayes, JR; Scheidemantel, TJ; Baril, NF; Jackson, BR; Won, DJ; Zhang, F; Margine, ER; Gopalan, V; Crespi, VH; Badding, JV			Microstructured optical fibers as high-pressure microfluidic reactors	SCIENCE			English	Article							FIELD-EFFECT TRANSISTORS; PHOTONIC CRYSTAL FIBERS; WAVE-GUIDES; SILICON NANOWIRES; DEPOSITION; LOSSES; FILMS	Deposition of semiconductors and metals from chemical precursors onto planar substrates is a well-developed science and technology for microelectronics. Optical fibers are an established platform for both communications technology and fundamental research in photonics. Here, we describe a hybrid technology that integrates key aspects of both engineering disciplines, demonstrating the fabrication of tubes, solid nanowires, coaxial heterojunctions, and longitudinally patterned structures composed of metals, single-crystal semiconductors, and polycrystalline elemental or compound semiconductors within microstructured silica optical fibers. Because the optical fibers are constructed and the functional materials are chemically deposited in distinct and independent steps, the full design flexibilities of both platforms can now be exploited simultaneously for fiber-integrated optoelectronic materials and devices.	Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England; Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Penn State Univ, Dept Chem, University Pk, PA 16802 USA; Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA	University of Southampton; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Sazio, PJA (corresponding author), Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England.	pjas@orc.soton.ac.uk; jbadding@chem.psu.edu	Zhang, Feng/D-1450-2012; Badding, John/A-2737-2011	Badding, John/0000-0002-4517-830X; Margine, Elena Roxana/0000-0002-5573-9940; Finlayson, Chris/0000-0002-9068-7584; Sazio, Pier-John/0000-0002-6506-9266; Crespi, Vincent/0000-0003-3846-3193	Engineering and Physical Sciences Research Council [GR/S27771/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		ANASTASSAKIS E, 1987, J APPL PHYS, V62, P3346, DOI 10.1063/1.339296; Baudrier-Raybaut M, 2004, NATURE, V432, P374, DOI 10.1038/nature03027; Bayindir M, 2004, NATURE, V431, P826, DOI 10.1038/nature02937; Bogart TE, 2005, ADV MATER, V17, P114, DOI 10.1002/adma.200400373; Cabanas A, 2004, CHEM MATER, V16, P2028, DOI 10.1021/cm034739u; Duan XF, 2003, NATURE, V421, P241, DOI 10.1038/nature01353; Fokine M, 2002, OPT LETT, V27, P1643, DOI 10.1364/OL.27.001643; Foresi JS, 1996, APPL PHYS LETT, V68, P2052, DOI 10.1063/1.116300; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; Huang CC, 2004, OPT EXPRESS, V12, P2501, DOI 10.1364/OPEX.12.002501; Huang YY, 2004, APPL PHYS LETT, V85, P5182, DOI 10.1063/1.1828593; JONES AC, 1997, CVD COMPOUND SEMICON; Knight JC, 2003, NATURE, V424, P847, DOI 10.1038/nature01940; Koo SM, 2005, NANOTECHNOLOGY, V16, P1482, DOI 10.1088/0957-4484/16/9/011; Kumar GA, 2004, IEEE J QUANTUM ELECT, V40, P747, DOI 10.1109/JQE.2004.828263; Kuo YH, 2005, NATURE, V437, P1334, DOI 10.1038/nature04204; KURKJIAN CR, 1989, J LIGHTWAVE TECHNOL, V7, P1360, DOI 10.1109/50.50715; Lauhon LJ, 2002, NATURE, V420, P57, DOI 10.1038/nature01141; Liao L, 2000, J ELECTRON MATER, V29, P1380, DOI 10.1007/s11664-000-0122-4; Liu AS, 2004, NATURE, V427, P615, DOI 10.1038/nature02310; Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477; Meng ZG, 1997, J MATER RES, V12, P2548, DOI 10.1557/JMR.1997.0338; RICHARDSON DJ, 2005, P 2005 I EL EL ENG E; Roberts PJ, 2005, OPT EXPRESS, V13, P236, DOI 10.1364/OPEX.13.000236	24	379	388	1	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1583	1586		10.1126/science.1124281	http://dx.doi.org/10.1126/science.1124281			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543454				2022-12-28	WOS:000236029500038
J	Lesne, S; Koh, MT; Kotilinek, L; Kayed, R; Glabe, CG; Yang, A; Gallagher, M; Ashe, KH				Lesne, S; Koh, MT; Kotilinek, L; Kayed, R; Glabe, CG; Yang, A; Gallagher, M; Ashe, KH			A specific amyloid-beta protein assembly in the brain impairs memory	NATURE			English	Article							APP(SW) TRANSGENIC MICE; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; PRECURSOR PROTEIN; IN-VIVO; PLAQUES; AGE; OLIGOMERS; DEFICITS	Memory function often declines with age(1), and is believed to deteriorate initially because of changes in synaptic function rather than loss of neurons(2). Some individuals then go on to develop Alzheimer's disease with neurodegeneration. Here we use Tg2576 mice, which express a human amyloid-beta precursor protein ( APP) variant linked to Alzheimer's disease, to investigate the cause of memory decline in the absence of neurodegeneration or amyloid-beta protein amyloidosis. Young Tg2576 mice (< 6 months old) have normal memory and lack neuropathology, middle- aged mice ( 6 - 14 months old) develop memory deficits without neuronal loss, and old mice (> 14 months old) form abundant neuritic plaques containing amyloid-beta ( refs 3 - 6). We found that memory deficits in middle- aged Tg2576 mice are caused by the extracellular accumulation of a 56- kDa soluble amyloid-beta assembly, which we term A beta* 56 ( A beta star 56). A beta* 56 purified from the brains of impaired Tg2576 mice disrupts memory when administered to young rats. We propose that A beta*56 impairs memory independently of plaques or neuronal loss, and may contribute to cognitive deficits associated with Alzheimer's disease.	Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Grad Program Neurosci, Minneapolis, MN 55455 USA; Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; Minneapolis VA Med Ctr, Ctr Geriatr Res Educ & Clin, Minneapolis, MN 55417 USA; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ So Calif, Dept Pharmaceut Sci, Los Angeles, CA 90089 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of California System; University of California Irvine; University of Southern California	Ashe, KH (corresponding author), Univ Minnesota, Sch Med, Dept Neurol, Minneapolis, MN 55455 USA.	hsiao005@umn.edu		Lesne, Sylvain/0000-0001-9411-1868				Albert MS, 2002, ANN NEUROL, V51, P282, DOI 10.1002/ana.10156; Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Chen GQ, 2000, NATURE, V408, P975, DOI 10.1038/35050103; Craik F. I. M., 1977, HDB PSYCHOL AGING; Duff K, 2005, NAT MED, V11, P826, DOI 10.1038/nm0805-826; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GORDON JA, 1968, J BIOL CHEM, V243, P5663; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Irizarry MC, 1997, J NEUROPATH EXP NEUR, V56, P965, DOI 10.1097/00005072-199709000-00002; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kawas CH, 2003, NEUROLOGY, V60, P1089, DOI 10.1212/01.WNL.0000055813.36504.BF; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Orr HT, 2004, NATURE, V431, P747, DOI 10.1038/431747a; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sergeant N, 2002, J NEUROCHEM, V81, P663, DOI 10.1046/j.1471-4159.2002.00901.x; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002	28	2285	2375	79	485	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					352	357		10.1038/nature04533	http://dx.doi.org/10.1038/nature04533			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541076				2022-12-28	WOS:000235997600056
J	Marmot, MG				Marmot, MG			Status syndrome - A challenge to medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; EMPLOYMENT GRADE; MORTALITY		UCL, Dept Epidemiol & Publ Hlth, Int Inst Soc & Hlth, London WC1E 6BT, England	University of London; University College London	Marmot, MG (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Int Inst Soc & Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER; AHRQ HHS [HS06516] Funding Source: Medline; Medical Research Council [G19/35, G8802774, G0100222] Funding Source: Medline; NHLBI NIH HHS [HL36310] Funding Source: Medline; NIA NIH HHS [AG13196] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Acheson D., 1998, INEQUALITIES HLTH RE; Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Britton A, 2004, BMJ-BRIT MED J, V329, P318, DOI 10.1136/bmj.38156.690150.AE; Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD; CHANDOLA T, 2006, BMJ             0120, DOI DOI 10.1136/BMJ.38693.435301.80; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Erikson R, 2001, CRADLE GRAVE LIFE CO; Farmer P., 1999, INFECT INEQUALITIES; Hemingway H, 2005, CIRCULATION, V111, P3071, DOI 10.1161/CIRCULATIONAHA.104.497347; Kuper H, 2002, OCCUP ENVIRON MED, V59, P777, DOI 10.1136/oem.59.11.777; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Marmot M, 2004, STATUS SYNDROME; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; McDonough P, 1997, AM J PUBLIC HEALTH, V87, P1476, DOI 10.2105/AJPH.87.9.1476; MURRAY CJL, 1998, US PATTERNS MORTALIT, P1; Putnam R.D., 2000, BOWLING COLLAPSE REV; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Sen A, 1992, INEQUALITY RE EXAMIN; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; United Nations Development and Programme, 2005, HUMAN DEV REPORT 200; van Rossum CTM, 2000, J EPIDEMIOL COMMUN H, V54, P178, DOI 10.1136/jech.54.3.178; Williams D.R., 2001, AM BECOMING RACIAL T, P371; Willms JD, 1999, DEVELOPMENTAL HEALTH AND THE WEALTH OF NATIONS, P72	26	242	245	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2006	295	11					1304	1307		10.1001/jama.295.11.1304	http://dx.doi.org/10.1001/jama.295.11.1304			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021GV	16537740				2022-12-28	WOS:000235972600029
J	Boothroyd, RA; Banks, SM				Boothroyd, RA; Banks, SM			Assessing outcomes in individually-tailored interventions	LANCET			English	Editorial Material							CLINICALLY IMPORTANT CHANGE; ATTAINMENT; ADOLESCENTS; CHILDREN; CARE		Univ S Florida, Dept Mental Hlth Law & Policy, Louis de la Parte Florida Mental Hlth, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Boothroyd, RA (corresponding author), Univ S Florida, Dept Mental Hlth Law & Policy, Louis de la Parte Florida Mental Hlth, MHC 2719, Tampa, FL 33612 USA.	boothroyd@fmhi.usf.edu						Becker H, 2000, NURS RES, V49, P176, DOI 10.1097/00006199-200005000-00011; Bickman L, 2000, J CONSULT CLIN PSYCH, V68, P710, DOI 10.1037/0022-006X.68.4.710; Boothroyd Roger A, 2004, Ment Health Serv Res, V6, P143, DOI 10.1023/B:MHSR.0000036488.12833.6e; Bravo G, 2005, INT J QUAL HEALTH C, V17, P511, DOI 10.1093/intqhc/mzi064; CALSYN RJ, 1978, COMMUNITY MENT HLT J, V14, P300, DOI 10.1007/BF00778605; CYRYNBAUM S, 1979, EVAL Q, V3, P5; GOLDENBERG HJ, 1978, J CLIN PSYCHOL, V34, P732; Gordon JE, 1999, AGE AGEING, V28, P275, DOI 10.1093/ageing/28.3.275; GRENVILLE J, 1995, J ADV NURS, V22, P965; Kazdin AE, 2005, J CLIN CHILD ADOLESC, V34, P548, DOI 10.1207/s15374424jccp3403_10; Kiresuk T., 1994, GOAL ATTAINMENT SCAL; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; MacMillan HL, 2005, LANCET, V365, P1786, DOI 10.1016/S0140-6736(05)66388-X; MARSH EJ, 2005, J CLIN CHILD ADOLESC, V34, P362; Rockwood K, 1997, J CLIN EPIDEMIOL, V50, P581, DOI 10.1016/S0895-4356(97)00014-0; Rockwood K, 2002, J NEUROL NEUROSUR PS, V73, P500, DOI 10.1136/jnnp.73.5.500; Scriven M, 1973, SCH EVALUATION POLIT, P319; Shefler G, 2001, J CLIN PSYCHOL, V57, P971, DOI 10.1002/jclp.1063; Sladeczek IE, 2001, J EDUC PSYCHOL CONS, V12, P45, DOI 10.1207/S1532768XJEPC1201_03; Smith A, 1998, MED CARE, V36, P333, DOI 10.1097/00005650-199803000-00010; Stolee P, 1999, J AGING HEALTH, V11, P96, DOI 10.1177/089826439901100106	21	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					801	802		10.1016/S0140-6736(06)68317-7	http://dx.doi.org/10.1016/S0140-6736(06)68317-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021WL	16530563				2022-12-28	WOS:000236016500010
J	Helmy, KY; Katschke, KJ; Gorgani, NN; Elliott, JM; Diehl, L; Scales, SJ; Ghilardi, N; Campagne, MV				Helmy, KY; Katschke, KJ; Gorgani, NN; Elliott, JM; Diehl, L; Scales, SJ; Ghilardi, N; Campagne, MV			CRIg: A macrophage complement receptor required for phagocytosis of circulating pathogens	CELL			English	Article							IMMUNOGLOBULIN-LIKE DOMAINS; LISTERIA-MONOCYTOGENES; TRANSMEMBRANE PROTEINS; ALTERNATIVE PATHWAY; HUMAN NEUTROPHILS; DENDRITIC CELLS; KUPFFER CELLS; C3B RECEPTORS; 2 PARTS; LIVER	The complement system serves an important role in clearance of pathogens, immune complexes, and apoptotic cells present in the circulation. Complement fragments deposited on the particle surface serve as targets for complement receptors present on phagocytic cells. Although Kupffer cells, the liver resident macrophages, play a dominant role in clearing particles in circulation, complement receptors involved in this process have yet to be identified. Here we report the identification and characterization of a Complement Receptor of the Immunoglobulin superfamily, CRIg, that binds complement fragments C3b and iC3b. CRIg expression on Kupffer cells is required for efficient binding and phagocytosis of complement C3-opsonized particles. In turn, Kupffer cells from CRIg-deficient mice are unable to efficiently clear C3-opsonized pathogens in the circulation, resulting in increased infection and mortality of the host. CRIg therefore represents a dominant component of the phagocytic system responsible for rapid clearance of C3-opsonized particles from the circulation.	Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	menno@gene.com	Gorgani, Nick/GXF-5438-2022; Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283; Ghilardi, Nico/0000-0003-4945-3097				Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754; ARNAOUT MA, 1981, J IMMUNOL, V127, P1348; Austin CD, 2004, MOL BIOL CELL, V15, P5268, DOI 10.1091/mbc.E04-07-0591; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; BENACERRAF B, 1959, J EXP MED, V110, P27, DOI 10.1084/jem.110.1.27; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427; BRIONES V, 1992, AM J VET RES, V53, P191; BROWN EJ, 1991, CURR OPIN IMMUNOL, V3, P76, DOI 10.1016/0952-7915(91)90081-B; CARPENTIER JL, 1991, CELL REGUL, V2, P41, DOI 10.1091/mbc.2.1.41; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; COLTEN HR, 1992, ANNU REV IMMUNOL, V10, P809, DOI 10.1146/annurev.iy.10.040192.004113; CONLAN JW, 1994, J EXP MED, V179, P259, DOI 10.1084/jem.179.1.259; CROIZE J, 1993, INFECT IMMUN, V61, P5134, DOI 10.1128/IAI.61.12.5134-5139.1993; Cunnion KM, 2004, J LAB CLIN MED, V143, P358, DOI 10.1016/j.lab.2004.03.005; Dussurget O, 2004, ANNU REV MICROBIOL, V58, P587, DOI 10.1146/annurev.micro.57.030502.090934; Ebe Y, 1999, PATHOL INT, V49, P519, DOI 10.1046/j.1440-1827.1999.00910.x; Fang YF, 1998, J IMMUNOL, V160, P5273; FEARON DT, 1981, J EXP MED, V153, P1615, DOI 10.1084/jem.153.6.1615; GORDON DL, 1988, J INFECT DIS, V157, P697, DOI 10.1093/infdis/157.4.697; Gregory SH, 1996, J IMMUNOL, V157, P2514; Gregory SH, 2002, J IMMUNOL, V168, P308, DOI 10.4049/jimmunol.168.1.308; HAMMER CH, 1981, J BIOL CHEM, V256, P3995; HIRAKATA Y, 1991, INFECT IMMUN, V59, P289, DOI 10.1128/IAI.59.1.289-294.1991; HOLERS VM, 1992, IMMUNOL TODAY, V13, P231; HONG KS, 1991, J IMMUNOL, V146, P1868; Jelezarova E, 2003, J BIOL CHEM, V278, P51806, DOI 10.1074/jbc.M304613200; Langnaese K, 2000, BBA-GENE STRUCT EXPR, V1492, P522, DOI 10.1016/S0167-4781(00)00131-7; METLAY JP, 1990, J EXP MED, V171, P1753, DOI 10.1084/jem.171.5.1753; PANGBURN MK, 1980, J EXP MED, V152, P1102, DOI 10.1084/jem.152.4.1102; PINTO AJ, 1991, J LEUKOCYTE BIOL, V49, P579, DOI 10.1002/jlb.49.6.579; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; SENGELOV H, 1994, J IMMUNOL, V153, P804; Smith DK, 1997, J MOL BIOL, V274, P530, DOI 10.1006/jmbi.1997.1432; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Walker MG, 2002, BBA-GENE STRUCT EXPR, V1574, P387, DOI 10.1016/S0167-4781(01)00358-X; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wu HZ, 2003, INFECT IMMUN, V71, P5986, DOI 10.1128/IAI.71.10.5986-5993.2003	46	373	403	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					915	927		10.1016/j.cell.2005.12.039	http://dx.doi.org/10.1016/j.cell.2005.12.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530040	Bronze			2022-12-28	WOS:000237241200015
J	Nam, Y; Sliz, P; Song, LY; Aster, JC; Blacklow, SC				Nam, Y; Sliz, P; Song, LY; Aster, JC; Blacklow, SC			Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes	CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LEUKEMIA; KAPPA-B COMPLEX; CRYSTAL-STRUCTURE; ANKYRIN DOMAIN; MAMMALIAN NOTCH; C-ELEGANS; ALAGILLE-SYNDROME; HUMAN HOMOLOG; HUMAN JAGGED1	Notch receptors transduce essential developmental signals between neighboring cells by forming a complex that leads to transcription of target genes upon activation. We report here the crystal structure of a Notch transcriptional activation complex containing the ankyrin domain of human Notch1 (ANK), the transcription factor CSL on cognate DNA, and a polypeptide from the coactivator Mastermind-like-1 (MAML-1). Together, CSL and ANK create a groove to bind the MAML-1 polypeptide as a kinked, 70 A helix. The composite binding surface likely restricts the recruitment of MAML proteins to promoters on which Notch:CSL complexes have been preassembled, ensuring tight transcriptional control of Notch target genes.	Harvard Univ, Sch Med, Biol & Biomed Sci Grad Program, Div Med Sci, Boston, MA 02115 USA; Howard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard University; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Blacklow, SC (corresponding author), Harvard Univ, Sch Med, Biol & Biomed Sci Grad Program, Div Med Sci, Boston, MA 02115 USA.	sblacklow@rics.bwh.harvard.edu		Nam, Yunsun/0000-0002-7939-8626; Sliz, Piotr/0000-0002-6522-0835	NCI NIH HHS [R01 CA119130-01, R01 CA119130, R01 CA092433-02, R01 CA092433-03, CA92433, R01 CA092433, R01 CA092433-02S1, CA119130, R01 CA092433-04, R01 CA092433-01A1] Funding Source: Medline; NCRR NIH HHS [P41 RR012408, P41 RR012408-108514] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R56CA092433, R01CA092433] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; KODOYIANNI V, 1992, MOL BIOL CELL, V3, P1199, DOI 10.1091/mbc.3.11.1199; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lubman OY, 2005, PROTEIN SCI, V14, P1274, DOI 10.1110/ps.041184105; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Nettles KW, 2005, ANNU REV PHYSIOL, V67, P309, DOI 10.1146/annurev.physiol.66.032802.154710; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Roehl H, 1996, EMBO J, V15, P7002, DOI 10.1002/j.1460-2075.1996.tb01092.x; ROEHL H, 1993, NATURE, V364, P632, DOI 10.1038/364632a0; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tani S, 2001, NUCLEIC ACIDS RES, V29, P1373, DOI 10.1093/nar/29.6.1373; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003	54	335	368	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					973	983		10.1016/j.cell.2005.12.037	http://dx.doi.org/10.1016/j.cell.2005.12.037			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530044	Bronze			2022-12-28	WOS:000237241200019
J	Wickless, SC; Shwayder, TA				Wickless, SC; Shwayder, TA			A medical mystery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Oakwood Hlth Syst, Dearborn, MI 48124 USA; Henry Ford Hlth Syst, Detroit, MI 48202 USA	Beaumont Health; Henry Ford Health System; Henry Ford Hospital	Wickless, SC (corresponding author), Oakwood Hlth Syst, Dearborn, MI 48124 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2004	351	15					1547	1547		10.1056/NEJMicm040304	http://dx.doi.org/10.1056/NEJMicm040304			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	859UP	16541560				2022-12-28	WOS:000224293700013
J	Zimmermann, TS; Lee, ACH; Akinc, A; Bramlage, B; Bumcrot, D; Fedoruk, MN; Harborth, J; Heyes, JA; Jeffs, LB; John, M; Judge, AD; Lam, K; McClintock, K; Nechev, LV; Palmer, LR; Racie, T; Rohl, I; Seiffert, S; Shanmugam, S; Sood, V; Soutschek, J; Toudjarska, I; Wheat, AJ; Yaworski, E; Zedalis, W; Koteliansky, V; Manoharan, M; Vornlocher, HP; MacLachlan, I				Zimmermann, TS; Lee, ACH; Akinc, A; Bramlage, B; Bumcrot, D; Fedoruk, MN; Harborth, J; Heyes, JA; Jeffs, LB; John, M; Judge, AD; Lam, K; McClintock, K; Nechev, LV; Palmer, LR; Racie, T; Rohl, I; Seiffert, S; Shanmugam, S; Sood, V; Soutschek, J; Toudjarska, I; Wheat, AJ; Yaworski, E; Zedalis, W; Koteliansky, V; Manoharan, M; Vornlocher, HP; MacLachlan, I			RNAi-mediated gene silencing in non-human primates	NATURE			English	Article							INTERFERING RNA; MODIFIED SIRNAS; PHARMACOKINETICS; CHOLESTEROL; INHIBITION; POTENT; MICE; CELL	The opportunity to harness the RNA interference (RNAi) pathway to silence disease-causing genes holds great promise for the development of therapeutics directed against targets that are otherwise not addressable with current medicines(1,2). Although there are numerous examples of in vivo silencing of target genes after local delivery of small interfering RNAs (siRNAs)(3-5), there remain only a few reports of RNAi-mediated silencing in response to systemic delivery of siRNA(6-8), and there are no reports of systemic efficacy in non-rodent species. Here we show that siRNAs, when delivered systemically in a liposomal formulation, can silence the disease target apolipoprotein B (ApoB) in non-human primates. APOB-specific siRNAs were encapsulated in stable nucleic acid lipid particles (SNALP) and administered by intravenous injection to cynomolgus monkeys at doses of 1 or 2.5 mg kg(-1). A single siRNA injection resulted in dose-dependent silencing of APOB messenger RNA expression in the liver 48 h after administration, with maximal silencing of >90%. This silencing effect occurred as a result of APOB mRNA cleavage at precisely the site predicted for the RNAi mechanism. Significant reductions in ApoB protein, serum cholesterol and low-density lipoprotein levels were observed as early as 24 h after treatment and lasted for 11 days at the highest siRNA dose, thus demonstrating an immediate, potent and lasting biological effect of siRNA treatment. Our findings show clinically relevant RNAi-mediated gene silencing in non-human primates, supporting RNAi therapeutics as a potential new class of drugs.	Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; Protiva Biotherapeut Inc, Burnaby, BC V5G 4Y1, Canada; Alnylam Europe AG, D-95326 Kulmbach, Germany		Zimmermann, TS (corresponding author), Alnylam Pharmaceut Inc, 300 3rd St, Cambridge, MA 02142 USA.	tzimmermann@alnylam.com; ian@protivabio.com		Fedoruk, Matthew/0000-0002-9553-9476				Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; CHONN A, 1991, J IMMUNOL, V146, P4234; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Lennernas H, 1997, CLIN PHARMACOKINET, V32, P403, DOI 10.2165/00003088-199732050-00005; Levin AA, 1999, BBA-GENE STRUCT EXPR, V1489, P69, DOI 10.1016/S0167-4781(99)00140-2; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Shankar P, 2005, JAMA-J AM MED ASSOC, V293, P1367, DOI 10.1001/jama.293.11.1367; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101	19	1094	1344	8	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					111	114		10.1038/nature04688	http://dx.doi.org/10.1038/nature04688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16565705				2022-12-28	WOS:000237248600043
J	Friedman, RA				Friedman, RA			The changing face of teenage drug abuse - The trend toward prescription drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Weill Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA	Cornell University	Friedman, RA (corresponding author), Weill Cornell Med Coll, Psychopharmacol Clin, New York, NY 10021 USA.							DOE J, 2005, COUNTER DIVERSION AB; *IMS HLTH, 2004, INT PROM SERV CMR; JOHNSTON LD, 2005, IN PRESS MONITORING; *OFF APPL STUD, 2005, NSDUH SER H, V28; *PHARM RES MAN AM, 2004, PHRMA ANN MEMB SURV	5	82	82	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1448	1450		10.1056/NEJMp068010	http://dx.doi.org/10.1056/NEJMp068010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	029DP	16598042				2022-12-28	WOS:000236539000002
J	Shubin, NH; Daeschler, EB; Jenkins, FA				Shubin, NH; Daeschler, EB; Jenkins, FA			The pectoral fin of Tiktaalik roseae and the origin of the tetrapod limb	NATURE			English	Article							DEVONIAN TETRAPOD; POLYODON-SPATHULA; NORTH-AMERICA; PAIRED FINS; EVOLUTION; SARCOPTERYGII; OSTEICHTHYES; EXPRESSION; SKELETON; FOSSILS	Wrists, ankles and digits distinguish tetrapod limbs from fins, but direct evidence on the origin of these features has been unavailable. Here we describe the pectoral appendage of a member of the sister group of tetrapods, Tiktaalik roseae, which is morphologically and functionally transitional between a fin and a limb. The expanded array of distal endochondral bones and synovial joints in the fin of Tiktaalik is similar to the distal limb pattern of basal tetrapods. The fin of Tiktaalik was capable of a range of postures, including a limb-like substrate-supported stance in which the shoulder and elbow were flexed and the distal skeleton extended. The origin of limbs probably involved the elaboration and proliferation of features already present in the fins of fish such as Tiktaalik.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Chicago; Drexel University; Harvard University; Harvard University	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu						Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; AHLBERG PE, 1989, ZOOL J LINN SOC-LOND, V96, P119, DOI 10.1111/j.1096-3642.1989.tb01824.x; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; [Anonymous], 1992, FOSSIL FISHES LIVING; CAPDEVILIA J, 2001, PERSPECTIVES EVOLUTI, P531; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Coates MI, 2002, EVOL DEV, V4, P390, DOI 10.1046/j.1525-142X.2002.02026.x; Daeschler EB, 1998, NATURE, V391, P133, DOI 10.1038/34317; DAESCHLER EB, 1994, SCIENCE, V265, P639, DOI 10.1126/science.265.5172.639; Davis MC, 2004, J MORPHOL, V262, P608, DOI 10.1002/jmor.10264; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; Mabee PM, 2004, J MORPHOL, V261, P334, DOI 10.1002/jmor.10253; Metscher BD, 2005, EVOL DEV, V7, P186, DOI 10.1111/j.1525-142X.2005.05021.x; Schultze Hans-Peter, 1996, P316; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P292; SHUBIN N, 1995, EVOL BIOL, V28, P39; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; SHUBIN NH, 1986, EVOL BIOL, V20, P319; Sordino P, 1996, TRENDS ECOL EVOL, V11, P114, DOI 10.1016/0169-5347(96)81089-5; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Vorobyeva E., 1991, P68; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x; VOROBYEVA EI, 1992, J COMM BIOL, V53, P149; Vorobyeva Emilia I., 1995, Geobios Memoire Special (Villeurbanne), V19, P285; Wagner GR, 2001, J EXP ZOOL, V291, P226, DOI 10.1002/jez.1100; Zakany J, 1997, P NATL ACAD SCI USA, V94, P13695, DOI 10.1073/pnas.94.25.13695	32	226	236	13	334	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					764	771		10.1038/nature04637	http://dx.doi.org/10.1038/nature04637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598250				2022-12-28	WOS:000236548400034
J	Jones, V; Grey, JE; Harding, KG				Jones, V; Grey, JE; Harding, KG			ABC of wound healing - Wound dressings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Cardiff Univ, Wound Healing Res Unit, Cardiff, Wales; Univ Wales Hosp, Cardiff & Vale NHS Trust, Cardiff, Wales	Cardiff University; Cardiff University	Jones, V (corresponding author), Cardiff Univ, Wound Healing Res Unit, Cardiff, Wales.	Joseph.gre@cardiffandvale.wales.nhs.uk	Harding, Keith/J-5605-2013	Harding, Keith/0000-0003-0048-3279				Choucair M., 1998, SKIN AGEING S, V6, P37; Hermans M H E, 1993, J Wound Care, V2, P362; Morgan DA, 1999, PHARM J, V263, P820; THOMAS S, 1998, WOUNDS BIOL MANAGEME, P166; Turner TD, 2001, CHRONIC WOUND CARE C; Ubbink DT, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004001.pub2; WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0	7	259	270	3	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					777	780		10.1136/bmj.332.7544.777	http://dx.doi.org/10.1136/bmj.332.7544.777			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032JA	16575081	Green Published			2022-12-28	WOS:000236769500026
J	Coleman, ML; Sullivan, MB; Martiny, AC; Steglich, C; Barry, K; DeLong, EF; Chisholm, SW				Coleman, ML; Sullivan, MB; Martiny, AC; Steglich, C; Barry, K; DeLong, EF; Chisholm, SW			Genomic islands and the ecology and evolution of Prochlorococcus	SCIENCE			English	Article							NORTH-ATLANTIC OCEAN; ESCHERICHIA-COLI; ECOTYPES; TEMPERATURE; EXPRESSION; ABUNDANCES; GENOTYPES; VIRUSES; GENES; LIGHT	Prochlorococcus ecotypes are a useful system for exploring the origin and function of diversity among closely related microbes. The genetic variability between phenotypically distinct strains that differ by less that 1% in 16S ribosomal RNA sequences occurs mostly in genomic islands. Island genes appear to have been acquired in part by phage-mediated lateral gene transfer, and some are differentially expressed under light and nutrient stress. Furthermore, genome fragments directly recovered from ocean ecosystems indicate that these islands are variable among co-occurring Prochlorococcus cells. Genomic islands in this free-living photoautotroph share features with pathogenicity islands of parasitic bacteria, suggesting a general mechanism for niche differentiation in microbial species.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; US DOE, Joint Genome Inst, Prod Genom Facil, Walnut Creek, CA 94598 USA	Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, 15 Vassar St, Cambridge, MA 02139 USA.	chisholm@mit.edu	chen, qi/C-8585-2011; Barry, Kerrie Whitelaw/AAA-5500-2020; Martiny, Adam/AAC-4459-2019; Sullivan, Matthew B/H-3256-2011	Barry, Kerrie Whitelaw/0000-0002-8999-6785; Martiny, Adam/0000-0003-2829-4314; Sullivan, Matthew B/0000-0003-4040-9831; Coleman, Maureen/0000-0001-5065-0106; Chisholm, Sallie/0000-0003-1480-2445				Ahlgren NA, 2006, ENVIRON MICROBIOL, V8, P441, DOI 10.1111/j.1462-2920.2005.00910.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dufresne A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r14; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; REITER WD, 1989, NUCLEIC ACIDS RES, V17, P1907, DOI 10.1093/nar/17.5.1907; Riehle MM, 2003, PHYSIOL GENOMICS, V14, P47, DOI 10.1152/physiolgenomics.00034.2002; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; West NJ, 2001, MICROBIOL-SGM, V147, P1731, DOI 10.1099/00221287-147-7-1731; Wright A, 1980, VIRUS RECEPTORS 1, P27; Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006	24	331	345	3	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1768	1770		10.1126/science.1122050	http://dx.doi.org/10.1126/science.1122050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556843	Green Submitted			2022-12-28	WOS:000236204300043
J	Duthie, C; Gibbs, G; Burns, KC				Duthie, C; Gibbs, G; Burns, KC			Seed dispersal by weta	SCIENCE			English	Article									Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Victoria University Wellington	Burns, KC (corresponding author), Victoria Univ Wellington, Sch Biol Sci, POB 600, Wellington, New Zealand.	kevin.burns@vuw.ac.nz		Burns, K.C./0000-0002-4938-2877				Amico G, 2000, NATURE, V408, P929, DOI 10.1038/35050170; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; Darwin Charles., 1866, ORIGIN SPECIES; Gibbs G., 2001, NZ WETA; Vulinec K, 2002, BIOTROPICA, V34, P297, DOI 10.1111/j.1744-7429.2002.tb00541.x; Williams PA, 2000, AUSTRAL ECOL, V25, P523, DOI 10.1046/j.1442-9993.2000.01078.x	6	51	54	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1575	1575		10.1126/science.1123544	http://dx.doi.org/10.1126/science.1123544			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543452				2022-12-28	WOS:000236029500035
J	Lee, JW; Helmann, JD				Lee, JW; Helmann, JD			The PerR transcription factor senses H2O2 by metal-catalysed histidine oxidation	NATURE			English	Article							BACILLUS-SUBTILIS; PEROXIDE STRESS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; 2-OXO-HISTIDINE; INTEGRATION; REGULATOR; REPRESSOR; PROTEINS; RESIDUES	The sensing of reactive oxygen species is essential for cellular responses to oxidative stress(1). The sensing of peroxides is typically mediated by redox- active cysteines in sensors such as the bacterial OxyR, OhrR, and Hsp33 proteins(2,3). Bacillus subtilis PerR is the prototype for a widespread family of metal- dependent peroxide sensors that regulate inducible peroxide- defence genes(4). Here we show that PerR senses peroxides by metal- catalysed oxidation. PerR contains two metal- binding sites: a structural Zn2+ site and a regulatory divalent metal ion site that preferentially binds Fe2+ or Mn2+ ( ref. 5). Protein oxidation, catalysed by a bound ferrous ion, leads to the rapid and direct incorporation of one oxygen atom into histidine 37 ( H37) or H91, two of the residues that coordinate the bound Fe2+. This mechanism accounts for the ability of PerR to sense low levels of hydrogen peroxide in vivo. The reduction of hydrogen peroxide by metal ions to generate highly reactive hydroxyl radicals underlies the genotoxic effects of peroxides(1), and has been shown to contribute to enzyme inactivation, but has not previously been shown to provide a regulatory mechanism for peroxide sensing.	Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	Cornell University	Helmann, JD (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	jdh9@cornell.edu	LEE, JIN-WON/L-1116-2016	LEE, JIN-WON/0000-0002-1201-8254; Helmann, John/0000-0002-3832-3249				Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; Berlett BS, 2001, P NATL ACAD SCI USA, V98, P451, DOI 10.1073/pnas.021552298; CHEN L, 1995, P NATL ACAD SCI USA, V92, P8190, DOI 10.1073/pnas.92.18.8190; Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Hahn JS, 2000, J BIOL CHEM, V275, P38254, DOI 10.1074/jbc.M006079200; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jewett SL, 1999, FREE RADICAL BIO MED, V26, P905, DOI 10.1016/S0891-5849(98)00274-3; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; Kiley PJ, 2004, PLOS BIOL, V2, P1714, DOI 10.1371/journal.pbio.0020400; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Lucana DOD, 2003, MOL GENET GENOMICS, V268, P618, DOI 10.1007/s00438-002-0776-0; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mongkolsuk S, 2002, MOL MICROBIOL, V45, P9, DOI 10.1046/j.1365-2958.2002.03015.x; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Pohl E, 2003, MOL MICROBIOL, V47, P903, DOI 10.1046/j.1365-2958.2003.03337.x; Schoneich C, 2002, CHEM RES TOXICOL, V15, P717, DOI 10.1021/tx025504k; Schoneich C, 2000, J PHARMACEUT BIOMED, V21, P1093, DOI 10.1016/S0731-7085(99)00182-X; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Toledano MB, 2004, TRENDS BIOCHEM SCI, V29, P351, DOI 10.1016/j.tibs.2004.05.005; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; UCHIDA K, 1993, FEBS LETT, V332, P208, DOI 10.1016/0014-5793(93)80632-5; Wright AF, 2004, NAT GENET, V36, P1153, DOI 10.1038/ng1448	27	411	422	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					363	367		10.1038/nature04537	http://dx.doi.org/10.1038/nature04537			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541078				2022-12-28	WOS:000235997600058
J	Schreijer, AJM; Cannegieter, SC; Meijers, JCM; Middeldorp, S; Buller, HR; Rosendaal, FR				Schreijer, AJM; Cannegieter, SC; Meijers, JCM; Middeldorp, S; Buller, HR; Rosendaal, FR			Activation of coagulation system during air travel: a crossover study	LANCET			English	Article							LONG-HAUL FLIGHTS; PULMONARY-EMBOLISM; ORAL-CONTRACEPTIVES; BIOCHEMICAL MARKERS; HUMAN-BEINGS; THROMBOSIS; HYPOXIA	Background There is an increased risk of venous thrombosis after air travel, but the underlying mechanism is unclear. Our aim was to ascertain whether flying leads to a hypercoagulable state. Methods We did a crossover study in 71 healthy volunteers (15 men, 56 women), in whom we measured markers of activation of coagulation and fibrinolysis before, during, and after an 8-h flight. The same individuals participated in two control exposure situations (8-h movie marathon and daily life) to separate the effect of air travel on the coagulation system from those of immobilisation and circadian rhythm. To study the effect of risk factors for thrombosis, we included participants with the factor V Leiden mutation (n=11), those who took oral contraceptives (n=15), or both (n=15), as well as 30 individuals with no specific risk factors. Findings After the flight, median concentrations of thrombin-antithrombin (TAT) complex increased by 30.1% (95% CI 11.2-63.2), but decreased by 2.1% (-11.2 to 14) after the cinema and by 7.9% (-16.2 to -1.2) after the daily life situation. We recorded a high response in TAT levels in 17% (11 of 66) of individuals after air travel (3% [2 of 68] for movie marathon; 1% [1 of 70] in daily life). These findings were most evident in the group with the factor V Leiden mutation who used oral contraceptives. We noted a high response in all variables (prothrombin fragment 1 and 2, TAT, and D-dimer) in four of 63 (6.3%) volunteers after the flight, but in no-one after either of the control situations. Interpretation Activation of coagulation occurs in some individuals after an 8-h flight, indicating an additional mechanism to immobilisation underlying air travel related thrombosis.	Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Haematol, NL-2300 RC Leiden, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Rosendaal, FR (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands.	f.r.rosendaal@lumc.nl	Rosendaal, Frits/Q-3842-2017; Cannegieter, Suzanne/W-3696-2019; Meijers, J.C.M./S-5981-2019; Middeldorp, Saskia/ABI-8197-2020	Rosendaal, Frits/0000-0003-2558-7496; Cannegieter, Suzanne/0000-0003-4707-2303; Meijers, J.C.M./0000-0002-4198-6780; Middeldorp, Saskia/0000-0002-1006-6420				Bartsch T, 2001, LANCET, V357, P955; Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; Boccalon H, 2005, J THROMB HAEMOST, V3, P1539, DOI 10.1111/j.1538-7836.2005.01469.x; Crosby A, 2003, LANCET, V361, P2207, DOI 10.1016/S0140-6736(03)13777-4; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; Jacobson BF, 2003, SAMJ S AFR MED J, V93, P522; Kelman CW, 2003, BRIT MED J, V327, P1072, DOI 10.1136/bmj.327.7423.1072; Kemmeren JM, 2004, BLOOD, V103, P927, DOI 10.1182/blood-2003-04-1285; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; Martinelli I, 2003, ARCH INTERN MED, V163, P2771, DOI 10.1001/archinte.163.22.2771; Perez-Rodriguez E, 2003, ARCH INTERN MED, V163, P2766, DOI 10.1001/archinte.163.22.2766; Schobersberger W, 2004, BLOOD COAGUL FIBRIN, V15, P419, DOI 10.1097/01.mbc.0000114438.81125.cf; Schobersberger W, 2002, THROMB RES, V108, P19, DOI 10.1016/S0049-3848(02)00347-X; Schwarz T, 2003, ARCH INTERN MED, V163, P2759, DOI 10.1001/archinte.163.22.2759; Simons R, 1996, LANCET, V348, P416, DOI 10.1016/S0140-6736(05)65046-5; Stricker H, 2003, J THROMB HAEMOST, V1, P380, DOI 10.1046/j.1538-7836.2003.00047.x	16	116	122	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					832	838		10.1016/S0140-6736(06)68339-6	http://dx.doi.org/10.1016/S0140-6736(06)68339-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530577	Green Submitted			2022-12-28	WOS:000236016500028
J	Patsopoulos, NA; Analatos, AA; Ioannidis, JPA				Patsopoulos, NA; Analatos, AA; Ioannidis, JPA			Origin and funding of the most frequently cited papers in medicine: database analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONFLICTS-OF-INTEREST; INDUSTRY; IMPACT; CITATION; BUDGET	Objective To evaluate changes in the role of academics and the sources of funding for the medical research cited most frequently over the past decade. Design Database analysis. Data sources Web of Knowledge database. Methods For each year from 1994 to 2003, articles in the domain of clinical medicine that had been cited most often by the end of 2004 were identified. Changes in author's affiliations and funding sources were evaluated. Results Of the 289 frequently cited articles, most had at least one author with a university (76%) or hospital (57%) affiliation, and the proportion of articles with each type of affiliation was constant over time. Government or public funding was most common (60% of articles), followed by industry (36%). The proportion of most frequently cited articles funded by industry increased over time (odds ratio 1.17 per year, P = 0.001) and was equal to the proportion funded by government or public sources by 2001. 65 of the 77 most cited randomised controlled trials received funding from industry, and the proportion increased significantly over time (odds ratio 1.59 per year, P = 0.003). 18 of the 32 most cited trials published after 1999 were funded by industry alone. Conclusion Academic affiliations remain prominent among the authors of the most frequently cited medical research. Such research is increasingly funded by industry, often exclusively so. Academics may be losing control of the clinical research agenda.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; Univ Thessaly, Sch Med, Larisa, Greece	University of Ioannina; University of Thessaly	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011; Analatos, Apostolos/AAF-1257-2020	Patsopoulos, Nikolaos/0000-0003-3757-8941				Awasthi S, 2005, PLOS MED, V2, P606, DOI 10.1371/journal.pmed.0020207; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Boyd EA, 2000, JAMA-J AM MED ASSOC, V284, P2209, DOI 10.1001/jama.284.17.2209; Clark J, 2004, BMJ-BRIT MED J, V329, P751, DOI 10.1136/bmj.329.7469.751; Crowley WF, 2004, JAMA-J AM MED ASSOC, V291, P1120, DOI 10.1001/jama.291.9.1120; Danforth W, 2003, ACAD MED, V78, P237; Dickersin K, 2002, JAMA-J AM MED ASSOC, V287, P2772, DOI 10.1001/jama.287.21.2772; DICKERSIN K, 2002, JAMA-J AM MED ASSOC, V287, P272; Egger M, 2001, BRIT MED J, V323, P1253, DOI 10.1136/bmj.323.7323.1253a; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; Ioannidis JP, 2004, J TRANSL MED, V2, P5, DOI DOI 10.1186/1479-5876-2-5; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2004, BMJ-BRIT MED J, V329, P789; Isaakidis P, 2002, BRIT MED J, V324, P702, DOI 10.1136/bmj.324.7339.702; Johns MME, 2003, JAMA-J AM MED ASSOC, V289, P741, DOI 10.1001/jama.289.6.741; Kaiser J, 2005, SCIENCE, V307, P1023; Korn D, 2002, SCIENCE, V296, P1401, DOI 10.1126/science.1072486; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Smith R, 2005, PLOS MED, V2, P364, DOI 10.1371/journal.pmed.0020138.g001; Smith R, 2005, PLOS MED, V2, P821, DOI 10.1371/journal.pmed.0020241; Tyers M, 2005, SCIENCE, V308, P1867; Wilkinson D, 2004, BMJ-BRIT MED J, V329, P787	23	113	116	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1061	1063		10.1136/bmj.38768.420139.80	http://dx.doi.org/10.1136/bmj.38768.420139.80			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16547014	Bronze, Green Published			2022-12-28	WOS:000237518400015
J	Ogden, CL; Carroll, MD; Curtin, LR; McDowell, MA; Tabak, CJ; Flegal, KM				Ogden, CL; Carroll, MD; Curtin, LR; McDowell, MA; Tabak, CJ; Flegal, KM			Prevalence of overweight and obesity in the United States, 1999-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							US CHILDREN; TRENDS; ADOLESCENTS; UNDERWEIGHT; ADULTS; CHINA	Context The prevalence of overweight in children and adolescents and obesity in adults in the United States has increased over several decades. Objective To provide current estimates of the prevalence and trends of overweight in children and adolescents and obesity in adults. Design, Setting, and Participants Analysis of height and weight measurements from 3958 children and adolescents aged 2 to 19 years and 4431 adults aged 20 years or older obtained in 2003-2004 as part of the National Health and Nutrition Examination Survey ( NHANES), a nationally representative sample of the US population. Data from the NHANES obtained in 1999-2000 and in 2001-2002 were compared with data from 2003-2004. Main Outcome Measures Estimates of the prevalence of overweight in children and adolescents and obesity in adults. Overweight among children and adolescents was defined as at or above the 95th percentile of the sex-specific body mass index (BMI) for age growth charts. Obesity among adults was defined as a BMI of 30 or higher; extreme obesity was defined as a BMI of 40 or higher. Results In 2003-2004, 17.1% of US children and adolescents were overweight and 32.2% of adults were obese. Tests for trend were significant for male and female children and adolescents, indicating an increase in the prevalence of overweight in female children and adolescents from 13.8% in 1999-2000 to 16.0% in 2003-2004 and an increase in the prevalence of overweight in male children and adolescents from 14.0% to 18.2%. Among men, the prevalence of obesity increased significantly between 1999-2000 (27.5%) and 2003-2004 (31.1%). Among women, no significant increase in obesity was observed between 1999-2000 (33.4%) and 2003-2004 (33.2%). The prevalence of extreme obesity ( body mass index >= 40) in 2003-2004 was 2.8% in men and 6.9% in women. In 2003-2004, significant differences in obesity prevalence remained by race/ethnicity and by age. Approximately 30% of non-Hispanic white adults were obese as were 45.0% of non-Hispanic black adults and 36.8% of Mexican Americans. Among adults aged 20 to 39 years, 28.5% were obese while 36.8% of adults aged 40 to 59 years and 31.0% of those aged 60 years or older were obese in 2003-2004. Conclusions The prevalence of overweight among children and adolescents and obesity among men increased significantly during the 6-year period from 1999 to 2004; among women, no overall increases in the prevalence of obesity were observed. These estimates were based on a 6-year period and suggest that the increases in body weight are continuing in men and in children and adolescents while they may be leveling off in women.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA	Ogden, CL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4414, Hyattsville, MD 20782 USA.	Cogden@cdc.gov	Flegal, Katherine M/A-4608-2013; Bannuru, Raveendhara/G-2601-2011	Bannuru, Raveendhara/0000-0002-8069-5783; Flegal, Katherine/0000-0002-0838-469X				Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Guo, 2002, VITAL HLTH STAT, V11, DOI DOI 10.1016/J.BBRC.2015.06.114; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Luo J, 2002, INT J OBESITY, V26, P553, DOI 10.1038/sj.ijo.0801944; *NIH, 1998, OBES RES, V6, P464; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Silventoinen K, 2004, INT J OBESITY, V28, P710, DOI 10.1038/sj.ijo.0802614; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971	14	6597	6753	10	777	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1549	1555		10.1001/jama.295.13.1549	http://dx.doi.org/10.1001/jama.295.13.1549			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16595758	Bronze			2022-12-28	WOS:000236505400022
J	Lyness, JM; Heo, M; Datto, CJ; Ten Have, TR; Katz, IR; Drayer, R; Reynolds, CF; Alexopoulos, GS; Bruce, ML				Lyness, JM; Heo, M; Datto, CJ; Ten Have, TR; Katz, IR; Drayer, R; Reynolds, CF; Alexopoulos, GS; Bruce, ML			Outcomes of minor and subsyndromal depression among elderly patients in primary care settings	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CEREBROVASCULAR RISK-FACTORS; GERIATRIC DEPRESSION; LATE-LIFE; MAJOR DEPRESSION; OLDER-ADULTS; SUBTHRESHOLD DEPRESSION; FUNCTIONAL DISABILITY; CARDIOVASCULAR HEALTH; VASCULAR DEPRESSION	Background: Although depressive conditions in later life are a major public health problem, the outcomes of minor and subsyndromal depression are largely unknown. Objective: To compare outcomes among patients with minor and subsyndromal depression, major depression, and no depression, and to examine putative outcome predictors. Design: Cohort study Setting: Patients from primary care practices in greater New York City, and Philadelphia and Pittsburgh, Pennsylvania. Patients: 622 patients who were at least 60 years of age and presented for treatment in primary care practices that provided usual care in a randomized, controlled trial of suicide prevention. Of the 441 (70.9%) patients who completed 1 year of follow-up, 122 had major depression, 205 had minor or subsyndromal depression, and 114 did not have depression at baseline. Measurements: One year after a baseline evaluation, data were collected by using the following tools: Hamilton Depression Rating Scale, the depressive disorders section of the Structured Clinical Interview for DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, fourth edition), Charlson Comorbidity Index, Multilevel Assessment Instrument for measuring instrumental activities of daily living, Physical Component Summary of the Medical Outcomes Study Short Form-36, and Duke Social Support Index. Results: Patients with minor or subsyndromal depression had intermediate depressive and functional outcomes. Mean adjusted 1-year Hamilton depression score was 10.9 (95% Cl, 9.6 to 12.2) for those with initial major depression, 7.0 (Cl, 5.9 to 8.1) for those with minor or subsyndromal depression, and 2.9 (Cl, 1.6 to 4.2) for those without depression (P < 0.001 for each paired comparison). Compared with patients who were not depressed, those who had minor or subsyndromal depression had a 5.5-fold risk (Cl, 3.1-fold to 10.0-fold) for major depression at 1 year after controlling for demographic characteristics (P < 0.001). Cerebrovascular risk factors were not associated with a diagnosis of depression at 1 year after controlling for overall medical burden. initial medical burden, self-rated health, and subjective social support were significant independent predictors of depression outcome. Limitations: Participants received care at practices that had personnel who had been given enhanced education about depression treatment; 29.1% of participants withdrew from the study before completing 1 year of follow-up. Conclusions: The intermediate outcomes of minor and subsyndromal depression demonstrate the clinical significance of these conditions and suggest that they are part of a spectrum of depressive illness. Greater medical burden, poor subjective health status, and poorer subjective social support confer a higher risk for poor outcome.	Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA; Cornell Univ, Weill Med Coll, White Plains, NY 10605 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA	University of Rochester; Cornell University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lyness, JM (corresponding author), Univ Rochester, Med Ctr, Dept Psychiat, 300 Crittenden Blvd, Rochester, NY 14642 USA.	Jeffrey_Lyness@urmc.rochester.edu	; Ho, Rainbow Tin Hung/A-8705-2012	Heo, Moonseong/0000-0001-7711-1209; Ho, Rainbow Tin Hung/0000-0002-6173-621X; Alexopoulos, George/0000-0001-5677-7001	NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH052129, R01MH059381, P30MH068638, P30MH071944, P30MH052247, R01MH061429, K02MH001634, R01MH059380, R01MH059366] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH59366, R01 MH59380, R01 MH59381, R01 MH61429, K02 MH01634, P30 MH52129, P30 MH71944, P30 MH68638, P30 MH52247] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alexopoulos GS, 2005, AM J PSYCHIAT, V162, P718, DOI 10.1176/appi.ajp.162.4.718; Alexopoulos GS, 2004, NEUROPSYCHOPHARMACOL, V29, P2278, DOI 10.1038/sj.npp.1300557; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Alexopoulos GS, 1996, AM J PSYCHIAT, V153, P877; *AM HEART ASS, 1990, STROK RISK FACT PRED; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Beekman ATF, 1997, PSYCHOL MED, V27, P1397, DOI 10.1017/S0033291797005734; BRUCE ML, 1994, AM J PUBLIC HEALTH, V84, P1796, DOI 10.2105/AJPH.84.11.1796; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; Caine Eric D, 1993, Am J Geriatr Psychiatry, V1, P4, DOI 10.1097/00019442-199300110-00003; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P833, DOI 10.1111/j.1532-5415.1994.tb06554.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Charney DS, 2003, ARCH GEN PSYCHIAT, V60, P664, DOI 10.1001/archpsyc.60.7.664; Ciechanowski P, 2004, JAMA-J AM MED ASSOC, V291, P1569, DOI 10.1001/jama.291.13.1569; Conwell Y, 2002, BIOL PSYCHIAT, V52, P193, DOI 10.1016/S0006-3223(02)01347-1; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HEDEKER D, 1994, BIOMETRICS, V50, P933, DOI 10.2307/2533433; HORWATH E, 1992, ARCH GEN PSYCHIAT, V49, P817; Hybels CF, 2001, GERONTOLOGIST, V41, P357, DOI 10.1093/geront/41.3.357; Judd LL, 2002, PSYCHIAT CLIN N AM, V25, P685, DOI 10.1016/S0193-953X(02)00026-6; Kivela SL, 2000, INT PSYCHOGERIATR, V12, P183, DOI 10.1017/S1041610200006311; Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497; KUKULL WA, 1986, J AFFECT DISORDERS, V10, P153, DOI 10.1016/0165-0327(86)90037-6; Kumar A, 1998, P NATL ACAD SCI USA, V95, P7654, DOI 10.1073/pnas.95.13.7654; LANDERMAN R, 1989, AM J COMMUN PSYCHOL, V17, P625, DOI 10.1007/BF00922639; Lavretsky H, 2002, AM J GERIAT PSYCHIAT, V10, P239, DOI 10.1176/appi.ajgp.10.3.239; LAWTON MP, 1982, J GERONTOL, V37, P91, DOI 10.1093/geronj/37.1.91; LEBOWITZ BD, 1997, JAMA-J AM MED ASSOC, V27, P1186; Lyness Jeffrey M, 2002, CNS Spectr, V7, P712; Lyness JM, 1999, AM J GERIAT PSYCHIAT, V7, P252, DOI 10.1097/00019442-199908000-00010; Lyness JM, 1996, J AM GERIATR SOC, V44, P198, DOI 10.1111/j.1532-5415.1996.tb02440.x; Lyness JM, 2000, AM J PSYCHIAT, V157, P1499, DOI 10.1176/appi.ajp.157.9.1499; Lyness JM, 1999, J AM GERIATR SOC, V47, P647, DOI 10.1111/j.1532-5415.1999.tb01584.x; Lyness JM, 2004, JAMA-J AM MED ASSOC, V291, P1626, DOI 10.1001/jama.291.13.1626; Lyness JM, 1997, ARCH INTERN MED, V157, P449, DOI 10.1001/archinte.157.4.449; Lyness JM, 2002, AM J GERIAT PSYCHIAT, V10, P275, DOI 10.1176/appi.ajgp.10.3.275; Mast BT, 2004, AM J GERIAT PSYCHIAT, V12, P93, DOI 10.1176/appi.ajgp.12.1.93; Mueller TI, 2004, AM J GERIAT PSYCHIAT, V12, P22, DOI 10.1176/appi.ajgp.12.1.22; MURRELL SA, 1984, J COMMUNITY PSYCHOL, V12, P301, DOI 10.1002/1520-6629(198410)12:4<301::AID-JCOP2290120403>3.0.CO;2-I; Neter J., 1996, APPL LINEAR STAT MOD; Oxman TE, 2003, AM J GERIAT PSYCHIAT, V11, P507; Oxman TE, 2002, AM J GERIAT PSYCHIAT, V10, P256, DOI 10.1176/appi.ajgp.10.3.256; PARMELEE PA, 1989, J GERONTOL, V44, pM22, DOI 10.1093/geronj/44.1.M22; Pasternak RE, 1997, AM J GERIAT PSYCHIAT, V5, P54; PINQUART M, IN PRESS AM J PSYCHI; Radloff L, 1992, APPL PSYCH MEAS, V7, P343; Reynolds CF, 2001, INT J GERIATR PSYCH, V16, P602, DOI 10.1002/gps.466; Rollman BL, 1999, J AM GERIATR SOC, V47, P757, DOI 10.1111/j.1532-5415.1999.tb01605.x; Schulberg HC, 1998, INT J PSYCHIAT MED, V28, P421, DOI 10.2190/G23R-NGGN-K1P1-MQ8N; Sinclair PA, 2001, AM J PSYCHIAT, V158, P416, DOI 10.1176/appi.ajp.158.3.416; Spitzer RL, 1986, STRUCTURED CLIN INTE; Steffens DC, 1999, STROKE, V30, P2159, DOI 10.1161/01.STR.30.10.2159; Steffens DC, 2002, STROKE, V33, P1636, DOI 10.1161/01.STR.0000018405.59799.D5; Steffens DC, 1999, AM J GERIAT PSYCHIAT, V7, P34; Tanner MA, 1993, TOOLS STAT INFERENCE; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; *US DHHS, 1993, CLIN PRACT GUID, V5; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wells K, 2005, AM J PSYCHIAT, V162, P1149, DOI 10.1176/appi.ajp.162.6.1149; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; Williams JW, 2000, JAMA-J AM MED ASSOC, V284, P1519, DOI 10.1001/jama.284.12.1519	62	192	197	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2006	144	7					496	504		10.7326/0003-4819-144-7-200604040-00008	http://dx.doi.org/10.7326/0003-4819-144-7-200604040-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	031DU	16585663				2022-12-28	WOS:000236685100004
J	Bonneux, L; Van Damme, W				Bonneux, L; Van Damme, W			Avian influenza - Preparing for the pandemic - An iatrogenic pandemic of panic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; EPIDEMICS; MORTALITY		Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Van Damme, W (corresponding author), Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium.	wvdamme@itg.be	Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007				Barton JH, 2005, JAMA-J AM MED ASSOC, V294, P2075, DOI 10.1001/jama.294.16.2075; Bellaby P, 2003, BRIT MED J, V327, P725, DOI 10.1136/bmj.327.7417.725; Bernard A, 1999, NATURE, V401, P231, DOI 10.1038/45717; BEVERIDGE WIB, 1991, HIST PHIL LIFE SCI, V13, P223; BOERSEMA D, 2005, VOLKSKRANT      1020; *CDCP, SPREAD AV INFL VIR B; *CNN, 2005, BIRD FLU MAY KILL 15; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Lokuge B, 2006, MED J AUSTRALIA, V184, P16, DOI 10.5694/j.1326-5377.2006.tb00089.x; Macfarlane JT, 2005, BMJ-BRIT MED J, V331, P975, DOI 10.1136/bmj.38649.389005.DE; Moynihan, 2005, SELLING SICKNESS WOR; *NAT I HLTH CLIN E, 58 NAT I HLTH CLIN E; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Van Damme W, 2004, TROP MED INT HEALTH, V9, P281, DOI 10.1046/j.1365-3156.2003.01189.x; Van Damme W, 2000, TROP MED INT HEALTH, V5, P511; [No title captured]	19	45	48	5	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					786	788		10.1136/bmj.332.7544.786	http://dx.doi.org/10.1136/bmj.332.7544.786			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032JA	16575086	Green Published			2022-12-28	WOS:000236769500030
J	Craft, AW; McIntosh, N				Craft, AW; McIntosh, N			Southall and colleagues vindicated once more	LANCET			English	Editorial Material							RESPIRATORY-FAILURE; INFANTS		Royal Victoria Infirm, Inst Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Edinburgh, Dept Child Life & Hlth, Edinburgh EH9 1UW, Midlothian, Scotland	Newcastle University - UK; University of Edinburgh	Craft, AW (corresponding author), Royal Victoria Infirm, Inst Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	a.w.craft@ncl.ac.uk						Field D, 2005, PEDIATRICS, V115, P926, DOI 10.1542/peds.2004-1209; Hey E, 2000, BRIT MED J, V321, P752, DOI 10.1136/bmj.321.7263.752; Samuels MP, 1996, PEDIATRICS, V98, P1154; SCHECHTMAN VL, 1991, PEDIATRICS, V87, P841; SOUTHALL DP, 1981, BRIT HEART J, V45, P281; Southall DP, 1997, PEDIATRICS, V100, P735, DOI 10.1542/peds.100.5.735; Telford K, 2006, LANCET, V367, P1080, DOI 10.1016/S0140-6736(06)68475-4	7	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 1	2006	367	9516					1035	1037		10.1016/S0140-6736(06)68447-X	http://dx.doi.org/10.1016/S0140-6736(06)68447-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581386				2022-12-28	WOS:000236673200007
J	Khan, KS; Wojdyla, D; Say, L; Gulmezoglu, AM; Van Look, PFA				Khan, KS; Wojdyla, D; Say, L; Gulmezoglu, AM; Van Look, PFA			WHO analysis of causes of maternal death: a systematic review	LANCET			English	Review							EPIDEMIOLOGY; METAANALYSIS; MORTALITY; CHILDREN	Background The reduction of maternal deaths is a key international development goal. Evidence-based health policies and programmes aiming to reduce maternal deaths need reliable and valid information. We undertook a systematic review to determine the distribution of causes of maternal deaths. Methods We selected datasets using prespecified criteria, and recorded dataset characteristics, methodological features, and causes of maternal deaths. All analyses were restricted to datasets representative of populations. We analysed joint causes of maternal deaths from datasets reporting at least four major causes (haemorrhage, hypertensive disorders, sepsis, abortion, obstructed labour, ectopic pregnancy, embolism). We examined datasets reporting individual causes of death to investigate the heterogeneity due to methodological features and geographical region and the contribution of haemorrhage, hypertensive disorders, abortion, and sepsis as causes of maternal death at the country level. Findings 34 datasets (35 197 maternal deaths) were included in the primary analysis. We recorded wide regional variation in the causes of maternal deaths. Haemorrhage was the leading cause of death in Africa (point estimate 33.9%, range 13.3-43.6; eight datasets, 4508 deaths) and in Asia (30.8%, 5.9-48.5; 11, 16 089). In Latin America and the Caribbean, hypertensive disorders were responsible for the most deaths (25.7%, 7.9-52.4; ten, 11777). Abortion deaths were the highest in Latin America and the Caribbean (12%), which can be as high as 30% of all deaths in some countries in this region. Deaths due to sepsis were higher in Africa (odds ratio 2.71), Asia (1.91), and Latin America and the Caribbean (2.06) than in developed countries. Interpretation Haemorrhage and hypertensive disorders are major contributors to maternal deaths in developing countries. These data should inform evidence-based reproductive health-care policies and programmes at regional and national levels. Capacity-strengthening efforts to improve the quality of burden-of-disease studies will further validate future estimates.	WHO, Dept Reprod Hlth & Res, UNDP UNFPA WHO World Bank Special Programme Res D, CH-1211 Geneva 27, Switzerland; Univ Birmingham, Acad Dept Obstet & Gynaecol, Birmingham, W Midlands, England; Ctr Rosarino Estudios Perinatales, Rosario, Santa Fe, Argentina	United Nations Population Fund; World Health Organization; University of Birmingham	Gulmezoglu, AM (corresponding author), WHO, Dept Reprod Hlth & Res, UNDP UNFPA WHO World Bank Special Programme Res D, CH-1211 Geneva 27, Switzerland.	gulmezoglum@who.int	Khan, Khalid S/AAT-8824-2020; , lalesay/AAG-1912-2021	Khan, Khalid S/0000-0001-5084-7312; 				Allison P. D., 1999, LOGISTIC REGRESSION; Betran AP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-131; Dickersin K, 2002, INT J EPIDEMIOL, V31, P6, DOI 10.1093/ije/31.1.6; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; Glasziou P, 2001, SYSTEMATIC REV HLTH, P67; Gulmezoglu A Metin, 2004, BMC Med Res Methodol, V4, P16, DOI 10.1186/1471-2288-4-16; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; PATTINSON RC, 1998, SAVING MOTEHRS REPOR; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; SMITH JC, 1984, AM J PUBLIC HEALTH, V74, P780, DOI 10.2105/AJPH.74.8.780; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; *UN GEN ASS, ARES552192000 UN GEN; *WHO, 1992, INT CLASS DIS REL H; WHO, REV GLOB BURD DIS 20; *WHO, 1991, WHOMCHMSM913; World Health Organization, 2004, NUMB REV MAT DEATHS	17	2260	2382	6	181	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1066	1074		10.1016/S0140-6736(06)68397-9	http://dx.doi.org/10.1016/S0140-6736(06)68397-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581405				2022-12-28	WOS:000236673200030
J	Pickles, H				Pickles, H			Avian influenza - Preparing for the pandemic - Using lessons from the past to plan for pandemic flu	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Hillingdon Primary Care Trust, W Drayton UB7 7HJ, Middx, England		Pickles, H (corresponding author), Hillingdon Primary Care Trust, W Drayton UB7 7HJ, Middx, England.	hilary.pickles@hillingdon.nhs.uk						Berridge V., 1996, AIDS UK MAKING POLIC; Brahmbhatt M, 2005, AVIAN HUMAN PANDEMIC; *BTS BIS HPA, 2005, CLIN GUID PAT INFL L; Budko R., 2018, 10 THINGS YOU NEED K; *CAB OFF, 2002, FOOT MOUTH DIS 2001; *CAB OFF STRAT UN, 2002, RISK IMPR GOV CAP HA; *DEP HLTH, 2005, UK HLTH DEP INFL PAN; *DEP HLTH HLTH PRO, 2005, GUID PAND INFL INF C; Department of Health (DOH), 2005, HLTH REF ENGL UPD NE; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Hong Kong SAR Government, 2020, VACC PASS Q A; *HOUS COMM AGR COM, 1990, BOV SPONG ENC BSE; *HOUS LORDS SCI TE, 2003, FIGHT INF OR EV WRIT, P367; *HOUS LORDS SCI TE, 2003, FIGHT INF; *HOUS LORDS SCI TE, 2005, PAND INFL; Hugill J., 1986, REPORT COMMITTEE INQ; PHILLIPS, 2000, BSE INQUIRY; Pickles H, 2004, Commun Dis Public Health, V7, P241; Pickles H, 2003, Commun Dis Public Health, V6, P216; PICKLES H, 2006, PHARM J, V276, P11; Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A; Special Advisory Committee on the Epidemic of Opioid Overdoses, 2022, OP STIM REL HARMS CA; 2006, CM6738	23	12	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					783	786		10.1136/bmj.332.7544.783	http://dx.doi.org/10.1136/bmj.332.7544.783			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032JA	16575084	Green Published			2022-12-28	WOS:000236769500028
J	Li, W; Feng, ZY; Sternberg, PW; Xu, XZS				Li, W; Feng, ZY; Sternberg, PW; Xu, XZS			A C-elegans stretch receptor neuron revealed by a mechanosensitive TRP channel homologue	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENE; MECHANOTRANSDUCTION; PROTEIN; PATHWAY; SYSTEM; FAMILY	The nematode Caenorhabditis elegans is commonly used as a genetic model organism for dissecting integration of the sensory and motor systems(1). Despite extensive genetic and behavioural analyses that have led to the identification of many genes and neural circuits involved in regulating C. elegans locomotion behaviour(1), it remains unclear whether and how somatosensory feedback modulates motor output during locomotion. In particular, no stretch receptors have been identified in C. elegans, raising the issue of whether stretch-receptor-mediated proprioception is used by C. elegans to regulate its locomotion behaviour. Here we have characterized TRP-4, the C. elegans homologue of the mechanosensitive TRPN channel. We show that trp-4 mutant worms bend their body abnormally, exhibiting a body posture distinct from that of wild-type worms during locomotion, suggesting that TRP-4 is involved in stretch-receptor-mediated proprioception. We show that TRP-4 acts in a single neuron, DVA, to mediate its function in proprioception, and that the activity of DVA can be stimulated by body stretch. DVA both positively and negatively modulates locomotion, providing a unique mechanism whereby a single neuron can fine-tune motor activity. Thus, DVA represents a stretch receptor neuron that regulates sensory - motor integration during C. elegans locomotion.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Xu, XZS (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	shawnxu@umich.edu		Sternberg, Paul/0000-0002-7699-0173	NIGMS NIH HHS [R01 GM078276, R01 GM078276-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078276] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cattaert D, 2001, PROG NEUROBIOL, V63, P199, DOI 10.1016/S0301-0082(00)00030-7; Chalfie M., 1988, NEMATODE CAENORHABDI, P337; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Ernstrom GG, 2002, ANNU REV GENET, V36, P411, DOI 10.1146/annurev.genet.36.061802.101708; Goldberg CJ, 1999, STUD HEALTH TECHNOL, V59, P53; Goodman MB, 2003, ANNU REV PHYSIOL, V65, P429, DOI 10.1146/annurev.physiol.65.092101.142659; HALL WC, 2001, NEUROSCIENCE, P347; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; Lints R, 1999, DEVELOPMENT, V126, P5819; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Samuel ADT, 2005, CURR BIOL, V15, pR341, DOI 10.1016/j.cub.2005.04.021; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Sidi S, 2003, SCIENCE, V301, P96, DOI 10.1126/science.1084370; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8	21	208	226	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					684	687		10.1038/nature04538	http://dx.doi.org/10.1038/nature04538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572173	Green Published, Green Accepted			2022-12-28	WOS:000236350400047
J	Overpeck, JT; Otto-Bliesner, BL; Miller, GH; Muhs, DR; Alley, RB; Kiehl, JT				Overpeck, JT; Otto-Bliesner, BL; Miller, GH; Muhs, DR; Alley, RB; Kiehl, JT			Paleoclimatic evidence for future ice-sheet instability and rapid sea-level rise	SCIENCE			English	Article							LAST INTERGLACIAL PERIOD; ANTARCTIC PENINSULA; CLIMATE; 21ST-CENTURY; DURATION; RETREAT; CORALS; RECORD; WARMTH; AGES	Sea-level rise from melting of polar ice sheets is one of the largest potential threats of future climate change. Polar warming by the year 2100 may reach levels similar to those of 130,000 to 127,000 years ago that were associated with sea levels several meters above modern levels; both the Greenland Ice Sheet and portions of the Antarctic Ice Sheet may be vulnerable. The record of past ice-sheet melting indicates that the rate of future melting and related sea-level rise could be faster than widely thought.	Univ Arizona, Dept Geosci, Inst Study Planet Earth, Tucson, AZ 85721 USA; Univ Arizona, Dept Atmospher Sci, Tucson, AZ 85721 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; US Geol Survey, Lakewood, CO 80225 USA; Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Penn State Univ, Penn State Ice & Climate Explorat Ctr, University Pk, PA 16802 USA	University of Arizona; University of Arizona; National Center Atmospheric Research (NCAR) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Overpeck, JT (corresponding author), Univ Arizona, Dept Geosci, Inst Study Planet Earth, Tucson, AZ 85721 USA.	ito@u.arizona.edu	Otto-Bliesner, Bette/AAY-7691-2020					Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; *ARCT CLIM IMP ASS, 2004, IMP WARM ARCT ARCT C, P184; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Cazenave A, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000139; CHEN JH, 1991, GEOL SOC AM BULL, V103, P82, DOI 10.1130/0016-7606(1991)103<0082:PCOTLI>2.3.CO;2; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; Domack E, 2005, NATURE, V436, P681, DOI 10.1038/nature03908; DROXLER AW, 2003, AGU MONOGR, V137, P240; Fruijtier C, 2000, GEOL SOC AM BULL, V112, P267, DOI 10.1130/0016-7606(2000)112<0267:MSUTAF>2.3.CO;2; Gregory JM, 2004, NATURE, V428, P616, DOI 10.1038/428616a; Hansen J, 2004, P NATL ACAD SCI USA, V101, P423, DOI 10.1073/pnas.2237157100; Hansen JE, 2005, CLIMATIC CHANGE, V68, P269, DOI 10.1007/s10584-005-4135-0; Huybrechts P, 2004, GLOBAL PLANET CHANGE, V42, P83, DOI 10.1016/j.gloplacha.2003.11.011; IPCC, 2001, 3 IPCC; Israelson C, 1999, QUATERNARY RES, V51, P306, DOI 10.1006/qres.1998.2030; Jouzel J, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002677; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; Meehl GA, 2005, SCIENCE, V307, P1769, DOI 10.1126/science.1106663; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Muhs DR, 2002, QUATERNARY SCI REV, V21, P1355, DOI 10.1016/S0277-3791(01)00114-7; Nicholls RJ, 2004, GLOBAL ENVIRON CHANG, V14, P69, DOI 10.1016/j.gloenvcha.2003.10.007; Oppenheimer M, 2004, CLIMATIC CHANGE, V64, P1, DOI 10.1023/B:CLIM.0000024792.06802.31; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Scherer RP, 1998, SCIENCE, V281, P82, DOI 10.1126/science.281.5373.82; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; STIRLING CH, 1995, EARTH PLANET SC LETT, V135, P115, DOI 10.1016/0012-821X(95)00152-3; Tarasov L, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001731; Thompson WG, 2005, SCIENCE, V308, P401, DOI 10.1126/science.1104035; Watanabe O, 2003, NATURE, V422, P509, DOI 10.1038/nature01525; Wigley TML, 2005, SCIENCE, V307, P1766, DOI 10.1126/science.1103934; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	38	315	328	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1747	1750		10.1126/science.1115159	http://dx.doi.org/10.1126/science.1115159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556837	Green Submitted			2022-12-28	WOS:000236204300036
J	Gilbert, MJ; Thornton, CR; Wakley, GE; Talbot, NJ				Gilbert, MJ; Thornton, CR; Wakley, GE; Talbot, NJ			A P-type ATPase required for rice blast disease and induction of host resistance	NATURE			English	Article							GENE; PATHOGENICITY; PENETRATION; PROTEIN; IDENTIFICATION; INFECTION	To cause diseases in plants, pathogenic microorganisms have evolved mechanisms to deliver proteins directly into plant cells, where they suppress plant defences and facilitate tissue invasion(1-3). How plant pathogenic fungi, which cause many of the world's most serious plant diseases, deliver proteins during plant infection is currently unknown. Here we report the characterization of a P-type ATPase-encoding gene, MgAPT2, in the economically important rice blast pathogen Magnaporthe grisea, which is required for exocytosis during plant infection. Targeted gene replacement showed that MgAPT2 is required for both foliar and root infection by the fungus, and for the rapid induction of host defence responses in an incompatible reaction. Delta Mgapt2 mutants are impaired in the secretion of a range of extracellular enzymes and accumulate abnormal Golgi-like cisternae. However, the loss of MgAPT2 does not significantly affect hyphal growth or sporulation, indicating that the establishment of rice blast disease involves the use of MgApt2-dependent exocytotic processes that operate during plant infection.	Univ Exeter, Sch Biosci, Washington Singer Labs, Exeter EX4 4QG, Devon, England	University of Exeter	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	n.j.talbot@exeter.ac.uk	Talbot, Nicholas J/I-5618-2019; Talbot, Nicholas J/I-9584-2014	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757				Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Balhadere PV, 2001, PLANT CELL, V13, P1987, DOI 10.1105/tpc.13.9.1987; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; CHIDA T, 1987, J PESTIC SCI, V12, P49; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gall WE, 2002, CURR BIOL, V12, P1623, DOI 10.1016/S0960-9822(02)01148-X; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Kim S, 2001, MOL CELLS, V11, P115; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; LUTSENKO S, 1995, BIOCHEMISTRY-US, V34, P15607, DOI 10.1021/bi00048a001; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Rose MD., 1990, METHODS YEAST GENETI; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tucker SL, 2004, PLANT CELL, V16, P1575, DOI 10.1105/tpc.021279; VALENT B, 1991, GENETICS, V127, P87; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Zeng LR, 2004, PLANT CELL, V16, P2795, DOI 10.1105/tpc.104.025171	28	86	95	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					535	539		10.1038/nature04567	http://dx.doi.org/10.1038/nature04567			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554820				2022-12-28	WOS:000236176100057
J	Muggleton, SH				Muggleton, SH			Exceeding human limits	NATURE			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Dept Comp, London SW7 2BZ, England; Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol, London SW7 2BZ, England	Imperial College London; Imperial College London	Muggleton, SH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Comp, 180 Queens Gate, London SW7 2BZ, England.				Engineering and Physical Sciences Research Council [GR/R54071/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		De Raedt L, 2004, LECT NOTES ARTIF INT, V3244, P19; FLETCHER P, 2001, DEKKER ENCY NANOSCIE; HALPERN JY, 1990, ARTIF INTELL, V46, P311, DOI 10.1016/0004-3702(90)90019-V; Jacko J. A., 2003, HUMAN COMPUTER INTER; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Microsoft, 2006, 2020 SCI; Sternberg MJE, 2003, QSAR COMB SCI, V22, P527, DOI 10.1002/qsar.200310005; Takahashi K, 2003, BIOINFORMATICS, V19, P1727, DOI 10.1093/bioinformatics/btg221; TAMADDONINEZHAD A, 2004, P 14 INT C IND LOG P, P305	9	31	35	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					409	410		10.1038/440409a	http://dx.doi.org/10.1038/440409a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554781				2022-12-28	WOS:000236176100019
J	Nichols, CG				Nichols, CG			K-ATP channels as molecular sensors of cellular metabolism	NATURE			English	Review							SENSITIVE POTASSIUM CHANNELS; NUCLEOTIDE-BINDING FOLDS; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; SULFONYLUREA RECEPTOR; ACTIVATING MUTATIONS; INSULIN-SECRETION; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; GATING MECHANISM; LIGAND-BINDING	In responding to cytoplasmic nucleotide levels, ATP-sensitive potassium (K-ATP) channel activity provides a unique link between cellular energetics and electrical excitability. Over the past ten years, a steady drumbeat of crystallographic and electrophysiological studies has led to detailed structural and kinetic models that define the molecular basis of channel activity. In parallel, the uncovering of disease-causing mutations of K-ATP has led to an explanation of the molecular basis of disease and, in turn, to a better understanding of the structural basis of channel function.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	cnichols@cellbio.wustl.edu	Nichols, Colin/D-6336-2012					Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Campbell JD, 2004, DIABETES, V53, pS123, DOI 10.2337/diabetes.53.suppl_3.S123; Cartier EA, 2003, J BIOL CHEM, V278, P7081, DOI 10.1074/jbc.M211395200; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chan KW, 2002, BIOPHYS J, V82, p590A; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Chutkow WA, 2001, P NATL ACAD SCI USA, V98, P11760, DOI 10.1073/pnas.201390398; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Crawford RM, 2002, EMBO J, V21, P3936, DOI 10.1093/emboj/cdf388; Dhar-Chowdhury P, 2005, J BIOL CHEM, V280, P38464, DOI 10.1074/jbc.M508744200; Domene C, 2005, BIOPHYS J, V89, pL1, DOI 10.1529/biophysj.105.060855; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drain P, 2004, BIOPHYS J, V86, P2101, DOI 10.1016/S0006-3495(04)74269-1; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Enkvetchakul D, 2004, J BIOL CHEM, V279, P47076, DOI 10.1074/jbc.C400417200; Enkvetchakul D, 2003, J GEN PHYSIOL, V122, P471, DOI 10.1085/jgp.200308878; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Flagg TP, 2005, J MOL CELL CARDIOL, V39, P61, DOI 10.1016/j.yjmcc.2005.01.005; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Haider S, 2005, J MOL CELL CARDIOL, V38, P927, DOI 10.1016/j.yjmcc.2005.01.007; Haider S, 2005, BIOPHYS J, V88, P3310, DOI 10.1529/biophysj.104.052019; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hough E, 2002, BIOCHEM BIOPH RES CO, V294, P191, DOI 10.1016/S0006-291X(02)00454-0; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Koster JC, 2005, DIABETES, V54, P3065, DOI 10.2337/diabetes.54.11.3065; Koster JC, 2005, DIABETES, V54, P2645, DOI 10.2337/diabetes.54.9.2645; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lammens A, 2004, CURR BIOL, V14, P1778, DOI 10.1016/j.cub.2004.09.044; Li LH, 2000, BIOPHYS J, V79, P841, DOI 10.1016/S0006-3495(00)76340-5; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loussouarn G, 2001, P NATL ACAD SCI USA, V98, P4227, DOI 10.1073/pnas.061452698; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; MacGregor GG, 2002, P NATL ACAD SCI USA, V99, P2726, DOI 10.1073/pnas.042688899; Markworth E, 2000, DIABETES, V49, P1413, DOI 10.2337/diabetes.49.9.1413; Masia R, 2005, J MOL CELL CARDIOL, V39, P491, DOI 10.1016/j.yjmcc.2005.03.009; Massa O, 2005, HUM MUTAT, V25, P22, DOI 10.1002/humu.20124; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Mikhailov MV, 2000, J BIOL CHEM, V275, P3360, DOI 10.1074/jbc.275.5.3360; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Miki T, 2005, J MOL CELL CARDIOL, V38, P917, DOI 10.1016/j.yjmcc.2004.11.019; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Neagoe I, 2005, J MOL CELL CARDIOL, V38, P887, DOI 10.1016/j.yjmcc.2004.11.023; Nestorowicz A, 1998, HUM MOL GENET, V7, P1119, DOI 10.1093/hmg/7.7.1119; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Partridge CJ, 2001, J BIOL CHEM, V276, P35947, DOI 10.1074/jbc.M104762200; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Phillips LR, 2003, J GEN PHYSIOL, V122, P795, DOI 10.1085/jgp.200308953; Phillips LR, 2003, NEURON, V37, P953, DOI 10.1016/S0896-6273(03)00155-7; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Sackin H, 2005, BIOPHYS J, V88, P2597, DOI 10.1529/biophysj.104.051474; Sagen JV, 2004, DIABETES, V53, P2713, DOI 10.2337/diabetes.53.10.2713; Schwanstecher C, 2002, DIABETES, V51, P875, DOI 10.2337/diabetes.51.3.875; Seghers V, 2000, J BIOL CHEM, V275, P9270, DOI 10.1074/jbc.275.13.9270; Seino S, 2004, J PHYSIOL-LONDON, V554, P295, DOI 10.1113/jphysiol.2003.047175; Sharma N, 2000, KIDNEY INT, V57, P803, DOI 10.1046/j.1523-1755.2000.00918.x; Shiota C, 2002, J BIOL CHEM, V277, P37176, DOI 10.1074/jbc.M206757200; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570; Tornovsky S, 2004, J CLIN ENDOCR METAB, V89, P6224, DOI 10.1210/jc.2004-1233; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1999, P NATL ACAD SCI USA, V96, P1268, DOI 10.1073/pnas.96.4.1268; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Yorifuji T, 2005, J CLIN ENDOCR METAB, V90, P3174, DOI 10.1210/jc.2005-0096; Zingman LV, 2002, J BIOL CHEM, V277, P14206, DOI 10.1074/jbc.M109452200; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7; Zung A, 2004, J CLIN ENDOCR METAB, V89, P5504, DOI 10.1210/jc.2004-1241	92	634	657	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					470	476		10.1038/nature04711	http://dx.doi.org/10.1038/nature04711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554807				2022-12-28	WOS:000236176100044
J	Wadman, M				Wadman, M			Drive for drugs leads to baby clinical trials	NATURE			English	News Item								The FDA announced new rules that will allow small doses of experimental drugs to be tested in people before full-scale clinical trials begin. At the same time, it loosened manufacturing requirements for early-stage drug candidates.											0	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2006	440	7083					406	407		10.1038/440406a	http://dx.doi.org/10.1038/440406a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554774				2022-12-28	WOS:000236176100014
J	Tillie-Leblond, I; Marquette, CH; Perez, T; Scherpereel, A; Zanetti, C; Tonnel, AB; Remy-Jardin, M				Tillie-Leblond, I; Marquette, CH; Perez, T; Scherpereel, A; Zanetti, C; Tonnel, AB; Remy-Jardin, M			Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: Prevalence and risk factors	ANNALS OF INTERNAL MEDICINE			English	Article							SPIRAL CT; D-DIMER; DIAGNOSIS; ANGIOGRAPHY; THROMBOSIS; EMERGENCY; ARTERIES; BEDSIDE; TESTS; LUNG	Background: Diagnosis of pulmonary embolism (PE) is difficult in patients with chronic obstructive pulmonary disease (COPD) and exacerbation. Objective: To evaluate PE in patients with COPD and exacerbation of unknown origin and explore factors associated with PE. Design: Prospective cohort study. Setting: University-affiliated hospital in France. Patients: 211 consecutive patients, all current or former smokers with COPD, who were admitted to the hospital for severe exacerbation of unknown origin and did not require invasive mechanical ventilation. Measurements: Spiral computed tomography angiography (CTA) and ultrasonography within 48 hours of admission and assessment of the Geneva score. Patients were classified as PE positive (positive results on CTA or negative results on CTA and positive results on ultrasonography) or PE negative (negative results on CTA and negative results on ultrasonography or negative results on CTA and no recurrence of PE at follow-up 3 months later). Results: 49 of 197 patients (25% [95% Cl, 19% to 32%]) met the diagnostic criteria for PE. Clinical factors associated with PE were previous thromboembolic disease (risk ratio, 2.43 [Cl, 1.49 to 3.94]), malignant disease (risk ratio, 1.82 [Cl, 1.13 to 2.92)), and decrease in PaCO2 of at least 5 mm Hg (risk ratio, 2.10 [Cl, 1.23 to 3.58]). A total of 9.2% (Cl, 4.7% to 15.9%) of patients with a low-probability Geneva score received a diagnosis of PE. An exploratory analysis suggested that substituting malignant disease for recent surgery in the Geneva score might improve its performance in excluding PE in this sample who were more likely to have malignant disease than to have had recent surgery. However, this improvement seems insufficient to exclude PE with enough certainty to withhold therapy for low-risk patients on the basis of the modified score. Limitations: This study was done in only 1 center. Patients with COPD requiring invasive mechanical ventilation in the intensive care unit were not included. The upper bound of the 95% Cl for the low probability of PE according to the Geneva score is too high to rule out PE. The classification of COPD exacerbation of unknown origin was based on the clinician's assessment, not on a standard evaluation for all patients. Conclusion: This study showed a 25% prevalence of PE in patients with COPD hospitalized for severe exacerbation of unknown origin. Three clinical factors are associated with the increased risk for PE. The Geneva score and the modified Geneva score should be prospectively evaluated in patients with COPD.	Univ Hosp A Calmette, CHRU, Lung Dept, F-59037 Lille, France	Universite de Lille - ISITE; CHU Lille	Tillie-Leblond, I (corresponding author), Univ Hosp A Calmette, CHRU, Lung Dept, 1 Rue Leclercq, F-59037 Lille, France.		Marquette, Charles Hugo/O-4084-2016	Marquette, Charles Hugo/0000-0002-0846-9941				BAUM GL, 1960, AM J MED SCI, V240, P609; Bourriot K, 2003, CHEST, V123, P359, DOI 10.1378/chest.123.2.359; Carson JL, 1996, CHEST, V110, P1212, DOI 10.1378/chest.110.5.1212; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Hartmann IJC, 2000, AM J RESP CRIT CARE, V162, P2232, DOI 10.1164/ajrccm.162.6.2006030; Hyers TM, 1999, AM J RESP CRIT CARE, V159, P1; LESSER BA, 1992, CHEST, V102, P17, DOI 10.1378/chest.102.1.17; LIPPMANN M, 1981, CHEST, V79, P39, DOI 10.1378/chest.79.1.39; LIPPMANN ML, 1993, CHEST, V104, P983, DOI 10.1378/chest.104.3.983c; Mispelaere D, 2002, REV MAL RESPIR, V19, P415; Mitchell R S, 1968, Aspen Emphysema Conf, V9, P109; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Prediletto R, 1999, CRIT CARE, V3, P111, DOI 10.1186/cc352; PRESCOTT SM, 1981, AM REV RESPIR DIS, V123, P32; Remy-Jardin M, 2002, EUR RADIOL, V12, P1971, DOI 10.1007/s00330-002-1485-0; Remy-Jardin M, 2000, EUR RADIOL, V10, P1297, DOI 10.1007/s003300000460; RemyJardin M, 1997, RADIOLOGY, V204, P157, DOI 10.1148/radiology.204.1.9205239; Rodger MA, 2001, CHEST, V120, P115, DOI 10.1378/chest.120.1.115; RYAN SF, 1963, AM J PATHOL, V43, P767; Stein PD, 1996, CHEST, V109, P78, DOI 10.1378/chest.109.1.78; Tillie-Leblond I, 2002, RADIOLOGY, V223, P461, DOI 10.1148/radiol.2232010913; van Strijen MJL, 2005, J THROMB HAEMOST, V3, P17, DOI 10.1111/j.1538-7836.2004.01064.x; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92; WINTER JH, 1983, THORAX, V38, P605, DOI 10.1136/thx.38.8.605	27	189	203	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					390	396		10.7326/0003-4819-144-6-200603210-00005	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549851				2022-12-28	WOS:000236251800002
J	Lienhardt, C; Rustomjee, R				Lienhardt, C; Rustomjee, R			Improving tuberculosis control: an interdisciplinary approach	LANCET			English	Editorial Material							COUNTRIES		Inst Rech Dev, Programme TB, UMR 145, Montpellier, France; Int Union TB & Lung Dis, Paris, France; MRC, Unit Clin & Biomed TB Res, Durban, South Africa	Institut de Recherche pour le Developpement (IRD)	Lienhardt, C (corresponding author), IUATLD, 68 Blvd St Michel, F-75006 Paris, France.	clienhardt@iuatld.org	Lienhardt, Christian/AAU-4969-2021	Lienhardt, Christian/0000-0003-0233-893X				Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Harries AD, 2002, B WORLD HEALTH ORGAN, V80, P464; Jaffre Y., 2003, MED INHOSPITALIERE D; Jaiswal A, 2003, TROP MED INT HEALTH, V8, P625, DOI 10.1046/j.1365-3156.2003.01061.x; Lienhardt C, 2004, TROP MED INT HEALTH, V9, P833, DOI 10.1111/j.1365-3156.2004.01273.x; OGDEN JA, 2000, T ROY SOC TROP MED H, V94, P1; *WHO, TB EM DECL WHO REG O; *WHO, 2005, WHOHTMTB2005349; World Health Organization, 1994, WHOTB94179	10	7	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					949	950		10.1016/S0140-6736(06)68390-6	http://dx.doi.org/10.1016/S0140-6736(06)68390-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546548				2022-12-28	WOS:000236242100036
J	Maeda, K; Teramura, K; Lu, DL; Takata, T; Saito, N; Inoue, Y; Domen, K				Maeda, K; Teramura, K; Lu, DL; Takata, T; Saito, N; Inoue, Y; Domen, K			Photocatalyst releasing hydrogen from water - Enhancing catalytic performance holds promise for hydrogen production by water splitting in sunlight.	NATURE			English	Editorial Material							SOLID-SOLUTION		Japan Sci & Technol Corp, Solut Orientes Res Sci & Technol Programmes, Kawaguchi, Saitama 3320012, Japan; Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; Nagaoka Univ Technol, Dept Chem, Nagaoka, Niigata 9402188, Japan	Japan Science & Technology Agency (JST); University of Tokyo; Nagaoka University of Technology	Domen, K (corresponding author), Japan Sci & Technol Corp, Solut Orientes Res Sci & Technol Programmes, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.	domen@chemsys.t.u-tokyo.ac.jp	Teramura, Kentaro/J-7601-2016; Maeda, Kazuhiko/F-5802-2015; TAKATA, Tsuyoshi/H-2610-2011	Teramura, Kentaro/0000-0003-2916-4597; Maeda, Kazuhiko/0000-0001-7245-8318; 				BARD AJ, 1995, ACCOUNTS CHEM RES, V28, P141, DOI 10.1021/ar00051a007; FUJISHIMA A, 1972, NATURE, V238, P38; Kato H, 2002, J PHYS CHEM B, V106, P5029, DOI 10.1021/jp0255482; Maeda K, 2005, J AM CHEM SOC, V127, P8286, DOI 10.1021/ja0518777; Maeda K, 2005, J PHYS CHEM B, V109, P20504, DOI 10.1021/jp053499y; Sayama K, 2001, CHEM COMMUN, P2416, DOI 10.1039/b107673f	6	2412	2468	34	1769	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					295	295		10.1038/440295a	http://dx.doi.org/10.1038/440295a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	021QG	16541063	Bronze			2022-12-28	WOS:000235997600041
J	Harnden, A; Ninis, N; Thompson, M; Perera, R; Levin, M; Mant, D; Mayon-White, R				Harnden, A; Ninis, N; Thompson, M; Perera, R; Levin, M; Mant, D; Mayon-White, R			Parenteral penicillin for children with meningococcal disease before hospital admission: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ANTIBIOTIC-TREATMENT; CASE-FATALITY; ENDOTOXIN; RELEASE	Objective To explore the impact on mortality and morbidity of parenteral penicillin given to children before admission to hospital with suspected meningococcal disease. Design Retrospective comparison of fatal and non-fatal cases. Setting England, Wales, and Northern Ireland; December 1997 to February 1999. Participants 158 children aged 0-16 years (26 died, 132 survived) in whom a general practitioner had made the diagnosis of meningococcal disease before hospital admission. Results Administration of parenteral penicillin by general practitioners was associated with increased odds ratios for death (7.4, 95% confidence interval 1.5 to 37.7) and complications in survivors (5.0,1.7 to 15.0). Children who received penicillin had more severe disease on admission (median Glasgow meningococcal septicaemia prognostic score (GMSPS) 6.5 v 4.0, P = 0.002). Severity on admission did not differ significantly with time taken to reach hospital. Conclusions Children who were given parenteral penicillin by a general practitioner had more severe disease on reaching hospital than those who were not given penicillin before admission. The association with poor outcome may be because children who arc more severely 01 are being given penicillin before admission.	Univ Oxford, Dept Primary Hlth Care, Inst Hlth Sci, Oxford OX3 7LF, England; Univ London Imperial Coll Sci Technol & Med, Dept Paediat, Fac Med, London, England; Brighton & Sussex Med Sch, Div Med, Brighton, E Sussex, England	University of Oxford; Imperial College London; University of Brighton; University of Sussex	Harnden, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Inst Hlth Sci, Oxford OX3 7LF, England.	anthony.harnden@dphpc.ox.ac.uk	Mant, David CA/C-7763-2009	Perera, Rafael/0000-0003-2418-2091; Levin, Michael/0000-0003-2767-6919	MRC [G0000340] Funding Source: UKRI; Medical Research Council [G0000340] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSEN BM, 1980, ACTA PATH MICRO IM B, V88, P231; Brandtzaeg P, 1988, Prog Clin Biol Res, V272, P263; BRANDTZAEG P, 1989, J INFECT DIS, V159, P195, DOI 10.1093/infdis/159.2.195; CARTWRIGHT K, 1992, BMJ-BRIT MED J, V305, P143, DOI 10.1136/bmj.305.6846.143; HURLEY JC, 1992, CLIN INFECT DIS, V15, P840, DOI 10.1093/clind/15.5.840; MELLADO MC, 1991, EPIDEMIOL INFECT, V106, P283, DOI 10.1017/S0950268800048421; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Norgard B, 2002, J INFECTION, V45, P144, DOI 10.1053/jinf.2002.1037; Sorensen HT, 1998, J CLIN EPIDEMIOL, V51, P717, DOI 10.1016/S0895-4356(98)00064-X; STRANG JR, 1992, BRIT MED J, V305, P141, DOI 10.1136/bmj.305.6846.141	10	34	34	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 3	2006	332	7553					1295	1297		10.1136/bmj.38789.723611.55	http://dx.doi.org/10.1136/bmj.38789.723611.55			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16554335	Green Published, Bronze			2022-12-28	WOS:000238197000014
J	Wang, XH; Aliyari, R; Li, WX; Li, HW; Kim, K; Carthew, R; Atkinson, P; Ding, SW				Wang, XH; Aliyari, R; Li, WX; Li, HW; Kim, K; Carthew, R; Atkinson, P; Ding, SW			RNA interference directs innate immunity against viruses in adult Drosophila	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; ANTIVIRAL RESPONSE; DISTINCT ROLES; ANIMAL VIRUS; PATHWAY; SUPPRESSION; INDUCTION; PROTEINS	Innate immunity against bacterial. and fungal pathogens is mediated by Toll. and immune deficiency (Imd) pathways, but little is known about the antiviral response in Drosophila. Here, we demonstrate that an RNA interference pathway protects adult flies from infection by two evolutionarily diverse viruses. Our work also describes a molecular framework for the viral immunity, in which Viral double-stranded RNA produced during infection acts as the pathogen trigger whereas Drosophila Dicer-2 and Argonaute-2 act as host sensor and effector, respectively. These findings establish a Drosophila model for studying the innate immunity against viruses in animals.	Univ Calif Riverside, Grad Program Microbiol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; Northwestern University	Ding, SW (corresponding author), Univ Calif Riverside, Grad Program Microbiol, Riverside, CA 92521 USA.	dingsw@ucr.edu	Ding, Shou Wei/AAC-2533-2020	Ding, SW/0000-0002-4697-8413	NIAID NIH HHS [R01 AI052447, AI052447] Funding Source: Medline; NIGMS NIH HHS [R01 GM068743] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052447] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068743] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ball LA, 1999, ADV VIRUS RES, V53, P229, DOI 10.1016/S0065-3527(08)60350-4; Dong XF, 1998, J VIROL, V72, P6024, DOI 10.1128/JVI.72.7.6024-6033.1998; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	18	537	569	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					452	454		10.1126/science.1125694	http://dx.doi.org/10.1126/science.1125694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16556799	Green Accepted			2022-12-28	WOS:000236941800054
J	Miller, KM; Rog, O; Cooper, JP				Miller, KM; Rog, O; Cooper, JP			Semi-conservative DNA replication through telomeres requires Taz1	NATURE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; FORK REVERSAL; PROTEIN; RECOMBINATION; HELICASE; LENGTH; CELLS; ORIGINS	Telomere replication is achieved through the combined action of the conventional DNA replication machinery and the reverse transcriptase, telomerase. Telomere-binding proteins have crucial roles in controlling telomerase activity; however, little is known about their role in controlling semi-conservative replication, which synthesizes the bulk of telomeric DNA(1). Telomere repeats in the fission yeast Schizosaccharomyces pombe are bound by Taz1, a regulator of diverse telomere functions(2-4). It is generally assumed that telomere-binding proteins impede replication fork progression. Here we show that, on the contrary, Taz1 is crucial for efficient replication fork progression through the telomere. Using two-dimensional gel electrophoresis(5), we find that loss of Taz1 leads to stalled replication forks at telomeres and internally placed telomere sequences, regardless of whether the telomeric G-rich strand is replicated by leading-or lagging-strand synthesis. In contrast, the Taz1-interacting protein Rap1 is dispensable for efficient telomeric fork progression. Upon loss of telomerase, taz1 Delta telomeres are lost precipitously, suggesting that maintenance of taz1 Delta telomere repeats cannot be sustained through semi-conservative replication. As the human telomere proteins TRF1 and TRF2 are Taz1 orthologues, we predict that one or both of the human TRFs may orchestrate fork passage through human telomeres. Stalled forks at dysfunctional human telomeres are likely to accelerate the genomic instability that drives tumorigenesis.	Canc Res UK, Telomere Biol Lab, London WC2A 3PX, England	Cancer Research UK	Cooper, JP (corresponding author), Canc Res UK, Telomere Biol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julie.cooper@cancer.org.uk		Miller, Kyle/0000-0002-4544-0013; cooper, julia promisel/0000-0003-2171-2587				Ahn JS, 2005, EMBO J, V24, P2011, DOI 10.1038/sj.emboj.7600670; Beernink HTH, 2003, CURR BIOL, V13, P575, DOI 10.1016/S0960-9822(03)00169-6; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; DUBEY DD, 1994, EMBO J, V13, P3638, DOI 10.1002/j.1460-2075.1994.tb06671.x; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Londono-Vallejo JA, 2004, CANCER RES, V64, P2324, DOI 10.1158/0008-5472.CAN-03-4035; Lustig AJ, 2003, NAT REV GENET, V4, P916, DOI 10.1038/nrg1207; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Ohki R, 2004, NUCLEIC ACIDS RES, V32, P1627, DOI 10.1093/nar/gkh309; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sugawara N., 1988, DNA SEQUENCES TELOME; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011	28	199	199	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					824	828		10.1038/nature04638	http://dx.doi.org/10.1038/nature04638			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598261				2022-12-28	WOS:000236548400047
J	Gonzalez, S; Klatt, P; Delgado, S; Conde, E; Lopez-Rios, F; Sanchez-Cespedes, M; Mendez, J; Antequera, F; Serrano, M				Gonzalez, S; Klatt, P; Delgado, S; Conde, E; Lopez-Rios, F; Sanchez-Cespedes, M; Mendez, J; Antequera, F; Serrano, M			RETRACTED: Oncogenic activity of Cdc6 through repression of the INK4/ARF locus (Retracted article. See vol. 547, pg. 246, 2017)	NATURE			English	Article; Retracted Publication							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; HUMAN-CELLS; INITIATION SITES; TUMOR; PROTEINS; IDENTIFICATION; TRANSCRIPTION; METHYLATION; P16(INK4A)	The INK4/ARF locus encodes three tumour suppressors (p15(INK4b), ARF and p16(INK4a)) and is among the most frequently inactivated loci in human cancer(1,2). However, little is known about the mechanisms that govern the expression of this locus. Here we have identified a putative DNA replication origin at the INK4/ARF locus that assembles a multiprotein complex containing Cdc6, Orc2 and MCMs, and that coincides with a conserved noncoding DNA element ( regulatory domain RDINK4/ARF). Targeted and localized RNA-interference-induced heterochromatinization of RDINK4/ARF results in transcriptional repression of the locus, revealing that RDINK4/ARF is a relevant transcriptional regulatory element. Cdc6 is overexpressed in human cancers, where it might have roles in addition to DNA replication(3-5). We have found that high levels of Cdc6 result in RDINK4/ARF-dependent transcriptional repression, recruitment of histone deacetylases and heterochromatinization of the INK4/ARF locus, and a concomitant decrease in the expression of the three tumour suppressors encoded by this locus. This mechanism is reminiscent of the silencing of the mating-type HM loci in yeast by replication factors(6). Consistent with its ability to repress the INK4/ARF locus, Cdc6 has cellular immortalization activity and neoplastic transformation capacity in cooperation with oncogenic Ras. Furthermore, human lung carcinomas with high levels of Cdc6 are associated with low levels of p16(INK4a). We conclude that aberrant expression of Cdc6 is oncogenic by directly repressing the INK4/ARF locus through the RDINK4/ARF element.	Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; Spanish Natl Canc Res Ctr CNIO, Lung Canc Grp, E-28029 Madrid, Spain; Spanish Natl Canc Res Ctr CNIO, DNA Replicat Grp, E-28029 Madrid, Spain; Univ Salamanca, CSIC, Inst Microbiol Bioquim, E-37007 Salamanca, Spain; Hosp Univ 12 Octubre, Dept Anat Patol, E-28041 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Hospital Universitario 12 de Octubre	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain.	mserrano@cnio.es	Serrano, Manuel/H-2634-2015; Sanchez-Cespedes, Montse/H-8485-2012; Antequera, Francisco/B-1115-2017; Gonzalez, Susana/I-3154-2015	Serrano, Manuel/0000-0001-7177-9312; Sanchez-Cespedes, Montse/0000-0002-6045-5627; Antequera, Francisco/0000-0003-2623-4131; Gonzalez, Susana/0000-0002-7443-6195				Abdurashidova G, 2003, EMBO J, V22, P4294, DOI 10.1093/emboj/cdg404; Antequera F, 2004, EMBO J, V23, P4365, DOI 10.1038/sj.emboj.7600450; Araujo FD, 1999, J BIOL CHEM, V274, P9335, DOI 10.1074/jbc.274.14.9335; Arcellana-Panlilio MY, 2000, GENE CHROMOSOME CANC, V29, P63, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1006>3.0.CO;2-L; Cvetic C, 2005, SEMIN CELL DEV BIOL, V16, P343, DOI 10.1016/j.semcdb.2005.02.009; Delgado S, 1998, EMBO J, V17, P2426, DOI 10.1093/emboj/17.8.2426; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Fox CA, 2005, J BIOL CHEM, V280, P8629, DOI 10.1074/jbc.R400033200; Frolova NS, 2002, MOL BIOL CELL, V13, P1298, DOI 10.1091/mbc.01-08-0382; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Karakaidos P, 2004, AM J PATHOL, V165, P1351, DOI 10.1016/S0002-9440(10)63393-7; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Ladenburger EM, 2002, MOL CELL BIOL, V22, P1036, DOI 10.1128/MCB.22.4.1036-1048.2002; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Murphy N, 2005, J CLIN PATHOL, V58, P525, DOI 10.1136/jcp.2004.018895; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Pennacchio LA, 2001, NAT REV GENET, V2, P100, DOI 10.1038/35052548; Semple JW, 2004, BIOTECHNOL ADV, V22, P621, DOI 10.1016/j.biotechadv.2004.06.001; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Stucki M, 2001, PROG NUCLEIC ACID RE, V65, P261; Tao L, 2000, J CELL BIOCHEM, V78, P442, DOI 10.1002/1097-4644(20000901)78:3<442::AID-JCB9>3.0.CO;2-1; Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738	28	147	158	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					702	706		10.1038/nature04585	http://dx.doi.org/10.1038/nature04585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572177				2022-12-28	WOS:000236350400051
J	Harper, JW; Schulman, BA				Harper, JW; Schulman, BA			Structural complexity in ubiquitin recognition	CELL			English	Review							SUMO-BINDING MOTIF; PROTEINS; RABEX-5; DOMAINS	Ubiquitinated proteins are sorted into distinct pathways via association with several classes of ubiquitin binding domain-containing proteins. A virtual explosion in the field of ubiquitin binding proteins has revealed several new classes and interactions with distinct surfaces on ubiquitin, providing a clearer understanding of how sorting of ubiquitinated proteins is achieved.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; St Jude Childrens Hosp, Howard Hughes Med Inst, Dept Biol Struct Biol, Memphis, TN 38105 USA; St Jude Childrens Hosp, Howard Hughes Med Inst, Dept Tumor Cell Biol, Memphis, TN 38105 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu; brenda.schulman@stjude.org		Harper, Jeffrey/0000-0002-6944-7236	NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG011085] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Lee S, 2006, NAT STRUCT MOL BIOL, V13, P264, DOI 10.1038/nsmb1064; Mattera R, 2006, J BIOL CHEM, V281, P6874, DOI 10.1074/jbc.M509939200; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032	12	106	109	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1133	1136		10.1016/j.cell.2006.03.009	http://dx.doi.org/10.1016/j.cell.2006.03.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564007	Bronze			2022-12-28	WOS:000237241400014
J	Loring, JF; Campbell, C				Loring, JF; Campbell, C			Science and law - Intellectual property and human embryonic stem cell research	SCIENCE			English	Editorial Material									Burnham Inst Med Res, La Jolla, CA 92037 USA; McDermott Will & Emery LLP, Washington, DC 20005 USA	Sanford Burnham Prebys Medical Discovery Institute	Loring, JF (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	jloring@burnham.org; ccampbell@mwe.com	Loring, Jeanne F/A-1620-2011	Loring, Jeanne F/0000-0001-6226-9767				BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; RAEBURN P, 1994, MILWAUKEE J     1104; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Vogel G, 2004, SCIENCE, V305, P1887; 2003, Patent No. 10430496; 2001, Patent No. 09982637; 2005, Patent No. 11036245; 2005, Patent No. 11033335	8	23	25	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1716	1717		10.1126/science.1120953	http://dx.doi.org/10.1126/science.1120953			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	024OA	16556826				2022-12-28	WOS:000236204300024
J	Foster, I				Foster, I			A two-way street to science's future	NATURE			English	Editorial Material									Univ Chicago, Computat Inst, Chicago, IL 60637 USA; Argonne Natl Lab, Argonne, IL 60439 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Foster, I (corresponding author), Univ Chicago, Computat Inst, Chicago, IL 60637 USA.		Foster, Ian T/A-1357-2007; Foster, Ian/GNH-1877-2022	Foster, Ian T/0000-0003-2129-5269; Foster, Ian/0000-0003-2129-5269				Cohen JE, 2004, PLOS BIOL, V2, P2017, DOI 10.1371/journal.pbio.0020439; Dawkins R., 1986, BLIND WATCHMAKER; DENNING PJ, 1989, COMMUN ACM, V32, P9, DOI 10.1145/63238.63239; DJORGOVSKI GS, 2005, 7 INT WORKSH COMP AR, P125; Szalay AS, 2000, SIGMOD REC, V29, P451, DOI 10.1145/335191.335439	5	24	24	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					419	419		10.1038/440419a	http://dx.doi.org/10.1038/440419a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554785	Bronze			2022-12-28	WOS:000236176100023
J	Hoffman, RM				Hoffman, RM			Viewpoint: Limiting prostate cancer screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY; OLDER MEN; ANTIGEN; TRENDS; TRIAL; LUNG	Prostate cancer screening is controversial, and major professional associations offer differing screening guidelines. The author addresses 3 key issues about prostate cancer screening: 1) the prostate-specific antigen (PSA) criteria to recommend a prostate biopsy, 2) the appropriate age to start screening, and 3) the appropriate age to stop screening. The author argues, on the basis of evidence published since 2000, that data supporting the efficacy of PSA screening remain unconvincing. The author recommends that screening should not be expanded to include average-risk men younger than age 50 years or older than age 75 years and that a PSA threshold below 4.0 ng/mL should not be used to trigger biopsy referral.	New Mexico Vet Affairs Hlth Care Syst, Albuquerque, NM 87108 USA; Univ New Mexico, Sch Med, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA	University of New Mexico	Hoffman, RM (corresponding author), New Mexico Vet Affairs Hlth Care Syst, 111GIM,1501 San Pedro Dr SE, Albuquerque, NM 87108 USA.	rhoffman@unm.edu		Hoffman, Richard/0000-0002-4714-7726				Alibhai SMH, 2003, J CLIN ONCOL, V21, P3318, DOI 10.1200/JCO.2003.09.034; Berg AO, 2002, ANN INTERN MED, V137, P915, DOI 10.7326/0003-4819-137-11-200212030-00013; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bubolz T, 2001, UROLOGY, V58, P977, DOI 10.1016/S0090-4295(01)01434-0; Carroll P, 2001, UROLOGY, V57, P225, DOI 10.1016/S0090-4295(00)00994-8; de Koning HJ, 2002, INT J CANCER, V97, P237, DOI 10.1002/ijc.1588; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Etzioni R, 2002, J NATL CANCER I, V94, P981; Fang JY, 2001, UROLOGY, V58, P411, DOI 10.1016/S0090-4295(01)01304-8; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Krumholtz JS, 2002, UROLOGY, V60, P469, DOI 10.1016/S0090-4295(02)01875-7; Krumholtz JS, 2002, UROLOGY, V60, P474; Lu-Yao GL, 1999, UROLOGY, V54, P301, DOI 10.1016/S0090-4295(99)00100-4; LUYAO GL, 1993, JAMA-J AM MED ASSOC, V269, P2633, DOI 10.1001/jama.269.20.2633; *NAT COMPR CANC NE, 2005, PROST CANC EARL DET; Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399; Ross LE, 2004, PREV MED, V38, P732, DOI 10.1016/j.ypmed.2004.01.005; Schroder F H, 1994, Can J Oncol, V4 Suppl 1, P102; SCHRODER FH, 1994, CAN J ONCOL S1, V4, P106; Smith RA, 2002, CA-CANCER J CLIN, V52, P8, DOI 10.3322/canjclin.52.1.8; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007	24	24	24	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					438	440		10.7326/0003-4819-144-6-200603210-00011	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00011			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549856				2022-12-28	WOS:000236251800008
J	Dye, C				Dye, C			Global epidemiology of tuberculosis	LANCET			English	Editorial Material							PREVALENCE; TRENDS; BURDEN		WHO, HIV AIDS TB & Malaria, CH-1211 Geneva 27, Switzerland	World Health Organization	Dye, C (corresponding author), WHO, HIV AIDS TB & Malaria, CH-1211 Geneva 27, Switzerland.	dyec@who.int	Dye, Christopher/AIC-4659-2022	Dye, Christopher/0000-0002-2957-1793				Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; *WHO, 2006, GLOB TUB CONTR SURV, P242; *WHO IUATALD, 2004, 3 WHO IUATALD, P299; World Health Organization, 2004, WORLD HLTH REP 2004	10	528	552	0	46	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					938	940		10.1016/S0140-6736(06)68384-0	http://dx.doi.org/10.1016/S0140-6736(06)68384-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546542				2022-12-28	WOS:000236242100030
J	Blasiak, LC; Vaillancourt, FH; Walsh, CT; Drennan, CL				Blasiak, LC; Vaillancourt, FH; Walsh, CT; Drennan, CL			Crystal structure of the non-haem iron halogenase SyrB2 in syringomycin biosynthesis	NATURE			English	Article							ALPHA-KETOGLUTARATE DIOXYGENASE; ESCHERICHIA-COLI; GENE-CLUSTER; INTERMEDIATE; CHLORINATION; MECHANISM; PROGRAM; TAURINE; ENZYMES; SYSTEM	Non- haem Fe( II)/ alpha-ketoglutarate ( alpha KG)- dependent enzymes harness the reducing power of alpha KG to catalyse oxidative reactions, usually the hydroxylation of unactivated carbons, and are involved in processes such as natural product biosynthesis, the mammalian hypoxic response, and DNA repair(1,2). These enzymes couple the decarboxylation of alpha KG with the formation of a high- energy ferryl- oxo intermediate that acts as a hydrogen- abstracting species(2-4). All previously structurally characterized mononuclear iron enzymes contain a 2- His, 1- carboxylate motif that coordinates the iron(1,2). The two histidines and one carboxylate, known as the ' facial triad', form one triangular side of an octahedral iron coordination geometry. A subclass of mononuclear iron enzymes has been shown to catalyse halogenation reactions, rather than the more typical hydroxylation reaction(5,6). SyrB2, a member of this subclass, is a non- haem Fe( II)/ alpha KG-dependent halogenase that catalyses the chlorination of threonine in syringomycin E biosynthesis(5). Here we report the structure of SyrB2 with both a chloride ion and alpha KG coordinated to the iron ion at 1.6 angstrom resolution. This structure reveals a previously unknown coordination of iron, in which the carboxylate ligand of the facial triad is replaced by a chloride ion.	MIT, Dept Chem, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	cdrennan@MIT.EDU						Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; DeLano W.L, PYMOL MOL GRAPHICS S; Dong CJ, 2005, SCIENCE, V309, P2216, DOI 10.1126/science.1116510; Goldsmith CR, 2002, INORG CHEM, V41, P4642, DOI 10.1021/ic025616z; GRGURINA I, 1994, EXPERIENTIA, V50, P130, DOI 10.1007/BF01984950; Grzyska PK, 2005, BIOCHEMISTRY-US, V44, P3845, DOI 10.1021/bi048746n; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KLEYWEGT GJ, 1994, CCP4 ESF EACBM NEWSL, V31, P9; Koehntop KD, 2005, J BIOL INORG CHEM, V10, P87, DOI 10.1007/s00775-005-0624-x; KOJIMA T, 1993, J AM CHEM SOC, V115, P11328, DOI 10.1021/ja00077a035; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Price JC, 2005, BIOCHEMISTRY-US, V44, P8138, DOI 10.1021/bi050227c; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vaillancourt FH, 2005, NATURE, V436, P1191, DOI 10.1038/nature03797; Vaillancourt FH, 2005, P NATL ACAD SCI USA, V102, P10111, DOI 10.1073/pnas.0504412102; VAILLANCOURT FH, IN PRESS CHEMBIOCHEM; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723	29	260	265	5	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					368	371		10.1038/nature04544	http://dx.doi.org/10.1038/nature04544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541079				2022-12-28	WOS:000235997600059
J	WOLF, S; DEOM, CM; BEACHY, RN; LUCAS, WJ				WOLF, S; DEOM, CM; BEACHY, RN; LUCAS, WJ			MOVEMENT PROTEIN OF TOBACCO MOSAIC-VIRUS MODIFIES PLASMODESMATAL SIZE EXCLUSION LIMIT	SCIENCE			English	Article									WASHINGTON UNIV,DEPT BIOL,ST LOUIS,MO 63130	Washington University (WUSTL)	WOLF, S (corresponding author), UNIV CALIF DAVIS,DEPT BOT,DAVIS,CA 95616, USA.			Deom, C. Michael/0000-0002-7008-9720				ALLISON AV, 1974, PHYTOPATHOLOGY, V64, P784, DOI 10.1094/Phyto-64-784; ATABEKOV JG, 1984, ADV VIRUS RES, V29, P313, DOI 10.1016/S0065-3527(08)60412-1; DEOM CM, 1987, SCIENCE, V237, P389, DOI 10.1126/science.237.4813.389; ERWEE MG, 1983, PLANTA, V158, P320, DOI 10.1007/BF00397334; ERWEE MG, 1985, PLANTA, V163, P9, DOI 10.1007/BF00395891; ERWEE MG, 1984, PROTOPLASMA, V122, P162, DOI 10.1007/BF01281693; Esau, 1969, PHLOEM HDB PFLANZENA; FISHER DG, 1988, PLANT CELL ENVIRON, V11, P639, DOI 10.1111/j.1365-3040.1988.tb01806.x; FLAGGNEWTON J, 1979, SCIENCE, V205, P404, DOI 10.1126/science.377490; Gibbs A, 1976, INTERCELLULAR COMMUN, P149; Gunning B. E. S., 1976, Transport and transfer processes in plants. [Wardlaw, I.F.; Passioura, J.B. (Editors)]., P15; Gunning B. E. S., 1976, Intercellular communication in plants: studies in plasmodesmata., P1; KITAJIMA EW, 1969, VIROLOGY, V37, P681, DOI 10.1016/0042-6822(69)90288-8; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Loewenstein W R, 1978, Ann N Y Acad Sci, V307, P285, DOI 10.1111/j.1749-6632.1978.tb41958.x; Lucas W E, 2014, UNPUB; MADORE MA, 1986, PLANT PHYSIOL, V82, P432, DOI 10.1104/pp.82.2.432; MESHI T, 1987, EMBO J, V6, P2557, DOI 10.1002/j.1460-2075.1987.tb02544.x; NISHIGUCHI M, 1978, J GEN VIROL, V39, P53, DOI 10.1099/0022-1317-39-1-53; NISHIGUCHI M, 1980, J GEN VIROL, V46, P497, DOI 10.1099/0022-1317-46-2-497; OPARKA KJ, 1988, PLANTA, V176, P533, DOI 10.1007/BF00397661; PALEVITZ BA, 1985, PLANTA, V164, P473, DOI 10.1007/BF00395962; PEARCE RH, 1978, J CHROMATOGR, V151, P548; PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1; POITEVIN E, 1988, BIOPHYS CHEM, V31, P247, DOI 10.1016/0301-4622(88)80030-9; SIMPSON I, 1978, ANAL BIOCHEM, V89, P304, DOI 10.1016/0003-2697(78)90755-8; SQUIRE PG, 1981, J CHROMATOGR, V210, P433, DOI 10.1016/S0021-9673(00)80335-0; STEWART WW, 1981, NATURE, V292, P17, DOI 10.1038/292017a0; TERRY BR, 1987, PLANTA, V171, P145, DOI 10.1007/BF00391090; TUCKER EB, 1985, PROTOPLASMA, V128, P167, DOI 10.1007/BF01276338; TUCKER EB, 1982, PROTOPLASMA, V113, P193, DOI 10.1007/BF01280907; VANBEL AJE, 1985, PLANT CELL ENVIRON, V8, P173; WEINTRAUB M, 1976, J ULTRA MOL STRUCT R, V56, P351, DOI 10.1016/S0022-5320(76)90010-1; WOLF S, UNPUB	34	518	540	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 20	1989	246	4928					377	379		10.1126/science.246.4928.377	http://dx.doi.org/10.1126/science.246.4928.377			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AV670	16552920				2022-12-28	WOS:A1989AV67000037
J	Ramsey, IS; Moran, MM; Chong, JHA; Clapham, DE				Ramsey, IS; Moran, MM; Chong, JHA; Clapham, DE			A voltage-gated proton-selective channel lacking the pore domain	NATURE			English	Article							ALVEOLAR EPITHELIAL-CELLS; NADPH OXIDASE; HUMAN-NEUTROPHILS; H+ CURRENTS; PHAGOCYTES; SENSOR; DEPENDENCE; REVEALS; PH	Voltage changes across the cell membrane control the gating of many cation-selective ion channels. Conserved from bacteria to humans(1), the voltage-gated-ligand superfamily of ion channels are encoded as polypeptide chains of six transmembrane-spanning segments (S1-S6). S1-S4 functions as a self-contained voltage-sensing domain (VSD), in essence a positively charged lever that moves in response to voltage changes. The VSD 'ligand' transmits force via a linker to the S5-S6 pore domain 'receptor'(2), thereby opening or closing the channel. The ascidian VSD protein Ci-VSP gates a phosphatase activity rather than a channel pore, indicating that VSDs function independently of ion channels(3). Here we describe a mammalian VSD protein (H(V)1) that lacks a discernible pore domain but is sufficient for expression of a voltage-sensitive proton-selective ion channel activity. H(v)1 currents are activated at depolarizing voltages, sensitive to the transmembrane pH gradient, H+-selective, and Zn2+-sensitive. Mutagenesis of H(v)1 identified three arginine residues in S4 that regulate channel gating and two histidine residues that are required for extracellular inhibition of H(v)1 by Zn2+. H(v)1 is expressed in immune tissues and manifests the characteristic properties of native proton conductances (G(vH+)). In phagocytic leukocytes(4), G(vH+) are required to support the oxidative burst that underlies microbial killing by the innate immune system(4,5). The data presented here identify H(v)1 as a long-sought voltage-gated H+ channel and establish H(v)1 as the founding member of a family of mammalian VSD proteins.	Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp,Dept Cardiol,Howard Hughes Med Ins, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Childrens Hosp,Dept Cardiol,Howard Hughes Med Ins, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bokoch GM, 2003, TRENDS BIOCHEM SCI, V28, P502, DOI 10.1016/S0968-0004(03)00194-4; Cherny V V, 1997, Membr Cell Biol, V11, P337; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; DeCoursey TE, 2002, J GEN PHYSIOL, V120, P773, DOI 10.1085/jgp.20028704; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2001, J PHYSIOL-LONDON, V535, P767, DOI 10.1111/j.1469-7793.2001.00767.x; DeCoursey TE, 2001, J BIOL CHEM, V276, P36063, DOI 10.1074/jbc.C100352200; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; Eder C, 2001, PROG NEUROBIOL, V64, P277, DOI 10.1016/S0301-0082(00)00062-9; GOLDBERG J, 1995, NATURE, V376, P745, DOI 10.1038/376745a0; Henderson LM, 1999, J GEN PHYSIOL, V114, P771, DOI 10.1085/jgp.114.6.771; HENDERSON LM, 1988, BIOCHEM J, V255, P285; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Morgan D, 2002, J GEN PHYSIOL, V119, P571, DOI 10.1085/jgp.20018544; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; QU AY, 1994, AM J PHYSIOL, V266, pC1263, DOI 10.1152/ajpcell.1994.266.5.C1263; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; SASAKI M, IN PRESS SCIENCE; Schilling T, 2002, J PHYSIOL-LONDON, V545, P93, DOI 10.1113/jphysiol.2002.028878; SMITH RM, 1991, BLOOD, V77, P673; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; YU FH, 2004, SCI STKE	30	453	461	3	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1213	1216		10.1038/nature04700	http://dx.doi.org/10.1038/nature04700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16554753	Green Accepted			2022-12-28	WOS:000237080000050
J	Ireland, TR; Holden, P; Norman, MD; Clarke, J				Ireland, TR; Holden, P; Norman, MD; Clarke, J			Isotopic enhancements of O-17 and O-18 from solar wind particles in the lunar regolith	NATURE			English	Article							OXYGEN; NEBULA; GRAINS; ORIGIN; SYSTEM; METEORITES; OXIDATION; ANOMALIES; NITROGEN; RECORD	Differences in isotopic abundances between meteorites and rocks on Earth leave unclear the true composition of the gas out of which the Solar System formed(1-4). The Sun should have preserved in its outer layers the original composition, and recent work has indicated that the solar wind is enriched in O-16, relative to Earth, Mars and bulk meteorites(5). This suggests that self-shielding of CO due to photo-dissociation, which is a well understood process in molecular clouds, also led to evolution in the isotopic abundances in the early Solar System. Here we report measurements of oxygen isotopic abundances in lunar grains that were recently exposed to the solar wind. We find that O-16 is underabundant, opposite to an earlier finding(5) based on studies of ancient metal grains. Our result, however, is more difficult to understand within the context of current models, because there is no clear way to make O-16 more abundant in Solar System rocks than in the Sun.	Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Lunar & Planetary Inst, Houston, TX 77058 USA	Australian National University	Ireland, TR (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia.	Trevor.Ireland@anu.edu.au	Ireland, Trevor R/A-4993-2008; Ireland, Trevor R./GSJ-1884-2022	Ireland, Trevor R/0000-0001-7617-3889; Norman, Marc/0000-0002-1357-5415				Birck JL, 2004, REV MINERAL GEOCHEM, V55, P25, DOI 10.2138/gsrmg.55.1.25; *CELIAS MTOF, 2005, CELIAS MTOF EXP SOL; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; CLAYTON RN, 1984, EARTH PLANET SC LETT, V67, P151, DOI 10.1016/0012-821X(84)90110-9; EUGSTER O, 1973, GEOCHIM COSMOCHIM AC, V37, P1991, DOI 10.1016/0016-7037(73)90001-X; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Hashizume K, 2005, NATURE, V434, P619, DOI 10.1038/nature03432; Hashizume K, 2004, ASTROPHYS J, V600, P480, DOI 10.1086/379637; Hashizume K, 2002, EARTH PLANET SC LETT, V202, P201, DOI 10.1016/S0012-821X(02)00781-1; IRELAND TR, 2004, LUNAR PLANET SCI, V35; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; MARTIN M, 1994, THIN SOLID FILMS, V250, P61, DOI 10.1016/0040-6090(94)90166-X; Nuth JA, 1998, EARTH MOON PLANETS, V80, P73, DOI 10.1023/A:1006305627042; PILLINGER CT, 1979, REP PROG PHYS, V42, P897, DOI 10.1088/0034-4885/42/5/003; TAKADA J, 1986, Z METALLKD, V77, P6; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Wieler R, 1996, NATURE, V384, P46, DOI 10.1038/384046a0; Wieler R., 1980, P LUNAR PLANET SCI C, P1369; Wiens RC, 1999, METEORIT PLANET SCI, V34, P99, DOI 10.1111/j.1945-5100.1999.tb01735.x; Wiens RC, 2004, EARTH PLANET SC LETT, V226, P547, DOI 10.1016/j.epsl.2004.07.010; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452; YOUNG ED, 2005, WORKSH OX EARL SOL S; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989; Ziegler JF., 1985, TREATISE HEAVY ION S	27	61	61	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					776	778		10.1038/nature04611	http://dx.doi.org/10.1038/nature04611			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598252				2022-12-28	WOS:000236548400036
J	Yusuf, S; Mehta, SR; Bassand, JP; Budaj, A; Chrolavicius, S; Fox, KAA; Granger, CB; Joyner, C; Peters, RJG; Wallentin, L; Avezum, A; Boden, W; Cardona, E; Ceremuzynski, L; Col, J; Commerford, PJ; Diaz, R; Faxon, D; Flather, M; Fodor, G; Franzosi, MG; Granger, C; Halon, D; Hunt, D; Karatzas, N; Keltai, M; Kenda, M; Kim, JH; Lanas, F; Lau, CP; Lewis, BS; Morais, J; Moccetti, T; Pais, P; Paolasso, E; Parkhomenko, A; Petrauskiene, B; Piegas, L; Pipilis, A; Robaayah, D; Ruda, M; Rumboldt, Z; Rupprecht, HJ; Sitkei, E; Steg, PG; Swahn, E; Theroux, P; Valentin, V; Varigos, J; Weitz, J; White, H; Widimsky, P; Xavier, D; Zhu, JR; Ameriso, S; Bonilla, C; Braekken, S; Chan, YK; Chen, W; Chenniappan, M; Cohen, E; Cottin, Y; Csiba, L; Czepiel, A; De Raedt, H; Finet, G; Gardinale, E; Gaxiola, E; Gorecki, A; Gregor, P; Happola, O; Heras, M; Himbert, D; Irkin, O; Isaaz, K; Iyengar, SS; Kalvach, P; Kevers, L; Klosiewicz-Wasek, B; Laine, M; Leys, D; Lundstrom, E; Lusic, I; Lutay, Y; Maggioni, A; Massaro, A; Mayosi, BM; Moulin, T; Narendra, J; Naslund, U; Peeters, A; Penicka, M; Perakis, A; Petersen, P; Polic, S; Radhakrishnan, S; Renkin, J; Stockins, B; Sundararajan, R; Thygesen, K; Turazza, F; Van Belle, E; Vik-Mo, H; Zaborski, J; Sleight, P; Anderson, JL; Johnstone, DE; Hirsh, J; deMets, D; Holmes, DR; Meeks, B; Afzal, R; Pogue, J; Boccalon, S; Chrysler, K; Cracknell, B; Horsman, C; Hoskin, T; Jedrzejowski, B; Johnson, J; Kotlan, S; Lawrence, M; Smiley, M; Stevens, C; Yallup, R; Connolly, S; Demers, C; Devereaux, PJ; Healey, J; Lonn, E; Magloire, P; McKelvie, R; Morillo, C; Natarajan, M; Rokoss, M; Teo, K; Valettas, N; Velianou, J; Albisu, JP; Amuchastegui, M; Bello, FA; Bluguermann, JJ; Bono, JO; Caccavo, A; Carlevaro, OO; Cassettari, A; Cuneo, C; Farras, HA; Fuselli, J; Garrido, M; Guerrero, R; Hasbani, E; Hominal, MA; Hrabar, A; Marquez, LL; Luciardi, HL; Riera, LM; Marzetti, EM; Memoli, R; Nordaby, R; Orlandini, AD; Perez, M; Piasentin, JA; Ramos, HR; Risolo, AM; Sala, J; Salomone, O; Schygiel, PO; Ubaldini, J; Vico, M; Amerena, J; Arnolda, L; Aroney, G; Boyd, P; Cahill, P; Chew, D; Counsell, JT; Cross, D; Edington, J; Fitzpatrick, D; Hicks, P; Horowitz, JD; Horrigan, MCG; New, G; Owensby, D; Schoeman, M; Thompson, P; Tulloch, G; Waites, J; Whelan, A; Ziffer, R; Huber, K; Jordanova, N; Al Shawafi, K; Convens, C; Coussement, P; de Meester, A; El Allaf, D; Janssens, L; Marcovitch, O; Muyldermans, L; Roosen, J; Soeur, F; Van Lierde, J; Vrolix, M; Leaes, P; Carvalho, AC; Schramm, EC; Mora, RD; Amino, JD; Dutra, O; Manenti, ERF; Gun, C; Saraiva, JFK; Hayashi, EK; Lichter, A; Lima, A; Marin-Neto, JA; Teixeira, SPM; Abrantes, JAM; Baracioli, LM; Nicolau, JC; Maia, LN; Jaeger, CP; Esteves, JP; Rabelo, A; Ramos, RF; Reis, G; Rossi, P; dos Santos, FR; Teixeira, MS; Silveira, DS; Lemos, MABT; Timerman, A; Greque, GV; Vaz, R; Bhargava, R; Brons, S; Colclough, M; Constance, C; Costi, P; Dacyk, A; Davies, T; Diodati, J; Dupuis, R; Elliott, H; Fell, DA; Fung, AY; Gladstone, PJS; Gosselin, G; Grondin, F; Huynh, T; Janzen, I; Kalaparambath, T; Kornder, J; Kouz, S; Kuritzky, R; Labelle-Stimac, S; Lamothe, M; Lauzon, C; LeMay, M; Ma, P; MacCallum, GC; McCallum, A; Mitchell, D; Montigny, M; Nguyen, N; Pearce, M; Pistawka, KJ; Rebane, T; Roy, M; Senaratne, M; Smith, J; Stimac, J; Traboulsi, M; Vizel, S; Weeks, A; Zadra, R; Zimmerman, RH; Alcaino, ME; Castro, P; Chen, J; Chen, J; Chen, JL; Fan, W; Ge, J; Hu, D; Huang, J; Jingxuan, G; Ke, Y; Ma, H; Wu, Y; Yingxian, S; Yu, B; Zhu, W; Bakula, M; Bergovec, M; Lukin, A; Milicevic, G; Padovan, M; Polic, S; Raguz, M; Aschermann, M; Belohlavek, J; Bocek, P; Branny, M; Budesinsky, T; Groch, L; Holm, F; Jansky, P; Jelinek, P; Jirka, V; Kaislerova, M; Konecny, P; Lisa, L; Maly, M; Marcinek, G; Oscipovsky, M; Stumar, J; Vacha, M; Nielsen, T; Vigholt, E; Laanmets, P; Soopold, U; Voitk, J; Naveri, H; Niemela, M; Peuhkurinen, K; Tuomainen, P; Ylitalo, A; Py, A; Amat, G; Bessede, G; Boschat, J; Carrie, D; Charbonnier, B; Coliet, JP; Dambrine, P; Dubois-Rande, JL; Ferrari, E; Fouche, R; Grollier, G; Jaboureck, O; Ketelers, R; Khalife, K; Leroy, F; Lognone, T; Macquin-Mavier, I; Montalescot, G; Pacouret, G; Poulard, JE; Puel, J; Richard, M; Schiele, F; Bischoff, KO; Buerke, M; Buerke, U; Dominick, K; Drexler, H; Feiler, A; Guelker, H; Haltern, G; Katus, HA; Klauss, V; Klutmann, M; Koeth, O; Meinhardt, G; Muenzel, TM; Nitschke, T; Offterdinger, M; Rieber, J; Schieffer, B; Stangl, K; Stangl, V; vom Dahl, J; Witzenbichler, B; Zeymer, U; Alexopoulos, D; Blassopoulou, N; Christon, A; Fotiadis, I; Foussas, S; Grapsas, N; Moschos, N; Papasteriadis, E; Symeonidis, D; Tyrologos, A; Leung, WS; Li, SK; Arabadzisz, H; Csikazs, J; Dancs, T; Davidovits, Z; Edes, I; Farkas, E; Herczeg, B; Janos, S; Janosi, A; Kadar, A; Kis, E; Kristof, E; Lupkovics, G; Mark, L; Nagy, A; Nagy, L; Poor, F; Regos, L; Sebo, J; Tomcsanyi, J; Toth, K; Bharani, A; Chidambaram, N; Haridas, KK; Iyengar, SS; Jain, A; Jain, A; Jain, PRK; Jaison, TM; Kerkar, PG; Naik, S; Nambiar, A; Narendra, J; Panwar, RB; Parikh, K; Puri, VK; Rajesh, T; Ramesh, M; Singh, B; Thanikachalam, S; Tongia, RK; Varma, S; Barbiero, M; Bardelli, G; Bernardi, D; Bolognese, L; Capponi, L; De Ferrari, G; Fanelli, R; Frediani, L; Galli, M; Izzo, A; Lombardi, A; Maresta, A; Martinoni, A; Melloni, C; Meneghetti, P; Mennuni, M; Moretti, L; Orlandi, M; Pancaldi, LG; Petronzelli, S; Piovaccari, G; Salvioni, A; Severini, D; Terrosu, P; Zanini, R; Erglis, A; Kalnins, U; Verboenko, J; Zakke, I; Kugiene, R; Zaliunas, R; Bin Othman, A; Chee, KH; Hian, SK; Gutierrez, AC; Diaz, AC; Garcia-Castillo, A; Guerrero, MC; Morales, CL; Ramos-Lopez, G; Baldew, SC; Basart, DCG; Clappers, N; Daniels, MCG; de Weerd, GJ; den Hartog, FR; Hendriks, IHGM; Herrman, JPR; Kofflard, M; Krasznai, K; Michels, HR; Stoel, I; ten Berg, JM; Umans, VAWN; van Beek, GJ; van Daele, MERM; van den Berg, BJ; van Hessen, MWJ; van Kalmthout, PM; van Rossum, P; Verheugt, FWA; Viergever, EP; Withagen, AJAM; Achremczyk, P; Arasimowicz, P; Baranowska, T; Biegayto, J; Bronisz, M; Buszman, P; Czepiel, A; Dalkowski, M; Dluzniewski, M; Gessek, J; Goch, JH; Gorecki, A; Janik, K; Janion, M; Kawecki, D; Kleinrok, A; Komorowski, P; Krasowski, W; Krauze-Wielicka, M; Malinowski, S; Nowak, T; Nowakowski, P; Ogorek, M; Piepiorka, M; Pluta, W; Puzio, E; Puzniak, M; Rekosz, J; Rybka, P; Sendrowski, D; Siminiak, T; Skura, M; Stopinski, M; Szetemej, R; Szolkiewicz, M; Szpajer, M; Trusz-Gluza, M; Waszyrowski, T; Wita, K; Wodniecki, J; Wojewoda, P; Zambrzycki, J; Zielinski, Z; Cardoso, P; Carrageta, DM; Ferreira, D; Gomes, MV; Santos, L; Arkhipov, M; Belousov, Y; Charchoglyan, R; Gordeev, IG; Gratsiansky, NA; Grinshtein, Y; Khrustalev, O; Kokorin, VA; Komarov, A; Kozulin, V; Minushkina, LO; Panchenko, E; Panov, A; Petrik, ES; Shakhnovich, RM; Shalaev, SV; Sukhinina, TS; Trifonov, IR; Zateyshchikov, DA; Khoo, BCH; Tan, HC; Tan, RS; Hricak, V; Motovska, Z; Poliacik, P; Kanic, V; Kovacic, D; Kranjec, I; Voga, G; Bayat, J; Essop, MR; Maritz, F; Marx, JD; Ntsekhe, M; Pretorius, MP; Ranjith, N; Theron, H; Chae, IH; Chae, SC; Choe, KH; Chung, NS; Jeong, MH; Kim, CJ; Kim, HS; Kim, W; Rhim, CY; Shin, EK; Shin, GJ; Alameda, M; Alonso-Orcajo, N; Bethencourt, A; Calvo, F; Avellaneda, JLC; Delgado, V; Diaz-Castro, O; Esplugas, E; Faus, R; Fernandez-Ortiz, A; Frutos, A; Goirena, P; Heras, M; Iglesias, FC; Llorian, AR; Macaya, C; Mancisidor, X; Melgares, R; Pascual, C; Ruiz-Nodar, JM; Simon, JM; Agewall, S; Ahlstrom, P; Ali, M; Andersson, L; Bandh, S; Digerfeldt, C; Ericsson, H; Forsgren, M; Jabro, J; Janzon, M; Joborn, H; Johnston, N; Karlsson, JE; Larsson, LE; Linderfalk, C; Lonnberg, I; Mooe, T; Naslund, U; Oldgren, J; Pihl, E; Risenfors, M; Sjolund, E; Soderberg, I; Stjerna, A; Svennberg, L; Wodlin, P; Pagnamenta, A; Pieper, M; Rossi, MG; Weber, K; Peng, MC; Cheng, JJ; Chiang, FT; Kuo, CT; Tseng, CD; Andreyeshcheva, I; Dzyak, GV; Fedtchouk, L; Gontar, A; Karpenko, O; Kononenko, L; Koval, EA; Kovalsky, I; Kraitz, I; Lutay, Y; Netiazhenko, V; Polyvoda, S; Prokopenko, Y; Prudkiy, I; Rudenko, L; Serediuk, N; Zolotaykina, V; Adgey, J; Ahsan, A; Brack, M; Bridges, AB; Burton, J; Findlay, I; Fluck, DS; Radford, L; Robson, RH; Senior, R; Starkey, IR; Alexander, J; Baber, Z; Campbell, M; Caputo, R; Chandna, H; Chandrashekhar, Y; Chu, A; DeRaad, RE; Druken, B; Goyal, A; Holly, D; Kemp, A; Kotlaba, D; Levine, MJ; Miller, GP; Nygaard, T; Parikh, DK; Ramos, C; Rivera, E; Rodriguez, R; Sangani, B; Walder, JS				Yusuf, S; Mehta, SR; Bassand, JP; Budaj, A; Chrolavicius, S; Fox, KAA; Granger, CB; Joyner, C; Peters, RJG; Wallentin, L; Avezum, A; Boden, W; Cardona, E; Ceremuzynski, L; Col, J; Commerford, PJ; Diaz, R; Faxon, D; Flather, M; Fodor, G; Franzosi, MG; Granger, C; Halon, D; Hunt, D; Karatzas, N; Keltai, M; Kenda, M; Kim, JH; Lanas, F; Lau, CP; Lewis, BS; Morais, J; Moccetti, T; Pais, P; Paolasso, E; Parkhomenko, A; Petrauskiene, B; Piegas, L; Pipilis, A; Robaayah, D; Ruda, M; Rumboldt, Z; Rupprecht, HJ; Sitkei, E; Steg, PG; Swahn, E; Theroux, P; Valentin, V; Varigos, J; Weitz, J; White, H; Widimsky, P; Xavier, D; Zhu, JR; Ameriso, S; Bonilla, C; Braekken, S; Chan, YK; Chen, W; Chenniappan, M; Cohen, E; Cottin, Y; Csiba, L; Czepiel, A; De Raedt, H; Finet, G; Gardinale, E; Gaxiola, E; Gorecki, A; Gregor, P; Happola, O; Heras, M; Himbert, D; Irkin, O; Isaaz, K; Iyengar, SS; Kalvach, P; Kevers, L; Klosiewicz-Wasek, B; Laine, M; Leys, D; Lundstrom, E; Lusic, I; Lutay, Y; Maggioni, A; Massaro, A; Mayosi, BM; Moulin, T; Narendra, J; Naslund, U; Peeters, A; Penicka, M; Perakis, A; Petersen, P; Polic, S; Radhakrishnan, S; Renkin, J; Stockins, B; Sundararajan, R; Thygesen, K; Turazza, F; Van Belle, E; Vik-Mo, H; Zaborski, J; Sleight, P; Anderson, JL; Johnstone, DE; Hirsh, J; deMets, D; Holmes, DR; Meeks, B; Afzal, R; Pogue, J; Boccalon, S; Chrysler, K; Cracknell, B; Horsman, C; Hoskin, T; Jedrzejowski, B; Johnson, J; Kotlan, S; Lawrence, M; Smiley, M; Stevens, C; Yallup, R; Connolly, S; Demers, C; Devereaux, PJ; Healey, J; Lonn, E; Magloire, P; McKelvie, R; Morillo, C; Natarajan, M; Rokoss, M; Teo, K; Valettas, N; Velianou, J; Albisu, JP; Amuchastegui, M; Bello, FA; Bluguermann, JJ; Bono, JO; Caccavo, A; Carlevaro, OO; Cassettari, A; Cuneo, C; Farras, HA; Fuselli, J; Garrido, M; Guerrero, R; Hasbani, E; Hominal, MA; Hrabar, A; Marquez, LL; Luciardi, HL; Riera, LM; Marzetti, EM; Memoli, R; Nordaby, R; Orlandini, AD; Perez, M; Piasentin, JA; Ramos, HR; Risolo, AM; Sala, J; Salomone, O; Schygiel, PO; Ubaldini, J; Vico, M; Amerena, J; Arnolda, L; Aroney, G; Boyd, P; Cahill, P; Chew, D; Counsell, JT; Cross, D; Edington, J; Fitzpatrick, D; Hicks, P; Horowitz, JD; Horrigan, MCG; New, G; Owensby, D; Schoeman, M; Thompson, P; Tulloch, G; Waites, J; Whelan, A; Ziffer, R; Huber, K; Jordanova, N; Al Shawafi, K; Convens, C; Coussement, P; de Meester, A; El Allaf, D; Janssens, L; Marcovitch, O; Muyldermans, L; Roosen, J; Soeur, F; Van Lierde, J; Vrolix, M; Leaes, P; Carvalho, AC; Schramm, EC; Mora, RD; Amino, JD; Dutra, O; Manenti, ERF; Gun, C; Saraiva, JFK; Hayashi, EK; Lichter, A; Lima, A; Marin-Neto, JA; Teixeira, SPM; Abrantes, JAM; Baracioli, LM; Nicolau, JC; Maia, LN; Jaeger, CP; Esteves, JP; Rabelo, A; Ramos, RF; Reis, G; Rossi, P; dos Santos, FR; Teixeira, MS; Silveira, DS; Lemos, MABT; Timerman, A; Greque, GV; Vaz, R; Bhargava, R; Brons, S; Colclough, M; Constance, C; Costi, P; Dacyk, A; Davies, T; Diodati, J; Dupuis, R; Elliott, H; Fell, DA; Fung, AY; Gladstone, PJS; Gosselin, G; Grondin, F; Huynh, T; Janzen, I; Kalaparambath, T; Kornder, J; Kouz, S; Kuritzky, R; Labelle-Stimac, S; Lamothe, M; Lauzon, C; LeMay, M; Ma, P; MacCallum, GC; McCallum, A; Mitchell, D; Montigny, M; Nguyen, N; Pearce, M; Pistawka, KJ; Rebane, T; Roy, M; Senaratne, M; Smith, J; Stimac, J; Traboulsi, M; Vizel, S; Weeks, A; Zadra, R; Zimmerman, RH; Alcaino, ME; Castro, P; Chen, J; Chen, J; Chen, JL; Fan, W; Ge, J; Hu, D; Huang, J; Jingxuan, G; Ke, Y; Ma, H; Wu, Y; Yingxian, S; Yu, B; Zhu, W; Bakula, M; Bergovec, M; Lukin, A; Milicevic, G; Padovan, M; Polic, S; Raguz, M; Aschermann, M; Belohlavek, J; Bocek, P; Branny, M; Budesinsky, T; Groch, L; Holm, F; Jansky, P; Jelinek, P; Jirka, V; Kaislerova, M; Konecny, P; Lisa, L; Maly, M; Marcinek, G; Oscipovsky, M; Stumar, J; Vacha, M; Nielsen, T; Vigholt, E; Laanmets, P; Soopold, U; Voitk, J; Naveri, H; Niemela, M; Peuhkurinen, K; Tuomainen, P; Ylitalo, A; Py, A; Amat, G; Bessede, G; Boschat, J; Carrie, D; Charbonnier, B; Coliet, JP; Dambrine, P; Dubois-Rande, JL; Ferrari, E; Fouche, R; Grollier, G; Jaboureck, O; Ketelers, R; Khalife, K; Leroy, F; Lognone, T; Macquin-Mavier, I; Montalescot, G; Pacouret, G; Poulard, JE; Puel, J; Richard, M; Schiele, F; Bischoff, KO; Buerke, M; Buerke, U; Dominick, K; Drexler, H; Feiler, A; Guelker, H; Haltern, G; Katus, HA; Klauss, V; Klutmann, M; Koeth, O; Meinhardt, G; Muenzel, TM; Nitschke, T; Offterdinger, M; Rieber, J; Schieffer, B; Stangl, K; Stangl, V; vom Dahl, J; Witzenbichler, B; Zeymer, U; Alexopoulos, D; Blassopoulou, N; Christon, A; Fotiadis, I; Foussas, S; Grapsas, N; Moschos, N; Papasteriadis, E; Symeonidis, D; Tyrologos, A; Leung, WS; Li, SK; Arabadzisz, H; Csikazs, J; Dancs, T; Davidovits, Z; Edes, I; Farkas, E; Herczeg, B; Janos, S; Janosi, A; Kadar, A; Kis, E; Kristof, E; Lupkovics, G; Mark, L; Nagy, A; Nagy, L; Poor, F; Regos, L; Sebo, J; Tomcsanyi, J; Toth, K; Bharani, A; Chidambaram, N; Haridas, KK; Iyengar, SS; Jain, A; Jain, A; Jain, PRK; Jaison, TM; Kerkar, PG; Naik, S; Nambiar, A; Narendra, J; Panwar, RB; Parikh, K; Puri, VK; Rajesh, T; Ramesh, M; Singh, B; Thanikachalam, S; Tongia, RK; Varma, S; Barbiero, M; Bardelli, G; Bernardi, D; Bolognese, L; Capponi, L; De Ferrari, G; Fanelli, R; Frediani, L; Galli, M; Izzo, A; Lombardi, A; Maresta, A; Martinoni, A; Melloni, C; Meneghetti, P; Mennuni, M; Moretti, L; Orlandi, M; Pancaldi, LG; Petronzelli, S; Piovaccari, G; Salvioni, A; Severini, D; Terrosu, P; Zanini, R; Erglis, A; Kalnins, U; Verboenko, J; Zakke, I; Kugiene, R; Zaliunas, R; Bin Othman, A; Chee, KH; Hian, SK; Gutierrez, AC; Diaz, AC; Garcia-Castillo, A; Guerrero, MC; Morales, CL; Ramos-Lopez, G; Baldew, SC; Basart, DCG; Clappers, N; Daniels, MCG; de Weerd, GJ; den Hartog, FR; Hendriks, IHGM; Herrman, JPR; Kofflard, M; Krasznai, K; Michels, HR; Stoel, I; ten Berg, JM; Umans, VAWN; van Beek, GJ; van Daele, MERM; van den Berg, BJ; van Hessen, MWJ; van Kalmthout, PM; van Rossum, P; Verheugt, FWA; Viergever, EP; Withagen, AJAM; Achremczyk, P; Arasimowicz, P; Baranowska, T; Biegayto, J; Bronisz, M; Buszman, P; Czepiel, A; Dalkowski, M; Dluzniewski, M; Gessek, J; Goch, JH; Gorecki, A; Janik, K; Janion, M; Kawecki, D; Kleinrok, A; Komorowski, P; Krasowski, W; Krauze-Wielicka, M; Malinowski, S; Nowak, T; Nowakowski, P; Ogorek, M; Piepiorka, M; Pluta, W; Puzio, E; Puzniak, M; Rekosz, J; Rybka, P; Sendrowski, D; Siminiak, T; Skura, M; Stopinski, M; Szetemej, R; Szolkiewicz, M; Szpajer, M; Trusz-Gluza, M; Waszyrowski, T; Wita, K; Wodniecki, J; Wojewoda, P; Zambrzycki, J; Zielinski, Z; Cardoso, P; Carrageta, DM; Ferreira, D; Gomes, MV; Santos, L; Arkhipov, M; Belousov, Y; Charchoglyan, R; Gordeev, IG; Gratsiansky, NA; Grinshtein, Y; Khrustalev, O; Kokorin, VA; Komarov, A; Kozulin, V; Minushkina, LO; Panchenko, E; Panov, A; Petrik, ES; Shakhnovich, RM; Shalaev, SV; Sukhinina, TS; Trifonov, IR; Zateyshchikov, DA; Khoo, BCH; Tan, HC; Tan, RS; Hricak, V; Motovska, Z; Poliacik, P; Kanic, V; Kovacic, D; Kranjec, I; Voga, G; Bayat, J; Essop, MR; Maritz, F; Marx, JD; Ntsekhe, M; Pretorius, MP; Ranjith, N; Theron, H; Chae, IH; Chae, SC; Choe, KH; Chung, NS; Jeong, MH; Kim, CJ; Kim, HS; Kim, W; Rhim, CY; Shin, EK; Shin, GJ; Alameda, M; Alonso-Orcajo, N; Bethencourt, A; Calvo, F; Avellaneda, JLC; Delgado, V; Diaz-Castro, O; Esplugas, E; Faus, R; Fernandez-Ortiz, A; Frutos, A; Goirena, P; Heras, M; Iglesias, FC; Llorian, AR; Macaya, C; Mancisidor, X; Melgares, R; Pascual, C; Ruiz-Nodar, JM; Simon, JM; Agewall, S; Ahlstrom, P; Ali, M; Andersson, L; Bandh, S; Digerfeldt, C; Ericsson, H; Forsgren, M; Jabro, J; Janzon, M; Joborn, H; Johnston, N; Karlsson, JE; Larsson, LE; Linderfalk, C; Lonnberg, I; Mooe, T; Naslund, U; Oldgren, J; Pihl, E; Risenfors, M; Sjolund, E; Soderberg, I; Stjerna, A; Svennberg, L; Wodlin, P; Pagnamenta, A; Pieper, M; Rossi, MG; Weber, K; Peng, MC; Cheng, JJ; Chiang, FT; Kuo, CT; Tseng, CD; Andreyeshcheva, I; Dzyak, GV; Fedtchouk, L; Gontar, A; Karpenko, O; Kononenko, L; Koval, EA; Kovalsky, I; Kraitz, I; Lutay, Y; Netiazhenko, V; Polyvoda, S; Prokopenko, Y; Prudkiy, I; Rudenko, L; Serediuk, N; Zolotaykina, V; Adgey, J; Ahsan, A; Brack, M; Bridges, AB; Burton, J; Findlay, I; Fluck, DS; Radford, L; Robson, RH; Senior, R; Starkey, IR; Alexander, J; Baber, Z; Campbell, M; Caputo, R; Chandna, H; Chandrashekhar, Y; Chu, A; DeRaad, RE; Druken, B; Goyal, A; Holly, D; Kemp, A; Kotlaba, D; Levine, MJ; Miller, GP; Nygaard, T; Parikh, DK; Ramos, C; Rivera, E; Rodriguez, R; Sangani, B; Walder, JS		OASIS-5	Comparison of fondaparinux and enoxaparin in acute coronary syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNFRACTIONATED HEPARIN; MYOCARDIAL-INFARCTION; AMERICAN-COLLEGE; TASK-FORCE; ELEVATION; METAANALYSIS; MANAGEMENT; OUTCOMES	Background: The combined use of anticoagulants, antiplatelet agents, and invasive coronary procedures reduces ischemic coronary events but also increases bleeding in patients with acute coronary syndromes. We therefore assessed whether fondaparinux would preserve the anti-ischemic benefits of enoxaparin while reducing bleeding. Methods: We randomly assigned 20,078 patients with acute coronary syndromes to receive either fondaparinux (2.5 mg daily) or enoxaparin (1 mg per kilogram of body weight twice daily) for a mean of six days and evaluated death, myocardial infarction, or refractory ischemia at nine days (the primary outcome); major bleeding; and their combination. Patients were followed for up to six months. Results: The number of patients with primary-outcome events was similar in the two groups (579 with fondaparinux [5.8 percent] vs. 573 with enoxaparin [5.7 percent]; hazard ratio in the fondaparinux group, 1.01; 95 percent confidence interval, 0.90 to 1.13), satisfying the noninferiority criteria. The number of events meeting this combined outcome showed a nonsignificant trend toward a lower value in the fondaparinux group at 30 days (805 vs. 864, P=0.13) and at the end of the study (1222 vs. 1308, P=0.06). The rate of major bleeding at nine days was markedly lower with fondaparinux than with enoxaparin (217 events [2.2 percent] vs. 412 events [4.1 percent]; hazard ratio, 0.52; P < 0.001). The composite of the primary outcome and major bleeding at nine days favored fondaparinux (737 events [7.3 percent] vs. 905 events [9.0 percent]; hazard ratio, 0.81; P < 0.001). Fondaparinux was associated with a significantly reduced number of deaths at 30 days (295 vs. 352, P=0.02) and at 180 days (574 vs. 638, P=0.05). Conclusions: Fondaparinux is similar to enoxaparin in reducing the risk of ischemic events at nine days, but it substantially reduces major bleeding and improves long term mortality and morbidity.	Hamilton Gen Hosp, McMaster Clin, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute	Yusuf, S (corresponding author), Hamilton Gen Hosp, McMaster Clin, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.		Комаров, Андрей Леонидович/AAN-1678-2020; Grinshtein, Yury/M-4091-2014; Chee, Kok Han/I-2138-2013; STEG, Philippe Gabriel/Z-1567-2019; Rumboldt, Zvonko/D-6274-2017; Arnolda, Leonard/Z-1174-2019; Lima, Thaísa/AAG-6483-2021; Panchenko, Elizaveta/AAN-1884-2020; Munzel, Thomas/A-2912-2014; ameriso, sebastian/AAV-2296-2020; Shalaev, Sergei V./D-4321-2018; Lusic, Ivo/D-7706-2017; Dziak, Georgii/ABD-6506-2021; Avezum, Alvaro/AAP-7687-2020; Arnolda, Leonard F/B-7711-2013; Lanas, Fernando/AAE-8842-2022; Marin-Neto, Jose Antonio/F-6099-2012; Lutay, Yaroslav/GLT-9262-2022; Arnolda, Leonard F/B-7986-2008; Granger, Christopher B/D-3458-2014; Kokorin, Valentin Alexandrovich/ABG-9667-2021; Avezum, Alvaro AA/K-6137-2016; Édes, István/B-8795-2011; Zateyshchikov, Dmitry A/D-6575-2012; Nicolau, Jose C/E-1487-2012; Fox, keith A A/I-3742-2013; Maia, Lilia/B-8116-2008; Nambiar, Arjun/T-6204-2019; Turazza, Fabio/AAB-8736-2020; Motovska, Zuzana/J-1122-2016; MAR, ALAMEDA/AAM-1952-2020; Minushkina, Larisa/G-9450-2013; ntsekhe, mpiko/AAI-8001-2021; Widimsky, Petr/P-8088-2016; Fernandez-Ortiz, Antonio/B-2227-2017; LEYS, Didier/G-2955-2016; Peeters, Anna/M-8284-2019; Verheugt, F.W.A./H-8105-2014; Devereaux, PJ/AAY-1757-2021; Weitz, Jeffrey/AAD-1929-2019; COTTIN, YVES/ABA-4622-2020; Buszman, Pawel/AAX-9336-2020; Witzenbichler, Bernhard/ABC-2525-2021; Devereaux, PJ/AAF-2862-2019; Agewall, Stefan/ABE-6327-2020; Martinoni, Alessandro/HHC-5847-2022	Комаров, Андрей Леонидович/0000-0001-9141-103X; Grinshtein, Yury/0000-0001-8847-235X; Chee, Kok Han/0000-0002-4485-0504; Rumboldt, Zvonko/0000-0002-6811-275X; Arnolda, Leonard/0000-0001-8173-3318; Munzel, Thomas/0000-0001-5503-4150; Shalaev, Sergei V./0000-0003-2724-4016; Lusic, Ivo/0000-0002-0642-8257; Dziak, Georgii/0000-0003-2352-1055; Arnolda, Leonard F/0000-0001-8173-3318; Granger, Christopher B/0000-0002-0045-3291; Kokorin, Valentin Alexandrovich/0000-0001-8614-6542; Avezum, Alvaro AA/0000-0002-3073-6890; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Nicolau, Jose C/0000-0002-9680-3689; Turazza, Fabio/0000-0002-2348-5309; Motovska, Zuzana/0000-0002-5319-473X; MAR, ALAMEDA/0000-0002-4315-9615; Minushkina, Larisa/0000-0002-4203-3586; ntsekhe, mpiko/0000-0002-0851-7675; Widimsky, Petr/0000-0001-5686-7752; Fernandez-Ortiz, Antonio/0000-0002-3239-1910; LEYS, Didier/0000-0003-4408-4392; Peeters, Anna/0000-0003-4340-9132; Weitz, Jeffrey/0000-0002-1092-7550; Fox, Keith/0000-0002-0140-2752; Yusuf, Salim/0000-0003-4776-5601				Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Boersma E, 2002, LANCET, V359, P2120; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Buller HR, 2004, ANN INTERN MED, V140, P867, DOI 10.7326/0003-4819-140-11-200406010-00007; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Coussement PK, 2001, EUR HEART J, V22, P1716, DOI 10.1053/euhj.2001.2777; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; Eikelboom JW, 2000, LANCET, V356, P600; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Mehta SR, 2005, AM HEART J, V150, P1107, DOI 10.1016/j.ahj.2005.09.025; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Mehta SR, 2005, CIRCULATION, V111, P1390, DOI 10.1161/01.CIR.0000158485.70761.67; Palla A, 2004, NEW ENGL J MED, V350, P423; Petersen JL, 2004, JAMA-J AM MED ASSOC, V292, P89, DOI 10.1001/jama.292.1.89; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Simoons ML, 2004, J AM COLL CARDIOL, V43, P2183, DOI 10.1016/j.jacc.2004.02.051; Turpie AGG, 2002, ARCH INTERN MED, V162, P1833, DOI 10.1001/archinte.162.16.1833; Weitz JI, 2001, CHEST, V119, p95S, DOI 10.1378/chest.119.1_suppl.95S; Wiens BL, 2002, CONTROL CLIN TRIALS, V23, P774; Wiens BL, 2002, CONTROL CLIN TRIALS, V23, P2, DOI 10.1016/S0197-2456(01)00196-9; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2002, LANCET, V359, P294; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; [No title captured]	28	846	904	2	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1464	1476						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16537663				2022-12-28	WOS:000236539000005
J	Moayyedi, P; Talley, NJ; Fennerty, MB; Vakil, N				Moayyedi, P; Talley, NJ; Fennerty, MB; Vakil, N			Can the clinical history distinguish between organic and functional dyspepsia?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; PEPTIC-ULCER DISEASE; OPEN ACCESS GASTROSCOPY; GENERAL-PRACTICE; HELICOBACTER-PYLORI; SCORING SYSTEM; GASTROINTESTINAL SYMPTOMS; DISCRIMINATIVE VALUE; ENDOSCOPIC FINDINGS; PRIMARY-CARE	Context Upper gastrointestinal symptoms occur in 40% of the population. An accurate diagnosis would help rationalize investigation and treatment. Objective To systematically review the literature of the accuracy of primary care physicians, gastroenterologists, or computer models in diagnosing organic dyspepsia. Data Sources A search of Cochrane Controlled Trials Register ( December 2003), MEDLINE (1966-December 2003), EMBASE (1988-December 2003), and CINAHL (1982-December 2003) for studies that reported on cohorts of patients attending for endoscopy that had symptoms, clinical opinion, or both recorded before investigation. Study Selection Studies that prospectively compared the diagnosis reached by a clinician, computer model, or both with results of upper gastrointestinal endoscopy in adult patients with upper gastrointestinal symptoms. Data Extraction Two authors independently assessed studies (n = 79) for eligibility and abstracted data for estimating likelihood ratios (LRs) of clinical opinion, computer models, or both in diagnosing an organic cause for dyspepsia. Data Synthesis Fifteen studies were identified that evaluated 11 366 patients, with 4817 patients (42%) classified as having organic dyspepsia. The computer models performed similarly to the clinician; therefore, the 2 approaches were combined. The diagnosis reached by the clinician or computer model suggesting organic dyspepsia had an LR of 1.6 (95% confidence interval [CI], 1.4-1.8), and a negative result decreased the likelihood of organic dyspepsia ( LR, 0.46; 95% CI, 0.38-0.55). A diagnosis of peptic ulcer disease performed similarly with an LR of 2.2 ( 95% CI, 1.9-2.6), but an evaluation that suggested the absence of peptic ulcer disease had an LR of 0.45 ( 95% CI, 0.38-0.53). A clinical history suggesting esophagitis had an LR of 2.4 ( 95% CI, 1.9-3.0) vs a negative history that had an LR of 0.50 ( 95% CI, 0.42-0.60). Conclusion Neither clinical impression nor computer models that incorporated patient demographics, risk factors, history items, and symptoms adequately distinguished between organic and functional disease in patients referred for endoscopic evaluation of dyspepsia.	McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; Ctr Enter Neurosci & Translat Epidemiol Res, Rochester, MN USA; Oregon Hlth & Sci Univ, Portland, OR USA; Univ Wisconsin, Sch Med, Madison, WI 53706 USA; Marquette Univ, Coll Hlth Sci, Milwaukee, WI 53233 USA	McMaster University; Oregon Health & Science University; University of Wisconsin System; University of Wisconsin Madison; Marquette University	Moayyedi, P (corresponding author), McMaster Univ, Dept Med, HSC 4W8,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	moayyep@mcmaster.ca	Moayyedi, Paul/M-6178-2014; Talley, Nicholas J/D-5399-2013	Moayyedi, Paul/0000-0002-3616-9292; Talley, Nicholas J/0000-0003-2537-3092				Adang RP, 1996, DIGESTION, V57, P118, DOI 10.1159/000201325; Andrews CN, 2005, GASTROENTEROLOGY, V128, pA456, DOI 10.1053/j.gastro.2005.09.020; Armstrong D, 2004, ALIMENT PHARM THER, V20, P413, DOI 10.1111/j.1365-2036.2004.02085.x; Armstrong D, 1999, YALE J BIOL MED, V72, P93; Avidan B, 2001, AM J GASTROENTEROL, V96, P41; Barenys M, 2000, EUR J GASTROEN HEPAT, V12, P1275, DOI 10.1097/00042737-200012120-00003; BYTZER P, 1992, SCAND J GASTROENTERO, V27, P987, DOI 10.3109/00365529209000176; Bytzer P, 2000, ALIMENT PHARM THERAP, V14, P1479, DOI 10.1046/j.1365-2036.2000.00862.x; Bytzer P, 1996, EUR J GASTROEN HEPAT, V8, P359, DOI 10.1097/00042737-199604000-00014; *COCHR COLL, COCHR METH GROUP SYS; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DELANEY B, 2005, DYSPEPSIA HLTH CARE; DELANEY B, DYSPEPSIA HLTH CARE; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIMENAS E, 1995, SCAND J GASTROENTERO, V30, P1046, DOI 10.3109/00365529509101605; FJOSNE U, 1986, SCAND J GASTROENTERO, V21, P433, DOI 10.3109/00365528609015159; Ford AC, 2004, AM J GASTROENTEROL, V99, P1833, DOI 10.1111/j.1572-0241.2004.40014.x; GRACE E, 2004, THESIS MCMASTER U HA; Hallas J, 1998, EUR J GASTROEN HEPAT, V10, P27, DOI 10.1097/00042737-199801000-00006; Hammer J, 2004, GUT, V53, P666, DOI 10.1136/gut.2003.021857; Hansen JM, 1998, SCAND J GASTROENTERO, V33, P799; Heading RC, 1997, EUR J GASTROEN HEPAT, V9, P779, DOI 10.1097/00042737-199708000-00008; HEIKKINEN M, 1995, SCAND J GASTROENTERO, V30, P519, DOI 10.3109/00365529509089783; HOLDSTOCK G, 1986, GASTROENTEROLOGY, V90, P1164, DOI 10.1016/0016-5085(86)90381-1; Huang JQ, 1998, GASTROENTEROLOGY, V114, P1169, DOI 10.1016/S0016-5085(98)70422-6; HUNGIN APS, 1994, BRIT J GEN PRACT, V44, P519; JOHANNESSEN T, 1990, SCAND J GASTROENTERO, V25, P689, DOI 10.3109/00365529008997594; Kahrilas Peter J, 2003, Gastrointest Endosc Clin N Am, V13, P1, DOI 10.1016/S1052-5157(02)00103-4; LANCE P, 1985, POSTGRAD MED J, V61, P411, DOI 10.1136/pgmj.61.715.411; LEVINE MS, 1995, GASTROENTEROL CLIN N, V24, P289; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; LINDBERG G, 1987, SCAND J GASTROENTERO, V22, P190, DOI 10.3109/00365528709090990; Locke GR, 2003, GASTROINTEST ENDOSC, V58, P661, DOI 10.1016/S0016-5107(03)02011-X; LYDEARD S, 1989, J ROY COLL GEN PRACT, V39, P495; MANN J, 1983, BRIT MED J, V287, P937, DOI 10.1136/bmj.287.6397.937; Meineche-Schmidt V, 2004, AM J GASTROENTEROL, V99, P1050, DOI 10.1111/j.1572-0241.2004.30089.x; Moayyedi P, 1999, AM J GASTROENTEROL, V94, P3122, DOI 10.1111/j.1572-0241.1999.01502.x; Moayyedi P, 2000, AM J GASTROENTEROL, V95, P1448, DOI 10.1111/j.1572-0241.2000.2126_1.x; North of England Dyspepsia Guideline Development G. National Institute for Health and Clinical Excellence: Guidance, 2004, DYSP MAN DYSP AD PRI; NUMANS ME, 1994, FAM PRACT, V11, P382, DOI 10.1093/fampra/11.4.382; Numans ME, 2003, ALIMENT PHARM THER, V17, P1049, DOI 10.1046/j.1365-2036.2003.01549.x; Ofman JJ, 2003, AM J GASTROENTEROL, V98, pS8, DOI 10.1016/S0002-9270(03)00010-8; PRIEBE WM, 1982, GASTROENTEROLOGY, V82, P16; Rune S, 2001, AM J GASTROENTEROL, V96, P1417; *SCOTT INT GUID NE, 2003, 68 SCOTT INT GUID NE; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; TALLEY NJ, 1993, GASTROENTEROLOGY, V105, P1378, DOI 10.1016/0016-5085(93)90142-Y; Talley NJ, 1999, GUT, V45, P37; Timmons S, 2004, AM J GASTROENTEROL, V99, P739, DOI 10.1111/j.1572-0241.2004.04086.x; *UK DEP HLTH, 2003, END RAT ENGL WAL HOS; Watson RGP, 1997, GUT, V40, P587, DOI 10.1136/gut.40.5.587	52	111	119	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1566	1576		10.1001/jama.295.13.1566	http://dx.doi.org/10.1001/jama.295.13.1566			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16595759				2022-12-28	WOS:000236505400024
J	Fossey, J; Ballard, C; Juszczak, E; James, I; Aldler, N; Jacoby, R; Howard, R				Fossey, J; Ballard, C; Juszczak, E; James, I; Aldler, N; Jacoby, R; Howard, R			Effect of enhanced psychosocial care on antipsychotic use in nurshig home residents with severe dementia: cluster randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PSYCHOLOGICAL SYMPTOMS; BEHAVIORAL SYMPTOMS; MANAGEMENT; PLACEBO; SKILLS	Objective To evaluate die effectiveness of a training and support intervention for nursing home staff in reducing the proportion of residents with dementia who are prescribed neuroleptics. Design Cluster randomised controlled trial With blinded assessment of outcome. Setting 12 Specialist nursing homes for people with dementia in London, Newcastle, and Oxford. Participants Residents of the 12 nursing homes; numbers varied during die Study period. Intervention Training and support intervention delivered to nursing home staff over 10 months, focusing Oil alternatives to drugs for the management of agitated behaviour in dementia. Main outcome measures Proportion Of residents in each home who were prescribed neuroleptics and mean levels of agitated and disruptive behaviour (Cohen-Mansfield agitation inventory) in each home at 12 months. Results At 12 months the proportion of residents taking neuroleptics ill I-lie intervention homes (23.0%) was significantly lower than that in the control homes (42.1%): average reduction in neuroleptic use 19.1% (95% confidence interval 0.5% to 37.7%). No significant differences were found in the levels of agitated or disruptive behaviour between intervention and control homes. Conclusions Promotion of person centred care and good practice in the management of patients with dementia with behavioural symptoms provides all effective alternative to neuroleptics.	Kings Coll London, Inst Psychiat, MRC, Ctr Neurodegenerat Res, London SE5 8AF, England; Univ Oxford, Oxford OX1 2JD, England; Oxford Mental Healthcare Trust, Oxford, England; Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; Newcastle Univ, Ctr Hlth Elderly, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Oxford, Dept Psychiat, Oxford OX1 2JD, England	University of London; King's College London; University of Oxford; University of Oxford; Newcastle University - UK; University of Oxford	Howard, R (corresponding author), Kings Coll London, Inst Psychiat, MRC, Ctr Neurodegenerat Res, London SE5 8AF, England.	r.howard@iop.kcl.ac.uk	Howard, Robert/E-4890-2010	Ballard, Clive/0000-0003-0022-5632; Howard, Robert/0000-0002-3071-2338				Aylward S, 2003, GERONTOLOGIST, V43, P259, DOI 10.1093/geront/43.2.259; Ballard C, 2001, INT PSYCHOGERIATR, V13, P93, DOI 10.1017/S1041610201007499; Brooker D, 1998, AGING MENT HEALTH, V2, P60, DOI 10.1080/13607869856957; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P722, DOI 10.1111/j.1532-5415.1986.tb04303.x; CohenMansfield J, 1997, J GERONTOL A-BIOL, V52, pM369, DOI 10.1093/gerona/52A.6.M369; COHN MD, 1990, MENTAL HLTH CONSULTA; Cole RP, 2000, AGING MENT HEALTH, V4, P359, DOI 10.1080/713649966; De Deyn PP, 1999, NEUROLOGY, V53, P946, DOI 10.1212/WNL.53.5.946; Donner A, 1998, J R STAT SOC C-APPL, V47, P95, DOI 10.1111/1467-9876.00100; Edberg AK, 1999, AGING-CLIN EXP RES, V11, P395, DOI 10.1007/BF03339819; Howard R, 2001, INT J GERIATR PSYCH, V16, P714, DOI 10.1002/gps.418; James I, 2003, J DEMENTIA CARE, V11, P24; Kitwood T., 1997, DEMENTIA RECONSIDERE; Kitwood T., 1997, EVALUATING DEMENTIA; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lai CKY, 2004, INT PSYCHOGERIATR, V16, P33, DOI 10.1017/S1041610204000055; Margallo-Lana M, 2001, INT J GERIATR PSYCH, V16, P39, DOI 10.1002/1099-1166(200101)16:1<39::AID-GPS269>3.0.CO;2-F; McGrath AM, 1996, BRIT MED J, V312, P611; Rovner BW, 1996, J AM GERIATR SOC, V44, P7, DOI 10.1111/j.1532-5415.1996.tb05631.x; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Stevens AB, 1998, GERONTOLOGIST, V38, P379; Street JS, 2000, ARCH GEN PSYCHIAT, V57, P968, DOI 10.1001/archpsyc.57.10.968; Yudkin PL, 2001, STAT MED, V20, P341, DOI 10.1002/1097-0258(20010215)20:3<341::AID-SIM796>3.0.CO;2-G	23	323	328	1	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					756	758A		10.1136/bmj.38782.575868.7C	http://dx.doi.org/10.1136/bmj.38782.575868.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032JA	16543297	Bronze, Green Published			2022-12-28	WOS:000236769500020
J	Kaleeba, JAR; Berger, EA				Kaleeba, JAR; Berger, EA			Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: Cystine transporter xCT	SCIENCE			English	Article							SURFACE HEPARAN-SULFATE; TARGET-CELLS; HUMAN-HERPESVIRUS-8; PROTEIN; TAT; INDUCTION; INFECTION; DEPLETION; CHAIN	Kaposi's sarcoma-associated herpesvirus (KSHV, human herpesvirus 8) is the causative agent of Kaposi's sarcoma and other lymphoproliferative syndromes often associated with HIV/AIDS. Functional complementary DNA selection for a receptor mediating KSHV cell fusion identified xCT, the 12-transmembrane light chain of the human cystine/glutamate exchange transporter system x(c)(-). Expression of recombinant xCT rendered otherwise not susceptible target cells permissive for both KSHV cell fusion and virion entry. Antibodies against xCT blocked KSHV fusion and entry with naturally permissive target cells. KSHV target cell permissiveness correlated closely with endogenous expression of xCT messenger RNA and protein in diverse human and nonhuman cell types.	NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Berger, EA (corresponding author), NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA.	edward_berger@nih.gov	Kaleeba, Johnan/ABI-1548-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000733, ZIAAI000733] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1; Akula SM, 2001, VIROLOGY, V282, P245, DOI 10.1006/viro.2000.0851; Aoki Y, 2004, BLOOD, V104, P810, DOI 10.1182/blood-2003-07-2533; Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537; Bechtel JT, 2003, J VIROL, V77, P6474, DOI 10.1128/JVI.77.11.6474-6481.2003; Birkmann A, 2001, J VIROL, V75, P11583, DOI 10.1128/JVI.75.23.11583-11593.2001; Bridges CC, 2004, INVEST OPHTH VIS SCI, V45, P2906, DOI 10.1167/iovs.03-1355; Bubman D, 2003, HEMATOL ONCOL CLIN N, V17, P717, DOI 10.1016/S0889-8588(03)00044-3; Choi J, 2000, J BIOL CHEM, V275, P3693, DOI 10.1074/jbc.275.5.3693; DEY B, 2003, CURRENT PROTOCOLS S, V54; Haque M, 2003, J VIROL, V77, P6761, DOI 10.1128/JVI.77.12.6761-6768.2003; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; KALEEBA JAR, UNPUB; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Opalenik SR, 1998, ARCH BIOCHEM BIOPHYS, V351, P17, DOI 10.1006/abbi.1997.0566; Pertel PE, 2002, J VIROL, V76, P4390, DOI 10.1128/JVI.76.9.4390-4400.2002; Qiang W, 2004, J VIROL, V78, P11926, DOI 10.1128/JVI.78.21.11926-11938.2004; Sasaki H, 2002, J BIOL CHEM, V277, P44765, DOI 10.1074/jbc.M208704200; Sato H, 2000, ANTIOXID REDOX SIGN, V2, P665, DOI 10.1089/ars.2000.2.4-665; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Smith Ernest S, 2004, Methods Mol Biol, V269, P65; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Tailor CS, 2003, CURR TOP MICROBIOL, V281, P29; Triantafilou K, 2001, CRIT REV IMMUNOL, V21, P311; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; WANG JF, 2004, BLOOD, V104	30	116	123	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1921	1924		10.1126/science.1120878	http://dx.doi.org/10.1126/science.1120878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574866				2022-12-28	WOS:000236387800044
J	Prlic, M; Bevan, MJ				Prlic, M; Bevan, MJ			Immunology - An antibody paradox, resolved	SCIENCE			English	Editorial Material							T-CELLS; HOMEOSTASIS; EXPRESSION; IL-15	The immune effect of a cytokine bound to an antibody is paradoxically much stronger than that of the cytokine alone, suggesting a way to lower therapeutic doses and thereby reduce side effects.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Prlic, M (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mprlic@u.washington.edu; mbevan@u.washington.edu		Prlic, Martin/0000-0002-0685-9321				Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	7	9	11	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2006	311	5769					1875	1876		10.1126/science.1126030	http://dx.doi.org/10.1126/science.1126030			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574856				2022-12-28	WOS:000236387800031
J	Sine, SM; Engel, AG				Sine, SM; Engel, AG			Recent advances in Cys-loop receptor structure and function	NATURE			English	Review							NICOTINIC ACETYLCHOLINE-RECEPTOR; CHANNEL MYASTHENIC SYNDROME; AGONIST BINDING-AFFINITY; CHARGED AMINO-ACIDS; LIGAND-BINDING; EXTRACELLULAR DOMAIN; ACH-BINDING; ELECTROSTATIC INTERACTIONS; CONFORMATIONAL-CHANGES; GATING MECHANISM	Throughout the nervous system, moment-to-moment communication relies on postsynaptic receptors to detect neurotransmitters and change the membrane potential. For the Cys-loop superfamily of receptors, recent structural data have catalysed a leap in our understanding of the three steps of chemical-to-electrical transduction: neurotransmitter binding, communication between the binding site and the barrier to ions, and opening and closing of the barrier. The emerging insights might be expected to explain how mutations of receptors cause neurological disease, but the opposite is generally true. Namely, analyses of disease-causing mutations have clarified receptor structure-function relationships as well as mechanisms governing the postsynaptic response.	Mayo Clin & Mayo Fdn, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Neurol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Sine, SM (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Physiol & Biomed Engn, 200 1st St SW, Rochester, MN 55905 USA.	sine@mayo.edu						Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; Auerbach A, 2005, P NATL ACAD SCI USA, V102, P1408, DOI 10.1073/pnas.0406787102; Beeson David, 2005, Neuromuscul Disord, V15, P498, DOI 10.1016/j.nmd.2005.05.001; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chakrapani S, 2003, J GEN PHYSIOL, V122, P521, DOI 10.1085/jgp.200308885; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; COLQUHOUN D, 1981, NATURE, V294, P464, DOI 10.1038/294464a0; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P469, DOI 10.1146/annurev.ph.57.030195.002345; Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007; Engel AG, 1996, HUM MOL GENET, V5, P1217, DOI 10.1093/hmg/5.9.1217; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; FERSHT AR, 1987, BIOCHEMISTRY-US, V26, P6030, DOI 10.1021/bi00393a013; Fukudome T, 1998, NEUROREPORT, V9, P1907, DOI 10.1097/00001756-199806010-00044; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Harper CM, 2003, NEUROLOGY, V60, P1710, DOI 10.1212/01.WNL.0000061483.11417.1B; Hatton CJ, 2003, J PHYSIOL-LONDON, V547, P729, DOI 10.1113/jphysiol.2002.034173; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Jackson M B, 1999, Adv Neurol, V79, P511; JACKSON MB, 1986, BIOPHYS J, V49, P663, DOI 10.1016/S0006-3495(86)83693-1; JACKSON MB, 1988, J PHYSIOL-LONDON, V397, P555, DOI 10.1113/jphysiol.1988.sp017019; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Le Novere N, 2001, PHILOS T R SOC B, V356, P1121; Le Novere N, 2002, P NATL ACAD SCI USA, V99, P3210, DOI 10.1073/pnas.042699699; Lee WY, 2004, J GEN PHYSIOL, V124, P555, DOI 10.1085/jgp.200409077; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; LINGLE CJ, 1992, J MEMBRANE BIOL, V126, P195; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Lyford LK, 2003, MOL PHARMACOL, V64, P650, DOI 10.1124/mol.64.3.650; Maconochie DJ, 1998, J PHYSIOL-LONDON, V506, P53, DOI 10.1111/j.1469-7793.1998.053bx.x; Milone M, 1997, J NEUROSCI, V17, P5651; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; Molles BE, 2002, BIOCHEMISTRY-US, V41, P7895, DOI 10.1021/bi025732d; MONTASTRUC P, 1989, BRIT J PHARMACOL, V98, P101, DOI 10.1111/j.1476-5381.1989.tb16868.x; MUKHTASIMOVA F, 2005, J GEN PHYSIOL, V506, P53; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Ohno K, 1997, HUM MOL GENET, V6, P753, DOI 10.1093/hmg/6.5.753; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Paas Y, 2005, P NATL ACAD SCI USA, V102, P15877, DOI 10.1073/pnas.0507599102; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Schapira Matthieu, 2002, BMC Structural Biology, V2, P1, DOI 10.1186/1472-6807-2-1; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; Shelley C, 2005, J PHYSIOL-LONDON, V564, P377, DOI 10.1113/jphysiol.2004.081497; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Sine SM, 2002, J GEN PHYSIOL, V120, P483, DOI 10.1085/jgp.20028568; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; TAKEUCHI A, 1959, J NEUROPHYSIOL, V22, P395, DOI 10.1152/jn.1959.22.4.395; Taly A, 2005, BIOPHYS J, V88, P3954, DOI 10.1529/biophysj.104.050229; Tsujino A, 2003, P NATL ACAD SCI USA, V100, P7377, DOI 10.1073/pnas.1230273100; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vaughan CK, 2002, ACTA CRYSTALLOGR D, V58, P591, DOI 10.1107/S0907444902001567; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326; Wang HL, 1997, J GEN PHYSIOL, V109, P757, DOI 10.1085/jgp.109.6.757; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; ZHANG YN, 1995, J PHYSIOL-LONDON, V486, P189, DOI 10.1113/jphysiol.1995.sp020802; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; Zhou Y, 2005, BIOPHYS J, V89, P3680, DOI 10.1529/biophysj.105.067215	82	405	423	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					448	455		10.1038/nature04708	http://dx.doi.org/10.1038/nature04708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554804				2022-12-28	WOS:000236176100041
J	Patel; Senior, R				Patel; Senior, R			A 28 year old postpartum woman with right sided chest discomfort: case outcome - Commentary: Patient's experience	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Northwick Pk Hosp & Clin Res Ctr, Dept Cardiovasc Med, Harrow HA1 3UJ, Middx, England	Imperial College London	Senior, R (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Dept Cardiovasc Med, Harrow HA1 3UJ, Middx, England.	roxy.senior@virgin.net						Dwivedi G, 2006, BRIT MED J, V332, P643, DOI 10.1136/bmj.332.7542.643	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2006	332	7542					644	644		10.1136/bmj.332.7542.644	http://dx.doi.org/10.1136/bmj.332.7542.644			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543330	Green Published			2022-12-28	WOS:000236314700019
J	Thorpe, MJ; Moll, KD; Jones, RJ; Safdi, B; Ye, J				Thorpe, MJ; Moll, KD; Jones, RJ; Safdi, B; Ye, J			Broadband cavity ringdown spectroscopy for sensitive and rapid molecular detection	SCIENCE			English	Article							FREQUENCY	We demonstrate highly efficient cavity ringdown spectroscopy in which a broad-bandwidth optical frequency comb is coherently coupled to a high-finesse optical cavity that acts as the sample chamber. 125,000 optical comb components, each coupled into a specific longitudinal cavity mode, undergo ringdown decays when the cavity input is shut off. Sensitive intracavity absorption information is simultaneously available across 100 nanometers in the visible and near-infrared spectral regions. Real-time, quantitative measurements were made of the trace presence, the transition strengths and linewidths, and the population redistributions due to collisions and the temperature changes for molecules such as C2H2, O-2, H2O, and NH3.	Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder	Ye, J (corresponding author), Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	ye@jila.colorado.edu	Ye, Jun/C-3312-2011	Ye, Jun/0000-0003-0076-2112; Safdi, Benjamin R./0000-0001-9531-1319				Crosson ER, 1999, REV SCI INSTRUM, V70, P4, DOI 10.1063/1.1149533; Cundiff ST, 2003, REV MOD PHYS, V75, P325, DOI 10.1103/RevModPhys.75.325; Debecker I, 2005, OPT EXPRESS, V13, P2906, DOI 10.1364/OPEX.13.002906; Gherman T, 2002, OPT EXPRESS, V10, P1033, DOI 10.1364/OE.10.001033; He Y, 2004, APPL PHYS B-LASERS O, V79, P941, DOI 10.1007/s00340-004-1691-3; Herregodts F, 2000, CHEM PHYS LETT, V316, P460, DOI 10.1016/S0009-2614(99)01324-X; Jones RJ, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.051803; Keilmann F, 2004, OPT LETT, V29, P1542, DOI 10.1364/OL.29.001542; Kharitonov SA, 2001, AM J RESP CRIT CARE, V163, P1693, DOI 10.1164/ajrccm.163.7.2009041; Narasimhan LR, 2001, P NATL ACAD SCI USA, V98, P4617, DOI 10.1073/pnas.071057598; Reichert J, 1999, OPT COMMUN, V172, P59, DOI 10.1016/S0030-4018(99)00491-5; Sanders S, 2005, OPT PHOTONICS NEWS, V16, P36, DOI 10.1364/OPN.16.5.000036; Scherer JJ, 2001, APPL OPTICS, V40, P6725, DOI 10.1364/AO.40.006725; Sukenik CI, 2002, REV SCI INSTRUM, V73, P493, DOI 10.1063/1.1433953; Thorpe MJ, 2005, OPT EXPRESS, V13, P882, DOI 10.1364/OPEX.13.000882; Vega A, 2003, APPL OPTICS, V42, P4152, DOI 10.1364/AO.42.004152; Ye J, 1998, J OPT SOC AM B, V15, P6, DOI 10.1364/JOSAB.15.000006; Ye J, 1996, OPT LETT, V21, P1000, DOI 10.1364/OL.21.001000; Ye J, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.061802; Ye J., 1997, THESIS U COLORADO	20	380	398	7	173	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1595	1599		10.1126/science.1123921	http://dx.doi.org/10.1126/science.1123921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543457				2022-12-28	WOS:000236029500042
J	Berman, JR; Kenyon, C				Berman, JR; Kenyon, C			Germ-cell loss extends C-elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone signaling	CELL			English	Article							CAVERNOUS MALFORMATIONS CCM1; CAENORHABDITIS-ELEGANS; REPRODUCTIVE DEVELOPMENT; BINDING-PROTEIN; ENCODING KRIT1; PATHWAY; LONGEVITY; INSULIN/IGF-1; RECEPTOR; INTERFERENCE	In C. elegans, removing the germ cells extends life span by triggering the nuclear localization and activation of the DAF-16/FOXO transcription factor in the intestine. In this study, we identify and analyze genes required for germline removal to extend life span. We find that the reproductive system communicates with the intestine through lipophilic-hormone signaling and that a gene called kri-1 is likely to act in the intestine to promote DAF-16 nuclear localization in response to this signal. This lipophilic-signaling pathway and kri-1 are not required for DAF-16's nuclear localization and life-span extension in animals with decreased insulin/IGF-1 signaling. Thus, this pathway specifically enables the integration of cues from the reproductive system with central DAF-16-activation pathways to influence the aging of the animal.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Miss Bay,Genentech Hall,600 16th St,Room S312D, San Francisco, CA 94143 USA.	ckenyon@biochem.ucsf.edu		Kenyon, Cynthia/0000-0003-3446-2636	NIA NIH HHS [AG020932] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG020932] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Antebi A, 2000, GENE DEV, V14, P1512; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; BRENNER S, 1974, GENETICS, V77, P71; Cargill SL, 2003, AGING CELL, V2, P185, DOI 10.1046/j.1474-9728.2003.00049.x; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; DORMAN JB, 1995, GENETICS, V141, P1399; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gems D, 1998, GENETICS, V150, P129; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gil EB, 1999, P NATL ACAD SCI USA, V96, P2925, DOI 10.1073/pnas.96.6.2925; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Mak HY, 2004, DEVELOPMENT, V131, P1777, DOI 10.1242/dev.01069; Mello C, 1995, METHOD CELL BIOL, V48, P451; Nanji M, 2005, AGING CELL, V4, P235, DOI 10.1111/j.1474-9726.2005.00166.x; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; PRIESS JR, 1987, CELL, V51, P601, DOI 10.1016/0092-8674(87)90129-2; Riddle DL, 1997, C ELEGANS, P739; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	38	223	231	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					1055	1068		10.1016/j.cell.2006.01.039	http://dx.doi.org/10.1016/j.cell.2006.01.039			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530050	Bronze			2022-12-28	WOS:000237241200025
J	Lei, EP; Corces, VG				Lei, EP; Corces, VG			A long-distance relationship between RNAi and polycomb	CELL			English	Editorial Material							FISSION YEAST; DROSOPHILA; PROTEIN; HETEROCHROMATIN; MACHINERY; SOP-2	RNA interference (RNAi) pathways can result in sequence-specific transcriptional gene silencing on the level of chromatin. In this issue of Cell, Grimaud et al. (2006) reveal that the RNAi machinery is required for long-distance physical interactions between chromosomes mediated by the Polycomb repressive complex. These results suggest that the RNAi machinery may regulate higher-order nuclear organization.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Corces, VG (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	corces@jhu.edu		Corces, Victor/0000-0001-5140-4337	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015601, ZIADK015601] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Zhang H, 2004, MOL CELL, V14, P841, DOI 10.1016/j.molcel.2004.06.001; Zhang H, 2004, NAT GENET, V36, P507, DOI 10.1038/ng1336	9	15	15	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					886	888		10.1016/j.cell.2006.02.026	http://dx.doi.org/10.1016/j.cell.2006.02.026			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530034	Bronze			2022-12-28	WOS:000237241200009
J	Lonn, E; Yusuf, S; Arnold, MJ; Sheridan, P; Pogue, J; Micks, M; McQueen, MJ; Probstfield, J; Fodor, G; Held, C; Genest, J				Lonn, E; Yusuf, S; Arnold, MJ; Sheridan, P; Pogue, J; Micks, M; McQueen, MJ; Probstfield, J; Fodor, G; Held, C; Genest, J		HOPE 2 Investigators	Homocysteine lowering with folic acid and B vitamins in vascular disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; RANDOMIZED-TRIALS; SECONDARY PREVENTION; METAANALYSIS; RISK; HOMOCYST(E)INE; COMMITTEE; OUTCOMES	BACKGROUND: In observational studies, lower homocysteine levels are associated with lower rates of coronary heart disease and stroke. Folic acid and vitamins B(sub 6) and B(sub 12) lower homocysteine levels. We assessed whether supplementation reduced the risk of major cardiovascular events in patients with vascular disease. METHODS: We randomly assigned 5522 patients 55 years of age or older who had vascular disease or diabetes to daily treatment either with the combination of 2.5 mg of folic acid, 50 mg of vitamin B(sub 6), and 1 mg of vitamin B(sub 12) or with placebo for an average of five years. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, and stroke. RESULTS: Mean plasma homocysteine levels decreased by 2.4 micromol per liter (0.3 mg per liter) in the active-treatment group and increased by 0.8 micromol per liter (0.1 mg per liter) in the placebo group. Primary outcome events occurred in 519 patients (18.8 percent) assigned to active therapy and 547 (19.8 percent) assigned to placebo (relative risk, 0.95; 95 percent confidence interval, 0.84 to 1.07; P=0.41). As compared with placebo, active treatment did not significantly decrease the risk of death from cardiovascular causes (relative risk, 0.96; 95 percent confidence interval, 0.81 to 1.13), myocardial infarction (relative risk, 0.98; 95 percent confidence interval, 0.85 to 1.14), or any of the secondary outcomes. Fewer patients assigned to active treatment than to placebo had a stroke (relative risk, 0.75; 95 percent confidence interval, 0.59 to 0.97). More patients in the active-treatment group were hospitalized for unstable angina (relative risk, 1.24; 95 percent confidence interval, 1.04 to 1.49). CONCLUSIONS: Supplements combining folic acid and vitamins B(sub 6) and B(sub 12) did not reduce the risk of major cardiovascular events in patients with vascular disease.	McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8S 4L8, Canada; Hamilton Hlth Sci, Dept Med, Div Cardiol, Hamilton, ON, Canada; Univ Western Ontario, Dept Med, Div Cardiol, London, ON, Canada; Univ Washington, Sch Med, Seattle, WA USA; Univ Ottawa, Inst Heart, Ottawa, ON, Canada; Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; McGill Univ, Div Cardiol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada; Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada	McMaster University; Population Health Research Institute; McMaster University; Western University (University of Western Ontario); University of Washington; University of Washington Seattle; University of Ottawa; University of Ottawa Heart Institute; Karolinska Institutet; Karolinska University Hospital; McGill University; McGill University; Royal Victoria Hospital	Lonn, E (corresponding author), Hamilton Gen Hosp, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	lonnem@mcmaster.ca	Held, Claes/AAA-3973-2021; Hramiak, Irene/G-3305-2011; Arnold, Malcolm/G-2869-2011; Zinman, Bernard/E-7266-2013	Held, Claes/0000-0001-9402-7404; Yusuf, Salim/0000-0003-4776-5601				Alpert JS, 2001, J AM COLL CARDIOL, V37, P973; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Clarke R, 2006, AM HEART J, V151, P282, DOI 10.1016/j.ahj.2005.04.025; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; HARKER LA, 1983, CIRC RES, V53, P731, DOI 10.1161/01.RES.53.6.731; HARKER LA, 1974, NEW ENGL J MED, V291, P537, DOI 10.1056/NEJM197409122911101; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Liem A, 2003, J AM COLL CARDIOL, V41, P2105, DOI 10.1016/S0735-1097(03)00485-6; Lonn E, 2006, CAN J CARDIOL, V22, P47, DOI 10.1016/S0828-282X(06)70238-0; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Vivekananthan DP, 2003, LANCET, V361, P2017, DOI 10.1016/S0140-6736(03)13637-9; Vivekananthan DP, 2004, LANCET, V363, P662; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507	20	1277	1363	2	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1567	1577						11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16531613	Bronze			2022-12-28	WOS:000236736900005
J	Suzuki, N; Suzuki, S; Millar, DG; Unno, M; Hara, H; Calzascia, T; Yamasaki, S; Yokosuka, T; Chen, NJ; Elford, AR; Suzuki, J; Takeuchi, A; Mirtsos, C; Bouchard, D; Ohashi, PS; Yeh, WC; Saito, T				Suzuki, N; Suzuki, S; Millar, DG; Unno, M; Hara, H; Calzascia, T; Yamasaki, S; Yokosuka, T; Chen, NJ; Elford, AR; Suzuki, J; Takeuchi, A; Mirtsos, C; Bouchard, D; Ohashi, PS; Yeh, WC; Saito, T			A critical role for the innate immune signaling molecule IRAK-4 in T cell activation	SCIENCE			English	Article							ANTIGEN RECEPTOR; MECHANISM; KINASE; MALT1; BCL10; MICE	IRAK-4 is a protein kinase that is pivotal in mediating signals for innate immune responses. Here, we report that IRAK-4 signaling is also essential for eliciting adaptive immune responses. Thus, in the absence of IRAK-4, in vivo T cell responses were significantly impaired. Upon T cell receptor stimulation, IRAK-4 is recruited to T cell lipid rafts, where it induces downstream signals, including protein kinase C theta activation through the association with Zap70. This signaling pathway was found to be required for optimal activation of nuclear factor kappa B. Our findings suggest that T cells use this critical regulator of innate immunity for the development of acquired immunity, suggesting that IRAK-4 may be involved in direct signal cross talk between the two systems.	RIKEN Res Ctr Allergy & Immunol, Lab Cell Signaling, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Univ Hlth Network, Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; Univ Hlth Network, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Chiba Univ, Grad Sch Med, Dept Mol Genet, Chuo Ku, Chiba 2608670, Japan	RIKEN; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Chiba University	Yeh, WC (corresponding author), Amgen San Francisco, 1120 Vet Blvd, San Francisco, CA 94080 USA.	wyeh@uhnres.utoronto.ca; saito@rcai.riken.jp	Saito, Takashi/C-9684-2009	Saito, Takashi/0000-0001-9495-3547; Ohashi, Pamela S./0000-0003-2915-9317; Millar, Douglas/0000-0002-8640-7148; Takeuchi, Arata/0000-0003-0412-533X; Calzascia, Thomas/0000-0001-8225-6744				Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Habiro K, 2003, TRANSPLANTATION, V76, P854, DOI 10.1097/01.TP.0000084868.09385.83; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Ohta A, 1997, J IMMUNOL METHODS, V209, P85, DOI 10.1016/S0022-1759(97)00152-X; Samelson LE, 2002, ANNU REV IMMUNOL, V20, P371, DOI 10.1146/annurev.immunol.20.092601.111357; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Suzuki N, 2003, J IMMUNOL, V171, P6065, DOI 10.4049/jimmunol.171.11.6065; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	16	88	99	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1927	1932		10.1126/science.1124256	http://dx.doi.org/10.1126/science.1124256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574867				2022-12-28	WOS:000236387800046
J	Shaw, P; Greenstein, D; Lerch, J; Clasen, L; Lenroot, R; Gogtay, N; Evans, A; Rapoport, J; Giedd, J				Shaw, P; Greenstein, D; Lerch, J; Clasen, L; Lenroot, R; Gogtay, N; Evans, A; Rapoport, J; Giedd, J			Intellectual ability and cortical development in children and adolescents	NATURE			English	Article							FALSE DISCOVERY RATE; GENERAL INTELLIGENCE; CEREBRAL-CORTEX; HUMAN-BRAIN; MRI DATA; THICKNESS; POPULATION; CHILDHOOD; PEOPLE; VOLUME	Children who are adept at any one of the three academic 'R's ( reading, writing and arithmetic) tend to be good at the others, and grow into adults who are similarly skilled at diverse intellectually demanding activities(1-3). Determining the neuroanatomical correlates of this relatively stable individual trait of general intelligence has proved difficult, particularly in the rapidly developing brains of children and adolescents. Here we demonstrate that the trajectory of change in the thickness of the cerebral cortex, rather than cortical thickness itself, is most closely related to level of intelligence. Using a longitudinal design, we find a marked developmental shift from a predominantly negative correlation between intelligence and cortical thickness in early childhood to a positive correlation in late childhood and beyond. Additionally, level of intelligence is associated with the trajectory of cortical development, primarily in frontal regions implicated in the maturation of intelligent activity(4,5). More intelligent children demonstrate a particularly plastic cortex, with an initial accelerated and prolonged phase of cortical increase, which yields to equally vigorous cortical thinning by early adolescence. This study indicates that the neuroanatomical expression of intelligence in children is dynamic.	NIMH, Child Psychiat Branch, Bethesda, MD 20182 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); McGill University	Shaw, P (corresponding author), NIMH, Child Psychiat Branch, Bethesda, MD 20182 USA.	shawp@mail.nih.gov	Gogtay, Nitin/A-3035-2008; Kennedy, Kristen M/B-4699-2008; Giedd, Jay N./A-3080-2008; Giedd, Jay/J-9644-2015; Gogtay, Nitin/GRR-1980-2022; Shaw, Philip/A-1129-2008; Staff, Roger T/G-1826-2011; Giedd, Jay N/B-7302-2012	Kennedy, Kristen M/0000-0001-5373-9026; Giedd, Jay/0000-0003-2002-8978; Shaw, Philip/0000-0002-1313-2526; Staff, Roger T/0000-0003-0620-8673; Giedd, Jay N/0000-0003-0827-3460	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002794, Z01MH002581, ZIAMH002240, ZIAMH002581, Z01MH002794, Z01MH002240] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth JR, 2003, NEUROIMAGE, V20, P737, DOI 10.1016/S1053-8119(03)00404-X; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kostovic I, 2002, CEREB CORTEX, V12, P536, DOI 10.1093/cercor/12.5.536; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Kraemer HC, 2000, AM J PSYCHIAT, V157, P163, DOI 10.1176/appi.ajp.157.2.163; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Pinheiro J, 2001, MIXED EFFECTS MODELS; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Wechsler D., 1974, MANUAL WECHSLER INTE; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X; Yakovlev P.I., 1967, REGIONAL DEV BRAIN E; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	30	1027	1051	15	227	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2006	440	7084					676	679		10.1038/nature04513	http://dx.doi.org/10.1038/nature04513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572172	Green Published			2022-12-28	WOS:000236350400045
J	Reynolds, RM; Padfield, PL; Seckl, JR				Reynolds, RM; Padfield, PL; Seckl, JR			Disorders of sodium balance	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VASOPRESSIN RECEPTOR ANTAGONIST; HYPONATREMIC ENCEPHALOPATHY; HEART-FAILURE; SERUM SODIUM; TRIAL; WOMEN; MULTICENTER; MANAGEMENT; MORTALITY; CIRRHOSIS		Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Seckl, JR (corresponding author), Univ Edinburgh, Queens Med Res Inst, Endocrinol Unit, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland.	j.seckl@ed.ac.uk	Reynolds, Rebecca M/C-3044-2008; Seckl, Jonathan R/C-3555-2013	Reynolds, Rebecca M/0000-0001-6226-8270; 				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; ANDERSON RJ, 1986, KIDNEY INT, V29, P1237, DOI 10.1038/ki.1986.134; ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401; AYUS JC, 1992, ANN INTERN MED, V117, P891, DOI 10.7326/0003-4819-117-11-891; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; CHUNG HM, 1987, AM J MED, V83, P905, DOI 10.1016/0002-9343(87)90649-8; Ellis SJ, 1995, QJM-MON J ASSOC PHYS, V88, P905; Ferguson JW, 2003, CLIN SCI, V105, P1, DOI 10.1042/CS20030062; Gerbes AL, 2003, GASTROENTEROLOGY, V124, P933, DOI 10.1053/gast.2003.50143; Goldsmith SR, 2005, J AM COLL CARDIOL, V46, P1785, DOI 10.1016/j.jacc.2005.02.095; HANTMAN D, 1973, ANN INTERN MED, V78, P870, DOI 10.7326/0003-4819-78-6-870; Ishikawa S, 2003, CLIN ENDOCRINOL, V58, P1, DOI 10.1046/j.1365-2265.2003.01647.x; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; Kumar S, 1998, LANCET, V352, P220, DOI 10.1016/S0140-6736(97)12169-9; Reynolds RM, 2005, CLIN ENDOCRINOL, V63, P366, DOI 10.1111/j.1365-2265.2005.02318.x; Saeed BO, 2002, J CLIN PATHOL, V55, P893, DOI 10.1136/jcp.55.12.893; Smith DM, 2000, CLIN ENDOCRINOL, V52, P667, DOI 10.1046/j.1365-2265.2000.01027.x; Weiss-Guillet EM, 2003, BEST PRACT RES CL EN, V17, P623, DOI 10.1016/S1521-690X(03)00056-3; Wong F, 2003, HEPATOLOGY, V37, P182, DOI 10.1053/jhep.2003.50021	19	127	130	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2006	332	7543					702	705		10.1136/bmj.332.7543.702	http://dx.doi.org/10.1136/bmj.332.7543.702			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	027VH	16565125	Green Published, Green Submitted			2022-12-28	WOS:000236443300024
J	Szalay, A; Gray, J				Szalay, A; Gray, J			Science in an exponential world	NATURE			English	Editorial Material									Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Microsoft Res, San Francisco, CA 94105 USA	Johns Hopkins University; Microsoft	Szalay, A (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.							Microsoft, 2006, 2020 SCI	1	125	131	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2006	440	7083					413	414		10.1038/440413a	http://dx.doi.org/10.1038/440413a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554783	Green Submitted			2022-12-28	WOS:000236176100021
J	Chen, TY; Smith, W; Rosenstock, JL; Lessnau, KD				Chen, TY; Smith, W; Rosenstock, JL; Lessnau, KD			A life-threatening complication of Atkins diet	LANCET			English	Editorial Material							WEIGHT		New York Sch Med, New York, NY 10128 USA; Lenox Hill Hosp, Dept Med, New York, NY 10028 USA	Northwell Health	Lessnau, KD (corresponding author), New York Sch Med, 300 E 93rd St 18B, New York, NY 10128 USA.	KLessnau@pol.net						Astrup A, 2004, LANCET, V364, P897, DOI 10.1016/S0140-6736(04)16986-9; Atkins RC, 1972, ATKINS DIET REVOLUTI; Ballaban-Gil K, 1998, EPILEPSIA, V39, P744, DOI 10.1111/j.1528-1157.1998.tb01160.x; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Toth HL, 2003, AM J KIDNEY DIS, V42, DOI 10.1053/S0272-6386(03)01023-0	5	49	51	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					958	958		10.1016/S0140-6736(06)68394-3	http://dx.doi.org/10.1016/S0140-6736(06)68394-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546552				2022-12-28	WOS:000236242100040
J	Lob-Levyt, J; Affolder, R				Lob-Levyt, J; Affolder, R			Innovative financing for human development	LANCET			English	Editorial Material									UNICEF, GAVI Alliance Secretariat, CH-1211 Geneva, Switzerland		Lob-Levyt, J (corresponding author), UNICEF, GAVI Alliance Secretariat, Palais Nations Geneva, CH-1211 Geneva, Switzerland.	jloblevyt@gavialliance.org						Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; *FRENCH MIN FOR AF, 2006, INN WAYS FUND DEV; *HM TREAS, 2004, INT FIN FAC; *OECD, INT DEV STAT IDS ONL; *OECD, 2005, AID RIS SHARPL ACC L; *OECD DAC, 2005, OECD DAC HIGH LEV FO	6	3	3	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					885	887		10.1016/S0140-6736(06)68360-8	http://dx.doi.org/10.1016/S0140-6736(06)68360-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546525				2022-12-28	WOS:000236242100009
J	Newell, JN; Baral, SC; Pande, SB; Bam, DS; Malla, P				Newell, JN; Baral, SC; Pande, SB; Bam, DS; Malla, P			Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial	LANCET			English	Article							HEALTH-WORKERS; TB TREATMENT; ADHERENCE	Background A key component of the DOTS strategy for tuberculosis control (short-course chemotherapy following WHO guidelines) is direct observation of treatment. WHO technical guidelines recommend that health workers should undertake this part of the strategy, but will also accept direct observation of treatment in the community; WHO does not think that a family member should undertake this role. Supporting evidence for these recommendations is not available. The Nepal national tuberculosis programme asked us to develop and test a strategy of direct observation of treatment for the hill districts of Nepal, where direct observation of treatment by health workers is not feasible. We aimed to assess the success rates of two DOTS strategies developed for such areas. Methods Between mid-July, 2002, and mid-July, 2003, we undertook a cluster-randomised controlled trial to compare two strategies-community DOTS and family-member DOTS-in ten hill and mountain districts of Nepal. Districts were used as the unit of randomisation. Primary outcome was success rate (proportion of registered patients who achieved cure or completed treatment), and analysis was by intention to treat. Findings Five districts (549 patients) were allocated to community DOTS and five (358 patients) were allocated family-member DOTS. Community DOTS and family-member DOTS achieved success rates of 85% and 89%, respectively (odds ratio of success for community DOTS relative to family-member DOTS, 0.67 [95% CI 0.41-1.10]; p=0.09). Estimated case-finding rates were 63% with the community strategy and 44% with family-member DOTS. Interpretation The family-member DOTS and community DOTS strategies can both attain international targets for treatment success tinder programme conditions, and thus are appropriate for the hill and mountain districts of Nepal. Both strategies might also be appropriate in other parts of the world where directly observed treatment by health workers is not feasible. Our findings lend support to adoption of this patient-responsive approach to direct observation of treatment within global tuberculosis control policy.	Univ Leeds, Inst Hlth Sci & Publ Hlth Res, Nuffield Ctr Int Hlth & Dev, Leeds LS2 9PL, W Yorkshire, England; Hlth Res & Social Dev Forum, Kathmandu, Nepal; Minist Hlth & Populat, Kathmandu, Nepal; Natl TB Ctr, Bhaktapur, Nepal	University of Leeds	Newell, JN (corresponding author), Univ Leeds, Inst Hlth Sci & Publ Hlth Res, Nuffield Ctr Int Hlth & Dev, Leeds LS2 9PL, W Yorkshire, England.	j.n.newell@leeds.ac.uk						Akkslip S, 1999, INT J TUBERC LUNG D, V3, P1061; Armitage P., 2002, STAT METHODS MED RES; Borgdorff MW, 2002, B WORLD HEALTH ORGAN, V80, P501; Clarke M, 2005, INT J TUBERC LUNG D, V9, P673; Enarson D.A., 2000, MANAGEMENT TUBERCULO; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hayes RJ, 2000, STAT METHODS MED RES, V9, P95, DOI 10.1191/096228000670953670; *HMG NEP MIN HLTH, 2001, DEP HLTH SERV ANN RE; MAHER D, 1999, GLOB TUB RES IN 2 M; Manders AJE, 2001, INT J TUBERC LUNG D, V5, P838; MARTIN DC, 1993, STAT MED, V12, P329, DOI 10.1002/sim.4780120315; *NAT PLANN COMM SE, 2002, POP CENS 2001 NAT RE; *NAT TUB CTR, 2001, ANN REP NAT TUB CONT; *NAT TUB PROGR, 2003, TUB NEP; Pope DS, 2003, INT J TUBERC LUNG D, V7, P611; Styblo K., 1985, B INT UNION TUBERC, V60, P117; *UNAIDS, 2004, 2004 REP GLOB HIV AI; Volmink J, 1997, BMJ-BRIT MED J, V315, P1403, DOI 10.1136/bmj.315.7120.1403; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Wandwalo E, 2004, INT J TUBERC LUNG D, V8, P1248; *WHO, 2004, GLOB TUB CONTR SURV; *WHO, 1997, WHO REP TUB EP; *WHO, 2003, COMM CONTR TB CAR PR; WILKINSON D, 1994, LANCET, V343, P647, DOI 10.1016/S0140-6736(94)92640-9; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Wright J, 2004, TROP MED INT HEALTH, V9, P559, DOI 10.1111/j.1365-3156.2004.01230.x; Yudkin PL, 2001, STAT MED, V20, P341, DOI 10.1002/1097-0258(20010215)20:3<341::AID-SIM796>3.0.CO;2-G; Zwarenstein M, 1998, LANCET, V352, P1340, DOI 10.1016/S0140-6736(98)04022-7	29	94	97	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					903	909		10.1016/S0140-6736(06)68380-3	http://dx.doi.org/10.1016/S0140-6736(06)68380-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546538				2022-12-28	WOS:000236242100026
J	Su, CY; Luo, DG; Terakita, A; Shichida, Y; Liao, HW; Kazmi, MA; Sakmar, TP; Yau, KW				Su, CY; Luo, DG; Terakita, A; Shichida, Y; Liao, HW; Kazmi, MA; Sakmar, TP; Yau, KW			Parietal-eye phototransduction components and their potential evolutionary implications	SCIENCE			English	Article							G-PROTEIN; CONE PHOTORECEPTORS; ALPHA-GUSTDUCIN; PINEAL; TRANSDUCIN; SUBUNIT; OPSIN; TASTE; EXPRESSION; MASTOPARAN	The parietal-eye photoreceptor is unique because it has two antagonistic light signaling pathways in the same cell - a hyperpolarizing pathway maximally sensitive to blue light and a depolarizing pathway maximally sensitive to green light. Here, we report the molecular components of these two pathways. We found two opsins in the same cell: the blue-sensitive pinopsin and a previously unidentified green-sensitive opsin, which we name parietopsin. Signaling components included gustducin-alpha and G alpha(o), but not rod or cone transducin-alpha. Single-cell recordings demonstrated that G(o) mediates the depolarizing response. Gustducin-alpha resembles transducin-alpha functionally and likely mediates the hyperpolarizing response. The parietopsin-G(o) signaling pair provides clues about how rod and cone phototransduction might have evolved.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan; Core Res Evolut Sci & Technol, Kyoto 6068502, Japan; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Johns Hopkins University; Kyoto University; Japan Science & Technology Agency (JST); Rockefeller University	Su, CY (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	chih-ying.su@yale.edu; kwyau@mail.jhmi.edu	Luo, Donggen/D-5990-2011; Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953; Terakita, Akihisa/0000-0002-8379-8913	NEI NIH HHS [R01 EY006837-18, R01 EY014596-01, R01 EY006837-16A1, R01 EY006837-17, R01 EY014596, R01 EY006837-19, R37 EY006837-15S1, R01 EY014596-03, R37 EY006837, R01 EY014596-04, R01 EY014596-02, EY06837, R01 EY006837] Funding Source: Medline; NIDCD NIH HHS [R01 DC006904, R01 DC006904-01, R01 DC006904-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY006837, R01EY014596, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Blackshaw S, 1997, J NEUROSCI, V17, P8083; EAKIN RM, 1973, 3 EYE; Finn JT, 1997, NATURE, V385, P815, DOI 10.1038/385815a0; Gomez MD, 2000, J NEUROSCI, V20, P5254, DOI 10.1523/JNEUROSCI.20-14-05254.2000; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; He W, 2002, CHEM SENSES, V27, P719, DOI 10.1093/chemse/27.8.719; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Kasahara T, 2000, J NEUROCHEM, V75, P217, DOI 10.1046/j.1471-4159.2000.0750217.x; Kojima D, 1997, J BIOL CHEM, V272, P22979, DOI 10.1074/jbc.272.37.22979; LEE RH, 1992, J BIOL CHEM, V267, P24776; Max M, 1998, J BIOL CHEM, V273, P26820, DOI 10.1074/jbc.273.41.26820; MAX M, 1995, SCIENCE, V267, P1502, DOI 10.1126/science.7878470; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; Pichaud F, 2002, CURR OPIN GENET DEV, V12, P430, DOI 10.1016/S0959-437X(02)00321-0; PU GA, 1981, J NEUROPHYSIOL, V46, P1018, DOI 10.1152/jn.1981.46.5.1018; SOLESSIO E, 1993, NATURE, V364, P442, DOI 10.1038/364442a0; TAMOTSU S, 1986, J COMP PHYSIOL A, V159, P1, DOI 10.1007/BF00612489; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200; Vardi N, 1998, J COMP NEUROL, V395, P43; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Xiong WH, 1998, NAT NEUROSCI, V1, P359, DOI 10.1038/nn0998_359	28	83	83	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1617	1621		10.1126/science.1123802	http://dx.doi.org/10.1126/science.1123802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543463				2022-12-28	WOS:000236029500049
J	Steinbrook, R				Steinbrook, R			The potential of human papillomavrius vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTION; TYPE-16											Blumenthal PD, 2005, JAMA-J AM MED ASSOC, V294, P2225, DOI 10.1001/jama.294.17.2225; GOODMAN E, 2005, BOSTON GLOBE    1112, pA11; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171	5	58	67	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1109	+		10.1056/NEJMp058305	http://dx.doi.org/10.1056/NEJMp058305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540608				2022-12-28	WOS:000235981700001
J	Whiting, P; Harbord, R; Main, C; Deeks, JJ; Filippini, G; Egger, M; Sterne, JAC				Whiting, P; Harbord, R; Main, C; Deeks, JJ; Filippini, G; Egger, M; Sterne, JAC			Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MCDONALD CRITERIA; RISK; MRI; GUIDELINES; TESTS	Objective To determine the accuracy of magnetic resonance imaging criteria for die early diagnosis of multiple sclerosis in patients with suspected disease. Design Systematic review. Data sources 12 electronic databases, citation searches, and reference lists of included studies. Review methods Studies on accuracy of diagnosis that compared magnetic resonance imaging, or diagnostic criteria incorporating such imaging, to a reference standard for the diagnosis of multiple sclerosis. Results 29 Studies (18 cohort studies, 11 other designs) wee included. On average, studies of other designs (mainly diagnostic case-control studies) produced higher estimated diagnostic odds ratios than did cohort studies. Among 15 studies of higher methodological quality (cohort design, clinical follow-up as reference standard), those with longer follow-up produced higher estimates of specificity mid lower estimates of sensitivity Only two such studies followed patients for more than 10 years. Even in die presence of many lesions (> 10 or >8), magnetic resonance imaging could not accurately rule in multiple sclerosis (likelihood ratio of a positive test result 3.0 and 2.0, respectively). Similarly, the absence of lesions was Of limited utility in ruling out a diagnosis of multiple sclerosis (likelihood ratio of a negative test result 0.1 and 0.5). Conclusions Many evaluations of the accuracy of magnetic resonance imaging for the early detection of multiple sclerosis have produced inflated estimates of test performance owing to methodological weaknesses. Use of magnetic resonance imaging to confirm multiple sclerosis on the basis of a single attack of neurological dysfunction may lead to over-diagnosis and over-treatment	Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England; Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; Univ Oxford Wolfson Coll, Ctr Stat Med, Oxford OX2 6UD, England; Ist Nazl Neurol Carlo Besta, Unit Neuroepidemiol, Milan, Italy; Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland	University of York - UK; University of Oxford; IRCCS Istituto Neurologico Besta; University of Bern	Whiting, P (corresponding author), Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol BS8 2PR, Avon, England.	penny.whiting@bristol.ac.uk	Harbord, Roger M/A-8699-2008; Deeks, Jon/AAV-5745-2020; Sterne, Jonathan/Z-3106-2019	Harbord, Roger M/0000-0002-2257-8271; Deeks, Jon/0000-0002-8850-1971; Sterne, Jonathan/0000-0001-8496-6053; Egger, Matthias/0000-0001-7462-5132; Whiting, Penny/0000-0003-1138-5682	Medical Research Council [MC_U145079314] Funding Source: Medline; MRC [MC_U145079314] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944; BEER S, 1995, J NEUROL NEUROSUR PS, V59, P152, DOI 10.1136/jnnp.59.2.152; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Dalton CM, 2003, ANN NEUROL, V53, P673, DOI 10.1002/ana.10580; Dalton CM, 2002, ANN NEUROL, V52, P47, DOI 10.1002/ana.10240; DECKS JJ, 2004, BRIT MED J, V329, P163; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Di Legge S, 2002, NEUROLOGY, V58, pA173; Frohman EM, 2003, NEUROLOGY, V61, P602, DOI 10.1212/01.WNL.0000082654.99838.EF; Heesen C, 2003, ACTA NEUROL SCAND, V107, P363, DOI 10.1034/j.1600-0404.2003.00086.x; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Koopman W, 1999, J Neurosci Nurs, V31, P17; Macaskill P, 2004, J CLIN EPIDEMIOL, V57, P925, DOI 10.1016/j.jclinepi.2003.12.019; MCDONALD WI, 1977, BRIT MED BULL, V33, P4, DOI 10.1093/oxfordjournals.bmb.a071393; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MILLER DH, 1988, J NEUROL NEUROSUR PS, V51, P1569, DOI 10.1136/jnnp.51.12.1569; Miller DH, 2004, ANN NEUROL, V56, P273, DOI 10.1002/ana.20156; Moons KGM, 2004, CLIN CHEM, V50, P473, DOI 10.1373/clinchem.2003.024752; MUSHLIN AI, 1993, JAMA-J AM MED ASSOC, V269, P3146, DOI 10.1001/jama.269.24.3146; MUSHLIN AI, 1994, ARCH NEUROL-CHICAGO, V51, P67, DOI 10.1001/archneur.1994.00540130093017; *NAT COLL CTR CHRO, 2004, MULT SCLER NAT DIN G; O'Connor P, 2002, NEUROLOGY, V59, P998; OCONNOR P, 1994, ARCH NEUROL-CHICAGO, V51, P46, DOI 10.1001/archneur.1994.00540130072013; Poser CM, 2004, CLIN NEUROL NEUROSUR, V106, P147, DOI 10.1016/j.clineuro.2004.02.004; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; SHARIEF MK, 1991, ANN NEUROL, V29, P147, DOI 10.1002/ana.410290206; The National Collaborating Centre for Chronic Conditions, 2004, MULT SCLER NAT CLIN; Tintore M, 2003, NEUROLOGY, V60, P27, DOI 10.1212/WNL.60.1.27; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010	32	44	46	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 15	2006	332	7546					875	878		10.1136/bmj.38771.583796.7C	http://dx.doi.org/10.1136/bmj.38771.583796.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037FK	16565096	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000237132100013
J	Di Giorgio, A; Destito, C; Mercuri, M; Marin, AW				Di Giorgio, A; Destito, C; Mercuri, M; Marin, AW			Asymptomatic enterothorax	LANCET			English	Editorial Material									Univ Sacred Heart, Sch Med, Dept Surg Sci, Div Gen Surg, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Di Giorgio, A (corresponding author), Univ Sacred Heart, Sch Med, Dept Surg Sci, Div Gen Surg, Largo F Vito 1, I-00168 Rome, Italy.	andrea.digorgio@rm.unicatt.it		Di Giorgio, Andrea/0000-0003-3981-1145					0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1086	1086		10.1016/S0140-6736(06)68476-6	http://dx.doi.org/10.1016/S0140-6736(06)68476-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581408	Bronze			2022-12-28	WOS:000236673200033
J	Milne, S; Cohen, A				Milne, S; Cohen, A			Lesson of the week - Secondary drowning in a patient with epilepsy	BMJ-BRITISH MEDICAL JOURNAL			English	Article									St James Hosp, Intens Care Unit, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Cohen, A (corresponding author), St James Hosp, Intens Care Unit, Leeds LS9 7TF, W Yorkshire, England.	a.t.cohen@leeds.ac.uk						EDMONDS C, 1970, MIL MED, V135, P779, DOI 10.1093/milmed/135.9.779; FULLER RH, 1963, MIL MED, V128, P22, DOI 10.1093/milmed/128.1.22; GOLDEN FC, 1979, BRIT J ANAESTH, V79, P214; Haglund P, 1974, Resuscitation, V3, P121, DOI 10.1016/0300-9572(74)90036-7; Ibsen LM, 2002, CRIT CARE MED, V30, pS402, DOI 10.1097/00003246-200211001-00004; MODELL JH, 1976, CHEST, V70, P231, DOI 10.1378/chest.70.2.231; ORLOWSKI JP, 1987, PEDIATR CLIN N AM, V34, P75; PEARN JH, 1980, BRIT MED J, V281, P1103, DOI 10.1136/bmj.281.6248.1103; RIVERS JF, 1970, BRIT MED J, V2, P157, DOI 10.1136/bmj.2.5702.157	9	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					775	776		10.1136/bmj.332.7544.775	http://dx.doi.org/10.1136/bmj.332.7544.775			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032JA	16575080	Green Published			2022-12-28	WOS:000236769500025
J	Rees, J				Rees, J			Asthma control in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							QUALITY-OF-LIFE; PRIMARY-CARE; LONG-TERM; EXACERBATIONS; SALMETEROL; MANAGEMENT; TRIAL; SALMETEROL/FLUTICASONE; BUDESONIDE/FORMOTEROL; CORTICOSTEROIDS		Guys Kings Coll & St Thomas Hosp, Sch Med, Sherman Educ Ctr, London SE1 9RT, England	University of London; King's College London	Rees, J (corresponding author), Guys Kings Coll & St Thomas Hosp, Sch Med, Sherman Educ Ctr, London SE1 9RT, England.	john.rees@kcl.ac.uk						Aalbers R, 2004, CURR MED RES OPIN, V20, P225, DOI 10.1185/030079903125002928; Adams N, 2001, Cochrane Database Syst Rev, pCD003271; Adams N, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002310.pub3; Adams RJ, 2004, THORAX, V59, P930, DOI 10.1136/thx.2003.010256; *AM THOR SOC, 2005, TASK FORC PROV REC A; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Ampon RD, 2005, THORAX, V60, P735, DOI 10.1136/thx.2005.040311; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bellamy David, 2005, Prim Care Respir J, V14, P252, DOI 10.1016/j.pcrj.2005.04.003; Bisgaard H, 2006, LANCET, V367, P286, DOI 10.1016/S0140-6736(06)68051-3; Bousquet J, 2006, ALLERGY, V61, P72, DOI 10.1111/j.1398-9995.2005.00931.x; Carlton BG, 2005, J ASTHMA, V42, P529, DOI 10.1081/JAS-200067000; de Asis MLB, 2004, J ASTHMA, V41, P559, DOI 10.1081/JAS-120037657; DRUMMOND N, 1994, BRIT MED J, V308, P564, DOI 10.1136/bmj.308.6928.564; Ducharme F, 2004, Cochrane Database Syst Rev, pCD003133, DOI 10.1002/14651858.CD003133.pub2; FitzGerald JM, 2005, CLIN THER, V27, P393, DOI 10.1016/j.clinthera.2005.03.006; Fleming S. L., 2004, COCHRANE DB SYST REV; Gallefoss F, 1999, AM J RESP CRIT CARE, V160, P2000, DOI 10.1164/ajrccm.160.6.9901028; GIBSON PG, 2003, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001117; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Griffiths C, 2004, BMJ-BRIT MED J, V328, P144, DOI 10.1136/bmj.37950.784444.EE; Haahtela T, 1999, ALLERGY, V54, P74, DOI 10.1111/j.1398-9995.1999.tb04392.x; Harrison TW, 2004, LANCET, V363, P271, DOI 10.1016/S0140-6736(03)15384-6; Ind PW, 2004, RESP MED, V98, P464, DOI 10.1016/j.rmed.2003.07.010; Jones K, 1999, BRIT J GEN PRACT, V49, P23; Juniper EF, 1999, EUR RESPIR J, V14, P32, DOI 10.1034/j.1399-3003.1999.14a08.x; Juniper EF, 2003, CURR OPIN PULM MED, V9, pS8, DOI 10.1097/00063198-200304001-00003; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; JUNIPER EF, 1992, THORAX, V47, P76, DOI 10.1136/thx.47.2.76; JUNIPER EF, 2005, RESP MED        1012; KENDRICK AH, 1993, BRIT MED J, V307, P422, DOI 10.1136/bmj.307.6901.422; LAITINEN LA, 1993, AM REV RESPIR DIS, V147, P697, DOI 10.1164/ajrccm/147.3.697; LAITINEN LA, 1994, AM J RESP CRIT CARE, V150, pS87, DOI 10.1164/ajrccm/150.5_Pt_2.S87; Lotvall J, 2004, CURR MED RES OPIN, V20, P1711, DOI 10.1185/030079904X3104; Lundback B, 2006, RESP MED, V100, P2, DOI 10.1016/j.rmed.2005.09.006; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Neville RG, 1996, BRIT J GEN PRACT, V46, P583; Ng D, 2004, COCHRANE DATABASE SY, DOI [10.1002/14651858.CD002314.pub2, DOI 10.1002/14651858.CD002314.PUB2]; OSMAN LM, 1994, BRIT MED J, V308, P568, DOI 10.1136/bmj.308.6928.568; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Powell H, 2003, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004109.PUB2, 10.1002/14651858.CD004109.pub2]; Ram FS, 2005, COCHRANE DB SYST REV; Rasmussen LM, 2005, J ALLERGY CLIN IMMUN, V115, P1137, DOI 10.1016/j.jaci.2005.03.030; Rimington LD, 2001, THORAX, V56, P266, DOI 10.1136/thorax.56.4.266; Ryan D, 2005, J TELEMED TELECARE, V11, P43, DOI 10.1258/1357633054461714; Selroos O, 2004, RESP MED, V98, P254, DOI 10.1016/j.rmed.2003.10.007; Shrewsbury S, 2000, BMJ-BRIT MED J, V320, P1368, DOI 10.1136/bmj.320.7246.1368; Sin DD, 2004, JAMA-J AM MED ASSOC, V292, P367, DOI 10.1001/jama.292.3.367; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Steven K, 2002, Br J Community Nurs, V7, P300; Taramarcaz P, 2003, Cochrane Database Syst Rev, pCD003570, DOI 10.1002/14651858.CD003570; Toelle BG, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002171.PUB2; Veen JCCMI, 1998, AM J RESP CRIT CARE, V158, P1134, DOI 10.1164/ajrccm.158.4.9710087; Wedzicha JA, 2003, THORAX, V58, P1, DOI 10.1136/thorax.58.1.1; Yawn BP, 2006, RESP MED, V100, P26, DOI 10.1016/j.rmed.2005.04.010	58	22	22	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2006	332	7544					767	+		10.1136/bmj.332.7544.767	http://dx.doi.org/10.1136/bmj.332.7544.767			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032JA	16575078	Green Published			2022-12-28	WOS:000236769500023
J	Pormann, PE				Pormann, PE			Why the modern Middle East?	LANCET			English	Editorial Material									Univ London, Warburg Inst, London WC1H 0AB, England	University of London	Pormann, PE (corresponding author), Univ London, Warburg Inst, London WC1H 0AB, England.	peter.pormann@sas.ac.uk						CORM G, 2002, LE MOYEN ORIENT EXPO; DECORDOBA A, 1880, INDICULUS LUMINOSUS, V121, P555; ENDRESS G, 2002, ISLAM HIST INTRO NEW; Gelvin James L., 2005, MODERN MIDDLE E HIST; Gutas D., 1998, GREEK THOUGHT ARABIC; Kepel G., 2004, JIHAD TRAIL POLITICA; Kepel G., 2004, WAR MUSLIM MINDS ISL; Macfie AlexanderLyons., 2000, ORIENTALISM; MUNK MS, 1850, J ASIATIQUE, V4, P337; Pappe Ilan, 2004, HIST MODERN PALESTIN; Quataert Donald, 2005, OTTOMAN EMPIRE 1700; Simpson J. A., 1989, OXFORD ENGLISH DICT; Siraisi N.G., 1987, AVICENNA RENAISSANCE; Soanes C., 2005, OXFORD DICT ENGLISH; *WHO REG OFF E MED, GEN INF	15	0	0	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					971	972		10.1016/S0140-6736(06)68407-9	http://dx.doi.org/10.1016/S0140-6736(06)68407-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564348				2022-12-28	WOS:000236474200010
J	Janes, KA; Gaudet, S; Albeck, JG; Nielsen, UB; Lauffenburger, DA; Sorger, PK				Janes, KA; Gaudet, S; Albeck, JG; Nielsen, UB; Lauffenburger, DA; Sorger, PK			The response of human epithelial cells to TNF involves an inducible autocrine cascade	CELL			English	Article							TUMOR-NECROSIS-FACTOR; EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; TYROSINE KINASE ACTIVATION; CYTOKINE-INDUCED APOPTOSIS; FACTOR-I RECEPTOR; FACTOR-ALPHA; CANCER; EGF; THERAPY	Tumor necrosis factor (TNF) is a proinflammatory cytokine that induces conflicting pro- and antiapoptotic signals whose relative strengths determine the extent of cell death. TNF receptor (TNFR) has been studied in considerable detail, but it is not known how crosstalk among antagonistic pro- and antiapoptotic signals is achieved. Here we report an experimental and computational analysis of crosstalk between prodeath TNF and prosurvival growth factors in human epithelial cells. By applying classifier-based regression to a cytokine-signaling compendium of similar to 8000 intracellular protein measurements, we demonstrate that cells respond to TNF both directly, via activated TNF receptor, and indirectly, via the sequential release of transforming growth factor-alpha (TGF-alpha), interleukin-1 alpha (IL-1 alpha), and IL-1 receptor antagonist (IL-1ra.). We refer to the contingent and time-varying series of extracellular signals induced by TNF as an "autocrine cascade." Time-dependent crosstalk of synergistic and antagonistic autocrine circuits may serve to link cellular responses to the local environment.	MIT, Ctr Cell Decis Proc, Cambridge, MA 02139 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Merrimack Pharamceut, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sorger, PK (corresponding author), MIT, Ctr Cell Decis Proc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	psorger@mit.edu	Eckhardt, Erik/G-1567-2010	Sorger, Peter/0000-0002-3364-1838; Gaudet, Suzanne/0000-0002-5701-2825	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER; NIGMS NIH HHS [P50-GM68762] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Anderson GM, 2004, CURR OPIN PHARMACOL, V4, P314, DOI 10.1016/j.coph.2004.04.004; ANZANO MA, 1989, CANCER RES, V49, P2898; Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Barnhart BC, 2003, CELL, V114, P148, DOI 10.1016/S0092-8674(03)00561-0; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Chailler Pierre, 1999, Frontiers in Bioscience, V4, pD87, DOI 10.2741/Chailler; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen WNU, 2004, J BIOL CHEM, V279, P18488, DOI 10.1074/jbc.M310874200; Dinarello CA, 2000, NEW ENGL J MED, V343, P732, DOI 10.1056/NEJM200009073431011; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Dumont JE, 2002, AM J PHYSIOL-CELL PH, V283, pC2, DOI 10.1152/ajpcell.00581.2001; Efron B., 1994, MONOGRAPHS STAT APPL; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; FRANSEN L, 1986, EUR J CANCER CLIN ON, V22, P419, DOI 10.1016/0277-5379(86)90107-0; GarciaLloret MI, 1996, J CELL PHYSIOL, V167, P324, DOI 10.1002/(SICI)1097-4652(199605)167:2<324::AID-JCP17>3.0.CO;2-7; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hambek M, 2001, CANCER RES, V61, P1045; Hofmann F, 2005, DRUG DISCOV TODAY, V10, P1041, DOI 10.1016/S1359-6446(05)03512-9; IZUMI H, 1994, EXP CELL RES, V214, P654, DOI 10.1006/excr.1994.1303; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2004, J COMPUT BIOL, V11, P544, DOI 10.1089/1066527041887258; Janes KA, 2003, MOL CELL PROTEOMICS, V2, P463, DOI 10.1074/mcp.M300045-MCP200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KOBAYASHI Y, 1990, P NATL ACAD SCI USA, V87, P5548, DOI 10.1073/pnas.87.14.5548; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nielsen UB, 2003, P NATL ACAD SCI USA, V100, P9330, DOI 10.1073/pnas.1633513100; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Panja A, 1998, J IMMUNOL, V161, P3675; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qian H, 2001, BIOCHEM BIOPH RES CO, V284, P1176, DOI 10.1006/bbrc.2001.5100; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Ruan H, 2003, CYTOKINE GROWTH F R, V14, P447, DOI 10.1016/S1359-6101(03)00052-2; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Sfikakis PP, 2003, CURR OPIN RHEUMATOL, V15, P380, DOI 10.1097/00002281-200307000-00003; SINGH P, 1993, GASTROENTEROLOGY, V105, P1218, DOI 10.1016/0016-5085(93)90971-E; STAMPFER MR, 1993, CANCER SURV, V18, P7; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Streetz K, 2000, GASTROENTEROLOGY, V119, P446, DOI 10.1053/gast.2000.9364; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Wu YL, 1996, J CELL PHYSIOL, V168, P499, DOI 10.1002/(SICI)1097-4652(199609)168:3<499::AID-JCP2>3.0.CO;2-K; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487	58	159	165	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1225	1239		10.1016/j.cell.2006.01.041	http://dx.doi.org/10.1016/j.cell.2006.01.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564013	Bronze			2022-12-28	WOS:000237241400022
J	Otto-Bliesner, BL; Marsha, SJ; Overpeck, JT; Miller, GH; Hu, AX				Otto-Bliesner, BL; Marsha, SJ; Overpeck, JT; Miller, GH; Hu, AX		CAPE Last Interglacial Project Mem	Simulating arctic climate warmth and icefield retreat in the last interglaciation	SCIENCE			English	Article							GREENLAND ICE-SHEET; SEA-LEVEL; GLACIAL CYCLE; CORE EVIDENCE; ELEVATION; HOLOCENE; RECORD; EXTENT; MODEL	In the future, Arctic warming and the melting of polar glaciers will be considerable, but the magnitude of both is uncertain. We used a global climate model, a dynamic ice sheet model, and paleoclimatic data to evaluate Northern Hemisphere high-latitude warming and its impact on Arctic icefields during the Last Interglaciation. Our simulated climate matches paleoclimatic observations of past warming, and the combination of physically based climate and ice-sheet modeling with ice-core constraints indicate that the Greenland Ice Sheet and other circum-Arctic ice fields likely contributed 2.2 to 3.4 meters of sea-level rise during the Last Interglaciation.	Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA; Univ Calgary, Dept Geog, Calgary, AB T2N 1N4, Canada; Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; Univ Arizona, Dept Atmospher Sci, Tucson, AZ 85721 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	National Center Atmospheric Research (NCAR) - USA; University of Calgary; University of Arizona; University of Arizona; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Otto-Bliesner, BL (corresponding author), Natl Ctr Atmospher Res, Climate & Global Dynam Div, POB 3000, Boulder, CO 80305 USA.	ottobli@ucar.edu	Hu, Aixue/E-1063-2013; Otto-Bliesner, Bette/AAY-7691-2020	Hu, Aixue/0000-0002-1337-287X; Frechette, Bianca/0000-0002-4986-5772; Miller, Heinrich/0000-0003-1015-2828				Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33983, DOI 10.1029/2001JD900181; Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; BENNIKE O, 1994, BOREAS, V23, P479; BRIGHAMGRETTE J, 1995, QUATERNARY RES, V43, P154; Comiso JC, 2003, J CLIMATE, V16, P3498, DOI 10.1175/1520-0442(2003)016<3498:WTITAF>2.0.CO;2; CROWLEY TJ, 1994, SCIENCE, V265, P1566, DOI 10.1126/science.265.5178.1566; Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; Edwards ME, 2003, ARCT ANTARCT ALP RES, V35, P460, DOI 10.1657/1523-0430(2003)035[0460:IEOTBF]2.0.CO;2; Flato GM, 2004, CLIM DYNAM, V23, P229, DOI 10.1007/s00382-004-0436-7; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; HARRISON SP, 1995, QUATERNARY RES, V43, P174, DOI 10.1006/qres.1995.1018; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; Kerwin MW, 1999, PALEOCEANOGRAPHY, V14, P200, DOI 10.1029/1998PA900011; Kiehl JT, 2004, J CLIMATE, V17, P3666, DOI 10.1175/1520-0442(2004)017<3666:TCCSMV>2.0.CO;2; Koerner RM, 2002, ANN GLACIOL-SER, V35, P19, DOI 10.3189/172756402781817338; KOERNER RM, 1989, SCIENCE, V244, P964, DOI 10.1126/science.244.4907.964; Krabill W, 2000, SCIENCE, V289, P428, DOI 10.1126/science.289.5478.428; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Kutzbach J. E., 1991, QUATERN INT, V10-12, P223, DOI [10.1016/1040-6182(91)90054-R, DOI 10.1016/1040-6182(91)90054-R]; LOZHKIN AV, 1995, QUATERNARY RES, V43, P147, DOI 10.1006/qres.1995.1016; Marshall SJ, 2000, EARTH PLANET SC LETT, V179, P73, DOI 10.1016/S0012-821X(00)00108-4; McCulloch MT, 2000, CHEM GEOL, V169, P107, DOI 10.1016/S0009-2541(00)00260-6; Montoya M, 2000, J CLIMATE, V13, P1057, DOI 10.1175/1520-0442(2000)013<1057:CSFKBW>2.0.CO;2; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Paterson WSB, 2001, NATURE, V414, P60, DOI 10.1038/35102044; Raynaud D, 1997, J GEOPHYS RES-OCEANS, V102, P26607, DOI 10.1029/97JC01908; STOUFFER RJ, IN PRESS J CLIM; Stroeve JC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021810; Tarasov L, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001731	29	659	682	3	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1751	1753		10.1126/science.1120808	http://dx.doi.org/10.1126/science.1120808			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556838	Green Submitted			2022-12-28	WOS:000236204300037
J	Sanguinetti, MC; Tristani-Firouzi, M				Sanguinetti, MC; Tristani-Firouzi, M			hERG potassium channels and cardiac arrhythmia	NATURE			English	Review							LONG-QT-SYNDROME; DEPENDENT K+ CHANNEL; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; VOLTAGE SENSOR; MOLECULAR-MECHANISM; PROTEIN TRAFFICKING; HOMOLOGY MODEL; SUDDEN-DEATH; GENE	hERG potassium channels are essential for normal electrical activity in the heart. Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias. Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs. This side effect is a common reason for drug failure in preclinical safety trials. Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.	Univ Utah, Dept Physiol, Salt Lake City, UT 84112 USA; Univ Utah, Nora Eccles Harrison Cardiovasc Res & Training In, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Sanguinetti, MC (corresponding author), Univ Utah, Dept Physiol, 95 South 2000 East, Salt Lake City, UT 84112 USA.	sanguinetti@cvrti.utah.edu	Sanguinetti, Michael/AAN-2615-2020					Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Cavalli A, 2002, J MED CHEM, V45, P3844, DOI 10.1021/jm0208875; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chiesa N, 1997, J PHYSIOL-LONDON, V501, P313, DOI 10.1111/j.1469-7793.1997.313bn.x; CLAY JR, 1988, J PHYSIOL-LONDON, V403, P525, DOI 10.1113/jphysiol.1988.sp017262; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; De Bruin ML, 2005, EUR HEART J, V26, P590, DOI 10.1093/eurheartj/ehi092; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dubin AE, 2005, J BIOMOL SCREEN, V10, P168, DOI 10.1177/1087057104272295; Ekins S, 2002, J PHARMACOL EXP THER, V301, P427, DOI 10.1124/jpet.301.2.427; Fan JS, 1999, BIOPHYS J, V76, P3128, DOI 10.1016/S0006-3495(99)77464-3; Farrelly AM, 2003, AM J PHYSIOL-GASTR L, V284, pG883, DOI 10.1152/ajpgi.00394.2002; Fernandez D, 2005, J PHYSIOL-LONDON, V567, P737, DOI 10.1113/jphysiol.2005.089094; Fernandez D, 2004, J BIOL CHEM, V279, P10120, DOI 10.1074/jbc.M310683200; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Haverkamp W, 2000, EUR HEART J, V21, P1216, DOI 10.1053/euhj.2000.2249; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Kagan A, 2000, J BIOL CHEM, V275, P11241, DOI 10.1074/jbc.275.15.11241; Kang JS, 2005, MOL PHARMACOL, V67, P827, DOI 10.1124/mol.104.006577; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Laine M, 2004, FEBS LETT, V564, P257, DOI 10.1016/S0014-5793(04)00273-X; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Lastraioli E, 2004, CANCER RES, V64, P606, DOI 10.1158/0008-5472.CAN-03-2360; Liu J, 2003, J GEN PHYSIOL, V121, P599, DOI 10.1085/jgp.200308788; London B, 1997, CIRC RES, V81, P870; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; NOBLE D, 1969, J PHYSIOL-LONDON, V200, P205, DOI 10.1113/jphysiol.1969.sp008689; Osterberg F, 2005, FEBS LETT, V579, P2939, DOI 10.1016/j.febslet.2005.04.039; Pearlstein R, 2003, J MED CHEM, V46, P2017, DOI 10.1021/jm0205651; Pearlstein RA, 2003, BIOORG MED CHEM LETT, V13, P1829, DOI 10.1016/S0960-894X(03)00196-3; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Piper DR, 2003, P NATL ACAD SCI USA, V100, P10534, DOI 10.1073/pnas.1832721100; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Pourrier M, 2003, CIRC RES, V93, P189, DOI 10.1161/01.RES.0000084851.60947.B5; Priebe L, 1998, CIRC RES, V82, P1206, DOI 10.1161/01.RES.82.11.1206; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Priori SG, 2001, CIRCULATION, V103, P196; Rajamani R, 2005, BIOORG MED CHEM LETT, V15, P1737, DOI 10.1016/j.bmcl.2005.01.008; Recanatini M, 2005, MED RES REV, V25, P133, DOI 10.1002/med.20019; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; Schott JJ, 1999, NAT GENET, V23, P20, DOI 10.1038/12618; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; Shi WM, 1997, J NEUROSCI, V17, P9423; SHIBASAKI T, 1987, J PHYSIOL-LONDON, V387, P227, DOI 10.1113/jphysiol.1987.sp016571; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Smith PL, 2002, J GEN PHYSIOL, V119, P275, DOI 10.1085/jgp.119.3.275; Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0; Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vitola J, 1998, J CARDIOVASC ELECTR, V9, P1109, DOI 10.1111/j.1540-8167.1998.tb00888.x; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Weerapura M, 2002, J PHYSIOL-LONDON, V540, P15, DOI 10.1113/jphysiol.2001.013296; Wimmers S, 2001, PFLUG ARCH EUR J PHY, V441, P450, DOI 10.1007/s004240000467; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	88	1104	1176	4	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2006	440	7083					463	469		10.1038/nature04710	http://dx.doi.org/10.1038/nature04710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554806				2022-12-28	WOS:000236176100043
J	[Anonymous]				[Anonymous]			A scramble for Africa	NATURE			English	Editorial Material																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					383	384		10.1038/440383b	http://dx.doi.org/10.1038/440383b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554759	Bronze			2022-12-28	WOS:000236176100002
J	Fletcher, J; Fox, R				Fletcher, J; Fox, R			A 28 year old postpartum woman with right sided chest discomfort: case outcome - Commentary: Pattern recognition versus bayesian approach for diagnosis in primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; WOMEN		Bicester Hlth Ctr, Bicester OX26 6AT, Oxon, England		Fletcher, J (corresponding author), Bicester Hlth Ctr, Bicester OX26 6AT, Oxon, England.	jfletcher@bmj.com						Dwivedi G, 2006, BRIT MED J, V332, P643, DOI 10.1136/bmj.332.7542.643; Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Wild S, 1997, BRIT MED J, V314, P705, DOI 10.1136/bmj.314.7082.705	4	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAR 18	2006	332	7542					646	646		10.1136/bmj.332.7542.646	http://dx.doi.org/10.1136/bmj.332.7542.646			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543333	Green Published			2022-12-28	WOS:000236314700022
J	Hunter, DJ; Felson, DT				Hunter, DJ; Felson, DT			Osteoarthritis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							KNEE OSTEOARTHRITIS; OLDER-ADULTS; TOTAL HIP; REPLACEMENT; ARTHRITIS; PAIN; ACETAMINOPHEN; GLUCOSAMINE; MANAGEMENT; COMMUNITY		Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA	Boston University	Hunter, DJ (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA.	djhunter@bu.edu		Felson, David/0000-0002-2668-2447	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR47785] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bellamy N, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005328; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; BROUWER RW, 2005, COCHRANE DB SYST REV; CALLAHAN CM, 1994, JAMA-J AM MED ASSOC, V271, P1349, DOI 10.1001/jama.271.17.1349; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Ettinger WH, 1997, JAMA-J AM MED ASSOC, V277, P25, DOI 10.1001/jama.277.1.25; Fortin PR, 1999, ARTHRITIS RHEUM, V42, P1722, DOI 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-R; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Hill CL, 2001, J RHEUMATOL, V28, P1330; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Kirkley A, 1999, J BONE JOINT SURG AM, V81A, P539, DOI 10.2106/00004623-199904000-00012; Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115; Maillefert JF, 2001, OSTEOARTHR CARTILAGE, V9, P738, DOI 10.1053/joca.2001.0470; Mancuso CA, 1996, J ARTHROPLASTY, V11, P34, DOI 10.1016/S0883-5403(96)80159-8; Martin J A, 2001, Iowa Orthop J, V21, P1; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Morelli V, 2003, AM FAM PHYSICIAN, V67, P339; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Naudie D, 1999, CLIN ORTHOP RELAT R, P18; Nuki G, 1999, Z RHEUMATOL, V58, P142, DOI 10.1007/s003930050164; Peach CA, 2005, TRENDS MOL MED, V11, P186, DOI 10.1016/j.molmed.2005.02.005; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Pincus T, 2000, J RHEUMATOL, V27, P1020; Pincus T, 2001, ARTHRITIS RHEUM-US, V44, P1587, DOI 10.1002/1529-0131(200107)44:7<1587::AID-ART282>3.0.CO;2-X; Segal L, 2004, MED J AUSTRALIA, V180, pS11; Stukenborg-Colsman C, 2001, KNEE, V8, P187, DOI 10.1016/S0968-0160(01)00097-7; SuperioCabuslay E, 1996, ARTHRIT CARE RES, V9, P292, DOI 10.1002/1529-0131(199608)9:4<292::AID-ANR1790090414>3.0.CO;2-4; Tallon D, 2000, LANCET, V355, P2037, DOI 10.1016/S0140-6736(00)02351-5; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2	32	394	409	0	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2006	332	7542					639	642B		10.1136/bmj.332.7542.639	http://dx.doi.org/10.1136/bmj.332.7542.639			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CQ	16543327	Green Published			2022-12-28	WOS:000236314700017
J	Zumla, A; Mullan, Z				Zumla, A; Mullan, Z			Turning the tide against tuberculosis	LANCET			English	Editorial Material									UCL Royal Free & UCL Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London W1T 4JF, England; The Lancet, London, England	University of London; University College London	Zumla, A (corresponding author), UCL Royal Free & UCL Med Sch, Windeyer Inst Med Sci, Ctr Infect Dis & Int Hlth, London W1T 4JF, England.	a.zumla@ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; *UN, 2005, UN MILL DEV GOALS RE; *WORLD EC FOR, 2006, OB BROWN GAT WORLD L; Zumla Alimuddin, 2003, RETURN WHITE PLAGUE, P237; GLOBAL PLAN STOP TB	6	6	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					877	878		10.1016/S0140-6736(06)68355-4	http://dx.doi.org/10.1016/S0140-6736(06)68355-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546520				2022-12-28	WOS:000236242100004
J	Cooks, RG; Ouyang, Z; Takats, Z; Wiseman, JM				Cooks, RG; Ouyang, Z; Takats, Z; Wiseman, JM			Ambient mass spectrometry	SCIENCE			English	Review							DESORPTION ELECTROSPRAY-IONIZATION; ATMOSPHERIC-PRESSURE; BIOLOGICAL TISSUE; MECHANISMS; EXPLOSIVES; PROTEINS; SURFACES; SAMPLES	A recent innovation in mass spectrometry is the ability to record mass spectra on ordinary samples, in their native environment, without sample preparation or preseparation by creating ions outside the instrument. In desorption electrospray ionization (DESI), the principal method described here, electrically charged droplets are directed at the ambient object of interest; they release ions from the surface, which are then vacuumed through the air into a conventional mass spectrometer. Extremely rapid analysis is coupled with high sensitivity and high chemical specificity. These characteristics are advantageously applied to high-throughput metabolomics, explosives detection, natural products discovery, and biological tissue imaging, among other applications. Future possible uses of DESI for in vivo clinical analysis and its adaptation to portable mass spectrometers are described.	Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; Hungarian Acad Sci, Chem Res Ctr, Inst Struct Chem, Budapest, Hungary	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Cooks, RG (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	cooks@purdue.edu	Cockshutt, Naomi/AAJ-2721-2020; Cooks, R Graham/G-1051-2015	Cooks, R Graham/0000-0002-9581-9603				Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; CHEN H, IN PRESS RAPID COMMU; CHEN H, IN PRESS CHEM COMMUN; Chen HW, 2005, ANAL CHEM, V77, P6915, DOI 10.1021/ac050989d; Cody RB, 2005, ANAL CHEM, V77, P2297, DOI 10.1021/ac050162j; Cotte-Rodriguez I, 2005, ANAL CHEM, V77, P6755, DOI 10.1021/ac050995+; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; GAO LY, UNPUB; HALL KA, 2005, 53 AM SOC MASS SPECT; HENION J, 2005, 53 AM SOC MASS SPECT; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Kebarle P, 2000, J MASS SPECTROM, V35, P804, DOI 10.1002/1096-9888(200007)35:7<804::AID-JMS22>3.3.CO;2-H; Laiko VV, 2000, ANAL CHEM, V72, P652, DOI 10.1021/ac990998k; Leuthold LA, 2006, RAPID COMMUN MASS SP, V20, P103, DOI 10.1002/rcm.2280; Loo JA, 1997, MASS SPECTROM REV, V16, P1; MAHONEY JF, 1991, RAPID COMMUN MASS SP, V5, P441, DOI 10.1002/rcm.1290051004; McDonnell LA, 2005, J MASS SPECTROM, V40, P160, DOI 10.1002/jms.735; McEwen CN, 2005, ANAL CHEM, V77, P7826, DOI 10.1021/ac051470k; Nefliu M, 2006, CHEM COMMUN, P888, DOI 10.1039/b514057a; NEFLIU M, UNPUB; Pacholski ML, 1999, CHEM REV, V99, P2977, DOI 10.1021/cr980137w; PACHUTA SJ, 1987, CHEM REV, V87, P647, DOI 10.1021/cr00079a009; Rodriguez-Cruz SE, 2006, RAPID COMMUN MASS SP, V20, P53, DOI 10.1002/rcm.2267; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Shiea J, 2005, RAPID COMMUN MASS SP, V19, P3701, DOI 10.1002/rcm.2243; Takats Z, 2005, CHEM COMMUN, P1950, DOI 10.1039/b418697d; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Takats Z, 2005, J MASS SPECTROM, V40, P1261, DOI 10.1002/jms.922; Talaty N, 2005, ANALYST, V130, P1624, DOI 10.1039/b511161g; Todd PJ, 2001, J MASS SPECTROM, V36, P355, DOI 10.1002/jms.153; Touboul D, 2005, J AM SOC MASS SPECTR, V16, P1608, DOI 10.1016/j.jasms.2005.06.005; Van Berkel GJ, 2005, ANAL CHEM, V77, P1207, DOI 10.1021/ac048217p; VINCENTI M, 1988, ORG MASS SPECTROM, V23, P317, DOI 10.1002/oms.1210230506; Weston DJ, 2005, ANAL CHEM, V77, P7572, DOI 10.1021/ac051277q; Williams JP, 2005, RAPID COMMUN MASS SP, V19, P3643, DOI 10.1002/rcm.2251; Wiseman JM, 2005, ANGEW CHEM INT EDIT, V44, P7094, DOI 10.1002/anie.200502362	36	1113	1209	23	970	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1566	1570		10.1126/science.1119426	http://dx.doi.org/10.1126/science.1119426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543450				2022-12-28	WOS:000236029500033
J	Lien, WH; Klezovitch, O; Fernandez, TE; Delrow, J; Vasioukhin, V				Lien, WH; Klezovitch, O; Fernandez, TE; Delrow, J; Vasioukhin, V			alpha E-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway	SCIENCE			English	Article							SONIC-HEDGEHOG; CELL-ADHESION; INHIBITION; GROWTH; APOPTOSIS; POLARITY	During development, cells monitor and adjust their rates of accumulation to produce organs of predetermined size. We show here that central nervous system-specific deletion of the essential adherens junction gene, alpha E-catenin, causes abnormal activation of the hedgehog pathway, resulting in shortening of the cell cycle, decreased apoptosis, and cortical hyperplasia. We propose that alpha E-catenin connects cell-density-dependent adherens junctions with the developmental hedgehog pathway and that this connection may provide a negative feedback loop controlling the size of developing cerebral cortex.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Vasioukhin, V (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.	vvasiouk@fhcrc.org	Fuchs, Elaine/G-1565-2016	Lien, Wen-Hui/0000-0002-2282-3169; Vasioukhin, Valeri/0000-0002-6730-0281	NATIONAL CANCER INSTITUTE [R01CA098161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA098161-02, R01 CA098161-03, R01 CA098161-04, R01 CA098161-01A1, R01 CA098161] Funding Source: Medline; NCRR NIH HHS [P41 RR011823-128171, P41 RR011823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; BURGER PC, 1994, ATLAS TUMOR PATHOLOG; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Graham D. I., 2002, GREENFIELDS NEUROPAT; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Ishibashi M, 2002, DEVELOPMENT, V129, P4807; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; RUIZ IAA, 2002, NAT REV NEUROSCI, V3, P24, DOI DOI 10.1038/NRN704; Saitsu H, 2005, DEV DYNAM, V232, P282, DOI 10.1002/dvdy.20236; SANGUEZA OP, 1994, J AM ACAD DERMATOL, V31, P356, DOI 10.1016/S0190-9622(94)70172-5; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X	20	205	207	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1609	1612		10.1126/science.1121449	http://dx.doi.org/10.1126/science.1121449			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543460	Green Accepted			2022-12-28	WOS:000236029500046
J	Jiang, H; Chess, L				Jiang, H; Chess, L			Mechanisms of disease - Regulation of immune responses by T cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NKT CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; NEGATIVE SELECTION; DIABETES-MELLITUS; SELF-TOLERANCE; PROTECTS MICE; TGF-BETA; ACTIVATION; KILLER; RECOGNITION		Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Jiang, H (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med Rheumatol, 630 W 168th St, New York, NY 10032 USA.	hj4@columbia.edu						Baxter AG, 1997, DIABETES, V46, P572, DOI 10.2337/diabetes.46.4.572; BENDELAC A, 1995, CURR OPIN IMMUNOL, V7, P367, DOI 10.1016/0952-7915(95)80112-X; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BEVAN MJ, 1978, IMMUNOL REV, V42, P3, DOI 10.1111/j.1600-065X.1978.tb00256.x; BEVAN MJ, 1977, NATURE, V269, P417, DOI 10.1038/269417a0; Bouneaud C, 2000, IMMUNITY, V13, P829, DOI 10.1016/S1074-7613(00)00080-7; Boussiotis VA, 1996, IMMUNOL REV, V153, P5, DOI 10.1111/j.1600-065X.1996.tb00918.x; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; Chai JG, 2005, TRANSPLANTATION, V79, P1310, DOI 10.1097/01.TP.0000159147.56408.9C; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Charlton B, 1995, CURR OPIN IMMUNOL, V7, P793, DOI 10.1016/0952-7915(95)80050-6; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; COFFMAN RL, 1991, RES IMMUNOL, V142, P7, DOI 10.1016/0923-2494(91)90002-Z; Cohn M, 2004, CELL IMMUNOL, V227, P81, DOI 10.1016/j.cellimm.2004.02.004; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; D'Orazio TJ, 1998, J IMMUNOL, V160, P2089; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Del Prete G, 1998, Int Rev Immunol, V16, P427, DOI 10.3109/08830189809043004; Falcone M, 1999, J EXP MED, V190, P963, DOI 10.1084/jem.190.7.963; FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frey AB, 1999, AUTOIMMUNITY, V29, P201, DOI 10.3109/08916939908998535; Furlan R, 2003, EUR J IMMUNOL, V33, P1830, DOI 10.1002/eji.200323885; Furtado GD, 2001, IMMUNOL REV, V182, P122; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; HENGARTNER H, 1988, NATURE, V336, P388, DOI 10.1038/336388a0; Horwitz DA, 2004, SEMIN IMMUNOL, V16, P135, DOI 10.1016/j.smim.2003.12.009; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; Jiang H, 1998, P NATL ACAD SCI USA, V95, P4533, DOI 10.1073/pnas.95.8.4533; Jiang H, 2000, ANNU REV IMMUNOL, V18, P185, DOI 10.1146/annurev.immunol.18.1.185; Jiang H, 2005, J CLIN INVEST, V115, P302, DOI 10.1172/JCI200523879; Jiang H, 2004, J CLIN INVEST, V114, P1198, DOI 10.1172/JCI200423411; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Jiang H, 2003, P NATL ACAD SCI USA, V100, P8378, DOI 10.1073/pnas.1432871100; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; JIANG H, 1995, IMMUNITY, V2, P185, DOI 10.1016/S1074-7613(95)80079-4; Kelsen J, 2005, CLIN EXP IMMUNOL, V141, P549, DOI 10.1111/j.1365-2249.2005.02876.x; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; KLAUS SJ, 1994, J IMMUNOL, V152, P5643; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; Kronenberg M, 2005, IMMUNITY, V22, P657, DOI 10.1016/j.immuni.2005.06.001; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Levings MK, 2000, J ALLERGY CLIN IMMUN, V106, pS109, DOI 10.1067/mai.2000.106635; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Manavalan JS, 2004, INT IMMUNOL, V16, P1055, DOI 10.1093/intimm/dxh107; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Panoutsakopoulou V, 2004, J CLIN INVEST, V113, P1218, DOI 10.1172/JCI200420772; Piccirillo CA, 2004, TRENDS IMMUNOL, V25, P374, DOI 10.1016/j.it.2004.04.009; Roncarolo MG, 2000, CURR OPIN IMMUNOL, V12, P676, DOI 10.1016/S0952-7915(00)00162-X; Rudensky A, 2005, PHILOS T R SOC B, V360, P1645, DOI 10.1098/rstb.2005.1731; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sandberg JK, 2000, J IMMUNOL, V165, P25, DOI 10.4049/jimmunol.165.1.25; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schubert LA, 2001, J BIOL CHEM, V276, P37672, DOI 10.1074/jbc.M104521200; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sharif S, 2001, NAT MED, V7, P1057, DOI 10.1038/nm0901-1057; Sharif S, 2002, ANN NY ACAD SCI, V958, P77; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shevach EM, 2001, J EXP MED, V193, pF41, DOI 10.1084/jem.193.11.F41; Shortman K, 1990, Semin Immunol, V2, P3; Singh AK, 2001, J EXP MED, V194, P1801, DOI 10.1084/jem.194.12.1801; SPRENT J, 1995, CURR OPIN IMMUNOL, V7, P196, DOI 10.1016/0952-7915(95)80004-2; VONBOEHMER H, 1990, SCIENCE, V248, P1369, DOI 10.1126/science.1972594; WALDMANN H, 1978, IMMUNOL REV, V42, P202, DOI 10.1111/j.1600-065X.1978.tb00263.x; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; WARE R, 1995, IMMUNITY, V2, P177, DOI 10.1016/S1074-7613(95)80066-2; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wilson SB, 1999, NATURE, V399, P84, DOI 10.1038/20007; Wilson SB, 1998, NATURE, V391, P177, DOI 10.1038/34419; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440; ZINKERNAGEL RM, 1978, IMMUNOL REV, V42, P224, DOI 10.1111/j.1600-065X.1978.tb00264.x	97	172	218	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1166	1176		10.1056/NEJMra055446	http://dx.doi.org/10.1056/NEJMra055446			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540617				2022-12-28	WOS:000235981700010
J	Katz, IT; Wright, AA				Katz, IT; Wright, AA			Preventing cervical cancer in the developing world	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Wright, Alexi/T-5793-2019	Katz, Ingrid/0000-0002-3014-238X				Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Lazcano-Ponce EC, 1999, ARCH MED RES, V30, P240, DOI 10.1016/S0188-0128(99)00006-8; *POP REF BUR PATH, 2004, PREV CERV CANC WORLD	3	31	33	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1110	1110		10.1056/NEJMp068031	http://dx.doi.org/10.1056/NEJMp068031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540609	Bronze			2022-12-28	WOS:000235981700002
J	Podolsky, DK; Gonzalez, RG; Hasserjian, RP; Siegel, CA; Hochberg, EP				Podolsky, DK; Gonzalez, RG; Hasserjian, RP; Siegel, CA; Hochberg, EP			A 71-year-old woman with Crohn's disease and altered mental status - Diffuse large-B-cell lymphoma, EBV-positive, associated with iatrogenic immunosuppression.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFLAMMATORY-BOWEL-DISEASE; EPSTEIN-BARR-VIRUS; POPULATION-BASED COHORT; COLORECTAL-CANCER; CLONAL ANALYSIS; INCREASED RISK; AZATHIOPRINE; INFLIXIMAB; 6-MERCAPTOPURINE; DISORDERS		Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Podolsky, DK (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.							Aithal GP, 2001, ALIMENT PHARM THERAP, V15, P1101, DOI 10.1046/j.1365-2036.2001.01023.x; Arseneau KO, 2001, INFLAMM BOWEL DIS, V7, P106, DOI 10.1097/00054725-200105000-00005; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Bouhnik Y, 1996, LANCET, V347, P215, DOI 10.1016/S0140-6736(96)90402-X; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; CHOI PM, 1994, GUT, V35, P950, DOI 10.1136/gut.35.7.950; CLEARY ML, 1984, NEW ENGL J MED, V310, P477, DOI 10.1056/NEJM198402233100801; Colombel JF, 2004, GASTROENTEROLOGY, V126, P19, DOI 10.1053/j.gastro.2003.10.047; CONNELL WR, 1994, LANCET, V343, P1249, DOI 10.1016/S0140-6736(94)92150-4; dAmore F, 1996, BLOOD, V87, P1045, DOI 10.1182/blood.V87.3.1045.bloodjournal8731045; Dayharsh GA, 2002, GASTROENTEROLOGY, V122, P72, DOI 10.1053/gast.2002.30328; EKBOM A, 1990, LANCET, V336, P357, DOI 10.1016/0140-6736(90)91889-I; Farrell RJ, 2000, GUT, V47, P514, DOI 10.1136/gut.47.4.514; Fraser AG, 2002, ALIMENT PHARM THER, V16, P1225, DOI 10.1046/j.1365-2036.2002.01297.x; GILLEN CD, 1994, GUT, V35, P651, DOI 10.1136/gut.35.5.651; GREENSTEIN AJ, 1992, CANCER-AM CANCER SOC, V69, P1119; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KINLEN LJ, 1985, AM J MED, V78, P44, DOI 10.1016/0002-9343(85)90245-1; Lewis JD, 2001, GASTROENTEROLOGY, V121, P1080, DOI 10.1053/gast.2001.28703; Ljung T, 2004, GUT, V53, P849, DOI 10.1136/gut.2003.018515; Losco A, 2004, INFLAMM BOWEL DIS, V10, P425; PERSSON PG, 1994, GASTROENTEROLOGY, V107, P1675, DOI 10.1016/0016-5085(94)90807-9; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Vardiman J., 2001, WHO CLASSIFICATION T, V3; Wong NACS, 2003, J PATHOL, V201, P312, DOI 10.1002/path.1442	27	12	12	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1178	1184		10.1056/NEJMcpc059035	http://dx.doi.org/10.1056/NEJMcpc059035			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540619				2022-12-28	WOS:000235981700013
J	Scherer, SE; Muzny, DM; Buhay, CJ; Chen, R; Cree, A; Ding, Y; Dugan-Rocha, S; Gill, R; Gunaratne, P; Harris, RA; Hawes, AC; Hernandez, J; Hodgson, AV; Hume, J; Jackson, A; Khan, ZM; Kovar-Smith, C; Lewis, LR; Lozado, RJ; Metzker, ML; Milosavljevic, A; Miner, GR; Montgomery, KT; Morgan, MB; Nazareth, LV; Scott, G; Sodergren, E; Song, XZ; Steffen, D; Lovering, RC; Wheeler, DA; Worley, KC; Yuan, Y; Zhang, ZD; Adams, CQ; Ansari-Lari, MA; Ayele, M; Brown, MJ; Chen, G; Chen, ZJ; Clerc-Blankenburg, KP; Davis, C; Delgado, O; Dinh, HH; Draper, H; Gonzalez-Garay, ML; Havlak, P; Jackson, LR; Jacob, LS; Kelly, SH; Li, L; Li, ZW; Liu, J; Liu, W; Lu, J; Maheshwari, M; Nguyen, BV; Okwuonu, GO; Pasternak, S; Perez, LM; Plopper, FJH; Santibanez, J; Shen, H; Tabor, PE; Verduzco, D; Waldron, L; Wang, QY; Williams, GA; Zhang, JK; Zhou, JL; Nelson, D; Kucherlapati, R; Weinstock, G; Gibbs, RA				Scherer, SE; Muzny, DM; Buhay, CJ; Chen, R; Cree, A; Ding, Y; Dugan-Rocha, S; Gill, R; Gunaratne, P; Harris, RA; Hawes, AC; Hernandez, J; Hodgson, AV; Hume, J; Jackson, A; Khan, ZM; Kovar-Smith, C; Lewis, LR; Lozado, RJ; Metzker, ML; Milosavljevic, A; Miner, GR; Montgomery, KT; Morgan, MB; Nazareth, LV; Scott, G; Sodergren, E; Song, XZ; Steffen, D; Lovering, RC; Wheeler, DA; Worley, KC; Yuan, Y; Zhang, ZD; Adams, CQ; Ansari-Lari, MA; Ayele, M; Brown, MJ; Chen, G; Chen, ZJ; Clerc-Blankenburg, KP; Davis, C; Delgado, O; Dinh, HH; Draper, H; Gonzalez-Garay, ML; Havlak, P; Jackson, LR; Jacob, LS; Kelly, SH; Li, L; Li, ZW; Liu, J; Liu, W; Lu, J; Maheshwari, M; Nguyen, BV; Okwuonu, GO; Pasternak, S; Perez, LM; Plopper, FJH; Santibanez, J; Shen, H; Tabor, PE; Verduzco, D; Waldron, L; Wang, QY; Williams, GA; Zhang, JK; Zhou, JL; Nelson, D; Kucherlapati, R; Weinstock, G; Gibbs, RA		Baylor Coll Med Human Genome Seque	The finished DNA sequence of human chromosome 12	NATURE			English	Article							HUMAN-GENOME; PERICENTRIC-INVERSION; MOLECULAR CLOCKS; PHYSICAL MAP; EVOLUTION; LINEAGES; MONKEYS; MOUSE; APES	Human chromosome 12 contains more than 1,400 coding genes(1) and 487 loci that have been directly implicated in human disease(2). The q arm of chromosome 12 contains one of the largest blocks of linkage disequilibrium found in the human genome(3). Here we present the finished sequence of human chromosome 12, which has been finished to high quality and spans approximately 132 megabases, representing similar to 4.5% of the human genome. Alignment of the human chromosome 12 sequence across vertebrates reveals the origin of individual segments in chicken, and a unique history of rearrangement through rodent and primate lineages. The rate of base substitutions in recent evolutionary history shows an overall slowing in hominids compared with primates and rodents.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Harvard Univ, Sch Med, Partners Healthcare Ctr Genet & Genom, Boston, MA 02115 USA; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England	Baylor College of Medicine; Harvard University; Harvard Medical School; Partners Healthcare System; University of London; University College London	Scherer, SE (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	sscherer@bcm.tmc.edu	Wheeler, David A/M-9740-2018; Driemeier, David/H-3461-2012; Norouzi, Neil/H-2530-2012; Weinstock, George M/C-6314-2013; Kucherlapati, Raju/ABC-8807-2021	Wheeler, David A/0000-0002-9056-6299; Driemeier, David/0000-0003-3766-0654; Weinstock, George M/0000-0002-2997-4592; Lovering, Ruth/0000-0002-9791-0064; Worley, Kim/0000-0002-0282-1000; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Delgado, Oliver/0000-0003-2547-5857; minja, emmanuel/0000-0001-9724-1174; /0000-0002-9833-2817	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AnsariLari MA, 1996, GENOME RES, V6, P314, DOI 10.1101/gr.6.4.314; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; Hsu F, 2005, NUCLEIC ACIDS RES, V33, pD454, DOI 10.1093/nar/gki100; *JOHNS HOPK U MCK, ONL MEND INH MAN OMI; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; Kehrer-Sawatzki H, 2005, CYTOGENET GENOME RES, V108, P91, DOI 10.1159/000080806; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Li Y, 2004, P NATL ACAD SCI USA, V101, P15688, DOI 10.1073/pnas.0403535101; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Montgomery KT, 2001, NATURE, V409, P945, DOI 10.1038/35057174; Nickerson E, 1998, GENOMICS, V50, P368, DOI 10.1006/geno.1998.5332; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; STEGMAIER K, 1995, BLOOD, V86, P38, DOI 10.1182/blood.V86.1.38.bloodjournal86138; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Vermeesch JR, 2003, CYTOGENET GENOME RES, V103, P63, DOI 10.1159/000076291; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wienberg J, 2005, CYTOGENET GENOME RES, V108, P139, DOI 10.1159/000080811; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Yu FL, 2005, PLOS GENET, V1, P404, DOI 10.1371/journal.pgen.0010041; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	31	37	618	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					346	351		10.1038/nature04569	http://dx.doi.org/10.1038/nature04569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541075	Bronze			2022-12-28	WOS:000235997600055
J	Stone, GW; Ellis, SG; O'Shaughnessy, CD; Martin, SL; Satler, L; McGarry, T; Turco, MA; Kereiakes, DJ; Kelley, L; Popma, JJ; Russell, ME				Stone, GW; Ellis, SG; O'Shaughnessy, CD; Martin, SL; Satler, L; McGarry, T; Turco, MA; Kereiakes, DJ; Kelley, L; Popma, JJ; Russell, ME		TAXUS V ISR Investigators	Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents - The TAXUS VISR randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL FOLLOW-UP; BALLOON ANGIOPLASTY; BETA-RADIATION; SLOW-RELEASE; CORONARY; TERM; ATHERECTOMY; IRRADIATION; INHIBIT	Context Restenosis within bare-metal stents is often treated with repeat percutaneous coronary intervention, although subsequent recurrence rates are high, with vascular brachytherapy (VBT) affording the best results. The effectiveness of drug-eluting stents in this setting has not been established. Objective To investigate the safety and efficacy of the polymer-based, slow-release paclitaxel-eluting stent in patients with restenotic lesions after prior stent implantation in native coronary arteries. Design, Setting, and Patients Prospective, multicenter, randomized trial conducted between June 6, 2003, and July 16, 2004, at 37 North American academic and community-based institutions in 396 patients with in-stent restenosis of a previously implanted bare-metal coronary stent (vessel diameter, 2.5-3.75 mm; lesion length, <= 46 mm). Interventions Patients were randomly assigned to undergo angioplasty followed by VBT with a beta source (n = 201) or paclitaxel-eluting stent implantation (n = 195). Clinical and angiographic follow-up at 9 months was scheduled in all patients. Main Outcome Measure Ischemia-driven target vessel revascularization at 9 months. Results Diabetes mellitus was present in 139 patients (35.1%). Median reference vessel diameter was 2.65 mm and median lesion length was 15.3 mm. In the VBT group, new stents were implanted in 22 patients (10.9%) and in the paclitaxel-eluting stent group, multiple stents were required in 57 patients (29.2%), with median stent length of 24 mm. Follow-up at 9 months was complete in 194 patients in the VBT group and 191 patients in the paclitaxel-eluting stent group (96.5% and 97.9%, respectively). For VBT and paclitaxel-eluting stents, respectively, the number of events and 9-month rates for ischemic target lesion revascularization were 27 (13.9%) vs 12 (6.3%) (relative risk [RR], 0.45; 95% confidence interval [CI], 0.24-0.86; P = .01); for ischemic target vessel revascularization, 34 (17.5%) vs 20 (10.5%) (RR, 0.60; 95% CI, 0.36-1.00; P = .046); and for overall major adverse cardiac events, 39 (20.1%) vs 22 (11.5%) (RR, 0.57; 95% CI, 0.35-0.93; P = .02), with similar rates of cardiac death or myocardial infarction (10 [5.2%] vs 7 [3.7%]; RR, 0.71; 95% CI, 0.28-1.83; P = .48) and target vessel thrombosis (5 [2.6%] vs 3 [1.6%]; RR, 0.61; 95% CI, 0.15-2.50; P = .72). Angiographic restenosis at 9 months was 31.2% (53 of 170 patients) with VBT and 14.5% (25 of 172 patients) with paclitaxel-eluting stents (RR, 0.47; 95% CI, 0.30-0.71; P < .001). Conclusion Treatment of bare-metal in-stent restenotic lesions with paclitaxel-eluting stents rather than angioplasty followed by VBT reduces clinical and angiographic restenosis at 9 months and improves event-free survival.	Columbia Univ, Med Ctr, Dept Cardiol, New York, NY 10032 USA; Cardiovasc Res Fdn, New York, NY USA; Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA; Elyria Mem Hosp, Dept Cardiol, Elyria, OH USA; Nebraska Heart Inst, Lincoln, NE USA; Washington Hosp Ctr, Dept Cardiol, Washington, DC 20010 USA; Oklahoma Heart Inst, Dept Cardiol, Oklahoma City, OK USA; Washington Adventist Hosp, Dept Cardiol, Takoma Pk, MD USA; Christ Hosp, Dept Cardiol, Cincinnati, OH 45219 USA; Boston Sci Corp, Natick, MA USA; Brigham & Womens Hosp, Dept Cardiol, Boston, MA 02115 USA	Columbia University; Cardiovascular Research Foundation (CRF); Cleveland Clinic Foundation; MedStar Washington Hospital Center; Christ Hospital - Ohio; Boston Scientific; Harvard University; Brigham & Women's Hospital	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Dept Cardiol, Herbert Irving Pavil,5th Floor,161 Ft Washington, New York, NY 10032 USA.	gs2184@columbia.edu						Airoldi F, 2003, AM J CARDIOL, V92, P725, DOI 10.1016/S0002-9149(03)00839-7; Alfonso F, 2005, J AM COLL CARDIOL, V45, p83A; Alfonso F, 2003, J AM COLL CARDIOL, V42, P796, DOI 10.1016/S0735-1097(03)00852-0; Baierl V, 2005, AM J CARDIOL, V96, P1399, DOI 10.1016/j.amjcard.2005.06.087; CARROZZA JP, 1992, J AM COLL CARDIOL, V20, P328, DOI 10.1016/0735-1097(92)90098-8; Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6; Costa MA, 1999, CIRCULATION, V100, P789, DOI 10.1161/01.CIR.100.8.789; Giri S, 2001, CATHETER CARDIO INTE, V52, P24, DOI 10.1002/1522-726X(200101)52:1<24::AID-CCD1007>3.0.CO;2-Y; Hodgson JM, 2004, CATHETER CARDIO INTE, V62, P1, DOI 10.1002/ccd.20025; HOLMES DR, 2005, 17 ANN SCI SESS TRAN; Kastrati A, 1997, J AM COLL CARDIOL, V30, P1428, DOI 10.1016/S0735-1097(97)00334-3; Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165; KEMIS SJ, 2005, AM J CARDIOL, V96, pH47; Lansky AJ, 2002, J AM COLL CARDIOL, V39, P274, DOI 10.1016/S0735-1097(01)01745-4; Leon MB, 2001, NEW ENGL J MED, V344, P250, DOI 10.1056/NEJM200101253440402; Leon MB, 2004, CIRCULATION, V110, P405; Mahdi NA, 1998, AM J CARDIOL, V82, P1345, DOI 10.1016/S0002-9149(98)00639-0; Mehran R, 1999, CIRCULATION, V100, P1872, DOI 10.1161/01.CIR.100.18.1872; Mehran R, 2001, AM HEART J, V141, P610, DOI 10.1067/mhj.2001.113998; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Pershukov IV, 2003, KARDIOLOGIYA, V43, P35; Popma JJ, 2002, CIRCULATION, V106, P1090, DOI 10.1161/01.CIR.0000027814.96651.72; Reimers B, 1997, J AM COLL CARDIOL, V30, P186, DOI 10.1016/S0735-1097(97)00142-3; Sabate M, 2000, CIRCULATION, V101, P2467, DOI 10.1161/01.CIR.101.21.2467; Salame MY, 2000, CIRCULATION, V101, P1087, DOI 10.1161/01.CIR.101.10.1087; Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; STONE GW, 2005, CIRCULATION, V112, P2063; Tanabe K, 2003, CIRCULATION, V107, P559, DOI 10.1161/01.CIR.0000048184.96491.8A; TEIRSTEIN PS, 2001, CIRCULATION, V110, P233; vom Dahl J, 2002, CIRCULATION, V105, P583, DOI 10.1161/hc0502.103347; Waksman R, 2002, LANCET, V359, P551, DOI 10.1016/S0140-6736(02)07741-3	33	206	227	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2006	295	11					1253	1263		10.1001/jama.295.11.1253	http://dx.doi.org/10.1001/jama.295.11.1253			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021GV	16531618	Bronze			2022-12-28	WOS:000235972600023
J	Braitstein, P; Brinkhof, MWG; Dabis, F; Schechter, M; Boulle, A; Miotti, P; Wood, R; Laurent, C; Sprinz, E; Seyler, C; Bangsberg, DR; Balestre, E; Sterne, JAC; May, M; Egger, M				Braitstein, P; Brinkhof, MWG; Dabis, F; Schechter, M; Boulle, A; Miotti, P; Wood, R; Laurent, C; Sprinz, E; Seyler, C; Bangsberg, DR; Balestre, E; Sterne, JAC; May, M; Egger, M		ART-LINC Grp; ART-CC Grp	Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries	LANCET			English	Article							HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; RESOURCE-POOR SETTINGS; OPPORTUNISTIC INFECTIONS; OBSERVATIONAL DATABASE; WORLD-HEALTH; COHORT; SURVIVAL; AIDS; TUBERCULOSIS	Background Highly active antiretroviral therapy (HAART) is being scaled up in developing countries. We compared baseline characteristics and outcomes during the first year of HAART between HIV-1-infected patients in low-income and high-income settings. Methods 18 HAART programmes in Africa, Asia, and South America (low-income settings) and 12 HIV cohort studies from Europe and North America (high-income settings) provided data for 4810 and 22 217, respectively, treatment-naive adult patients starting HAART. All patients from high-income settings and 2725 (57%) patients from low-income settings were actively followed-up and included in survival analyses. Findings Compared with high-income countries, patients starting HAART in low-income settings had lower CD4 cell counts (median 108 cells per mu L vs 234 cells per mu L), were more likely to be female (51% vs 25%), and more likely to start treatment with a non-nucleoside reverse transcriptase inhibitor (NNRTI) (70% vs 23%). At 6 months, the median number of CD4 cells gained (106 cells per mu L vs 103 cells per mu L) and the percentage of patients reaching HIV-1 RNA levels lower than 500 copies/mL (76% vs 77%) were similar. Mortality was higher in low-income settings (124 deaths during 2236 person-years of follow-up) than in high-income settings (414 deaths during 20 532 person-years). The adjusted hazard ratio (HR) of mortality comparing tow-income with high-income settings fell from 4.3 (95% CI 1.6-11.8) during the first month to 1.5 (0.7-3.0) during months 7-12. The provision of treatment free of charge in low-income settings was associated with lower mortality (adjusted HR 0.23; 95% CI 0.08-0.61). Interpretation Patients starting HAART in resource-poor settings have increased mortality rates in the first months on therapy, compared with those in developed countries. Timely diagnosis and assessment of treatment eligibility, coupled with free provision of HAART, might reduce this excess mortality.	Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland	University of Bern	Egger, M (corresponding author), Univ Bern, Dept Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	egger@ispm.unibe.ch	Sterne, Jonathan/Z-3106-2019; VALLET, Yannick/F-9979-2011; Boulle, Andrew/C-1413-2008; hlupeni, admire/M-1539-2018; sprinz, eduardo/V-7961-2019; Schechter, Mauro/AAG-7445-2020; DABIS, FRANCOIS/S-9298-2019; Wood, Robin/G-8509-2011; May, Margaret/E-8099-2013	Sterne, Jonathan/0000-0001-8496-6053; Boulle, Andrew/0000-0002-7713-8062; sprinz, eduardo/0000-0003-4343-8304; DABIS, FRANCOIS/0000-0002-1614-8857; Egger, Matthias/0000-0001-7462-5132; Brinkhof, Martin/0000-0002-9319-665X; May, Margaret/0000-0002-9733-1003; Laurent, Christian/0000-0003-2658-7113	MRC [G0100221] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER; Medical Research Council [G0100221] Funding Source: Medline; NIMH NIH HHS [R01 MH054907] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Abbasi K, 1999, BMJ-BRIT MED J, V318, P1003, DOI 10.1136/bmj.318.7189.1003; Anglaret X, 2004, JAIDS-J ACQ IMM DEF, V35, P320, DOI 10.1097/00126334-200403010-00015; Attia A, 2001, J ACQ IMMUN DEF SYND, V28, P478, DOI 10.1097/00042560-200112150-00012; Badri M, 2004, AIDS, V18, P1159, DOI 10.1097/00002030-200405210-00009; Becker SL, 2001, J ACQ IMMUN DEF SYND, V26, P72, DOI 10.1097/00126334-200101010-00011; Binquet C, 2001, AM J EPIDEMIOL, V153, P386, DOI 10.1093/aje/153.4.386; Brodt HR, 1997, AIDS, V11, P1731, DOI 10.1097/00002030-199714000-00010; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger M, 2005, INT J EPIDEMIOL, V34, P509, DOI 10.1093/ije/dyi110; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Fatkenheuer G, 1997, AIDS, V11, pF113, DOI 10.1097/00002030-199714000-00001; French N, 1999, J ACQ IMMUN DEF SYND, V22, P509; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gutierrez RG, 2002, STATA J, V2, P22, DOI 10.1177/1536867X0200200102; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Holmes CB, 2003, CLIN INFECT DIS, V36, P652, DOI 10.1086/367655; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Keiding N, 1997, STAT MED, V16, P215; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lundgren JD, 1997, J ACQ IMMUN DEF SYND, V16, P153, DOI 10.1097/00042560-199711010-00003; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; Mocroft A, 1999, AIDS, V13, P1255, DOI 10.1097/00002030-199907090-00016; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Monforte AD, 2000, AIDS, V14, P499, DOI 10.1097/00002030-200003310-00005; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; SCHNEIDER M, 2005, HQ03463871 UNAIDS JO; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Seyler C, 2005, AM J RESP CRIT CARE, V172, P123, DOI 10.1164/rccm.200410-1342OC; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van der Loeff MFS, 2002, AIDS, V16, P1775, DOI 10.1097/00002030-200209060-00010; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; [WHO] World Health Organization, 2005, PREV CHRON DIS VIT I, P1; Yamey G, 2001, BRIT MED J, V322, P257; Zhou J, 2005, HIV MED, V6, P216, DOI 10.1111/j.1468-1293.2005.00292.x; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	45	902	921	0	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					817	824						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530575				2022-12-28	WOS:000236016500026
J	Maxwell, SRJ; Webb, DJ				Maxwell, SRJ; Webb, DJ			Clinical pharmacology - too young to die?	LANCET			English	Editorial Material							INHIBITORS		Univ Edinburgh, Clin Pharmacol Unit, Queens Med Res Inst, Royal Infirm Edinburgh, Edinburgh EH16 4TJ, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Maxwell, SRJ (corresponding author), Univ Edinburgh, Clin Pharmacol Unit, Queens Med Res Inst, Royal Infirm Edinburgh, Edinburgh EH16 4TJ, Midlothian, Scotland.	s.maxwell@ed.ac.uk		Maxwell, Simon/0000-0002-3032-7237				*AUD COMM, 2001, SPOONF SUG MED MAN H; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; *DEP HLTH, 2005, DEP REP 2005; *FED ROYAL COLL PH, 2003, CENS CONS PHYS UK; Maxwell SRJ, 2005, LANCET, V365, P449; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; The Association of the British Pharmaceutical Industry, 2005, SUST SKILLS PIP PHAR; *UK AC MED SCI, 2005, SAF MED; Webb DJ, 2002, BRIT J CLIN PHARMACO, V54, P341, DOI 10.1046/j.1365-2125.2002.t01-1-01715.x; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1	11	56	57	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					799	800		10.1016/S0140-6736(06)68316-5	http://dx.doi.org/10.1016/S0140-6736(06)68316-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530562				2022-12-28	WOS:000236016500009
J	Lawler, ML; Brun, YV				Lawler, ML; Brun, YV			A molecular beacon defines bacterial cell asymmetry	CELL			English	Editorial Material							CAULOBACTER-CRESCENTUS; LOCALIZATION FACTOR; PODJ	Many cells divide asymmetrically by generating two different cell ends or poles prior to cell division, but the mechanisms by which cells distinguish one pole from the other is poorly understood. In this issue of Cell, Huitema et al. (2006) and Lam et al. (2006) describe a protein that defines one specific pole of a bacterial cell by localizing to the site of cell division to be inherited by both progeny at the resulting new poles.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Brun, YV (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ybrun@indiana.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051986] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051986] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Chang F, 2003, NAT CELL BIOL, V5, P294, DOI 10.1038/ncb0403-294; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Hinz AJ, 2003, MOL MICROBIOL, V47, P929, DOI 10.1046/j.1365-2958.2003.03349.x; HUGUENEL ED, 1982, DIFFERENTIATION, V21, P71, DOI 10.1111/j.1432-0436.1982.tb01199.x; Janakiraman A, 2004, TRENDS MICROBIOL, V12, P518, DOI 10.1016/j.tim.2004.09.003; Lawler ML, 2006, MOL MICROBIOL, V59, P301, DOI 10.1111/j.1365-2958.2005.04935.x; Ryan KR, 2003, ANNU REV BIOCHEM, V72, P367, DOI 10.1146/annurev.biochem.72.121801.161824; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; Wagner JK, 2005, J BACTERIOL, V187, P544, DOI 10.1128/JB.187.2.544-553.2005	9	9	9	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					891	893		10.1016/j.cell.2006.02.027	http://dx.doi.org/10.1016/j.cell.2006.02.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530036	Bronze			2022-12-28	WOS:000237241200011
J	Viboud, C; Bjornstad, ON; Smith, DL; Simonsen, L; Miller, MA; Grenfell, BT				Viboud, C; Bjornstad, ON; Smith, DL; Simonsen, L; Miller, MA; Grenfell, BT			Synchrony, waves, and spatial hierarchies in the spread of influenza	SCIENCE			English	Article							PANDEMIC INFLUENZA; DYNAMICS; POPULATION; MORTALITY; IMPACT; MODEL; TRANSMISSION; EPIDEMICS; EVOLUTION; PATTERNS	Quantifying long-range dissemination of infectious diseases is a key issue in their dynamics and control. Here, we use influenza-related mortality data to analyze the between-state progression of interpandemic influenza in the United States over the past 30 years. Outbreaks show hierarchical spatial spread evidenced by higher pairwise synchrony between more populous states. Seasons with higher influenza mortality are associated with higher disease transmission and more rapid spread than are mild ones. The regional spread of infection correlates more closely with rates of movement of people to and from their workplaces (workflows) than with geographical distance. Workflows are described in turn by a gravity model, with a rapid decay of commuting up to around 100 km and a long tail of rare longer range flow. A simple epidemiological model, based on the gravity formulation, captures the observed increase of influenza spatial synchrony with transmissibility; high transmission allows influenza to spread rapidly beyond local spatial constraints.	NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; NIAID, NIH, Bethesda, MD 20818 USA	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Viboud, C (corresponding author), NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.	viboudc@mail.nih.gov	Simonsen, Lone/K-4531-2014; Bjornstad, Ottar N/I-4518-2012; Smith, David L/L-8850-2013	Simonsen, Lone/0000-0003-1535-8526; Smith, David L/0000-0003-4367-3849				Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Bonabeau E, 1998, P ROY SOC B-BIOL SCI, V265, P2421, DOI 10.1098/rspb.1998.0593; CLIFF A, 1986, SPATIAL ASPECTS INFL; CLIFF AD, 1994, SPATIAL PROCESSES; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Ferrari MJ, 2005, MATH BIOSCI, V198, P14, DOI 10.1016/j.mbs.2005.08.002; FLAHAULT A, 1988, STAT MED, V7, P1147, DOI 10.1002/sim.4780071107; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Legendre P., 2012, NUMERICAL ECOLOGY; LONGINI IM, 1986, AM J EPIDEMIOL, V123, P383, DOI 10.1093/oxfordjournals.aje.a114253; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; MOLLISON D, 1991, MATH BIOSCI, V107, P255, DOI 10.1016/0025-5564(91)90009-8; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; SIMONSEN L, 1999, VACCINE S1, V17, P53; SMALLMANRAYNOR M, 2004, T I BR GEOGR, V27, P452, DOI DOI 10.1111/1475-5661.00065; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341; 1969, MORB MORTAL WKLY REP, V18, P217	29	559	570	8	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					447	451		10.1126/science.1125237	http://dx.doi.org/10.1126/science.1125237			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16574822				2022-12-28	WOS:000236941800053
J	Pertz, O; Hodgson, L; Klemke, RL; Hahn, KM				Pertz, O; Hodgson, L; Klemke, RL; Hahn, KM			Spatiotemporal dynamics of RhoA activity in migrating cells	NATURE			English	Article							FLUORESCENT PROTEIN; RAC; ACTIVATION; PHOSPHORYLATION; FIBROBLASTS; CDC42	Rho family GTPases regulate the actin and adhesion dynamics that control cell migration. Current models postulate that Rac promotes membrane protrusion at the leading edge and that RhoA regulates contractility in the cell body(1,2). However, there is evidence that RhoA also regulates membrane protrusion(3,4). Here we use a fluorescent biosensor, based on a novel design preserving reversible membrane interactions, to visualize the spatiotemporal dynamics of RhoA activity during cell migration. In randomly migrating cells, RhoA activity is concentrated in a sharp band directly at the edge of protrusions. It is observed sporadically in retracting tails, and is low in the cell body. RhoA activity is also associated with peripheral ruffles and pinocytic vesicles, but not with dorsal ruffles induced by platelet-derived growth factor (PDGF). In contrast to randomly migrating cells, PDGF-induced membrane protrusions have low RhoA activity, potentially because PDGF strongly activates Rac, which has previously been shown to antagonize RhoA activity(5,6). Our data therefore show that different extracellular cues induce distinct patterns of RhoA signalling during membrane protrusion.	Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Scripps Research Institute	Pertz, O (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	pertz@ucsd.edu; khahn@med.unc.edu		Hodgson, Louis/0000-0001-9188-7580; pertz, olivier/0000-0001-8579-4919; Hahn, Klaus/0000-0002-1970-7562				Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hodgson L, 2006, METHOD ENZYMOL, V406, P140, DOI 10.1016/S0076-6879(06)06012-5; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Kurokawa K, 2005, MOL BIOL CELL, V16, P4294, DOI 10.1091/mbc.E04-12-1076; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Norman JC, 1998, J CELL BIOL, V143, P1981, DOI 10.1083/jcb.143.7.1981; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048	21	601	615	5	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1069	1072		10.1038/nature04665	http://dx.doi.org/10.1038/nature04665			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16547516				2022-12-28	WOS:000236906000040
J	Epstein, E; Anna, K				Epstein, E; Anna, K			BMJ learning - Accidental hypothermia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TEMPERATURE		Walsall Manor Hosp, Walsall WS2 9PS, W Midlands, England		Epstein, E (corresponding author), Walsall Manor Hosp, Walsall WS2 9PS, W Midlands, England.	elliotepstein832@hotmail.com						American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, 2005, CIRCULATION, V112, P136; Arons MM, 1999, CRIT CARE MED, V27, P699, DOI 10.1097/00003246-199904000-00020; BASTOW MD, 1983, LANCET, V1, P143; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P173; COLLINS KJ, 1977, BRIT MED J, V1, P353, DOI 10.1136/bmj.1.6057.353; COLLINS KJ, 1981, BRIT MED J, V282, P175, DOI 10.1136/bmj.282.6259.175; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; DAVIES EB, 1998, LMS J COMPUT MATH, V1, P42, DOI DOI 10.1112/S1461157000000140; *DEP HLTH, KEEP WARM KEEP WELL; Department of Health, HOSP EP STAT; EDGE G, 1993, ANAESTHESIA, V48, P604, DOI 10.1111/j.1365-2044.1993.tb07127.x; EVANS JG, 2000, OXFORD TXB GERIATRIC; Guyton A.C., 2000, MED PHYSL, V10th; HISLOP LJ, 1995, BMJ-BRIT MED J, V11, P725; Kibayashi K, 2003, MED SCI LAW, V43, P127, DOI 10.1258/rsmmsl.43.2.127; LARACH MG, 1995, LANCET, V345, P493, DOI 10.1016/S0140-6736(95)90587-1; LEBLANC J, 1958, J APPL PHYSIOL, V13, P237, DOI 10.1152/jappl.1958.13.2.237; LEWIN S, 1981, ARCH INTERN MED, V141, P920, DOI 10.1001/archinte.141.7.920; Morgan R, 1996, J ROY SOC MED, V89, P85, DOI 10.1177/014107689608900207; SCHALLER MD, 1990, JAMA-J AM MED ASSOC, V264, P1842, DOI 10.1001/jama.264.14.1842; SHIELDS CP, 1990, ANN EMERG MED, V19, P1093, DOI 10.1016/S0196-0644(05)81510-0; Steele MT, 1996, ANN EMERG MED, V27, P479, DOI 10.1016/S0196-0644(96)70237-8; Walpoth BH, 1997, NEW ENGL J MED, V337, P1500, DOI 10.1056/NEJM199711203372103; WOODHOUSE P, 1989, LANCET, V2, P1201	24	27	26	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2006	332	7543					706	709		10.1136/bmj.332.7543.706	http://dx.doi.org/10.1136/bmj.332.7543.706			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	027VH	16565126	Green Published			2022-12-28	WOS:000236443300025
J	Mohit, A				Mohit, A			Report of WHO's World Mental Health Survey	LANCET			English	Editorial Material							DIAGNOSTIC INTERVIEW		WHO, Reg Off Eastern Mediterranean, Div Hlth Protect & Promot, Cairo, Egypt	Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization	Mohit, A (corresponding author), WHO, Reg Off Eastern Mediterranean, Div Hlth Protect & Promot, Cairo, Egypt.	mohita@emro.who.int						Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Goldberg D., 1979, PSYCHOL MED, V9, P131; Karam EG, 2006, LANCET, V367, P1000, DOI 10.1016/S0140-6736(06)68427-4; Noorbala AA, 2004, BRIT J PSYCHIAT, V184, P70, DOI 10.1192/bjp.184.1.70; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Saldivia S, 2004, PSYCHIAT SERV, V55, P71, DOI 10.1176/appi.ps.55.1.71; World Health Organization, 2005, MENT HLTH ATL, P176	8	3	3	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					968	969		10.1016/S0140-6736(06)68405-5	http://dx.doi.org/10.1016/S0140-6736(06)68405-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564346				2022-12-28	WOS:000236474200008
J	Lynch, M; Koskella, B; Schaack, S				Lynch, M; Koskella, B; Schaack, S			Mutation pressure and the evolution of organelle genomic architecture	SCIENCE			English	Review							MITOCHONDRIAL GENOME; GENE; NUCLEAR; POPULATION; DNA; CHLOROPLAST; SELECTION; CONTAINS; ORIGINS; INTRON	The nuclear genomes of multicellular animals and plants contain large amounts of noncoding DNA, the disadvantages of which can be too weak to be effectively countered by selection in lineages with reduced effective population sizes. In contrast, the organelle genomes of these two lineages evolved to opposite ends of the spectrum of genomic complexity, despite similar effective population sizes. This pattern and other puzzling aspects of organelle evolution appear to be consequences of differences in organelle mutation rates. These observations provide support for the hypothesis that the fundamental features of genome evolution are largely defined by the relative power of two nonadaptive forces: random genetic drift and mutation pressure.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Lynch, M (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	milynch@indiana.edu	Koskella, Britt/A-7398-2008; Koskella, Britt/ABD-6298-2021	Koskella, Britt/0000-0003-1760-8496; Koskella, Britt/0000-0003-1760-8496	NIGMS NIH HHS [R01 GM036827] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Berlin S, 2001, NATURE, V413, P37, DOI 10.1038/35092623; BIRKY CW, 1983, GENETICS, V103, P513; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gillespie JH, 2000, GENETICS, V155, P909; Gillham N.W., 1994, ORGANELLE GENES GENO; Gray MW, 1998, NUCLEIC ACIDS RES, V26, P865, DOI 10.1093/nar/26.4.865; Hahn MW, 2003, MOL BIOL EVOL, V20, P901, DOI 10.1093/molbev/msg096; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P629, DOI 10.1073/pnas.91.2.629; Horton TL, 2002, CURR OPIN MICROBIOL, V5, P620, DOI 10.1016/S1369-5274(02)00379-X; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Johnson AA, 2001, J BIOL CHEM, V276, P38097; JUKES TH, 1993, COMP BIOCHEM PHYS B, V106, P489, DOI 10.1016/0305-0491(93)90122-L; Knight RD, 2001, NAT REV GENET, V2, P49, DOI 10.1038/35047500; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Li W. H, 1997, MOL EVOLUTION; Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2005, MOL BIOL EVOL, V22, P1137, DOI 10.1093/molbev/msi100; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Lynch M, 2006, MOL BIOL EVOL, V23, P450, DOI 10.1093/molbev/msj050; Mason PA, 2003, FEBS LETT, V554, P6, DOI 10.1016/S0014-5793(03)01169-4; Miyamoto T, 2004, P NATL ACAD SCI USA, V101, P48, DOI 10.1073/pnas.0307163101; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Phreaner CG, 1996, PLANT CELL, V8, P107, DOI 10.1105/tpc.8.1.107; Pont-Kingdon G, 1998, J MOL EVOL, V46, P419, DOI 10.1007/PL00006321; Rand DM, 2001, ANNU REV ECOL SYST, V32, P415, DOI 10.1146/annurev.ecolsys.32.081501.114109; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Shields DC, 1997, MOL BIOL EVOL, V14, P344, DOI 10.1093/oxfordjournals.molbev.a025768; Swire J, 2005, J MOL EVOL, V60, P128, DOI 10.1007/s00239-004-0077-9; Tsudzuki T, 2001, J MOL EVOL, V53, P327, DOI 10.1007/s002390010222; van Oppen MJH, 2002, J MOL EVOL, V55, P1, DOI 10.1007/s00239-001-0075-0; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054	37	372	383	6	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1727	1730		10.1126/science.1118884	http://dx.doi.org/10.1126/science.1118884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556832				2022-12-28	WOS:000236204300030
J	Wei, W; Lu, Q; Chaudry, GJ; Leppla, SH; Cohen, SN				Wei, W; Lu, Q; Chaudry, GJ; Leppla, SH; Cohen, SN			The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin	CELL			English	Article							PSEUDOMONAS EXOTOXIN-A; WNT SIGNALING PATHWAY; MAMMALIAN-CELLS; PROTECTIVE ANTIGEN; BETA-CATENIN; GENE FAMILY; ENDOCYTOSIS; MICE; AXIN; INACTIVATION	Toxins, produced by Bacillus anthracis and other microbial pathogens require functions of host cell genes to yield toxic effects. Here we show that low density lipoprotein receptor-related protein 6 (LRP6), previously known to be a coreceptor for the Wnt signaling pathway, is required for anthrax toxin lethality in mammalian cells. Downregulation of LRP6 or coexpression of a truncated LRP6 dominant-negative peptide inhibited cellular uptake of complexes containing the protective antigen (PA) carrier of anthrax toxin moieties and protected targeted cells from death, as did antibodies against epitopes; in the LRP6 extracellular domain. Fluorescence microscopy and biochemical analyses showed that LRP6 enables toxin internalization by interacting at the cell surface with PA receptors TEM8/ATR and/or CMG2 to form a multicomponent complex that enters cells upon PA binding. Our results, which reveal a previously unsuspected biological role for LRP6, identify LRP6 as a potential target for countermeasures against anthrax toxin lethality.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; NIAID, Div Intramural Res, Microbial Pathogenesis Sect, NIH, Bethesda, MD 20892 USA	Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Cohen, SN (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	sncohen@stanford.edu	Wei, Wensheng/AAF-1325-2020; Chaudry, Ghulam/F-9761-2011	Wei, Wensheng/0000-0002-8053-2423	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000929, ZIAAI000929] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARORA N, 1992, J BIOL CHEM, V267, P15542; Bhatnagar R, 2001, CRIT REV MICROBIOL, V27, P167, DOI 10.1080/20014091096738; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carson-Walter EB, 2001, CANCER RES, V61, P6649; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Harlow E., 1999, USING ANTIBODIES LAB; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HOOVER DL, 1994, INFECT IMMUN, V62, P4432, DOI 10.1128/IAI.62.10.4432-4439.1994; Howard GC, 1996, J CLIN INVEST, V97, P1193, DOI 10.1172/JCI118533; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Leppla SH, 2000, HANDB EXP PHARM, V145, P445; LEPPLA SH, 1995, HANDB NAT T, V8, P543; LEPPLA SH, 1988, METHOD ENZYMOL, V165, P103; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Liu SH, 2003, EXPERT OPIN BIOL TH, V3, P843, DOI 10.1517/14712598.3.5.843; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; MILNE JC, 1994, J BIOL CHEM, V269, P20607; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; ORTH K, 1992, P NATL ACAD SCI USA, V89, P7422, DOI 10.1073/pnas.89.16.7422; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; SINGH Y, 1989, J BIOL CHEM, V264, P19103; STEFANSSON S, 1995, J BIOL CHEM, V270, P19417, DOI 10.1074/jbc.270.33.19417; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Willert K, 1999, DEVELOPMENT, V126, P4165; WILLNOW TE, 1994, J CELL SCI, V107, P719; Yu KCW, 2001, J CLIN INVEST, V107, P1387, DOI 10.1172/JCI11750; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	51	102	118	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1141	1154		10.1016/j.cell.2005.12.045	http://dx.doi.org/10.1016/j.cell.2005.12.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564009	Bronze			2022-12-28	WOS:000237241400016
J	Come, SE				Come, SE			A 62-year-old woman with a new diagnosis of breast cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ONCOLOGY-TECHNOLOGY-ASSESSMENT; ESTROGEN-RECEPTOR MODULATORS; ADJUVANT ENDOCRINE THERAPY; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; TAMOXIFEN THERAPY; AROMATASE INHIBITORS; PROGNOSTIC-FACTORS; PROGESTERONE-RECEPTOR		Beth Israel Deaconess Med Ctr, Breast Canc Program, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Come, SE (corresponding author), Beth Israel Deaconess Med Ctr, Breast Canc Program, 330 Brookline Ave,Room CC-913, Boston, MA 02215 USA.	scome@bidmc.harvard.edu						ABE O, 1992, LANCET, V339, P71; Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Abner AL, 1998, CANCER-AM CANCER SOC, V83, P2502, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2502::AID-CNCR14>3.3.CO;2-9; [Anonymous], 1992, Lancet, V339, P1; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Baum M, 2002, LANCET, V359, P2131; Baum M, 2003, Cancer, V98, P1802; Berry DA, 2004, BREAST CANCER RES TR, V88, pS17; Boccardo F, 2005, J CLIN ONCOL, V23, P5138, DOI 10.1200/JCO.2005.04.120; Bonneterre J, 2000, J CLIN ONCOL, V18, P3748, DOI 10.1200/JCO.2000.18.22.3748; Brufsky A, 2004, BREAST CANCER RES TR, V88, pS233; CLARK GM, 1984, J CLIN ONCOL, V2, P1102, DOI 10.1200/JCO.1984.2.10.1102; Clarke M, 1998, LANCET, V351, P1451; Coombes RC, 2004, BREAST CANCER RES TR, V88, pS7; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Cuzick J, 2005, J CLIN ONCOL, V23, P658; Dowsett M., 2003, BREAST CANC RES TREA, V82, pS10; Dubsky Peter C, 2002, Clin Breast Cancer, V3, P65, DOI 10.3816/CBC.2002.n.013; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Fallowfield L, 2004, J CLIN ONCOL, V22, P4261, DOI 10.1200/JCO.2004.08.029; Fallowfield LJ, 2004, BREAST CANCER RES TR, V88, pS8; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fisher B, 1996, JNCI-J NATL CANCER I, V88, P1529, DOI 10.1093/jnci/88.21.1529; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Galper S, 2005, INT J RADIAT ONCOL, V61, P348, DOI 10.1016/j.ijrobp.2004.06.011; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Goss PE, 2005, JNCI-J NATL CANCER I, V97, P1262, DOI 10.1093/jnci/dji250; Hilsenbeck SG, 2006, CLIN CANCER RES, V12, p1049S, DOI 10.1158/1078-0432.CCR-05-2123; Howell A, 2001, CLIN CANCER RES, V7, p4402S; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Jakesz R, 2005, LANCET, V366, P455, DOI 10.1016/S0140-6736(05)67059-6; Jelovac D, 2005, CANCER RES, V65, P5439, DOI 10.1158/0008-5472.CAN-04-2782; LEITNER SP, 1995, CANCER-AM CANCER SOC, V76, P2266, DOI 10.1002/1097-0142(19951201)76:11<2266::AID-CNCR2820761114>3.0.CO;2-T; MANSOUR EG, 1994, CANCER, V74, P381, DOI 10.1002/cncr.2820741326; McDonnell DP, 2005, CLIN CANCER RES, V11, p871S; MCGUIRE WL, 1992, NEW ENGL J MED, V326, P1756; Mouridsen H, 2003, J CLIN ONCOL, V21, P2101, DOI 10.1200/JCO.2003.04.194; Mouridsen H, 2004, ONCOLOGIST, V9, P489, DOI 10.1634/theoncologist.9-5-489; National Cancer Institute, SEER CANC STAT REV 1; *NIH, 2000, ADJ THER BREAST CANC; Olivotto IA, 2005, J CLIN ONCOL, V23, P2716, DOI 10.1200/JCO.2005.06.178; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paridaens R, 2003, ANN ONCOL, V14, P1391, DOI 10.1093/annonc/mdg362; PARIDAENS R, 2004, J CLIN ONCOL S, V22, P515; Punglia RS, 2005, J CLIN ONCOL, V23, P5178, DOI 10.1200/JCO.2005.02.964; QUIET CA, 1995, J CLIN ONCOL, V13, P1144, DOI 10.1200/JCO.1995.13.5.1144; Recht A, 2005, SEMIN RADIAT ONCOL, V15, P123, DOI 10.1016/j.semradonc.2004.10.002; ROSEN PP, 1993, J CLIN ONCOL, V11, P2090, DOI 10.1200/JCO.1993.11.11.2090; ROSEN PP, 1989, J CLIN ONCOL, V7, P1239, DOI 10.1200/JCO.1989.7.9.1239; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Smith IE, 2003, NEW ENGL J MED, V348, P2431, DOI 10.1056/NEJMra023246; Stewart HJ, 1996, BRIT J CANCER, V74, P297, DOI 10.1038/bjc.1996.356; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; THURLIMANN B, 2005, BREAST S1, V14, pS4; Tormey DC, 1996, JNCI-J NATL CANCER I, V88, P1828, DOI 10.1093/jnci/88.24.1828; Winer EP, 2003, J CLIN ONCOL, V21, P2597, DOI 10.1200/JCO.2003.04.596; Winer EP, 2005, J CLIN ONCOL, V23, P619, DOI 10.1200/JCO.2005.09.121; 2003, ADJUVANT; PRICES GENERIC TAMOX	65	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1434	1442		10.1001/jama.295.12.1434	http://dx.doi.org/10.1001/jama.295.12.1434			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551716				2022-12-28	WOS:000236157700022
J	Moher, D; Tsertsvadze, A				Moher, D; Tsertsvadze, A			Systematic reviews: when is an update an update?	LANCET			English	Editorial Material							HEALTH-CARE		Childrens Hosp Eastern Ontario, Res Inst, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario	Moher, D (corresponding author), Childrens Hosp Eastern Ontario, Res Inst, Chalmers Res Grp, Ottawa, ON K1H 8L1, Canada.	dmoher@uottawa.ca		Moher, David/0000-0003-2434-4206				[Anonymous], 1996, MERRIAM WEBSTERS COL; Atkins D, 2005, ANN INTERN MED, V142, P1035, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00002; CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862; CHALMERS I, 1993, MILBANK Q, V71, P411, DOI 10.2307/3350409; CHAPMAN A, 2005, COCHRANE METHODOL RE, P3; French Simon D, 2005, BMC Med Res Methodol, V5, P33, DOI 10.1186/1471-2288-5-33; Higgins J., 2005, COCHRANE REVIEWERS H, P3; HIGGINS JPT, 2005, COCHRANE LIB; KOCH G, 2005, COCHRANE METHODOL RE, P3; WELLER D, 1998, EV BAS HLTH ADV WORK	10	78	79	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					881	883		10.1016/S0140-6736(06)68358-X	http://dx.doi.org/10.1016/S0140-6736(06)68358-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546523				2022-12-28	WOS:000236242100007
J	Brown, MJ				Brown, MJ			Hypertension and ethnic group	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE FALL; UK HIGHER; RENIN; MANAGEMENT; AFRICAN; BLACKS; WHITES; AGE; POPULATIONS; SLAVERY		Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Brown, MJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England.	mjb14@cam.ac.uk						ABSON CP, 1981, S AFR MED J, V60, P47; Agyemang C, 2005, J HYPERTENS, V23, P913, DOI 10.1097/01.hjh.0000166827.94699.f9; Agyemang C, 2003, J HUM HYPERTENS, V17, P523, DOI 10.1038/sj.jhh.1001586; Agyemang C, 2002, J HUM HYPERTENS, V16, P739, DOI 10.1038/sj.jhh.1001488; [Anonymous], 1987, J Chronic Dis, V40, P839; [Anonymous], [No title captured]; Baker EH, 1998, LANCET, V351, P1388, DOI 10.1016/S0140-6736(97)07306-6; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; BUHLER FR, 1975, AM J CARDIOL, V36, P653, DOI 10.1016/0002-9149(75)90168-X; Campese VM, 1997, NEPHROL DIAL TRANSPL, V12, P399, DOI 10.1093/ndt/12.3.399; Cappuccio FP, 2002, BRIT MED J, V325, P1271, DOI 10.1136/bmj.325.7375.1271; Cappuccio FP, 1997, HEART, V78, P555, DOI 10.1136/hrt.78.6.555; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P456; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; CRUICKSHANK JK, 1980, BRIT MED J, V281, P1108, DOI 10.1136/bmj.281.6248.1108; CURTIN PD, 1992, AM J PUBLIC HEALTH, V82, P1681, DOI 10.2105/AJPH.82.12.1681; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; FALKNER B, 1990, HYPERTENSION, V15, P681, DOI 10.1161/01.HYP.15.6.681; Ferdinand KC, 2003, AM J HYPERTENS, V16, p50S, DOI 10.1016/S0895-7061(03)01069-0; FISHER NDL, 1994, HYPERTENSION, V23, P179, DOI 10.1161/01.HYP.23.2.179; Gibbs CR, 1999, QJM-INT J MED, V92, P187, DOI 10.1093/qjmed/92.4.187; GUYTON AC, 1972, AM J MED, V52, P584, DOI 10.1016/0002-9343(72)90050-2; GUYTON AC, 1992, HYPERTENSION, V19, pI2, DOI 10.1161/01.HYP.19.1_Suppl.I2; He FJ, 1998, HYPERTENSION, V32, P820, DOI 10.1161/01.HYP.32.5.820; JAMES GD, 1986, J HYPERTENS, V4, pS387; JULIUS S, 1988, AM HEART J, V116, P600, DOI 10.1016/0002-8703(88)90557-1; Kaufman JS, 2003, EPIDEMIOLOGY, V14, P111, DOI 10.1097/00001648-200301000-00027; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Khan JM, 2005, HEART, V91, P1105, DOI 10.1136/hrt.2004.044560; Kizer JR, 2004, HYPERTENSION, V43, P1182, DOI 10.1161/01.HYP.0000128738.94190.9f; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Lane DA, 2005, J HYPERTENS, V23, P1347, DOI 10.1097/01.hjh.0000173516.60610.b5; Laragh JH, 2001, AM J HYPERTENS, V14, P1173, DOI 10.1016/S0895-7061(01)02261-0; LARAGH JH, 1979, JAMA-J AM MED ASSOC, V241, P151, DOI 10.1001/jama.241.2.151; LUFT FC, 1979, CIRCULATION, V59, P643, DOI 10.1161/01.CIR.59.4.643; LUNDJOHANSEN P, 1991, HYPERTENSION, V18, pS54; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; Mackenzie IS, 2002, CLIN MED, V2, P465, DOI 10.7861/clinmedicine.2-5-465; MANATUNGA AK, 1993, HYPERTENSION, V22, P84, DOI 10.1161/01.HYP.22.1.84; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Padmanabhan S, 2006, HYPERTENSION, V47, P603, DOI 10.1161/01.HYP.0000197947.62601.9d; PRATT JH, 1989, NEW ENGL J MED, V321, P1152, DOI 10.1056/NEJM198910263211703; Preston RA, 1998, JAMA-J AM MED ASSOC, V280, P1168, DOI 10.1001/jama.280.13.1168; Raleigh VS, 1997, BMJ-BRIT MED J, V314, P209, DOI 10.1136/bmj.314.7075.209; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; WEIR MR, 1995, HYPERTENSION, V26, P124, DOI 10.1161/01.HYP.26.1.124; Williams B, 2004, BMJ-BRIT MED J, V328, P634, DOI 10.1136/bmj.328.7440.634; WILSON TW, 1991, HYPERTENSION, V17, pI122, DOI 10.1161/01.HYP.17.1_Suppl.I122; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988	53	89	91	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2006	332	7545					833	836B		10.1136/bmj.332.7545.833	http://dx.doi.org/10.1136/bmj.332.7545.833			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16601044	Green Published			2022-12-28	WOS:000236815900022
J	Speder, P; Adam, G; Noselli, S				Speder, P; Adam, G; Noselli, S			Type ID unconventional myosin controls left-right asymmetry in Drosophila	NATURE			English	Article							RIGHT DETERMINANT INVERSIN; COMPARTMENTAL ORGANIZATION; GENITAL DISC; N-CADHERIN; MELANOGASTER; CALMODULIN; ESTABLISHMENT; ROTATION; PATHWAY; EMBRYO	Breaking left - right symmetry in Bilateria embryos is a major event in body plan organization that leads to polarized adult morphology, directional organ looping, and heart and brain function(1-4). However, the molecular nature of the determinant(s) responsible for the invariant orientation of the left - right axis ( situs choice) remains largely unknown. Mutations producing a complete reversal of left - right asymmetry ( situs inversus) are instrumental for identifying mechanisms controlling handedness, yet only one such mutation has been found in mice ( inversin)(5) and snails(6,7). Here we identify the conserved type ID unconventional myosin 31DF gene (Myo31DF) as a unique situs inversus locus in Drosophila. Myo31DF mutations reverse the dextral looping of genitalia, a prominent left - right marker in adult flies. Genetic mosaic analysis pinpoints the A8 segment of the genital disc as a left - right organizer and reveals an anterior - posterior compartmentalization of Myo31DF function that directs dextral development and represses a sinistral default state. As expected of a determinant, Myo31DF has a trigger-like function and is expressed symmetrically in the organizer, and its symmetrical overexpression does not impair left - right asymmetry. Thus Myo31DF is a dextral gene with actin-based motor activity controlling situs choice. Like mouse inversin(8), Myo31DF interacts and colocalizes with beta-catenin, suggesting that situs inversus genes can direct left - right development through the adherens junction.	Univ Nice, Inst Signalling Dev Biol & Canc, CNRS, UMR6543, F-06108 Nice 2, France; Hungarian Acad Sci, Biol Res Ctr, Inst Genet, H-6701 Szeged, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Noselli, S (corresponding author), Univ Nice, Inst Signalling Dev Biol & Canc, CNRS, UMR6543, F-06108 Nice 2, France.	noselli@unice.fr		Speder, Pauline/0000-0002-2934-5841; Noselli, stephane/0000-0002-7296-324X				Adam G, 2003, DEVELOPMENT, V130, P2397, DOI 10.1242/dev.00460; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Bobinnec Y, 1999, EUR J CELL BIOL, V78, P671, DOI 10.1016/S0171-9335(99)80053-3; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Casares F, 1997, DEV GENES EVOL, V207, P216, DOI 10.1007/s004270050110; Chen EH, 1997, DEVELOPMENT, V124, P205; Dubruille R, 2002, DEVELOPMENT, V129, P5487, DOI 10.1242/dev.00148; Eley L, 2004, CELL BIOL INT, V28, P119, DOI 10.1016/j.cellbi.2003.11.009; Freeland DE, 1996, MECH DEVELOP, V56, P61, DOI 10.1016/0925-4773(96)00511-4; FREEMAN G, 1982, ROUX ARCH DEV BIOL, V191, P69, DOI 10.1007/BF00848443; Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047; Gleichauf R, 1936, Z WISS ZOOL ABT A, V148, P1; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Huber LA, 2000, TRAFFIC, V1, P494, DOI 10.1034/j.1600-0854.2000.010607.x; Levin M, 2005, MECH DEVELOP, V122, P3, DOI 10.1016/j.mod.2004.08.006; Macias A, 2004, INT J DEV BIOL, V48, P1087, DOI 10.1387/ijdb.041859am; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; MORGAN NS, 1995, DEV BIOL, V172, P51, DOI 10.1006/dbio.1995.0005; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Raya A, 2004, CURR OPIN GENET DEV, V14, P575, DOI 10.1016/j.gde.2004.07.011; Sanchez L, 1997, DEV GENES EVOL, V207, P229, DOI 10.1007/s004270050111; Shibazaki Y, 2004, CURR BIOL, V14, P1462, DOI 10.1016/j.cub.2004.08.018; Strutt H, 2003, CURR BIOL, V13, P1451, DOI 10.1016/S0960-9822(03)00545-1; Ueshima R, 2003, NATURE, V425, P679, DOI 10.1038/425679a; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407	28	144	149	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					803	807		10.1038/nature04623	http://dx.doi.org/10.1038/nature04623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598259				2022-12-28	WOS:000236548400043
J	Winblad, B; Kilander, L; Eriksson, S; Minthon, L; Batsman, S; Wetterholm, AL; Jarisson-Blixt, C; Hoglund, A				Winblad, B; Kilander, L; Eriksson, S; Minthon, L; Batsman, S; Wetterholm, AL; Jarisson-Blixt, C; Hoglund, A		Severe Alzheimers Dis Study Grp	Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; SEVERE IMPAIRMENT BATTERY; DEMENTED PATIENTS; NATURAL-HISTORY; MODERATE; EFFICACY; SAFETY; MEMANTINE; METAANALYSIS; GALANTAMINE	Background The cholinesterase inhibitor donepezil is used to treat mild-to-moderate Alzheimer's disease. Its efficacy in severe dementia has not been assessed and is controversial. Our aim was to ascertain the effectiveness of donepezil in patients with severe Alzheimer's disease, by focusing primarily on cognition and activities of daily living. Methods We did a 6-month, double-blind, parallel-group, placebo-controlled study in 248 patients with severe Alzheimer's disease (mini mental state examination score 1-10) who were living in assisted care nursing homes ran by trained staff in Sweden. We assigned patients oral donepezil (5 mg per day for 30 days then up to 10 mg per day thereafter, n=128) or matched placebo (n=120). Our primary endpoints were change from baseline to month 6 in the severe impairment battery (SIB) and modified Alzheimer's Disease Cooperative Study activities of daily living inventory for severe Alzheimer's disease (ADCS-ADL-severe). We analysed outcomes for patients with data at baseline and at one or more other timepoints (modified intent-to-treat population) with last observation carried forward used to replace missing data. Findings 95 patients assigned donepezil and 99 patients assigned placebo completed the study. Patients treated with donepezil improved more in SIB scores and declined less in ADCS-ADL-severe scores at 6 months after initiation of treatment compared with baseline than did controls (least squares [LS] mean difference, 5.7,95% Cl 1.5-9.8; p=0.008, and 1.7, 0.2-3.2; p=0.03, respectively). The incidence of adverse events was comparable between groups (donepezil 82% [n=105] vs placebo 76% [n=91]), with most being transient and mild or moderate in severity. More patients discontinued treatment because of adverse events in the donepezil group (n=20) than in the placebo group (n=8). Interpretation Donepezil improves cognition and preserves function in individuals with severe Alzheimer's disease who live in nursing homes.	Karolinska Inst, Karolinska Univ Hosp, Alzheimers Dis Res Ctr, Dept Neurotec,Div Geriatr Med, S-14186 Huddinge, Sweden; Uppsala Univ, Dept Publ Hlth & Caring Sci Geriatr, Uppsala, Sweden; Umea Univ, Dept Community Med & Rehabil, Geriatr Med Sect, Umea, Sweden; Malmo Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden; Kalix Vardcent, Dept Primary Care, Kalix, Sweden; Pfizer AB, Taby, Sweden	Karolinska Institutet; Karolinska University Hospital; Uppsala University; Umea University; Lund University; Pfizer	Winblad, B (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Alzheimers Dis Res Ctr, Dept Neurotec,Div Geriatr Med, S-14186 Huddinge, Sweden.	bengt.winblad@ki.se						Aguero-Torres H, 1998, INT J GERIATR PSYCH, V13, P755, DOI 10.1002/(SICI)1099-1166(1998110)13:11<755::AID-GPS862>3.0.CO;2-Y; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Burns A, 1999, DEMENT GERIATR COGN, V10, P237, DOI 10.1159/000017126; *CGI CLIN GLOB IMP, 1976, PUBL ADM; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; Feldman H, 2001, NEUROLOGY, V57, P613, DOI 10.1212/WNL.57.4.613; Feldman H, 2003, J AM GERIATR SOC, V51, P737, DOI 10.1046/j.1365-2389.2003.51260.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; GALASKO DR, 2000, NEUROBIOL AGING, V21, P168; Lopez OL, 2002, J NEUROL NEUROSUR PS, V72, P310, DOI 10.1136/jnnp.72.3.310; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; *NIH CLIN EXC, APPR CONS DOC DON GA; PANISSET M, 1994, ARCH NEUROL-CHICAGO, V51, P41, DOI 10.1001/archneur.1994.00540130067012; Pratt RD, 2002, INT J CLIN PRACT, V56, P710; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Ritchie CW, 2004, AM J GERIAT PSYCHIAT, V12, P358, DOI 10.1176/appi.ajgp.12.4.358; Rogers SL, 1998, NEUROLOGY, V50, P136, DOI 10.1212/WNL.50.1.136; Schmitt FA, 1997, ALZ DIS ASSOC DIS, V11, pS51; Sclan S G, 1992, Int Psychogeriatr, V4 Suppl 1, P55; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; Tariot PN, 2001, J AM GERIATR SOC, V49, P1590, DOI 10.1046/j.1532-5415.2001.t01-1-49266.x; Whitehead A, 2004, INT J GERIATR PSYCH, V19, P624, DOI 10.1002/gps.1133; Wilcock GK, 2000, BRIT MED J, V321, P1445, DOI 10.1136/bmj.321.7274.1445; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; Winblad B, 1999, INT J GERIATR PSYCH, V14, P135, DOI 10.1002/(SICI)1099-1166(199902)14:2<135::AID-GPS906>3.0.CO;2-0; 1989, COSTART CODING SYMBO	29	280	298	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1057	1065		10.1016/S0140-6736(06)68350-5	http://dx.doi.org/10.1016/S0140-6736(06)68350-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581404				2022-12-28	WOS:000236673200029
J	Turner, J; Lachlan-Cope, TA; Colwell, S; Marshall, GJ; Connolley, WM				Turner, J; Lachlan-Cope, TA; Colwell, S; Marshall, GJ; Connolley, WM			Significant warming of the Antarctic winter troposphere	SCIENCE			English	Article							TEMPERATURE TRENDS; CLIMATE-CHANGE; SURFACE; VARIABILITY; OCEAN	We report an undocumented major warming of the Antarctic winter troposphere that is larger than any previously identified regional tropospheric warming on Earth. This result has come to light through an analysis of recently digitized and rigorously quality controlled Antarctic radiosonde observations. The data show that regional midtropospheric temperatures have increased at a statistically significant rate of 0.5 degrees to 0.7 degrees Celsius per decade over the past 30 years. Analysis of the time series of radiosonde temperatures indicates that the data are temporally homogeneous. The available data do not allow us to unambiguously assign a cause to the tropospheric warming at this stage.	British Antarctic Survey, NERC, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Turner, J (corresponding author), British Antarctic Survey, NERC, Cambridge CB3 0ET, England.	j.turner@bas.ac.uk		Turner, John/0000-0002-6111-5122	Natural Environment Research Council [bas010014] Funding Source: researchfish; NERC [bas010014] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Angell JK, 1999, GEOPHYS RES LETT, V26, P2761, DOI 10.1029/1999GL900375; ANGELL JK, 2005, TRENDS ONLINE COMPEN; Bluestein H.B., 1993, SYNOPTIC DYNAMIC MET, VII; Bromwich DH, 2004, J CLIMATE, V17, P4603, DOI 10.1175/3241.1; Comiso JC, 2000, J CLIMATE, V13, P1674, DOI 10.1175/1520-0442(2000)013<1674:VATIAS>2.0.CO;2; Doran PT, 2002, NATURE, V415, P517, DOI 10.1038/nature710; GAFFEN DJ, 1994, J GEOPHYS RES-ATMOS, V99, P3667, DOI 10.1029/93JD03179; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Jacka TH, 1998, ANN GLACIOL, V27, P553; King JC, 2003, ANTARCT RES SER, V79, P17; Luers JK, 1998, J CLIMATE, V11, P1002, DOI 10.1175/1520-0442(1998)011<1002:UORTDI>2.0.CO;2; Lund R, 2002, J CLIMATE, V15, P2547, DOI 10.1175/1520-0442(2002)015<2547:DOUCAR>2.0.CO;2; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; RAPER SCB, 1984, MON WEATHER REV, V112, P1341, DOI 10.1175/1520-0493(1984)112<1341:VISATP>2.0.CO;2; Sherwood SC, 2005, SCIENCE, V309, P1556, DOI 10.1126/science.1115640; SPENCER RW, 1992, J CLIMATE, V5, P858, DOI 10.1175/1520-0442(1992)005<0858:PARVOS>2.0.CO;2; Swanson RE, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017938; Thorne PW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005753; Turner J, 2005, INT J CLIMATOL, V25, P279, DOI 10.1002/joc.1130; Turner J, 2002, NATURE, V418, P291, DOI 10.1038/418291b; Turner J, 2004, J CLIMATE, V17, P2890, DOI 10.1175/1520-0442(2004)017<2890:TSRPTA>2.0.CO;2	21	109	119	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1914	1917		10.1126/science.1121652	http://dx.doi.org/10.1126/science.1121652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574865				2022-12-28	WOS:000236387800042
J	Boyce, DE; Shokrollahi, K				Boyce, DE; Shokrollahi, K			ABC of wound healing - Reconstructive surgery	BRITISH MEDICAL JOURNAL			English	Editorial Material									Morriston Hosp, Welsh Ctr Plast Surg, Swansea, W Glam, Wales	Morriston Hospital	Boyce, DE (corresponding author), Morriston Hosp, Welsh Ctr Plast Surg, Swansea, W Glam, Wales.		Shokrollahi, Kayvan/V-4993-2019	Shokrollahi, Kayvan/0000-0003-1044-7781				Hasham S, 2005, BMJ-BRIT MED J, V330, P830, DOI 10.1136/bmj.330.7495.830; McGregor ADMI, 2000, FUNDAMENTAL TECHNIQU; TEOT L, 2004, SURG WOUNDS; Williams, 1998, WOUNDS BIOL MANAGEME	4	25	28	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 25	2006	332	7543					710	712		10.1136/bmj.332.7543.710	http://dx.doi.org/10.1136/bmj.332.7543.710			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	027VH	16565127	Green Published			2022-12-28	WOS:000236443300026
J	Hagel, B; Macpherson, A; Rivara, FP; Pless, B				Hagel, B; Macpherson, A; Rivara, FP; Pless, B			Arguments against helmet legislation are flawed	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEAD-INJURIES; BICYCLISTS; CYCLISTS; CHILDREN; HEALTH		McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3H 1P3, Canada	McGill University	Pless, B (corresponding author), McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3H 1P3, Canada.	barry.pless@mcgill.ca	Hagel, Brent/AAK-3319-2020					AUWELL RG, 2001, ACCIDENT ANAL PREV, V33, P345; Borglund S T, 1999, J Emerg Nurs, V25, P496, DOI 10.1016/S0099-1767(99)70013-9; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; Cook A, 2003, INJURY PREV, V9, P266, DOI 10.1136/ip.9.3.266; CUMMINGS P, IN PRESS ACCID ANAL; Henderson M, 1995, EFFECTIVENESS BICYCL; Lardelli-Claret P, 2003, INJURY PREV, V9, P128, DOI 10.1136/ip.9.2.128; LeBlanc JC, 2002, CAN MED ASSOC J, V166, P592; LIPPI G, 2006, CMAJ; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; McGuire L, 2000, Inj Prev, V6, P285, DOI 10.1136/ip.6.4.285; MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY; MORITZ WE, SURVEY N AM BICYCLE; MORRIS JN, 1990, BRIT HEART J, V63, P325; PLESS IB, IN PRESS ARCH PEDIAT; Robinson DL, 2006, BMJ-BRIT MED J, V332, P722, DOI 10.1136/bmj.332.7543.722-a; Scuffham P, 2000, ACCIDENT ANAL PREV, V32, P565, DOI 10.1016/S0001-4575(99)00081-0; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; SPAITE DW, 1991, J TRAUMA, V31, P1510, DOI 10.1097/00005373-199111000-00008; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thompson DC, 2000, COCHRANE DB SYST REV, V2; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351	25	16	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2006	332	7543					725	726A		10.1136/bmj.332.7543.725	http://dx.doi.org/10.1136/bmj.332.7543.725			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	027VH	16565133	Green Published			2022-12-28	WOS:000236443300030
J	Chong, AS; Shen, JK; Tao, J; Yin, DP; Kuznetsov, A; Hara, M; Philipson, LH				Chong, AS; Shen, JK; Tao, J; Yin, DP; Kuznetsov, A; Hara, M; Philipson, LH			Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration	SCIENCE			English	Article							NOD; MACROPHAGES; PANCREAS	Autoimmune destruction of beta cells is the predominant cause of type 1 diabetes mellitus (T1DM) in humans and is modeled in non-obese diabetic (NOD) mice. Many therapeutic interventions prevent the development of T1DM in NOD mice, but few can induce its reversal once established. Intervention with Freund's complete adjuvant, semi-allogeneic splenocytes, and temporary islet transplantation has been reported to cure NOD mice of established T1DM. Using the same approach, we report here that this treatment cured 32% of NOD mice of established diabetes (>340 milligrams per deciliter blood glucose), although beta cells in these mice were not derived from donor splenocytes.	Univ Chicago, Dept Surg, Sect Transplantat, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Endocrinol Sect, Chicago, IL 60637 USA; Univ Illinois, Dept Surg, Chicago, IL 60612 USA	University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chong, AS (corresponding author), Univ Chicago, Dept Surg, Sect Transplantat, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achong@uchicago.edu						Bock T, 2005, DIABETES, V54, P133, DOI 10.2337/diabetes.54.1.133; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Jansen A, 1996, J AUTOIMMUN, V9, P341, DOI 10.1006/jaut.1996.0046; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Molano RD, 2003, TRANSPLANTATION, V75, P1812, DOI 10.1097/01.TP.0000064622.54799.0E; Rosmalen JGM, 2000, LAB INVEST, V80, P769, DOI 10.1038/labinvest.3780080; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500	10	103	117	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1774	1775		10.1126/science.1123510	http://dx.doi.org/10.1126/science.1123510			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556844				2022-12-28	WOS:000236204300045
J	Motola, DL; Cummins, CL; Rottiers, V; Sharma, KK; Li, TT; Li, Y; Suino-Powell, K; Xu, HE; Auchus, RJ; Antebi, A; Mangelsdorf, DJ				Motola, DL; Cummins, CL; Rottiers, V; Sharma, KK; Li, TT; Li, Y; Suino-Powell, K; Xu, HE; Auchus, RJ; Antebi, A; Mangelsdorf, DJ			Identification of ligands for DAF-12 that govern Dauer formation and reproduction in C. elegans	CELL			English	Article							NUCLEAR RECEPTOR; CAENORHABDITIS-ELEGANS; LARVAL DEVELOPMENT; BILE-ACID; DEVELOPMENTAL AGE; RESPONSE ELEMENTS; LONGEVITY; DIAPAUSE; HORMONE; METABOLISM	In response to environmental and dietary cues, the C. elegans orphan nuclear receptor, DAF-12, regulates dauer diapause, reproductive development, fat metabolism, and life span. Despite strong evidence for hormonal control, the identification of the DAF-12 ligand has remained elusive. In this work, we identified two distinct 3-keto-cholestenoic acid metabolites of DAF-9, a cytochrome P450 involved in hormone production, that function as ligands for DAF-12. At nanomolar concentrations, these steroidal ligands (called dafachronic acids) bind and transactivate DAF-12 and rescue the hormone deficiency of daf-9 mutants. Interestingly, DAF-9 has a biochemical activity similar to mammalian CYP27A1 catalyzing addition of a terminal acid to the side chain of sterol metabolites. Together, these results define the first steroid hormones in nematodes as ligands for an invertebrate orphan nuclear receptor and demonstrate that steroidal regulation of reproduction, from biology to molecular mechanism, is conserved from worms to humans.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Huffington Ctr Aging, Houston, TX 77030 USA; Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor College of Medicine; Van Andel Institute	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	davo.mango@utsouthwestern.edu	Xu, H. Eric/ABD-7487-2021	Cummins, Carolyn/0000-0001-7603-6577; Xu, H. Eric/0000-0002-6829-8144; Mangelsdorf, David/0000-0002-4355-0796	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R21DK059942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027498] Funding Source: NIH RePORTER; NIA NIH HHS [AG027498] Funding Source: Medline; NIDDK NIH HHS [DK62434, DK0716620, DK59942] Funding Source: Medline; NIGMS NIH HHS [GM069338, GM07062] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; BRENNER S, 1974, GENETICS, V77, P71; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; CHITWOOD DJ, 1983, STEROIDS, V42, P311, DOI 10.1016/0039-128X(83)90042-9; Gems D, 1998, GENETICS, V150, P129; Gerisch B, 2004, DEVELOPMENT, V131, P1765, DOI 10.1242/dev.01068; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gill MS, 2004, AGING CELL, V3, P413, DOI 10.1111/j.1474-9728.2004.00126.x; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; HOOD SR, 1996, METHOD MOL BIOL, P203; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Jia KL, 2002, DEVELOPMENT, V129, P221; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; LARSEN PL, 1995, GENETICS, V139, P1567; Li J, 2004, DEVELOPMENT, V131, P5741, DOI 10.1242/dev.01408; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Mak HY, 2004, DEVELOPMENT, V131, P1777, DOI 10.1242/dev.01069; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Mooijaart SP, 2005, AGEING RES REV, V4, P351, DOI 10.1016/j.arr.2005.03.006; Norlin M, 2003, J LIPID RES, V44, P1515, DOI 10.1194/jlr.M300047-JLR200; Ohkura K, 2003, DEVELOPMENT, V130, P3237, DOI 10.1242/dev.00540; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; ROTTIERS V, 2006, IN PRESS DEV CELL; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Shostak Y, 2004, GENE DEV, V18, P2529, DOI 10.1101/gad.1218504; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; THOMAS JH, 1993, GENETICS, V134, P1105; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; UOMORI A, 1987, J CHEM SOC PERK T 1, P1713, DOI 10.1039/p19870001713; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; VOWELS JJ, 1992, GENETICS, V130, P105; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Zhang Z, 2001, J LIPID RES, V42, P649	42	353	373	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1209	1223		10.1016/j.cell.2006.01.037	http://dx.doi.org/10.1016/j.cell.2006.01.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16529801	Bronze			2022-12-28	WOS:000237241400021
J	Suri, A; Calderon, B; Esparza, TJ; Frederick, K; Bittner, P; Unanue, ER				Suri, A; Calderon, B; Esparza, TJ; Frederick, K; Bittner, P; Unanue, ER			Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells	SCIENCE			English	Article							COMPLETE FREUND ADJUVANT; NOD MICE; T-CELLS; INSULIN; PREVENTION; ONSET	Type 1 diabetes mellitus results from the autoimmune destruction of the beta cells of the pancreatic islets of Langerhans and is recapitulated in the nonobese diabetic strain of mice. In an attempt to rescue islet loss, diabetic mice were made normoglycemic by islet transplantation and immunization with Freund's complete adjuvant along with multiple injections of allogeneic mate splenocytes. This treatment allowed for survival of transplanted islets and recovery of endogenous beta cell function in a proportion of mice, but with no evidence for allogeneic splenocyte-derived differentiation of new islet beta cells. Control of the autoimmune disease at a crucial time in diabetogenesis can result in recovery of beta cell function.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Suri, A (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	anish@pathology.wustl.edu; unanue@pathbox.wustl.edu		Calderon, Boris/0000-0003-1575-0739				CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Johnson KL, 2000, BIOTECHNIQUES, V29, P1220, DOI 10.2144/00296st01; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Makhlouf L, 2004, TRANSPLANTATION, V77, P990, DOI 10.1097/01.TP.0000118410.61419.59; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Suri A, 2004, EUR J IMMUNOL, V34, P447, DOI 10.1002/eji.200324599; SURI AK, UNPUB; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; ULAETO D, 1992, P NATL ACAD SCI USA, V89, P3927, DOI 10.1073/pnas.89.9.3927; WEGMANN DR, 1993, J AUTOIMMUN, V6, P517, DOI 10.1006/jaut.1993.1043; WEGMANN DR, 1994, J AUTOIMMUN, V7, P833, DOI 10.1006/jaut.1994.1066; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820	17	87	98	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1778	1780		10.1126/science.1123500	http://dx.doi.org/10.1126/science.1123500			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556846				2022-12-28	WOS:000236204300047
J	Rana, O; McCrea, W				Rana, O; McCrea, W			Cholesterol emboli after coronary angioplasty	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Great Western Hosp, Swindon SN3 6BB, Wilts, England		Rana, O (corresponding author), Great Western Hosp, Swindon SN3 6BB, Wilts, England.		Rana, Omer/AAP-8523-2020	Rana, Omer/0000-0003-3597-2646					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1294	1294		10.1056/NEJMicm050895	http://dx.doi.org/10.1056/NEJMicm050895			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554531				2022-12-28	WOS:000236164200008
J	Rush, AJ; Trivedi, MH; Wisniewski, SR; Stewart, JW; Nierenberg, AA; Thase, ME; Ritz, L; Biggs, MM; Warden, D; Luther, JF; Shores-Wilson, K; Niederehe, G; Fava, M				Rush, AJ; Trivedi, MH; Wisniewski, SR; Stewart, JW; Nierenberg, AA; Thase, ME; Ritz, L; Biggs, MM; Warden, D; Luther, JF; Shores-Wilson, K; Niederehe, G; Fava, M		STAR D Study Team	Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAR-ASTERISK-D; SEQUENCED TREATMENT ALTERNATIVES; RESISTANT MAJOR DEPRESSION; REPORT QIDS-SR; REUPTAKE INHIBITORS; TREATMENT STRATEGY; QUICK INVENTORY; DISORDER; EFFICACY; SYMPTOMATOLOGY	BACKGROUND After unsuccessful treatment for depression with a selective serotonin-reuptake inhibitor (SSRI), it is not known whether switching to one antidepressant is more effective than switching to another. METHODS We randomly assigned 727 adult outpatients with a nonpsychotic major depressive disorder who had no remission of symptoms or could not tolerate the SSRI citalopram to receive one of the following drugs for up to 14 weeks: sustained-release bupropion (239 patients) at a maximal daily dose of 400 mg, sertraline (238 patients) at a maximal daily dose of 200 mg, or extended-release venlafaxine (250 patients) at a maximal daily dose of 375 mg. The study was conducted in 18 primary and 23 psychiatric care settings. The primary outcome was symptom remission, defined by a total score of 7 or less on the 17-item Hamilton Rating Scale for Depression (HRSD-17) at the end of the study. Scores on the Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR-16), obtained at treatment visits, determined secondary outcomes, including remission (a score of 5 or less at exit) and response (a reduction of 50 percent or more on baseline scores). RESULTS Remission rates as assessed by the HRSD-17 and the QIDS-SR-16, respectively, were 21.3 percent and 25.5 percent for sustained-release bupropion, 17.6 percent and 26.6 percent for sertraline, and 24.8 percent and 25.0 percent for extended-release venlafaxine. QIDS-SR-16 response rates were 26.1 percent for sustained-release bupropion, 26.7 percent for sertraline, and 28.2 percent for extended-release venlafaxine. These treatments did not differ significantly with respect to outcomes, tolerability, or adverse events. CONCLUSIONS After unsuccessful treatment with an SSRI, approximately one in four patients had a remission of symptoms after switching to another antidepressant. Any one of the medications in the study provided a reasonable second-step choice for patients with depression.	Univ Texas, SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Epidemiol Data Ctr, Pittsburgh, PA USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Coll Phys & Surg, New York, NY USA; Massachusetts Gen Hosp, Clin Psychopharmacol Unit, Boston, MA 02114 USA; NIMH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York State Psychiatry Institute; Columbia University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Rush, AJ (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	john.rush@utsouthwestern.edu	Howland, Robert H/K-6937-2015; Fava, Maurizio/AAH-3548-2020; Trivedi, Madhukar/A-9029-2013; anand, amit/A-7222-2009; Biggs, Dr. Melanie/C-1468-2010; Young, Alexander/A-1523-2009	Howland, Robert H/0000-0002-6533-6010; Trivedi, Madhukar/0000-0002-2983-1110; Young, Alexander/0000-0002-9367-9213; Rush, Augustus/0000-0003-2004-2382; Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH090003] Funding Source: NIH RePORTER; NIMH NIH HHS [N01MH90003] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AG HLTH CAR POL R, 1993, AHCPR PUBL; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 2000, Am J Psychiatry, V157, P1; [Anonymous], 1990, STAT ISSUES DRUG RES; de Montigny C, 1999, J CLIN PSYCHOPHARM, V19, P401, DOI 10.1097/00004714-199910000-00003; Fava M, 2003, PSYCHIAT CLIN N AM, V26, P457, DOI 10.1016/S0193-953X(02)00107-7; Fava M, 2003, J CLIN PSYCHIAT, V64, P13; Fava M, 2001, J CLIN PSYCHIAT, V62, P413, DOI 10.4088/JCP.v62n0603; Fava M, 2000, J CLIN PSYCHIAT, V61, P10; Fava M, 2003, J CLIN PSYCHOPHARM, V23, P365, DOI 10.1097/01.jcp.0000085409.08426.4c; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Joffe RT, 1996, J CLIN PSYCHIAT, V57, P114; Judd LL, 1999, ARCH GEN PSYCHIAT, V56, P764; Lavori PW, 2001, BIOL PSYCHIAT, V50, P792, DOI 10.1016/S0006-3223(01)01223-9; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Miller IW, 1998, J CLIN PSYCHIAT, V59, P608, DOI 10.4088/JCP.v59n1108; NIERENBERG AA, 1994, J CLIN PSYCHOPHARM, V14, P419; NOLEN WA, 1993, J AFFECT DISORDERS, V28, P189, DOI 10.1016/0165-0327(93)90104-R; NOLEN WA, 1988, ACTA PSYCHIAT SCAND, V78, P676, DOI 10.1111/j.1600-0447.1988.tb06403.x; NOLEN WA, 1988, ACTA PSYCHIAT SCAND, V78, P668, DOI 10.1111/j.1600-0447.1988.tb06402.x; Novick JS, 2005, J CLIN PSYCHIAT, V66, P1002, DOI 10.4088/JCP.v66n0807; Poirier MF, 1999, BRIT J PSYCHIAT, V175, P394; Rush AJ, 2005, J AFFECT DISORDERS, V87, P43, DOI 10.1016/j.jad.2005.03.005; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Rush AJ, 2003, BIOL PSYCHIAT, V54, P585, DOI 10.1016/S0006-3223(03)00786-8; Rush AJ, 2003, BIOL PSYCHIAT, V53, P743, DOI 10.1016/S0006-3223(03)00088-X; RUSH AJ, IN PRESS BIOL PSYCHI; Saiz-Ruiz J, 2002, PROG NEURO-PSYCHOPH, V26, P1129, DOI 10.1016/S0278-5846(02)00247-6; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Smith D, 2002, BRIT J PSYCHIAT, V180, P396, DOI 10.1192/bjp.180.5.396; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Thase ME, 2001, J CLIN PSYCHIAT, V62, P683, DOI 10.4088/JCP.v62n0904; Thase ME, 1997, J CLIN PSYCHIAT, V58, P16, DOI 10.4088/JCP.v58n0103; Trivedi MH, 2006, J CLIN PSYCHIAT, V67, P185, DOI 10.4088/JCP.v67n0203; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Wisniewski Stephen R, 2004, Clin Trials, V1, P387, DOI 10.1191/1740774504cn035oa; Zimmerman M, 2001, ARCH GEN PSYCHIAT, V58, P787, DOI 10.1001/archpsyc.58.8.787	41	750	764	2	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1231	1242		10.1056/NEJMoa052963	http://dx.doi.org/10.1056/NEJMoa052963			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554525				2022-12-28	WOS:000236164200002
J	Holloway, RG; Jozefowicz, RF				Holloway, RG; Jozefowicz, RF			Update in neurology	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ENDARTERECTOMY; STENOSIS		Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	University of Rochester	Jozefowicz, RF (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurol, 601 Elmwood Ave,Box 673, Rochester, NY 14642 USA.	Ralph_Jozefowicz@urmc.rochester.edu						[Anonymous], 2005, RED BOOK; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; *GUID CORP, RX ACCULINK CAR STEN; *US FDA, 2004, FDA APPR NEW STENT S; *US FDA, 2006, FDA APPR CONC MERC R; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035	7	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					421	426		10.7326/0003-4819-144-6-200603210-00009	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549854				2022-12-28	WOS:000236251800006
J	Perkins, MD; Roscigno, G; Zumla, A				Perkins, MD; Roscigno, G; Zumla, A			Progress towards improved tuberculosis diagnostics for developing countries	LANCET			English	Editorial Material							PULMONARY TUBERCULOSIS		Fdn Innovat New Diagnost, CH-1216 Geneva, Switzerland; UCL, Ctr Infect Dis & Int Hlth, Windeyer Inst Med Sci, London, England	Foundation For Innovative New Diagnostics; University of London; University College London	Perkins, MD (corresponding author), Fdn Innovat New Diagnost, 71 Ave Louis Casai, CH-1216 Geneva, Switzerland.	mark.perkins@finddiagnostics.org	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				Aderaye G, 2004, INFECTION, V32, P333, DOI 10.1007/s15010-004-3089-x; Brodie D, 2005, CLIN CHEST MED, V26, P247, DOI 10.1016/j.ccm.2005.02.012; Bruchfeld J, 2002, SCAND J INFECT DIS, V34, P331, DOI 10.1080/00365540110080025; Chintu C, 2005, INT J TUBERC LUNG D, V9, P477; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P847; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Talbot EA, 2004, CLIN INFECT DIS, V39, pE1, DOI 10.1086/421388; *WHO, 2004, GLOB TUB REP 2004	9	82	88	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2006	367	9514					942	943		10.1016/S0140-6736(06)68386-4	http://dx.doi.org/10.1016/S0140-6736(06)68386-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546544				2022-12-28	WOS:000236242100032
J	Amory, JK; Rosen, H; Sukut, C; Wallace, F; Saint, S				Amory, JK; Rosen, H; Sukut, C; Wallace, F; Saint, S			A jaundiced eye	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTIOUS-MONONUCLEOSIS; HUMAN CYTOMEGALOVIRUS; INDIVIDUALS		Univ Washington, Dept Internal Med, Div Gen Internal Med, Seattle, WA 98195 USA; Univ Washington, Sch Med, Seattle, WA USA; Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; Univ Michigan, Sch Med, Ann Arbor, MI USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan	Amory, JK (corresponding author), Univ Washington, Dept Internal Med, Div Gen Internal Med, Box 356429,1959 NE Pacific St, Seattle, WA 98195 USA.	jamory@u.washington.edu	Saint, Sanjay/AAF-5126-2019	Amory, John/0000-0002-7419-435X				COHEN JI, 1985, MEDICINE, V64, P100, DOI 10.1097/00005792-198503000-00003; EVANS AS, 1978, AM J MED SCI, V276, P325, DOI 10.1097/00000441-197811000-00010; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; HORWITZ CA, 1986, MEDICINE, V65, P124, DOI 10.1097/00005792-198603000-00005; Kano Y, 2000, J DERMATOL SCI, V22, P196, DOI 10.1016/S0923-1811(99)00085-7; PORATH A, 1987, ISRAEL J MED SCI, V23, P268; PULLEN H, 1967, LANCET, V2, P1176; Revello MG, 1998, J INFECT DIS, V177, P1170, DOI 10.1086/515277	8	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1516	1520		10.1056/NEJMcps053283	http://dx.doi.org/10.1056/NEJMcps053283			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16598049				2022-12-28	WOS:000236539000011
J	Kyle, RA; Therneau, TM; Rajkumar, SV; Larson, DR; Plevak, MF; Offord, JR; Dispenzieri, A; Katzmann, JA; Melton, LJ				Kyle, RA; Therneau, TM; Rajkumar, SV; Larson, DR; Plevak, MF; Offord, JR; Dispenzieri, A; Katzmann, JA; Melton, LJ			Prevalence of monoclonal gammopathy of undetermined significance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-MYELOMA; LONG-TERM; ADULT-POPULATION; M-COMPONENTS; PROTEINS; SERUM; FREQUENCY; COMMUNITY; HISTORY	BACKGROUND: The prevalence of monoclonal gammopathy of undetermined significance (MGUS), a premalignant plasma-cell disorder, among persons 50 years of age or older has not been accurately determined. We used sensitive laboratory techniques to ascertain the prevalence of MGUS in a large population in a well-defined geographic area. METHODS: We identified all living residents of Olmsted County, Minnesota, as of January 1, 1995. We obtained serum that remained after the performance of routine clinical tests at Mayo Clinic or asked subjects for whom such serum was unavailable to provide a sample. Agarose-gel electrophoresis was performed on all serum samples, and any serum sample with a discrete band of monoclonal protein or thought to have a localized band was subjected to immunofixation. RESULTS: Serum samples were obtained from 21,463 of the 28,038 enumerated residents 50 years of age or older (76.6 percent). MGUS was identified in 694 (3.2 percent) of these persons. Age-adjusted rates were higher in men than in women (4.0 percent vs. 2.7 percent, P<0.001). The prevalence of MGUS was 5.3 percent among persons 70 years of age or older and 7.5 percent among those 85 years of age or older. The concentration of monoclonal immunoglobulin was less than 1.0 g per deciliter in 63.5 percent and at least 2.0 g per deciliter in only 4.5 percent of 694 persons. The concentration of uninvolved immunoglobulins was reduced in 27.7 percent of 447 persons tested, and 21.5 percent of 79 tested had a monoclonal urinary light chain. CONCLUSIONS: Among residents of Olmsted County, Minnesota, MGUS was found in 3.2 percent of persons 50 years of age or older and 5.3 percent of persons 70 years of age or older.	Mayo Clin, Div Hematol, Rochester, MN 55905 USA; Mayo Clin, Div Biostat, Rochester, MN 55905 USA; Mayo Clin, Div Clin Biochem & Immunol, Rochester, MN 55905 USA; Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Kyle, RA (corresponding author), Mayo Clin, Div Hematol, 200 1st St SW, Rochester, MN 55905 USA.	kyle.robert@mayo.edu	Rajkumar, S. Vincent/AAV-1834-2021	Rajkumar, S. Vincent/0000-0002-5862-1833; Dispenzieri, Angela/0000-0001-8780-9512	NCI NIH HHS [CA 62242, CA 107476] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107476, P01CA062242] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGUZZI F, 1992, EUR J HAEMATOL, V48, P192; AXELSSON U, 1966, ACTA MED SCAND, V179, P235; CARRELL RW, 1971, AUST NZ J MED, V1, P398, DOI 10.1111/j.1445-5994.1971.tb02551.x; Cohen HJ, 1998, AM J MED, V105, P362; Cohen HJ, 1998, AM J MED, V104, P439, DOI 10.1016/S0002-9343(98)00080-1; HALLEN J, 1963, ACTA MED SCAND, V173, P737; HASTIE TJ, 1990, EN ADDITIVE MODELS; KYLE RA, 1972, BLOOD-J HEMATOL, V40, P719, DOI 10.1182/blood.V40.5.719.719; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2004, MAYO CLIN PROC, V79, P859, DOI 10.4065/79.7.859; KYLE RA, 2002, MANUAL CLIN LAB IMMU, P71; LUST JA, 2005, CANC DRUG DISC DEV, P519; MALACRIDA V, 1987, J CLIN PATHOL, V40, P793, DOI 10.1136/jcp.40.7.793; Melton LJ, 1998, OSTEOPOROSIS INT, V8, P68; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; SALEUN JP, 1982, J CLIN PATHOL, V35, P63, DOI 10.1136/jcp.35.1.63; VLADUTIU AO, 1987, ANN CLIN LAB SCI, V17, P157	22	850	874	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1362	1369		10.1056/NEJMoa054494	http://dx.doi.org/10.1056/NEJMoa054494			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571879	Bronze			2022-12-28	WOS:000236338000005
J	Ashcroft, FM				Ashcroft, FM			From molecule to malady	NATURE			English	Review							NICOTINIC ACETYLCHOLINE-RECEPTOR; EPITHELIAL SODIUM-CHANNEL; GATED ION CHANNELS; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE; K+ CHANNEL; MUTATIONS; DETERMINANTS; SELECTIVITY; DISORDERS	Ion channels are membrane proteins, found in virtually all cells, that are of crucial physiological importance. In the past decade, an explosion in the number of crystal structures of ion channels has led to a marked increase in our understanding of how ion channels open and close, and select between permeant ions. There has been a parallel advance in research on channelopathies (diseases resulting from impaired channel function), and mutations in over 60 ion-channel genes are now known to cause human disease. Characterization of their functional consequences has afforded unprecedented and unexpected insights into ion-channel mechanisms and physiological roles.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Oxford	Ashcroft, FM (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.	frances.ashcroft@physiol.ox.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ambrosius WT, 1999, HYPERTENSION, V34, P631, DOI 10.1161/01.HYP.34.4.631; Amiri S, 2005, MOL MEMBR BIOL, V22, P151, DOI 10.1080/09687860500063340; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Ashcroft F, 2004, HUM MOL GENET, V13, pR21, DOI 10.1093/hmg/ddh066; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Ashcroft FM, 2000, ION CHANNELS DIS; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cai SQ, 2005, NAT NEUROSCI, V8, P1503, DOI 10.1038/nn1557; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jentsch TJ, 2005, J CLIN INVEST, V115, P2039, DOI 10.1172/JCI25470; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnston GAR, 2005, CURR PHARM DESIGN, V11, P1867, DOI 10.2174/1381612054021024; Jurkat-Rott K, 2005, J CLIN INVEST, V115, P2000, DOI 10.1172/JCI25525; KUKULJAN M, 1995, AM J PHYSIOL-CELL PH, V268, pC535, DOI 10.1152/ajpcell.1995.268.3.C535; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lang B, 2003, AUTOIMMUN REV, V2, P94, DOI 10.1016/S1568-9972(02)00146-5; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Markworth E, 2000, DIABETES, V49, P1413, DOI 10.2337/diabetes.49.9.1413; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Newsom-Davis J, 2003, ANN NY ACAD SCI, V998, P202, DOI 10.1196/annals.1254.022; Pardo LA, 2005, J MEMBRANE BIOL, V205, P115, DOI 10.1007/s00232-005-0776-1; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Priori SG, 2005, J CLIN INVEST, V115, P2033, DOI 10.1172/JCI25664; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Proks P, 2004, P NATL ACAD SCI USA, V101, P17539, DOI 10.1073/pnas.0404756101; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Tasneem A, 2005, GENOME BIOL, V6; Ulbricht W, 2005, PHYSIOL REV, V85, P1271, DOI 10.1152/physrev.00024.2004; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; UNWIN PNT, 1984, NATURE, V307, P609, DOI 10.1038/307609a0; Webster SM, 2004, NATURE, V428, P864, DOI 10.1038/nature02468; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; YANG J, 1993, NATURE, V366, P158, DOI 10.1038/366158a0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	51	304	313	5	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					440	447		10.1038/nature04707	http://dx.doi.org/10.1038/nature04707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554803				2022-12-28	WOS:000236176100040
J	Cohen, JC; Boerwinkle, E; Mosley, TH; Hobbs, HH				Cohen, JC; Boerwinkle, E; Mosley, TH; Hobbs, HH			Sequence variations in PCSK9, low LDL, and protection against coronary heart disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SERUM-CHOLESTEROL; LIPOPROTEIN CHOLESTEROL; ATHEROSCLEROSIS RISK; PLASMA-CHOLESTEROL; RECEPTOR; STATINS; COMMUNITIES; MOUSE	BACKGROUND A low plasma level of low-density lipoprotein (LDL) cholesterol is associated with reduced risk of coronary heart disease (CHD), but the effect of lifelong reductions in plasma LDL cholesterol is not known. We examined the effect of DNA-sequence variations that reduce plasma levels of LDL cholesterol on the incidence of coronary events in a large population. METHODS We compared the incidence of CHD (myocardial infarction, fatal CHD, or coronary revascularization) over a 15-year interval in the Atherosclerosis Risk in Communities study according to the presence or absence of sequence variants in the proprotein convertase subtilisin/kexin type 9 serine protease gene (PCSK9) that are associated with reduced plasma levels of LDL cholesterol. RESULTS Of the 3363 black subjects examined, 2.6 percent had nonsense mutations in PCSK9; these mutations were associated with a 28 percent reduction in mean LDL cholesterol and an 88 percent reduction in the risk of CHD (P=0.008 for the reduction; hazard ratio, 0.11; 95 percent confidence interval, 0.02 to 0.81; P=0.03). Of the 9524 white subjects examined, 3.2 percent had a sequence variation in PCSK9 that was associated with a 15 percent reduction in LDL cholesterol and a 47 percent reduction in the risk of CHD (hazard ratio, 0.50; 95 percent confidence interval, 0.32 to 0.79; P=0.003). CONCLUSIONS These data indicate that moderate lifelong reduction in the plasma level of LDL cholesterol is associated with a substantial reduction in the incidence of coronary events, even in populations with a high prevalence of non-lipid-related cardiovascular risk factors.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Mississippi; University of Mississippi Medical Center	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	helen.hobbs@utsouthwestern.edu	Girelli, Domenico/B-1183-2008	Girelli, Domenico/0000-0001-9684-1899	NHLBI NIH HHS [N01-HC-55018, N01-HC-55021, N01-HC-55022, HL 20948, N01-HC-55015, N01-HC-55020, N01-HC-55019, N01-HC-55016] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055016, N01HC055018, N01HC055021, N01HC055015, N01HC055019, N01HC055020, N01HC055022] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1991, J Neuroimaging, V1, P68; *ARIC COORD CTR, 1987, ARIC MAN OP 2 COH CO; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lalanne F, 2005, J LIPID RES, V46, P1312, DOI 10.1194/jlr.M400396-JLR200; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McGill HC, 1998, AM J CARDIOL, V82, p30T; McGill HC, 2003, JAMA-J AM MED ASSOC, V290, P2320, DOI 10.1001/jama.290.17.2320; Napoli C, 1999, LANCET, V354, P1234, DOI 10.1016/S0140-6736(99)02131-5; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; WELTY FK, 1995, CIRCULATION, V92, P2036, DOI 10.1161/01.CIR.92.8.2036; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	25	2166	2286	4	174	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1264	1272		10.1056/NEJMoa054013	http://dx.doi.org/10.1056/NEJMoa054013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554528				2022-12-28	WOS:000236164200005
J	Jimenez, R; Haiman, Z				Jimenez, R; Haiman, Z			Significant primordial star formation at redshifts z similar to 3-4	NATURE			English	Article							POPULATION-III STARS; LY-ALPHA; 1ST STARS; ULTRAVIOLET-SPECTRA; IONIZING FLUXES; GALAXIES; MODELS; METALLICITY; ENRICHMENT; EVOLUTION	Four recent observational results have challenged our understanding of high-redshift galaxies, as they require the presence of far more ultraviolet photons than should be emitted by normal stellar populations. First, there is significant ultraviolet emission(1) from Lyman break galaxies (LBGs) at wavelengths shorter than 912 angstrom. Second, there is strong Lyman alpha emission(2) from extended 'blobs' with little or no associated apparent ionizing continuum. Third, there is a population of galaxies with unusually strong Lyman alpha emission lines(3). And fourth, there is a strong He II (1,640 angstrom) emission line(4) in a composite of LBGs. The proposed explanations for the first three observations are internally inconsistent, and the fourth puzzle has remained hitherto unexplained. Here we show that all four problems are resolved simultaneously if 10-30 per cent of the stars in many galaxies at z approximate to 3-4 are mainly primordial-unenriched by elements heavier than helium ('metals'). Most models of hierarchical galaxy formation assume efficient intragalactic metal mixing, and therefore do not predict(5-9) metal-free star formation at redshifts significantly below z approximate to 5. Our results imply that micromixing of metals within galaxies is inefficient on an approximately gigayear timescale, a conclusion that can be verified with higher-resolution simulations, and future observations of the He II emission line.	Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; Columbia Univ, Dept Astron, New York, NY 10027 USA	University of Pennsylvania; Columbia University	Jimenez, R (corresponding author), Univ Penn, Dept Phys & Astron, 209 S 33rd St, Philadelphia, PA 19104 USA.	raulj@physics.upenn.edu; zoltan@astro.columbia.edu		Jimenez, Raul/0000-0002-3370-3103; Haiman, Zoltan/0000-0003-3633-5403				Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Bromm V, 2001, MON NOT R ASTRON SOC, V328, P969, DOI 10.1046/j.1365-8711.2001.04915.x; BROMM V, 2005, HIGH REDSHIFT GAMMA; Dawson S, 2004, ASTROPHYS J, V617, P707, DOI 10.1086/425572; Haehnelt MG, 2001, ASTROPHYS J, V549, pL151, DOI 10.1086/319170; Hui L, 2002, ASTROPHYS J, V564, P525, DOI 10.1086/324401; Jimenez R, 2004, MON NOT R ASTRON SOC, V349, P240, DOI 10.1111/j.1365-2966.2004.07492.x; Kudritzki RP, 2000, ASTROPHYS J, V536, P19, DOI 10.1086/308925; Kudritzki RP, 2002, ASTROPHYS J, V577, P389, DOI 10.1086/342178; Leitherer C, 1999, ASTROPHYS J SUPPL S, V123, P3, DOI 10.1086/313233; Madau P, 2001, ASTROPHYS J, V555, P92, DOI 10.1086/321474; Malhotra S, 2002, ASTROPHYS J, V565, pL71, DOI 10.1086/338980; Marigo P, 2003, ASTRON ASTROPHYS, V399, P617, DOI 10.1051/0004-6361:20021756; Matsuda Y, 2004, ASTRON J, V128, P569, DOI 10.1086/422020; MEYNET G, 2005, EARLY STAR GENERATIO; Nagao T, 2005, ASTROPHYS J, V631, pL5, DOI 10.1086/497135; Najarro F, 1996, ASTRON ASTROPHYS, V306, P892; Norman ML, 2004, ASTROPHYS J, V601, pL115, DOI 10.1086/382045; Scannapieco E, 2003, ASTROPHYS J, V589, P35, DOI 10.1086/374412; Schaerer D, 1997, ASTRON ASTROPHYS, V322, P598; Schaerer D, 2003, ASTRON ASTROPHYS, V397, P527, DOI 10.1051/0004-6361:20021525; Schneider R, 2002, ASTROPHYS J, V571, P30, DOI 10.1086/339917; Steidel CC, 2001, ASTROPHYS J, V546, P665, DOI 10.1086/318323; Tumlinson J, 2000, ASTROPHYS J, V528, pL65, DOI 10.1086/312432; Yoshida N, 2004, ASTROPHYS J, V605, P579, DOI 10.1086/382499	30	78	78	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					501	504		10.1038/nature04580	http://dx.doi.org/10.1038/nature04580			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554812	Green Submitted			2022-12-28	WOS:000236176100049
J	Wolff, EW; Fischer, H; Fundel, F; Ruth, U; Twarloh, B; Littot, GC; Mulvaney, R; Rothlisberger, R; de Angelis, M; Boutron, CF; Hansson, M; Jonsell, U; Hutterli, MA; Lambert, F; Kaufmann, P; Stauffer, B; Stocker, TF; Steffensen, JP; Bigler, M; Siggaard-Andersen, ML; Udisti, R; Becagli, S; Castellano, E; Severi, M; Wagenbach, D; Barbante, C; Gabrielli, P; Gaspari, V				Wolff, EW; Fischer, H; Fundel, F; Ruth, U; Twarloh, B; Littot, GC; Mulvaney, R; Rothlisberger, R; de Angelis, M; Boutron, CF; Hansson, M; Jonsell, U; Hutterli, MA; Lambert, F; Kaufmann, P; Stauffer, B; Stocker, TF; Steffensen, JP; Bigler, M; Siggaard-Andersen, ML; Udisti, R; Becagli, S; Castellano, E; Severi, M; Wagenbach, D; Barbante, C; Gabrielli, P; Gaspari, V			Southern Ocean sea-ice extent, productivity and iron flux over the past eight glacial cycles	NATURE			English	Article							DOME-C; EAST ANTARCTICA; SALT AEROSOL; DUST; EPICA; CORE; CLIMATE; MAXIMUM; VOSTOK; CO2	Sea ice and dust flux increased greatly in the Southern Ocean during the last glacial period. Palaeorecords provide contradictory evidence about marine productivity in this region, but beyond one glacial cycle, data were sparse. Here we present continuous chemical proxy data spanning the last eight glacial cycles (740,000 years) from the Dome C Antarctic ice core. These data constrain winter sea-ice extent in the Indian Ocean, Southern Ocean biogenic productivity and Patagonian climatic conditions. We found that maximum sea-ice extent is closely tied to Antarctic temperature on multi-millennial timescales, but less so on shorter timescales. Biological dimethylsulphide emissions south of the polar front seem to have changed little with climate, suggesting that sulphur compounds were not active in climate regulation. We observe large glacial-interglacial contrasts in iron deposition, which we infer reflects strongly changing Patagonian conditions. During glacial terminations, changes in Patagonia apparently preceded sea-ice reduction, indicating that multiple mechanisms may be responsible for different phases of CO2 increase during glacial terminations. We observe no changes in internal climatic feedbacks that could have caused the change in amplitude of Antarctic temperature variations observed 440,000 years ago.	British Antarctic Survey, Cambridge CB3 0ET, England; Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany; Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Stockholm Univ, Dept Phys Geog & Quaternary Geol, S-10691 Stockholm, Sweden; Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; Univ Copenhagen, Dept Geophys, DK-2100 Copenhagen O, Denmark; Univ Florence, Dept Chem, Analyt Chem Sect, I-50019 Florence, Italy; Heidelberg Univ, Inst Umweltphys, D-69120 Heidelberg, Germany; Univ Venice, Dept Environm Sci, I-30123 Venice, Italy; Univ Venice, CNR, Inst Dynam Environm Proc, I-30123 Venice, Italy	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Stockholm University; University of Bern; University of Copenhagen; University of Florence; Ruprecht Karls University Heidelberg; Universita Ca Foscari Venezia; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Dinamica dei Processi Ambientali (IDPA-CNR); Universita Ca Foscari Venezia	Wolff, EW (corresponding author), British Antarctic Survey, High Cross,Madingley Rd, Cambridge CB3 0ET, England.	ewwo@bas.ac.uk	Barbante, Carlo/B-3195-2011; Jonsell, Ulf/F-3116-2015; Fundel, Felix/C-5469-2009; Wolff, Eric/AAB-1097-2021; Udisti, Roberto/M-7966-2015; Mulvaney, Robert/K-3929-2012; Fischer, Hubertus/A-1211-2014; Stocker, Thomas/B-1273-2013; Severi, Mirko/J-2508-2012; Lambert, Fabrice/M-2003-2014	Jonsell, Ulf/0000-0001-6532-8590; Wolff, Eric/0000-0002-5914-8531; Udisti, Roberto/0000-0003-4440-8238; Mulvaney, Robert/0000-0002-5372-8148; Fischer, Hubertus/0000-0002-2787-4221; Steffensen, Jorgen Peder/0000-0002-5516-1093; Barbante, Carlo/0000-0003-4177-2288; Severi, Mirko/0000-0003-1511-6762; Becagli, Silvia/0000-0003-3633-4849; Lambert, Fabrice/0000-0002-2192-024X	NERC [bas010016] Funding Source: UKRI; Natural Environment Research Council [bas010016] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Basile I, 1997, EARTH PLANET SC LETT, V146, P573, DOI 10.1016/S0012-821X(96)00255-5; Bopp L, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000810; Bowen H. J. M, 1979, ENV CHEM ELEMENTS; Castellano E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005259; Castellano E, 2004, GLOBAL PLANET CHANGE, V42, P195, DOI 10.1016/j.gloplacha.2003.11.007; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Cosme E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD004881; Delmas RJ, 2003, TELLUS B, V55, P71, DOI 10.1034/j.1600-0889.2003.00032.x; Delmonte B, 2004, EARTH-SCI REV, V66, P63, DOI 10.1016/j.earscirev.2003.10.004; Delmonte B, 2002, CLIM DYNAM, V18, P647, DOI 10.1007/s00382-001-0193-9; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Guilderson TP, 2000, GEOCHEM GEOPHY GEOSY, V1; Hara K, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004713; Kaplan MR, 2005, QUATERNARY RES, V63, P301, DOI 10.1016/j.yqres.2004.12.003; Kirchner JW, 2003, CLIMATIC CHANGE, V58, P21, DOI 10.1023/A:1023494111532; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Krinner G, 2003, TELLUS B, V55, P54, DOI 10.1034/j.1600-0889.2003.00004.x; Legrand M, 1995, NATO ASI SER SER I, V30, P91; LEGRAND M, 1987, J PHYS-PARIS, V48, P77, DOI 10.1051/jphyscol:1987111; LEGRAND M, 1991, NATURE, V350, P144, DOI 10.1038/350144a0; Legrand M, 1998, J GEOPHYS RES-ATMOS, V103, P10991, DOI 10.1029/98JD00929; Legrand M. R., 1988, ANN GLACIOL, V10, P116; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Littot GC, 2002, ANN GLACIOL-SER, V35, P299, DOI 10.3189/172756402781817022; Lovelock J, 1997, PHILOS T ROY SOC B, V352, P143, DOI 10.1098/rstb.1997.0009; Lunt DJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015656; Lunt DJ, 2001, GEOPHYS RES LETT, V28, P295, DOI 10.1029/2000GL012170; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Planchon FAM, 2001, ANAL CHIM ACTA, V450, P193, DOI 10.1016/S0003-2670(01)01379-4; Rankin AM, 2004, ANN GLACIOL-SER, V39, P276, DOI 10.3189/172756404781814681; Rankin AM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002492; Reader MC, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002063; Rothlisberger R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020338; Rothlisberger R, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015186; Rothlisberger R, 2000, ENVIRON SCI TECHNOL, V34, P338, DOI 10.1021/es9907055; Rothlisberger R, 2000, J GEOPHYS RES-ATMOS, V105, P20565, DOI 10.1029/2000JD900264; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Traversi R, 2002, ANN GLACIOL-SER, V35, P291, DOI 10.3189/172756402781816564; Udisti R, 2004, ANN GLACIOL-SER, V39, P457, DOI 10.3189/172756404781814096; *US DEP COMM NAT O, 2001, ETOPO2 2 MIN GRIDD G; Wagenbach D, 1998, J GEOPHYS RES-ATMOS, V103, P10961, DOI 10.1029/97JD01804; Wagnon P, 1999, J GEOPHYS RES-ATMOS, V104, P3423, DOI 10.1029/98JD02855; Wainer I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021244; Watanabe O., 2003, MEM NATL I POLAR RES, V57, P1; Weller R, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004189; Wolff EW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018454	50	392	410	0	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					491	496		10.1038/nature04614	http://dx.doi.org/10.1038/nature04614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554810	Bronze, Green Published			2022-12-28	WOS:000236176100047
J	Spigelman, M; Gillespie, S				Spigelman, M; Gillespie, S			Tuberculosis drug development pipeline: progress and hope	LANCET			English	Editorial Material									UCL Royal Free Hosp, Royal Free & Univ Coll Med Sch, Ctr Med Microbiol, London NW3 2PF, England; Global Alliance TB Drug Dev, New York, NY USA	University of London; University College London	Gillespie, S (corresponding author), UCL Royal Free Hosp, Royal Free & Univ Coll Med Sch, Ctr Med Microbiol, London NW3 2PF, England.	s.gillespie@medsch.ucl.ac.uk						Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; GINSBERG A, IN PRESS TUBERCULOSI; MATUSMOTO M, 45 ANN INT C ANT AG; Moore-Gillon J, 2001, ANN NY ACAD SCI, V953, P233, DOI 10.1111/j.1749-6632.2001.tb11382.x; O'Brien RJ, 2005, CLIN CHEST MED, V26, P327, DOI 10.1016/j.ccm.2005.02.013; Schatz A, 1944, P SOC EXP BIOL MED, V55, P66, DOI 10.3181/00379727-55-14461; SINHA RK, 44 ANN INT C ANT AG; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; *WHO GLO TUB PROGR, 1997, WHOGTB97225	10	42	45	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					945	947		10.1016/S0140-6736(06)68388-8	http://dx.doi.org/10.1016/S0140-6736(06)68388-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546546				2022-12-28	WOS:000236242100034
J	Mortimer, NJ; Johnston, GA				Mortimer, NJ; Johnston, GA			Giant ganglion cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Hosp Leicester Natl Hlth Serv Trust, Leicester LE1 5WW, Leics, England	University Hospitals of Leicester NHS Trust	Mortimer, NJ (corresponding author), Univ Hosp Leicester Natl Hlth Serv Trust, Leicester LE1 5WW, Leics, England.		Johnston, Graham/Y-2348-2019	Johnston, Graham/0000-0001-7494-0765					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					E10	E10		10.1056/NEJMicm040924	http://dx.doi.org/10.1056/NEJMicm040924			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540607				2022-12-28	WOS:000235981700012
J	Reynolds, CF; Dew, MA; Pollock, BG; Mulsant, BH; Frank, E; Miller, MD; Houck, PR; Mazumdar, S; Butters, MA; Stack, JA; Schlernitzauer, MA; Whyte, EM; Gildengers, A; Karp, J; Lenze, E; Szanto, K; Bensasi, S; Kupfer, DJ				Reynolds, CF; Dew, MA; Pollock, BG; Mulsant, BH; Frank, E; Miller, MD; Houck, PR; Mazumdar, S; Butters, MA; Stack, JA; Schlernitzauer, MA; Whyte, EM; Gildengers, A; Karp, J; Lenze, E; Szanto, K; Bensasi, S; Kupfer, DJ			Maintenance treatment of major depression in old age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; LONG-TERM TREATMENT; DOUBLE-BLIND; PRIMARY-CARE; CONTINUATION TREATMENT; SERTRALINE; RELAPSE; OUTPATIENTS; RECURRENCE; PREVENTION	Background: Elderly patients with major depression, including those having a first episode, are at high risk for recurrence of depression, disability, and death. Methods: We tested the efficacy of maintenance paroxetine and monthly interpersonal psychotherapy in patients 70 years of age or older who had depression (55 percent of whom were having a first episode) in a 2-by-2, randomized, double-blind, placebo-controlled trial. Among patients with a response to treatment with paroxetine and psychotherapy, 116 were randomly assigned to one of four maintenance-treatment programs (either paroxetine or placebo combined with either monthly psychotherapy or clinical-management sessions) for two years or until the recurrence of major depression. Clinical-management sessions, conducted by the same nurses, social workers, and psychologists who provided psychotherapy, involved discussion of symptoms. Results: Major depression recurred within two years in 35 percent of the patients receiving paroxetine and psychotherapy, 37 percent of those receiving paroxetine and clinical-management sessions, 68 percent of those receiving placebo and psychotherapy, and 58 percent of those receiving placebo and clinical-management sessions (P=0.02). After adjustment for the effect of psychotherapy, the relative risk of recurrence among those receiving placebo was 2.4 times (95 percent confidence interval, 1.4 to 4.2) that among those receiving paroxetine. The number of patients needed to be treated with paroxetine to prevent one recurrence was 4 (95 percent confidence interval, 2.3 to 10.9). Patients with fewer and less severe coexisting medical conditions (such as hypertension or cardiac disease) received greater benefit from paroxetine (P=0.03 for the interaction between treatment with paroxetine and baseline severity of medical illness). Conclusions: Patients 70 years of age or older with major depression who had a response to initial treatment with paroxetine and psychotherapy were less likely to have recurrent depression if they received two years of maintenance therapy with paroxetine. Monthly maintenance psychotherapy did not prevent recurrent depression. (ClinicalTrials.gov number, NCT00178100.)	Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Adv Ctr Intervent & Serv Res Late Life Mood Disor, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, John A Hartford Ctr Excellence Geriatr Psychiat, Pittsburgh, PA USA; Pittsburgh Vet Affairs Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Geriatric Research Education & Clinical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Reynolds, CF (corresponding author), Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Adv Ctr Intervent & Serv Res Late Life Mood Disor, 3811 OHara St,Rm E-1135, Pittsburgh, PA 15213 USA.	reynoldscf@upmc.edu	Butters, Meryl/AAR-2863-2021; Lenze, Eric J/AAW-8652-2021; Szanto, Katalin/B-8389-2014	Lenze, Eric/0000-0002-0471-9368; Gildengers, Ariel/0000-0001-9216-988X	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH071944, K01MH001613, K01MH001684, P30MH030915, K24MH065416, R37MH043832, R01MH037869, P30MH052247] Funding Source: NIH RePORTER; NIMHD NIH HHS [P60 MD000207] Funding Source: Medline; NIMH NIH HHS [K01 MH01613, R01 MH37869, K24 MH65416, P30 MH071944, P30 MH52247, P30 MH30915, R37 MH43832, K01 MH01684] Funding Source: Medline	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alexopoulos G S, 2001, J Psychiatr Pract, V7, P361; Alexopoulos GS, 2000, ARCH GEN PSYCHIAT, V57, P285, DOI 10.1001/archpsyc.57.3.285; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arean PA, 2005, BIOL PSYCHIAT, V58, P277, DOI 10.1016/j.biopsych.2005.03.037; Bruce ML, 2004, JAMA-J AM MED ASSOC, V291, P1081, DOI 10.1001/jama.291.9.1081; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Charney DS, 2003, ARCH GEN PSYCHIAT, V60, P664, DOI 10.1001/archpsyc.60.7.664; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; Driscoll HC, 2005, INT J GERIATR PSYCH, V20, P661, DOI 10.1002/gps.1334; Entsuah AR, 1996, INT CLIN PSYCHOPHARM, V11, P137, DOI 10.1097/00004850-199611020-00008; Feiger AD, 1999, INT CLIN PSYCHOPHARM, V14, P19, DOI 10.1097/00004850-199901000-00002; First M.B., 2016, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRANK E, 1990, ARCH GEN PSYCHIAT, V47, P1093; Gelenberg AJ, 2003, BIOL PSYCHIAT, V54, P806, DOI 10.1016/S0006-3223(02)01971-6; Gilaberte I, 2001, J CLIN PSYCHOPHARM, V21, P417, DOI 10.1097/00004714-200108000-00009; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hochstrasser B, 2001, BRIT J PSYCHIAT, V178, P304, DOI 10.1192/bjp.178.4.304; Keller MB, 1998, JAMA-J AM MED ASSOC, V280, P1665, DOI 10.1001/jama.280.19.1665; Klerman GL, 1984, INTERPERSONAL PSYCHO; Klysner R, 2002, BRIT J PSYCHIAT, V181, P29, DOI 10.1192/bjp.181.1.29; Lepine JP, 2004, AM J PSYCHIAT, V161, P1320; Lepine JP, 2004, AM J PSYCHIAT, V161, P836, DOI 10.1176/appi.ajp.161.5.836; Mattis S, 1988, DEMENTIA RATING SCAL; MILLER MD, 1992, PSYCHIAT RES, V41, P237, DOI 10.1016/0165-1781(92)90005-N; Rapaport MH, 2004, J CLIN PSYCHIAT, V65, P44; Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39; Roose SP, 2004, AM J PSYCHIAT, V161, P2050, DOI 10.1176/appi.ajp.161.11.2050; Schneider LS, 2003, AM J PSYCHIAT, V160, P1277, DOI 10.1176/appi.ajp.160.7.1277; Terra JL, 1998, INT CLIN PSYCHOPHARM, V13, P55, DOI 10.1097/00004850-199803000-00001; *THER IN, EV BAS DRUG THER DO; Unutzer J, 1997, JAMA-J AM MED ASSOC, V277, P1618, DOI 10.1001/jama.277.20.1618; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; WAGNER EF, 1992, J PSYCHOTHERAPY PRAC, V22, P281; Weihs KL, 2002, BIOL PSYCHIAT, V51, P753, DOI 10.1016/S0006-3223(01)01317-8; Whyte EM, 2004, J CLIN PSYCHIAT, V65, P1634, DOI 10.4088/JCP.v65n1208; Wilson K., 2001, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD000561, 10.1002/14651858.CD000561]; Wilson KCM, 2003, BRIT J PSYCHIAT, V182, P492, DOI 10.1192/bjp.182.6.492; Zis A P, 1980, Psychopharmacol Bull, V16, P47	40	265	274	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1130	1138		10.1056/NEJMoa052619	http://dx.doi.org/10.1056/NEJMoa052619			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021KI	16540613				2022-12-28	WOS:000235981700006
J	van Riel, D; Munster, VJ; de Wit, E; Rimmelzwaan, GF; Fouchier, RAM; Osterhaus, ADME; Kuiken, T				van Riel, D; Munster, VJ; de Wit, E; Rimmelzwaan, GF; Fouchier, RAM; Osterhaus, ADME; Kuiken, T			H5N1 virus attachment to lower respiratory tract	SCIENCE			English	Article							HUMANS; VIRULENCE; MAMMALS		Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kuiken, T (corresponding author), Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl	de Wit, Emmie/A-1549-2019; Munster, Vincent/I-7607-2018; Fouchier, Ron A/A-1911-2014	de Wit, Emmie/0000-0002-9763-7758; Munster, Vincent/0000-0002-2288-3196; Fouchier, Ron A/0000-0001-8095-2869; van Riel, Debby/0000-0001-9753-3564; Kuiken, Thijs/0000-0001-5501-9049				Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Lee CW, 2005, J VIROL, V79, P3692, DOI 10.1128/JVI.79.6.3692-3702.2005; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313	7	495	526	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					399	399		10.1126/science.1125548	http://dx.doi.org/10.1126/science.1125548			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16556800				2022-12-28	WOS:000236941800039
J	Heath, I				Heath, I			Commentary: Patients are not commodities	BRITISH MEDICAL JOURNAL			English	Editorial Material									Caversham Grp Practice, London NW5 2UP, England		Heath, I (corresponding author), Caversham Grp Practice, London NW5 2UP, England.	iona.heath@dsl.pipex.com						Chapman J., 2002, SYSTEM FAILURE WHY G; Davies M, 2006, BMJ-BRIT MED J, V332, P844, DOI 10.1136/bmj.332.7545.844; Pollock AM, 2004, NHS PLC PRIVATISATIO; St John of God Health Care, 2019, OUR VIS	4	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 8	2006	332	7545					846	847		10.1136/bmj.332.7545.846	http://dx.doi.org/10.1136/bmj.332.7545.846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16601049	Green Published			2022-12-28	WOS:000236815900027
J	Daeschler, EB; Shubin, NH; Jenkins, FA				Daeschler, EB; Shubin, NH; Jenkins, FA			A Devonian tetrapod-like fish and the evolution of the tetrapod body plan	NATURE			English	Article							EARLIEST-KNOWN TETRAPOD; DERMAL SKULL ROOF; ACANTHOSTEGA-GUNNARI; BRAINCASE; INTERRELATIONSHIPS; SARCOPTERYGII; PANDERICHTHYS; ANATOMY; LATVIA; STAPES	The relationship of limbed vertebrates (tetrapods) to lobe-finned fish (sarcopterygians) is well established, but the origin of major tetrapod features has remained obscure for lack of fossils that document the sequence of evolutionary changes. Here we report the discovery of a well-preserved species of fossil sarcopterygian fish from the Late Devonian of Arctic Canada that represents an intermediate between fish with fins and tetrapods with limbs, and provides unique insights into how and in what order important tetrapod characters arose. Although the body scales, fin rays, lower jaw and palate are comparable to those in more primitive sarcopterygians, the new species also has a shortened skull roof, a modified ear region, a mobile neck, a functional wrist joint, and other features that presage tetrapod conditions. The morphological features and geological setting of this new animal are suggestive of life in shallow-water, marginal and subaerial habitats.	Acad Nat Sci Philadelphia, Philadelphia, PA 19103 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Drexel University; University of Chicago; Harvard University; Harvard University	Daeschler, EB (corresponding author), Acad Nat Sci Philadelphia, 1900 Benjamin Franklin Pkwy, Philadelphia, PA 19103 USA.	daeschler@acnatsci.org; nshubin@uchicago.edu						Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Ahlberg PE, 1996, NATURE, V381, P61, DOI 10.1038/381061a0; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; [Anonymous], 2004, ACTA U LATVIENSIS; [Anonymous], DEVONIAN FISHES PLAN; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; CAMP CL, 1961, GEOL SOC AM MEM, V84, P1; CHI B I, 1976, Bulletin of Canadian Petroleum Geology, V24, P640; Clack J.A., 1994, Meddelelser om Gronland Geoscience, V31, P1; Clack J.A., 2002, GAINING GROUND ORIGI, P1; CLACK JA, 1994, NATURE, V369, P392, DOI 10.1038/369392a0; Clack JA, 2003, T ROY SOC EDIN-EARTH, V93, P163; Clack JA, 2002, T ROY SOC EDIN-EARTH, V93, P17, DOI 10.1017/S0263593300000304; CLACK JA, 1989, NATURE, V342, P425, DOI 10.1038/342425a0; Husken T.-C., 1997, Acta Universitatis Carolinae Geologica, V40, P445, DOI 10.1016/B978-012670950-6/50018-7; COATES MI, 1991, NATURE, V352, P234, DOI 10.1038/352234a0; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; EMBRY A, 1976, Bulletin of Canadian Petroleum Geology, V24, P485; Embry A.F., 1991, INNUITIAN OROGEN ARC, P263, DOI DOI 10.4095/133959; Janvier P., 1996, EARLY VERTEBRATES, P1; Jarvik Erik, 1996, Fossils and Strata, V40, P1; JENKINS FA, 1970, J MAMMAL, V51, P288, DOI 10.2307/1378479; Johanson Z, 2003, PALAEONTOLOGY, V46, P271, DOI 10.1111/1475-4983.00298; ROMER AS, 1955, NATURE, V176, P126, DOI 10.1038/176126a0; Schultze Hans-Peter, 1996, P316; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P292; Upeniece Ieva, 2001, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V4, P101; VOROBIEVA EI, 1989, DOKL AKAD NAUK SSSR+, V306, P188; Vorobyeva E., 1991, P68; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x; Vorobyeva Emilia I., 1995, Geobios Memoire Special (Villeurbanne), V19, P285; Westoll TS, 1938, NATURE, V141, P127, DOI 10.1038/141127a0	39	260	276	2	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					757	763		10.1038/nature04639	http://dx.doi.org/10.1038/nature04639			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598249	Bronze			2022-12-28	WOS:000236548400033
J	Pennington, TH				Pennington, TH			Avian influenza - Preparing for the pandemic - A slippery disease: a microbiologist's view	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Aberdeen, Aberdeen AB25 2ZD, Scotland	University of Aberdeen	Pennington, TH (corresponding author), Univ Aberdeen, Med Sch Bldg, Aberdeen AB25 2ZD, Scotland.	t.h.pennington@abdn.ac.uk						CROSBY AW, 1976, EPIDEMIC PEACE, P145; Hare R., 1970, BIRTH PENICILLIN; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]	4	0	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 1	2006	332	7544					789	790		10.1136/bmj.332.7544.789	http://dx.doi.org/10.1136/bmj.332.7544.789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032JA	16575087	Green Published			2022-12-28	WOS:000236769500031
J	Summers, MF; Hrabowski, FA				Summers, MF; Hrabowski, FA			Diversity - Preparing minority scientists and engineers	SCIENCE			English	Editorial Material							PERFORMANCE; WHITE	An undergraduate program involving mentorship, summer and other workshops, and targeting high-achieving high school students improves participation of underrepresented minorities in science.	Univ Maryland Baltimore Cty, Howard Hughes Med Inst, Baltimore, MD 21250 USA; Univ Maryland Baltimore Cty, Dept Chem & Biochem, Off President, Baltimore, MD 21250 USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Summers, MF (corresponding author), Univ Maryland Baltimore Cty, Howard Hughes Med Inst, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	summers@hhmi.umbc.edu						ALLEN WR, 1992, HARVARD EDUC REV, V62, P26, DOI 10.17763/haer.62.1.wv5627665007v701; *AM COUNC ED, 2005, MIN HIGH ED 2003 200; *COLL BOARD, UNPUB 2005 COLL BOUN; Gandara P., 1999, PRIMING PUMP REV PRO; Garibaldi AM, 1997, J NEGRO EDUC, V66, P105, DOI 10.2307/2967221; GARRISON HH, 1987, MINORITIES THEIR UND; Hrabowski III F. A., 1995, SCH SCI MATH, V95, P18; MANNAN G, 1986, J NEGRO EDUC, V55, P155, DOI 10.2307/2294878; MATON K, 2000, J RES SCI TEACH, V37, P7; Maton KI, 2004, AM PSYCHOL, V59, P547, DOI 10.1037/0003-066X.59.6.547; National Academy of Sciences, 2005, RIS GATH STORM EN EM; NETTLES MT, 1988, BLACK UNDERGRADUATE; *NSF, 2003, WOM MIN PERS DIS SCI; *NSF, 2004, DOCT REC US U SUMM R; Schuman Howard, 1997, RACIAL ATTITUDES AM; SEMOUR E, 1997, TALKING LEAVING WHY; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; United States Census Bureau, 2004, US INT PROJ AG SEX R; *US BUR CENS, 2005, US CENS BUR NEWS TEX	19	103	104	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2006	311	5769					1870	1871		10.1126/science.1125257	http://dx.doi.org/10.1126/science.1125257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	027BD	16574853				2022-12-28	WOS:000236387800028
J	Tsai, MY; Wang, SS; Heidinger, JM; Shumaker, DK; Adam, SA; Goldman, RD; Zheng, YX				Tsai, MY; Wang, SS; Heidinger, JM; Shumaker, DK; Adam, SA; Goldman, RD; Zheng, YX			A mitotic lamin B matrix induced by RanGTP required for spindle assembly	SCIENCE			English	Article							NUCLEAR-ENVELOPE BREAKDOWN; SMALL GTPASE RAN; CELL-CYCLE; BUILDING-BLOCKS; XENOPUS OOCYTES; IMPORTIN-BETA; AURORA-A; PROTEIN; ORGANIZATION; COMPLEX	Mitotic spindle morphogenesis is a series of highly coordinated movements that lead to chromosome segregation and cytokinesis. We report that the intermediate filament protein lamin B, a component of the interphase nuclear lamina, functions in spindle assembly. Lamin B assembled into a matrix-like network in mitosis through a process that depended on the presence of the guanosine triphosphate-bound form of the small guanosine triphosphatase Ran. Depletion of lamin B resulted in defects in spindle assembly. Dominant negative mutant lamin B proteins that disrupt lamin B assembly in interphase nuclei also disrupted spindle assembly in mitosis. Furthermore, lamin B was essential for the formation of the mitotic matrix that tethers a number of spindle assembly factors. We propose that lamin B is a structural component of the long-sought-after spindle matrix that promotes microtubule assembly and organization in mitosis.	Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21218 USA; Howard Hughes Med Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Carnegie Institution for Science; Howard Hughes Medical Institute; Johns Hopkins University; Northwestern University; Feinberg School of Medicine	Zheng, YX (corresponding author), Carnegie Inst Washington, Dept Embryol, Baltimore, MD 21218 USA.	zheng@ciwemb.edu		Adam, Stephen/0000-0003-3444-7655	NATIONAL CANCER INSTITUTE [R01CA031760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056312] Funding Source: NIH RePORTER; NCI NIH HHS [CA31760-24] Funding Source: Medline; NIGMS NIH HHS [GM56312] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; FIRMBACHKRAFT I, 1995, J CELL BIOL, V129, P17, DOI 10.1083/jcb.129.1.17; Georgatos SD, 1997, J CELL SCI, V110, P2129; Gindullis F, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-9; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Jekely G, 2003, BIOESSAYS, V25, P1129, DOI 10.1002/bies.10353; Johansen KM, 2002, CELL CYCLE, V1, P312, DOI 10.4161/cc.1.5.144; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; KIRKPATRICK D, 1994, GENETICS, V137, P381; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025; Lourim D, 1996, J CELL SCI, V109, P1775; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839; Mans BJ, 2004, CELL CYCLE, V3, P1612; Masuda K, 1997, EXP CELL RES, V232, P173, DOI 10.1006/excr.1997.3531; MIRZAYAN C, 1992, J CELL BIOL, V116, P1319, DOI 10.1083/jcb.116.6.1319; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; OUSPENSKI II, 1995, J BIOL CHEM, V270, P1975, DOI 10.1074/jbc.270.5.1975; Ouspenski II, 1998, EXP CELL RES, V244, P171, DOI 10.1006/excr.1998.4174; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Scholey JM, 2001, J CELL BIOL, V154, P261, DOI 10.1083/jcb.200101097; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; STICK R, 1988, EMBO J, V7, P3189, DOI 10.1002/j.1460-2075.1988.tb03186.x; TSAI ML, UNPUB; Tsai MY, 2003, NAT CELL BIOL, V5, P242, DOI 10.1038/ncb936; Tsai MY, 2005, CURR BIOL, V15, P2156, DOI 10.1016/j.cub.2005.10.054; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wilde A, 1999, SCIENCE, V284, P1359, DOI 10.1126/science.284.5418.1359; Wilde A, 2001, NAT CELL BIOL, V3, P221, DOI 10.1038/35060000; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Zheng YX, 2004, ANNU REV CELL DEV BI, V20, P867, DOI 10.1146/annurev.cellbio.20.012103.094648	47	228	233	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1887	1893		10.1126/science.1122771	http://dx.doi.org/10.1126/science.1122771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16543417				2022-12-28	WOS:000236387800035
J	Abbott, A				Abbott, A			Too little, too late?	NATURE			English	News Item																			0	9	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2006	440	7084					603	603		10.1038/440603a	http://dx.doi.org/10.1038/440603a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572143				2022-12-28	WOS:000236350400017
J	McMahon, SB; Wood, JN				McMahon, SB; Wood, JN			Increasingly irritable and close to tears: TRPA1 in inflammatory pain	CELL			English	Editorial Material							CHANNELS	TRP cation channels transduce mechanical, thermal, and pain-related inflammatory signals. In this issue of Cell, Bautista et al. (2006) report that TRPA1 has a central role in the pain response to endogenous inflammatory mediators and to a diverse array of volatile irritants, including those found in tear gas and garlic. In contrast, mechano- and thermosensation are normal in TRPA1-deficient mice.	Kings Coll London, London Pain Consortium, London WC2R 2LS, England; UCL, London Pain Consortium, London WC1E 6BT, England	University of London; King's College London; University of London; University College London	McMahon, SB (corresponding author), Kings Coll London, London Pain Consortium, London WC2R 2LS, England.	stephen.mcmahon@kcl.ac.uk		McMahon, Stephen/0000-0003-4656-5536	Biotechnology and Biological Sciences Research Council [BB/C505775/1] Funding Source: Medline; Medical Research Council [G9717869] Funding Source: Medline; MRC [G9717869] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z	3	45	59	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1123	1125		10.1016/j.cell.2006.03.006	http://dx.doi.org/10.1016/j.cell.2006.03.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564004	Bronze			2022-12-28	WOS:000237241400011
J	Yu, J; Xiao, J; Ren, XJ; Lao, KQ; Xie, XS				Yu, J; Xiao, J; Ren, XJ; Lao, KQ; Xie, XS			Probing gene expression in live cells, one protein molecule at a time	SCIENCE			English	Article							GREEN FLUORESCENT PROTEIN; MESSENGER-RNA DEGRADATION; ESCHERICHIA-COLI; SINGLE-CELL; NOISE; DNA; TRANSCRIPTION; TRANSLATION; REPRESSOR; OPERATOR	We directly observed real-time production of single protein molecules in individual Escherichia coli cells. A fusion protein of a fast-maturing yellow fluorescent protein (YFP) and a membrane-targeting peptide was expressed under a repressed condition. The membrane-localized YFP can be detected with single-molecule sensitivity. We found that the protein molecules are produced in bursts, with each burst originating from a stochastically transcribed single messenger RNA molecule, and that protein copy numbers in the bursts follow a geometric distribution. The quantitative study of low-level gene expression demonstrates the potential of single-molecule experiments in elucidating the workings of fundamental biological processes in living cells.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Appl Biosyst Inc, Foster City, CA 94404 USA	Harvard University; Thermo Fisher Scientific; Applied Biosystems	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu		Xiao, Jie/0000-0003-1433-5437				Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; BECKWITH JR, 1967, SCIENCE, V156, P597, DOI 10.1126/science.156.3775.597; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484; Bongaerts RJM, 2002, METHOD ENZYMOL, V358, P43; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Deich J, 2004, P NATL ACAD SCI USA, V101, P15921, DOI 10.1073/pnas.0404200101; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILBERT W, 1967, P NATL ACAD SCI USA, V58, P2415, DOI 10.1073/pnas.58.6.2415; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; HSIEH WT, 1987, J BIOL CHEM, V262, P14583; Ishijima A, 2001, TRENDS BIOCHEM SCI, V26, P438, DOI 10.1016/S0968-0004(01)01860-6; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Mowbray SL, 1998, J STRUCT BIOL, V124, P257, DOI 10.1006/jsbi.1998.4043; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; PTASHNE M, 2002, GENES SIGNALS; RIGNEY DR, 1979, J THEOR BIOL, V79, P247, DOI 10.1016/0022-5193(79)90250-9; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S	34	682	702	4	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1600	1603		10.1126/science.1119623	http://dx.doi.org/10.1126/science.1119623			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543458				2022-12-28	WOS:000236029500043
J	Becker, D; Selbach, M; Rollenhagen, C; Ballmaier, M; Meyer, TF; Mann, M; Bumann, D				Becker, D; Selbach, M; Rollenhagen, C; Ballmaier, M; Meyer, TF; Mann, M; Bumann, D			Robust Salmonella metabolism limits possibilities for new antimicrobials	NATURE			English	Article							COMPLETE GENOME SEQUENCE; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; ENTERICA; IDENTIFICATION; INFECTION; NETWORKS; BACTERIA	New antibiotics are urgently needed to control infectious diseases. Metabolic enzymes could represent attractive targets for such antibiotics, but in vivo target validation is largely lacking. Here we have obtained in vivo information about over 700 Salmonella enterica enzymes from network analysis of mutant phenotypes, genome comparisons and Salmonella proteomes from infected mice. Over 400 of these enzymes are non- essential for Salmonella virulence, reflecting extensive metabolic redundancies and access to surprisingly diverse host nutrients. The essential enzymes identified were almost exclusively associated with a small subgroup of pathways, enabling us to perform a nearly exhaustive screen. Sixty- four enzymes identified as essential in Salmonella are conserved in other important human pathogens, but almost all belong to metabolic pathways that are inhibited by current antibiotics or that have previously been considered for antimicrobial development. Our comprehensive in vivo analysis thus suggests a shortage of new metabolic targets for broad- spectrum antibiotics, and draws attention to some previously known but unexploited targets.	Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany; Hannover Med Sch, Flow Cytometry Core Facil, D-30625 Hannover, Germany; Hannover Med Sch, Inst Immunol, Mucosal Infect Jr Res Grp, D-30625 Hannover, Germany	Max Planck Society; Max Planck Society; Hannover Medical School; Hannover Medical School	Bumann, D (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany.	bumann.dirk@mh-hannover.de	Ballmaier, Matthias/J-4175-2014; Selbach, Matthias/C-5988-2008; Meyer, Thomas F. F/J-2485-2013; Mann, Matthias/A-3454-2013	Ballmaier, Matthias/0000-0002-1352-5995; Meyer, Thomas F. F/0000-0002-6120-8679; Mann, Matthias/0000-0003-1292-4799				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Badarinarayana V, 2001, NAT BIOTECHNOL, V19, P1060, DOI 10.1038/nbt1101-1060; BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Black MT, 2005, ADV DRUG DELIVER REV, V57, P1528, DOI 10.1016/j.addr.2005.04.006; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; CURTISS R, 1989, IMMUNOL INVEST, V18, P583, DOI 10.3109/08820138909112265; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Freiberg C, 2001, J MOL MICROB BIOTECH, V3, P483; Gerdes SY, 2002, J BACTERIOL, V184, P4555, DOI 10.1128/JB.184.16.4555-4572.2002; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Heath RJ, 2001, PROG LIPID RES, V40, P467, DOI 10.1016/S0163-7827(01)00012-1; Henry T, 2005, MOL MICROBIOL, V56, P252, DOI 10.1111/j.1365-2958.2005.04540.x; Hughes D, 2003, NAT REV GENET, V4, P432, DOI 10.1038/nrg1084; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Knuth K, 2004, MOL MICROBIOL, V51, P1729, DOI 10.1046/j.1365-2958.2003.03944.x; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; O'Ryan Miguel, 2005, Semin Pediatr Infect Dis, V16, P125, DOI 10.1053/j.spid.2005.12.008; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Porwollik S, 2005, J BACTERIOL, V187, P6545, DOI 10.1128/JB.187.18.6545-6555.2005; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Thomson CJ, 2004, CURR OPIN MICROBIOL, V7, P445, DOI 10.1016/j.mib.2004.08.009; Wendland M, 2002, FEBS LETT, V521, P105, DOI 10.1016/S0014-5793(02)02834-X	33	278	286	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					303	307		10.1038/nature04616	http://dx.doi.org/10.1038/nature04616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541065				2022-12-28	WOS:000235997600045
J	Treadway, K				Treadway, K			Becoming a physician: Heart sounds	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Treadway, K (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1112	1113		10.1056/NEJMp058202	http://dx.doi.org/10.1056/NEJMp058202			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540610				2022-12-28	WOS:000235981700003
J	Meggitt, SJ; Gray, JC; Reynolds, NJ				Meggitt, SJ; Gray, JC; Reynolds, NJ			Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; DERMATITIS; THERAPY; CROSSOVER; TOXICITY; MERCAPTOPURINE; HETEROZYGOSITY; CYCLOSPORINE; POLYMORPHISM; DERMATOLOGY	Background Atopic eczema affects 1-2% of adults, and can cause considerable morbidity. We aimed to assess the safety and efficacy of azathioprine as systemic monotherapy for moderate-to-severe atopic eczema, and the therapeutic importance of the thiopurine methyltransferase (TPMT) polymorphism (a key determinant of azathioprine-induced myelotoxicity) by using TPMT enzyme activity to establish azathioprine dose. Methods We did a parallel-group, double-blind, placebo-controlled trial in an outpatient setting. Minimisation was used to assign 63 patients with active disease despite optimum topical therapy to treatment with azathioprine (n=42) or placebo (n=21) for 12 weeks. As maintenance treatment, patients with heterozygous range TPMT activity received azathiorprine 1.0 mg/kg daily, Compared with 2.5 mg/kg daily in patients with normal TPMT activity. For the first 4 weeks, all participants received lower azathioprine doses (0.5 and 1.0 mg/kg daily, respectively) to reduce gastrointestinal side-effects. The primary measure of clinical response was disease activity assessed by the SASSAD (six area six sign atopic dermatitis) score. Analysis was by intention-to-treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN58943280. Findings 54 (86%) participants completed the study; two (3%) withdrew from the placebo group and seven (11%) from the azathioprine group. At week 12, there was a 37% (12.0 unit) improvement in mean disease activity with azathioprine compared with a 20% (6.6 unit) improvement with placebo (17% [5.4 unit] difference, 95% CI 4.3-29%). This finding was accompanied by significant improvements in patient-reported itch, area of involvement, global assessment, and quality of life. Between participants there was a wide variation in response to the drug. Generally, azathioprine was well tolerated, although two individuals developed drug hypersensitivity. Participants with heterozygous range TPMT activity responded to azathioprine in similar proportions to other participants, but none developed bone-marrow toxicity. TPMT-based dosing seemed to reduce predicted toxicity, and drug efficacy was maintained. Interpretation Treatment with azathioprine as systemic monotherapy produces clinically relevant improvement in moderate-to-severe atopic eczema that remains active despite optimum therapy with topical corticosteriods. We believe the study of azathioprine as systemic monotherapy for atopic eczema has major advantages, which should allow clarification of the relation between azathioprine effectiveness and metabolite profiles in other inflammatory diseases.	Newcastle Univ, Sch Clin & Lab Sci Dermatol Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Newcastle Univ, Newcastle Clin Trials Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Meggitt, SJ (corresponding author), Royal Victoria Infirm, Dept Dermatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	S.J.Meggitt@ncl.ac.uk		Reynolds, Nick/0000-0002-6484-825X				Berth-Jones J, 2002, BRIT J DERMATOL, V147, P324, DOI 10.1046/j.1365-2133.2002.04989.x; BerthJones J, 1996, BRIT J DERMATOL, V135, P25, DOI 10.1111/j.1365-2133.1996.tb00706.x; Black AJ, 1998, ANN INTERN MED, V129, P716, DOI 10.7326/0003-4819-129-9-199811010-00007; Buckley DA, 1998, J EUR ACAD DERMATOL, V11, P137, DOI 10.1016/S0926-9959(98)00074-9; Charman C, 2003, J INVEST DERMATOL, V120, P932, DOI 10.1046/j.1523-1747.2003.12251.x; Cuffari C, 2001, GUT, V48, P642, DOI 10.1136/gut.48.5.642; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dubinsky MC, 2002, GASTROENTEROLOGY, V122, P904, DOI 10.1053/gast.2002.32420; Dummer W, 1997, BRIT J DERMATOL, V137, P185, DOI 10.1046/j.1365-2133.1997.18031887.x; Evans WE, 2001, J CLIN ONCOL, V19, P2293, DOI 10.1200/JCO.2001.19.8.2293; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Fraser AG, 2002, ALIMENT PHARM THER, V16, P1225, DOI 10.1046/j.1365-2036.2002.01297.x; Hoare C, 2000, Health Technol Assess, V4, P1; HUNTER JAA, 1994, Q J MED, V87, P323; KERSTENS PJSM, 1993, LANCET, V342, P1245, DOI 10.1016/0140-6736(93)92231-H; LENNARD L, 1989, CLIN PHARMACOL THER, V46, P149, DOI 10.1038/clpt.1989.119; Liu HN, 1997, ARCH DERMATOL RES, V289, P94, DOI 10.1007/s004030050161; Lorenzo GD, 2003, MEDIAT INFLAMM, V12, P123, DOI 10.1080/0962935031000097736; Lowry PW, 2001, GUT, V49, P665, DOI 10.1136/gut.49.5.665; Luger T, 2001, BRIT J DERMATOL, V144, P788, DOI 10.1046/j.1365-2133.2001.04134.x; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; McLeod HL, 2003, CANCER INVEST, V21, P630, DOI 10.1081/CNV-120022384; Meggitt SJ, 2001, CLIN EXP DERMATOL, V26, P369, DOI 10.1046/j.1365-2230.2001.00837.x; Murphy LA, 2002, BRIT J DERMATOL, V147, P308, DOI 10.1046/j.1365-2133.2002.04922.x; Parnham AP, 1996, LANCET, V348, P542, DOI 10.1016/S0140-6736(05)64696-X; Powles AV, 1998, BRIT J DERMATOL, V138, P443; Reitamo Sakari, 2002, Am J Clin Dermatol, V3, P381, DOI 10.2165/00128071-200203060-00002; Relling MV, 1999, JNCI-J NATL CANCER I, V91, P2001, DOI 10.1093/jnci/91.23.2001; Reynolds NJ, 2001, LANCET, V357, P2012, DOI 10.1016/S0140-6736(00)05114-X; Ruzicka T, 1997, NEW ENGL J MED, V337, P816, DOI 10.1056/NEJM199709183371203; SAUER H, 1988, ARZNEIMITTELFORSCH, V38-1, P820; SHUPACK J, 1991, DERMATOLOGICA, V183, P21, DOI 10.1159/000247626; SNOW JL, 1995, ARCH DERMATOL, V131, P193, DOI 10.1001/archderm.131.2.193; SOWDEN JM, 1991, LANCET, V338, P137, DOI 10.1016/0140-6736(91)90134-B; TAVES DR, 1974, CLIN PHARMACOL THER, V15, P443; Thestrup-Pedersen K, 2000, CLIN EXP DERMATOL, V25, P535, DOI 10.1046/j.1365-2230.2000.00696.x; WHITE CR, 1978, ARCH DERMATOL, V114, P1314, DOI 10.1001/archderm.114.9.1314; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; YOUNGER IR, 1991, J AM ACAD DERMATOL, V25, P281, DOI 10.1016/0190-9622(91)70196-9	40	195	199	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					839	846		10.1016/S0140-6736(06)68340-2	http://dx.doi.org/10.1016/S0140-6736(06)68340-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530578				2022-12-28	WOS:000236016500029
J	Palumbo, A; Bringhen, S; Coravito, T; Merla, E; Capporella, V; Callea, V; Cangialosi, C; Grasso, M; Rossini, F; Galli, M; Catalano, L; Zamagni, E; Petrucci, MT; De Stefano, V; Ceccarelli, M; Ambrosini, MT; Avonto, I; Falco, P; Ciccone, G; Liberati, AM; Musto, P; Boccadoro, M				Palumbo, A; Bringhen, S; Coravito, T; Merla, E; Capporella, V; Callea, V; Cangialosi, C; Grasso, M; Rossini, F; Galli, M; Catalano, L; Zamagni, E; Petrucci, MT; De Stefano, V; Ceccarelli, M; Ambrosini, MT; Avonto, I; Falco, P; Ciccone, G; Liberati, AM; Musto, P; Boccadoro, M		GIMEMA	Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled-trial	LANCET			English	Article							LOW-DOSE THALIDOMIDE; SALVAGE THERAPY; DEXAMETHASONE; COMBINATION; DOXORUBICIN; CYCLOPHOSPHAMIDE; TRANSPLANTATION; VINCRISTINE; EFFICACY; VAD	Background Since 1960, oral melphalan and prednisone (MP) has been regarded as the standard of care in elderly multiple myeloma patients. This multicentre randomised trial compared oral MP plus thalidomide (MPT) with MP alone in patients aged 60-85 years. Methods Patients with newly diagnosed multiple myeloma were randomly assigned to receive oral MP for six 4-week cycles plus thalidomide (n=129; 100 mg per day continuously until any sign of relapse or progressive disease) or MP alone (n=126). Analysis was intention-to-treat. This study is registered at ClinicalTrial.gov, number NCT00232934. Results Patients treated with thalidomide had higher response rates and longer event-free survival (primary endpoints) than patients who were not. Combined complete or partial response rates were 76.0% for MPT and 47.6% for MP alone (absolute difference 28.3%, 95% CI 16.5-39.1), and the near-complete or complete response rates were 27.9% and 7.2%, respectively. 2-year event-free survival rates were 54% for MPT and 27% for MP (hazard ratio [HR] for MPT 0.51, 95% CI 0.35-0.75, p=0.0006). 3-year survival rates were 80% for MPT and 64% for MP (HR for MPT 0.68, 95% CI 0.38-1.22, p=0.19). Rates of grade 3 or 4 adverse events were 48% in MPT patients and 25% in MP patients (p=0.0002). Introduction of enoxaparin prophylaxis reduced rate of thromboembolism from 20% to 3% (p=0.005). Conclusion Oral MPT is an effective first-line treatment for elderly patients with multiple myeloma. Anticoagulant prophylaxis reduces frequency of thrombosis. Longer follow-up is needed to assess effect on overall survival.	Univ Turin, Div Ematol, Azienda Osped S Giovanni Battista, I-10126 Turin, Italy; Univ Roma Tor Vergata, Osped S Eugenio, Div Ematol, Rome, Italy; IRCCS Casa Sollievo Sofferenza, UO Ematol & Trapianto Cellule Staminali, San Giovanni Rotondo, Italy; Ctr Riferimento Oncol Reg, UO Ematol, Rionero In Vulture, Italy; Osped San Camillo de Lellis, Rieti, Italy; Osped Riuniti Reggio Calabria, Div Ematol, Reggio Di Calabria, Italy; Azienda Osped Cervello, Div Ematol & Trapianto Midollo Osseo, Palermo, Italy; Azienda Osped S Croce & Carle, Div Ematol, Cuneo, Italy; HS Gerardo, Monza, Italy; Osped Riuniti Bergamo, Div Ematol, Bergamo, Italy; Univ Naples Federico II, Cattedra & Div Ematol, Naples, Italy; Univ Bologna, Ist Ematol & Oncol Med Seragnoli, I-40126 Bologna, Italy; Univ Roma La Sapienza, Dipartimento Biotecnol, Rome, Italy; Univ Cattolica Sacro Cuore, Ist Ematol, I-00168 Rome, Italy; Azienda Osped S Giovanni Battista, Unita Epidemiol Tumori, Turin, Italy; CPO Piemonte, Turin, Italy; Monteluce Policlin, Med Clin 1, Perugia, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Sant'Eugenio Hospital; University of Rome Tor Vergata; IRCCS Casa Sollievo Della Sofferenza; IRCCS CROB; Ospedali Riuniti di Bergamo; University of Naples Federico II; University of Bologna; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte	Palumbo, A (corresponding author), Univ Turin, Div Ematol, Azienda Osped S Giovanni Battista, I-10126 Turin, Italy.	appalumbo@yahoo.com	Liberati, Anna Marina/C-1925-2017; Ciccone, Giovannino/K-3136-2016; De Stefano, Valerio/J-3650-2018	Ciccone, Giovannino/0000-0001-7644-9574; De Stefano, Valerio/0000-0002-5178-5827; Boccadoro, Mario/0000-0001-8130-5209; Zamagni, Elena/0000-0003-1422-7305; Musto, Pellegrino/0000-0003-3277-6594				[Anonymous], 1998, J Clin Oncol, V16, P3832; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Blade Joan, 1998, British Journal of Haematology, V102, P1115, DOI 10.1046/j.1365-2141.1998.00930.x; BOCCADORO M, 1991, J CLIN ONCOL, V9, P444, DOI 10.1200/JCO.1991.9.3.444; Cavo M, 2005, BLOOD, V106, P35, DOI 10.1182/blood-2005-02-0522; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Dingli D, 2005, HAEMATOLOGICA, V90, P1650; Durie BGM, 2002, SEMIN ONCOL, V29, P34, DOI 10.1053/sonc.2002.34075; Durie Brian G M, 2003, Hematol J, V4, P379; FANCON T, 2004, BLOOD, V104, P206; Ferlay J., 2004, IARC CANCERBASE; Garcia-Sanz R, 2004, LEUKEMIA, V18, P856, DOI 10.1038/sj.leu.2403322; Geitz H, 1996, IMMUNOPHARMACOLOGY, V31, P213, DOI 10.1016/0162-3109(95)00050-X; Ghobrial Irene M, 2003, J Support Oncol, V1, P194; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kropff MH, 2003, BRIT J HAEMATOL, V122, P607, DOI 10.1046/j.1365-2141.2003.04473.x; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Moehler TM, 2001, BLOOD, V98, P3846, DOI 10.1182/blood.V98.13.3846; Offidani M, 2004, EUR J HAEMATOL, V72, P403, DOI 10.1111/j.1600-0609.2004.00238.x; Osman K, 2001, NEW ENGL J MED, V344, P1951, DOI 10.1056/NEJM200106213442516; Palumbo A, 2005, CANCER-AM CANCER SOC, V104, P1428, DOI 10.1002/cncr.21342; Palumbo A, 2004, BLOOD, V104, P3052, DOI 10.1182/blood-2004-02-0408; Palumbo A, 2004, HEMATOL J, V5, P318, DOI 10.1038/sj.thj.6200403; Prandoni P, 2005, LANCET ONCOL, V6, P401, DOI 10.1016/S1470-2045(05)70207-2; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Tosi P, 2002, HAEMATOLOGICA, V87, P408; Tosi P, 2005, EUR J HAEMATOL, V74, P212, DOI 10.1111/j.1600-0609.2004.00382.x; Turk BE, 1996, P NATL ACAD SCI USA, V93, P7552, DOI 10.1073/pnas.93.15.7552; Weber D, 2003, J CLIN ONCOL, V21, P16, DOI 10.1200/JCO.2003.03.139; Yakoub-Agha Ibrahim, 2002, Hematol J, V3, P185, DOI 10.1038/sj.thj.6200175; Zangari M, 2002, BLOOD, V100, P1168, DOI 10.1182/blood-2002-01-0335; Zangari M, 2004, BRIT J HAEMATOL, V126, P715, DOI 10.1111/j.1365-2141.2004.05078.x; Zeldis JB, 1999, CLIN THER, V21, P319, DOI 10.1016/S0149-2918(00)88289-2; Zervas K, 2004, ANN ONCOL, V15, P134, DOI 10.1093/annonc/mdh026	36	632	668	2	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					825	831		10.1016/S0140-6736(06)68338-4	http://dx.doi.org/10.1016/S0140-6736(06)68338-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530576				2022-12-28	WOS:000236016500027
J	Wilson, JJ; Kovall, RA				Wilson, JJ; Kovall, RA			Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA	CELL			English	Article							TRANSCRIPTIONAL ACTIVATION; SECONDARY STRUCTURE; ANKYRIN REPEATS; MOUSE NOTCH1; RBP-J; PROTEIN; DOMAIN; REPLACEMENT; RECEPTOR; GENES	Notch signaling mediates communication between cells and is essential for proper embryonic patterning and development. CSL is a DNA binding transcription factor that regulates transcription of Notch target genes by interacting with coregulators. Transcriptional activation requires the displacement of corepressors; from CSL by the intracellular portion of the receptor Notch (NotchIC) and the recruitment of the coactivator protein Mastermind to the complex. Here we report the 3.1 angstrom. structure of the ternary complex formed by CSL, NotchIC, and Mastermind bound to DNA. As expected, the RAM domain of Notch interacts with the beta trefoil domain of CSL; however, the C-terminal domain of CSL has an unanticipated central role in the interface formed with the Notch ankyrin repeats and Mastermind. Ternary complex formation induces a substantial conformational change within CSL, suggesting a molecular mechanism for the conversion of CSL from a repressor to an activator.	Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Kovall, RA (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	kovallra@ucmail.uc.edu	Kovall, Rhett/A-3106-2008					Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Axelson H, 2004, SEMIN CANCER BIOL, V14, P317, DOI 10.1016/j.semcancer.2004.04.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bonde J, 2004, CURR OPIN HEMATOL, V11, P392, DOI 10.1097/01.moh.0000145672.42503.70; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Doyle TG, 2000, P NATL ACAD SCI USA, V97, P7877, DOI 10.1073/pnas.97.14.7877; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Fuchs KP, 2001, EUR J BIOCHEM, V268, P4639, DOI 10.1046/j.1432-1327.2001.02387.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; HSIEH JJD, 1995, SCIENCE, V268, P560, DOI 10.1126/science.7725102; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Kato H, 1997, DEVELOPMENT, V124, P4133; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Kovall RA, 2004, EMBO J, V23, P3441, DOI 10.1038/sj.emboj.7600349; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2003, J BIOL CHEM, V278, P21232, DOI 10.1074/jbc.M301567200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Zweifel ME, 2003, PROTEIN SCI, V12, P2622, DOI 10.1110/ps.03279003; Zweifel ME, 2001, BIOCHEMISTRY-US, V40, P14344, DOI 10.1021/bi011435h	50	261	288	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					985	996		10.1016/j.cell.2006.01.035	http://dx.doi.org/10.1016/j.cell.2006.01.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530045	Bronze			2022-12-28	WOS:000237241200020
J	Bowles, J; Knight, D; Smith, C; Wilhelm, D; Richman, J; Mamiya, S; Yashiro, K; Chawengsaksophak, K; Wilson, MJ; Rossant, J; Hamada, H; Koopman, P				Bowles, J; Knight, D; Smith, C; Wilhelm, D; Richman, J; Mamiya, S; Yashiro, K; Chawengsaksophak, K; Wilson, MJ; Rossant, J; Hamada, H; Koopman, P			Retinoid signaling determines germ cell fate in mice	SCIENCE			English	Article							ACID; FETAL; EXPRESSION; MEIOSIS; TESTIS; INHIBITION; MIGRATION; PROTEIN; GONADS; NUMBER	Germ cells in the mouse embryo can develop as oocytes or spermatogonia, depending on molecular cues that have not been identified. We found that retinoic acid, produced by mesonephroi of both sexes, causes germ cells in the ovary to enter meiosis and inititate oogenesis. Meiosis is retarded in the fetal testis by the action of the retinoid-degrading enzyme CYP26B1, ultimately leading to spermatogenesis. In testes of Cyp26b1-knockout mouse embryos, germ cells enter meiosis precociously, as if in a normal ovary. Thus, precise regulation of retinoid levels during fetal gonad development provides the molecular control mechanism that specifies germ cell fate.	Univ Queensland, Div Genet & Dev Biol, Brisbane, Qld 4072, Australia; Univ Queensland, Australian Res Council Ctr Excellence Biotechnol, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ British Columbia, Fac Dent, Dept Oral Hlth Sci, Vancouver, BC V6T 1Z3, Canada; Osaka Univ, Inst Mol & Cellular Biol, Div Mol Biol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Suita, Osaka 5650871, Japan; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Queensland; University of Queensland; University of British Columbia; Osaka University; Japan Science & Technology Agency (JST); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Koopman, P (corresponding author), Univ Queensland, Div Genet & Dev Biol, Brisbane, Qld 4072, Australia.	p.koopman@imb.uq.edu.au	Bowles, Josephine/AAG-4903-2020; Knight, Deon/F-1237-2010; Chawengsaksophak, Kallayanee/G-4427-2014; Richman, Joy M./C-3111-2018; Hamada, Hiroshi/N-6374-2015; Bowles, Josephine/B-6583-2013; Richman, Joy/AAD-9445-2020; Holt, Janet E/B-2415-2013; Wilhelm, Dagmar/B-6915-2009; Koopman, Peter A/C-9416-2009	Bowles, Josephine/0000-0003-2867-7438; Chawengsaksophak, Kallayanee/0000-0001-9401-2122; Richman, Joy M./0000-0002-1409-8163; Hamada, Hiroshi/0000-0002-7196-5948; Bowles, Josephine/0000-0003-2867-7438; Richman, Joy/0000-0002-1409-8163; Wilhelm, Dagmar/0000-0002-7757-4075; Koopman, Peter A/0000-0001-6939-0914; Wilson, Megan/0000-0003-3425-5071				Agarwal C, 1996, J BIOL CHEM, V271, P12209, DOI 10.1074/jbc.271.21.12209; Boulogne B, 1999, BIOL REPROD, V61, P1548, DOI 10.1095/biolreprod61.6.1548; Bowles J, 2000, GENESIS, V27, P124, DOI 10.1002/1526-968X(200007)27:3<124::AID-GENE50>3.0.CO;2-E; BOWLES J, UNPUB; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; BYSKOV AG, 1976, DEV BIOL, V52, P193, DOI 10.1016/0012-1606(76)90239-6; BYSKOV AGS, 1974, NATURE, V252, P396, DOI 10.1038/252396a0; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; Di Carlo A, 2000, INT J DEV BIOL, V44, P241; Haselbeck RJ, 1999, DEV GENET, V25, P353, DOI 10.1002/(SICI)1520-6408(1999)25:4<353::AID-DVG9>3.0.CO;2-G; Karl J, 1995, PHILOS T ROY SOC B, V350, P235, DOI 10.1098/rstb.1995.0157; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kikonyogo A, 1999, EUR J BIOCHEM, V262, P704, DOI 10.1046/j.1432-1327.1999.00415.x; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Li H, 2004, BIOL REPROD, V70, P687, DOI 10.1095/biolreprod.103.023135; Livera G, 2000, MOL CELL ENDOCRINOL, V165, P225, DOI 10.1016/S0303-7207(00)00271-9; McCaffery P, 1999, MECH DEVELOP, V82, P119, DOI 10.1016/S0925-4773(99)00022-2; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; Morita Y, 1999, ENDOCRINOLOGY, V140, P2696, DOI 10.1210/en.140.6.2696; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; WHITTEN WK, 1979, J EMBRYOL EXP MORPH, V52, P63; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	29	700	742	3	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					596	600		10.1126/science.1125691	http://dx.doi.org/10.1126/science.1125691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16574820				2022-12-28	WOS:000237296700050
J	Belevich, I; Verkhovsky, MI; Wikstrom, M				Belevich, I; Verkhovsky, MI; Wikstrom, M			Proton-coupled electron transfer drives the proton pump of cytochrome c oxidase	NATURE			English	Article							CATALYTIC CYCLE; SUBUNIT-I; TRANSLOCATION; REDUCTION; OXYGEN; HEME; BACTERIORHODOPSIN; RESPIRATION; MECHANISM; DIOXYGEN	Electron transfer in cell respiration is coupled to proton translocation across mitochondrial and bacterial membranes, which is a primary event of biological energy transduction. The resulting electrochemical proton gradient is used to power energy-requiring reactions, such as ATP synthesis. Cytochrome c oxidase is a key component of the respiratory chain, which harnesses dioxygen as a sink for electrons and links O-2 reduction to proton pumping(1). Electrons from cytochrome c are transferred sequentially to the O-2 reduction site of cytochrome c oxidase via two other metal centres, Cu-A and haem a, and this is coupled to vectorial proton transfer across the membrane by a hitherto unknown mechanism. On the basis of the kinetics of proton uptake and release on the two aqueous sides of the membrane, it was recently suggested that proton pumping by cytochrome c oxidase is not mechanistically coupled to internal electron transfer(2). Here we have monitored translocation of electrical charge equivalents as well as electron transfer within cytochrome c oxidase in real time. The results show that electron transfer from haem a to the O-2 reduction site initiates the proton pump mechanism by being kinetically linked to an internal vectorial proton transfer. This reaction drives the proton pump and occurs before relaxation steps in which protons are taken up from the aqueous space on one side of the membrane and released on the other(2).	Univ Helsinki, Helsinki Bioenerget Grp, Inst Biotechnol, FIN-00014 Helsinki, Finland	University of Helsinki	Wikstrom, M (corresponding author), Univ Helsinki, Helsinki Bioenerget Grp, Inst Biotechnol, FIN-00014 Helsinki, Finland.	marten.wikstrom@helsinki.fi	Wikstrom, Marten KF/A-4403-2008	Wikstrom, Marten/0000-0002-7527-4415; Belevich, Ilya/0000-0003-2190-4909				Adelroth P, 1997, BIOCHEMISTRY-US, V36, P13824, DOI 10.1021/bi9629079; Babcock GT, 1999, P NATL ACAD SCI USA, V96, P12971, DOI 10.1073/pnas.96.23.12971; BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; Branden G, 2005, BIOCHEMISTRY-US, V44, P10466, DOI 10.1021/bi0502745; Buse G, 1999, PROTEIN SCI, V8, P985, DOI 10.1110/ps.8.5.985; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Flock D, 2002, PROTEINS, V47, P75, DOI 10.1002/prot.10066; Gennis RB, 2004, FRONT BIOSCI, V9, P581, DOI 10.2741/1237; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Jasaitis A, 1999, BIOCHEMISTRY-US, V38, P2697, DOI 10.1021/bi982275l; Lanyi JK, 2001, CURR OPIN STRUC BIOL, V11, P415, DOI 10.1016/S0959-440X(00)00226-8; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; MITCHELL R, 1994, BBA-BIOENERGETICS, V1186, P19, DOI 10.1016/0005-2728(94)90130-9; Morgan JE, 2001, BIOCHEMISTRY-US, V40, P6882, DOI 10.1021/bi010246w; Namslauer A, 2003, BIOCHEMISTRY-US, V42, P1488, DOI 10.1021/bi026524o; Popovic DM, 2004, FEBS LETT, V566, P126, DOI 10.1016/j.febslet.2004.04.016; Ruitenberg M, 2002, NATURE, V417, P99, DOI 10.1038/417099a; Siegbahn PEM, 2003, J PHYS CHEM B, V107, P10946, DOI 10.1021/jp035486v; THOMAS JW, 1993, BIOCHEMISTRY-US, V32, P10923, DOI 10.1021/bi00091a048; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Verkhovskaya ML, 1997, P NATL ACAD SCI USA, V94, P10128, DOI 10.1073/pnas.94.19.10128; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; Wikstrom M, 1998, CURR OPIN STRUC BIOL, V8, P480, DOI 10.1016/S0959-440X(98)80127-9; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; WIKSTROM MKF, 1977, NATURE, V266, P271, DOI 10.1038/266271a0; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	29	217	236	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					829	832		10.1038/nature04619	http://dx.doi.org/10.1038/nature04619			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598262				2022-12-28	WOS:000236548400048
J	Mortimer, P				Mortimer, P			Robert Cory and the vaccine syphilis controversy: a forgotten hero?	LANCET			English	Review									Hlth Protect Agcy, Specialist & Reference Microbiol Div, London NW9 5HT, England	Health Protection Agency	Mortimer, P (corresponding author), Hlth Protect Agcy, Specialist & Reference Microbiol Div, London NW9 5HT, England.	Philip.Mortimer@hpa.org.uk						BARRY FW, 1889, REPORT EPIDEMIC SMAL; BROWN GH, 1955, LIVES FELLOWS ROYAL, P320; Copeman SM, 1899, VACCINATION ITS NATU; CORY R, 1898, LECT THEORY PRACTICE; CORY R, 1879, TIMES           1128; CORY R, 1878, TIMES           0612; CORY R, 1876, LANCET, V1, P885; CREIGHTON C, 1887, NATURAL HIST COX POW, P121; CROOKSHANK EM, 1896, BACTERIOLOGY INFECT, P685; DUDGEON JA, 1963, BRIT MED J, P1367; Hart E, 1879, Br Med J, V2, P843; Hime T W, 1896, Br Med J, V1, P1279; Hutchinson J, 1886, Br Med J, V1, P55; KIRTLAND G, 1896, BMJ-BRIT MED J, V1, P1276; LANCEREAUX E, 1869, TREATISE SYPHILIS; MCVAIL JC, 1887, VACCINATION VINDICAT; *MED OFF LOC GOV B, 1981, REP MED OFF LOC GOV, P34; Murphy FA, 2005, EMERG INFECT DIS, V11, P1086; Quetel Claude, 1992, HIST SYPHILIS; Richardson R, 1999, LANCET, V354, P1832; SEATON E, 1878, ANN REPORT MED OFFIC, pR7; SEATON E, 1868, HDB VACCINATION, pCH14; Steinhardt L, 1913, J INFECT DIS, V13, P294; WILSON GS, 1967, HAZARDS IMMUNISATION; 2002, NOTHNAGELS ENCY PRAC, P251; 1882, LANCET, V2, P802	26	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1112	1115		10.1016/S0140-6736(06)68479-1	http://dx.doi.org/10.1016/S0140-6736(06)68479-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581411				2022-12-28	WOS:000236673200036
J	Hassett, JP				Hassett, JP			Chemistry - Dissolved natural organic matter as a microreactor	SCIENCE			English	Editorial Material							HUMIC SUBSTANCES; MIREX		SUNY Coll Environm Sci & Forestry, Dept Chem, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry	Hassett, JP (corresponding author), SUNY Coll Environm Sci & Forestry, Dept Chem, 1 Forestry Dr, Syracuse, NY 13210 USA.	jphasset@syr.edu						BLOUGH NV, 1988, ENVIRON SCI TECHNOL, V22, P77, DOI 10.1021/es00166a008; Burns SE, 1997, ENVIRON SCI TECHNOL, V31, P1365, DOI 10.1021/es960581l; Lambrych KL, 2006, ENVIRON SCI TECHNOL, V40, P858, DOI 10.1021/es0511927; Latch DE, 2006, SCIENCE, V311, P1743, DOI 10.1126/science.1121636; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q	5	86	99	8	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1723	1724		10.1126/science.1123389	http://dx.doi.org/10.1126/science.1123389			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556830				2022-12-28	WOS:000236204300028
J	Pastorino, L; Sun, A; Lu, PJ; Zhou, XZ; Balastik, M; Finn, G; Wulf, G; Lim, J; Li, SH; Li, XJ; Xia, WM; Nicholson, LK; Lu, KP				Pastorino, L; Sun, A; Lu, PJ; Zhou, XZ; Balastik, M; Finn, G; Wulf, G; Lim, J; Li, SH; Li, XJ; Xia, WM; Nicholson, LK; Lu, KP			The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production	NATURE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; IN-VIVO; TRANSGENIC MICE; PHOSPHORYLATION; ISOMERIZATION; PRESENILIN-1; BINDING; PLAQUES; CANCER	Neuropathological hallmarks of Alzheimer's disease are neurofibrillary tangles composed of tau and neuritic plaques comprising amyloid-beta peptides (A beta) derived from amyloid precursor protein (APP), but their exact relationship remains elusive(1-3). Phosphorylation of tau and APP on certain serine or threonine residues preceding proline affects tangle formation and A beta production in vitro(3-5). Phosphorylated Ser/Thr-Pro motifs in peptides can exist in cis or trans conformations, the conversion of which is catalysed by the Pin1 prolyl isomerase(6,7). Pin1 has been proposed to regulate protein function by accelerating conformational changes(7-10), but such activity has never been visualized and the biological and pathological significance of Pin1 substrate conformations is unknown(7). Notably, Pin1 is downregulated and/or inhibited by oxidation in Alzheimer's disease neurons, Pin1 knockout causes tauopathy and neurodegeneration(8,9,11,12), and Pin1 promoter polymorphisms appear to associate with reduced Pin1 levels and increased risk for late-onset Alzheimer's disease(13,14). However, the role of Pin1 in APP processing and A beta production is unknown. Here we show that Pin1 has profound effects on APP processing and A beta production. We find that Pin1 binds to the phosphorylated Thr 668-Pro motif in APP and accelerates its isomerization by over 1,000-fold, regulating the APP intracellular domain between two conformations, as visualized by NMR. Whereas Pin1 overexpression reduces A beta secretion from cell cultures, knockout of Pin1 increases its secretion. Pin1 knockout alone or in combination with overexpression of mutant APP in mice increases amyloidogenic APP processing and selectively elevates insoluble A beta 42 (a major toxic species) in brains in an age-dependent manner, with A beta 42 being prominently localized to multivesicular bodies of neurons, as shown in Alzheimer's disease before plaque pathology(15). Thus, Pin1-catalysed prolyl isomerization is a novel mechanism to regulate APP processing and A beta production, and its deregulation may link both tangle and plaque pathologies. These findings provide new insight into the pathogenesis and treatment of Alzheimer's disease.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Biol Program, Boston, MA 02215 USA; Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 804, Taiwan; Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kaohsiung Veterans General Hospital; Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University	Lu, KP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Canc Biol Program, Boston, MA 02215 USA.	klu@bidmc.harvard.edu	Balastik, Martin/C-4410-2014; xia, weiming/E-5465-2016; Wulf, Gerburg/AAS-6713-2021; Lim, Jormay/A-7257-2011	Balastik, Martin/0000-0001-5833-9996; xia, weiming/0000-0002-7463-3295; Lim, Jormay/0000-0001-7191-545X	NIA NIH HHS [R01 AG029385] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG029385] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Ernst R. R., 1987, PRINCIPLES NUCL MAGN; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 2003, BIOESSAYS, V25, P174, DOI 10.1002/bies.10223; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535; Ramelot TA, 2000, BIOCHEMISTRY-US, V39, P2714, DOI 10.1021/bi992580m; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; SEGAT L, 2005, IN PRESS NEUROB 1226; Stukenberg PT, 2001, MOL CELL, V7, P1071, DOI 10.1016/S1097-2765(01)00245-3; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; SULTANA R, IN PRESS NEUROB 0609; SUZUKI T, 1994, EMBO J, V13, P1114, DOI 10.1002/j.1460-2075.1994.tb06360.x; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Wijsman EM, 2004, AM J HUM GENET, V75, P398, DOI 10.1086/423393; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Wulf G, 2004, EMBO J, V23, P3397, DOI 10.1038/sj.emboj.7600323; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	30	390	404	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					528	534		10.1038/nature04543	http://dx.doi.org/10.1038/nature04543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554819				2022-12-28	WOS:000236176100056
J	Hemingway, H; McCallum, A; Shipley, M; Manderbacka, K; Martikainen, P; Keskimaki, I				Hemingway, H; McCallum, A; Shipley, M; Manderbacka, K; Martikainen, P; Keskimaki, I			Incidence and prognostic implications of stable angina pectoris among women and men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; GENDER-DIFFERENCES; ARTERY-DISEASE; SEX BIAS; PREVALENCE; MORTALITY; VALIDITY; RISK; ONSET	Context Stable angina pectoris in women has often been considered a "soft" diagnosis, with less-severe prognostic implications than in men, but large-scale population studies are lacking. Objective To determine sex differences in the incidence and prognosis of stable angina in a large ambulatory population. Design Prospective cohort study using linked national registers. Setting All municipal primary health care centers, hospital outpatient clinics, occupational health care services, and the private sector in Finland. Participants Among ambulatory patients aged 45 to 89 years who had no history of coronary disease, we defined new cases of "nitrate angina" based on nitrate prescription ( 56 441 women and 34 885 men) or "test-positive angina" based on abnormal invasive or noninvasive test results ( 11 391 women and 15 806 men). Potentially eligible patients were evaluated between January 1, 1996, and December 31, 1998. Follow-up ended in December 2001. Main Outcome Measures Coronary mortality at 4 years (n= 7906 deaths) and fatal and nonfatal myocardial infarction at 1 year ( n= 3129 events). Results The age-standardized annual incidence per 100 population of all cases of angina was 2.03 in men and 1.89 in women, with a sex ratio of 1.07 (95% confidence interval [CI], 1.06-1.09). At every age, nitrate angina in women and men was associated with a similar increase in risk of coronary mortality relative to the general population. Women with test-positive angina who were younger than 75 years had higher coronary-standardized mortality ratios than men; for example, among those aged 55 to 64 years, it was 4.69 ( 95% CI, 3.60-6.11) in women compared with 2.40 ( 95% CI, 2.11-2.73) in men ( P <. 001 for interaction). There was a strong, graded relationship between amount of nitrates used and event rates; women using higher doses of nitrates had prognoses comparable with those of men. Among patients with diabetes and test-positive angina, age-standardized coronary event rates were 9.9 per 100 person-years in women vs 9.3 in men (P=. 69), and the fully adjusted male-female sex ratio was 1.07 ( 95% CI, 0.81-1.41). Conclusions Women have a similarly high incidence of stable angina compared with men. Furthermore, stable angina in women is associated with increased coronary mortality relative to women in the general population and, among easily identifiable clinical subgroups, has similarly high absolute rates of prognostic outcomes compared with men.	UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Helsinki, Natl Res & Dev Ctr Welf & Hlth, Helsinki, Finland; Univ Helsinki, Dept Sociol, Populat Res Unit, Helsinki, Finland	University of London; University College London; UCL Medical School; University of Helsinki; University of Helsinki	Hemingway, H (corresponding author), UCL, Sch Med, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	h.hemingway@ucl.ac.uk	Hemingway, Harry/C-1219-2009	Hemingway, Harry/0000-0003-2279-0624; McCallum, Alison Katherine/0000-0002-8113-2130; Martikainen, Pekka/0000-0001-9374-1438				BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Bottomley A, 1997, J EPIDEMIOL COMMUN H, V51, P87, DOI 10.1136/jech.51.1.87; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Britton A, 2004, BMJ-BRIT MED J, V329, P318, DOI 10.1136/bmj.38156.690150.AE; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; CANNON PJ, 1988, LANCET, V1, P979; Carlisle DM, 1999, AM J MED, V106, P391, DOI 10.1016/S0002-9343(99)00051-0; CASPER ML, 2000, WOMEN HEART DIS ATLA; *COLL STUD COORD C, ATH RISK COMM STUD D; Daly CA, 2005, EUR HEART J, V26, P1011, DOI 10.1093/eurheartj/ehi109; *FINL NAT PUBL HLT, STAT DAT 1 B 04 COR; Ford ES, 2003, ETHNIC DIS, V13, P85; Hemingway H, 2004, CAN J CARDIOL, V20, P305; Hemingway H, 2003, BRIT MED J, V327, P895, DOI 10.1136/bmj.327.7420.895; Hemingway H, 2001, NEW ENGL J MED, V344, P645, DOI 10.1056/NEJM200103013440906; Hetemaa T, 2004, J CLIN EPIDEMIOL, V57, P301, DOI 10.1016/j.jclinepi.2003.07.010; Hsia J, 2004, AM J CARDIOL, V93, P673, DOI 10.1016/j.amjcard.2003.12.002; JAGLAL SB, 1995, CAN MED ASSOC J, V152, P873; Javitz HS, 2004, AM J MANAG CARE, V10, pS358; Johnson BD, 2004, CIRCULATION, V109, P2993, DOI 10.1161/01.CIR.0000130642.79868.B2; Karjalainen A, 2001, AM J RESP CRIT CARE, V164, P565, DOI 10.1164/ajrccm.164.4.2012146; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Linfante A, 2004, CIRCULATION, V110, P664; Mackay J, 2004, ATLAS HEART DIS STRO; Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60; MURABITO JM, 1993, CIRCULATION, V88, P2548, DOI 10.1161/01.CIR.88.6.2548; Nilsson S, 2003, BRIT J GEN PRACT, V53, P378; ORENCIA A, 1993, JAMA-J AM MED ASSOC, V269, P2392, DOI 10.1001/jama.269.18.2392; Owen-Smith V, 2003, BRIT J GEN PRACT, V53, P784; Pajunen P, 2005, EUR J CARDIOV PREV R, V12, P132, DOI 10.1097/00149831-200504000-00007; Philpott S, 2001, SOC SCI MED, V52, P1565, DOI 10.1016/S0277-9536(00)00269-0; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; REUNANEN A, 1983, ACTA MED SCAND, P1; RICHEDWARDS JW, 1995, AM J EPIDEMIOL, V142, P909, DOI 10.1093/oxfordjournals.aje.a117738; Roger VL, 1998, J AM COLL CARDIOL, V32, P345, DOI 10.1016/S0735-1097(98)00229-0; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; Sorlie PD, 1996, J CLIN EPIDEMIOL, V49, P719, DOI 10.1016/0895-4356(96)00022-4; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Sutcliffe SJ, 2003, BRIT MED J, V326, P20, DOI 10.1136/bmj.326.7379.20; TOBIN JN, 1987, ANN INTERN MED, V107, P19, DOI 10.7326/0003-4819-107-1-19; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0; TUNSTALLPEDOE H, 1985, EUR HEART J, V6, P1; Warren J., 1812, N ENGL J MED SURG, V1, P1; *WHO COLL CTR DRUG, 2005, GUID AN CHEM THER AT; World Health Organization, 2022, INT CLASS DIS, V11th; Zaher C, 2004, AM J MANAG CARE, V10, pS339	48	175	178	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1404	1411		10.1001/jama.295.12.1404	http://dx.doi.org/10.1001/jama.295.12.1404			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551712				2022-12-28	WOS:000236157700018
J	Lee, JB; Park, C				Lee, JB; Park, C		Seoul Natl Univ Invest Comm	Verification that Snuppy is a clone	NATURE			English	Letter									Seoul Natl Univ, Off Res Affairs, Seoul 151742, South Korea; Seoul Natl Univ, Coll Med, Dept Forens Med, Seoul 110799, South Korea; Korea Adv Inst Sci & Technol, Dept Life Sci, Taejon 305701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Lee, JB (corresponding author), Seoul Natl Univ, Off Res Affairs, Seoul 151742, South Korea.		Park, Chankyu/C-1936-2011					Kim KS, 2001, GENES GENET SYST, V76, P243, DOI 10.1266/ggs.76.243; Lee BC, 2005, NATURE, V436, P641, DOI 10.1038/436641a; Sutovsky P, 2004, TRENDS BIOTECHNOL, V22, P205, DOI 10.1016/j.tibtech.2004.03.009; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Westhusin ME, 2001, J REP FER S, P287; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313	7	18	18	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2006	440	7081					E2	E3		10.1038/nature04686	http://dx.doi.org/10.1038/nature04686			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	019MC	16528814	Bronze			2022-12-28	WOS:000235839500035
J	Yates, J; James, D				Yates, J; James, D			Predicting the "strugglers": case-control study of students at Nottingham University Medical School	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERSONAL STATEMENTS; 5-FACTOR MODEL; PERFORMANCE; COMMUNICATION; ATTITUDES; ETHNICITY; EDUCATION; LANGUAGE; ENGLISH; SUCCESS	Objective To identify potential predictors of, undergraduate Students who struggle during their medical training. Design Case-control study Cases were students who had experienced academic or personal difficulties that affected their progression oil the Course ("strugglers"). Controls were selected at random from the corresponding year Cohorts, using a ratio of four controls for each struggler. Setting University of Nottingham Medical School. Participants Students who entered the course over five consecutive years. Main outcome measures Likelihood ratios for independent risk factors for struggling Oil the course Results 10-15% of each year's student intake were identified as strugglers. significant independent predictors of students being in this category Were negative comments in the academic reference (likelihood ratio 2.25, 95% confidence intervals 1.44 to 3.50), lower mean examination grade at A level (2.19 1.37 to 3.51), and the late offer of a place (1.98, 1.19 to 3.30). Male sex was a less significant risk factor (1.70, 1.09 to 2.65) as was a lower grade at GCSE science (2.13, 1.12 to 4.05). In UK students whose ethnicity was known, not being white was a significant predictor of struggling (2.77, 1.52 to 5.05) but the presence of negative comments was not. Age at entry to the course and the possession of a previous degree were not predictive. Conclusions Our results support retention of existing selection practices relating to academic achievement and critical review of students' references. We plan to undertake further investigation of the reasons why some Students, including males, those with late offers and those from ethnic minority backgrounds, may do less well oil the Nottingham course.	Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Med Educ Unit, Nottingham NG7 2UH, England	University of Nottingham	James, D (corresponding author), Univ Nottingham, Queens Med Ctr, Fac Med & Hlth Sci, Med Educ Unit, Nottingham NG7 2UH, England.	David.James@nottingham.ac.uk						ANGEL C, 2000, BRIT MED J, V321, P136; ChurHansen A, 1996, MED EDUC, V30, P412, DOI 10.1111/j.1365-2923.1996.tb00860.x; *COUNC HEAD MED SC, 2004, GUID PRINC ADM MED S; *COUNC HEADS MED S, 2004, GUID PRINC ADM MED S; Ferguson E, 2003, BRIT MED J, V326, P429, DOI 10.1136/bmj.326.7386.429; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Ferguson E, 2000, J OCCUP ORGAN PSYCH, V73, P321, DOI 10.1348/096317900167056; *GEN MED COUNC, 2003, TOM DOCT; Haidet P, 2002, MED EDUC, V36, P568, DOI 10.1046/j.1365-2923.2002.01233.x; Hamilton J, 2003, MED EDUC, V37, P1068, DOI 10.1046/j.1365-2923.2003.01708.x; HARMILTON J, 2003, MED EDUC, V37, P1968; Hawthorne L, 2004, MED TEACH, V26, P150, DOI 10.1080/0142159032000150539; HAYES SC, 1993, MED EDUC, V27, P6, DOI 10.1111/j.1365-2923.1993.tb00222.x; Howe A, 2004, BRIT MED J, V329, P327, DOI 10.1136/bmj.329.7461.327; James D, 2001, MED EDUC, V35, P1056, DOI 10.1046/j.1365-2923.2001.01042.x; Kay-Lambkin F, 2002, MED EDUC, V36, P154, DOI 10.1046/j.1365-2923.2002.01071.x; Klimidis S, 1997, MED EDUC, V31, P58, DOI 10.1111/j.1365-2923.1997.tb00045.x; Liddell MJ, 2004, MED EDUC, V38, P187, DOI 10.1111/j.1365-2923.2004.01753.x; Lievens F, 2002, MED EDUC, V36, P1050, DOI 10.1046/j.1365-2923.2002.01328.x; McManus IC, 2003, BRIT MED J, V327, P139, DOI 10.1136/bmj.327.7407.139; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; POWIS DA, 1992, AUST NZ J MED, V22, P692, DOI 10.1111/j.1445-5994.1992.tb04872.x; Powis DA, 2003, MED EDUC, V37, P1064, DOI 10.1046/j.1365-2923.2003.01706.x; Searle J, 2003, MED EDUC, V37, P458, DOI 10.1046/j.1365-2923.2003.01496.x; Skelton JR, 2001, MED EDUC, V35, P257, DOI 10.1046/j.1365-2923.2001.00873.x; Swadi H, 1997, MED TEACH, V19, P270, DOI 10.3109/01421599709034204; Townsend PP., 1988, HLTH DEPRIVATION INE; Treloar C, 2000, MED EDUC, V34, P708, DOI 10.1046/j.1365-2923.2000.00625.x; Wass V, 2003, BRIT MED J, V326, P800, DOI 10.1136/bmj.326.7393.800	29	88	91	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1009	1012A		10.1136/bmj.38730.678310.63	http://dx.doi.org/10.1136/bmj.38730.678310.63			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16543299	Bronze, Green Published			2022-12-28	WOS:000237403100018
J	Sasaki, M; Takagi, M; Okamura, Y				Sasaki, M; Takagi, M; Okamura, Y			A voltage sensor-domain protein is a voltage-gated proton channel	SCIENCE			English	Article							ALVEOLAR EPITHELIAL-CELLS; HYDROGEN-ION CURRENTS; INTRACELLULAR PH; LYMNAEA-STAGNALIS; NEURONS; SNAIL; CONDUCTANCE; REVEALS; PORE	Voltage-gated proton channels have been widely observed but have not been identified at a molecular level. Here we report that a four-transmembrane protein similar to the voltage-sensor domain of voltage-gated ion channels is a voltage-gated proton channel. Cells overexpressing this protein showed depolarization-induced outward currents accompanied by tail currents. Current reversal occured at equilibrium potentials for protons. The currents exhibited pH-dependent gating and zinc ion sensitivity, two features which are characteristic of voltage-gated proton channels. Responses of voltage dependence to sequence changes suggest that mouse voltage-sensor domain-only protein is itself a channel, rather than a regulator of another channel protein.	Okazaki Inst Integrat Biosci, Sect Dev Neurophysiol, Aichi 4448787, Japan; Grad Univ Adv Studies, Aichi 4448787, Japan; Natl Inst Nat Sci, Natl Inst Physiol Sci, Aichi 4448787, Japan; Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058566, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institute of Advanced Industrial Science & Technology (AIST)	Okamura, Y (corresponding author), Okazaki Inst Integrat Biosci, Sect Dev Neurophysiol, Higashiyama 5-1, Aichi 4448787, Japan.	yokamura@nips.ac.jp						Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BYERLY L, 1989, J PHYSIOL-LONDON, V413, P75, DOI 10.1113/jphysiol.1989.sp017642; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; Cherny VV, 2003, J GEN PHYSIOL, V121, P615, DOI 10.1085/jgp.200308813; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 1996, J MEMBRANE BIOL, V152, P131, DOI 10.1007/s002329900092; Eder C, 2001, PROG NEUROBIOL, V64, P277, DOI 10.1016/S0301-0082(00)00062-9; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lopez R, 2003, NUCLEIC ACIDS RES, V31, P3795, DOI 10.1093/nar/gkg573; MEECH RW, 1987, J PHYSIOL-LONDON, V390, P433, DOI 10.1113/jphysiol.1987.sp016710; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; RAMSEY IS, 2000, NATURE; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047	22	417	424	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					589	592		10.1126/science.1122352	http://dx.doi.org/10.1126/science.1122352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16556803				2022-12-28	WOS:000237296700048
J	Bonaa, KH; Njolstad, I; Ueland, PM; Schirmer, H; Tverdal, A; Steigen, T; Wang, H; Nordrehaug, JE; Arnesen, E; Rasmussen, K				Bonaa, KH; Njolstad, I; Ueland, PM; Schirmer, H; Tverdal, A; Steigen, T; Wang, H; Nordrehaug, JE; Arnesen, E; Rasmussen, K		NORVIT Trial Investigators	Homocysteine lowering and cardiovascular events after acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOLIC-ACID; MICROBIOLOGICAL ASSAY; ENDOTHELIAL DYSFUNCTION; VITAMIN INTERVENTION; FOLATE; PLASMA; DISEASE; STROKE; SERUM; PREVENTION	BACKGROUND: Homocysteine is a risk factor for cardiovascular disease. We evaluated the efficacy of homocysteine-lowering treatment with B vitamins for secondary prevention in patients who had had an acute myocardial infarction. METHODS: The trial included 3749 men and women who had had an acute myocardial infarction within seven days before randomization. Patients were randomly assigned, in a two-by-two factorial design, to receive one of the following four daily treatments: 0.8 mg of folic acid, 0.4 mg of vitamin B(sub 12), and 40 mg of vitamin B(sub 6); 0.8 mg of folic acid and 0.4 mg of vitamin B(sub 12); 40 mg of vitamin B(sub 6); or placebo. The primary end point during a median follow-up of 40 months was a composite of recurrent myocardial infarction, stroke, and sudden death attributed to coronary artery disease. RESULTS: The mean total homocysteine level was lowered by 27 percent among patients given folic acid plus vitamin B(sub 12), but such treatment had no significant effect on the primary end point (risk ratio, 1.08; 95 percent confidence interval, 0.93 to 1.25; P=0.31). Also, treatment with vitamin B(sub 6) was not associated with any significant benefit with regard to the primary end point (relative risk of the primary end point, 1.14; 95 percent confidence interval, 0.98 to 1.32; P=0.09). In the group given folic acid, vitamin B(sub 12), and vitamin B(sub 6), there was a trend toward an increased risk (relative risk, 1.22; 95 percent confidence interval, 1.00 to 1.50; P=0.05). CONCLUSIONS: Treatment with B vitamins did not lower the risk of recurrent cardiovascular disease after acute myocardial infarction. A harmful effect from combined B vitamin treatment was suggested. Such treatment should therefore not be recommended.	Univ Tromso, Inst Community Med, N-9037 Tromso, Norway; Univ Bergen, Inst Med, Pharmacol Sect, Bergen, Norway; Norwegian Inst Publ Hlth, Oslo, Norway; Univ Hosp No Norway, Dept Heart Dis, Tromso, Norway; Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway	UiT The Arctic University of Tromso; University of Bergen; Norwegian Institute of Public Health (NIPH); UiT The Arctic University of Tromso; University Hospital of North Norway; University of Bergen; Haukeland University Hospital	Bonaa, KH (corresponding author), Univ Tromso, Inst Community Med, N-9037 Tromso, Norway.	kaare.bonaa@stolav.no	Ueland, Per M/C-7340-2013; Njolstad, Inger/X-3784-2019	Schirmer, Henrik/0000-0002-9348-3149				*AM HEART ASS, 2004, STROK DEATHS RED FOL; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704; BAKER F, 2002, CIRCULATION S2, V106, P2; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; Chia S, 2005, CLIN SCI, V108, P65, DOI 10.1042/CS20040150; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Doshi SN, 2002, ATHEROSCLEROSIS, V165, P1, DOI 10.1016/S0021-9150(02)00191-0; DRISKELL JA, 1994, NUTR RES, V14, P293, DOI 10.1016/S0271-5317(05)80388-4; Durga J, 2005, ARCH INTERN MED, V165, P1388, DOI 10.1001/archinte.165.12.1388; Dusitanond P, 2005, STROKE, V36, P144, DOI 10.1161/01.STR.0000150494.91762.70; Faraci FM, 2004, STROKE, V35, P345, DOI 10.1161/01.STR.0000115161.10646.67; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Lange H, 2004, NEW ENGL J MED, V350, P2673, DOI 10.1056/NEJMoa032845; Lichtenstein AH, 2005, JAMA-J AM MED ASSOC, V294, P351, DOI 10.1001/jama.294.3.351; Liem A, 2003, J AM COLL CARDIOL, V41, P2105, DOI 10.1016/S0735-1097(03)00485-6; Liem AH, 2004, INT J CARDIOL, V93, P175, DOI 10.1016/j.ijcard.2003.02.001; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Matsubara K, 2004, INT J MOL MED, V14, P819; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Nygard O, 1997, NEW ENGL J MED, V337, P230, DOI 10.1056/NEJM199707243370403; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Orlandini A, 2006, EUR HEART J, V27, P527, DOI 10.1093/eurheartj/ehi701; Robinson, 1999, CIRCULATION, V99, P983; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Spence JD, 2005, STROKE, V36, P2404, DOI 10.1161/01.STR.0000185929.38534.f3; Stanger O, 2002, J PHARMACOL EXP THER, V303, P158, DOI 10.1124/jpet.102.036715; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Thambyrajah J, 2001, J AM COLL CARDIOL, V37, P1858, DOI 10.1016/S0735-1097(01)01235-9; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; van Dijk RAJM, 2001, ARTERIOSCL THROM VAS, V21, P2072, DOI 10.1161/hq1201.100223; Verhaar MC, 2002, ARTERIOSCL THROM VAS, V22, P6, DOI 10.1161/hq0102.102190; Vermeulen EGJ, 2004, EUR J CLIN INVEST, V34, P256, DOI 10.1111/j.1365-2362.2004.01332.x; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Wald NJ, 2003, BRIT MED J, V327, P586; Windelberg A, 2006, CLIN CHEM, V52, P342, DOI 10.1373/clinchem.2005.064980; Windelberg A, 2005, CLIN CHEM, V51, P2103, DOI 10.1373/clinchem.2005.053835; Woodman RJ, 2004, CLIN SCI, V106, P353, DOI 10.1042/CS20030296	42	1046	1099	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2006	354	15					1578	1588		10.1056/NEJMoa055227	http://dx.doi.org/10.1056/NEJMoa055227			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	031WW	16531614				2022-12-28	WOS:000236736900006
J	Gould, DB; Phalan, FC; van Mil, SE; Sundberg, JP; Vahedi, K; Massin, P; Bousser, MG; Heutink, P; Miner, JH; Tournier-Lasserve, E; John, SWM				Gould, DB; Phalan, FC; van Mil, SE; Sundberg, JP; Vahedi, K; Massin, P; Bousser, MG; Heutink, P; Miner, JH; Tournier-Lasserve, E; John, SWM			Role of COL4A1 in small-vessel disease and hemorrhagic stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RETINAL ARTERIOLAR TORTUOSITY; HEREDITARY ENDOTHELIOPATHY; RETINOPATHY; NEPHROPATHY; MUTATIONS	Small-vessel diseases of the brain underlie 20 to 30 percent of ischemic strokes and a larger proportion of intracerebral hemorrhages. In this report, we show that a mutation in the mouse Col4a1 gene, encoding procollagen type IV alpha l, predisposes both newborn and adult mice to intracerebral hemorrhage. Surgical delivery of mutant mice alleviated birth-associated trauma and hemorrhage. We identified a COL4A1 mutation in a human family with small-vessel disease. We concluded that mutation of COL4A1 may cause a spectrum of cerebrovascular phenotypes and that persons with COL4A1 mutations may be predisposed to hemorrhage, especially after environmental stress.	Jackson Lab, Bar Harbor, ME 04609 USA; Howard Hughes Med Inst, Bar Harbor, ME USA; VU Univ Med Ctr, Dept Human Genet, Sect Med Genom, Amsterdam, Netherlands; VU Univ, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; Hop Lariboisiere, Assistance Publ Hop Paris, Serv Neurol, F-75475 Paris, France; Hop Lariboisiere, Assistance Publ Hop Paris, Serv Ophtalmol, F-75475 Paris, France; Assistance Publ Hop Paris, INSERM, U740, Paris, France; Assistance Publ Hop Paris, Genet Lab, Paris, France; Washington Univ, Sch Med, Div Renal, St Louis, MO 63130 USA; Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Jackson Laboratory; Howard Hughes Medical Institute; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Washington University (WUSTL); Tufts University	John, SWM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	swmj@jax.org	Tournier-Lasserve, Elisabeth/N-7134-2017	Tournier-Lasserve, Elisabeth/0000-0002-3039-1677; Heutink, Peter/0000-0001-5218-1737; Dichgans, Martin/0000-0002-0654-387X	NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064687] Funding Source: NIH RePORTER; NCI NIH HHS [CA34196] Funding Source: Medline; NEI NIH HHS [EY117211] Funding Source: Medline; NIDDK NIH HHS [DK064687] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		American Heart Association, 2005, HEART DIS STROKE STA; BREEDVELD G, IN PRESS J MED GENET; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gupta MC, 1997, J CELL BIOL, V137, P1185, DOI 10.1083/jcb.137.5.1185; Hawes N L, 1999, Mol Vis, V5, P22; Jen J, 1997, NEUROLOGY, V49, P1322, DOI 10.1212/WNL.49.5.1322; Kase CS, 1998, STROKE PATHOPHYSIOLO, P649; Mancini GMS, 2004, EUR J PAEDIATR NEURO, V8, P45, DOI 10.1016/j.ejpn.2003.10.002; Ophoff RA, 2001, AM J HUM GENET, V69, P447, DOI 10.1086/321975; Plaisier E, 2005, KIDNEY INT, V67, P2354, DOI 10.1111/j.1523-1755.2005.00341.x; Sugiyama F, 2002, PHYSIOL GENOMICS, V10, P5, DOI 10.1152/physiolgenomics.00002.2002; Vahedi K, 2003, NEUROLOGY, V60, P57, DOI 10.1212/WNL.60.1.57	12	364	375	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1489	1496		10.1056/NEJMoa053727	http://dx.doi.org/10.1056/NEJMoa053727			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16598045	Bronze			2022-12-28	WOS:000236539000007
J	Somasundaram, R; Loddenkemper, C; Zeitz, M; Schneider, T				Somasundaram, R; Loddenkemper, C; Zeitz, M; Schneider, T			A souvenir from the Canary Islands	LANCET			English	Editorial Material							Q-FEVER; ORIGIN		Charite, Dept Gastroenterol, D-12200 Berlin, Germany; Charite, Dept Infect Dis, D-12200 Berlin, Germany; Charite, Dept Pathol, D-12200 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Somasundaram, R (corresponding author), Charite, Dept Gastroenterol, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	rajan.somasundaram@charite.de		Somasundaram, Rajan/0000-0003-3461-3326; Schneider, Thomas/0000-0003-1125-0518				BARBADO FJ, 1984, J MED, V15, P185; Bolanos M, 2003, ENFERM INFEC MICR CL, V21, P20, DOI 10.1157/13042133; Marrie TJ, 1996, J INFECT DIS, V173, P484, DOI 10.1093/infdis/173.2.484; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001	5	3	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 1	2006	367	9516					1116	1116		10.1016/S0140-6736(06)68480-8	http://dx.doi.org/10.1016/S0140-6736(06)68480-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581412				2022-12-28	WOS:000236673200037
J	Koch, C; Hepp, K				Koch, C; Hepp, K			Quantum mechanics in the brain	NATURE			English	Editorial Material									CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; ETH, Zurich, Switzerland	California Institute of Technology; California Institute of Technology; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Koch, C (corresponding author), CALTECH, Div Biol, 216-76, Pasadena, CA 91125 USA.			Koch, Christof/0000-0001-6482-8067				Hepp K, 1998, LECT NOTE PHYS, V517, P92; Koch Christof, 1999, P1; Koch Christof, 2004, QUEST CONSCIOUSNESS; Nielsen MA., 2002, QUANTUM COMPUTATION; Penrose R., 1989, EMPERORS NEW MIND	5	84	91	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					611	612		10.1038/440611a	http://dx.doi.org/10.1038/440611a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572152	Green Accepted, Bronze			2022-12-28	WOS:000236350400025
J	Mori, M; Umemura, M				Mori, M; Umemura, M			The evolution of galaxies from primeval irregulars to present-day ellipticals	NATURE			English	Article							LYMAN-BREAK GALAXIES; COLD DARK-MATTER; LY-ALPHA BLOBS; FORMING GALAXIES; STAR-FORMATION; REDSHIFT; SIMULATIONS; LUMINOSITY; REGION; DWARF	Galaxy formation is believed to proceed in a 'bottom up' manner, starting with the formation of small clumps of gas and stars that then merge hierarchically into giant systems(1,2). The baryonic gas loses thermal energy by radiative cooling and falls towards the centres of the new galaxies, while supernovae blow gas out(3,4). Any realistic model therefore requires a proper treatment of these processes, but hitherto this has been far from satisfactory(5). Here we report a simulation that follows evolution from the earliest stages of galaxy formation through the period of dynamical relaxation, at which point the resulting galaxy is in its final form. The bubble structures of gas revealed in our simulation (for times of less than 3 x 10(8) years) resemble closely high-red-shift Lyman-alpha emitters(6,7). After 10(9) years, these bodies are dominated by stellar continuum radiation and then resemble the Lyman break galaxies(8,9), which are high-redshift star-forming galaxies. At this point, the abundance of elements heavier than helium ('metallicity') appears to be solar. After 1.3 x 10(10) years, these galaxies resemble present-day ellipticals.	Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; Senshu Univ, Inst Nat Sci, Kanagawa 2148580, Japan; Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan	University of California System; University of California Los Angeles; University of Tsukuba	Mori, M (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	mmori@isc.senshu-u.ac.jp						Adelberger KL, 2003, ASTROPHYS J, V584, P45, DOI 10.1086/345660; BARNES J, 1987, ASTROPHYS J, V319, P575, DOI 10.1086/165480; BLUMENTHAL GR, 1984, NATURE, V311, P517, DOI 10.1038/311517a0; BOWER RG, 1992, MON NOT R ASTRON SOC, V254, P601, DOI 10.1093/mnras/254.4.601; Brandt WN, 2001, ASTROPHYS J, V558, pL5, DOI 10.1086/323570; de Vaucouleurs G., 1948, ANN DAP, V11, P247; DEY A, 1998, APJ, V498, P93; DJORGOVSKI S, 1987, ASTROPHYS J, V313, P59, DOI 10.1086/164948; Fardal MA, 2001, ASTROPHYS J, V562, P605, DOI 10.1086/323519; Fioc M, 1997, ASTRON ASTROPHYS, V326, P950; Giavalisco M, 2002, ANNU REV ASTRON ASTR, V40, P579, DOI 10.1146/annurev.astro.40.121301.111837; Haiman Z., 2000, APJ, V537, P5; Matsuda Y, 2004, ASTRON J, V128, P569, DOI 10.1086/422020; Mori M, 1997, ASTROPHYS J, V478, pL21, DOI 10.1086/310547; Mori M, 2004, ASTROPHYS J, V613, pL97, DOI 10.1086/425255; Mori M, 1999, ASTROPHYS J, V511, P585, DOI 10.1086/306724; Mori M, 2002, ASTROPHYS J, V571, P40, DOI 10.1086/339913; Nandra K, 2002, ASTROPHYS J, V576, P625, DOI 10.1086/341888; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; Shapley AE, 2004, ASTROPHYS J, V612, P108, DOI 10.1086/422467; Sommer-Larsen J, 2003, ASTROPHYS J, V596, P47, DOI 10.1086/377685; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; Steidel C. C., 1996, APJ, V462, P17; SUTHERLAND RS, 1993, ASTROPHYS J SUPPL S, V88, P253, DOI 10.1086/191823; Taniguchi Y, 2005, PUBL ASTRON SOC JPN, V57, P165, DOI 10.1093/pasj/57.1.165; Taniguchi Y, 2003, J KOREAN ASTRON SOC, V36, P123	30	68	69	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2006	440	7084					644	647		10.1038/nature04553	http://dx.doi.org/10.1038/nature04553			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572164	Green Submitted			2022-12-28	WOS:000236350400037
J	Robinson, DL				Robinson, DL			Do enforced bicycle helmet laws improve public health? No clear evidence from countries that have enforced the wearing of helmets	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEAD-INJURIES; CYCLISTS; VICTORIA; CHILDREN; LEGISLATION; SEVERITY; SAFETY		Univ New England, Armidale, NSW 2351, Australia	University of New England	Robinson, DL (corresponding author), Univ New England, Armidale, NSW 2351, Australia.	drobinso@aanet.com.au		Robinson, Dorothy/0000-0001-6113-1141				Abularrage JJ, 1997, ARCH PEDIAT ADOL MED, V151, P41, DOI 10.1001/archpedi.1997.02170380045007; Adams J, 2001, Inj Prev, V7, P89, DOI 10.1136/ip.7.2.89; Anderson A, 2001, INT J OSTEOARCHAEOL, V11, P2, DOI 10.1002/oa.539; *BLACKT CIT COUNC, BLACKT BIK STUD; *BMA BOARD SCI ED, 2005, LEG COMP WEAR CYCL H; Borglund S T, 1999, J Emerg Nurs, V25, P496, DOI 10.1016/S0099-1767(99)70013-9; CAMERON M, P AUSTR PED BIC SAF; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; Carrette L, 2001, FUEL CELLS, V1, P5, DOI 10.1002/1615-6854(200105)1:1<5::AID-FUCE5>3.0.CO;2-G; Chipman ML, 2002, CAN MED ASSOC J, V167, P339; *CIHI, 2003, INJ HOSP INCL 2000 0; Cook A, 2000, BRIT MED J, V321, P1055, DOI 10.1136/bmj.321.7268.1055; Curnow WJ, 2005, ACCIDENT ANAL PREV, V37, P569, DOI 10.1016/j.aap.2005.01.009; *CYCL SCOTL, CYCL SCOTL HELM POL; DIGUISEPPI CG, 1989, JAMA-J AM MED ASSOC, V262, P2256, DOI 10.1001/jama.262.16.2256; Finch C.F., 1993, 45 MON U ACC RES CTR; GENNARELLI TA, 1972, 16 STAPP CAR CRASH C; HEATHCOTE B, 1994, BICYCLE USE ATTITUDE; Hendrie D., 1999, EC EVALUATION MANDAT; Hewson Paul J, 2005, Traffic Inj Prev, V6, P127, DOI 10.1080/15389580590931590; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Kanny D, 2001, AM J EPIDEMIOL, V154, P1072, DOI 10.1093/aje/154.11.1072; KING M, 1993, BICYCLE HELMET LEGIS; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P76, DOI 10.2105/AJPH.77.1.76; Lardelli-Claret P, 2003, INJURY PREV, V9, P128, DOI 10.1136/ip.9.2.128; Lawlor DA, 2004, INT J EPIDEMIOL, V33, P464, DOI 10.1093/ije/dyh124; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; LeBlanc JC, 2002, CAN MED ASSOC J, V166, P592; Liller KD, 2003, INJ PREV, V9, P177, DOI 10.1136/ip.9.2.177; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; MARSHALL J, 1994, 894 S AUSTR DEP TRAN; McGuire L, 2000, Inj Prev, V6, P285, DOI 10.1136/ip.6.4.285; Parkinson GW, 2003, PEDIATRICS, V112, P320, DOI 10.1542/peds.112.2.320; Povey LJ, 1999, ACCIDENT ANAL PREV, V31, P763, DOI 10.1016/S0001-4575(99)00033-0; POWLES JW, 1993, BRIT MED J, V306, P125, DOI 10.1136/bmj.306.6870.125; Robinson DL, 2001, ACCIDENT ANAL PREV, V33, P687, DOI 10.1016/S0001-4575(00)00073-7; Robinson DL, 1996, ACCIDENT ANAL PREV, V28, P463, DOI 10.1016/0001-4575(96)00016-4; ROBINSON DL, 2002, PEDIATRICS, V110, pE60; Robinson Dorothy L, 2005, Health Promot J Austr, V16, P47; Rodgers GB, 2002, INJ PREV, V8, P42, DOI 10.1136/ip.8.1.42; Smith N, 1993, OBSERVATIONAL SURVEY; SPAITE DW, 1991, J TRAUMA, V31, P1510, DOI 10.1097/00005373-199111000-00008; Taylor M, 2002, INJ PREV, V8, P317, DOI 10.1136/ip.8.4.317; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]; Walker M., 1992, LAW COMPLIANCE CYCLI; WALKER M, P VEL AUSTR FREM W A; WEBBER R, 1992, AUSB 92 P NAT BIC C; SAFETY NUMBERS GRAPH	50	44	44	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2006	332	7543					722	725		10.1136/bmj.332.7543.722-a	http://dx.doi.org/10.1136/bmj.332.7543.722-a			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	027VH	16565131	Green Published			2022-12-28	WOS:000236443300029
J	Teebi, AS; El-Shanti, HI				Teebi, AS; El-Shanti, HI			Consanguinity: implications for practice, research, and policy	LANCET			English	Editorial Material							POPULATIONS; MARRIAGES; BEHAVIOR		Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON M5G 1X8, Canada; Childrens Hosp Iowa, Div Med Genet, Iowa City, IA USA; Univ Iowa, Iowa City, IA USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Iowa	Teebi, AS (corresponding author), Hosp Sick Children, Div Clin & Metab Genet, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ahmad.teebi@sickkids.ca	El-Shanti, Hatem/O-5990-2014; EL-SHANTI, HATEM/Q-4932-2016	El-Shanti, Hatem/0000-0001-6230-8316; EL-SHANTI, HATEM/0000-0001-6230-8316				AFZAL M, 1988, BEHAV GENET, V18, P583, DOI 10.1007/BF01082310; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; BITTLES AH, 1991, SCIENCE, V252, P789, DOI 10.1126/science.2028254; Hamamy H, 2005, CLIN GENET, V67, P511, DOI 10.1111/j.1399-0004.2005.00426.x; Hoodfar E, 1996, J MED GENET, V33, P212, DOI 10.1136/jmg.33.3.212; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; MORTON NE, 1978, P NATL ACAD SCI USA, V75, P3906, DOI 10.1073/pnas.75.8.3906; SHAMI SA, 1989, J MED GENET, V26, P267, DOI 10.1136/jmg.26.4.267; Sheffield VC, 2004, PEDIATR RES, V55, P908, DOI 10.1203/01.pdr.0000127013.14444.9c; Teebi AS, 2005, COMMUNITY GENET, V8, P21, DOI 10.1159/000083333; Teebi AS, 1997, GENETIC DISORDERS AR; Zlotogora J, 2002, AM J HUM BIOL, V14, P680, DOI 10.1002/ajhb.10082	12	27	28	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					970	971		10.1016/S0140-6736(06)68406-7	http://dx.doi.org/10.1016/S0140-6736(06)68406-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564347				2022-12-28	WOS:000236474200009
J	Bann, JG; Cegelski, L; Hultgren, SJ				Bann, JG; Cegelski, L; Hultgren, SJ			LRP6 holds the key to the entry of anthrax toxin	CELL			English	Editorial Material							ENDOCYTOSIS; RECEPTOR	In this issue of Cell, Wei et al. (2006) demonstrate that the low-density lipoprotein receptor-related protein 6 (LRP6) promotes endocytosis of the anthrax toxin into cells. LRP6 acts as a coreceptor with either TEM8 or CMG2, the two previously identified receptors for anthrax toxin.	Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Wichita State Univ, Dept Chem, Wichita, KS 67260 USA	Washington University (WUSTL); Wichita State University	Hultgren, SJ (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	hultgren@borcim.wustl.edu						Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Bell SE, 2001, J CELL SCI, V114, P2755; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Lu Q, 2004, P NATL ACAD SCI USA, V101, P17246, DOI 10.1073/pnas.0407794101; Lusso P, 2006, EMBO J, V25, P447, DOI 10.1038/sj.emboj.7600947; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; Tucker AE, 2003, CELL MICROBIOL, V5, P523, DOI 10.1046/j.1462-5822.2003.00298.x; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	11	7	7	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1119	1121		10.1016/j.cell.2006.03.007	http://dx.doi.org/10.1016/j.cell.2006.03.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564002	Bronze			2022-12-28	WOS:000237241400009
J	Parimon, T; Au, DH; Martin, PJ; Chien, JW				Parimon, T; Au, DH; Martin, PJ; Chien, JW			A risk score for mortality after allogeneic hematopoietic cell transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; FAILURE; LEUKEMIA; VALUES; COHORT	Background: Despite recent advances, mortality rates after allogeneic hematopoietic cell transplantation remain high and cannot be accurately predicted. Objective: To develop a reliable and valid predictor of all-cause mortality during the first 2 years after allogeneic hematopoietic cell transplantation. Design: Retrospective cohort. Setting: Tertiary hematopoietic cell transplantation center. Patients: Patients (n = 2802) who received a first hematopoietic cell transplant between 1990 and 2002 were assigned to a development group or a validation group. Measurements: Potential predictor variables were assessed with univariate and multivariable Cox proportional hazards methods to generate a prediction model. The c-statistic was calculated for 5 validation cohorts to assess model performance across early and late time periods and among patients with different diagnoses. Results: The authors constructed a 50-point Pretransplantation Assessment of Mortality (PAM) score that incorporated 8 pretransplantation clinical variables: patient age, donor type, disease risk, conditioning regimen, FEV1, carbon monoxide diffusion capacity, serum creatinine level, and serum alanine aminotransferase concentration. The risk for death within 2 years for patients with PAM scores in the highest category was significantly higher than for those with scores in the lowest category. C-statistic values ranged from 0.69 to 0.76 for all validation cohorts. Limitations: The predictor model was not validated in an external cohort and is only useful for predicting the risk for death within the first 2 years after hematopoietic cell transplantation. Conclusions: Integrating pretransplantation clinical variables into a single score reliably predicts survival within 2 years after allogeneic hematopoietic cell transplantation. Accurate estimates of the risk for death may be useful in clinical trials and in epidemiologic studies. Such information can also be used to help physicians counsel patients regarding the expected outcomes of this potentially curative procedure.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA	Fred Hutchinson Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Chien, JW (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,Suite D5-280, Seattle, WA 98109 USA.	jchien@fhcrc.org	Parimon, Tanyalak/AAH-6864-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL069860] Funding Source: NIH RePORTER; NHLBI NIH HHS [K23HL69860-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185; APPELBAUM FR, 1992, BONE MARROW TRANSPL, V10, P77; Bacigalupo A, 2004, HAEMATOLOGICA, V89, P1238; Camitta B, 1995, COLLOQ INSE, V235, P325; Castro-Malaspina H, 2002, BLOOD, V99, P1943, DOI 10.1182/blood.V99.6.1943; CLIFT RA, 1990, BLOOD, V76, P1867; CLIFT RA, 1991, BLOOD, V77, P1660; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P185; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Hingorani SR, 2005, KIDNEY INT, V67, P272, DOI 10.1111/j.1523-1755.2005.00078.x; MCDONALD GB, 1993, ANN INTERN MED, V118, P255, DOI 10.7326/0003-4819-118-4-199302150-00003; Parimon T, 2005, AM J RESP CRIT CARE, V172, P384, DOI 10.1164/rccm.200502-212OC; Sorror ML, 2004, BLOOD, V104, P961, DOI 10.1182/blood-2004-02-0545; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Strasser SI, 1999, HEPATOLOGY, V29, P1893, DOI 10.1002/hep.510290609; Weisdorf DJ, 2002, BLOOD, V99, P1971, DOI 10.1182/blood.V99.6.1971	18	146	146	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					407	414		10.7326/0003-4819-144-6-200603210-00007	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549853				2022-12-28	WOS:000236251800004
J	DiCicco-Bloom, E				DiCicco-Bloom, E			Neuroscience - Neuron, know thy neighbor	SCIENCE			English	Editorial Material							ALPHA-CATENIN; AUTISM; ACTIN; DISORDER		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol Pediat Neurol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	DiCicco-Bloom, E (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol Pediat Neurol, Piscataway, NJ 08854 USA.	diciccem@umdnj.edu						Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; DICICCOBLOOM E, 2005, KAPLAN SADOCKS COMPR, P33; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Ferguson KL, 2003, TRENDS NEUROSCI, V26, P283, DOI 10.1016/S0166-2236(03)00100-0; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; Lien WH, 2006, SCIENCE, V311, P1609, DOI 10.1126/science.1121449; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Palmen SJMC, 2004, BRAIN, V127, P2572, DOI 10.1093/brain/awh287; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020	13	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1560	1562		10.1126/science.1126397	http://dx.doi.org/10.1126/science.1126397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543446				2022-12-28	WOS:000236029500029
J	Ford, N; Darder, M				Ford, N; Darder, M			Registration problems for antiretrovirals in Africa	LANCET			English	Editorial Material									Med Sans Frontieres, ZA-7784 Khayelitsha, South Africa		Ford, N (corresponding author), Med Sans Frontieres, ZA-7784 Khayelitsha, South Africa.	Nathan.FORD@london.msf.org						BOULLE A, 2005, ANTIRETROVIRAL DRUGS; *GIL, 2005, GIL EXP GLOB ACC PRO; *GIL, 2002, GIL SCI PROV ACC ANT; *GUID DEV GROUP, 2005, ANT DRUGS TREATM HIV	4	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					794	795		10.1016/S0140-6736(06)68313-X	http://dx.doi.org/10.1016/S0140-6736(06)68313-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530559				2022-12-28	WOS:000236016500006
J	Newcomb, PA; Egan, KM				Newcomb, PA; Egan, KM			Dairy food and ovarian cancer risk	LANCET			English	Editorial Material							VITAMIN-D; MORTALITY-RATES; BREAST-CANCER; CALCIUM; EPIDEMIOLOGY; CONSUMPTION; INHIBITION; CARCINOMA; PRODUCTS; SUNLIGHT		Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98109 USA	Vanderbilt University; Fred Hutchinson Cancer Center	Newcomb, PA (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	pnewcomb@fhcrc.org						Cramer DW, 2000, CANCER EPIDEM BIOMAR, V9, P95; Freedman DM, 2002, OCCUP ENVIRON MED, V59, P257, DOI 10.1136/oem.59.4.257; Friedrich M, 2003, RECENT RES CANCER, V164, P239; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Goodman MT, 2002, AM J EPIDEMIOL, V156, P148, DOI 10.1093/aje/kwf022; Grant WB, 2003, RECENT RESULTS CANC, V164, P371; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Larsson SC, 2006, INT J CANCER, V118, P431, DOI 10.1002/ijc.21305; LEFKOWITZ ES, 1994, INT J EPIDEMIOL, V23, P1133, DOI 10.1093/ije/23.6.1133; Lipkin M, 1999, J AM COLL NUTR, V18, p392S, DOI 10.1080/07315724.1999.10718903; Lukanova A, 2005, CANCER EPIDEM BIOMAR, V14, P98; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; Mommers M, 2006, BRIT J CANCER, V94, P165, DOI 10.1038/sj.bjc.6602890; SAUNDERS DE, 1992, GYNECOL ONCOL, V44, P131, DOI 10.1016/0090-8258(92)90028-H; SAUNDERS DE, 1995, ANTI-CANCER DRUG, V6, P562, DOI 10.1097/00001813-199508000-00009; Seidman JD, 2003, HEMATOL ONCOL CLIN N, V17, P909, DOI 10.1016/S0889-8588(03)00061-3; SWARTZ WJ, 1988, FERTIL STERIL, V49, P522	17	0	0	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					797	799		10.1016/S0140-6736(06)68315-3	http://dx.doi.org/10.1016/S0140-6736(06)68315-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530561				2022-12-28	WOS:000236016500008
J	Yamada, M				Yamada, M		Cruetzfeldt-Jakob Dis Surveillance	The first Japanese case of variant Creutzfeldt-Jakob disease showing periodic electroencephalogram	LANCET			English	Editorial Material									Kanazawa Univ, Grad Sch Med, Dept Neurol & Neurobiol Aging, Creutzfeldt Jakob Surveillance Comm, Kanazawa, Ishikawa 920, Japan	Kanazawa University	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Neurol & Neurobiol Aging, Creutzfeldt Jakob Surveillance Comm, 13-1 Takara Machi, Kanazawa, Ishikawa 920, Japan.	m-yamada@med.kanazawa-u.ac.jp						[Anonymous], 1998, GLOBAL SURVEILLANCE; Collie DA, 2003, AM J NEURORADIOL, V24, P1560; *FOOD STAND AG, 2002, AG STUD REP HIST US; Will RG, 2004, CURR TOP MICROBIOL, V284, P121; 2001, REVISION SURVEILLANC	5	32	35	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2006	367	9513					874	874		10.1016/S0140-6736(06)68344-X	http://dx.doi.org/10.1016/S0140-6736(06)68344-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530582				2022-12-28	WOS:000236016500033
J	Huitema, E; Pritchard, S; Matteson, D; Radhakrishnan, SK; Viollier, PH				Huitema, E; Pritchard, S; Matteson, D; Radhakrishnan, SK; Viollier, PH			Bacterial birth scar proteins mark future flagellum assembly site	CELL			English	Article							CELL-CYCLE PROGRESSION; BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; DI-GMP; POLAR LOCALIZATION; DIVISION SITES; EAL DOMAINS; FTSZ; PHOSPHODIESTERASE; IDENTIFICATION	Many prokaryotic protein complexes underlie polar asymmetry. In Caulobacter crescentus, a flagellum is built exclusively at the pole that arose from the previous cell division. The basis for this pole specificity is unclear but could involve a cytokinetic birth scar that marks the newborn pole as the flagellum assembly site. We identified two developmental proteins, TipN and TipF, which localize to the division septum and the newborn pole after division. We show that septal localization of TipN/F depends on cytokinesis. Moreover, TipF, a c-di-GMP phosphodiesterase homolog, is a flagellum assembly factor that relies on TipN for proper positioning. In the absence of TipN, flagella are assembled at ectopic locations, and TipF is mislocalized to such sites. Thus TipN and TipF establish a link between bacterial cytokinesis and polar asymmetry, demonstrating that division does indeed leave a positional mark in its wake to direct the biogenesis of a polar organelle.	Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University	Viollier, PH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	patrick.viollier@case.edu	Viollier, Patrick/AAD-9405-2021; Huitema, Edgar/G-3760-2011	Huitema, Edgar/0000-0002-5766-0830; Radhakrishnan, Sunish/0000-0001-8729-263X; Viollier, Patrick/0000-0002-5249-9910				ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036; Charles M, 2001, P NATL ACAD SCI USA, V98, P9871, DOI 10.1073/pnas.171310498; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Din N, 1998, MOL MICROBIOL, V27, P1051, DOI 10.1046/j.1365-2958.1998.00752.x; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; ELY B, 1991, METHOD ENZYMOL, V204, P372; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; Gober JW, 2000, PROKARYOTIC DEVELOPMENT, P319; Hamoen LW, 2003, J BACTERIOL, V185, P693, DOI 10.1128/JB.185.2.693-697.2003; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Levin PA, 1997, MOL MICROBIOL, V25, P839; Losick R, 1999, GENE DEV, V13, P377, DOI 10.1101/gad.13.4.377; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; MACALISTER TJ, 1987, J BACTERIOL, V169, P3945, DOI 10.1128/jb.169.9.3945-3951.1987; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; McGrath PT, 2004, CURR OPIN MICROBIOL, V7, P192, DOI 10.1016/j.mib.2004.02.012; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Perry SE, 2004, MOL MICROBIOL, V54, P1237, DOI 10.1111/j.1365-2958.2004.04363.x; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Rafelski SM, 2005, BIOPHYS J, V89, P2146, DOI 10.1529/biophysj.105.061168; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Scott ME, 2001, P NATL ACAD SCI USA, V98, P13978, DOI 10.1073/pnas.241411198; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864; Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223; Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200; Thanbichler M, 2005, CURR OPIN GENET DEV, V15, P153, DOI 10.1016/j.gde.2005.01.001; Viollier PH, 2003, MOL MICROBIOL, V49, P331, DOI 10.1046/j.1365-2958.2003.03576.x; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999; West L, 2002, J BACTERIOL, V184, P2155, DOI 10.1128/JB.184.8.2155-2166.2002; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x	47	161	162	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					1025	1037		10.1016/j.cell.2006.01.019	http://dx.doi.org/10.1016/j.cell.2006.01.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530048	Bronze			2022-12-28	WOS:000237241200023
J	Plasterk, RHA				Plasterk, RHA			Micro RNAs in animal development	CELL			English	Editorial Material							C-ELEGANS; CAENORHABDITIS-ELEGANS; LET-7 MICRORNA; EXPRESSION; ZEBRAFISH; GENES; IDENTIFICATION; EVOLUTION; SEQUENCE; IMPACT	Micro RNAs (miRNAs) are similar to 22 nucleotide single-stranded noncoding RNA molecules that bind to target messenger RNAs (mRNAs) and silence their expression. This Essay explores the importance of miRNAs in animal development and their possible roles in disease and evolution.	Univ Utrecht, Hubrecht Lab, KNAW, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Plasterk, RHA (corresponding author), Univ Utrecht, Hubrecht Lab, KNAW, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl						Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481	22	358	386	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 10	2006	124	5					877	881		10.1016/j.cell.2006.02.030	http://dx.doi.org/10.1016/j.cell.2006.02.030			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530032	Bronze			2022-12-28	WOS:000237241200007
J	Raman, M; Cobb, MH				Raman, M; Cobb, MH			TGF-beta regulation by Emilin1: New links in the etiology of hypertension	CELL			English	Editorial Material								Hypertension is a complex disease influenced by multiple genetic and environmental factors. The TGF-beta signaling pathway has a long recognized role in blood pressure homeostasis. In this issue of Cell, Zacchigna et al. (2006) report that the secreted protein Emilin1 is a negative regulator of TGF-beta signaling. Emilin1 knockout mice display elevated blood pressure due to increased TGF-beta signaling in the vasculature.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Cobb, MH (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	melanie.cobb@utsouthwestern.edu		Cobb, Melanie/0000-0003-0833-5473; raman, malavika/0000-0002-4773-8673				Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Colombatti A, 2000, MATRIX BIOL, V19, P289, DOI 10.1016/S0945-053X(00)00074-3; Faury G, 2003, J CLIN INVEST, V112, P1419, DOI 10.1172/JCI200319028; Ghosh J, 2005, CARDIOVASC PATHOL, V14, P28, DOI 10.1016/j.carpath.2004.11.005; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Oft M, 1998, CURR BIOL, V8, P1243, DOI 10.1016/S0960-9822(07)00533-7; Zanetti M, 2004, MOL CELL BIOL, V24, P638, DOI 10.1128/MCB.24.2.638-650.2004	9	14	16	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					893	895		10.1016/j.cell.2006.02.031	http://dx.doi.org/10.1016/j.cell.2006.02.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530037	Bronze			2022-12-28	WOS:000237241200012
J	Guan, K; Nayernia, K; Maier, LS; Wagner, S; Dressel, R; Lee, JH; Nolte, J; Wolf, F; Li, MY; Engel, W; Hasenfuss, G				Guan, K; Nayernia, K; Maier, LS; Wagner, S; Dressel, R; Lee, JH; Nolte, J; Wolf, F; Li, MY; Engel, W; Hasenfuss, G			Pluripotency of spermatogonial stem cells from adult mouse testis	NATURE			English	Article							IN-VITRO; GERM-CELLS; GENE; EXPRESSION; EMBRYO; DIFFERENTIATION; MAINTENANCE; GENERATION; MYOGENESIS; CULTURE	Embryonic germ cells as well as germline stem cells from neonatal mouse testis are pluripotent and have differentiation potential similar to embryonic stem cells(1,2), suggesting that the germline lineage may retain the ability to generate pluripotent cells. However, until now there has been no evidence for the pluripotency and plasticity of adult spermatogonial stem cells (SSCs), which are responsible for maintaining spermatogenesis throughout life in the male(3). Here we show the isolation of SSCs from adult mouse testis using genetic selection, with a success rate of 27%. These isolated SSCs respond to culture conditions and acquire embryonic stem cell properties. We name these cells multipotent adult germline stem cells (maGSCs). They are able to spontaneously differentiate into derivatives of the three embryonic germ layers in vitro and generate teratomas in immunodeficient mice. When injected into an early blastocyst, SSCs contribute to the development of various organs and show germline transmission. Thus, the capacity to form multipotent cells persists in adult mouse testis. Establishment of human maGSCs from testicular biopsies may allow individual cell-based therapy without the ethical and immunological problems associated with human embryonic stem cells. Furthermore, these cells may provide new opportunities to study genetic diseases in various cell lineages.	Univ Gottingen, Ctr Heart, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany; Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Univ Gottingen, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany	University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; University of Gottingen	Hasenfuss, G (corresponding author), Univ Gottingen, Ctr Heart, Dept Cardiol & Pneumol, Robert Koch Str 40, D-37075 Gottingen, Germany.	wengel@gwdg.de; hasenfus@med.uni-goettingen.de	Dressel, Ralf/R-7065-2016; Guan, Kaomei/G-8882-2018; Wagner, Stefan/AAE-3721-2021; Maier, Lars/AAQ-8313-2021	Dressel, Ralf/0000-0002-1651-1214; Guan, Kaomei/0000-0002-0753-3083; Wagner, Stefan/0000-0002-9471-1166; Maier, Lars/0000-0001-9915-4429				Ben-Shushan E, 1998, MOL CELL BIOL, V18, P1866, DOI 10.1128/MCB.18.4.1866; Bonner AE, 2004, NEOPLASIA, V6, P490, DOI 10.1593/neo.04124; DAMJANOV I, 1982, AM J PATHOL, V108, P225; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; DONEHOWER LA, 1995, MOL CARCINOGEN, V14, P16, DOI 10.1002/mc.2940140105; FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517; Giuili G, 2002, EMBO REP, V3, P753, DOI 10.1093/embo-reports/kvf149; Guan K, 1999, CYTOTECHNOLOGY, V30, P211, DOI 10.1023/A:1008041420166; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; King T, 1998, MECH DEVELOP, V79, P29, DOI 10.1016/S0925-4773(98)00166-X; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Ling V, 1997, J CELL PHYSIOL, V171, P104, DOI 10.1002/(SICI)1097-4652(199704)171:1<104::AID-JCP12>3.0.CO;2-G; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagano M, 2003, BIOL REPROD, V68, P2207, DOI 10.1095/biolreprod.102.014050; Nayernia K, 2004, HUM MOL GENET, V13, P1451, DOI 10.1093/hmg/ddh166; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Rossi P, 2000, J ENDOCRINOL INVEST, V23, P609, DOI 10.1007/BF03343784; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; STEVENS LC, 1957, J NATL CANCER I, V18, P719; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	30	650	751	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1199	1203		10.1038/nature04697	http://dx.doi.org/10.1038/nature04697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16565704				2022-12-28	WOS:000237080000047
J	Fisher, S; Grice, EA; Vinton, RM; Bessling, SL; McCallion, AS				Fisher, S; Grice, EA; Vinton, RM; Bessling, SL; McCallion, AS			Conservation of RET regulatory function from human to zebrafish without sequence similarity	SCIENCE			English	Article							HIRSCHSPRUNG-DISEASE; COMPARATIVE GENOMICS; C-RET; EXPRESSION; ELEMENTS; REVEALS; REGIONS; PATTERN; LOCI	Evolutionary sequence conservation is an accepted criterion to identify noncoding regulatory sequences. We have used a transposon-based transgenic assay in zebrafish to evaluate noncoding sequences at the zebrafish ret locus, conserved among teleosts, and at the human RET locus, conserved among mammals. Most teleost sequences directed ret-specific reporter gene expression, with many displaying overlapping regulatory control. The majority of human RET noncoding sequences also directed ret-specific expression in zebrafish. Thus, vast amounts of functional sequence information may exist that would not be detected by sequence similarity approaches.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Fisher, S (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	sfisher@jhmi.edu; amccalli@jhmi.edu	Fisher, Shannon/K-7351-2012	Grice, Elizabeth/0000-0003-3939-2200	NIAMS NIH HHS [AR048101] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048101] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bagheri-Fam S, 2001, GENOMICS, V78, P73, DOI 10.1006/geno.2001.6648; Baroukh N, 2005, MAMM GENOME, V16, P91, DOI 10.1007/s00335-004-2442-9; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Bisgrove BW, 1997, J NEUROBIOL, V33, P749; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; FISHER S, UNPUB; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Hahn M, 2001, P NATL ACAD SCI USA, V98, P1053, DOI 10.1073/pnas.021558598; Kashuk CS, 2005, P NATL ACAD SCI USA, V102, P8949, DOI 10.1073/pnas.0503259102; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; MarcosGutierrez CV, 1997, ONCOGENE, V14, P879, DOI 10.1038/sj.onc.1201048; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; MCCALLION AS, 2004, INBORN ERRORS DEV; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Veeramachaneni V, 2005, NUCLEIC ACIDS RES, V33, pD442, DOI 10.1093/nar/gki094; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	28	251	262	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2006	312	5771					276	279		10.1126/science.1124070	http://dx.doi.org/10.1126/science.1124070			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032HK	16556802				2022-12-28	WOS:000236765300052
J	Kotagal, S; Pianosi, P				Kotagal, S; Pianosi, P			Sleep disorders in children and adolescents	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESTLESS LEGS; PREVALENCE; PATTERNS; HISTORY		Mayo Clin, Sleep Disorders Ctr, Rochester, MN USA	Mayo Clinic	Kotagal, S (corresponding author), Div Child Neurol, 200 1st St SW, Rochester, MN 55905 USA.	kotagal.suresh@mayo.edu	Pianosi, Paul/AAX-9037-2021	Pianosi, Paolo/0000-0001-8201-7591				American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Archer SN, 2003, SLEEP, V26, P413, DOI 10.1093/sleep/26.4.413; Brietzke SE, 2004, OTOLARYNG HEAD NECK, V131, P827, DOI 10.1016/j.otohns.2004.07.002; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; CARSKADON MA, 1982, SLEEPING WAKING DISO, P1; CHALLAMEL MJ, 1994, SLEEP, V17, pS17, DOI 10.1093/sleep/17.suppl_8.S17; Chervin RD, 2002, SLEEP, V25, P213; Dauvilliers Y, 2004, ANN NEUROL, V56, P905, DOI 10.1002/ana.20339; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Kotagal S, 2004, ANN NEUROL, V56, P803, DOI 10.1002/ana.20292; MARCUS CL, 1994, J APPL PHYSIOL, V77, P918, DOI 10.1152/jappl.1994.77.2.918; Marcus CL, 1998, PEDIATR PULM, V26, P6, DOI 10.1002/(SICI)1099-0496(199807)26:1<6::AID-PPUL3>3.3.CO;2-I; Mignot E, 2002, NAT NEUROSCI, V5, P1071, DOI 10.1038/nn944; Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772; Ohayon MM, 2000, J AM ACAD CHILD PSY, V39, P1549, DOI 10.1097/00004583-200012000-00019; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Sundaram S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001004.pub2; VAVRINA J, 1995, INT J PEDIATR OTORHI, V33, P239, DOI 10.1016/0165-5876(95)01217-6; Walters AS, 2002, SLEEP MED, V3, P93, DOI 10.1016/S1389-9457(01)00164-2; WOLFSON AR, 2002, ADOLESCENT SLEEP PAT, P200	22	42	44	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2006	332	7545					828	832		10.1136/bmj.332.7545.828	http://dx.doi.org/10.1136/bmj.332.7545.828			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032ZQ	16601043	Green Published			2022-12-28	WOS:000236815900021
J	Nissen, SE; Nicholls, SJ; Sipahi, I; Libby, P; Raichlen, JS; Ballantyne, CM; Davignon, J; Erbel, R; Fruchart, JC; Tardif, JC; Schoenhagen, P; Crowe, T; Cain, V; Wolski, K; Goormastic, M; Tuzcu, EM				Nissen, SE; Nicholls, SJ; Sipahi, I; Libby, P; Raichlen, JS; Ballantyne, CM; Davignon, J; Erbel, R; Fruchart, JC; Tardif, JC; Schoenhagen, P; Crowe, T; Cain, V; Wolski, K; Goormastic, M; Tuzcu, EM		ASTEROID Investigators	Effect of very high-intensity statin therapy on regression of coronary atherosclerosis - The ASTEROID trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; LIPID-LOWERING THERAPY; INTRAVASCULAR ULTRASOUND; ARTERY-DISEASE; CHOLESTEROL; PROGRESSION; ATORVASTATIN; SIMVASTATIN; INTERVENTIONS; PRAVASTATIN	Context Prior intravascular ultrasound (IVUS) trials have demonstrated slowing or halting of atherosclerosis progression with statin therapy but have not shown convincing evidence of regression using percent atheroma volume (PAV), the most rigorous IVUS measure of disease progression and regression. Objective To assess whether very intensive statin therapy could regress coronary atherosclerosis as determined by IVUS imaging. Design and Setting Prospective, open-label blinded end-points trial ( A Study to Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden [ ASTEROID]) was performed at 53 community and tertiary care centers in the United States, Canada, Europe, and Australia. A motorized IVUS pullback was used to assess coronary atheroma burden at baseline and after 24 months of treatment. Each pair of baseline and follow-up IVUS assessments was analyzed in a blinded fashion. Patients Between November 2002 and October 2003, 507 patients had a baseline IVUS examination and received at least 1 dose of study drug. After 24 months, 349 patients had evaluable serial IVUS examinations. Intervention All patients received intensive statin therapy with rosuvastatin, 40 mg/d. Main Outcome Measures Two primary efficacy parameters were prespecified: the change in PAV and the change in nominal atheroma volume in the 10-mm subsegment with the greatest disease severity at baseline. A secondary efficacy variable, change in normalized total atheroma volume for the entire artery, was also prespecified. Results The mean (SD) baseline low-density lipoprotein cholesterol (LDL-C) level of 130.4 (34.3) mg/dL declined to 60.8 (20.0) mg/dL, a mean reduction of 53.2% ( P <. 001). Mean ( SD) high-density lipoprotein cholesterol (HDL-C) level at baseline was 43.1 (11.1) mg/dL, increasing to 49.0 (12.6) mg/dL, an increase of 14.7% ( P <. 001). The mean ( SD) change in PAV for the entire vessel was - 0.98% (3.15%), with a median of - 0.79% (97.5% CI, - 1.21% to - 0.53%) ( P <. 001 vs baseline). The mean ( SD) change in atheroma volume in the most diseased 10-mm subsegment was - 6.1 (10.1) mm(3), with a median of - 5.6 mm(3) ( 97.5% CI, - 6.8 to - 4.0 mm(3)) ( P <. 001 vs baseline). Change in total atheroma volume showed a 6.8% median reduction; with a mean ( SD) reduction of - 14.7 ( 25.7) mm(3), with a median of - 12.5 mm(3) (95% CI, - 15.1 to - 10.5 mm(3)) ( P <. 001 vs baseline). Adverse events were infrequent and similar to other statin trials. Conclusions Very high-intensity statin therapy using rosuvastatin 40 mg/d achieved an average LDL-C of 60.8 mg/dL and increased HDL-C by 14.7%, resulting in significant regression of atherosclerosis for all 3 prespecified IVUS measures of disease burden. Treatment to LDL-C levels below currently accepted guidelines, when accompanied by significant HDL-C increases, can regress atherosclerosis in coronary disease patients. Further studies are needed to determine the effect of the observed changes on clinical outcome. Trial Registration ClinicalTrials. gov Identifier: NCT00240318.	Cleveland Clin, Lerner Sch Med, Dept Cardiovasc Med, Cleveland, OH 44106 USA; Cleveland Clin, Lerner Sch Med, Dept Diagnost Radiol, Cleveland, OH 44106 USA; Brigham & Womens Hosp, Dept Med, Donald W Reynolds Cardiovasc Clin Res Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; AstraZeneca, Wilmington, DE USA; Baylor Coll Med, Dept Med, Sect Atherosclerosis & Lipoprot Res, Houston, TX 77030 USA; Methodist DeBakey Heart Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX USA; Clin Res Inst Montreal, Hyperlipidemia & Atherosclerosis Res Grp, Montreal, PQ H2W 1R7, Canada; Univ Duisburg Essen, Dept Cardiol, Duisburg, Germany; INSERM, U545, Dept Rech Lipoprot & Atherosclerose, F-59045 Lille, France; Univ Lille 2, Lille, France; Montreal Heart Inst, MHI Res Ctr, Montreal, PQ H1T 1C8, Canada	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; AstraZeneca; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Duisburg Essen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Montreal	Nissen, SE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	nissens@ccf.org	SIPAHI, ILKE/K-9745-2013; Schoenhagen, Paul/A-2808-2012; Ballantyne, Christie/A-6599-2008; Libby, Peter/AAY-6404-2021	SIPAHI, ILKE/0000-0001-8581-9557; Schoenhagen, Paul/0000-0002-7751-5243; Libby, Peter/0000-0002-1502-502X; Nicholls, Stephen/0000-0002-9668-4368; Ballantyne, Christie/0000-0002-6432-1730				BLANKENHORN DH, 1993, ANN INTERN MED, V119, P969, DOI 10.7326/0003-4819-119-10-199311150-00002; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Davidson M, 2002, AM J CARDIOL, V89, P268, DOI 10.1016/S0002-9149(01)02226-3; Eisen HJ, 2003, NEW ENGL J MED, V349, P847, DOI 10.1056/NEJMoa022171; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Jensen LO, 2004, CIRCULATION, V110, P265, DOI 10.1161/01.CIR.0000135215.75876.41; JUKEMA JW, 1995, CIRCULATION, V91, P2528, DOI 10.1161/01.CIR.91.10.2528; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Okazaki S, 2004, CIRCULATION, V110, P1061, DOI 10.1161/01.CIR.0000140261.58966.A4; OLIVER MF, 1994, LANCET, V344, P633; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; PITT B, 1995, J AM COLL CARDIOL, V26, P1133, DOI 10.1016/0735-1097(95)00301-0; Schoenhagen P, 2003, J AM SOC ECHOCARDIOG, V16, P277, DOI 10.1067/mje.2003.45; Tardif JC, 2004, CIRCULATION, V110, P3372, DOI 10.1161/01.CIR.0000147777.12010.EF; Tardif JC, 2003, CIRCULATION, V107, P552, DOI 10.1161/01.CIR.0000047525.58618.3C; WATERS D, 1994, CIRCULATION, V89, P959, DOI 10.1161/01.CIR.89.3.959	22	1468	1609	4	89	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2006	295	13					1556	1565		10.1001/jama.295.13.jpc60002	http://dx.doi.org/10.1001/jama.295.13.jpc60002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028RG	16533939	Bronze			2022-12-28	WOS:000236505400023
J	Southall, DP; Samuels, MP				Southall, DP; Samuels, MP			CNEP needs to return	LANCET			English	Editorial Material							NEGATIVE EXTRATHORACIC PRESSURE; BRONCHIOLITIS RELATED APNEA; RESPIRATORY-FAILURE; YOUNG-CHILDREN; INFANTS; VENTILATION		Univ Hosp N Staffordshire, Acad Dept Paediat, Stoke On Trent ST4 6QG, Staffs, England	Keele University	Southall, DP (corresponding author), Univ Hosp N Staffordshire, Acad Dept Paediat, Stoke On Trent ST4 6QG, Staffs, England.	davids@doctors.org.uk						Al-balkhi A, 2005, ARCH DIS CHILD, V90, P288, DOI 10.1136/adc.2003.039404; CAMPBELL B, 2006, NURSERY WORLD   0302; GORNALL J, 2006, HOSP DOCTOR     0309; HARTMAN H, 1994, EUROPEAN RESP J S, V18, P379; Hartmann H, 1997, PEDIATR PULM, V23, P155; Henderson J, 2005, ARCH DIS CHILD, V90, P224, DOI 10.1136/adc.2004.054007; Hey E, 2002, ARCH DIS CHILD, V86, P1, DOI 10.1136/adc.86.1.1; Klonin H, 2000, PEDIATR PULM, V30, P260; RAINE J, 1992, BRIT HEART J, V67, P308; SAMUELS MP, 1989, BRIT MED J, V299, P1253, DOI 10.1136/bmj.299.6710.1253; Samuels MP, 1996, PEDIATRICS, V98, P1154; Telford K, 2006, LANCET, V367, P1080, DOI 10.1016/S0140-6736(06)68475-4	12	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1033	1035		10.1016/S0140-6736(06)68446-8	http://dx.doi.org/10.1016/S0140-6736(06)68446-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581385				2022-12-28	WOS:000236673200006
J	Bindschadler, R				Bindschadler, R			Climate change - Hitting the ice sheets where it hurts	SCIENCE			English	Editorial Material							PINE ISLAND GLACIER; WEST ANTARCTICA; ACCELERATION; OCEAN		NASA, Hydrospher & Biospher Sci Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Bindschadler, R (corresponding author), NASA, Hydrospher & Biospher Sci Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	robert.a.bindschadler@nasa.gov						DELANGE R, 2005, FALL 2005 M AM GEOPH; Hansen J, 2005, SCIENCE, V308, P1431, DOI 10.1126/science.1110252; HOLLAND DR, UNPUB; Jacobs SS, 1996, GEOPHYS RES LETT, V23, P957, DOI 10.1029/96GL00723; Krabill W, 1999, SCIENCE, V283, P1522, DOI 10.1126/science.283.5407.1522; KRABILL W, 2005, FALL 2005 M AM GEOPH; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Lythe MB, 2001, J GEOPHYS RES-SOL EA, V106, P11335, DOI 10.1029/2000JB900449; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2002, ANN GLACIOL, V34, P189, DOI 10.3189/172756402781817950; Rignot EJ, 1998, SCIENCE, V281, P549, DOI 10.1126/science.281.5376.549; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Shepherd A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014183; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; SHEPHERD A, 2005, ROYAL SOC M DYN ANT; STEARNS LA, 2005, FALL 2005 M AM GEOPH; Thomas R, 2004, ANN GLACIOL-SER, V39, P133, DOI 10.3189/172756404781814429; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	20	49	51	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2006	311	5768					1720	1721		10.1126/science.1125226	http://dx.doi.org/10.1126/science.1125226			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556828				2022-12-28	WOS:000236204300026
J	Johnson, ZI; Zinser, ER; Coe, A; McNulty, NP; Woodward, EMS; Chisholm, SW				Johnson, ZI; Zinser, ER; Coe, A; McNulty, NP; Woodward, EMS; Chisholm, SW			Niche partitioning among Prochlorococcus ecotypes along ocean-scale environmental gradients	SCIENCE			English	Article							NORTH-ATLANTIC OCEAN; MICROBIAL COMMUNITY STRUCTURE; SARGASSO SEA; CYANOBACTERIUM PROCHLOROCOCCUS; PHOTOSYNTHETIC PROKARYOTE; MERIDIONAL TRANSECT; PACIFIC-OCEAN; TIME-SERIES; SYNECHOCOCCUS; PICOPLANKTON	Prochlorococcus is the numerically dominant phytoplankter in the oligotrophic oceans, accounting for up to half of the photosynthetic biomass and production in some regions. Here, we describe how the abundance of six known ecotypes, which have small subunit ribosomal RNA sequences that differ by less than 3%, changed along local and basin-wide environmental gradients in the Atlantic Ocean. Temperature was significantly correlated with shifts in ecotype abundance, and laboratory experiments confirmed different temperature optima and tolerance ranges for cultured strains. Light, nutrients, and competitor abundances also appeared to play a role in shaping different distributions.	MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; Plymouth Marine Lab, Plymouth PL1 3DH, Devon, England	Massachusetts Institute of Technology (MIT); University of Hawaii System; University of Tennessee System; University of Tennessee Knoxville; Plymouth Marine Laboratory	Chisholm, SW (corresponding author), MIT, Dept Civil & Environm Engn, 15 Vasser St 48-119, Cambridge, MA 02139 USA.	chisholm@mit.edu	Woodward, Ernest M S/D-5755-2016; Johnson, Zackary I/E-4601-2011	Woodward, Ernest M S/0000-0002-7187-6689; Johnson, Zackary I/0000-0003-0793-8512; Chisholm, Sallie/0000-0003-1480-2445	Natural Environment Research Council [NER/O/S/2001/00680] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ahlgren NA, 2006, ENVIRON MICROBIOL, V8, P441, DOI 10.1111/j.1462-2920.2005.00910.x; Aiken J, 2000, PROG OCEANOGR, V45, P257, DOI 10.1016/S0079-6611(00)00005-7; Campbell L, 1997, DEEP-SEA RES PT I, V44, P167, DOI 10.1016/S0967-0637(96)00102-1; Campbell L, 1998, DEEP-SEA RES PT II, V45, P2301, DOI 10.1016/S0967-0645(98)00072-1; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; CHISHOLM SW, 1988, NATURE, V334, P340, DOI 10.1038/334340a0; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Hooker SB, 2000, PROG OCEANOGR, V45, P313, DOI 10.1016/S0079-6611(00)00006-9; Johnson Z, 2000, DEEP-SEA RES PT I, V47, P1485, DOI 10.1016/S0967-0637(99)00111-9; Mann EL, 2002, LIMNOL OCEANOGR, V47, P976, DOI 10.4319/lo.2002.47.4.0976; Monger BC, 1999, LIMNOL OCEANOGR, V44, P1917, DOI 10.4319/lo.1999.44.8.1917; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; OLSON RJ, 1990, DEEP-SEA RES, V37, P1033, DOI 10.1016/0198-0149(90)90109-9; PALENIK B, 1992, NATURE, V355, P265, DOI 10.1038/355265a0; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Urbach E, 1998, LIMNOL OCEANOGR, V43, P1615, DOI 10.4319/lo.1998.43.7.1615; Urbach E, 1998, J MOL EVOL, V46, P188, DOI 10.1007/PL00006294; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2	29	670	690	8	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1737	1740		10.1126/science.1118052	http://dx.doi.org/10.1126/science.1118052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556835				2022-12-28	WOS:000236204300033
J	Berkowitz, RL; Roberts, J; Minkoff, H				Berkowitz, RL; Roberts, J; Minkoff, H			Challenging the strategy of maternal age-based prenatal genetic counseling	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							AMNIOCENTESIS		Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10032 USA; SUNY Hlth Sci Ctr, SUNY Downstate, Brooklyn, NY 11203 USA; Maimonides Hosp, Brooklyn, NY 11219 USA	Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Maimonides Medical Center	Berkowitz, RL (corresponding author), Columbia Univ, Med Ctr, Dept Obstet & Gynecol, PH 16-66,622 W 168th St, New York, NY 10032 USA.	rb2212@columbia.edu						*AM COLL OBST GYN, 2001, ACOG PRACT B, V27; *AM COLL OBST GYN, 2004, COMM OP 108 INF CONS; *AM COLL OBST GYN, 1972, ACOG TECHN B, V19; American College of Obstetricians and Gynecologists, 1976, ACOG TECHN B, V39; BERKOWITZ RL, IN PRESS OBSTET GYNE; CRANDALL BF, 1980, OBSTET GYNECOL, V56, P625; Eddleman K, 2003, AM J OBSTET GYNECOL, V189, pS111, DOI 10.1016/j.ajog.2003.10.174; HOOK EB, 1983, JAMA-J AM MED ASSOC, V249, P2034, DOI 10.1001/jama.249.15.2034; HOOK EB, 1992, PRENATAL DIAGNOSIS S; Kuppermann M, 1999, AM J PUBLIC HEALTH, V89, P160, DOI 10.2105/AJPH.89.2.160; KUPPERMANN M, 1996, MED DECIS MAKING, V16, P466; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; NICOLAIDES KH, 1994, ULTRASOUND OBST GYN, V4, P353, DOI 10.1046/j.1469-0705.1994.04050353.x; *NIH, 1979, REP CONS DEV C SPONS; Resta Robert G, 2002, Med Secoli, V14, P793; TABOR A, 1986, LANCET, V1, P1287	16	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1446	1448		10.1001/jama.295.12.1446	http://dx.doi.org/10.1001/jama.295.12.1446			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551717				2022-12-28	WOS:000236157700024
J	Schall, P; Cohen, I; Weitz, DA; Spaepen, F				Schall, P; Cohen, I; Weitz, DA; Spaepen, F			Visualizing dislocation nucleation by indenting colloidal crystals	NATURE			English	Article							INCIPIENT PLASTICITY; NANOINDENTATION; DEFORMATION; INDENTATION; DYNAMICS	The formation of dislocations is central to our understanding of yield, work hardening, fracture, and fatigue(1) of crystalline materials. While dislocations have been studied extensively in conventional materials, recent results have shown that colloidal crystals offer a potential model system for visualizing their structure and dynamics directly in real space(2). Although thermal fluctuations are thought to play a critical role in the nucleation of these defects, it is difficult to observe them directly. Nano-indentation, during which a small tip deforms a crystalline film, is a common tool for introducing dislocations into a small volume that is initially defect-free(3-10). Here, we show that an analogue of nano- indentation performed on a colloidal crystal provides direct images of defect formation in real time and on the single particle level, allowing us to probe the effects of thermal fluctuations. We implement a new method to determine the strain tensor of a distorted crystal lattice and we measure the critical dislocation loop size and the rate of dislocation nucleation directly. Using continuum models, we elucidate the relation between thermal fluctuations and the applied strain that governs defect nucleation. Moreover, we estimate that although bond energies between particles are about fifty times larger in atomic systems, the difference in attempt frequencies makes the effects of thermal fluctuations remarkably similar, so that our results are also relevant for atomic crystals.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Schall, P (corresponding author), Univ Amsterdam, Van der Waals Zeeman Inst, Valckenierstr 65, NL-1018 XE Amsterdam, Netherlands.	pschall@science.uva.nl		Cohen, Itai/0000-0001-9218-043X				[Anonymous], 2007, PRINCIPLES CONDENSED; [Anonymous], 1956, DISLOCATIONS PLASTIC; DAVIES RM, 1949, PROC R SOC LON SER-A, V197, P416, DOI 10.1098/rspa.1949.0073; Falk ML, 1998, PHYS REV E, V57, P7192, DOI 10.1103/PhysRevE.57.7192; Frank F., 1950, S PLASTIC DEFORMATIO, P89; FRENKEL D, 1987, PHYS REV LETT, V59, P1169, DOI 10.1103/PhysRevLett.59.1169; Gouldstone A, 2001, NATURE, V411, P656, DOI 10.1038/35079687; HIGASHIGAKI Y, 1981, J PHYS CHEM-US, V85, P2531, DOI 10.1021/j150617a024; Hirth J. P., 1972, THEORY DISLOCATIONS; HIRTH JP, 1963, RELATION STRUCTURE M, P217; Kelchner CL, 1998, PHYS REV B, V58, P11085, DOI 10.1103/PhysRevB.58.11085; Kiely JD, 1999, J MATER RES, V14, P2219, DOI 10.1557/JMR.1999.0298; Li J, 2002, NATURE, V418, P307, DOI 10.1038/nature00865; Lilleodden ET, 2003, J MECH PHYS SOLIDS, V51, P901, DOI 10.1016/S0022-5096(02)00119-9; Minor AM, 2004, J MATER RES, V19, P176, DOI 10.1557/jmr.2004.19.1.176; Schall P, 2004, SCIENCE, V305, P1944, DOI 10.1126/science.1102186; Stach EA, 2001, MICROSC MICROANAL, V7, P507, DOI 10.1007/s10005-001-0012-4; Suresh S, 1999, SCRIPTA MATER, V41, P951, DOI 10.1016/S1359-6462(99)00245-6; vanBlaaderen A, 1997, NATURE, V385, P321, DOI 10.1038/385321a0; Weeks ER, 2000, SCIENCE, V287, P627, DOI 10.1126/science.287.5453.627	20	182	184	4	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					319	323		10.1038/nature04557	http://dx.doi.org/10.1038/nature04557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541069				2022-12-28	WOS:000235997600049
J	Costa, J; Borges, M; David, C; Carneiro, AV				Costa, Joao; Borges, Margarida; David, Claudio; Carneiro, Antnio Vaz			Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SCANDINAVIAN-SIMVASTATIN-SURVIVAL; SERUM-CHOLESTEROL CONCENTRATION; PRIMARY-PREVENTION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; SUBGROUP ANALYSIS; RISK-FACTORS; EVENTS	Objective To evaluate the clinical benefit of lipid lowering drug treatment in patients with and without diabetes mellitus, for primary and secondary prevention. Design Systematic review and meta-analysis. Data sources Cochrane, Medline, Embase, and reference lists up to April 2004. Study selection Randomised, placebo controlled, double blind trials with a follow-up of at least three years that evaluated lipid lowering drug treatment in patients with and without diabetes mellitus. Data extraction Two independent reviewers extracted data. The primary outcome was major coronary events defined as coronary heart disease death, non-fatal myocardial infarction, or myocardial revascularisation procedures. Results Twelve studies were included. Lipid lowering drug treatment was found to be at least as effective in diabetic patients as in non-diabetic patients. In primary prevention, the risk reduction for major coronary events was 21% (95% confidence interval 11% to 30%; P <0.0001) in diabetic patients and 23% (12% to 33%; P = 0.0003) in non-diabetic patients. In secondary prevention, the corresponding risk reductions were 21% (10% to 31%; P = 0.0005) and 23% (19% to 26%; P <= 0.00001). However, the absolute risk difference was three times higher in secondary prevention. When results were adjusted for baseline risk, diabetic patients benefited more in both primary and secondary prevention. Blood lipids were reduced to a similar degree in both groups. Conclusions The evidence that lipid lowering drug treatment (especially statins) significantly reduce cardiovascular risk in diabetic and non-diabetic patients is strong and suggests that diabetic patients benefit more, in both primary and secondary prevention. Future research should define the threshold for treatment of these patients and the desired target lipid concentrations, especially for primary prevention.	Univ Lisbon, Sch Med, Ctr Evidence Based Med, P-1699 Lisbon, Portugal; Santa Maria Univ Hosp, Dept Cardiol, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Carneiro, AV (corresponding author), Fac Med Lisbon, CEMBE, Piso 6,Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.	avc@fm.ul.pt	borges, margarida/GWR-0803-2022; Vaz-Carneiro, António/L-8026-2013	Vaz-Carneiro, António/0000-0002-2783-0544				*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI DOI 10.1016/S1062-1458(03)00049-7; Am Diabetes Assoc, 1999, CIRCULATION, V100, P1132, DOI 10.1161/01.cir.100.10.1132; Austin MA, 1996, CURR OPIN LIPIDOL, V7, P167, DOI 10.1097/00041433-199606000-00010; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Campeau L, 1997, NEW ENGL J MED, V336, P153; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cheung BMY, 2004, BRIT J CLIN PHARMACO, V57, P640, DOI 10.1111/j.1365-2125.2003.02060.x; Chiquette Elaine, 2002, Curr Atheroscler Rep, V4, P134, DOI 10.1007/s11883-002-0037-z; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2003, LANCET, V361, P2005; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Freeman DJ, 2001, CIRCULATION, V103, P357; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Garg A, 2004, LANCET, V364, P641, DOI 10.1016/S0140-6736(04)16907-9; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Haffner SM, 1999, ARCH INTERN MED, V159, P2661, DOI 10.1001/archinte.159.22.2661; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hoogwerf BJ, 1999, DIABETES, V48, P1289, DOI 10.2337/diabetes.48.6.1289; Keech A, 2003, DIABETES CARE, V26, P2713, DOI 10.2337/diacare.26.10.2713; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; PEDERSEN TR, 1994, LANCET, V344, P1383; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; REAVEN GM, 1993, J CLIN INVEST, V92, P141, DOI 10.1172/JCI116541; Rubins HB, 2002, ARCH INTERN MED, V162, P2597, DOI 10.1001/archinte.162.22.2597; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Smeeth L, 1999, BMJ-BRIT MED J, V318, P1548, DOI 10.1136/bmj.318.7197.1548; Snow V, 2004, ANN INTERN MED, V140, P644, DOI 10.7326/0003-4819-140-8-200404200-00012; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Steiner G, 2001, LANCET, V357, P905; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Turner R, 1996, ANN INTERN MED, V124, P136, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00011; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; VERSCHUREN WMM, 1995, JAMA-J AM MED ASSOC, V274, P131, DOI 10.1001/jama.274.2.131; Vijan S, 2004, ANN INTERN MED, V140, P650, DOI 10.7326/0003-4819-140-8-200404200-00013; Winkler K, 2002, J CLIN ENDOCR METAB, V87, P5485, DOI 10.1210/jc.2002-020370	50	216	226	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2006	332	7550					1115	1118C		10.1136/bmj.38793.468449.AE	http://dx.doi.org/10.1136/bmj.38793.468449.AE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	044OT	16585050	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000237682700014
J	Norman, GR				Norman, GR			Commentary: Standardising the process versus improving the methods	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-SCHOOL		McMaster Univ, Michael DeGroote Ctr Learning, Program Educ Res & Dev, Hamilton, ON L8N 3Z5, Canada	McMaster University	Norman, GR (corresponding author), McMaster Univ, Michael DeGroote Ctr Learning, Program Educ Res & Dev, Hamilton, ON L8N 3Z5, Canada.	norman@mcmaster.ca						Eva KW, 2004, ACAD MED, V79, pS40, DOI 10.1097/00001888-200410001-00012; Lumsden MA, 2005, MED EDUC, V39, P258, DOI 10.1111/j.1365-2929.2005.02087.x; Parry J, 2006, BMJ-BRIT MED J, V332, P1005, DOI 10.1136/bmj.38768.590174.55; Salvatori P, 2001, ADV HEALTH SCI EDUC, V6, P159, DOI 10.1023/A:1011489618208	4	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 29	2006	332	7548					1008	1009		10.1136/bmj.38776.497627.55	http://dx.doi.org/10.1136/bmj.38776.497627.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16543301	Green Published, Bronze			2022-12-28	WOS:000237403100017
J	Harris, M; Rizvi, S; Hindmarsh, J; Bryan, R				Harris, M; Rizvi, S; Hindmarsh, J; Bryan, R			Lesson of the week - Testicular tumour presenting as gynaecomastia	BRITISH MEDICAL JOURNAL			English	Review									Friarage Hosp, Dept Urol, Northallerton DL6 1JG, Yorks, England; Friarage Hosp, Dept Gen Surg, Northallerton DL6 1JG, Yorks, England		Harris, M (corresponding author), Friarage Hosp, Dept Urol, Northallerton DL6 1JG, Yorks, England.	maya.harris@stees.nhs.uk						BRAUNSTEIN GD, 1993, NEW ENGL J MED, V328, P490; Carlson HE, 2004, J CLIN ENDOCR METAB, V89, P4119, DOI 10.1210/jc.2003-031882; Daniels IR, 2003, EUR J SURG ONCOL, V29, P437, DOI 10.1016/S0748-7983(03)00004-0; HENDRY WS, 1984, BRIT J RADIOL, V57, P571, DOI 10.1259/0007-1285-57-679-571; MOUL JW, 1992, MIL MED, V157, P433, DOI 10.1093/milmed/157.8.433	5	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	APR 8	2006	332	7545					837	837		10.1136/bmj.332.7545.837	http://dx.doi.org/10.1136/bmj.332.7545.837			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16601045	Green Published			2022-12-28	WOS:000236815900023
J	Greenberg, SM				Greenberg, SM			Research on stroke: Small vessels, big problems	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLOOD-PRESSURE		Massachusetts Gen Hosp, Neurol Clin Trials Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Greenberg, SM (corresponding author), Massachusetts Gen Hosp, Neurol Clin Trials Unit, Boston, MA 02114 USA.		Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789	NIA NIH HHS [R01 AG026484] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG026484] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Dufouil C, 2005, CIRCULATION, V112, P1644, DOI 10.1161/CIRCULATIONAHA.104.501163; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Iadecola C, 2004, STROKE, V35, P348, DOI 10.1161/01.STR.0000115162.16321.AA; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066	4	93	96	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1451	1453		10.1056/NEJMp068043	http://dx.doi.org/10.1056/NEJMp068043			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	029DP	16598043				2022-12-28	WOS:000236539000003
J	Kyaw, MH; Lynfield, R; Schaffner, W; Craig, AS; Hadler, J; Reingold, A; Thomas, AR; Harrison, LH; Bennett, NM; Farley, MM; Facklam, RR; Jorgensen, JH; Besser, J; Zell, ER; Schuchat, A; Whitney, CG				Kyaw, MH; Lynfield, R; Schaffner, W; Craig, AS; Hadler, J; Reingold, A; Thomas, AR; Harrison, LH; Bennett, NM; Farley, MM; Facklam, RR; Jorgensen, JH; Besser, J; Zell, ER; Schuchat, A; Whitney, CG		Active Bacterial Core Surveillance	Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	43rd Interscience Conference on Antimicrobial Agents and Chemotherapy	SEP 14-17, 2003	CHICAGO, IL				ACUTE OTITIS-MEDIA; PRACTICE GUIDELINES; CARRIAGE; EFFICACY; MANAGEMENT; SEROTYPES; CHILDREN; DISEASE; SPREAD; TRIAL	Background: Five of seven serotypes in the pneumococcal conjugate vaccine, introduced for infants in the United States in 2000, are responsible for most penicillin-resistant infections. We examined the effect of this vaccine on invasive disease caused by resistant strains. Methods: We used laboratory-based data from Active Bacterial Core surveillance to measure disease caused by antibiotic-nonsusceptible pneumococci from 1996 through 2004. Cases of invasive disease, defined as disease caused by pneumococci isolated from a normally sterile site, were identified in eight surveillance areas. Isolates underwent serotyping and susceptibility testing. Results: Rates of invasive disease caused by penicillin-nonsusceptible strains and strains not susceptible to multiple antibiotics peaked in 1999 and decreased by 2004, from 6.3 to 2.7 cases per 100,000 (a decline of 57 percent; 95 percent confidence interval, 55 to 58 percent) and from 4.1 to 1.7 cases per 100,000 (a decline of 59 percent; 95 percent confidence interval, 58 to 60 percent), respectively. Among children under two years of age, disease caused by penicillin-nonsusceptible strains decreased from 70.3 to 13.1 cases per 100,000 (a decline of 81 percent; 95 percent confidence interval, 80 to 82 percent). Among persons 65 years of age or older, disease caused by penicillin-nonsusceptible strains decreased from 16.4 to 8.4 cases per 100,000 (a decline of 49 percent). Rates of resistant disease caused by vaccine serotypes fell 87 percent.An increase was seen in disease caused by serotype 19A, a serotype not included in the vaccine (from 2.0 to 8.3 per 100,000 among children under two years of age). Conclusions: The rate of antibiotic-resistant invasive pneumococcal infections decreased in young children and older persons after the introduction of the conjugate vaccine. There was an increase in infections caused by serotypes not included in the vaccine.	Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Minnesota Dept Hlth, Minneapolis, MN USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Tennessee Dept Hlth, Nashville, TN USA; Connecticut Dept Publ Hlth, Hartford, CT USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Oregon Dept Human Serv, Emerging Infect Programs, Hlth Div, Portland, OR USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Monroe Cty Dept Hlth, Rochester, NY USA; Univ Rochester, Rochester, NY USA; Emory Univ, Sch Med, Atlanta, GA USA; Vet Affairs Med Ctr, Atlanta, GA 30033 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Vanderbilt University; Tennessee Department Health; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Rochester; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Texas System; University of Texas Health San Antonio	Whitney, CG (corresponding author), CDC Mailstop C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	cwhitney@cdc.gov						[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P717; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1007; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; Hausdorff WP, 2002, PEDIATR INFECT DIS J, V21, P1008, DOI 10.1097/00006454-200211000-00007; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Kilpi T, 2003, CLIN INFECT DIS, V37, P1155, DOI 10.1086/378744; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; McCormick AW, 2003, NAT MED, V9, P424, DOI 10.1038/nm839; National Committee for Clinical Laboratory Stardards, 2004, M100S14 NAT COMM CLI; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Pelton SI, 2004, PEDIATR INFECT DIS J, V23, P1015, DOI 10.1097/01.inf.0000143645.58215.f0; PICKERING LK, 2003, RED BOOK 2003 REPORT, P490; Schrag SJ, 2000, CLIN MICROBIOL REV, V13, P588, DOI 10.1128/CMR.13.4.588-601.2000; Talbot TR, 2004, CLIN INFECT DIS, V39, P641, DOI 10.1086/422653; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; 2001, MMWR MORB MORTAL WKL, V50, P532; 2005, MMWR MORB MORTAL WKL, V54, P935	26	613	643	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2006	354	14					1455	1463		10.1056/NEJMoa051642	http://dx.doi.org/10.1056/NEJMoa051642			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	029DP	16598044	Bronze			2022-12-28	WOS:000236539000004
J	Briggs, RW; Sieh, K; Meltzner, AJ; Natawidjaja, D; Galetzka, J; Suwargadi, B; Hsu, YJ; Simons, M; Hananto, N; Suprihanto, I; Prayudi, D; Avouac, JP; Prawirodirdjo, L; Bock, Y				Briggs, RW; Sieh, K; Meltzner, AJ; Natawidjaja, D; Galetzka, J; Suwargadi, B; Hsu, YJ; Simons, M; Hananto, N; Suprihanto, I; Prayudi, D; Avouac, JP; Prawirodirdjo, L; Bock, Y			Deformation and slip along the Sunda Megathrust in the great 2005 Nias-Simeulue earthquake	SCIENCE			English	Article							SUMATRAN SUBDUCTION ZONE; CRUSTAL DEFORMATION; BOUNDARY; MODEL; MICROATOLLS; MECHANISM; INDONESIA; HISTORY; JAPAN; ARC	Seismic rupture produced spectacular tectonic deformation above a 400-kilometer strip of the Sunda megathrust, offshore northern Sumatra, in March 2005. Measurements from coral microatolls and Global Positioning System stations reveal trench-parallel belts of uplift up to 3 meters high on the outer-arc islands above the rupture and a 1-meter-deep subsidence trough farther from the trench. Surface deformation reflects more than 11 meters of fault slip under the islands and a pronounced lessening of slip trenchward. A saddle in megathrust slip separates the northwestern edge of the 2005 rupture from the great 2004 Sumatra-Andaman rupture. The southeastern edge abuts a predominantly aseismic section of the megathrust near the equator.	CALTECH, Div Geol & Planetary Sci, Tecton Observ, Pasadena, CA 91125 USA; Indonesian Inst Sci, Res Ctr Geotechnol, Bandung, Indonesia; Jl Mahoni, Kota Jakarta 14270, Indonesia; Univ Calif San Diego, Scripps Inst Oceanog, Cecil H & Ida M Green Inst Geophys & Planetary Ph, La Jolla, CA 92093 USA	California Institute of Technology; Indonesian Institute of Sciences; University of California System; University of California San Diego; Scripps Institution of Oceanography	Briggs, RW (corresponding author), CALTECH, Div Geol & Planetary Sci, Tecton Observ, Pasadena, CA 91125 USA.	briggs@gps.caltech.edu	Simons, Mark/N-4397-2015; Meltzner, Aron J/A-5585-2009; Avouac, Jean-Philippe/B-5699-2015; Briggs, Richard/A-1348-2013; Hsu, Ya-Ju/O-2709-2016	Simons, Mark/0000-0003-1412-6395; Meltzner, Aron J/0000-0002-2955-0896; Avouac, Jean-Philippe/0000-0002-3060-8442; Briggs, Richard/0000-0001-8108-0046; Hsu, Ya-Ju/0000-0003-1389-9994				Agnew DC, 1997, J GEOPHYS RES-SOL EA, V102, P5109, DOI 10.1029/96JB03458; Bassin C., 2000, EOS T AM GEOPHYS UN, V81, pF897; Bilham R, 2005, SEISMOL RES LETT, V76, P299, DOI 10.1785/gssrl.76.3.299; BORRERO J, 2005, INT M SUM EARTHQ CHA; CHLIEH M, COMMUNICATION; Curray JR, 2005, J ASIAN EARTH SCI, V25, P187, DOI 10.1016/j.jseaes.2004.09.001; DAVIS D, 1983, J GEOPHYS RES, V88, P1153, DOI 10.1029/JB088iB02p01153; DeShon HR, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024188; Egbert GD, 2002, J ATMOS OCEAN TECH, V19, P183, DOI 10.1175/1520-0426(2002)019<0183:EIMOBO>2.0.CO;2; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; FITCH TJ, 1971, J GEOPHYS RES, V76, P7260, DOI 10.1029/JB076i029p07260; HSU Y, 2005, EOS T AGU, V86; Hsu Y. T., UNPUB; KANAMORI H, 1973, ANNU REV EARTH PL SC, V1, P213, DOI 10.1146/annurev.ea.01.050173.001241; KARIG DE, 1980, J GEOL SOC LONDON, V137, P77, DOI 10.1144/gsjgs.137.1.0077; Kerr RA, 2005, SCIENCE, V308, P341; KONCA AO, 2005, EOS T AGU, V86; Meltzner AJ, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003891; Natawidjaja DH, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002398; Nikolaidis R., 2002, OBSERVATION GEODETIC; PANDOLFI JM, 1994, GEOLOGY, V22, P239, DOI 10.1130/0091-7613(1994)022<0239:CEOMHP>2.3.CO;2; PLAFKER G, 1965, SCIENCE, V148, P1675, DOI 10.1126/science.148.3678.1675; PLAFKER G, 1970, GEOL SOC AM BULL, V81, P1001, DOI 10.1130/0016-7606(1970)81[1001:MOTCEO]2.0.CO;2; Prawirodirdjo L, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002944; SCOFFIN TP, 1978, PHILOS T ROY SOC B, V284, P99, DOI 10.1098/rstb.1978.0055; Sieh K, 1999, GEOPHYS RES LETT, V26, P3141, DOI 10.1029/1999GL005409; Sieh K, 2000, J GEOPHYS RES-SOL EA, V105, P28295, DOI 10.1029/2000JB900120; SIEH K, 2005, EOS T AGU, V86; Smith W., 1997, SCIENCE, V277, P956, DOI DOI 10.1126/SCIENCE.277.5334.1956; *SRTM, SHUTTL RAD TOP MISS; Subarya C, 2006, NATURE, V440, P46, DOI 10.1038/nature04522; TAYLOR FW, 1987, J GEOPHYS RES-SOLID, V92, P4905, DOI 10.1029/JB092iB06p04905; *US GEOL SURV, 2005, NOT FIELD USGS SCI S; VERSTAPPEN HT, 1973, GEOMORPHICAL RECONNA; Zachariasen J, 2000, B SEISMOL SOC AM, V90, P897, DOI 10.1785/0119980016	35	236	243	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1897	1901		10.1126/science.1122602	http://dx.doi.org/10.1126/science.1122602			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574861	Green Submitted, Green Accepted			2022-12-28	WOS:000236387800037
J	Jaramillo, C; Rueda, MJ; Mora, G				Jaramillo, C; Rueda, MJ; Mora, G			Cenozoic plant diversity in the Neotropics	SCIENCE			English	Article							RAIN-FOREST; EASTERN CORDILLERA; SOUTH-AMERICA; CLIMATE; VEGETATION; BASIN; PLEISTOCENE; QUATERNARY; PATTERNS; MIOCENE	Several mechanisms have been proposed to explain the high levels of plant diversity in the Neotropics today, but little is known about diversification patterns of Neotropical floras through geological time. Here, we present the longest time series compiled for palynological plant diversity of the Neotropics (15 stratigraphic sections, 1530 samples, 1411 morphospecies, and 287,736 occurrences) from the Paleocene to the early Miocene (65 to 20 million years ago) in central Colombia and western Venezuela. The record shows a low-diversity Paleocene flora, a significantly more diverse early to middle Eocene flora exceeding Holocene levels, and a decline in diversity at the end of the Eocene and early Oligocene. A good correlation between diversity fluctuations and changes in global temperature was found, suggesting that tropical climate change may be directly driving the observed diversity pattern. Alternatively, the good correspondence may result from the control that climate exerts on the area available for tropical plants to grow.	Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archeol, Unit 0948, APO, AA 34002 USA; Paleoflora Colombian Petr Inst, Bucaramanga, Colombia; Iowa State Univ, Dept Geol & Atmospher Sci, Ames, IA 50011 USA	Smithsonian Institution; Smithsonian Tropical Research Institute; Iowa State University	Jaramillo, C (corresponding author), Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archeol, Unit 0948, APO, AA 34002 USA.	jaramilloc@si.edu		jaramillo, carlos/0000-0002-2616-5079				Barnosky AD, 2005, PLOS BIOL, V3, P1356, DOI 10.1371/journal.pbio.0030266; BERRIO JC, 2002, LATE GLACIAL HOLOCEN; BOLTOVSKOY D, 1988, J PALEONTOL, V62, P157; Burnham RJ, 1999, ANN MO BOT GARD, V86, P546, DOI 10.2307/2666185; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Clyde WC, 1998, GEOLOGY, V26, P1011, DOI 10.1130/0091-7613(1998)026<1011:MCRTTL>2.3.CO;2; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; DENGO CA, 1993, AAPG BULL, V77, P1315; EDWARDS L E, 1989, Palaios, V4, P127, DOI 10.2307/3514601; FINE PV, 2005, ANN M ASS TROP BIOL; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; GRAHAM A, 1994, AM J BOT, V81, P301, DOI 10.2307/2445456; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hooghiemstra H, 1998, EARTH-SCI REV, V44, P147, DOI 10.1016/S0012-8252(98)00027-0; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V109, P1, DOI 10.1016/0031-0182(94)90117-1; Jaramillo CA, 2002, PALEOBIOLOGY, V28, P222, DOI 10.1666/0094-8373(2002)028<0222:ROTVTP>2.0.CO;2; Johnson KR, 2002, SCIENCE, V296, P2379, DOI 10.1126/science.1072102; Kaandorp RJG, 2005, PALAEOGEOGR PALAEOCL, V221, P1, DOI 10.1016/j.palaeo.2004.12.024; Kastner TP, 2003, GEOLOGY, V31, P291, DOI 10.1130/0091-7613(2003)031<0291:CITVOT>2.0.CO;2; Leigh EG, 2004, BIOTROPICA, V36, P447, DOI 10.1111/j.1744-7429.2004.tb00342.x; MacFadden BJ, 2004, OECOLOGIA, V140, P169, DOI 10.1007/s00442-004-1571-x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Morley RJ., 2000, ORIGIN EVOLUTION TRO, P362; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Ricklefs Robert E., 1993, P350; ROMERO EJ, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P62; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Thomas WW, 1999, BIODIVERS CONSERV, V8, P1007, DOI 10.1023/A:1008857429787; Tripati A, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000605; VANDERHAMMEN T, 1973, REV PALAEOBOT PALYNO, V16, P1, DOI 10.1016/0034-6667(73)90031-6; Wilf P, 2005, AM NAT, V165, P634, DOI 10.1086/430055; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; WING S, 2004, INT ORG PAL 7 QUADR; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	44	294	314	2	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1893	1896		10.1126/science.1121380	http://dx.doi.org/10.1126/science.1121380			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574860				2022-12-28	WOS:000236387800036
J	Brown, MS; Goldstein, JL				Brown, MS; Goldstein, JL			Biomedicine - Lowering LDL - Not only how low, but how long?	SCIENCE			English	Editorial Material							HEART-DISEASE; CHOLESTEROL; PCSK9; STATINS; MUTATIONS; PROGRAM; SREBP; GENE		Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Brown, MS (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	mike.brown@utsouthwestern.edu; joe.goldstein@utsouthwestern.edu						Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bansal N, 2005, CURR OPIN LIPIDOL, V16, P400, DOI 10.1097/01.mol.0000174154.61307.16; Brown MS, 2004, ATHEROSCLEROSIS SUPP, V5, P13, DOI 10.1016/j.atherosclerosissup.2004.08.007; CHEN ZM, 1991, BRIT MED J, V303, P276, DOI 10.1136/bmj.303.6797.276; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Vaughan CJ, 2004, CIRCULATION, V110, P886, DOI 10.1161/01.CIR.0000139312.10076.BA; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	23	157	187	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1721	1723		10.1126/science.1125884	http://dx.doi.org/10.1126/science.1125884			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556829				2022-12-28	WOS:000236204300027
J	Chang, CI; Chelliah, Y; Borek, D; Mengin-Lecreulx, D; Deisenhofer, J				Chang, CI; Chelliah, Y; Borek, D; Mengin-Lecreulx, D; Deisenhofer, J			Structure of tracheal cytotoxin in complex with a heterodimeric pattern-recognition receptor	SCIENCE			English	Article							PEPTIDOGLYCAN-RECOGNITION; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER; ANGSTROM RESOLUTION; IMMUNE-SYSTEM; PROTEINS; PATHWAY	Tracheal cytotoxin (TCT), a naturally occurring fragment of Gram-negative peptidoglycan, is a potent elicitor of innate immune responses in Drosophila. It induces the heterodimerization of its recognition receptors, the peptidoglycan recognition proteins (PGRPs) LCa and LCx, which activates the immune deficiency pathway. The crystal structure at 2.1 angstrom resolution of TCT in complex with the ectodomains of PGRP-LCa and PGRP-LCx shows that TCT is bound to and presented by the LCx ectodomain for recognition by the LCa ectodomain; the latter lacks a canonical peptidoglycan-docking groove conserved in other PGRPs. The interface, revealed in atomic detail, between TCT and the receptor complex highlights the importance of the anhydro-containing disaccharide in bridging the two ectodomains together and the critical role of diaminopimelic acid as the specificity determinant for PGRP interaction.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; CNRS, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Centre National de la Recherche Scientifique (CNRS); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Deisenhofer, J (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	johann.deisenhofer@utsouthwestern.edu	Borek, Dominika M/D-2943-2011	Borek, Dominika M/0000-0002-4321-6253; Chang, Chung-I/0000-0003-0989-1228; MENGIN-LECREULX, Dominique/0000-0003-3205-0275				Chang CI, 2004, PLOS BIOL, V2, P1293, DOI 10.1371/journal.pbio.0020277; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; GOLDMAN WE, 1982, INFECT IMMUN, V36, P782, DOI 10.1128/IAI.36.2.782-794.1982; Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101; Guan RJ, 2005, J MOL BIOL, V347, P683, DOI 10.1016/j.jmb.2005.01.070; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Liu C, 2000, J BIOL CHEM, V275, P24490, DOI 10.1074/jbc.M001239200; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Reiser JB, 2004, J MOL BIOL, V340, P909, DOI 10.1016/j.jmb.2004.04.077; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772	18	113	118	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1761	1764		10.1126/science.1123056	http://dx.doi.org/10.1126/science.1123056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556841				2022-12-28	WOS:000236204300041
J	Ochman, H; Davalos, LM				Ochman, H; Davalos, LM			The nature and dynamics of bacterial genomes	SCIENCE			English	Review							RNA-ENCODING GENES; ESCHERICHIA-COLI; YERSINIA-PESTIS; SEQUENCE; EVOLUTION; INSIGHTS; IDENTIFICATION; PSEUDOGENES; ANNOTATION; EXPRESSION	Though generally small and gene rich, bacterial. genomes are constantly subjected to both mutational and population-level. processes that operate to increase amounts of functionless DNA As a result, the coding potential of bacterial genomes can be substantially lower than originally predicted. Whereas only a single pseudogene was included in the original annotation of the bacterium Escherichia coli, we estimate that this genome harbors hundreds of inactivated and otherwise functionless genes. Such regions Will never yield a detectable phenotype, but their identification is vital to efforts to elucidate the biological role of all the proteins within the cell.	Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA	University of Arizona	Ochman, H (corresponding author), Univ Arizona, Dept Biochem & Mol Biophys, Tucson, AZ 85721 USA.	hochman@email.arizona.edu		Davalos, Liliana/0000-0002-4327-7697	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056120] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; Andersson JO, 1999, CURR OPIN GENET DEV, V9, P664, DOI 10.1016/S0959-437X(99)00024-6; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Arends SJR, 2004, J BACTERIOL, V186, P880, DOI 10.1128/JB.186.3.880-884.2004; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Bergthorsson U, 1998, MOL BIOL EVOL, V15, P6, DOI 10.1093/oxfordjournals.molbev.a025847; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bocs S, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-5; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Charles H, 1999, MOL BIOL EVOL, V16, P1820, DOI 10.1093/oxfordjournals.molbev.a026096; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Hershberg R, 2003, NUCLEIC ACIDS RES, V31, P1813, DOI 10.1093/nar/gkg297; Homma K, 2002, GENE, V294, P25, DOI 10.1016/S0378-1119(02)00794-1; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Kolker E, 2004, NUCLEIC ACIDS RES, V32, P2353, DOI 10.1093/nar/gkh555; Lawrence J, 2003, TRENDS GENET, V19, P131, DOI 10.1016/S0168-9525(02)00038-0; Lerat E, 2005, NUCLEIC ACIDS RES, V33, P3125, DOI 10.1093/nar/gki631; Lerat E, 2004, GENOME RES, V14, P2273, DOI 10.1101/gr.2925604; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Misra RV, 2005, NUCLEIC ACIDS RES, V33, pD329, DOI 10.1093/nar/gki028; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ochman H, 2002, TRENDS GENET, V18, P335, DOI 10.1016/S0168-9525(02)02668-9; Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Petrov DA, 2000, J HERED, V91, P221, DOI 10.1093/jhered/91.3.221; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Serres MH, 2004, NUCLEIC ACIDS RES, V32, pD300, DOI 10.1093/nar/gkh087; Taoka M, 2004, MOL CELL PROTEOMICS, V3, P780, DOI 10.1074/mcp.M400030-MCP200; Ussery DW, 2004, MICROBIOL-SGM, V150, P2015, DOI 10.1099/mic.0.27338-0; Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957	48	188	195	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1730	1733		10.1126/science.1119966	http://dx.doi.org/10.1126/science.1119966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556833				2022-12-28	WOS:000236204300031
J	Reyes-Turcu, FE; Horton, JR; Mullally, JE; Heroux, A; Cheng, XD; Wilkinson, KD				Reyes-Turcu, FE; Horton, JR; Mullally, JE; Heroux, A; Cheng, XD; Wilkinson, KD			The ubiquitin binding domain ZnFUBP recognizes the C-terminal diglycine motif of unanchored ubiquitin	CELL			English	Article							FREE POLYUBIQUITIN CHAINS; DEUBIQUITINATING ENZYMES; ISOPEPTIDASE-T; SACCHAROMYCES-CEREVISIAE; UBA DOMAIN; CUE DOMAIN; PROTEIN; MECHANISM; COMPLEX; SYSTEM	Ubiquitin binding proteins regulate the stability, function, and/or localization of ubiquitinated proteins. Here we report the crystal structures of the zinc-finger ubiquitin binding domain (ZnF UBP) from the deubiquitinating enzyme isopeptidase T (IsoT, or USP5) alone and in complex with ubiquitin. Unlike other ubiquitin binding domains, this domain contains a deep binding pocket where the C-terminal diglycine motif of ubiquitin is inserted, thus explaining the specificity of IsoT for an unmodified C terminus on the proximal subunit of polyubiquitin. Mutations in the domain demonstrate that it is required for optimal catalytic activation of IsoT. This domain is present in several other protein families, and the ZnF UBP domain from an E3 ligase also requires the C terminus of ubiquitin for binding. These data suggest that binding the ubiquitin C terminus may be necessary for the function of other proteins.	Brookhaven Natl Lab, Dept Biol, Upton, NY 11794 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Wilkinson, KD (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	genekdw@emory.edu	Hu, Ruogu/B-2203-2008; Horton, John/F-2375-2010; Horton, John R/ABB-4770-2020	Horton, John/0000-0001-9749-8068	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068680, F31GM075426, R01GM030308, T32GM008367] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM068680, 5T32GM008367, GM30308, 1F31GM075426-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Amerik AY, 1997, EMBO J, V16, P4826; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Davies BA, 2003, J BIOL CHEM, V278, P19826, DOI 10.1074/jbc.M301059200; Doelling JH, 2001, PLANT J, V27, P393, DOI 10.1046/j.1365-313X.2001.01106.x; Gabriel JM, 2002, BIOCHEMISTRY-US, V41, P13755, DOI 10.1021/bi026096m; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HERMANSON GT, 1992, IMMOBILIZED AFFINITY, P80; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; LEE S, 2006, IN PRESS NAT STRUCT; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Lindsey DF, 1998, J BIOL CHEM, V273, P29178, DOI 10.1074/jbc.273.44.29178; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips CL, 2001, ACTA CRYSTALLOGR D, V57, P341, DOI 10.1107/S090744490001800X; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Russell Nathaniel S., 2005, V301, P207; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; STEIN RL, 1995, BIOCHEMISTRY-US, V34, P12616, DOI 10.1021/bi00039a017; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019	52	231	240	4	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 24	2006	124	6					1197	1208		10.1016/j.cell.2006.02.038	http://dx.doi.org/10.1016/j.cell.2006.02.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564012	Bronze			2022-12-28	WOS:000237241400020
J	Balcer, LJ				Balcer, LJ			Optic neuritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-SCLEROSIS; VISUAL FUNCTION; RANDOMIZED-TRIAL; EXPERIENCE; CORTICOSTEROIDS; RISK; METHYLPREDNISOLONE; IMMUNOGLOBULIN; INVOLVEMENT; MANAGEMENT		Univ Penn, Sch Med, Dept Neurol, Div Neuroophthalmol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Ophthalmol, Div Neuroophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Balcer, LJ (corresponding author), Univ Penn, Sch Med, Dept Neurol, Div Neuroophthalmol, 3 E Gates,3400 Spruce St, Philadelphia, PA 19104 USA.	lbalcer@mail.med.upenn.edu						[Anonymous], 1997, Arch Ophthalmol, V115, P1545; Arnold AC, 2005, AM J OPHTHALMOL, V139, P1101, DOI 10.1016/j.ajo.2005.01.031; Balcer LJ, 2003, NEUROLOGY, V61, P1367, DOI 10.1212/01.WNL.0000094315.19931.90; Balcer LJ, 2004, CONNS CURRENT THERAP, P187; BECH RW, 1991, ARCH OPHTHALMOL-CHIC, V109, P1673, DOI 10.1001/archopht.1991.01080120057025; BECK RW, 1993, ARCH NEUROL-CHICAGO, V50, P841, DOI 10.1001/archneur.1993.00540080050013; BECK RW, 1993, NEW ENGL J MED, V329, P1764, DOI 10.1056/NEJM199312093292403; Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944; BECK RW, 1992, NEW ENGL J MED, V326, P581, DOI 10.1056/NEJM199202273260901; BECK RW, 1994, OPHTHALMOLOGY, V101, P1771; Beck RW, 2004, AM J OPHTHALMOL, V137, P77, DOI 10.1016/S0002-9394(02)00862-6; Brady KM, 1999, J AAPOS, V3, P98, DOI 10.1016/S1091-8531(99)70078-9; Brex PA, 2001, J NEUROL NEUROSUR PS, V70, P390, DOI 10.1136/jnnp.70.3.390; Brodsky M, 1997, NEUROLOGY, V49, P1404; Cole SR, 2000, INVEST OPHTH VIS SCI, V41, P1017; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; DICKERSIN K, 1995, JAMA-J AM MED ASSOC, V273, P625, DOI 10.1001/jama.1995.03520320035038; Fang JP, 1999, AM J OPHTHALMOL, V128, P554, DOI 10.1016/S0002-9394(99)00298-6; Fisher JB, 2006, OPHTHALMOLOGY, V113, P324, DOI 10.1016/j.ophtha.2005.10.040; Foroozan Rod, 2002, Curr Opin Ophthalmol, V13, P375, DOI 10.1097/00055735-200212000-00006; Fraser CL, 2006, OPHTHALMOLOGY, V113, P315, DOI 10.1016/j.ophtha.2005.10.017; FRISEN L, 1974, ARCH OPHTHALMOL-CHIC, V92, P91, DOI 10.1001/archopht.1974.01010010097001; Frohman EM, 2005, LANCET NEUROL, V4, P111, DOI 10.1016/S1474-4422(05)00992-0; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; KAPPOS L, 2005, 21 C EUR COMM TREATM; Kaufman DI, 2000, NEUROLOGY, V54, P2039, DOI 10.1212/WNL.54.11.2039; KELTNER JL, 1993, ARCH OPHTHALMOL-CHIC, V111, P231, DOI 10.1001/archopht.1993.01090020085029; Keltner JL, 1999, AM J OPHTHALMOL, V128, P543, DOI 10.1016/S0002-9394(99)00304-9; Kinkel RP, 2006, NEUROLOGY, V66, P678; LIU GT, 2001, NEUROOPHTHALMOLOGY D, P103; Lucchinetti CF, 1997, NEUROLOGY, V49, P1413, DOI 10.1212/WNL.49.5.1413; Newman NJ, 2004, EYE, V18, P1144, DOI 10.1038/sj.eye.6701591; Noseworthy JH, 2001, NEUROLOGY, V56, P1514, DOI 10.1212/WNL.56.11.1514; O'Connor P, 2001, AM J OPHTHALMOL, V132, P463; Roed HG, 2005, NEUROLOGY, V64, P804, DOI 10.1212/01.WNL.0000152873.82631.B3; Rolak LA, 1996, NEUROLOGY, V46, P368, DOI 10.1212/WNL.46.2.368; Sellebjerg F, 1999, NEUROLOGY, V52, P1479, DOI 10.1212/WNL.52.7.1479; Sisto D, 2005, INVEST OPHTH VIS SCI, V46, P1264, DOI 10.1167/iovs.03-1213; Trip SA, 2005, ANN NEUROL, V58, P383, DOI 10.1002/ana.20575; Trobe JD, 1996, AM J OPHTHALMOL, V121, P547, DOI 10.1016/S0002-9394(14)75429-7; Wakakura M, 1999, JPN J OPHTHALMOL, V43, P133, DOI 10.1016/S0021-5155(98)00071-9	41	220	234	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1273	1280		10.1056/NEJMcp053247	http://dx.doi.org/10.1056/NEJMcp053247			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554529				2022-12-28	WOS:000236164200006
J	Wilson, JF				Wilson, JF			The pain divide between men and women	ANNALS OF INTERNAL MEDICINE			English	News Item												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	14	16	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2006	144	6					461	464		10.7326/0003-4819-144-6-200603210-00031	http://dx.doi.org/10.7326/0003-4819-144-6-200603210-00031			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025FX	16549870				2022-12-28	WOS:000236251800026
J	Onyebujoh, P; Rodriguez, W; Mwaba, P				Onyebujoh, P; Rodriguez, W; Mwaba, P			Priorities in tuberculosis research	LANCET			English	Editorial Material									Ctr Casai, UNICEF,UNDP,World Bank, WHO Special Programme Res & Training Trop Dis, Implementat Res & Methods, CH-1216 Geneva, Switzerland; Harvard Univ, Sch Med, Div AIDS, Landmark Ctr, Boston, MA USA; Univ Zambia, Sch Med, Dept Med, Lusaka, Zambia	The World Bank; World Health Organization; Harvard University; Harvard Medical School; University of Zambia	Onyebujoh, P (corresponding author), Ctr Casai, UNICEF,UNDP,World Bank, WHO Special Programme Res & Training Trop Dis, Implementat Res & Methods, CH-1216 Geneva, Switzerland.	onyebujohp@who.int	Mwaba, Peter/V-6017-2019					Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], STOP TB PARTNERSHIP; CAMP R, WHATS PIPELINE HIV D; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; *GLOB ALL TB DRUG, 2001, EC TB DRUG DEV; *WHO, 1991, WHA448 WHO; WHO, 2004, INT POL COLL TB HIV; *WHO, 2000, SCI WORK GROUP TUB	8	23	23	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					940	942		10.1016/S0140-6736(06)68385-2	http://dx.doi.org/10.1016/S0140-6736(06)68385-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546543				2022-12-28	WOS:000236242100031
J	Shuler, MG; Bear, MF				Shuler, MG; Bear, MF			Reward timing in the primary visual cortex	SCIENCE			English	Article							OCULAR DOMINANCE PLASTICITY; SHORT-TERM-MEMORY; PREFRONTAL CORTEX; WORKING-MEMORY; NEURAL MECHANISMS; NEURONAL-ACTIVITY; ATTENTION; CORRELATE; THALAMUS; MONKEYS	We discovered that when adult rats experience an association between visual stimuli and subsequent rewards, the responses of a substantial fraction of neurons in the primary visual cortex evolve from those that relate solely to the physical attributes of the stimuli to those that accurately predict the timing of reward. In addition to revealing a remarkable type of response plasticity in adult V1, these data demonstrate that reward-timing activity - a "higher" brain function - can occur very early in sensory-processing paths. These findings challenge the traditional interpretation of activity in the primary visual cortex.	MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health	Bear, MF (corresponding author), MIT, Howard Hughes Med Inst, Picower Inst Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	mbear@mit.edu		Bear, Mark/0000-0002-9903-2541				Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GAFFAN EA, 1988, J NEUROSCI, V8, P3144; Gilbert C, 2000, VISION RES, V40, P1217, DOI 10.1016/S0042-6989(99)00234-5; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; HUBEL D, 1959, J PHYSL, V150, P91; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Liu Z, 2000, NAT NEUROSCI, V3, P1307, DOI 10.1038/81841; Miller EK, 1996, J NEUROSCI, V16, P5154; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Purves D, 2001, PHILOS T ROY SOC B, V356, P285, DOI 10.1098/rstb.2000.0772; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Salazar RF, 2004, EUR J NEUROSCI, V20, P1391, DOI 10.1111/j.1460-9568.2004.03579.x; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Super H, 2001, SCIENCE, V293, P120, DOI 10.1126/science.1060496; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Watanabe Y, 2004, J NEUROPHYSIOL, V92, P1738, DOI 10.1152/jn.00994.2003	26	396	399	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1606	1609		10.1126/science.1123513	http://dx.doi.org/10.1126/science.1123513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543459				2022-12-28	WOS:000236029500045
J	Chast, F				Chast, F			Pierre Potier (1934-2006) - Obituary	NATURE			English	Biographical-Item									Hop Hotel Dieu, Dept Pharm Pharmacol & Toxicol, F-75004 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Chast, F (corresponding author), Hop Hotel Dieu, Dept Pharm Pharmacol & Toxicol, 1 Pl Parvis Notre Dame, F-75004 Paris, France.	francois.chast@htd.aphp.fr							0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2006	440	7082					291	291		10.1038/440291a	http://dx.doi.org/10.1038/440291a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541061	Bronze			2022-12-28	WOS:000235997600039
J	Inouye, SK				Inouye, SK			Current concepts - Delirium in older persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROGNOSTIC-SIGNIFICANCE; MEDICAL INPATIENTS; ELDERLY-PATIENTS; CARE; SYMPTOMS; DEMENTIA; QUALITY; INTERVENTION; MANAGEMENT; DIAGNOSIS		Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Harvard Medical School	Inouye, SK (corresponding author), Hebrew Senior Life, Aging Brain Ctr, 1200 Ctr St, Boston, MA 02131 USA.		Inouye, Sharon/R-7216-2019		NATIONAL INSTITUTE ON AGING [K24AG000949, R21AG025193] Funding Source: NIH RePORTER; NIA NIH HHS [K24AG00949, R21AG025193] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*ADM AG, 2000, PROF OLD AM; Agostini JV, 2003, PRINCIPLES GERIATRIC, P1503; [Anonymous], 1999, Am J Psychiatry, V156, P1; Baker FM, 1999, J NATL MED ASSOC, V91, P625; Breitbart W, 1996, AM J PSYCHIAT, V153, P231; Breitbart W, 2000, CLIN GERIATR MED, V16, P357, DOI 10.1016/S0749-0690(05)70061-6; Broadhurst C, 2001, BRIT J PSYCHIAT, V179, P288, DOI 10.1192/bjp.179.4.288; Burns A, 2004, J NEUROL NEUROSUR PS, V75, P362, DOI 10.1136/jnnp.2003.023366; Casarett DJ, 2001, ANN INTERN MED, V135, P32, DOI 10.7326/0003-4819-135-1-200107030-00011; CLARFIELD AM, 1988, ANN INTERN MED, V109, P476, DOI 10.7326/0003-4819-109-6-476; Cole M, 2003, J AM GERIATR SOC, V51, P754, DOI 10.1046/j.1365-2389.2003.51255.x; Cole MG, 2003, J NEUROPSYCH CLIN N, V15, P200, DOI 10.1176/jnp.15.2.200; Cole MG, 2004, AM J GERIAT PSYCHIAT, V12, P7, DOI 10.1176/appi.ajgp.12.1.7; *DEP HLTH HUM SERV, 2004, CMS PUBL; Eikelenboom P, 1999, DEMENT GERIATR COGN, V10, P319, DOI 10.1159/000017162; Fick D, 2000, J Gerontol Nurs, V26, P30; Folstein M F, 1991, Int Psychogeriatr, V3, P169, DOI 10.1017/S1041610291000637; FRANCIS J, 1992, J AM GERIATR SOC, V40, P601, DOI 10.1111/j.1532-5415.1992.tb02111.x; GILLICK MR, 1982, SOC SCI MED, V16, P1033, DOI 10.1016/0277-9536(82)90175-7; Gleason OC, 2003, AM FAM PHYSICIAN, V67, P1027; Han L, 2001, ARCH INTERN MED, V161, P1099, DOI 10.1001/archinte.161.8.1099; Inouye SK, 1999, AM J MED, V106, P565, DOI 10.1016/S0002-9343(99)00070-4; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; Inouye SK, 1998, CLIN GERIATR MED, V14, P745; Inouye SK, 1997, COGNITIVE DECLINE ST, P85; *IOM COMM QUAL HLT, 2000, ERR IS HUM BUILD SAF, P26; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Kiely DK, 2004, J GERONTOL A-BIOL, V59, P344; Laurila JV, 2004, INT J GERIATR PSYCH, V19, P271, DOI 10.1002/gps.1079; LEVKOFF SE, 1992, ARCH INTERN MED, V152, P334, DOI 10.1001/archinte.152.2.334; LEVKOFF SE, 1994, AM J GERIAT PSYCHIAT, V2, P230, DOI 10.1097/00019442-199400230-00007; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Marcantonio ER, 2000, J AM GERIATR SOC, V48, P618, DOI 10.1111/j.1532-5415.2000.tb04718.x; McCusker J, 2003, J GEN INTERN MED, V18, P696, DOI 10.1046/j.1525-1497.2003.20602.x; McCusker J, 2001, CAN MED ASSOC J, V165, P575; Meijer OC, 1998, CRIT REV NEUROBIOL, V12, P1; Moran Juli A., 2001, Australian Journal of Hospital Pharmacy, V31, P35; MURRAY AM, 1993, J GERONTOL, V48, pM181, DOI 10.1093/geronj/48.5.M181; OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x; Pisani MA, 2003, CLIN CHEST MED, V24, P727, DOI 10.1016/S0272-5231(03)00092-3; Rahkonen T, 2001, INT PSYCHOGERIATR, V13, P37, DOI 10.1017/S104161020100744X; Robertsson B, 2001, INT CLIN PSYCHOPHARM, V16, P39, DOI 10.1097/00004850-200101000-00005; Roche V, 2003, AM J MED SCI, V325, P20, DOI 10.1097/00000441-200301000-00005; Rockwood K, 1999, AGE AGEING, V28, P551, DOI 10.1093/ageing/28.6.551; ROCKWOOD K, 1993, J GERONTOL, V48, pM162, DOI 10.1093/geronj/48.4.M162; ROLFSON D, 2002, DELIRIUM OLD AGE, P101; Romano J, 1944, ARCH NEURO PSYCHIATR, V51, P356, DOI 10.1001/archneurpsyc.1944.02290280054003; Rothschild JM, 2000, ARCH INTERN MED, V160, P2717, DOI 10.1001/archinte.160.18.2717; Shigeta H, 2001, AM J SURG, V182, P449, DOI 10.1016/S0002-9610(01)00761-9; Sloss EM, 2000, J AM GERIATR SOC, V48, P363, DOI 10.1111/j.1532-5415.2000.tb04691.x; Thomas EJ, 1999, INQUIRY-J HEALTH CAR, V36, P255; Trzepacz P., 2002, DELIRIUM OLD AGE, P51; UNO H, 1989, J NEUROSCI, V9, P1705, DOI 10.1523/jneurosci.09-05-01705.1989; WILLIAMSON JW, 1978, JAMA-J AM MED ASSOC, V239, P631, DOI 10.1001/jama.239.7.631; Yokota H, 2003, PSYCHIAT CLIN NEUROS, V57, P337, DOI 10.1046/j.1440-1819.2003.01126.x	58	1198	1273	2	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1157	1165		10.1056/NEJMra052321	http://dx.doi.org/10.1056/NEJMra052321			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540616	Green Published			2022-12-28	WOS:000235981700009
J	Sellick, GS; Catovsky, D; Houlston, RS				Sellick, GS; Catovsky, D; Houlston, RS			Familial cancer associated with a polymorphism in ARLTS1	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Inst Canc Res, Sutton SM2 5NG, Surrey, England	University of London; Institute of Cancer Research - UK	Sellick, GS (corresponding author), Inst Canc Res, Sutton SM2 5NG, Surrey, England.			Calin, George/0000-0001-6704-5615; Houlston, Richard/0000-0002-5268-0242				Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280	1	5	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1204	1204						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540626				2022-12-28	WOS:000235981700029
J	Toma, M; McAlister, FA; Bialy, L; Adams, D; Vandermeer, B; Armstrong, PW				Toma, M; McAlister, FA; Bialy, L; Adams, D; Vandermeer, B; Armstrong, PW			Transition from meeting abstract to full-length journal article for randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CAROTID ENDARTERECTOMY; PREPUBLICATION RELEASE; PUBLICATION; STENOSIS; QUALITY; BIAS	Context Not all research presented at scientific meetings is subsequently published and, even when it is, there may be inconsistencies between these results and what is ultimately printed. Although late-breaking trials sessions are now integrated into several major scientific meetings and the results are often promptly and prominently communicated, no studies have examined the publication fate and degree of consistency between meeting abstracts or presentations and subsequent full-length article publications for randomized controlled trials (RCTs) presented at these sessions. Objective To compare RCT abstracts presented in the late-breaking trials session vs other sessions at a major scientific meeting and subsequent full-length publications. Design RCTs were identified by hand searching abstract proceedings booklets and related Web sites for the American College of Cardiology scientific meetings (1999-2002). Subsequent full-length articles were identified via electronic databases. Main Outcome Measures Publication fate and degree of consistency between meeting abstract results and subsequent full-length publication results. Results The 86 late-breaking RCTs were significantly larger (median, 2737 patients vs 896; P<.001), were more likely to be preceded by a published design paper (27 [31%] vs 13 [13%]; P=.002), had higher quality scores when eventually published (mean Jadad score 2.69 vs 2.19; P=.01), and were less likely to report favorable results for the intervention than the 100 randomly chosen comparison RCTs presented in other sessions (50 [58%] vs 75 [75%]; P=.01; odds ratio 0.46; 95% confidence interval, 0.24-0.90). RCTs presented at the late-breaking trials sessions were significantly more likely to be published (79 [92%] vs 69 [69%]; P<.001) and appeared earlier after presentation (median 11.5 months vs 22.0 months; P<.001) than RCTs presented in other sessions, an association that persisted even after adjusting for sample size, conclusion of study, and RCT design: adjusted hazard ratio, 1.80 (95% confidence interval, 1.24-2.61). Sixty (41%) of the 148 RCTs that were subsequently published exhibited discrepancies between the efficacy estimate reported in the meeting abstract vs the one reported in the full-length article for the primary outcome. The mean change in effect was 0.44 SDs and in 20 cases (14%), the point estimate was statistically significant in only 1 member of the pair. The discrepancy rate was the same for late-breaking RCTs as for RCTs presented in other American College of Cardiology sessions (P=.92). Conclusions Late-breaking trials were larger, more likely to be preceded by a design paper, and less likely to report positive results than RCTs presented at other sessions, but discrepancies between the meeting abstract results and subsequent full-length publication results were common even for late-breaking trials.	Univ Alberta, Walter Mackenzie Hlth Sci Ctr 2E3 24, Div Gen Internal Med, Edmonton, AB T6G 2R7, Canada; Capital Hlth Evidence Based Practice Ctr, Edmonton, AB, Canada; Univ Alberta, Div Cardiol, Edmonton, AB, Canada	University of Alberta; University of Alberta	McAlister, FA (corresponding author), Univ Alberta, Walter Mackenzie Hlth Sci Ctr 2E3 24, Div Gen Internal Med, 8440 112 St, Edmonton, AB T6G 2R7, Canada.	finlay.mcalister@ualberta.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341; Armstrong, Paul/0000-0002-0460-3445				Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P615, DOI 10.2106/00004623-200204000-00017; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; Fontanarosa PB, 2000, JAMA-J AM MED ASSOC, V284, P2927, DOI 10.1001/jama.284.22.2927; Gross CP, 2000, JAMA-J AM MED ASSOC, V284, P2886, DOI 10.1001/jama.284.22.2886; Hartling L, 2005, ANN INTERN MED, V142, P1100, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00010; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Klassen TP, 2002, ARCH PEDIAT ADOL MED, V156, P474, DOI 10.1001/archpedi.156.5.474; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WEINTRAUB WH, 1987, J PEDIATR SURG, V22, P11, DOI 10.1016/S0022-3468(87)80005-2	15	124	124	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2006	295	11					1281	1287		10.1001/jama.295.11.1281	http://dx.doi.org/10.1001/jama.295.11.1281			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021GV	16537738	Bronze			2022-12-28	WOS:000235972600026
J	Kumagai, A; Lee, J; Yoo, HY; Dunphy, WG				Kumagai, A; Lee, J; Yoo, HY; Dunphy, WG			TopBP1 activates the ATR-ATRIP complex	CELL			English	Article							DNA-REPLICATION CHECKPOINT; XENOPUS EGG EXTRACTS; CELL-CYCLE CHECKPOINT; II-BINDING-PROTEIN; SINGLE-STRANDED-DNA; DEPENDENT CHECKPOINT; DAMAGE CHECKPOINT; KINASE-ACTIVITIES; POLYMERASE-ALPHA; HUMAN CLASPIN	ATR is a key regulator of checkpoint responses to incompletely replicated and damaged DNA, but the mechanisms underlying control of its kinase activity are unknown. TopBP1, the vertebrate homolog of yeast Cut5/Dbp11, has dual roles in initiation of DNA replication and regulation of checkpoint responses. We show that recombinant TopBP1 induces a large increase in the kinase activity of both Xenopus and human ATR. The ATR-activating domain resides in a conserved segment of TopBP1 that is distinct from its numerous BRCT repeats. The isolated ATR-activating domain from TopBP1 induces ectopic activation of ATR-dependent signaling in both Xenopus egg extracts and human cells. Furthermore, Xenopus egg extracts containing a version of TopBP1 with an inactivating point mutation in the ATR-activating domain are defective in checkpoint regulation. These studies establish that activation of ATR by TopBP1 is a crucial step in the initiation of ATR-dependent signaling processes.	CALTECH, Div Biol 21 76, Pasadena, CA 91125 USA	California Institute of Technology	Dunphy, WG (corresponding author), CALTECH, Div Biol 21 76, Pasadena, CA 91125 USA.	dunphy@cco.caltech.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070891, R37GM043974, R01GM043974] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM043974, GM070891] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ARAKI H, 1995, P NATL ACAD SCI USA, V92, P11791, DOI 10.1073/pnas.92.25.11791; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Ball HL, 2005, J BIOL CHEM, V280, P31390, DOI 10.1074/jbc.M504961200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Canman CE, 2003, CURR BIOL, V13, pR488, DOI 10.1016/S0960-9822(03)00410-X; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; CONSTANZO V, 2003, MOL CELL, V11, P203; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hekmat-Nejad M, 2000, CURR BIOL, V10, P1565, DOI 10.1016/S0960-9822(00)00855-1; Holway AH, 2005, GENETICS, V169, P1451, DOI 10.1534/genetics.104.036137; Honda Y, 2002, J BIOL CHEM, V277, P3599, DOI 10.1074/jbc.M104347200; Itakura E, 2005, MOL BIOL CELL, V16, P5551, DOI 10.1091/mbc.E05-05-0427; Kim SM, 2005, J BIOL CHEM, V280, P38355, DOI 10.1074/jbc.M508673200; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Liu QH, 2000, GENE DEV, V14, P1448; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Parrilla-Castellar E, 2003, J BIOL CHEM, V278, P45507, DOI 10.1074/jbc.C300418200; Perera D, 2004, MOL BIOL CELL, V15, P1568, DOI 10.1091/mbc.E03-06-0444; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Stokes MP, 2002, J CELL BIOL, V158, P863, DOI 10.1083/jcb.200204127; Unsal-Kacmaz K, 2004, MOL CELL BIOL, V24, P1292, DOI 10.1128/MCB.24.3.1292-1300.2003; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Yamane K, 1997, EUR J BIOCHEM, V250, P794, DOI 10.1111/j.1432-1033.1997.00794.x; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2003, CANCER RES, V63, P3049; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; You ZZ, 2002, J BIOL CHEM, V277, P27088, DOI 10.1074/jbc.M204120200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	53	554	565	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					943	955		10.1016/j.cell.2005.12.041	http://dx.doi.org/10.1016/j.cell.2005.12.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530042	Bronze			2022-12-28	WOS:000237241200017
J	Yilmaz, OH; Valdez, R; Theisen, BK; Guo, W; Ferguson, DO; Wu, H; Morrison, SJ				Yilmaz, Omer H.; Valdez, Riccardo; Theisen, Brian K.; Guo, Wei; Ferguson, David O.; Wu, Hong; Morrison, Sean J.			Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; SELF-RENEWAL; CANCER; BMI-1; DIFFERENTIATION; IDENTIFICATION; INHIBITION; MECHANISMS; SENESCENCE	Recent advances have highlighted extensive phenotypic and functional similarities between normal stem cells and cancer stem cells. This raises the question of whether disease therapies can be developed that eliminate cancer stem cells without eliminating normal stem cells. Here we address this issue by conditionally deleting the Pten tumour suppressor gene in adult haematopoietic cells. This led to myeloproliferative disease within days and transplantable leukaemias within weeks. Pten deletion also promoted haematopoietic stem cell (HSC) proliferation. However, this led to HSC depletion via a cell-autonomous mechanism, preventing these cells from stably reconstituting irradiated mice. In contrast to leukaemia-initiating cells, HSCs were therefore unable to maintain themselves without Pten. These effects were mostly mediated by mTOR as they were inhibited by rapamycin. Rapamycin not only depleted leukaemia-initiating cells but also restored normal HSC function. Mechanistic differences between normal stem cells and cancer stem cells can thus be targeted to deplete cancer stem cells without damaging normal stem cells.	Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329				Aggerholm A, 2000, EUR J HAEMATOL, V65, P109, DOI 10.1034/j.1600-0609.2000.90181.x; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheong JW, 2003, BRIT J HAEMATOL, V122, P454, DOI 10.1046/j.1365-2141.2003.04452.x; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roman-Gomez J, 2004, BLOOD, V104, P2492, DOI 10.1182/blood-2004-03-0954; Singh SK, 2003, CANCER RES, V63, P5821; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; Smith LH, 1970, EXP HEMATOL, V20, P82; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933	42	1057	1142	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					475	482		10.1038/nature04703	http://dx.doi.org/10.1038/nature04703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16598206	Green Published			2022-12-28	WOS:000237778900042
J	Hirjibehedin, CF; Lutz, CP; Heinrich, AJ				Hirjibehedin, CF; Lutz, CP; Heinrich, AJ			Spin coupling in engineered atomic structures	SCIENCE			English	Article							SCANNING TUNNELING MICROSCOPE; MAGNETIC-ANISOTROPY; SINGLE ATOMS; SPECTROSCOPY; MANIPULATION; RESONANCE; CLUSTERS; CHAINS	We used a scanning tunneling microscope to probe the interactions between spins in individual atomic-scale magnetic structures. Linear chains of 1 to 10 manganese atoms were assembled one atom at a time on a thin insulating layer, and the spin excitation spectra of these structures were measured with inelastic electron tunneling spectroscopy. We observed excitations of the coupled atomic spins that can change both the total spin and its orientation. Comparison with a model spin-interaction Hamiltonian yielded the collective spin configuration and the strength of the coupling between the atomic spins.	IBM Corp, Almaden Res Ctr, Div Res, San Jose, CA 95120 USA	International Business Machines (IBM)	Hirjibehedin, CF (corresponding author), IBM Corp, Almaden Res Ctr, Div Res, 650 Harry Rd, San Jose, CA 95120 USA.	hirjibe@us.ibm.com		Hirjibehedin, Cyrus/0000-0003-1706-2147				Abragan A, 1970, ELECT PARAMAGNETIC R; Bartels L, 1997, PHYS REV LETT, V79, P697, DOI 10.1103/PhysRevLett.79.697; Bode M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.067201; Caciuffo R, 1998, PHYS REV LETT, V81, P4744, DOI 10.1103/PhysRevLett.81.4744; Cavar E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196102; DEJONGH LJ, 1974, ADV PHYS, V23, P1, DOI 10.1080/00018739700101558; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Friedman JR, 1996, PHYS REV LETT, V76, P3830, DOI 10.1103/PhysRevLett.76.3830; Gambardella P, 2003, SCIENCE, V300, P1130, DOI 10.1126/science.1082857; Gambardella P, 2002, NATURE, V416, P301, DOI 10.1038/416301a; Heinrich AJ, 2004, SCIENCE, V306, P466, DOI 10.1126/science.1101077; Hill S, 2003, SCIENCE, V302, P1015, DOI 10.1126/science.1090082; Imre A, 2006, SCIENCE, V311, P205, DOI 10.1126/science.1120506; JAMNEALA T, 2000, PHYS REV LETT, V87; Kahn O., 1993, MOL MAGNETISM; Koppens FHL, 2005, SCIENCE, V309, P1346, DOI 10.1126/science.1113719; LAMBE J, 1968, PHYS REV, V165, P821, DOI 10.1103/PhysRev.165.821; Lee HJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.186802; LEIBSLE FM, 1993, PHYS REV B, V47, P15865, DOI 10.1103/PhysRevB.47.15865; Leuenberger MN, 2001, NATURE, V410, P789, DOI 10.1038/35071024; Li JT, 1998, PHYS REV LETT, V80, P2893, DOI 10.1103/PhysRevLett.80.2893; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Nilius N, 2002, SCIENCE, V297, P1853, DOI 10.1126/science.1075242; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Qiu XH, 2003, SCIENCE, V299, P542, DOI 10.1126/science.1078675; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; Rugar D, 2004, NATURE, V430, P329, DOI 10.1038/nature02658; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Thomas L, 1996, NATURE, V383, P145, DOI 10.1038/383145a0; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Xu XS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237209; Yamasaki A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.127201; Zhao AD, 2005, SCIENCE, V309, P1542, DOI 10.1126/science.1113449	34	605	610	5	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1021	1024		10.1126/science.1125398	http://dx.doi.org/10.1126/science.1125398			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16574821				2022-12-28	WOS:000237628800036
J	Price, DJ; Rosswog, S				Price, DJ; Rosswog, S			Producing ultrastrong magnetic fields in neutron star mergers	SCIENCE			English	Article							HIGH-RESOLUTION CALCULATIONS; HOST GALAXY; BURSTS; FLARE	We report an extremely rapid mechanism for magnetic field amplification during the merger of a binary neutron star system. This has implications for the production of the short class of gamma-ray bursts, which recent observations suggest may originate in such mergers. In detailed magnetohydrodynamic simulations of the merger process, the fields are amplified by Kelvin-Helmholtz instabilities beyond magnetar field strength and may therefore represent the strongest magnetic fields in the universe. The amplification occurs in the shear layer that forms between the neutron stars and on a time scale of only 1 millisecond, that is, long before the remnant can collapse into a black hole.	Int Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England	University of Exeter	Rosswog, S (corresponding author), Int Jacobs Univ Bremen, Sch Sci & Engn, Campus Ring 1, D-28759 Bremen, Germany.	s.rosswog@iu-bremen.de	Rosswog, Stephan/G-6211-2018; Price, Daniel J/A-8142-2016	Price, Daniel J/0000-0002-4716-4235				ABRAMOVICI A, 1992, SCIENCE, V256, P325, DOI 10.1126/science.256.5055.325; Aloy MA, 2005, ASTRON ASTROPHYS, V436, P273, DOI 10.1051/0004-6361:20041865; Barthelmy SD, 2005, NATURE, V438, P994, DOI 10.1038/nature04392; Berger E, 2005, NATURE, V438, P988, DOI 10.1038/nature04238; BILDSTEN L, 1992, ASTROPHYS J, V400, P175, DOI 10.1086/171983; Bloom JS, 2006, ASTROPHYS J, V638, P354, DOI 10.1086/498107; DUNCAN RC, 1986, ASTROPHYS J, V309, P141, DOI 10.1086/164587; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; EICHLER D, 1989, NATURE, V340, P126, DOI 10.1038/340126a0; Grote H, 2005, CLASSICAL QUANT GRAV, V22, pS193, DOI 10.1088/0264-9381/22/10/009; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Kalogera V, 2004, ASTROPHYS J, V614, pL137, DOI 10.1086/425868; Kluzniak W, 1998, ASTROPHYS J, V505, pL113, DOI 10.1086/311622; Landau L. D., 1976, MECHANICS, V1; Lyutikov M, 2003, ASTROPHYS J, V597, P998, DOI 10.1086/378497; Lyutikov M, 2003, MON NOT R ASTRON SOC, V346, P540, DOI 10.1046/j.1365-2966.2003.07110.x; Meszaros P, 1997, ASTROPHYS J, V482, pL29, DOI 10.1086/310692; Monaghan JJ, 2005, REP PROG PHYS, V68, P1703, DOI 10.1088/0034-4885/68/8/R01; NARAYAN R, 1992, ASTROPHYS J, V395, pL83, DOI 10.1086/186493; Palmer DM, 2005, NATURE, V434, P1107, DOI 10.1038/nature03525; Piran T, 2004, REV MOD PHYS, V76, P1143, DOI 10.1103/RevModPhys.76.1143; Price DJ, 2005, MON NOT R ASTRON SOC, V364, P384, DOI 10.1111/j.1365-2966.2005.09576.x; Rosswog S, 2003, MON NOT R ASTRON SOC, V345, P1077, DOI 10.1046/j.1365-2966.2003.07032.x; Rosswog S, 2003, MON NOT R ASTRON SOC, V343, pL36, DOI 10.1046/j.1365-8711.2003.06889.x; Rosswog S, 2003, MON NOT R ASTRON SOC, V342, P673, DOI 10.1046/j.1365-8711.2003.06579.x; Rosswog S, 2002, MON NOT R ASTRON SOC, V334, P481, DOI 10.1046/j.1365-8711.2002.05409.x; Shen H, 1998, NUCL PHYS A, V637, P435, DOI 10.1016/S0375-9474(98)00236-X; Shibata M, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.084021; STERN DP, 1970, AM J PHYS, V38, P494, DOI 10.1119/1.1976373; USOV VV, 1992, NATURE, V357, P472, DOI 10.1038/357472a0	31	228	231	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					719	722		10.1126/science.1125201	http://dx.doi.org/10.1126/science.1125201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16574823				2022-12-28	WOS:000237312100042
J	Beugnon, J; Jones, MPA; Dingjan, J; Darquie, B; Messin, G; Browaeys, A; Grangier, P				Beugnon, J; Jones, MPA; Dingjan, J; Darquie, B; Messin, G; Browaeys, A; Grangier, P			Quantum interference between two single photons emitted by independently trapped atoms	NATURE			English	Article							ENTANGLEMENT	When two indistinguishable single photons are fed into the two input ports of a beam splitter, the photons will coalesce and leave together from the same output port. This is a quantum interference effect, which occurs because two possible paths - in which the photons leave by different output ports - interfere destructively. This effect was first observed in parametric downconversion(1) ( in which a nonlinear crystal splits a single photon into two photons of lower energy), then from two separate downconversion crystals(2), as well as with single photons produced one after the other by the same quantum emitter(3-6). With the recent developments in quantum information research, much attention has been devoted to this interference effect as a resource for quantum data processing using linear optics techniques(2,7-11). To ensure the scalability of schemes based on these ideas, it is crucial that indistinguishable photons are emitted by a collection of synchronized, but otherwise independent sources. Here we demonstrate the quantum interference of two single photons emitted by two independently trapped single atoms, bridging the gap towards the simultaneous emission of many indistinguishable single photons by different emitters. Our data analysis shows that the observed coalescence is mainly limited by wavefront matching of the light emitted by the two atoms, and to a lesser extent by the motion of each atom in its own trap.	Ctr Univ Orsay, Lab Charles Fabry Inst Opt, UMR 8501, F-91403 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay	Browaeys, A (corresponding author), Ctr Univ Orsay, Lab Charles Fabry Inst Opt, UMR 8501, Batiment 503, F-91403 Orsay, France.	antoine.browaeys@iota.u-psud.fr	Browaeys, Antoine/E-1547-2017; Beugnon, Jérôme/R-4691-2017; Jones, Matthew/C-2595-2009	Browaeys, Antoine/0000-0001-9941-8869; Jones, Matthew/0000-0003-1514-5977; Beugnon, Jerome/0000-0003-1701-8533				Barrett SD, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.155307; Bergamini S, 2004, J OPT SOC AM B, V21, P1889, DOI 10.1364/JOSAB.21.001889; Blinov BB, 2004, NATURE, V428, P153, DOI 10.1038/nature02377; Darquie B, 2005, SCIENCE, V309, P454, DOI 10.1126/science.1113394; de Riedmatten H, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.022301; Dingjan J, 2006, APPL PHYS B-LASERS O, V82, P47, DOI 10.1007/s00340-005-2027-7; Dowling JP, 2004, QUANTUM INF PROCESS, V3, P205, DOI 10.1007/s11128-004-9419-1; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Kiraz A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.223602; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Legero T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.070503; Legero T, 2003, APPL PHYS B-LASERS O, V77, P797, DOI 10.1007/s00340-003-1337-x; Lim YL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030505; Paillard M, 2001, PHYS REV LETT, V86, P1634, DOI 10.1103/PhysRevLett.86.1634; Pan JW, 1998, PHYS REV LETT, V80, P3891, DOI 10.1103/PhysRevLett.80.3891; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Schrader D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.150501; Simon C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110405; Varoutsis S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.041303; ZOLLER P, 2004, LES HOUCHES, P187	22	243	245	5	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					779	782		10.1038/nature04628	http://dx.doi.org/10.1038/nature04628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598253	Green Accepted, Green Submitted			2022-12-28	WOS:000236548400037
J	Strous, M; Pelletier, E; Mangenot, S; Rattei, T; Lehner, A; Taylor, MW; Horn, M; Daims, H; Bartol-Mavel, D; Wincker, P; Barbe, V; Fonknechten, N; Vallenet, D; Segurens, B; Schenowitz-Truong, C; Medigue, C; Collingro, A; Snel, B; Dutilh, BE; Op den Camp, HJM; van der Drift, C; Cirpus, I; van de Pas-Schoonen, KT; Harhangi, HR; van Niftrik, L; Schmid, M; Keltjens, J; van de Vossenberg, J; Kartal, B; Meier, H; Frishman, D; Huynen, MA; Mewes, HW; Weissenbach, J; Jetten, MSM; Wagner, M; Le Paslier, D				Strous, M; Pelletier, E; Mangenot, S; Rattei, T; Lehner, A; Taylor, MW; Horn, M; Daims, H; Bartol-Mavel, D; Wincker, P; Barbe, V; Fonknechten, N; Vallenet, D; Segurens, B; Schenowitz-Truong, C; Medigue, C; Collingro, A; Snel, B; Dutilh, BE; Op den Camp, HJM; van der Drift, C; Cirpus, I; van de Pas-Schoonen, KT; Harhangi, HR; van Niftrik, L; Schmid, M; Keltjens, J; van de Vossenberg, J; Kartal, B; Meier, H; Frishman, D; Huynen, MA; Mewes, HW; Weissenbach, J; Jetten, MSM; Wagner, M; Le Paslier, D			Deciphering the evolution and metabolism of an anammox bacterium from a community genome	NATURE			English	Article							SEQUENCE; OXIDATION	Anaerobic ammonium oxidation (anammox) has become a main focus in oceanography and wastewater treatment(1,2). It is also the nitrogen cycle's major remaining biochemical enigma. Among its features, the occurrence of hydrazine as a free intermediate of catabolism(3,4), the biosynthesis of ladderane lipids(5,6) and the role of cytoplasm differentiation(7) are unique in biology. Here we use environmental genomics(8,9) - the reconstruction of genomic data directly from the environment - to assemble the genome of the uncultured anammox bacterium Kuenenia stuttgartiensis(10) from a complex bioreactor community. The genome data illuminate the evolutionary history of the Planctomycetes and allow us to expose the genetic blueprint of the organism's special properties. Most significantly, we identified candidate genes responsible for ladderane biosynthesis and biological hydrazine metabolism, and discovered unexpected metabolic versatility.	Radboud Univ Nijmegen, Dept Microbiol, IWWR, NL-6525 ED Nijmegen, Netherlands; CNRS, UMR 8030, F-91057 Evry, France; Tech Univ Munich, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany; Univ Vienna, Dept Microbial Ecol, A-1090 Vienna, Austria; Univ Zurich, Inst Lebensmittelsicherheit & Hyg, CH-8057 Zurich, Switzerland; Radboud Univ Nijmegen Med Ctr, Ctr Mol & Biomol Informat, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; Delft Univ Technol, Kluyver Lab Biotechnol, NL-2628 BC Delft, Netherlands; Tech Univ Munich, Lehrstuhl Rechnertech & Rechnerorg Parallelrechne, Inst Informat, D-85748 Garching, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Bioinformat, D-85764 Neuherberg, Germany	Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; Technical University of Munich; University of Vienna; University of Zurich; Radboud University Nijmegen; Delft University of Technology; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Jetten, MSM (corresponding author), Radboud Univ Nijmegen, Dept Microbiol, IWWR, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	m.jetten@science.ru.nl; wagner@microbial-ecology.net	Huynen, Martijn A/A-1530-2014; Wagner, Michael/A-7801-2011; Dutilh, Bas E./B-9719-2011; Frishman, Dmitrij/AAT-7815-2020; Collingro, Astrid/ABA-2082-2021; Jetten, Mike/B-8834-2011; Kartal, Boran/ABD-5400-2021; Horn, Matthias/G-1136-2011; van Niftrik, Laura/AAQ-7724-2020; Keltjens, Jan/M-3002-2013; Daims, Holger/I-8410-2012; Rattei, Thomas/F-1366-2011; Schmid, Markus C/D-2669-2012; Lehner, Angelika/B-2363-2018; Kartal, Boran/D-2488-2014; Snel, Berend/B-8886-2011; van Niftrik, Laura/C-3269-2011; Huijnen, M.A./H-8051-2014; Camp, Huub J.M. Op den/F-5114-2011; Strous, Marc/B-4064-2017; Mewes, Hans-Werner/A-8204-2019	Huynen, Martijn A/0000-0001-6189-5491; Wagner, Michael/0000-0002-9778-7684; Dutilh, Bas E./0000-0003-2329-7890; Collingro, Astrid/0000-0002-4100-832X; Jetten, Mike/0000-0002-4691-7039; Horn, Matthias/0000-0002-8309-5855; van Niftrik, Laura/0000-0002-7011-7234; Daims, Holger/0000-0002-4195-0913; Rattei, Thomas/0000-0002-0592-7791; Lehner, Angelika/0000-0003-1863-5090; Snel, Berend/0000-0002-5804-8547; Camp, Huub J.M. Op den/0000-0003-1990-9030; Strous, Marc/0000-0001-9600-3828; Taylor, Michael/0000-0002-0463-7813; Kartal, Boran/0000-0003-4199-952X; Vallenet, David/0000-0001-6648-0332; Valeeva, Aygul V./0000-0002-9968-9586; Le Paslier, Denis/0000-0003-4335-9956; Mewes, Hans-Werner/0000-0002-9713-6398; van de Vossenberg, Jack/0000-0003-4497-6155; Pelletier, Eric/0000-0003-4228-1712				Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Brasseur G, 2004, BBA-BIOENERGETICS, V1656, P114, DOI 10.1016/j.bbabio.2004.02.008; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Chopra I, 1998, MICROBIOL-UK, V144, P2673, DOI 10.1099/00221287-144-10-2673; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Damste JSS, 2002, NATURE, V419, P708, DOI 10.1038/nature01128; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Drake HL, 2004, RES MICROBIOL, V155, P422, DOI 10.1016/j.resmic.2004.03.003; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; Fuerst JA, 2005, ANNU REV MICROBIOL, V59, P299, DOI 10.1146/annurev.micro.59.030804.121258; Glockner FO, 2003, P NATL ACAD SCI USA, V100, P8298, DOI 10.1073/pnas.1431443100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guven D, 2005, APPL ENVIRON MICROB, V71, P1066, DOI 10.1128/AEM.71.2.1066-1071.2005; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Le Paslier MC, 2000, GENOMICS, V65, P87, DOI 10.1006/geno.2000.6147; Lindsay MR, 2001, ARCH MICROBIOL, V175, P413, DOI 10.1007/s002030100280; Mascitti V, 2004, J AM CHEM SOC, V126, P15664, DOI 10.1021/ja044089a; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Schalk J, 2000, BIOCHEMISTRY-US, V39, P5405, DOI 10.1021/bi992721k; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schouten S, 2004, APPL ENVIRON MICROB, V70, P3785, DOI 10.1128/AEM.70.6.3785-3788.2004; Staley JT, 2005, FEMS MICROBIOL LETT, V243, P9, DOI 10.1016/j.femsle.2004.11.034; Strous M, 2004, ANNU REV MICROBIOL, V58, P99, DOI 10.1146/annurev.micro.58.030603.123605; Teeling H, 2004, INT J SYST EVOL MICR, V54, P791, DOI 10.1099/ijs.0.02913-0; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; vandeGraaf AA, 1997, MICROBIOL-SGM, V143, P2415, DOI 10.1099/00221287-143-7-2415; Vishwanath P, 2004, MOL PHYLOGENET EVOL, V33, P615, DOI 10.1016/j.ympev.2004.07.003; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005	30	837	978	64	1062	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					790	794		10.1038/nature04647	http://dx.doi.org/10.1038/nature04647			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598256				2022-12-28	WOS:000236548400040
J	Wang, ZX; Chakrabarty, D; Kaplan, DL				Wang, ZX; Chakrabarty, D; Kaplan, DL			A debris disk around an isolated young neutron star	NATURE			English	Article							X-RAY PULSARS; PLANETARY SYSTEM; FALLBACK DISKS; VARIABILITY; 4U0142+61; ACCRETION; SUPERNOVA; EMISSION	Pulsars are rotating, magnetized neutron stars that are born in supernova explosions following the collapse of the cores of massive stars. If some of the explosion ejecta fails to escape, it may fall back onto the neutron star(1) or it may possess sufficient angular momentum to form a disk(2). Such 'fallback' is both a general prediction of current supernova models(3) and, if the material pushes the neutron star over its stability limit, a possible mode of black hole formation(4). Fallback disks could dramatically affect the early evolution of pulsars(2,5), yet there are few observational constraints on whether significant fallback occurs or even the actual existence of such disks. Here we report the discovery of mid-infrared emission from a cool disk around an isolated young X-ray pulsar. The disk does not power the pulsar's X-ray emission but is passively illuminated by these X-rays. The estimated mass of the disk is of the order of 10 Earth masses, and its lifetime (>= 10(6) years) significantly exceeds the spin-down age of the pulsar, supporting a supernova fallback origin. The disk resembles protoplanetary disks seen around ordinary young stars(6), suggesting the possibility of planet formation around young neutron stars.	MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Chakrabarty, D (corresponding author), MIT, Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	deepto@space.mit.edu		Kaplan, David/0000-0001-6295-2881				Alpar MA, 2001, ASTROPHYS J, V554, P1245, DOI 10.1086/321393; BECKWITH SVW, 1990, ASTRON J, V99, P924, DOI 10.1086/115385; Chatterjee P, 2000, ASTROPHYS J, V534, P373, DOI 10.1086/308748; CHEVALIER RA, 1989, ASTROPHYS J, V346, P847, DOI 10.1086/168066; COLGATE SA, 1971, ASTROPHYS J, V163, P221, DOI 10.1086/150760; deJong JA, 1996, ASTRON ASTROPHYS, V314, P484; Durant M, 2005, ASTROPHYS J, V627, P376, DOI 10.1086/429714; DURANT M, UNPUB ASTROPHYS J; Eksi KY, 2005, ASTROPHYS J, V623, pL41, DOI 10.1086/429915; Gavriil FP, 2002, ASTROPHYS J, V567, P1067, DOI 10.1086/338698; Heger A, 2003, ASTROPHYS J, V591, P288, DOI 10.1086/375341; Hulleman F, 2004, ASTRON ASTROPHYS, V416, P1037, DOI 10.1051/0004-6361:20031756; Hulleman F, 2000, NATURE, V408, P689, DOI 10.1038/35047024; Hurley K, 2005, NATURE, V434, P1098, DOI 10.1038/nature03519; Kern B, 2002, NATURE, V417, P527, DOI 10.1038/417527a; LIN DNC, 1991, NATURE, V353, P827, DOI 10.1038/353827a0; Lohmer O, 2004, ASTRON ASTROPHYS, V425, P763, DOI 10.1051/0004-6361:20041263; Menou K, 2001, ASTROPHYS J, V554, pL63, DOI 10.1086/320927; MICHEL FC, 1981, ASTROPHYS J, V251, P654, DOI 10.1086/159511; Miller MC, 2001, ASTROPHYS J, V550, P863, DOI 10.1086/319813; Perna R, 2000, ASTROPHYS J, V541, P344, DOI 10.1086/309404; PHINNEY ES, 1993, ASTR SOC P, V36, P371; TARN CR, 2004, ASTROPHYS J, V617, pL53; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; VANPARADIJS J, 1995, ASTRON ASTROPHYS, V299, pL41; VRTILEK SD, 1990, ASTRON ASTROPHYS, V235, P162; WOLSZCZAN A, 1994, SCIENCE, V264, P538, DOI 10.1126/science.264.5158.538; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0; WOODS PM, IN PRESS COMPACT STE; [No title captured]	30	226	230	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2006	440	7085					772	775		10.1038/nature04669	http://dx.doi.org/10.1038/nature04669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	029GH	16598251	Green Submitted			2022-12-28	WOS:000236548400035
J	Mullan, Z				Mullan, Z			Letters or lectures?	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Mullan, Z (corresponding author), Lancet, London NW1 7BY, England.	Zoe.mullan@lancet.com							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 1	2006	367	9516					1042	1042		10.1016/S0140-6736(06)68451-1	http://dx.doi.org/10.1016/S0140-6736(06)68451-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581390				2022-12-28	WOS:000236673200011
J	Emile, O; Le Floch, A; Vollrath, F				Emile, O; Le Floch, A; Vollrath, F			Biopolymers: Shape memory in spider draglines	NATURE			English	Editorial Material							SILK; DNA		Univ Rennes 1, Phys Lasers Lab, CNRS, UMR 6627, F-35042 Rennes, France; Dept Zool, Oxford OX1 3PS, England	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Emile, O (corresponding author), Univ Rennes 1, Phys Lasers Lab, CNRS, UMR 6627, F-35042 Rennes, France.	olivier.emile@univ-rennes1.fr		Le Floch, Albert/0000-0002-4516-9817; Vollrath, Fritz/0000-0003-3484-9005				Ashley S, 2003, SCI AM, V289, P84, DOI 10.1038/scientificamerican1103-84; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Bhattacharya K, 2004, NATURE, V428, P55, DOI 10.1038/nature02378; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Craig C, 2003, SPIDERWEBS SILK; Feynman R. P., 1964, FEYNMAN LECT PHYS; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Koster DA, 2005, NATURE, V434, P671, DOI 10.1038/nature03395; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780	10	78	84	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2006	440	7084					621	621		10.1038/440621a	http://dx.doi.org/10.1038/440621a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572162	Bronze			2022-12-28	WOS:000236350400033
J	Jones, DH; Nakashima, T; Sanchez, OH; Kozieradzki, I; Komarova, SV; Sarosi, I; Morony, S; Rubin, E; Sarao, R; Hojilla, CV; Komnenovic, V; Kong, YY; Schreiber, M; Dixon, SJ; Sims, SM; Khokha, R; Wada, T; Penninger, JM				Jones, DH; Nakashima, T; Sanchez, OH; Kozieradzki, I; Komarova, SV; Sarosi, I; Morony, S; Rubin, E; Sarao, R; Hojilla, CV; Komnenovic, V; Kong, YY; Schreiber, M; Dixon, SJ; Sims, SM; Khokha, R; Wada, T; Penninger, JM			Regulation of cancer cell migration and bone metastasis by RANKL	NATURE			English	Article							OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN-LIGAND; MURINE MODEL; GROWTH; OSTEOLYSIS	Bone metastases are a frequent complication of many cancers that result in severe disease burden and pain(1-3). Since the late nineteenth century, it has been thought that the microenvironment of the local host tissue actively participates in the propensity of certain cancers to metastasize to specific organs, and that bone provides an especially fertile 'soil' 4. In the case of breast cancers, the local chemokine milieu is now emerging as an explanation for why these tumours preferentially metastasize to certain organs(5). However, as the inhibition of chemokine receptors in vivo only partially blocks metastatic behaviour(6), other factors must exist that regulate the preferential metastasis of breast cancer cells. Here we show that the cytokine RANKL ( receptor activator of NF-kappa B ligand)(7,8) triggers migration of human epithelial cancer cells and melanoma cells that express the receptor RANK. RANK is expressed on cancer cell lines and breast cancer cells in patients. In a mouse model of melanoma metastasis(9), in vivo neutralization of RANKL by osteoprotegerin results in complete protection from paralysis and a marked reduction in tumour burden in bones but not in other organs. Our data show that local differentiation factors such as RANKL have an important role in cell migration and the tissue-specific metastatic behaviour of cancer cells.	Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; McGill Univ, Fac Dent, Montreal, PQ H3A 1A4, Canada; Amgen Inc, Thousand Oaks, CA 91320 USA; Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang 790784, South Korea; Med Univ Vienna, Dept Obstet & Gynecol, A-1090 Vienna, Austria; Univ Western Ontario, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodeling, London, ON N6A 5C1, Canada; Univ Western Ontario, Div Oral Biol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McGill University; Amgen; Pohang University of Science & Technology (POSTECH); Medical University of Vienna; Western University (University of Western Ontario); Western University (University of Western Ontario)	Penninger, JM (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Dixon, S. Jeffrey/G-3657-2013; Martin, Schreiber/F-2175-2013; Sims, Stephen/G-4510-2013; Penninger, Josef M/I-6860-2013	Dixon, S. Jeffrey/0000-0001-9162-1686; Martin, Schreiber/0000-0003-1102-7789; Penninger, Josef M/0000-0002-8194-3777				Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ARGUELLO F, 1988, CANCER RES, V48, P6876; Bakewell SJ, 2003, P NATL ACAD SCI USA, V100, P14205, DOI 10.1073/pnas.2234372100; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Guise Theresa A., 2000, Cancer, V88, P2892, DOI 10.1002/1097-0142(20000615)88:12+<2892::AID-CNCR2>3.0.CO;2-Y; Komarova SV, 2003, J BIOL CHEM, V278, P8286, DOI 10.1074/jbc.M206421200; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Moore MAS, 2001, BIOESSAYS, V23, P674, DOI 10.1002/bies.1095; Morony S, 2001, CANCER RES, V61, P4432; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Peyruchaud O, 2001, J BONE MINER RES, V16, P2027, DOI 10.1359/jbmr.2001.16.11.2027; SanchezSweatman OH, 1997, EUR J CANCER, V33, P918, DOI 10.1016/S0959-8049(97)00513-3; Sloan EK, 2002, CELL MOL LIFE SCI, V59, P1491, DOI 10.1007/s00018-002-8524-5; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; VERSCHUEREN H, 1994, J LEUKOCYTE BIOL, V55, P552, DOI 10.1002/jlb.55.4.552; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	22	587	629	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2006	440	7084					692	696		10.1038/nature04524	http://dx.doi.org/10.1038/nature04524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026OY	16572175	Bronze			2022-12-28	WOS:000236350400049
J	Thorne, SH; Negrin, RS; Contag, CH				Thorne, SH; Negrin, RS; Contag, CH			Synergistic antitumor effects of immune cell-viral biotherapy	SCIENCE			English	Article							VACCINIA VIRUS; T-CELLS; THYMIDINE KINASE; GENE-THERAPY; ONCOLYTIC VIROTHERAPY; FUTURE-DIRECTIONS; NK CELLS; CANCER; NKG2D; LYMPHOMA	Targeted biological therapies hold tremendous potential for treatment of cancer, yet their use has been limited by constraints on delivery and effective tumor targeting. We combined an immune effector cell population [cytokine-induced killer (CIK) cells] with an oncolytic viral therapy to achieve directed delivery to, and regression of, tumors in both immunodeficient and immunocompetent mouse models. Preinfection of CIK cells with modified vaccinia virus resulted in a prolonged eclipse phase with the virus remaining hidden until interaction with the tumor. Whole-body imaging revealed that the cells retained their ability to traffic to and to infiltrate the tumor effectively before releasing the virus. These results illustrate the potential of combining biotherapeutics for synergistic effects that more. effectively treat cancer.	Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Div Bone Marrow Transplantat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Contag, CH (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.	ccontag@cmgm.stanford.edu		Contag, Christopher/0000-0002-1011-8278	NCI NIH HHS [R24 CA 92862, P50 CA114747, P01 CA49605] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA049605, P50CA114747, R24CA092862] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Baker J, 2001, BLOOD, V97, P2923, DOI 10.1182/blood.V97.10.2923; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; BULLER RML, 1985, NATURE, V317, P813, DOI 10.1038/317813a0; BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Cole C, 2005, NAT MED, V11, P1073, DOI 10.1038/nm1297; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639; HENGSTSCHLAGER M, 1994, J BIOL CHEM, V269, P13836; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Leemhuis T, 2005, BIOL BLOOD MARROW TR, V11, P181, DOI 10.1016/j.bbmt.2004.11.019; LU PH, 1994, J IMMUNOL, V153, P1687; Mastrangelo MJ, 1999, CANCER GENE THER, V6, P409, DOI 10.1038/sj.cgt.7700066; McCart JA, 2001, CANCER RES, V61, P8751; Puhlmann M, 2000, CANCER GENE THER, V7, P66, DOI 10.1038/sj.cgt.7700075; Thorne SH, 2005, SEMIN ONCOL, V32, P537, DOI 10.1053/j.seminoncol.2005.09.007; Thorne SH, 2004, EXPERT OPIN BIOL TH, V4, P1307, DOI 10.1517/14712598.4.8.1307; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Yu YA, 2004, NAT BIOTECHNOL, V22, P313, DOI 10.1038/nbt937	25	227	271	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1780	1784		10.1126/science.1121411	http://dx.doi.org/10.1126/science.1121411			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556847				2022-12-28	WOS:000236204300048
J	Shinya, K; Ebina, M; Yamada, S; Ono, M; Kasai, N; Kawaoka, Y				Shinya, K; Ebina, M; Yamada, S; Ono, M; Kasai, N; Kawaoka, Y			Influenza virus receptors in the human airway	NATURE			English	Editorial Material							A VIRUSES		Univ Tokyo, Dept Microbiol & Immunol, Div Virol, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo 1088639, Japan; Tohoku Univ, Inst Anim Experimentat, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; University of Tokyo; Tohoku University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Shinya, K (corresponding author), Tottori Univ, Avian Zoonosis Res Ctr, Tottori 6808550, Japan.	kawaokay@svm.vetmed.wisc.edu						BAUM LG, 1990, ACTA HISTOCHEM, P35; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Shinya K, 2005, J VIROL, V79, P9926, DOI 10.1128/JVI.79.15.9926-9932.2005; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313	8	986	1076	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2006	440	7083					435	436		10.1038/440435a	http://dx.doi.org/10.1038/440435a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554799				2022-12-28	WOS:000236176100036
J	Vinge, V				Vinge, V			The creativity machine	NATURE			English	Editorial Material									San Diego State Univ, San Diego, CA 92182 USA	California State University System; San Diego State University	Vinge, V (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.							BUTLER D, AVIAN FLU MAPS GOGGL; Kilgarriff A, 2003, COMPUT LINGUIST, V29, P333, DOI 10.1162/089120103322711569; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066	3	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2006	440	7083					411	411		10.1038/440411a	http://dx.doi.org/10.1038/440411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024DV	16554782				2022-12-28	WOS:000236176100020
J	Mora, S; Lee, IM; Buring, JE; Ridker, PM				Mora, S; Lee, IM; Buring, JE; Ridker, PM			Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; LOW-DOSE ASPIRIN; RISK-FACTORS; PRIMARY PREVENTION; CARDIORESPIRATORY FITNESS; PROGENITOR CELLS; HEART-DISEASE; EXERCISE; OBESITY; HEALTH	Context There are few data directly comparing the effects of physical activity and body weight on cardiovascular biomarkers. Objective To examine the association of physical activity and body mass index (BMI, defined as weight in kilograms divided by the square of height in meters) alone and in combination with cardiovascular biomarkers. Design, Setting, and Participants Cross-sectional analysis of 27 158 apparently healthy US women ( mean age, 54.7 years) at the time of enrollment (1992-1995) in the Women's Health Study, a randomized, double-blind, placebo-controlled trial of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer. Main Outcome Measures The association of physical activity and BMI with high-sensitivity C-reactive protein (CRP), fibrinogen, soluble intracellular adhesion molecule 1 (ICAM-1), homocysteine, low- and high-density lipoprotein (LDL and HDL) cholesterol, total cholesterol, apolipoprotein A-1 and B-100, lipoprotein( a), and creatinine. Results Lower levels of physical activity and higher levels of BMI were independently associated ( P for trend < .001) with adverse levels of nearly all lipid and inflammatory biomarkers. High BMI showed stronger associations with these biomarkers than physical inactivity. For example, using the reference group of physically active, normal weight women ( energy expenditure >= 1000 kcal/week; BMI, 18.5-24.9) and adjusting for age, race, smoking, blood pressure, diabetes, menopausal status, and hormone use, the odds ratios (95% confidence intervals [CIs]) for having CRP > 3 mg/L were: for inactive, normal weight women 1.26 (1.15-1.37); active, overweight 2.68 (2.41-2.98); inactive, overweight 3.11 (2.84-3.41); active, obese 8.25 (7.15-9.51); and inactive, obese 9.86 (8.84-10.99). In similar analyses, the odds ratios ( 95% CIs) for having HDL cholesterol < 50 mg/dL were 1.20 (1.11-1.30); 2.25 (2.04-2.49); 2.62 (2.41-2.85); 4.21 (3.68-4.81); and 5.27 (4.77-5.84), respectively, and for having apolipoprotein B-100 > 120 mg/dL they were 1.21 (1.11-1.33); 1.86 (1.66-2.08); 2.06 (1.88-2.67); 2.35 (2.04-2.70); and 2.33 (2.09-2.59). Fibrinogen, ICAM-1, apolipoprotein A1, total cholesterol, and LDL cholesterol showed similar associations. By contrast, homocysteine, lipoprotein ( a), and creatinine showed weak or nonsignificant associations. Conclusions High BMI was more strongly related to adverse cardiovascular biomarker levels than physical inactivity. However, within BMI categories, physical activity was generally associated with more favorable cardiovascular biomarker levels than inactivity.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02215 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mora, S (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	smora2@partners.org	Lee, I-Min/ABD-5409-2021	Mora, Samia/0000-0001-6283-0980	NCI NIH HHS [CA-47988] Funding Source: Medline; NHLBI NIH HHS [HL-43851] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abramson JL, 2002, ARCH INTERN MED, V162, P1286, DOI 10.1001/archinte.162.11.1286; *AM HEART ASS, 2004, HEART DIS STROK STAT; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; Carmena R, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000131511.50734.44; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1208; Christou DD, 2005, CIRCULATION, V111, P1904, DOI 10.1161/01.CIR.0000161818.28974.1A; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Church TS, 2002, INT J OBESITY, V26, P805, DOI 10.1038/sj.ijo.0802001; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; DeSouza CA, 1998, ARTERIOSCL THROM VAS, V18, P362, DOI 10.1161/01.ATV.18.3.362; Despres J P, 1998, Obes Res, V6 Suppl 1, p8S; ELWOOD PC, 1993, BRIT HEART J, V69, P183; Folsom A R, 1992, Ann Epidemiol, V2, P481; Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/00001648-200209000-00012; Geffken DF, 2001, AM J EPIDEMIOL, V153, P242, DOI 10.1093/aje/153.3.242; Gibbons RJ, 2002, J AM COLL CARDIOL, V40, P1531, DOI 10.1016/S0735-1097(02)02164-2; Grundy SM, 2002, CIRCULATION, V105, P2696, DOI 10.1161/01.CIR.0000020650.86137.84; Haddock BL, 1998, MED SCI SPORT EXER, V30, P893, DOI 10.1097/00005768-199806000-00018; HAINLINE A, 1982, MANUAL LAB OPERATION; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Manson JE, 2004, ARCH INTERN MED, V164, P249, DOI 10.1001/archinte.164.3.249; MANSON JE, 1992, JAMA-J AM MED ASSOC, V268, P63, DOI 10.1001/jama.268.1.63; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Rawson ES, 2003, MED SCI SPORT EXER, V35, P1160, DOI 10.1249/01.MSS.0000074565.79230.AB; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Sandri M, 2005, CIRCULATION, V111, P3391, DOI 10.1161/CIRCULATIONAHA.104.527135; Shamsuzzaman ASM, 2004, CIRCULATION, V109, P2181, DOI 10.1161/01.CIR.0000127960.28627.75; Steiner S, 2005, ATHEROSCLEROSIS, V181, P305, DOI 10.1016/j.atherosclerosis.2005.01.006; Tomaszewski M, 2003, ARTERIOSCL THROM VAS, V23, P1640, DOI 10.1161/01.ATV.0000087036.75849.0B; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; Weinstein AR, 2004, JAMA-J AM MED ASSOC, V292, P1188, DOI 10.1001/jama.292.10.1188; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	43	270	277	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2006	295	12					1412	1419		10.1001/jama.295.12.1412	http://dx.doi.org/10.1001/jama.295.12.1412			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023WU	16551713	Bronze			2022-12-28	WOS:000236157700019
J	Heffernan, MP; Saag, KG; Robinson, JK; Callen, JP				Heffernan, MP; Saag, KG; Robinson, JK; Callen, JP			Prevention of osteoporosis associated with chronic glucocorticoid therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORTICOSTEROID-INDUCED OSTEOPOROSIS; RANDOMIZED CONTROLLED-TRIAL; INDUCED BONE LOSS; HIP FRACTURE; MYCOPHENOLATE-MOFETIL; RHEUMATOID-ARTHRITIS; ORAL CORTICOSTEROIDS; PEMPHIGUS-VULGARIS; RISK-FACTORS; MORTALITY		Univ Louisville, Sch Med, Dept Med, Div Dermatol, Louisville, KY 40202 USA; Wright State Univ, Boonshoft Sch Med, Div Dermatol, Dayton, OH 45435 USA; Univ Alabama, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA	University of Louisville; University System of Ohio; Wright State University Dayton; University of Alabama System; University of Alabama Birmingham; Northwestern University; Feinberg School of Medicine	Callen, JP (corresponding author), Univ Louisville, Sch Med, Dept Med, Div Dermatol, 310 E Broadway, Louisville, KY 40202 USA.	jefca@aol.com						Adachi JD, 2000, SEMIN ARTHRITIS RHEU, V29, P228, DOI 10.1016/S0049-0172(00)80011-6; Adler RA, 2003, ARCH INTERN MED, V163, P2619, DOI 10.1001/archinte.163.21.2619; BONAR SK, 1990, J AM GERIATR SOC, V38, P1139, DOI 10.1111/j.1532-5415.1990.tb01378.x; Burruss JB, 1996, J AM ACAD DERMATOL, V35, P720, DOI 10.1016/S0190-9622(96)90727-6; Bystryn JC, 1996, ARCH DERMATOL, V132, P203, DOI 10.1001/archderm.132.2.203; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; CHRISCHILLES EA, 1991, ARCH INTERN MED, V151, P2026, DOI 10.1001/archinte.151.10.2026; CHRISCHILLES EA, 1922, IN PRESS ARCH INTERN, V152, P655; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Da Silva JAP, 2006, ANN RHEUM DIS, V65, P285, DOI 10.1136/ard.2005.038638; Edge JC, 2006, ARCH DERMATOL, V142, P65, DOI 10.1001/archderm.142.1.65; Enk AH, 1999, ARCH DERMATOL, V135, P54, DOI 10.1001/archderm.135.1.54; Geusens PP, 2004, ANN RHEUM DIS, V63, P324, DOI 10.1136/ard.2003.008060; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Hantash B, 2006, ARCH DERMATOL, V142, P109, DOI 10.1001/archderm.142.1.109; Hochberg MC, 1996, ARTHRITIS RHEUM-US, V39, P1791; IP M, 1994, CHEST, V105, P1722, DOI 10.1378/chest.105.6.1722; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Lane NE, 1998, J CLIN INVEST, V102, P1627, DOI 10.1172/JCI3914; Lester RS, 1998, DERMATOL CLIN, V16, P277, DOI 10.1016/S0733-8635(05)70010-3; Liu RH, 2006, ARCH DERMATOL, V142, P37, DOI 10.1001/archderm.142.1.37; Lozsadi DA, 2006, CLIN NEUROL NEUROSUR, V108, P157, DOI 10.1016/j.clineuro.2005.05.008; LUENGO M, 1991, THORAX, V46, P803, DOI 10.1136/thx.46.11.803; MICHEL BA, 1993, J RHEUMATOL, V20, P1666; MILLER CW, 1978, J BONE JOINT SURG AM, V60, P930, DOI 10.2106/00004623-197860070-00010; Mimouni D, 2003, ARCH DERMATOL, V139, P739, DOI 10.1001/archderm.139.6.739; Naunton M, 2004, J RHEUMATOL, V31, P550; PECK WA, 1993, AM J MED, V94, P646; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Rehman Q, 2003, MED PEDIATR ONCOL, V41, P212, DOI 10.1002/mpo.10339; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Sambrook P N, 2001, Aust Fam Physician, V30, P793; Solomon DH, 2004, ARTHRIT RHEUM-ARTHR, V51, P383, DOI 10.1002/art.20403; SULZBERGER MB, 1951, AMA ARCH DERM SYPH, V64, P573, DOI 10.1001/archderm.1951.01570110043006; Summey BT, 2006, ARCH DERMATOL, V142, P82, DOI 10.1001/archderm.142.1.82; Trombetti A, 2002, OSTEOPOROSIS INT, V13, P731, DOI 10.1007/s001980200100; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Walsh LJ, 1996, BRIT MED J, V313, P344, DOI 10.1136/bmj.313.7053.344	40	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2006	295	11					1300	1303		10.1001/jama.295.11.1300	http://dx.doi.org/10.1001/jama.295.11.1300			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021GV	16541489				2022-12-28	WOS:000235972600028
J	Kumar, S				Kumar, S			Progress in the treatment of multiple myeloma	LANCET			English	Editorial Material							THALIDOMIDE; CHEMOTHERAPY; DEXAMETHASONE; COMBINATION; MELPHALAN; TRIAL		Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic	Kumar, S (corresponding author), Mayo Clin, Div Hematol, Rochester, MN 55905 USA.	kumar.shaji@mayo.edu	Kumar, Shaji K/A-9853-2008	Kumar, Shaji K/0000-0001-5392-9284				ALEXANIAN R, 1969, J AMER MED ASSOC, V208, P1680, DOI 10.1001/jama.208.9.1680; [Anonymous], 1998, J Clin Oncol, V16, P3832; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Child JA, 2003, NEW ENGL J MED, V348, P1875, DOI 10.1056/NEJMoa022340; Facon T, 2005, BLOOD, V106, p230A; Garcia-Sanz R, 2004, LEUKEMIA, V18, P856, DOI 10.1038/sj.leu.2403322; Kumar S, 2005, NAT CLIN PRACT ONCOL, V2, P262, DOI 10.1038/ncponc0174; Kumar S, 2003, MAYO CLIN PROC, V78, P34, DOI 10.4065/78.1.34; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rajkumar SV, 2006, J CLIN ONCOL, V24, P431, DOI 10.1200/JCO.2005.03.0221; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102	12	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					791	792		10.1016/S0140-6736(06)68311-6	http://dx.doi.org/10.1016/S0140-6736(06)68311-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021WL	16530557				2022-12-28	WOS:000236016500004
J	McMichael, AJ; Woodruff, RE; Hales, S				McMichael, AJ; Woodruff, RE; Hales, S			Climate change and human health: present and future risks	LANCET			English	Review							TICK-BORNE ENCEPHALITIS; WATERBORNE DISEASE OUTBREAKS; EL-NINO; UNITED-STATES; COLD WEATHER; HEAT WAVES; MALARIA TRANSMISSION; AMBIENT-TEMPERATURE; DENGUE-FEVER; GLOBAL DISTRIBUTION	There is near unanimous scientific consensus that greenhouse gas emissions generated by human activity will change Earth's climate. The recent (globally averaged) warming by 0.5 degrees C is partly attributable to such anthropogenic emissions. Climate change will affect human health in many ways-mostly adversely. Here, we summarise the epidemiological evidence of how climate variations and trends affect various health outcomes. We assess the little evidence there is that recent global warming has already affected some health outcomes. We review the published estimates of future health effects of climate change over coming decades. Research so far has mostly focused on thermal stress, extreme weather events, and infectious diseases, with some attention to estimates of future regional food yields and hunger prevalence. An emerging broader approach addresses a wider spectrum of health risks due to the social, demographic, and economic disruptions of climate change. Evidence and anticipation of adverse health effects will strengthen the case for pre-emptive policies, and will also guide priorities for planned adaptive strategies.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Univ Otago, Wellington Sch Med & Hlth Sci, Wellington, New Zealand	Australian National University; University of Otago	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	Nahas, Alberth/C-8379-2013; hales, simon/E-5768-2010	Hales, Simon/0000-0002-4529-7595				Afza M, 2001, J PUBLIC HEALTH MED, V23, P312, DOI 10.1093/pubmed/23.4.312; *AG FRANC PRESS, TUV PM BLAM GLOB WAR; Aronow WS, 2004, J GERONTOL A-BIOL, V59, P146; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; Balls MJ, 2004, T ROY SOC TROP MED H, V98, P400, DOI 10.1016/j.trstmh.2003.11.005; Bambrick HJ, 2004, MED J AUSTRALIA, V181, P61, DOI 10.5694/j.1326-5377.2004.tb06171.x; Bankoff G, 2003, DISASTERS, V27, P224, DOI 10.1111/1467-7717.00230; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Bentham G, 2001, INT J BIOMETEOROL, V45, P22, DOI 10.1007/s004840000083; BENTHAM G, 1995, INT J BIOMETEOROL, V39, P81, DOI 10.1007/BF01212585; Black AR, 2002, SCI TOTAL ENVIRON, V294, P169, DOI 10.1016/S0048-9697(02)00062-1; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Bonora S, 2001, TRENDS PARASITOL, V17, P572, DOI 10.1016/S1471-4922(01)02095-5; Booth S, 2005, ENVIRON HEALTH PERSP, V113, P521, DOI 10.1289/ehp.7603; Bouchama A, 2004, INTENS CARE MED, V30, P1, DOI 10.1007/s00134-003-2062-y; Bouma MJ, 1997, TROP MED INT HEALTH, V2, P1122, DOI 10.1046/j.1365-3156.1997.d01-210.x; Bouma MJ, 1997, LANCET, V350, P1435, DOI 10.1016/S0140-6736(97)04509-1; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Bouma MJ, 1996, AM J TROP MED HYG, V55, P131, DOI 10.4269/ajtmh.1996.55.131; Bronstert A, 2003, RISK ANAL, V23, P545, DOI 10.1111/1539-6924.00335; Campbell-Lendrum D., 2003, CLIMATE CHANGE HUMAN, P133; Carlson JC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-33; Changnon SA, 2000, B AM METEOROL SOC, V81, P437, DOI 10.1175/1520-0477(2000)081<0437:HFETIL>2.3.CO;2; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; D'Souza RM, 2004, EPIDEMIOLOGY, V15, P86, DOI 10.1097/01.ede.0000101021.03453.3e; DANIELOVA V, 1975, MED BIOL, V53, P282; Davis RE, 2003, INT J BIOMETEOROL, V47, P166, DOI 10.1007/s00484-003-0160-8; del Ninno C, 2005, ECON HUM BIOL, V3, P65, DOI 10.1016/j.ehb.2004.12.002; Dhainaut JF, 2004, CRIT CARE, V8, P1, DOI 10.1186/cc2404; Diaz J, 2002, INT ARCH OCC ENV HEA, V75, P163, DOI 10.1007/s00420-001-0290-4; Diaz J, 2002, INT J BIOMETEOROL, V46, P145, DOI 10.1007/s00484-002-0129-z; Donaldson GC, 1997, BRIT MED J, V315, P1055, DOI 10.1136/bmj.315.7115.1055; Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Ebi K. L., 2005, INTEGRATION PUBLIC H; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Folland CK, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P99; Frich P, 2002, CLIMATE RES, V19, P193, DOI 10.3354/cr019193; *GLOB URB OBS STAT, 2005, GLOB TRENDS; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Hajat S, 2004, EUR J EPIDEMIOL, V19, P959, DOI 10.1007/s10654-004-5731-4; Hales S, 1996, LANCET, V348, P1664, DOI 10.1016/S0140-6736(05)65737-6; Hales S, 1999, ENVIRON HEALTH PERSP, V107, P99, DOI 10.2307/3434364; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hales S, 2000, GLOB CHANGE HUMAN HL, V1, P66, DOI DOI 10.1023/A:1011527832009; Hall C. B., 1995, PRINCIPLES PRACTICE, V4, P1501; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Hopp MJ, 2003, CLIM RES, V25, P85, DOI 10.3354/cr025085; Houghton J., 2004, GLOBAL WARMING COMPL; Houser S., 2001, CLIMATE CHANGE IMPAC, P351; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; *INT FED RED CROSS, WORLD DIS REP; Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285; Keatinge W R, 2000, Int J Circumpolar Health, V59, P154; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Keatinge WR, 2004, SOUTH MED J, V97, P1093, DOI 10.1097/01.SMJ.0000144635.07975.66; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Kovats RS, 2005, INT J BIOMETEOROL, V49, P207, DOI 10.1007/s00484-004-0241-3; Kovats RS, 2004, EPIDEMIOL INFECT, V132, P443, DOI 10.1017/S0950268804001992; Ledrans Martine, 2004, Rev Prat, V54, P1289; Lindblade KA, 1999, T ROY SOC TROP MED H, V93, P480, DOI 10.1016/S0035-9203(99)90344-9; Lindgren E, 1998, ECOL MODEL, V110, P55, DOI 10.1016/S0304-3800(98)00041-6; Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509; Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; Maelzer D, 1999, ENVIRON HEALTH PERSP, V107, P817, DOI 10.2307/3454579; Malhi Y, 2004, PHILOS T R SOC B, V359, P549, DOI 10.1098/rstb.2003.1449; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; MARTENS WJM, 2002, ENV CHANGE CLIMATE H, P197; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; McMichael A., 2004, COMP QUANTIFICATION, V2, P1543; Mcmichael A.J., 2003, ATL HLTH CLIM; McMichael AJ, 2001, P NUTR SOC, V60, P195, DOI 10.1079/PNS200090; MCMICHAEL AJ, 2003, HUMAN HLTH CLIMATE C, P116; MCMICHAEL AJ, 1996, CLIMATE CHANGE HUMAN, P51; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Milly PCD, 2002, NATURE, V415, P514, DOI 10.1038/415514a; Morris JG, 1999, ANNU REV ENERG ENV, V24, P367, DOI 10.1146/annurev.energy.24.1.367; Mudelsee M, 2003, NATURE, V425, P166, DOI 10.1038/nature01928; Ndymugyenyi R, 2004, ANN TROP MED PARASIT, V98, P315, DOI 10.1179/000349804225003433; New M, 2000, J CLIMATE, V13, P2217, DOI 10.1175/1520-0442(2000)013<2217:RTCSTC>2.0.CO;2; Nichols GL, 2005, EMERG INFECT DIS, V11, P361, DOI 10.3201/eid1103.040460; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; *OFDA CRED, EM DAT INT DIS DAT; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Pascual M, 2005, PLOS MED, V2, P18, DOI 10.1371/journal.pmed.0020005; Patz JA, 2000, ENVIRON HEALTH PERSP, V108, P367, DOI 10.2307/3454357; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Philander S, 1990, EL NINO LA NINA SO O; Pilkey OH, 2004, SCIENCE, V303, P1781, DOI 10.1126/science.1093515; Poff NL, 2002, PHILOS T R SOC A, V360, P1497, DOI 10.1098/rsta.2002.1012; Randolph SE, 2000, P ROY SOC B-BIOL SCI, V267, P1741, DOI 10.1098/rspb.2000.1204; Reacher M, 2004, Commun Dis Public Health, V7, P39; REEVES WC, 1994, J MED ENTOMOL, V31, P323, DOI 10.1093/jmedent/31.3.323; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Rignot E, 2003, SCIENCE, V302, P434, DOI 10.1126/science.1087393; Robson AJ, 2002, PHILOS T ROY SOC A, V360, P1327, DOI 10.1098/rsta.2002.1003; Rodo X, 2002, P NATL ACAD SCI USA, V99, P12901, DOI 10.1073/pnas.182203999; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; Rooney C, 1998, J EPIDEMIOL COMMUN H, V52, P482, DOI 10.1136/jech.52.8.482; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011; Rose JB, 2000, J AM WATER WORKS ASS, V92, P77; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Smoyer KE, 2000, INT J BIOMETEOROL, V44, P190, DOI 10.1007/s004840000070; Smoyer KE, 1998, INT J BIOMETEOROL, V42, P44, DOI 10.1007/s004840050082; Snow R. W., 1999, EPIDEMIOLOGY POLITIC; Stachel B, 2004, WATER SCI TECHNOL, V50, P309, DOI 10.2166/wst.2004.0342; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Thomas CJ, 2004, TRENDS PARASITOL, V20, P216, DOI 10.1016/j.pt.2004.03.001; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Tol RSJ, 2003, RISK ANAL, V23, P575, DOI 10.1111/1539-6924.00338; Tong SL, 2004, TROP MED INT HEALTH, V9, P298, DOI 10.1046/j.1365-3156.2003.01175.x; Trenberth KE, 2001, SCIENCE, V293, P48, DOI 10.1126/science.293.5527.48; TULU AN, 1996, THESIS U LONDON; United Nations Population Division. Department of Economic and Social Affairs of the United Nations Secretariat, WORLD POP PROSP 2002; van Lieshout M, 2004, GLOBAL ENVIRON CHANG, V14, P87, DOI 10.1016/j.gloenvcha.2003.10.009; VERGER P, 2000, REV EPIDEMIOL SAN S2, V48; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Watson R, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, pIX; Weerasinghe DP, 2002, HEART, V88, P30, DOI 10.1136/heart.88.1.30; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Weisskopf MG, 2002, AM J PUBLIC HEALTH, V92, P830, DOI 10.2105/AJPH.92.5.830; White NJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021391; Wilcox BA, 2004, ECOHEALTH, V1, P211, DOI [10.1007/s10393-004-0122-6, DOI 10.1007/S10393-004-0122-6]; Woodruff RE, 2002, EPIDEMIOLOGY, V13, P384, DOI 10.1097/00001648-200207000-00005; Woodward A, 2000, B WORLD HEALTH ORGAN, V78, P1148; Zeman P, 1997, INT J EPIDEMIOL, V26, P1121, DOI 10.1093/ije/26.5.1121; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	144	1484	1536	34	1055	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2006	367	9513					859	869		10.1016/S0140-6736(06)68079-3	http://dx.doi.org/10.1016/S0140-6736(06)68079-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	021WL	16530580				2022-12-28	WOS:000236016500031
J	Bartek, J; Mailand, N				Bartek, J; Mailand, N			TOPping up ATR activity	CELL			English	Editorial Material							DNA-DAMAGE; BINDING; CHK1	The nuclear protein kinase ATR is a key regulator of genome integrity that functions at checkpoints for damaged or incompletely replicated DNA. In this issue of Cell, Kumagai et al. (2006) shed light on the molecular mechanism that controls ATR. They report that a physical interaction between ATR and a distinct domain of TopBP1 greatly enhances ATR kinase activity.	Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark	Danish Cancer Society; Danish Cancer Society	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, Stransdlvd 49, DK-2100 Copenhagen, Denmark.	jb@cancer.dk	Bartek, Jiri/G-5870-2014					Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Chini CCS, 2004, DNA REPAIR, V3, P1033, DOI 10.1016/j.dnarep.2004.03.001; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim SM, 2005, J BIOL CHEM, V280, P38355, DOI 10.1074/jbc.M508673200; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	10	12	13	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					888	890		10.1016/j.cell.2006.02.029	http://dx.doi.org/10.1016/j.cell.2006.02.029			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530035	Bronze			2022-12-28	WOS:000237241200010
J	Lakadamyali, M; Rust, MJ; Zhuang, XW				Lakadamyali, M; Rust, MJ; Zhuang, XW			Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes	CELL			English	Article							LOW-DENSITY-LIPOPROTEIN; EPIDERMAL-GROWTH-FACTOR; TRANSFERRIN RECEPTOR; MEMBRANE DOMAINS; INFLUENZA-VIRUS; COATED PITS; PATHWAY; PROTEINS; INTERNALIZATION; VESICLE	Cells rely on the correct sorting of endocytic ligands and receptors for proper function. Early endosomes have been considered as the initial sorting station where cargos for degradation separate from those for recycling. Using live-cell imaging to monitor individual endosomes and ligand particles in real time, we have discovered a sorting mechanism that takes place prior to early endosome entry. We show that early endosomes are in fact comprised of two distinct populations: a dynamic population that is highly mobile on microtubules and matures rapidly toward late endosomes and a static population that matures much more slowly. Several cargos destined for degradation are preferentially targeted to the dynamic endosomes, whereas the recycling ligand transferrin is nonselectively delivered to all early endosomes and effectively enriched in the larger, static population. This pre-early endosome sorting process begins at clathrin-coated vesicles, depends on microtubule-dependent motility, and appears to involve endocytic adaptors.	Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	zhuang@chemistry.harvard.edu			NIGMS NIH HHS [R01 GM068518-05, R01 GM068518] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068518] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; ANDERSON RGW, 1982, J CELL BIOL, V93, P523, DOI 10.1083/jcb.93.3.523; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Cao TT, 1998, J BIOL CHEM, V273, P24592, DOI 10.1074/jbc.273.38.24592; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DICKSON RB, 1983, BIOCHEMISTRY-US, V22, P5667, DOI 10.1021/bi00293a033; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; GHOSH RN, 1994, J CELL SCI, V107, P2177; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; HUGHSON EJ, 1990, J CELL BIOL, V110, P337, DOI 10.1083/jcb.110.2.337; Hussain NK, 2003, J BIOL CHEM, V278, P28823, DOI 10.1074/jbc.M300995200; Jiang XJ, 2003, TRAFFIC, V4, P529, DOI 10.1034/j.1600-0854.2003.t01-1-00109.x; Kittel A, 1999, J COMP NEUROL, V412, P649, DOI 10.1002/(SICI)1096-9861(19991004)412:4<649::AID-CNE6>3.0.CO;2-4; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; MUNDIGL O, 1993, J CELL BIOL, V122, P1207, DOI 10.1083/jcb.122.6.1207; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; PARTON RG, 1992, J CELL BIOL, V119, P123, DOI 10.1083/jcb.119.1.123; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Sheff D, 2002, J CELL BIOL, V156, P797, DOI 10.1083/jcb.20111048; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sorkin A, 2004, CURR OPIN CELL BIOL, V16, P392, DOI 10.1016/j.ceb.2004.06.001; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANLEUVEN F, 1980, CELL, V20, P37, DOI 10.1016/0092-8674(80)90232-9; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; WALL DA, 1980, CELL, V21, P79, DOI 10.1016/0092-8674(80)90116-6; Watanabe R, 1999, J NEUROCHEM, V73, P1375, DOI 10.1046/j.1471-4159.1999.0731375.x; Wei ML, 1998, J CELL BIOL, V140, P565, DOI 10.1083/jcb.140.3.565; YAMASHIRO DJ, 1987, J CELL BIOL, V105, P2723, DOI 10.1083/jcb.105.6.2723; YOSHIMURA A, 1984, J VIROL, V51, P497, DOI 10.1128/JVI.51.2.497-504.1984; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	70	430	435	2	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 10	2006	124	5					997	1009		10.1016/j.cell.2005.12.038	http://dx.doi.org/10.1016/j.cell.2005.12.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RQ	16530046	Green Accepted, Bronze			2022-12-28	WOS:000237241200021
J	Chima, SC				Chima, SC			Global medicine - Regulation of biomedical research in Africa	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ETHICS		Northumbria Univ, Sch Law, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	Northumbria University	Chima, SC (corresponding author), 384A Green Lanes, London N13 5PD, England.	chimas01@cs.com	Chima, Sylvester C./N-5564-2013	Chima, Sylvester C./0000-0001-7067-6469				[Anonymous], 2005, LANCET, V365, P1111; Ashcroft RE, 2005, BRIT MED J, V331, P587, DOI 10.1136/bmj.331.7517.587; BARAZA R, 2001, BRIT MED J, V316, P625; BASTIAN H, 2001, BMJ-BRIT MED J, V323, P1417; Benatar SR, 2000, BMJ-BRIT MED J, V321, P824, DOI 10.1136/bmj.321.7264.824; Bhutta Z, 2004, BRIT MED J, V329, P1114, DOI 10.1136/bmj.329.7475.1114; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Edejer TTT, 1999, BMJ-BRIT MED J, V319, P438, DOI 10.1136/bmj.319.7207.438; Food and Drug Administration, 2004, FED REGISTER, V69, P32467; FORD J, 2004, ELECT LAW J LAW SOCI; HENLEY S, 2003, WALL STREET5 J  1004; Ijsselmuiden CB, 1998, NEW ENGL J MED, V338, P838; LEVINE RJ, 1993, ANN INTERN MED, V119, P339, DOI 10.7326/0003-4819-119-4-199308150-00016; LUNE P, 2005, LANCET, V365, P1117; *NAT BIOETH ADV CO, 2001, PRES BIOETH COMM ISS; Plomer Aurora, 2005, LAW ETHICS MED RES I; SELGELID MJ, 2005, DEV WORLD BIOETHICS, V5, P54; Shapiro K, 2005, J MED ETHICS, V31, P39, DOI 10.1136/jme.2004.008102; *WORLD MED ASS, 2000, ETH PRIN MED RES INV; HALSBURYS LAWS ENGLA, V33, P621	20	29	29	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2006	332	7545					848	851		10.1136/bmj.332.7545.848	http://dx.doi.org/10.1136/bmj.332.7545.848			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	032ZQ	16601051	Green Published			2022-12-28	WOS:000236815900029
J	Healy, B; Freedman, AN				Healy, B; Freedman, AN			ABC of wound healing - Infections	BRITISH MEDICAL JOURNAL			English	Editorial Material							NECROTIZING FASCIITIS		Univ Wales Hosp, Cardiff, Wales	Cardiff University	Healy, B (corresponding author), Univ Wales Hosp, Cardiff, Wales.			Healy, Brendan/0000-0002-5698-856X				Bisno AL, 2000, CLIN INFECT DIS, V31, P607, DOI 10.1086/313980; Eron Lawrence J., 2003, Journal of Antimicrobial Chemotherapy, V52, pi3; Hasham S, 2005, BMJ-BRIT MED J, V330, P830, DOI 10.1136/bmj.330.7495.830; Weigelt J, 2005, ANTIMICROB AGENTS CH, V49, P2260, DOI 10.1128/AAC.49.6.2260-2266.2005	4	68	70	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 8	2006	332	7545					838	841		10.1136/bmj.332.7545.838	http://dx.doi.org/10.1136/bmj.332.7545.838			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	032ZQ	16601046	Green Published			2022-12-28	WOS:000236815900025
J	Leverich, GS; Post, RM				Leverich, GS; Post, RM			Course of bipolar illness after history of childhood trauma	LANCET			English	Editorial Material							DISORDER; ADOLESCENTS; ABUSE		NIMH, Biol Psychiat Branch, NIH, DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Leverich, GS (corresponding author), NIMH, Biol Psychiat Branch, NIH, DHHS, Bethesda, MD 20892 USA.	levericg@mail.nih.gov						Fergus EL, 2003, J AFFECT DISORDERS, V77, P71, DOI 10.1016/S0165-0327(02)00176-3; Garno JL, 2005, BRIT J PSYCHIAT, V186, P121, DOI 10.1192/bjp.186.2.121; Goldberg JF, 2005, J PSYCHIAT RES, V39, P595, DOI 10.1016/j.jpsychires.2004.11.002; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kowatch RA, 2005, J AM ACAD CHILD PSY, V44, P213, DOI 10.1097/00004583-200503000-00006; Leverich GS, 2003, J CLIN PSYCHIAT, V64, P506, DOI 10.4088/JCP.v64n0503; Leverich GS, 2002, BIOL PSYCHIAT, V51, P288, DOI 10.1016/S0006-3223(01)01239-2; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; *NAT CLEAR CHILD A, 2004, LONGT CONS CHILD AB; Pavuluri MN, 2005, J AM ACAD CHILD PSY, V44, P846, DOI 10.1097/01.chi.0000170554.23422.c1; Perlis RH, 2004, BIOL PSYCHIAT, V55, P875, DOI 10.1016/j.biopsych.2004.01.022; Plotsky PM, 2005, NEUROPSYCHOPHARMACOL, V30, P2192, DOI 10.1038/sj.npp.1300769; POST RM, NIMH PED BIP DIS C C; POST RM, 2000, MED PSYCHIATRY, V15, P387; Wilens TE, 2004, J AM ACAD CHILD PSY, V43, P1380, DOI 10.1097/01.chi.0000140454.89323.99	15	90	92	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2006	367	9516					1040	1042		10.1016/S0140-6736(06)68450-X	http://dx.doi.org/10.1016/S0140-6736(06)68450-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	030ZF	16581389				2022-12-28	WOS:000236673200010
J	Zaloga, GP				Zaloga, GP			Parenteral nutrition in adult inpatients with functioning gastrointestinal tracts: assessment of outcomes	LANCET			English	Review							CRITICALLY-ILL PATIENTS; BONE-MARROW TRANSPLANTATION; RANDOMIZED CLINICAL-TRIAL; TOTAL ENTERAL NUTRITION; CROHNS-DISEASE; DOUBLE-BLIND; HEAD-INJURY; BOWEL REST; GLUTAMINE SUPPLEMENTATION; INFECTIOUS COMPLICATIONS	Malnutrition is a common comorbidity that places inpatients at risk of complications, infections, long length of stay, higher costs, and increased mortality. Thus, nutrition support has become an important therapeutic adjunctive to the care of these patients. For patients unable to feed themselves, nutrition can be delivered via the parenteral or enteral routes. The formulations used to deliver nutrients and the route of nutrient delivery, absorption, and processing differ substantially between parenteral and enteral nutrition. Over the past two decades, many randomised clinical trials have assessed the effects of parenteral versus enteral nutrition on outcomes (ie, complications, infections, length of stay, costs, mortality) in diverse inpatient populations. From a search of medical publications, studies were selected that assessed important clinical outcomes of parenteral versus enteral feeding or intravenous fluids in patients with trauma/burn injuries, surgery, cancer, pancreatic disease, inflammatory bowel disease, critical illness, liver failure, acute renal failure, and organ transplantation. Our goal was to determine the optimum route of feeding in these patient groups. The available evidence lends support to the use of enteral over parenteral feeding in inpatients with functioning gastrointestinal tracts.	Methodist Res Inst, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University System; Indiana University-Purdue University Indianapolis	Zaloga, GP (corresponding author), Methodist Res Inst, 1812 N Capitol Ave, Indianapolis, IN 46202 USA.	gzaloga@clarian.org						ABADLACRUZ A, 1990, JPEN-PARENTER ENTER, V14, P618, DOI 10.1177/0148607190014006618; ADAMS S, 1986, J TRAUMA, V26, P882, DOI 10.1097/00005373-198610000-00004; ALVERDY J C, 1990, Journal of Parenteral and Enteral Nutrition, V14, p8S; ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, JPEN J PARENTER E S1, V26, p1SA; BASTTISTELLA FD, 1997, J TRAUMA, V43, P52; Bauer P, 2000, INTENS CARE MED, V26, P893, DOI 10.1007/s001340051278; Borzotta Anthony P., 1993, Surgical Forum, V44, P29; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; BOWER RH, 1986, ARCH SURG-CHICAGO, V121, P1040; Bozzetti F, 2001, LANCET, V358, P1487, DOI 10.1016/S0140-6736(01)06578-3; Braga M, 2001, CRIT CARE MED, V29, P242, DOI 10.1097/00003246-200102000-00003; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; BRENNAN MF, 1994, ANN SURG, V220, P436, DOI 10.1097/00000658-199410000-00003; BUZBY GP, 1980, AM J SURG, V139, P160, DOI 10.1016/0002-9610(80)90246-9; CERRA FB, 1988, SURGERY, V104, P727; Cetin T, 2002, NUTRITION, V18, P599, DOI 10.1016/S0899-9007(02)00779-7; Chiarelli A G, 1996, Minerva Anestesiol, V62, P1; CRAVO M, 1991, AM J GASTROENTEROL, V86, P317; DELANY HM, 1994, AM J SURG, V167, P135, DOI 10.1016/0002-9610(94)90064-7; DETSKY AS, 1987, ANN INTERN MED, V107, P195, DOI 10.7326/0003-4819-107-2-195; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P440, DOI 10.1177/0148607187011005440; DETSKY AS, 1987, ANN INTERN MED, V107, P252; Dhaliwal R, 2004, INTENS CARE MED, V30, P1666, DOI 10.1007/s00134-004-2345-y; DICKINSON RJ, 1980, GASTROENTEROLOGY, V79, P1199; DUNHAM CM, 1994, J TRAUMA, V37, P30, DOI 10.1097/00005373-199407000-00007; EISENBERG JM, 1993, JPEN-PARENTER ENTER, V17, P201, DOI 10.1177/0148607193017003201; FAN ST, 1994, NEW ENGL J MED, V331, P1547, DOI 10.1056/NEJM199412083312303; FELICIANO D V, 1991, Contemporary Surgery, V39, P30; Furst P, 1994, New Horiz, V2, P215; Gianotti L, 1997, ARCH SURG-CHICAGO, V132, P1222, DOI 10.1001/archsurg.1997.01430350072012; Goeters C, 2002, CRIT CARE MED, V30, P2032, DOI 10.1097/00003246-200209000-00013; GONZALEZHUIX F, 1993, AM J GASTROENTEROL, V88, P227; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; GREENBERG GR, 1988, GUT, V29, P1309, DOI 10.1136/gut.29.10.1309; Griffiths RD, 1997, NUTRITION, V13, P295; HADLEY MN, 1986, NEUROSURGERY, V19, P367, DOI 10.1097/00006123-198609000-00006; Herndon D N, 1989, J Burn Care Rehabil, V10, P309, DOI 10.1097/00004630-198907000-00004; HERNDON DN, 1987, J TRAUMA, V27, P195, DOI 10.1097/00005373-198702000-00018; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Heyland DK, 1998, JAMA-J AM MED ASSOC, V280, P2013, DOI 10.1001/jama.280.23.2013; IOVINELLI G, 1993, JPEN-PARENTER ENTER, V17, P445, DOI 10.1177/0148607193017005445; JONES VA, 1987, DIGEST DIS SCI, V32, pS100, DOI 10.1007/BF01312473; Kaushik Neeraj, 2004, Nutr Clin Pract, V19, P25, DOI 10.1177/011542650401900125; KLEIN S, 1986, CANCER, V58, P1378, DOI 10.1002/1097-0142(19860915)58:6<1378::AID-CNCR2820580635>3.0.CO;2-S; KORETZ RL, 1984, J CLIN ONCOL, V2, P534, DOI 10.1200/JCO.1984.2.5.534; Koretz RL, 2001, GASTROENTEROLOGY, V121, P970, DOI [10.1053/gast.2001.28031, 10.1016/S0016-5085(01)92000-1]; Kotani J, 1999, ARCH SURG-CHICAGO, V134, P287, DOI 10.1001/archsurg.134.3.287; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; KUDSK KA, 1981, J SURG RES, V31, P105, DOI 10.1016/0022-4804(81)90037-8; KUDSK KA, 1983, J TRAUMA, V23, P605, DOI 10.1097/00005373-198307000-00010; Kudsk KA, 2001, JPEN-PARENTER ENTER, V25, P174, DOI 10.1177/0148607101025004174; Lin MT, 1996, ANN SURG, V223, P84, DOI 10.1097/00000658-199601000-00012; Marik PE, 2001, CRIT CARE MED, V29, P2264, DOI 10.1097/00003246-200112000-00005; Marik PE, 2004, BMJ-BRIT MED J, V328, P1407, DOI 10.1136/bmj.38118.593900.55; McClave Stephen A, 2004, Nutr Clin Pract, V19, P1, DOI 10.1177/011542650401900101; McCowen KC, 2000, CRIT CARE MED, V28, P3606, DOI 10.1097/00003246-200011000-00007; MCGEER AJ, 1990, NUTRITION, V6, P233; MCINTYRE PB, 1986, GUT, V27, P481, DOI 10.1136/gut.27.5.481; Middleton MH, 2001, INTERN MED J, V31, P455, DOI 10.1046/j.1445-5994.2001.00109.x; MOORE FA, 1989, J TRAUMA, V29, P916, DOI 10.1097/00005373-198907000-00003; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; MULLER JM, 1982, LANCET, V1, P68; NAYLOR C D, 1987, Renal Failure, V10, P141, DOI 10.3109/08860228709047649; NAYLOR CD, 1989, GASTROENTEROLOGY, V97, P1033, DOI 10.1016/0016-5085(89)91517-5; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; Peter JV, 2005, CRIT CARE MED, V33, P213, DOI 10.1097/01.CCM.0000150960.36228.C0; PETERSEN SR, 1981, J TRAUMA, V21, P528, DOI 10.1097/00005373-198107000-00004; PETERSON VM, 1988, SURGERY, V104, P199; Powell-Tuck J, 1999, GUT, V45, P82, DOI 10.1136/gut.45.1.82; Reynolds JV, 1997, JPEN-PARENTER ENTER, V21, P196, DOI 10.1177/0148607197021004196; Roberts P R, 1994, New Horiz, V2, P237; ROBINSON G, 1987, JPEN-PARENTER ENTER, V11, P49, DOI 10.1177/014860718701100149; SAKO K, 1981, J SURG ONCOL, V16, P391, DOI 10.1002/jso.2930160413; Sand J, 1997, EUR J SURG, V163, P761; SANDSTROM R, 1993, ANN SURG, V217, P185, DOI 10.1097/00000658-199302000-00013; Shirabe K, 1997, HEPATO-GASTROENTEROL, V44, P205; SHOU J, 1994, ANN SURG, V219, P291, DOI 10.1097/00000658-199403000-00009; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Suchner U, 1996, NUTRITION, V12, P13, DOI 10.1016/0899-9007(95)00016-X; SZELUGA DJ, 1987, CANCER RES, V47, P3309; TRICE S, 1997, NUTR CLIN PRACT, V12, P114; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; WEISDORF SA, 1987, TRANSPLANTATION, V43, P833, DOI 10.1097/00007890-198743060-00012; WHITE LJ, 1989, ANN INTERN MED, V110, P734; WICKS C, 1994, LANCET, V344, P837, DOI 10.1016/S0140-6736(94)92824-X; WILLIFORD WO, 1991, NEW ENGL J MED, V325, P525; Wischmeyer PE, 2001, CRIT CARE MED, V29, P2075, DOI 10.1097/00003246-200111000-00006; WRIGHT RA, 1990, J CLIN GASTROENTEROL, V12, P396, DOI 10.1097/00004836-199008000-00008; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zaloga GP, 2004, MINI-REV MED CHEM, V4, P815, DOI 10.2174/1389557043403477; ZALOGA GP, 1991, CRIT CARE MED, V19, P54, DOI 10.1097/00003246-199101000-00015; ZALOGA GP, 1993, CIRC SHOCK, V39, P263; ZALOGA GP, 1994, NUTR CRITICAL CARE, P313; ZIEGLER TR, 1992, ANN INTERN MED, V116, P821, DOI 10.7326/0003-4819-116-10-821	95	114	118	1	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 1	2006	367	9516					1101	1111		10.1016/S0140-6736(06)68307-4	http://dx.doi.org/10.1016/S0140-6736(06)68307-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZF	16581410				2022-12-28	WOS:000236673200035
J	Kang, S; Goyal, A; Li, J; Gapud, AA; Martin, PM; Heatherly, L; Thompson, JR; Christen, DK; List, FA; Paranthaman, M; Lee, DF				Kang, S; Goyal, A; Li, J; Gapud, AA; Martin, PM; Heatherly, L; Thompson, JR; Christen, DK; List, FA; Paranthaman, M; Lee, DF			High-performance high-T-c superconducting wires	SCIENCE			English	Article							YBA2CU3O7-DELTA FILMS; COATED CONDUCTORS; CRITICAL CURRENTS; COLUMNAR DEFECTS; THICK-FILMS	We demonstrated short segments of a superconducting wire that meets or exceeds performance requirements for many large-scale applications of high-temperature superconducting materials, especially those requiring a high supercurrent and/or a high engineering critical current density in applied magnetic fields. The performance requirements for these varied applications were met in 3-micrometer-thick YBa2Cu3O7-delta films epitaxially grown via pulsed laser ablation on rolling assisted biaxially textured substrates. Enhancements of the critical current in self-field as well as excellent retention of this current in high applied magnetic fields were achieved in the thick films via incorporation of a periodic array of extended columnar defects, composed of self-aligned nanodots of nonsuperconducting material extending through the entire thickness of the film. These columnar defects are highly effective in pinning the superconducting vortices or flux lines, thereby resulting in the substantially enhanced performance of this wire.	Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Goyal, A (corresponding author), Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA.	goyala@ornl.gov	Paranthaman, Mariappan/AAO-9751-2021; Christen, David/A-9709-2008; Paranthaman, Mariappan Parans/N-3866-2015	Paranthaman, Mariappan Parans/0000-0003-3009-8531; Gapud, Albert/0000-0001-9048-9230				Bauer M, 1999, IEEE T APPL SUPERCON, V9, P1502, DOI 10.1109/77.784678; Castellanos A, 1997, APPL PHYS LETT, V71, P962, DOI 10.1063/1.119701; CIVALE L, 1991, PHYS REV LETT, V67, P648, DOI 10.1103/PhysRevLett.67.648; *CONECTUS, 2004, NEW SUP MARK SURV 20; Dam B, 1999, NATURE, V399, P439, DOI 10.1038/20880; GERBER C, 1991, NATURE, V350, P279, DOI 10.1038/350279a0; Goyal A, 2005, SUPERCOND SCI TECH, V18, P1533, DOI 10.1088/0953-2048/18/11/021; Goyal A, 1996, APPL PHYS LETT, V69, P1795, DOI 10.1063/1.117489; Goyal A, 2004, 2004 ANN PEER REV US; Goyal A., 2009, 2 GENERATION HTS CON; Groves JR, 2002, PHYSICA C, V382, P43, DOI 10.1016/S0921-4534(02)01194-2; Hassenzahl WV, 2004, P IEEE, V92, P1655, DOI 10.1109/JPROC.2004.833674; Haugan T, 2003, J MATER RES, V18, P2618, DOI 10.1557/JMR.2003.0366; Kang S, 2005, J AM CERAM SOC, V88, P2677, DOI 10.1111/j.1551-2916.2005.00375.x; Leonard KJ, 2003, J MATER RES, V18, P1723, DOI 10.1557/JMR.2003.0237; Macmanus-Driscoll JL, 2004, NAT MATER, V3, P439, DOI 10.1038/nmat1156; MaggioAprile I, 1997, NATURE, V390, P487, DOI 10.1038/37312; XIA Q, 2002, APPL PHYS LETT, V80, P1601; Yamada Y, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2061874	19	368	384	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1911	1914		10.1126/science.1124872	http://dx.doi.org/10.1126/science.1124872			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574864				2022-12-28	WOS:000236387800041
J	Moskun, AC; Jailaubekov, AE; Bradforth, SE; Tao, GH; Stratt, RM				Moskun, AC; Jailaubekov, AE; Bradforth, SE; Tao, GH; Stratt, RM			Rotational coherence and a sudden breakdown in linear response seen in room-temperature liquids	SCIENCE			English	Article							SOLVATION DYNAMICS; MOLECULAR-DYNAMICS; ICN; PHOTODISSOCIATION; STATE; WATER; SPECTROSCOPY; PHOTOISOMERIZATION; ULTRAVIOLET; RELAXATION	Highly energized molecules normally are rapidly equilibrated by a solvent; this finding is central to the conventional (linear-response) view of how chemical reactions occur in solution. However, when a reaction initiated by 33-femtosecond deep ultraviolet laser pulses is used to eject highly rotationally excited diatomic molecules into alcohols and water, rotational coherence persists for many rotational periods despite the solvent. Molecular dynamics simulations trace this slow development of molecular-scale friction to a clearly identifiable molecular event: an abrupt liquid-structure change triggered by the rapid rotation. This example shows that molecular relaxation can sometimes switch from linear to nonlinear response.	Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Brown Univ, Dept Chem, Providence, RI 02912 USA	University of Southern California; Brown University	Bradforth, SE (corresponding author), Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.	bradfort@usc.edu; richard_stratt@brown.edu	Bradforth, Stephen/GSM-7470-2022; Bradforth, Stephen E/B-5186-2008	Bradforth, Stephen E/0000-0002-6164-3347				Alexander MH, 2000, J CHEM PHYS, V112, P781, DOI 10.1063/1.480720; Bursing H, 2000, PHYS CHEM CHEM PHYS, V2, P73, DOI 10.1039/a907736g; CHANDLER D, 1987, INTRO MODERN STAT ME, pCH8; Danten Y, 2000, J PHYS CHEM A, V104, P9415, DOI 10.1021/jp001091p; DANTUS M, 1988, J CHEM PHYS, V89, P6128, DOI 10.1063/1.455428; Durfee CG, 1997, OPT LETT, V22, P1565, DOI 10.1364/OL.22.001565; FONSECA T, 1991, J PHYS CHEM-US, V95, P2116, DOI 10.1021/j100159a007; Geissler PL, 2000, J CHEM PHYS, V113, P9759, DOI 10.1063/1.1290136; Grebenev S, 1998, SCIENCE, V279, P2083, DOI 10.1126/science.279.5359.2083; Jailaubekov AE, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1992655; Kuhne T, 1998, J PHYS CHEM A, V102, P4177, DOI 10.1021/jp973154i; Larsen J, 2002, J CHEM PHYS, V116, P7997, DOI 10.1063/1.1467897; MARINELLI WJ, 1984, J PHYS CHEM-US, V88, P6685, DOI 10.1021/j150670a036; Moskun AC, 2003, J CHEM PHYS, V119, P4500, DOI 10.1063/1.1591726; NADLER I, 1985, J CHEM PHYS, V82, P3885, DOI 10.1063/1.448879; Schinke R., 1993, PHOTODISSOCIATION DY; Smallwood CJ, 2003, J CHEM PHYS, V119, P11263, DOI 10.1063/1.1618733; Stratt RM, 1996, J PHYS CHEM-US, V100, P12981, DOI 10.1021/jp9608483; Tauber MJ, 2003, REV SCI INSTRUM, V74, P4958, DOI 10.1063/1.1614874; TAYLOR DG, 1989, J CHEM PHYS, V90, P768, DOI 10.1063/1.456101; Turi L, 2000, CHEM PHYS LETT, V316, P465, DOI 10.1016/S0009-2614(99)01328-7; Voth GA, 1996, J PHYS CHEM-US, V100, P13034, DOI 10.1021/jp960317e; Winter N, 2003, J CHEM PHYS, V119, P2127, DOI 10.1063/1.1585019; Yang X, 2000, J CHEM PHYS, V112, P4474, DOI 10.1063/1.481010	25	86	86	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2006	311	5769					1907	1911		10.1126/science.1123738	http://dx.doi.org/10.1126/science.1123738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	027BD	16574863				2022-12-28	WOS:000236387800040
J	Goldman, HH; Frank, RG; Burnam, MA; Huskamp, HA; Ridgely, MS; Normand, SLT; Young, AS; Barry, CL; Azzone, V; Busch, AB; Azrin, ST; Moran, G; Lichtenstein, C; Blasinsky, M				Goldman, HH; Frank, RG; Burnam, MA; Huskamp, HA; Ridgely, MS; Normand, SLT; Young, AS; Barry, CL; Azzone, V; Busch, AB; Azrin, ST; Moran, G; Lichtenstein, C; Blasinsky, M			Behavioral health insurance parity for Federal Employees	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COSTS	BACKGROUND: To improve insurance coverage of mental health and substance-abuse services, the Federal Employees Health Benefits (FEHB) Program offered mental health and substance-abuse benefits on a par with general medical benefits beginning in January 2001. The plans were encouraged to manage care. METHODS: We compared seven FEHB plans from 1999 through 2002 with a matched set of health plans that did not have benefits on a par with mental health and substance-abuse benefits (parity of mental health and substance-abuse benefits). Using a difference-in-differences analysis, we compared the claims patterns of matched pairs of FEHB and control plans by examining the rate of use, total spending, and out-of-pocket spending among users of mental health and substance-abuse services. RESULTS: The difference-in-differences analysis indicated that the observed increase in the rate of use of mental health and substance-abuse services after the implementation of the parity policy was due almost entirely to a general trend in increased use that was observed in comparison health plans as well as FEHB plans. The implementation of parity was associated with a statistically significant increase in use in one plan (+0.78 percent, P<0.05) a significant decrease in use in one plan (-0.96 percent, P<0.05), and no significant difference in use in the other five plans (range, -0.38 percent to +0.23 percent; P>0.05 for each comparison). For beneficiaries who used mental health and substance-abuse services, spending attributable to the implementation of parity decreased significantly for three plans (range, -$201.99 to -$68.97; P<0.05 for each comparison) and did not change significantly for four plans (range, -$42.13 to +$27.11; P>0.05 for each comparison). The implementation of parity was associated with significant reductions in out-of-pocket spending in five of seven plans. CONCLUSIONS: When coupled with management of care, implementation of parity in insurance benefits for behavioral health care can improve insurance protection without increasing total costs.	Univ Maryland, Sch Med, Baltimore, MD 21227 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; RAND Corp, Santa Monica, CA USA; Dept Vet Affairs, Los Angeles, CA USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Yale Univ, Sch Med, New Haven, CT USA; McLean Hosp, Belmont, MA 02178 USA; Westat Corp, Rockville, MD 20850 USA; Northrop Grumman Informat Technol, Fed Enterprise Solut, Hlth Solut, Rockville, MD USA; CSR, Arlington, VA USA	University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; Harvard University; McLean Hospital; Westat	Goldman, HH (corresponding author), Univ Maryland, Sch Med, 3700 Koppers St,Suite 402, Baltimore, MD 21227 USA.	hh.goldman@verizon.net	Young, Alexander/A-1523-2009; Busch, Alisa/ABE-1524-2021; Busch, Alisa/AAA-4885-2021	Young, Alexander/0000-0002-9367-9213; Normand, Sharon-Lise/0000-0001-7027-4769	NIMH NIH HHS [1 K01 MH66109, T32 MH19773 08, P30 MH068639] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH068639, K01MH066109] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AG HLTH CAR POL R, 1993, PUBL AHCPR; Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; American Psychiatric Association, 2000, AM J PSYCHIAT S, V157, pS1; [Anonymous], 2004, STAT HLTH CAR QUAL; Efron B, 1998, INTRO BOOTSTRAP; *FEHB, 2004, FEHB HDB; *FEHB, 2001, 200017 FEHB OFF PERS; Frank RG, 2001, NEW ENGL J MED, V345, P1701, DOI 10.1056/NEJM200112063452311; Frank RG, 2000, HDB HLTH EC; GOLDMAN HH, 1983, PSYCHIAT ANN, V13, P488, DOI 10.3928/0048-5713-19830601-09; Goldman W, 1998, HEALTH AFFAIR, V17, P40, DOI 10.1377/hlthaff.17.2.40; Huskamp AA, 1999, INQUIRY-J HEALTH CAR, V36, P147; Ma CA, 1998, HEALTH AFFAIR, V17, P53, DOI 10.1377/hlthaff.17.2.53; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Ridgely MS, 2006, MILBANK Q, V84, P201, DOI 10.1111/j.1468-0009.2006.00443.x; ROSENBACH M, 2003, DHHS PUBLICATION	16	140	140	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1378	1386		10.1056/NEJMsa053737	http://dx.doi.org/10.1056/NEJMsa053737			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	026KO	16571881				2022-12-28	WOS:000236338000007
J	Walker, DH				Walker, DH			Targetting rickettsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONORII; PROTEIN		Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Walker, DH (corresponding author), Univ Texas, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA.							Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Gouin E, 2004, NATURE, V427, P457, DOI 10.1038/nature02318; Martinez JJ, 2005, CELL, V123, P1013, DOI 10.1016/j.cell.2005.08.046; Martinez JJ, 2004, J CELL SCI, V117, P5097, DOI 10.1242/jcs.01382; Whitworth T, 2005, INFECT IMMUN, V73, P6668, DOI 10.1128/IAI.73.10.6668-6673.2005	5	10	12	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2006	354	13					1418	1420		10.1056/NEJMcibr055756	http://dx.doi.org/10.1056/NEJMcibr055756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026KO	16571887				2022-12-28	WOS:000236338000015
J	Belmaker, I; Dukhan, L; Elgrici, M; Yosef, Y; Shahar-Rotberg, L				Belmaker, I; Dukhan, L; Elgrici, M; Yosef, Y; Shahar-Rotberg, L			Reduction of vaccine-preventable communicable diseases in a Bedouin population: summary of a community-based intervention programme	LANCET			English	Article							CHILDREN; INFANTS	Background The Bedouin Arab population of southern Israel is in transition from a semi-nomadic lifestyle to permanent settlement, with many characteristics of a third-world population. A major outbreak of measles in the winter of 1990-91, with an incidence of 415.6 per 100 000 and a case fatality rate of 2.2 % among the Bedouin, led which recommended an intervention programme. We report on the to the establishment of a national committee, effect of the programme implementation on the reduction of vaccine-preventable communicable diseases in a Bedouin Arab population. Methods We compared immunisation coverage and incidence of reportable vaccine-preventable communicable diseases before and after implementation of the intervention programme. Findings Implementation of the intervention programme was associated with a marked increase in immunisation coverage, from 53% for first measles immunisation among those born in 1988, and reaching 2 years of age in 1990 at the start of the outbreak, to 90% at age 2 years among those born in 2001. We noted a decrease in all vaccine-preventable communicable diseases, except for pertussis, during this period. Interpretation The implementation of a targeted programme to improve immunisation coverage, and other concomitant changes in health-care delivery, was temporally associated with reduction of vaccine-preventable communicable diseases in a population of Bedouin Arabs in Israel who are living in semi-nomadic conditions. The success of the programme could be applicable to semi-nomadic populations living in other areas of the middle east.	Minist Hlth, Reg Hlth Off, So Reg, Beer Sheva, Israel; Reg Minist Hlth, Dept Epidemiol Infect Dis, Beer Sheva, Israel; Reg Minist Hlth, Publ Hlth Nursing Serv, Beer Sheva, Israel		Belmaker, I (corresponding author), Minist Hlth, Reg Hlth Off, So Reg, POB 10050, Beer Sheva, Israel.	ilna.belmaker@lbr.health.gov.il						ABDULLAHI SA, MOBILE HLTH SERVICES; ABRAMSON O, 1995, ARCH PEDIAT ADOL MED, V149, P1237, DOI 10.1001/archpedi.1995.02170240055008; *AV IN, 1998, EV IMPR MAT CHILD PR; Beckerleg S., 1997, ANTHROPOL MED, V4, P273; *CENTR BUR STAT, 1992, STAT ABSTR ISR; *CENTR BUR STAT, 2004, STAT ABSTR ISR; FORMAN MR, 1990, AM J CLIN NUTR, V51, P343, DOI 10.1093/ajcn/51.3.343; GLASSBERG E, 1997, THESIS B GURION U BE; Kobayashi M, 2003, JPN J INFECT DIS, V56, P175; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; MARGOLIS CZ, 1991, EUR M MED SCH PAR FR; Shoham-Vardi I, 2004, PRENATAL DIAG, V24, P869, DOI 10.1002/pd.867; Shulman LM, 2000, J CLIN MICROBIOL, V38, P945, DOI 10.1128/JCM.38.3.945-952.2000; Swarzt T. A., 1993, Public Health Reviews, V21, P99; Tulchinsky Theodore H., 1992, Public Health Reviews, V20, P285; *WHO, 1983, WHO PUBL, V6; *WHO REG OFF E MED, 2005, POL ER; 1999, MMWR MORB MORTAL WKL, V48, P1057; 2000, MMWR MORB MORTAL WKL, V49, P758	19	19	19	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2006	367	9515					987	991		10.1016/S0140-6736(06)68425-0	http://dx.doi.org/10.1016/S0140-6736(06)68425-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564360				2022-12-28	WOS:000236474200026
J	El-Shanti, H; Majeed, HA; El-Khateeb, M				El-Shanti, H; Majeed, HA; El-Khateeb, M			Familial Mediterranean fever in Arabs	LANCET			English	Review							RECURRENT HEREDITARY POLYSEROSITIS; PROTRACTED FEBRILE MYALGIA; GENOTYPE-PHENOTYPE CORRELATION; NON-ASHKENAZI JEWS; NF-KAPPA-B; MEFV-GENE; CUTANEOUS MANIFESTATIONS; COLCHICINE TREATMENT; CLINICAL-PATTERNS; MUTATION ANALYSIS	Autoinflammatory diseases are a group of disorders characterised by seemingly unprovoked inflammation in the absence of high-titre autoantibodies or antigen-specific T cells, and include the hereditary periodic fever syndromes. Familial Mediterranean fever (FMF) is an archetypal autoinflammatory disorder, which is autosomal recessive and has a high prevalence in non-Ashkenazi Jews, Armenians, Turks, and Arabs. The classic clinical picture is recurrent acute short-lived febrile and painful attacks with variable periods of remission. In a subset of patients, the disorder is complicated by amyloidosis that leads to renal failure. The gene responsible for FMF-MEFV-has been identified and its role in inflammation is being assessed. There seems to be a distinctive clinical picture in Arab patients with FMF, and the range and distribution of MEFV mutations is different from that noted in other affected ethnic groups. Here, we discuss the clinical and molecular aspects of FMF in Arabs.	Univ Iowa, Dept Pediat, Div Med Genet, Iowa City, IA 52242 USA; Univ Jordan, Dept Paediat, Amman, Jordan; Univ Jordan, Dept Med Lab Sci, Amman, Jordan	University of Iowa; University of Jordan; University of Jordan	El-Shanti, H (corresponding author), Childrens Hosp Iowa, 2615 JCP,200 Hawkins Dr, Iowa City, IA 52242 USA.	hatem-el-shanti@uiowa.edu	El-Shanti, Hatem/O-5990-2014; EL-SHANTI, HATEM/Q-4932-2016	El-Shanti, Hatem/0000-0001-6230-8316; EL-SHANTI, HATEM/0000-0001-6230-8316				Aivazian A A, 1977, Klin Med (Mosk), V55, P91; Aksentijevich I, 1999, AM J HUM GENET, V64, P949, DOI 10.1086/302327; Aksentijevich I, 1997, CELL, V90, P797; Al-Alami JR, 2003, SAUDI MED J, V24, P1055; ARMENIAN HK, 1973, LEBAN MED J, V26, P605; Ayesh SK, 2005, SAUDI MED J, V26, P732; AZIZI E, 1976, ARCH DERMATOL, V112, P364, DOI 10.1001/archderm.112.3.364; BAKIR F, 1975, T ROY SOC TROP MED H, V69, P111, DOI 10.1016/0035-9203(75)90019-X; Balci B, 2002, NEPHROL DIAL TRANSPL, V17, P1921, DOI 10.1093/ndt/17.11.1921; BARAKAT MH, 1986, Q J MED, V60, P837; BARAKAT MH, 1988, ARCH NEUROL-CHICAGO, V45, P926, DOI 10.1001/archneur.1988.00520320128030; Barzilai A, 2000, J AM ACAD DERMATOL, V42, P791, DOI 10.1067/mjd.2000.103048; Ben-Chetrit E, 1998, SEMIN ARTHRITIS RHEU, V28, P48, DOI 10.1016/S0049-0172(98)80028-0; Ben-Chetrit E, 2002, CLIN EXP RHEUMATOL, V20, pS25; Ben-Chetrit E, 2000, HUM MUTAT, V15, P385, DOI 10.1002/(SICI)1098-1004(200004)15:4<385::AID-HUMU22>3.0.CO;2-A; BENCHETRIT E, 1991, SEMIN ARTHRITIS RHEU, V20, P241, DOI 10.1016/0049-0172(91)90019-V; Bernot A, 1998, HUM MOL GENET, V7, P1317, DOI 10.1093/hmg/7.8.1317; Bernot A, 1997, NAT GENET, V17, P25; Booth DR, 1998, QJM-INT J MED, V91, P603, DOI 10.1093/qjmed/91.9.603; Brik R, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.5.e70; Brik R, 2001, J PEDIATR-US, V138, P759, DOI 10.1067/mpd.2001.113357; Buskila D, 1997, CLIN EXP RHEUMATOL, V15, P355; CABILI S, 1985, P EUR DIAL TRANS, V21, P709; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Dewalle M, 1998, EUR J HUM GENET, V6, P95, DOI 10.1038/sj.ejhg.5200170; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Dode C, 2000, AM J MED GENET, V92, P241, DOI 10.1002/(SICI)1096-8628(20000605)92:4<241::AID-AJMG3>3.3.CO;2-7; Dowds TA, 2003, BIOCHEM BIOPH RES CO, V302, P575, DOI 10.1016/S0006-291X(03)00221-3; EHRENFELD M, 1987, BRIT J OBSTET GYNAEC, V94, P1186, DOI 10.1111/j.1471-0528.1987.tb02320.x; ESHEL G, 1988, ANN INTERN MED, V109, P164, DOI 10.7326/0003-4819-109-2-164; ESHEL G, 1994, BRIT J SURG, V81, P894, DOI 10.1002/bjs.1800810633; FLATAU E, 1982, ARTHRITIS RHEUM, V25, P42, DOI 10.1002/art.1780250107; GAFNI J, 1968, ISRAEL J MED SCI, V4, P995; GEDALIA A, 1993, PEDIATR NEUROL, V9, P301, DOI 10.1016/0887-8994(93)90068-N; Gershoni-Baruch R, 2003, J PEDIATR-US, V143, P658, DOI 10.1067/S0022-3476(03)00502-X; Gershoni-Baruch R, 2002, EUR J HUM GENET, V10, P145, DOI 10.1038/sj.ejhg.5200776; Gershoni-Baruch R, 2002, AM J MED GENET, V109, P198, DOI 10.1002/ajmg.10352; Gershoni-Baruch R, 2001, EUR J HUM GENET, V9, P634, DOI 10.1038/sj.ejhg.5200672; GOLDFINGER SE, 1972, NEW ENGL J MED, V287, P1302; GRUBERG L, 1992, AM J REPROD IMMUNOL, V28, P241, DOI 10.1111/j.1600-0897.1992.tb00803.x; HELLER H, 1961, ARCH INTERN MED, V107, P539, DOI 10.1001/archinte.1961.03620040065007; HELLER H, 1958, ARCH INTERN MED, V102, P50, DOI 10.1001/archinte.1958.00260190052007; HELLER H, 1966, ARTHRITIS RHEUM, V9, P1, DOI 10.1002/art.1780090102; ISMAJOVICH B, 1973, FERTIL STERIL, V24, P844; Karachaliou I, 2005, INT J CLIN PRACT, V59, P60, DOI 10.1111/j.1368-504X.2005.00290.x; Kastner Daniel L, 2005, Hematology Am Soc Hematol Educ Program, P74; Kees S, 1997, QJM-MON J ASSOC PHYS, V90, P643; KHACHADURIAN A K, 1974, Birth Defects Original Article Series, V10, P62; Kogan A, 2001, AM J MED GENET, V102, P272, DOI 10.1002/ajmg.1438; Konstantopoulos K, 2001, ISR MED ASSOC J, V3, P862; Kotevoglu N, 2004, CLIN EXP RHEUMATOL, V22, pS69; LANGEVITZ P, 1994, J RHEUMATOL, V21, P1708; Livneh A, 1999, AMYLOID, V6, P1, DOI 10.3109/13506129908993281; LIVNEH A, 1994, J UROLOGY, V151, P431, DOI 10.1016/S0022-5347(17)34973-X; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; MAJEED HA, 1990, Q J MED, V75, P607; Majeed HA, 2005, SEMIN ARTHRITIS RHEU, V34, P813, DOI 10.1016/j.semarthrit.2005.01.010; Majeed HA, 1998, ANN TROP PAEDIATR, V18, P13, DOI 10.1080/02724936.1998.11747919; Majeed HA, 1999, QJM-INT J MED, V92, P309, DOI 10.1093/qjmed/92.6.309; Majeed HA, 2002, SEMIN ARTHRITIS RHEU, V31, P371, DOI 10.1053/sarh.2002.32551; MAJEED HA, 1989, EUR J PEDIATR, V148, P636, DOI 10.1007/BF00441519; Majeed HA, 2000, CURR OPIN RHEUMATOL, V12, P439, DOI 10.1097/00002281-200009000-00016; Majeed HA, 1997, QJM-MON J ASSOC PHYS, V90, P37; Majeed HA, 2000, PEDIATR SURG INT, V16, P72, DOI 10.1007/s003830050019; Majeed HA, 2000, SEMIN ARTHRITIS RHEU, V30, P138, DOI 10.1053/sarh.2000.16646; Mansfield E, 2001, BLOOD, V98, P851, DOI 10.1182/blood.V98.3.851; Mansour I, 2001, EUR J HUM GENET, V9, P51, DOI 10.1038/sj.ejhg.5200574; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; Matzner Y, 2000, BLOOD, V96, P727; Medlej-Hashim M, 2001, EUR J HUM GENET, V9, P849, DOI 10.1038/sj.ejhg.5200725; Medlej-Hashim M, 2002, CLIN GENET, V61, P71, DOI 10.1034/j.1399-0004.2002.10114.x; Medlej-Hashim Myrna, 2004, BMC Med Genet, V5, P4, DOI 10.1186/1471-2350-5-4; Medlej-Hashim M, 2000, HUM MUTAT, V15, P384, DOI 10.1002/(SICI)1098-1004(200004)15:4<384::AID-HUMU19>3.0.CO;2-U; Melikoglu M, 2000, ANN RHEUM DIS, V59, P910; MICHAELI D, 1966, BRIT MED J, V2, P30, DOI 10.1136/bmj.2.5504.30; Mijatovic V, 2003, EUR J OBSTET GYN R B, V108, P171, DOI 10.1016/S0301-2115(02)00417-7; Mor A, 2005, SEMIN ARTHRITIS RHEU, V35, P57, DOI 10.1016/j.semarthrit.2005.02.002; NEEQUAYE J, 1994, J TROP PEDIATRICS, V40, P243, DOI 10.1093/tropej/40.4.243; OZDEMIR A I, 1969, American Journal of Gastroenterology, V51, P311; OZER FL, 1971, AM J MED, V50, P336, DOI 10.1016/0002-9343(71)90222-1; Ozkan E, 1972, MED B ISTANBUL, V5, P44; Padeh S, 2005, PEDIATR CLIN N AM, V52, P577, DOI 10.1016/j.pcl.2005.01.005; Padeh S, 2003, J RHEUMATOL, V30, P185; Papin S, 2000, HUM MOL GENET, V9, P3001, DOI 10.1093/hmg/9.20.3001; Pras E, 1998, AM J MED GENET, V75, P216, DOI 10.1002/(SICI)1096-8628(19980113)75:2<216::AID-AJMG20>3.0.CO;2-R; PRAS E, 1994, HUM GENET, V94, P576; PRAS E, 1992, NEW ENGL J MED, V326, P1509, DOI 10.1056/NEJM199206043262301; PRAS M, 1982, JOHNS HOPKINS MED J, V150, P22; PRIEST RJ, 1959, ANN INTERN MED, V51, P1253, DOI 10.7326/0003-4819-51-6-1253; Pugnere D, 2003, NUCLEIC ACIDS RES, V31, P286, DOI 10.1093/nar/gkg097; RABINOVITCH O, 1992, AM J REPROD IMMUNOL, V28, P245, DOI 10.1111/j.1600-0897.1992.tb00805.x; Rawashdeh MO, 1996, EUR J PEDIATR, V155, P540, DOI 10.1007/s004310050438; Saatci U, 1997, EUR J PEDIATR, V156, P619, DOI 10.1007/s004310050677; SAATCI U, 1993, ACTA PAEDIATR, V82, P705, DOI 10.1111/j.1651-2227.1993.tb18045.x; SACHS D, 1987, BRIT J RHEUMATOL, V26, P139; SAID R, 1992, KIDNEY INT, V41, P414, DOI 10.1038/ki.1992.57; SAID R, 1988, AM J NEPHROL, V8, P417, DOI 10.1159/000167628; SAID R, 1989, AM J KIDNEY DIS, V14, P412, DOI 10.1016/S0272-6386(89)80176-3; SAID R, 1990, CLIN NEPHROL, V33, P227; Salai M, 1997, SEMIN ARTHRITIS RHEU, V27, P169, DOI 10.1016/S0049-0172(97)80016-9; Samuels J, 1998, MEDICINE, V77, P268, DOI 10.1097/00005792-199807000-00005; Sayarlioglu M, 2005, INT J CLIN PRACT, V59, P202, DOI 10.1111/j.1368-5031.2004.00294.x; SCHLESINGER M, 1985, ISRAEL J MED SCI, V21, P83; SCHWABE AD, 1974, MEDICINE, V53, P453, DOI 10.1097/00005792-197411000-00005; SCHWABE AD, 1988, AM J MED, V85, P715; Shinar Y, 2000, J RHEUMATOL, V27, P1703; Shohat M, 1999, EUR J HUM GENET, V7, P287, DOI 10.1038/sj.ejhg.5200303; SHOHAT M, 1992, AM J MED GENET, V44, P183, DOI 10.1002/ajmg.1320440213; SHOHAT M, 1992, AM J HUM GENET, V51, P1349; Sidi G, 2000, SCAND J RHEUMATOL, V29, P174; SIEGAL S, 1945, ANN INTERN MED, V23, P1, DOI 10.7326/0003-4819-23-1-1; SNEH E, 1977, RHEUMATOL REHABIL, V16, P102, DOI 10.1093/rheumatology/16.2.102; SOHAR E, 1967, AM J MED, V43, P227, DOI 10.1016/0002-9343(67)90167-2; SOHAR E, 1961, ARCH INTERN MED, V107, P529, DOI 10.1001/archinte.1961.03620040055006; Stehlik C, 2004, J EXP MED, V200, P551, DOI 10.1084/jem.20032234; Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446; Stojanov S, 2005, CURR OPIN RHEUMATOL, V17, P586, DOI 10.1097/bor.0000174210.78449.6b; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Tunca M, 2005, MEDICINE, V84, P1, DOI 10.1097/01.md.0000152370.84628.0c; VILASECA J, 1982, ARCH INTERN MED, V142, P378, DOI 10.1001/archinte.142.2.378; Yalcinkaya F, 1997, BRIT J RHEUMATOL, V36, P1228; Yalcinkaya F, 2000, RHEUMATOLOGY, V39, P67, DOI 10.1093/rheumatology/39.1.67; Yilmaz E, 2001, EUR J HUM GENET, V9, P553, DOI 10.1038/sj.ejhg.5200674; Yu JW, 2006, CELL DEATH DIFFER, V13, P236, DOI 10.1038/sj.cdd.4401734; YUVAL Y, 1995, AM J MED GENET, V57, P455, DOI 10.1002/ajmg.1320570319; ZEMER D, 1974, NEW ENGL J MED, V291, P932, DOI 10.1056/NEJM197410312911803; ZEMER D, 1991, ARTHRITIS RHEUM-US, V34, P973, DOI 10.1002/art.1780340806	129	106	110	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					1016	1024		10.1016/S0140-6736(06)68430-4	http://dx.doi.org/10.1016/S0140-6736(06)68430-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564365				2022-12-28	WOS:000236474200031
J	Molyneux, DH				Molyneux, DH			Elimination of transmission of lymphatic filariasis in Egypt	LANCET			English	Editorial Material							NEGLECTED TROPICAL DISEASES; POLICY		Univ Liverpool, Liverpool Sch Trop Med, Lymphat Filariasis Support Ctr, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Molyneux, DH (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Lymphat Filariasis Support Ctr, Liverpool L3 5QA, Merseyside, England.	david.molyneux@liv.ac.uk						*AFR PROGR ONCH CO, 2002, ANN TROP MED PARASIT, V96, pS3; *COMM AFR, 2005, OUR COMM INT; Fenwick A, 2005, LANCET, V365, P1029, DOI 10.1016/s0140-6736(05)71134-x; Gyapong JO, 2006, TROP MED INT HEALTH, V11, P125, DOI 10.1111/j.1365-3156.2005.01542.x; Gyapong JO, 2005, EXPERT OPIN PHARMACO, V6, P179, DOI 10.1517/14656566.6.2.179; HARB M, 1993, B WORLD HEALTH ORGAN, V71, P49; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hutton G, 2004, B WORLD HEALTH ORGAN, V82, P893; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; Nunn JF, 2000, T ROY SOC TROP MED H, V94, P147, DOI 10.1016/S0035-9203(00)90252-9; Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2; RAMZY RMR, 2004, FILARIA J, V4, P7; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Tisch DJ, 2005, LANCET INFECT DIS, V5, P514, DOI 10.1016/S1473-3099(05)70192-4; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P202	16	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2006	367	9515					966	968		10.1016/S0140-6736(06)68404-3	http://dx.doi.org/10.1016/S0140-6736(06)68404-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	028GE	16564345				2022-12-28	WOS:000236474200007
J	Nishio, J; Gaglia, JL; Turvey, SE; Campbell, C; Benoist, C; Mathis, D				Nishio, J; Gaglia, JL; Turvey, SE; Campbell, C; Benoist, C; Mathis, D			Islet recovery and reversal of murine type 1 diabetes in the absence of any infused spleen cell contribution	SCIENCE			English	Article							NOD MICE; IMMUNOTHERAPY; MOUSE	A cure for type 1 diabetes will probably require the provision or elicitation of new pancreatic islet beta cells as welt as the reestablishment of immunological tolerance. A 2003 study. reported achievement of both advances in the NOD mouse model by coupling injection of Freund's complete adjuvant with infusion of allogeneic spleen cells. it was concluded that the adjuvant eliminated anti-islet autoimmunity and the donor splenocytes differentiated into insulin-producing (presumably beta) cells, culminating in islet regeneration. Here, we provide data indicating that the recovered islets were all of host origin, reflecting that the diabetic NOD mice actually retain substantial beta cell mass, which can be rejuvenated/regenerated to reverse disease upon adjuvant-dependent dampening of autoimmunity.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, Boston, MA 02215 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02215 USA; Harvard Stem Cell Inst, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Benoist, C (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Immunol & Immunogenet, 1 Joslin Pl, Boston, MA 02215 USA.	cbdm@joslin.harvard.edu	Turvey, Stuart/HGV-1191-2022; Flerin, Christopher C/T-9447-2019	Flerin, Christopher C/0000-0003-1883-871X; Turvey, Stuart/0000-0003-1599-1065; Gaglia, Jason/0000-0003-2904-312X	NCI NIH HHS [T32 CA09382] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009382] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEKIERKUNST A, 1971, INFECT IMMUN, V4, P245, DOI 10.1128/IAI.4.3.245-255.1971; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Kodama S, 2005, TRENDS MOL MED, V11, P271, DOI 10.1016/j.molmed.2005.04.004; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; NISHIO J, UNPUB; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; SHEHADEH N, 1994, LANCET, V343, P706, DOI 10.1016/S0140-6736(94)91583-0; Singh B, 1997, DIABETES METAB REV, V13, P320; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; WANG T, 1992, DIABETES, V41, P114, DOI 10.2337/diabetes.41.1.114	13	93	106	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2006	311	5768					1775	1778		10.1126/science.1124004	http://dx.doi.org/10.1126/science.1124004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024OA	16556845				2022-12-28	WOS:000236204300046
J	Weigel, D; Izaurralde, E				Weigel, D; Izaurralde, E			A tiny helper lightens the maternal load	CELL			English	Editorial Material							MICRORNAS; MORPHOGENESIS; ZEBRAFISH	In a recent issue of Science, Giraldez and colleagues (2006) solve the puzzle of how a large number of maternal mRNAs can be coordinately destroyed at the mid-blastula transition of early animal embryogenesis. The mysterious agent is not a protein but rather a microRNA that is transcribed at this transition point.	Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Max Planck Society; European Molecular Biology Laboratory (EMBL)	Weigel, D (corresponding author), Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org; elisa.izaurralde@embl-heidelberg.de	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Izaurralde, Elisa/G-3239-2012	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Izaurralde, Elisa/0000-0001-7365-2649				Audic Y, 2002, DEV DYNAM, V225, P511, DOI 10.1002/dvdy.10191; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; GIRALDEZ AJ, 2006, SCIENCE; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; WU L, 2006, P NATL ACAD SCI US	11	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 24	2006	124	6					1117	1118		10.1016/j.cell.2006.03.005	http://dx.doi.org/10.1016/j.cell.2006.03.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RS	16564001	Bronze			2022-12-28	WOS:000237241400008
J	Trivedi, MH; Fava, M; Wisniewski, SR; Thase, ME; Quitkin, F; Warden, D; Ritz, L; Nierenberg, AA; Lebowitz, BD; Biggs, MM; Luther, JF; Shores-Wilson, K; Rush, AJ				Trivedi, MH; Fava, M; Wisniewski, SR; Thase, ME; Quitkin, F; Warden, D; Ritz, L; Nierenberg, AA; Lebowitz, BD; Biggs, MM; Luther, JF; Shores-Wilson, K; Rush, AJ		STAR D Study Team	Medication augmentation after the failure of SSRIs for depression	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEQUENCED TREATMENT ALTERNATIVES; STAR-ASTERISK-D; RATIONALE	BACKGROUND Although clinicians frequently add a second medication to an initial, ineffective antidepressant drug, no randomized controlled trial has compared the efficacy of this approach. METHODS We randomly assigned 565 adult outpatients who had nonpsychotic major depressive disorder without remission despite a mean of 11.9 weeks of citalopram therapy (mean final dose, 55 mg per day) to receive sustained-release bupropion (at a dose of up to 400 mg per day) as augmentation and 286 to receive buspirone (at a dose of up to 60 mg per day) as augmentation. The primary outcome of remission of symptoms was defined as a score of 7 or less on the 17-item Hamilton Rating Scale for Depression (HRSD-17) at the end of this study; scores were obtained over the telephone by raters blinded to treatment assignment. The 16-item Quick Inventory of Depressive Symptomatology - Self-Report (QIDS-SR-16) was used to determine the secondary outcomes of remission (defined as a score of less than 6 at the end of this study) and response (a reduction in baseline scores of 50 percent or more). RESULTS The sustained-release bupropion group and the buspirone group had similar rates of HRSD-17 remission (29.7 percent and 30.1 percent, respectively), QIDS-SR-16 remission (39.0 percent and 32.9 percent), and QIDS-SR-16 response (31.8 percent and 26.9 percent). Sustained-release bupropion, however, was associated with a greater reduction (from baseline to the end of this study) in QIDS-SR-16 scores than was buspirone (25.3 percent vs. 17.1 percent, P<0.04), a lower QIDS-SR-16 score at the end of this study (8.0 vs. 9.1, P<0.02), and a lower dropout rate due to intolerance (12.5 percent vs. 20.6 percent, P<0.009). CONCLUSIONS Augmentation of citalopram with either sustained-release bupropion or buspirone appears to be useful in actual clinical settings. Augmentation with sustained-release bupropion does have certain advantages, including a greater reduction in the number and severity of symptoms and fewer side effects and adverse events.	Univ Texas, SW Med Ctr, Dept Psychiat, Mood Disorder Program & Clin, Dallas, TX 75390 USA; Massachusetts Gen Hosp, Clin Psychopharmacol Unit, Boston, MA 02114 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Epidemiol Data Ctr, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA; NIMH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York State Psychiatry Institute; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Trivedi, MH (corresponding author), Univ Texas, SW Med Ctr, Dept Psychiat, Mood Disorder Program & Clin, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	trivedi@utsouthwestern.edu	anand, amit/A-7222-2009; Young, Alexander/A-1523-2009; Biggs, Dr. Melanie/C-1468-2010; Fava, Maurizio/AAH-3548-2020; Howland, Robert H/K-6937-2015; Trivedi, Madhukar/A-9029-2013	Young, Alexander/0000-0002-9367-9213; Howland, Robert H/0000-0002-6533-6010; Trivedi, Madhukar/0000-0002-2983-1110; Rush, Augustus/0000-0003-2004-2382; Lebowitz, Barry/0000-0002-6467-646X; Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH090003] Funding Source: NIH RePORTER; NIMH NIH HHS [N01MH90003] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AG HLTH CAR POL R, 1993, AHCPR PUBL; Crismon ML, 1999, J CLIN PSYCHIAT, V60, P142, DOI 10.4088/JCP.v60n0302; Fava M, 2003, PSYCHIAT CLIN N AM, V26, P457, DOI 10.1016/S0193-953X(02)00107-7; FAVA M, IN PRESS PSYCHOTHER; Fisher L.D., 1990, STAT ISSUES DRUG RES, P331, DOI DOI 10.1201/9780203738610; Greden JF, 2001, REV PSYCHIAT SER, V20, P1; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; JOFFE RT, 1993, ARCH GEN PSYCHIAT, V50, P387; Lavori PW, 2001, BIOL PSYCHIAT, V50, P792, DOI 10.1016/S0006-3223(01)01223-9; Redrobe JP, 1998, PSYCHOPHARMACOLOGY, V138, P198, DOI 10.1007/s002130050663; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Rush AJ, 2003, BIOL PSYCHIAT, V54, P585, DOI 10.1016/S0006-3223(03)00786-8; Rush AJ, 2006, NEW ENGL J MED, V354, P1231, DOI 10.1056/NEJMoa052963; RUSHDI AM, 2005, P 2 SAUD SCI C 4, P1; Thase Michael E., 1995, P1081; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Trivedi MH, 2004, ARCH GEN PSYCHIAT, V61, P669, DOI 10.1001/archpsyc.61.7.669; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28	18	730	749	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2006	354	12					1243	1252		10.1056/NEJMoa052964	http://dx.doi.org/10.1056/NEJMoa052964			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	023ZH	16554526				2022-12-28	WOS:000236164200003
J	Sharma, SK; Liu, JJ				Sharma, SK; Liu, JJ			Progress of DOTS in global tuberculosis control	LANCET			English	Editorial Material									All India Inst Med Sci, Dept Med, Div Pulm & Crit Care Med, New Delhi 110029, India; Chinese Ctr Dis Control, Beijing, Peoples R China	All India Institute of Medical Sciences (AIIMS) New Delhi; Chinese Center for Disease Control & Prevention	Sharma, SK (corresponding author), All India Inst Med Sci, Dept Med, Div Pulm & Crit Care Med, New Delhi 110029, India.	sksharma@aiims.ac.in						*CENTR TB DIV, 2005, RNTCP STAT REP FRONT; Chen XY, 2004, LANCET, V364, P417; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Frieden TR, 2005, CLIN CHEST MED, V26, P197, DOI 10.1016/j.ccm.2005.02.001; Gupta R, 2002, TROP MED INT HEALTH, V7, P970, DOI 10.1046/j.1365-3156.2002.00960.x; Kim JY, 2003, TUBERCULOSIS, V83, P59, DOI 10.1016/S1472-9792(02)00078-1; *MIN HLTH FAM WELF, 2005, RNTCP PERF REP; Sharma S K, 2003, J Indian Med Assoc, V101, P157; SHARMA SK, 2003, J INDIAN MED ASSOC, V101, P166; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; *UN STAT DIV, MILL IND DAT; *WHO, 2005, WHOHTMTB200549	12	24	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2006	367	9514					951	952		10.1016/S0140-6736(06)68391-8	http://dx.doi.org/10.1016/S0140-6736(06)68391-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	025CE	16546549				2022-12-28	WOS:000236242100037
J	Ebron, VH; Yang, ZW; Seyer, DJ; Kozlov, ME; Oh, JY; Xie, H; Razal, J; Hall, LJ; Ferraris, JP; MacDiarmid, AG; Baughman, RH				Ebron, VH; Yang, ZW; Seyer, DJ; Kozlov, ME; Oh, JY; Xie, H; Razal, J; Hall, LJ; Ferraris, JP; MacDiarmid, AG; Baughman, RH			Fuel-powered artificial muscles	SCIENCE			English	Article							AUTONOMOUS MOVEMENT; CATALYTIC NANOMOTORS; STRAIN; GEL	Artificial muscles and electric motors found in autonomous robots and prosthetic limbs are typically battery-powered, which severely restricts the duration of their performance and can necessitate long inactivity during battery recharge. To help solve these problems, we demonstrated two types of artificial muscles that convert the chemical energy of high-energy-density fuels to mechanical energy. The first type stores electrical charge and uses changes in stored charge for mechanical actuation. In contrast with electrically powered electrochemical muscles, only half of the actuator cycle is electrochemical. The second type of fuel-powered muscle provides a demonstrated actuator stroke and power density comparable to those of natural skeletal muscle and generated stresses that are over a hundred times higher.	Univ Texas, Dept Chem, Richardson, TX 75083 USA; Univ Texas, NanoTech Inst, Richardson, TX 75083 USA; Pusan Natl Univ, Res Ctr Dielect & Adv Matter Phys, Pusan 609735, South Korea; Pusan Natl Univ, Dept Phys, Pusan 609735, South Korea	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; Pusan National University; Pusan National University	Baughman, RH (corresponding author), Univ Texas, Dept Chem, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Baughman, Ray/A-8628-2018; Razal, Joselito M/E-6741-2011; Razal, Joselito M/G-7597-2011	Baughman, Ray/0000-0001-5845-5137; Razal, Joselito M/0000-0002-9758-3702				ASAKA K, 1995, POLYM J, V27, P436, DOI 10.1295/polymj.27.436; Barbir F, 1997, INT J HYDROGEN ENERG, V22, P1027, DOI 10.1016/S0360-3199(96)00175-9; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 2005, SCIENCE, V308, P63, DOI 10.1126/science.1099010; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; BAUGHMAN RH, 2003, Patent No. 6555945; Catchmark JM, 2005, SMALL, V1, P202, DOI 10.1002/smll.200400061; Fournier-Bidoz S, 2005, CHEM COMMUN, P441, DOI 10.1039/b414896g; Hara S, 2004, J MATER CHEM, V14, P1516, DOI 10.1039/b404232h; HOWARD RJ, 2005, Patent No. 20050028901; Ismagilov RF, 2002, ANGEW CHEM INT EDIT, V41, P652, DOI 10.1002/1521-3773(20020215)41:4<652::AID-ANIE652>3.0.CO;2-U; Kaneko D, 2002, J MATER CHEM, V12, P2169, DOI 10.1039/b109981g; Kline TR, 2005, ANGEW CHEM INT EDIT, V44, P744, DOI 10.1002/anie.200461890; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Nemat-Nasser S, 2002, J APPL PHYS, V92, P2899, DOI 10.1063/1.1495888; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Paxton WF, 2004, J AM CHEM SOC, V126, P13424, DOI 10.1021/ja047697z; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Rediniotis OK, 2002, P SOC PHOTO-OPT INS, V4698, P441, DOI 10.1117/12.475087; Schreyer HB, 2000, BIOMACROMOLECULES, V1, P642, DOI 10.1021/bm005557l; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; Weissmuller J, 2003, SCIENCE, V300, P312, DOI 10.1126/science.1081024; Zhang QM, 1998, SCIENCE, V280, P2101, DOI 10.1126/science.280.5372.2101	23	116	128	6	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1580	1583		10.1126/science.1120182	http://dx.doi.org/10.1126/science.1120182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543453				2022-12-28	WOS:000236029500037
J	Mitchell, CJ; Horanyi, M; Havnes, O; Porco, CC				Mitchell, CJ; Horanyi, M; Havnes, O; Porco, CC			Saturn's spokes: Lost and found	SCIENCE			English	Article							MOVING PLASMA CLOUDS; RING; SYSTEM; MODEL	The spokes are intermittently appearing radial markings in Saturn's B ring that are believed to form when micrometer-sized dust particles are levitated above the ring by electrostatic forces. First observed by the Voyagers, the spokes disappeared from October 1998 until September 2005, when the Cassini spacecraft saw them reappear. The trajectories of the charged dust particles comprising the spokes depend critically on the background plasma density above the rings, which is a function of the solar elevation angle. Because the rings are more open to the Sun now than when Voyager flew by, the charging environment above the rings has prevented the formation of spokes until very recently. We show that this notable effect is capable of stopping spoke formation entirely and restricting the size of the particles in the spokes.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80304 USA; Univ Colorado, Dept Phys, Boulder, CO 80304 USA; Univ Tromso, Auroral Observ, Dept Phys, N-9000 Tromso, Norway; Space Sci Inst, Cassini Imaging Cent Lab Operat, Boulder, CO 80301 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; UiT The Arctic University of Tromso	Horanyi, M (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80304 USA.	horanyi@colorado.edu		Horanyi, Mihaly/0000-0002-5920-9226				Cuzzi J.N., 1984, PLANETARY RINGS, V75, P73; DOYLE LR, 1990, ICARUS, V85, P168, DOI 10.1016/0019-1035(90)90109-M; Farmer AJ, 2005, ICARUS, V179, P535, DOI 10.1016/j.icarus.2005.07.025; GOERTZ CK, 1983, ICARUS, V53, P219, DOI 10.1016/0019-1035(83)90143-4; HILL JR, 1981, MOON PLANETS, V24, P431, DOI 10.1007/BF00896908; Horanyi M, 2004, REV GEOPHYS, V42, DOI 10.1029/2004RG000151; McGhee CA, 2005, ICARUS, V173, P508, DOI 10.1016/j.icarus.2004.09.001; Morfill GE, 2005, ICARUS, V179, P539, DOI 10.1016/j.icarus.2005.08.008; MORFILL GE, 1983, ICARUS, V55, P111, DOI 10.1016/0019-1035(83)90054-4; Nitter T, 1998, J GEOPHYS RES-SPACE, V103, P6605, DOI 10.1029/97JA03523; SMITH BA, 1981, SCIENCE, V212, P163, DOI 10.1126/science.212.4491.163; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; Tokar RL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022690; Waite JH, 2005, SCIENCE, V307, P1260, DOI 10.1126/science.1105734	14	46	47	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2006	311	5767					1587	1589		10.1126/science.1123783	http://dx.doi.org/10.1126/science.1123783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022BK	16543455				2022-12-28	WOS:000236029500039
J	Lavier, LL; Manatschal, G				Lavier, LL; Manatschal, G			A mechanism to thin the continental lithosphere at magma-poor margins	NATURE			English	Article							RHEOLOGICAL EVOLUTION; UPPER-MANTLE; REGIMES; CREEP; FAULT; ALPS	Where continental plates break apart, slip along multiple normal faults provides the required space for the Earth's crust to thin and subside(1). After initial rifting, however, the displacement on normal faults observed at the sea floor seems not to match the inferred extension(2). Here we show that crustal thinning can be accomplished in such extensional environments by a system of conjugate concave downward faults instead of multiple normal faults. Our model predicts that these concave faults accumulate large amounts of extension and forma very thin crust (< 10 km) by exhumation of mid- crustal and mantle material. This transitional crust is capped by sub- horizontal detachment surfaces over distances exceeding 100 km with little visible deformation. Our rift model is based on numerical experiments constrained by geological and geophysical observations from the Alpine Tethys and Iberia/ Newfoundland margins(3-9). Furthermore, we suggest that the observed transition from broadly distributed and symmetric extension to localized and asymmetric rifting is directly controlled by the existence of a strong gabbroic lower crust. The presence of such lower crustal gabbros is well constrained for the Alpine Tethys system(4,9). Initial decoupling of upper crustal deformation from lower crustal and mantle deformation by progressive weakening of the middle crust is an essential requirement to reproduce the observed rift evolution. This is achieved in our models by the formation of weak ductile shear zones.	Univ Texas, Inst Geophys, Jackson Sch Geosci, Austin, TX 78759 USA; Univ Strasbourg, CGS EOST, F-67084 Strasbourg, France	University of Texas System; University of Texas Austin; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lavier, LL (corresponding author), Univ Texas, Inst Geophys, Jackson Sch Geosci, 8701 Mopac Blvd, Austin, TX 78759 USA.	luc@ig.utexas.edu	Lavier, Luc/G-6141-2010					BERTOTTI G, 1991, MEM SCI GEOL PADOVA, V43, P17; BOILLOT G, 1987, TECTONOPHYSICS, V132, P335, DOI 10.1016/0040-1951(87)90352-0; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; BRAUN J, 1987, CAN SOC PET GEOL MEM, V12, P241; Contrucci I, 2004, GEOPHYS J INT, V158, P529, DOI 10.1111/j.1365-246X.2004.02303.x; Decandia F.A., 1972, MEM SOC GEOL ITAL, V11, P503; Escartin J, 1997, EARTH PLANET SC LETT, V151, P181, DOI 10.1016/S0012-821X(97)81847-X; FRICKE HC, 1992, CONTRIB MINERAL PETR, V111, P203, DOI 10.1007/BF00348952; FROITZHEIM N, 1990, GEOL SOC AM BULL, V102, P1297, DOI 10.1130/0016-7606(1990)102<1297:EDFITE>2.3.CO;2; GILBERT LE, 1994, J GEOPHYS RES-SOL EA, V99, P23975, DOI 10.1029/94JB01558; GOETZE C, 1978, PHILOS T R SOC A, V288, P99, DOI 10.1098/rsta.1978.0008; HANDY MR, 1991, GEOL SOC AM BULL, V103, P236, DOI 10.1130/0016-7606(1991)103<0236:TTAREO>2.3.CO;2; HANDY MR, 1989, TECTONOPHYSICS, V163, P119, DOI 10.1016/0040-1951(89)90122-4; HIRTH G, 1992, J STRUCT GEOL, V14, P145, DOI 10.1016/0191-8141(92)90053-Y; Huismans RS, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002026; Ingebritsen SE, 1999, GEOLOGY, V27, P1107, DOI 10.1130/0091-7613(1999)027<1107:GIOAPD>2.3.CO;2; JORDAN P, 1988, GEOL RUNDSCH, V77, P285, DOI 10.1007/BF01848690; Karner GD, 2003, GEOL SOC SPEC PUBL, V207, P105, DOI 10.1144/GSL.SP.2003.207.6; Lavier LL, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000513; Manatschal G, 2004, INT J EARTH SCI, V93, P432, DOI 10.1007/s00531-004-0394-7; MCNUTT MK, 1988, J GEOPHYS RES-SOLID, V93, P8825, DOI 10.1029/JB093iB08p08825; Muntener O, 2000, J PETROL, V41, P175, DOI 10.1093/petrology/41.2.175; Perez-Gussinye M, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000901; POLIAKOV ANB, 1993, TECTONOPHYSICS, V228, P199, DOI 10.1016/0040-1951(93)90341-G; RESTON TJ, 1995, GEOL SOC LOND SPEC P, V90, P93; Rutter E.H., 1992, CONTINENTAL LOWER CR, P201; RUTTER EH, 1993, J STRUCT GEOL, V15, P647, DOI 10.1016/0191-8141(93)90153-2; Shelton G., 1981, EOS T AM GEOPHYS UN, V62, P396; TANKARD AJ, 1989, AM ASS PET GEOL MEM, V46, P265; Taylor B, 1999, J GEOPHYS RES-SOL EA, V104, P7497, DOI 10.1029/1998JB900115; VENINGMEINESZ FA, 1950, B I R COLONIAL BELGE, V21, P539; WHITE SH, 1980, J STRUCT GEOL, V2, P175, DOI 10.1016/0191-8141(80)90048-6; Whitmarsh RB, 2001, NATURE, V413, P150, DOI 10.1038/35093085	33	445	459	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2006	440	7082					324	328		10.1038/nature04608	http://dx.doi.org/10.1038/nature04608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021QG	16541070				2022-12-28	WOS:000235997600050
J	Sobel, RK				Sobel, RK			Becoming a physician: Does laughter make good medicine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Sobel, RK (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.								0	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2006	354	11					1114	1115		10.1056/NEJMp058089	http://dx.doi.org/10.1056/NEJMp058089			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	021KI	16540611				2022-12-28	WOS:000235981700004
